data_1xfn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xfn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.782 0.325 . . . . 4.68 110.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.7 150.95 17.28 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.909 -0.662 . . . . 0.96 112.51 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.44 104.92 3.68 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.031 -0.729 . . . . 1.26 109.031 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.489 ' HB ' HG11 ' A' ' 120' ' ' VAL . 21.7 mt -116.74 156.49 17.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.1 -0.5 . . . . 1.67 109.731 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 62.6 tt0 -121.81 111.73 17.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.391 -0.596 . . . . 1.02 109.391 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -112.32 148.96 33.1 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.655 -0.498 . . . . 2.24 109.655 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -104.44 168.07 9.33 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.119 -0.233 . . . . 1.22 110.373 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.04 -7.13 29.1 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.387 -0.369 . . . . 0.79 113.891 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -89.11 -45.62 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 1.95 109.811 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 134.45 12.61 1.38 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.61 112.307 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 149.88 22.65 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.64 110.178 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 17.7 mt -94.08 145.36 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.808 -0.633 . . . . 1.58 109.781 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.4 mm? -106.52 -68.4 0.88 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.556 0.694 . . . . 2.1 110.075 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -133.89 133.29 41.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.185 -0.916 . . . . 1.99 110.656 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.942 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.7 m-30 -94.59 -176.23 3.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.635 -0.711 . . . . 1.25 110.3 171.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -118.53 165.79 13.5 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.56 -0.904 . . . . 2.14 108.56 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -76.88 19.09 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 1.87 111.332 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.33 -49.07 6.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 2.02 110.279 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' HB ' ' A' ' 50' ' ' THR . 3.6 mm-40 -69.7 -29.12 66.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.472 0.653 . . . . 2.12 110.026 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -88.26 -5.83 75.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.691 -0.766 . . . . 1.42 112.33 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.6 t70 -83.1 -60.17 2.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.771 0.319 . . . . 2.35 110.683 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' H ' HG12 ' A' ' 49' ' ' ILE . 2.8 pt -94.54 -46.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.291 -0.413 . . . . 2.98 111.93 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -70.64 -54.64 11.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.175 0.512 . . . . 3.86 110.56 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.501 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 110.47 39.61 1.46 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.765 -0.731 . . . . 2.91 112.405 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 3.1 mpt_? -118.81 98.26 6.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.59 -0.522 . . . . 3.64 109.59 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.8 m-20 -64.08 152.86 86.77 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.536 . . . . 2.1 110.559 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.942 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 48.0 Cg_exo -58.01 -18.74 37.15 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.37 2.713 . . . . 1.68 113.765 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.7 4.68 26.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.82 0.304 . . . . 4.08 111.82 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.857 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 80.9 mm-40 -90.45 -9.33 47.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.731 0.301 . . . . 3.05 111.43 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.725 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.7 m -111.87 25.73 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.986 0.736 . . . . 1.26 112.986 -171.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -89.78 126.5 42.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.248 -0.581 . . . . 1.66 110.333 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.23 87.79 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.78 110.844 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 47.3 mttm -106.73 138.79 42.25 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.072 -0.564 . . . . 2.37 110.619 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 25.8 t-20 -80.04 114.33 18.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.039 -0.528 . . . . 0.83 109.8 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.617 ' HA ' HD13 ' A' ' 39' ' ' ILE . 69.5 t80 -56.14 -43.34 78.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.961 -0.563 . . . . 0.7 111.416 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 39.6 m-85 -80.77 -6.25 58.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.457 -0.792 . . . . 1.45 112.329 -166.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.65 -45.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.448 0.536 . . . . 4.07 112.448 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.44 -23.56 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.314 -0.555 . . . . 2.2 111.833 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.93 14.01 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.116 -0.633 . . . . 2.34 110.998 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.29 74.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.904 -0.589 . . . . 1.2 110.543 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.88 13.64 1.43 Allowed 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.939 2.426 . . . . 0.98 113.698 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -97.12 -5.75 36.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.267 -0.573 . . . . 1.41 110.256 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 55.1 p -100.5 -28.87 12.68 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.61 -0.723 . . . . 1.74 111.653 -159.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.705 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 10.1 p-10 -75.29 78.49 2.39 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.591 1.186 . . . . 1.85 111.105 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.784 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 66.7 m -152.65 169.42 9.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 114.592 -1.185 . . . . 1.85 108.776 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.784 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 29.3 Cg_endo -61.99 -14.57 38.01 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.007 2.471 . . . . 1.4 114.926 -171.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.41 -34.29 13.51 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.901 -0.5 . . . . 2.56 111.554 -175.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 69.0 t80 -106.29 -69.43 0.83 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 4.11 110.459 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 63.8 t80 -60.62 -41.14 94.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 1.24 110.727 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -56.86 -49.15 73.03 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.6 112.383 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -67.48 -37.15 82.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 2.58 110.558 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.78 -40.75 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.614 . . . . 0.79 110.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -78.33 -18.59 54.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 1.63 112.229 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 35.1 mt-10 -66.12 -39.79 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.417 . . . . 2.07 110.939 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD11 ' A' ' 88' ' ' LEU . . . -69.71 -42.1 72.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.364 -0.922 . . . . 0.72 111.436 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 t -57.31 -51.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.38 . . . . 1.4 110.67 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -26.83 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.774 -0.648 . . . . 1.48 111.707 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -83.94 -77.94 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 2.15 110.172 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.87 -68.48 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.235 -0.746 . . . . 1.77 111.235 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -107.34 153.38 22.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 3.83 109.506 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 62.3 tp -118.19 126.41 52.14 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.932 -0.396 . . . . 3.54 109.932 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -166.15 94.12 0.54 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.939 0.876 . . . . 2.47 109.774 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.539 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 4.4 m -139.52 153.71 47.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.801 -1.09 . . . . 2.01 109.769 -174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 61.1 ttp -137.5 108.94 6.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.153 -0.314 . . . . 2.22 110.153 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.76 ' HE2' ' HE3' ' A' ' 109' ' ' MET . 47.1 p90 -123.76 167.29 14.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.472 -0.331 . . . . 3.82 110.76 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -102.68 132.79 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.622 -0.511 . . . . 2.39 109.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -144.21 150.84 38.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.531 . . . . 3.62 110.647 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 m -104.83 141.35 36.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.353 -0.385 . . . . 1.97 110.806 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.447 ' CE2' HG21 ' A' ' 105' ' ' VAL . 18.6 m-85 -104.63 120.81 42.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 1.47 109.832 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 99' ' ' GLN . 4.0 p30 -143.66 -156.93 0.73 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.639 -0.71 . . . . 2.57 109.527 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 58.1 t80 73.52 -24.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.152 0.581 . . . . 3.46 111.745 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.473 ' H ' ' C ' ' A' ' 97' ' ' ASP . 10.6 pt20 -158.74 -38.02 0.06 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.337 -0.616 . . . . 3.41 109.337 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 101' ' ' THR . 54.3 tpp -78.71 143.67 36.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.849 -0.797 . . . . 3.33 108.849 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 100' ' ' MET . 12.1 p -67.52 151.4 97.2 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 108.407 -0.96 . . . . 2.56 108.407 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.59 87.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.994 2.462 . . . . 1.72 113.864 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.672 HG23 ' HE ' ' A' ' 124' ' ' ARG . 85.8 m -100.78 129.89 46.73 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.457 -0.792 . . . . 1.93 110.422 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.34 114.76 29.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.48 -0.563 . . . . 3.47 109.48 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.3 m -126.95 165.88 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.784 -0.644 . . . . 1.96 111.151 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -115.19 128.09 55.95 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.499 -0.926 . . . . 2.22 108.499 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 91' ' ' MET . 98.9 t -104.51 104.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.459 -0.791 . . . . 1.97 109.201 -171.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.64 104.42 14.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.177 -0.675 . . . . 1.37 109.177 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.76 ' HE3' ' HE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -103.93 143.79 32.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.486 -0.779 . . . . 2.95 109.845 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.9 ptmt -154.31 154.24 33.04 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.466 -0.568 . . . . 2.05 109.466 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.716 ' HZ3' ' HB3' ' A' ' 111' ' ' LYS . 3.6 ttpm? -78.6 140.52 38.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.846 0.355 . . . . 2.66 111.557 -171.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -113.25 169.08 9.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.982 -0.554 . . . . 1.57 110.359 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 -6.2 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.524 -0.307 . . . . 4.89 111.525 177.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 p -61.49 -39.53 91.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.02 0.914 . . . . 2.9 109.167 170.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.02 22.21 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 108.749 -1.741 . . . . 2.62 108.749 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.27 89.8 0.06 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.474 0.637 . . . . 2.76 110.062 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 11.8 p -177.13 -170.02 0.27 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.521 -0.763 . . . . 1.61 110.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 15.9 m-85 -129.0 158.46 38.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.631 -0.877 . . . . 1.4 108.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 77.8 m95 -102.59 109.25 20.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.957 -0.757 . . . . 0.75 108.957 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 31' ' ' ILE . 7.4 p -102.5 120.85 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.887 0.851 . . . . 1.6 110.597 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.514 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 97.6 m-85 -103.61 136.53 43.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.467 -0.788 . . . . 0.97 110.992 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.48 107.76 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.078 -0.965 . . . . 1.83 110.026 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -103.65 104.42 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 3.79 110.182 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.672 ' HE ' HG23 ' A' ' 103' ' ' THR . 34.3 ttt-85 -83.55 126.9 33.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.035 -0.357 . . . . 4.65 110.035 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.125 -0.941 . . . . 2.87 111.443 -179.476 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.0 p90 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 110.044 -0.354 . . . . 4.68 110.044 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.8 118.58 6.14 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.554 -0.832 . . . . 0.96 111.354 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.89 106.63 17.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.878 0.37 . . . . 1.26 110.481 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.716 ' HB ' HG12 ' A' ' 120' ' ' VAL . 20.7 mt -111.66 147.78 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.344 -0.613 . . . . 1.67 109.344 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -118.38 116.24 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.576 -0.528 . . . . 1.02 109.576 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 19.0 mt -115.71 154.12 30.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 110.276 -0.268 . . . . 2.24 110.276 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.718 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.2 p30 -112.03 167.4 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.497 -0.186 . . . . 1.22 110.497 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -19.11 50.55 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.507 0.563 . . . . 0.79 114.507 -171.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 38.7 t70 -81.38 -14.85 56.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.367 0.603 . . . . 1.95 109.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 104.53 7.82 38.91 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.502 -0.772 . . . . 0.61 112.009 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.718 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 40.1 m-80 -82.62 154.34 24.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.143 0.497 . . . . 1.64 110.483 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.749 HG23 ' HE2' ' A' ' 42' ' ' TYR . 9.1 mt -102.09 158.19 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.258 -0.883 . . . . 1.58 108.767 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.0 mp -116.77 -68.35 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.635 0.731 . . . . 2.1 109.754 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.5 151.7 40.6 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.585 -174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.749 ' HE2' HG23 ' A' ' 39' ' ' ILE . 2.7 m-85 -109.94 179.04 4.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.636 -1.166 . . . . 1.25 109.116 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -109.74 163.75 13.21 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.874 -0.787 . . . . 2.14 108.874 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.26 -7.12 44.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 1.87 111.842 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.74 -23.77 33.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.458 -0.337 . . . . 2.02 111.378 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.02 -53.14 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.268 -0.642 . . . . 2.12 109.268 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.591 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -55.76 -24.75 41.95 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.639 -0.71 . . . . 1.42 112.672 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.36 -33.36 75.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.842 0.353 . . . . 2.35 110.918 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -96.07 -69.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 2.98 110.916 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.8 m -84.29 -60.43 2.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.727 0.299 . . . . 3.86 110.281 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.591 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 119.39 40.51 0.62 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.091 -1.052 . . . . 2.91 113.121 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -92.88 119.44 32.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.165 -0.68 . . . . 3.64 109.165 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 19.6 m-20 -65.86 139.04 96.67 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 2.1 112.503 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 17.8 Cg_exo -66.98 121.56 8.77 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.691 2.261 . . . . 1.68 111.796 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 68.7 mttm 83.96 7.17 0.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.028 0.83 . . . . 4.08 112.604 171.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' HG3' HG11 ' A' ' 57' ' ' VAL . 2.6 pt20 -84.01 -16.96 42.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.909 0.862 . . . . 3.05 109.209 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.959 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.8 m -97.0 24.97 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.523 -1.217 . . . . 1.26 112.789 -170.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.41 125.71 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.732 -0.469 . . . . 1.66 109.732 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.95 5.77 88.82 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.227 -0.987 . . . . 0.78 111.102 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.959 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 39.8 mttm -98.46 139.43 34.21 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.388 . . . . 2.37 110.234 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 22.2 t-20 -86.25 111.96 20.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.761 -0.459 . . . . 0.83 109.761 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 39' ' ' ILE . 80.9 t80 -57.72 -32.63 67.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.7 111.585 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.471 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 30.0 m-85 -86.42 1.22 52.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.9 -0.591 . . . . 1.45 111.365 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -136.3 -62.55 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.327 0.492 . . . . 4.07 112.327 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.82 -24.06 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.375 0.509 . . . . 2.2 112.375 -164.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.83 13.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.215 0.45 . . . . 2.34 112.215 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.97 88.18 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.573 0.546 . . . . 1.2 110.637 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.09 29.9 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.581 2.187 . . . . 0.98 113.066 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.0 m -79.06 -30.61 44.12 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.983 -1.118 . . . . 1.41 107.983 167.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 6.8 m -96.99 -25.15 15.49 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.57 -2.105 . . . . 1.74 108.553 -119.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 11.0 p-10 -74.22 104.23 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.093 -0.958 . . . . 1.85 109.105 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' ' 76' ' ' TYR . 48.7 m -160.29 151.65 16.17 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.283 -0.871 . . . . 1.85 109.624 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.85 -31.01 87.53 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.95 2.433 . . . . 1.4 112.803 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.98 -2.36 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.343 0.497 . . . . 2.56 112.343 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -134.73 -74.33 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.888 -0.325 . . . . 4.11 110.537 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 85.8 t80 -57.54 -35.86 70.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.962 0.41 . . . . 1.24 110.171 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 81' ' ' GLU . . . -57.67 -45.69 93.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.743 -0.662 . . . . 0.6 112.048 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 72.5 mmtt -75.9 -38.68 57.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.669 0.235 . . . . 2.58 111.096 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.797 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 66.4 t80 -56.06 -40.13 73.08 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.554 0.692 . . . . 0.79 110.477 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -88.53 -16.66 32.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.292 -0.867 . . . . 1.63 111.034 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 29.3 tt0 -70.25 -35.64 73.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.154 -0.476 . . . . 2.07 110.563 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.739 ' HA3' HD11 ' A' ' 88' ' ' LEU . . . -76.37 -40.33 28.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.549 -0.834 . . . . 0.72 111.513 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.819 HG21 ' HH ' ' A' ' 118' ' ' TYR . 20.6 t -54.49 -50.35 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.832 0.349 . . . . 1.4 110.36 174.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.15 73.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.506 -0.77 . . . . 1.48 111.988 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 p -90.74 -72.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 2.15 110.959 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.75 -56.54 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.431 -0.89 . . . . 1.77 113.497 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -122.1 149.62 43.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.379 0.609 . . . . 3.83 112.055 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.739 HD11 ' HA3' ' A' ' 82' ' ' GLY . 3.9 mm? -112.8 107.61 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.108 -0.951 . . . . 3.54 109.581 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.2 p30 -169.68 110.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.989 0.9 . . . . 2.47 111.796 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.822 HG22 ' HE2' ' A' ' 109' ' ' MET . 13.8 t -166.05 158.62 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.777 -1.101 . . . . 2.01 109.413 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -127.77 119.97 26.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.127 0.489 . . . . 2.22 109.701 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.65 165.84 24.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.527 -0.545 . . . . 3.82 109.527 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 51.1 mt-10 -104.32 115.2 29.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.06 0.457 . . . . 2.39 110.423 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -118.33 152.74 35.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 3.62 109.825 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -104.01 132.09 50.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 1.97 110.594 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -113.54 119.63 38.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.671 -0.492 . . . . 1.47 109.671 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -123.2 -147.05 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 2.57 109.629 -175.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 65.87 -85.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.044 0.537 . . . . 3.46 111.514 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.68 -51.17 20.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.45 0.643 . . . . 3.41 109.509 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.629 ' HE2' ' HB ' ' A' ' 103' ' ' THR . 47.5 ttp -93.27 130.41 39.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.338 -0.846 . . . . 3.33 109.783 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 m -52.85 117.55 11.36 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.766 -0.457 . . . . 2.56 109.766 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -20.25 92.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.552 4.168 . . . . 1.72 114.725 -169.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.629 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 25.5 m -105.52 144.45 32.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 1.93 111.184 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -103.32 117.66 35.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 3.47 110.421 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 124' ' ' ARG . 29.5 m -127.97 165.06 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.991 0.425 . . . . 1.96 111.001 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HE2' HG11 ' A' ' 125' ' ' VAL . 18.5 ttmm -104.92 129.58 53.27 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.662 -1.236 . . . . 2.22 107.662 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 121' ' ' PHE . 7.6 p -113.69 128.92 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.578 0.704 . . . . 1.97 110.096 -175.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -105.13 115.2 29.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.276 -0.875 . . . . 1.37 109.078 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.822 ' HE2' HG22 ' A' ' 90' ' ' THR . 37.0 ttp -102.99 127.22 50.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.461 -0.94 . . . . 2.95 108.461 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.8 ptmt -154.5 141.39 19.18 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.135 -0.32 . . . . 2.05 110.135 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' LEU . 31.3 ttmt -84.46 136.77 33.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.122 0.487 . . . . 2.66 111.367 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . . . -112.65 165.84 11.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.718 -0.845 . . . . 1.57 108.718 169.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.94 29.99 6.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.59 . . . . 4.89 111.139 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -76.51 79.84 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.625 -1.25 . . . . 2.9 107.625 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.31 -88.37 0.33 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.121 -1.192 . . . . 2.62 110.121 -167.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.7 83.9 0.46 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.217 -1.031 . . . . 2.76 108.217 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 p -146.42 152.27 38.77 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.683 -0.689 . . . . 1.61 109.394 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.819 ' HH ' HG21 ' A' ' 83' ' ' VAL . 1.7 m-85 -115.95 158.39 23.12 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.27 -0.641 . . . . 1.4 109.27 -170.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 83.6 m95 -101.59 110.09 22.02 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.963 -0.754 . . . . 0.75 108.963 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -102.73 110.52 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 122.029 0.918 . . . . 1.6 110.041 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.722 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 94.0 m-85 -103.93 127.91 51.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.4 -0.818 . . . . 0.97 111.17 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.28 104.8 17.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.787 0.803 . . . . 1.83 111.072 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -118.99 119.73 35.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.432 -0.803 . . . . 3.79 109.919 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HA ' HG11 ' A' ' 105' ' ' VAL . 79.3 ttt180 -68.88 135.72 51.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.987 0.423 . . . . 4.65 110.696 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.583 HG11 ' HE2' ' A' ' 106' ' ' LYS . 2.6 m . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.262 -0.875 . . . . 2.87 110.776 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 113.38 0.881 . . . . 4.68 113.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 43' ' ' ASN . . . -101.24 104.39 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.472 -0.87 . . . . 0.96 112.717 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.61 109.15 18.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.261 -0.469 . . . . 1.26 109.819 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 32' ' ' GLN . 18.9 mt -105.26 153.93 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.134 -0.691 . . . . 1.67 109.134 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.8 tt0 -113.57 110.1 19.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.686 -0.486 . . . . 1.02 109.686 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 34.9 mt -111.98 150.36 30.68 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 109.45 -0.574 . . . . 2.24 109.45 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 47.4 p30 -103.06 169.17 8.72 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.658 -0.417 . . . . 1.22 110.519 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.76 -14.67 16.34 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.357 -0.383 . . . . 0.79 113.922 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.65 -28.74 23.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.95 110.037 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.43 8.22 14.88 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.562 -0.744 . . . . 0.61 111.443 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 90.1 m-20 -76.98 149.1 35.96 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.977 0.417 . . . . 1.64 110.744 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.72 HG22 ' CE2' ' A' ' 42' ' ' TYR . 10.4 mt -92.87 153.68 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.132 -0.692 . . . . 1.58 109.132 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' O ' HG12 ' A' ' 58' ' ' ILE . 39.7 mt -122.67 -71.94 0.71 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.449 . . . . 2.1 110.189 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -125.71 136.36 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.399 0.619 . . . . 1.99 111.119 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.966 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -93.86 -176.0 3.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.936 -1.029 . . . . 1.25 111.005 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' CG ' ' HA2' ' A' ' 29' ' ' GLY . 7.8 p30 -125.05 -167.93 1.75 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.929 -1.032 . . . . 2.14 109.764 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.32 -28.35 53.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.158 0.429 . . . . 1.87 112.158 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.78 75.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 2.02 111.52 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -34.81 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.623 -0.262 . . . . 2.12 110.634 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 52' ' ' ARG . . . -61.6 -21.35 60.34 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 121.205 -0.521 . . . . 1.42 112.828 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -71.57 -28.61 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 2.35 110.436 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -91.68 81.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.733 0.778 . . . . 2.98 109.734 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 50' ' ' THR . 5.8 t -11.22 105.78 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 112.716 -2.038 . . . . 3.86 114.363 174.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.88 22.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.231 -1.349 . . . . 2.91 112.32 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HG3' ' HE1' ' A' ' 42' ' ' TYR . 6.5 mpt_? -115.16 94.8 4.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.788 0.327 . . . . 3.64 110.878 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 16.5 m-20 -88.35 148.06 41.56 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.173 -0.467 . . . . 2.1 110.442 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.966 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 40.0 Cg_exo -58.06 -34.93 99.0 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.112 2.541 . . . . 1.68 113.653 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -131.61 19.61 4.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.75 0.648 . . . . 4.08 112.75 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.627 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.19 8.57 44.27 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.454 -0.498 . . . . 3.05 110.929 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -121.19 29.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 1.26 111.863 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 40' ' ' LEU . 22.7 mt -81.35 134.28 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.635 -0.426 . . . . 1.66 110.51 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.6 29.61 74.18 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.22 -0.752 . . . . 0.78 111.22 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 39' ' ' ILE . 3.7 mtmm -126.6 125.51 42.07 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.161 -0.52 . . . . 2.37 109.76 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 38' ' ' ASN . 10.1 t-20 -73.65 114.26 11.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.874 -0.603 . . . . 0.83 111.219 -170.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.535 ' HB2' HG12 ' A' ' 39' ' ' ILE . 90.6 t80 -56.47 -48.61 76.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.485 -0.78 . . . . 0.7 111.146 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -79.94 5.25 14.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.011 -0.541 . . . . 1.45 112.111 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -137.54 -53.16 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.028 0.381 . . . . 4.07 112.028 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -96.42 -24.13 16.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.441 0.534 . . . . 2.2 112.441 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.1 t -116.07 14.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 120.12 -0.632 . . . . 2.34 110.933 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.46 87.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.055 -0.52 . . . . 1.2 110.342 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.45 -4.75 15.9 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.589 2.193 . . . . 0.98 113.683 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -80.04 -13.62 59.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.227 -0.589 . . . . 1.41 109.653 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -101.72 -4.23 26.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.821 -1.082 . . . . 1.74 110.827 -157.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.07 95.63 6.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.918 -0.401 . . . . 1.85 109.918 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.775 ' HB2' ' HD1' ' A' ' 75' ' ' PHE . 66.8 m -166.33 155.28 10.1 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.035 -0.728 . . . . 1.85 109.035 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.43 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 31.0 Cg_endo -64.51 -20.87 66.22 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.456 2.104 . . . . 1.4 112.04 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.579 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -91.79 -15.51 28.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 2.56 111.5 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.775 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 87.7 m-85 -106.75 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.287 0.565 . . . . 4.11 109.72 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.517 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 41.1 t80 -63.53 -37.4 87.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.3 -0.864 . . . . 1.24 110.321 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -62.78 -27.37 69.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.108 -0.568 . . . . 0.6 112.483 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 68.1 mmtt -80.35 -29.52 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.751 0.31 . . . . 2.58 110.555 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 64.7 t80 -68.43 -35.66 77.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.848 -0.797 . . . . 0.79 108.848 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -82.94 -3.82 57.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.63 111.239 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -53.68 -46.96 70.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.778 0.323 . . . . 2.07 111.464 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.705 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -85.12 -42.84 6.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.086 -1.054 . . . . 0.72 111.711 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 118' ' ' TYR . 21.5 t -44.3 -49.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.667 0.787 . . . . 1.4 112.031 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -42.42 38.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.862 0.465 . . . . 1.48 111.953 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -77.46 -61.91 1.83 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.386 0.612 . . . . 2.15 109.524 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.05 -54.16 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.503 -1.039 . . . . 1.77 110.503 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 137.21 2.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.286 -0.957 . . . . 3.83 109.289 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.705 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 63.1 tp -165.89 125.18 1.65 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.868 -0.333 . . . . 3.54 111.514 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.56 131.56 44.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 2.47 110.514 173.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.531 HG23 ' HE1' ' A' ' 109' ' ' MET . 12.4 t -141.66 155.35 45.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.551 -0.75 . . . . 2.01 109.888 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.4 ttp -130.27 119.35 22.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.83 -0.623 . . . . 2.22 110.512 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -130.72 155.01 47.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.085 -0.709 . . . . 3.82 109.085 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 136.41 54.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.073 0.463 . . . . 2.39 111.007 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.853 ' HD1' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -162.16 168.86 21.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.056 -0.52 . . . . 3.62 110.418 -175.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.853 ' H ' ' HD1' ' A' ' 94' ' ' TYR . 25.6 m -102.53 143.29 32.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.97 111.237 -173.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 105' ' ' VAL . 17.4 m-85 -107.35 112.31 25.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.745 -0.835 . . . . 1.47 108.745 173.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.76 14.12 13.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.294 0.479 . . . . 2.57 112.294 -171.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.549 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 85.4 t80 -119.34 131.61 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.622 -0.51 . . . . 3.46 109.622 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.549 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 21.6 mm-40 75.51 -43.25 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.65 0.78 . . . . 3.41 110.477 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 tpt -105.88 142.03 36.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.505 -0.924 . . . . 3.33 108.505 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -62.96 141.04 97.61 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.868 -1.16 . . . . 2.56 107.868 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 51.0 Cg_exo -36.5 91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.78 2.987 . . . . 1.72 114.703 -173.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 t -108.9 146.57 33.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.903 -0.589 . . . . 1.93 109.747 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -106.51 125.02 50.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.148 0.499 . . . . 3.47 111.182 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 29.6 m -121.17 166.19 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 1.96 111.079 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 36.2 ttpt -118.64 121.47 40.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.312 -0.996 . . . . 2.22 108.312 174.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.6 103.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.905 -0.589 . . . . 1.97 109.499 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -105.55 102.13 11.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.673 -0.862 . . . . 1.37 108.673 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.653 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.44 149.81 25.83 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.863 -0.335 . . . . 2.95 110.356 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HZ1' ' HB3' ' A' ' 110' ' ' LYS . 8.8 mtpm? -146.62 147.19 30.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.203 -0.666 . . . . 2.05 109.203 -175.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 111' ' ' LYS . 1.2 tmmt? -87.18 137.48 32.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.266 0.555 . . . . 2.66 111.154 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.33 -176.12 4.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.027 -1.101 . . . . 1.57 108.027 171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.11 -93.94 0.14 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.84 -0.8 . . . . 4.89 108.84 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.6 p 42.89 38.96 1.55 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.231 0.826 . . . . 2.9 113.231 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.57 15.64 20.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.614 -0.803 . . . . 2.62 113.032 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 63.94 87.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.049 0.54 . . . . 2.76 110.507 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 p -173.74 -176.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 1.61 110.726 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.532 ' CZ ' HG21 ' A' ' 83' ' ' VAL . 42.0 m-85 -121.05 147.59 45.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.996 -0.742 . . . . 1.4 108.996 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -102.59 104.2 14.56 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.575 -0.898 . . . . 0.75 108.575 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 109' ' ' MET . 7.3 p -100.52 132.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.976 -1.011 . . . . 1.6 111.417 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.84 113.88 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.406 -0.815 . . . . 0.97 109.847 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -113.09 104.52 17.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 1.83 110.31 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 159.39 42.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.388 -0.597 . . . . 3.79 109.388 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 29.9 mtm180 -69.54 105.32 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.863 0.363 . . . . 4.65 111.107 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 106' ' ' LYS . 11.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.879 -1.055 . . . . 2.87 111.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.664 -0.495 . . . . 4.68 109.664 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.69 119.74 6.46 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.464 -0.874 . . . . 0.96 111.845 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.65 103.63 13.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.119 0.485 . . . . 1.26 110.093 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.747 ' HB ' HG12 ' A' ' 120' ' ' VAL . 31.5 mt -108.2 159.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.203 -1.036 . . . . 1.67 108.203 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.593 HE22 ' HB2' ' A' ' 113' ' ' LEU . 45.3 tt0 -133.42 134.16 43.28 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.618 -0.433 . . . . 1.02 110.317 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.93 161.89 38.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.977 -0.556 . . . . 2.24 110.536 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.656 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.5 p30 -103.93 169.09 8.71 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.062 -0.255 . . . . 1.22 110.741 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.65 -27.54 27.54 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 115.323 0.889 . . . . 0.79 115.323 -170.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.96 -10.39 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.818 0.809 . . . . 1.95 111.263 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.41 2.19 21.48 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.359 -0.924 . . . . 0.61 113.611 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.656 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 91.1 m-20 -71.06 126.7 30.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.191 0.496 . . . . 1.64 110.443 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.63 HG23 ' HE2' ' A' ' 42' ' ' TYR . 17.2 mt -84.06 150.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.446 . . . . 1.58 109.97 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 40' ' ' LEU . 6.9 mp -110.03 -54.22 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.249 0.547 . . . . 2.1 109.942 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -166.22 149.14 7.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.215 -0.902 . . . . 1.99 110.785 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.797 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 8.9 m-30 -98.4 -176.89 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.241 -0.891 . . . . 1.25 110.641 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -112.37 163.99 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.494 -0.928 . . . . 2.14 108.494 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.62 -27.6 17.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.87 111.474 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.494 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -46.14 -54.14 9.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.152 -0.931 . . . . 2.02 112.51 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -75.25 -29.92 60.35 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.961 0.41 . . . . 2.12 110.922 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 -22.6 68.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.849 -0.691 . . . . 1.42 111.635 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -87.81 -35.07 18.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.607 0.241 . . . . 2.35 110.69 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 45' ' ' ALA . 45.9 mm -53.04 -54.03 19.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.142 0.496 . . . . 2.98 110.249 176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 t -140.08 -41.38 0.43 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 3.86 111.041 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.408 -0.901 . . . . 2.91 111.734 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -113.78 99.53 7.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.002 -0.74 . . . . 3.64 109.002 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.648 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 18.9 t70 -54.8 127.62 61.38 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.481 0.488 . . . . 2.1 110.728 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.797 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 41.7 Cg_exo -59.16 -17.64 39.92 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.583 2.855 . . . . 1.68 113.855 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -94.73 -1.83 52.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.758 0.313 . . . . 4.08 111.025 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.648 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 54.7 mm-40 -102.64 5.24 39.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.12 0.486 . . . . 3.05 110.588 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.582 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.4 m -117.27 14.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.566 . . . . 1.26 111.654 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 40.0 mt -80.26 125.73 39.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.406 -0.517 . . . . 1.66 110.407 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.3 10.52 78.81 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.843 -0.903 . . . . 0.78 110.843 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.861 ' HD3' ' HB ' ' A' ' 66' ' ' VAL . 23.3 ttmt -104.88 135.72 45.72 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.64 -0.504 . . . . 2.37 109.64 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -83.49 117.74 23.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.234 -0.439 . . . . 0.83 111.491 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.494 ' HB2' HG12 ' A' ' 39' ' ' ILE . 57.8 t80 -72.11 0.63 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.799 -0.637 . . . . 0.7 111.669 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.631 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 82.0 m-85 -116.74 -9.76 11.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.081 -0.387 . . . . 1.45 111.222 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.3 -38.47 0.76 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.73 0.641 . . . . 4.07 112.73 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.424 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 22.8 m-20 -90.43 -87.56 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.928 0.344 . . . . 2.2 111.928 -174.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.861 ' HB ' ' HD3' ' A' ' 60' ' ' LYS . 6.4 p -83.16 14.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.992 0.901 . . . . 2.34 111.616 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.77 86.23 0.46 Allowed Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.155 -0.929 . . . . 1.2 110.486 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -90.8 4.38 4.39 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.365 2.044 . . . . 0.98 113.597 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 11.4 p -84.65 -15.62 44.79 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 120.494 -0.483 . . . . 1.41 110.152 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.631 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 6.8 p -87.46 -39.68 15.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.215 -1.357 . . . . 1.74 111.048 -160.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -51.89 108.54 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.966 -0.561 . . . . 1.85 110.784 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -161.74 149.63 12.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.85 109.902 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.13 -26.25 82.29 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.379 2.053 . . . . 1.4 111.409 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 13.9 pt-20 -96.91 1.29 50.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.851 -0.613 . . . . 2.56 111.912 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' HD2' ' HE1' ' A' ' 92' ' ' PHE . 67.0 t80 -127.3 -70.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 4.11 109.597 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.596 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 64.4 t80 -61.41 -38.39 86.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 1.24 110.002 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.66 -34.98 91.41 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.054 -0.593 . . . . 0.6 112.674 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HD2' ' O ' ' A' ' 74' ' ' GLU . 92.7 mttt -80.46 -31.18 37.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.311 0.577 . . . . 2.58 110.093 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.775 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 72.8 t80 -61.27 -32.22 72.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.79 110.377 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 13.2 mmmm -95.75 -5.48 41.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 1.63 110.879 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -59.96 -52.93 63.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 2.07 110.738 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -72.85 -27.9 68.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.57 -0.824 . . . . 0.72 112.245 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.34 -54.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 1.4 110.794 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.6 70.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.576 . . . . 1.48 110.566 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.0 m -74.04 -86.05 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.7 -0.682 . . . . 2.15 110.05 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.4 -64.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.971 -0.852 . . . . 1.77 110.971 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -92.37 132.72 36.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.801 -0.7 . . . . 3.83 110.182 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.1 tm? -110.26 105.5 14.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.943 -0.762 . . . . 3.54 108.943 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' MET . 22.7 p-10 -164.41 58.03 0.15 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.625 0.726 . . . . 2.47 110.665 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -104.47 155.4 18.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.443 -0.799 . . . . 2.01 110.499 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -128.96 124.15 34.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.611 -0.722 . . . . 2.22 110.024 177.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.52 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 50.5 p90 -144.23 168.1 20.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.507 -0.315 . . . . 3.82 110.967 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -103.3 133.04 49.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.053 -0.521 . . . . 2.39 110.087 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -149.44 166.48 28.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.026 -0.731 . . . . 3.62 109.026 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -104.91 159.23 15.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.858 0.688 . . . . 1.97 112.858 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -111.26 120.6 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.219 -0.66 . . . . 1.47 109.219 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 21.5 t70 -133.92 -152.46 0.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.798 -0.816 . . . . 2.57 108.798 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.531 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 40.4 t80 71.41 -68.1 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.956 0.503 . . . . 3.46 111.753 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.439 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 2.5 pp0? -112.24 -4.43 14.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.137 0.494 . . . . 3.41 110.755 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.6 tpp -126.92 143.8 51.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.723 -0.671 . . . . 3.33 110.372 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -54.69 128.37 62.09 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.199 -1.037 . . . . 2.56 108.199 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.1 90.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.547 2.831 . . . . 1.72 113.168 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.5 158.1 16.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.174 -0.921 . . . . 1.93 110.701 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.934 ' HE2' ' HB ' ' A' ' 125' ' ' VAL . 18.1 ptmt -106.25 127.56 53.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 3.47 111.387 -175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.769 HG21 HG12 ' A' ' 122' ' ' VAL . 11.5 p -125.0 151.99 31.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.591 -0.731 . . . . 1.96 110.353 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' N ' HG23 ' A' ' 105' ' ' VAL . 82.8 tttt -110.21 119.39 39.12 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.417 -0.957 . . . . 2.22 108.417 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.9 p -112.34 129.74 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.453 0.644 . . . . 1.97 111.241 -171.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -112.71 104.59 12.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.005 -1.109 . . . . 1.37 108.005 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.775 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 9.7 ptp -103.41 129.31 50.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.273 -0.421 . . . . 2.95 110.628 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 59.6 mtpt -138.72 126.16 21.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.484 0.659 . . . . 2.05 112.651 -168.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.832 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 25.3 tttp -70.36 114.63 8.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.51 1.124 . . . . 2.66 111.498 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -177.8 93.67 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.535 0.939 . . . . 1.57 113.535 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.711 ' HB3' ' HG ' ' A' ' 117' ' ' SER . 28.7 tp 177.68 86.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.433 0.531 . . . . 4.89 112.433 165.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 m 41.68 38.78 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.598 1.186 . . . . 2.9 112.292 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.77 -123.96 1.23 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.931 -1.128 . . . . 2.62 112.012 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.02 35.29 1.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.76 111.059 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.711 ' HG ' ' HB3' ' A' ' 113' ' ' LEU . 1.5 p -100.36 135.33 41.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.95 -0.568 . . . . 1.61 109.744 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.595 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 2.0 m-85 -109.37 161.33 15.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.775 -0.454 . . . . 1.4 109.775 -169.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' MET . 88.9 m95 -100.92 114.72 28.86 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.689 -0.856 . . . . 0.75 108.689 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.747 HG12 ' HB ' ' A' ' 31' ' ' ILE . 7.3 p -100.2 115.34 41.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.128 0.966 . . . . 1.6 110.207 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.91 123.38 46.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.246 -0.888 . . . . 0.97 111.146 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.769 HG12 HG21 ' A' ' 105' ' ' VAL . 66.3 t -104.7 105.62 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.122 -0.945 . . . . 1.83 110.99 -176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -131.58 131.04 42.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.849 0.357 . . . . 3.79 110.249 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HD2' ' C ' ' A' ' 124' ' ' ARG . 7.4 ppt_? -72.88 157.41 37.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 4.65 111.661 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.934 ' HB ' ' HE2' ' A' ' 104' ' ' LYS . 25.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.67 -0.681 . . . . 2.87 109.166 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.619 0.247 . . . . 4.68 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -103.68 132.82 11.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.59 -0.814 . . . . 0.96 111.497 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.926 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -132.04 134.03 45.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.635 -0.506 . . . . 1.26 109.635 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 120' ' ' VAL . 4.8 mp -128.01 144.43 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.982 -0.553 . . . . 1.67 109.775 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.841 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 40.4 tt0 -104.51 118.66 37.14 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.94 -1.133 . . . . 1.02 107.94 170.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -130.1 150.14 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.43 -0.508 . . . . 2.24 110.662 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -103.43 168.39 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.862 -0.421 . . . . 1.22 109.862 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.39 -29.05 22.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.381 0.512 . . . . 0.79 114.381 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -75.2 -21.14 58.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.275 0.537 . . . . 1.95 111.324 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.14 4.44 38.43 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.898 -0.668 . . . . 0.61 111.916 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.8 m-20 -77.23 141.18 40.15 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.978 -0.378 . . . . 1.64 109.978 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.5 mt -88.75 144.77 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.263 0.554 . . . . 1.58 110.381 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.841 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -99.89 -59.29 1.74 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.264 -0.88 . . . . 2.1 110.227 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -165.13 153.06 11.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.757 -1.11 . . . . 1.99 110.027 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 1.012 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 4.7 m-30 -97.46 156.63 16.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 1.25 110.367 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.926 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 64.0 t30 -74.76 10.73 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.919 -0.582 . . . . 2.14 111.104 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 42' ' ' TYR . . . 75.72 -42.34 0.46 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.896 -1.047 . . . . 1.87 112.213 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -56.87 -24.78 54.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.555 0.576 . . . . 2.02 112.555 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.75 -18.68 64.26 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.18 0.514 . . . . 2.12 110.944 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.59 -7.6 78.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.613 -0.803 . . . . 1.42 111.861 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.57 -46.87 5.57 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 2.35 109.204 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 45' ' ' ALA . 30.8 mm -66.34 -67.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.419 -0.81 . . . . 2.98 110.714 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 m -92.71 -56.97 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.479 -0.328 . . . . 3.86 110.984 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.72 42.12 0.25 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.683 -0.77 . . . . 2.91 112.156 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mmt180 -108.29 127.89 54.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.31 -0.256 . . . . 3.64 110.31 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.559 ' CG ' ' HG2' ' A' ' 56' ' ' GLN . 12.2 t70 -65.9 132.68 94.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 2.1 110.306 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 1.012 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 7.3 Cg_exo -73.62 -12.88 24.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.986 2.457 . . . . 1.68 114.209 -172.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -130.23 -7.45 4.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.605 0.965 . . . . 4.08 113.605 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG2' ' CG ' ' A' ' 53' ' ' ASP . 77.6 mm-40 -75.23 -13.18 60.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.264 -0.575 . . . . 3.05 110.864 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.702 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.4 m -88.49 14.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.4 0.889 . . . . 1.26 113.4 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 40' ' ' LEU . 38.6 mt -81.99 131.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.177 -0.609 . . . . 1.66 110.131 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.34 26.63 72.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.011 -0.836 . . . . 0.78 111.011 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -121.5 134.46 55.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.964 -0.618 . . . . 2.37 110.177 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.4 114.66 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.79 0.329 . . . . 0.83 110.297 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.73 -40.93 69.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.7 111.389 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 72.2 m-85 -80.56 3.66 21.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.351 -0.386 . . . . 1.45 111.534 -173.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -121.84 -51.65 2.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.48 -0.563 . . . . 4.07 109.48 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -78.34 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 2.2 112.155 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 66' ' ' VAL . 2.0 t -96.22 16.38 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.794 0.33 . . . . 2.34 111.853 -168.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.99 77.2 0.74 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 121.989 -0.444 . . . . 1.2 112.014 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -97.61 28.45 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.084 2.523 . . . . 0.98 113.208 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 p -120.71 22.96 10.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.539 -0.541 . . . . 1.41 109.539 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.9 m -136.58 -44.34 0.6 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.062 -1.426 . . . . 1.74 109.41 -133.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 11.2 p-10 -68.98 119.88 13.97 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.207 -0.664 . . . . 1.85 109.207 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -168.99 161.58 7.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.78 -0.645 . . . . 1.85 109.743 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.96 -31.11 91.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.36 2.04 . . . . 1.4 112.868 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.7 -4.66 54.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 2.56 112.072 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -124.77 -70.82 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.181 -0.303 . . . . 4.11 110.181 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 93.8 t80 -60.44 -39.44 87.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 1.24 110.284 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.11 -40.19 98.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.979 -0.629 . . . . 0.6 112.219 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 74.0 mmtt -73.56 -26.14 60.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 2.58 110.32 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -67.38 -35.49 79.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.79 110.276 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -84.5 -14.89 47.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.994 -0.548 . . . . 1.63 110.98 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.484 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 49.8 mm-40 -54.48 -52.28 62.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.154 0.502 . . . . 2.07 111.016 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -72.19 -33.34 62.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.72 112.213 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG21 ' OH ' ' A' ' 118' ' ' TYR . 23.1 t -61.7 -51.61 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 1.4 110.646 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.2 -21.7 66.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.843 -0.617 . . . . 1.48 111.881 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -96.41 -77.57 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 2.15 110.875 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.49 -77.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.5 -0.64 . . . . 1.77 111.5 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.8 p30 -95.24 144.88 25.47 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.543 -0.54 . . . . 3.83 109.543 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 54.6 tp -120.18 102.63 8.64 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.714 -0.476 . . . . 3.54 109.714 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 109' ' ' MET . 39.1 m-80 -148.65 97.41 2.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.017 -0.734 . . . . 2.47 109.017 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -149.19 165.14 32.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.787 -0.642 . . . . 2.01 110.496 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 ptp -132.97 129.58 38.41 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.828 -0.623 . . . . 2.22 109.972 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.437 ' O ' HG11 ' A' ' 107' ' ' VAL . 45.5 p90 -146.51 165.25 30.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.023 -0.362 . . . . 3.82 110.023 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -109.19 122.08 46.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 2.39 110.971 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -131.83 153.84 49.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.792 -0.64 . . . . 3.62 109.885 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 m -104.76 145.62 30.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.97 110.458 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.43 104.63 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.995 -0.372 . . . . 1.47 109.995 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 9.1 p-10 -135.13 115.08 13.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.473 0.654 . . . . 2.57 110.885 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -179.91 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.94 -1.027 . . . . 3.46 109.188 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -92.32 -35.87 13.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.905 -0.776 . . . . 3.41 108.905 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.28 144.17 25.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.131 -1.063 . . . . 3.33 108.131 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.59 160.31 53.64 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 109.664 -0.495 . . . . 2.56 109.664 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 50.3 Cg_exo -54.74 84.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 1.72 114.418 -171.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 p -102.13 147.7 26.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.331 -0.395 . . . . 1.93 110.291 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -121.24 130.36 53.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.007 -0.368 . . . . 3.47 110.007 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 124' ' ' ARG . 35.8 m -122.87 164.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.175 0.512 . . . . 1.96 111.658 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -104.25 111.72 24.45 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.837 -1.542 . . . . 2.22 106.837 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' MET . 14.6 p -104.27 136.64 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-O 121.329 0.585 . . . . 1.97 109.701 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -111.95 114.33 27.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.647 -0.872 . . . . 1.37 108.647 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.2 tpp -100.39 133.68 44.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.46 -0.791 . . . . 2.95 109.079 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 118' ' ' TYR . 12.2 mmmm -135.67 159.63 41.02 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.819 -0.808 . . . . 2.05 108.819 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.611 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 64.7 tttp -104.86 121.05 42.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.126 0.489 . . . . 2.66 111.657 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.605 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . . . -107.91 99.02 8.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.694 -0.685 . . . . 1.57 109.938 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.66 -19.54 62.08 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.595 -0.52 . . . . 4.89 109.595 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 m -73.34 80.81 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.543 -0.753 . . . . 2.9 110.174 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.05 9.18 13.84 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.524 -0.846 . . . . 2.62 112.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 55.95 41.34 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.896 0.379 . . . . 2.76 111.662 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -134.77 -167.14 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.514 -0.312 . . . . 1.61 110.828 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.693 ' OH ' HG21 ' A' ' 83' ' ' VAL . 82.4 m-85 -135.55 153.51 51.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.003 -0.74 . . . . 1.4 109.003 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.605 ' CD1' ' HB3' ' A' ' 112' ' ' ALA . 47.9 m95 -102.72 104.13 14.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.958 -0.756 . . . . 0.75 108.958 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 31' ' ' ILE . 11.6 p -100.34 125.66 54.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.108 0.956 . . . . 1.6 111.39 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.73 137.06 54.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.894 -1.048 . . . . 0.97 108.989 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 29' ' ' GLY . 27.0 m -104.69 141.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.093 -0.643 . . . . 1.83 111.567 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -124.23 103.54 8.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.306 -0.861 . . . . 3.79 109.257 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.545 ' HA ' HG13 ' A' ' 105' ' ' VAL . 15.0 ptm180 -75.05 120.78 21.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.506 -0.315 . . . . 4.65 110.268 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.712 1.258 . . . . 2.87 113.417 -174.025 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 121.673 0.749 . . . . 4.68 112.137 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.42 123.49 7.88 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 0.96 110.023 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -116.79 103.94 10.84 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.966 -0.294 . . . . 1.26 110.362 -170.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 53.2 mt -108.7 114.34 46.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.971 -0.559 . . . . 1.67 109.56 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -101.45 114.34 28.26 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.624 -0.88 . . . . 1.02 108.624 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.24 160.53 34.61 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.112 -0.495 . . . . 2.24 110.632 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.4 169.88 8.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 1.22 110.574 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.28 -23.69 26.86 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 114.521 0.568 . . . . 0.79 114.521 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -37.35 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.337 0.569 . . . . 1.95 110.751 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 128.96 11.3 2.9 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.479 -0.867 . . . . 0.61 113.285 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -71.14 127.19 31.75 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.366 0.583 . . . . 1.64 109.727 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 16.2 mt -81.52 151.36 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.309 -0.626 . . . . 1.58 109.309 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.712 ' HA ' HG21 ' A' ' 58' ' ' ILE . 77.7 mt -129.82 -67.46 0.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.459 0.647 . . . . 2.1 110.115 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 63.2 mt-30 -112.61 138.38 49.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.633 -0.712 . . . . 1.99 110.347 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.823 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -118.41 -4.07 10.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.703 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.639 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 66.2 t30 63.23 172.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.538 -0.756 . . . . 2.14 110.577 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 11.2 6.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 1.87 110.882 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -92.51 -63.78 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.229 -0.442 . . . . 2.02 111.472 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.26 -43.79 83.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 2.12 110.985 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA2' ' C ' ' A' ' 51' ' ' GLY . . . -68.82 -10.06 60.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.576 -0.821 . . . . 1.42 113.148 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.15 -41.91 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.122 0.461 . . . . 2.35 110.559 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 45' ' ' ALA . 6.1 pt -85.92 -47.56 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 112.296 0.48 . . . . 2.98 112.296 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.7 p -105.82 -49.33 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.976 -0.453 . . . . 3.86 111.175 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.409 ' C ' ' HA2' ' A' ' 47' ' ' GLY . . . 139.91 -175.25 21.95 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.222 -0.751 . . . . 2.91 111.222 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.681 ' HG2' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 71.57 99.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 3.64 111.407 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.463 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 3.6 m-20 -67.97 149.4 98.2 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 108.97 -0.752 . . . . 2.1 108.97 171.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.823 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 10.3 Cg_endo -52.52 -31.78 50.43 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.788 2.325 . . . . 1.68 111.938 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -71.35 -19.13 62.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.361 -0.836 . . . . 4.08 111.46 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 15.3 mm-40 -94.97 -14.49 24.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 3.05 111.73 -171.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.685 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -111.23 18.93 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 113.033 0.753 . . . . 1.26 113.033 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.712 HG21 ' HA ' ' A' ' 40' ' ' LEU . 8.3 pt -87.51 140.09 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.438 -0.505 . . . . 1.66 110.586 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.72 10.04 71.03 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.223 -0.989 . . . . 0.78 110.901 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 39' ' ' ILE . 87.1 mttt -114.71 135.99 53.55 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.761 -0.459 . . . . 2.37 109.761 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 21.8 t-20 -81.62 115.78 21.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.146 -0.479 . . . . 0.83 110.021 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.668 ' HA ' HD11 ' A' ' 39' ' ' ILE . 48.1 t80 -50.73 -37.91 44.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.7 111.618 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 38.2 m-85 -90.38 15.14 11.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.382 -0.372 . . . . 1.45 111.577 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -148.66 -49.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 4.07 111.716 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.03 -21.88 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.165 0.802 . . . . 2.2 113.165 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' HG2' ' A' ' 52' ' ' ARG . 5.4 p -149.58 14.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.357 -0.937 . . . . 2.34 112.82 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -171.25 94.52 0.43 Allowed Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.043 -0.526 . . . . 1.2 111.703 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.02 -18.88 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.618 2.212 . . . . 0.98 112.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -12.03 48.78 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.142 -0.223 . . . . 1.41 111.223 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 67' ' ' ALA . 10.9 t -82.56 -27.73 31.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.697 -0.401 . . . . 1.74 110.854 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.629 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 19.1 t70 -67.05 110.36 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.217 -0.66 . . . . 1.85 109.217 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -164.12 148.94 8.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.178 -0.464 . . . . 1.85 109.791 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.81 -21.59 64.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.691 2.261 . . . . 1.4 113.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.97 -21.59 19.69 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.97 -0.292 . . . . 2.56 111.573 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 50.2 t80 -107.46 -72.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.767 0.317 . . . . 4.11 110.176 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.69 -38.9 79.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 1.24 110.132 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.04 -40.25 93.17 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.6 112.546 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.716 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 58.1 mttm -87.91 -21.95 24.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 2.58 111.426 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.646 ' O ' HG23 ' A' ' 83' ' ' VAL . 84.6 t80 -62.17 -49.65 74.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.62 -0.882 . . . . 0.79 108.62 170.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.43 -20.16 60.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.825 -1.08 . . . . 1.63 110.309 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 30.3 tt0 -57.37 -36.72 71.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 2.07 109.693 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.97 -32.62 8.84 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.611 -0.722 . . . . 0.72 112.187 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.1 t -59.9 -53.04 54.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.59 0.219 . . . . 1.4 111.59 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.83 -59.37 4.59 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.423 0.452 . . . . 1.48 111.535 -175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.2 p -167.11 29.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.306 . . . . 2.15 111.561 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.17 -10.71 19.88 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.53 -1.319 . . . . 1.77 113.069 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 63.77 124.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.409 -0.589 . . . . 3.83 109.409 -169.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD21 ' CG ' ' A' ' 118' ' ' TYR . 32.9 tp -103.67 104.19 14.2 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.655 -0.818 . . . . 3.54 111.432 -166.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.3 p-10 -165.03 104.68 0.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.497 1.142 . . . . 2.47 109.429 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -165.41 166.63 18.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.996 -1.456 . . . . 2.01 108.514 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.5 ptt? -133.25 122.22 23.61 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.072 0.463 . . . . 2.22 110.304 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -124.3 167.48 14.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.149 -0.478 . . . . 3.82 110.41 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -102.59 119.32 38.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.748 -0.464 . . . . 2.39 109.748 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -133.96 153.82 51.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 3.62 110.319 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 p -104.45 150.49 24.51 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.72 0.295 . . . . 1.97 111.295 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -130.22 116.41 18.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.438 . . . . 1.47 110.319 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' MET . 8.0 p-10 -124.54 -158.53 0.83 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.504 -0.771 . . . . 2.57 109.238 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.502 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 67.1 t80 70.96 -74.64 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.685 0.394 . . . . 3.46 111.474 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 26.3 mm-40 -92.55 4.2 54.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.695 0.759 . . . . 3.41 110.357 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 tpt -150.0 152.0 34.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.659 -1.155 . . . . 3.33 108.243 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 100' ' ' MET . 13.7 p -63.38 147.79 94.55 Favored Pre-proline 0 N--CA 1.443 -0.809 0 N-CA-C 108.069 -1.086 . . . . 2.56 108.069 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.9 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.191 . . . . 1.72 112.649 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -99.51 149.22 23.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.931 -0.577 . . . . 1.93 110.798 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.85 118.57 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.198 -0.667 . . . . 3.47 109.198 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 124' ' ' ARG . 27.5 m -123.05 163.73 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.592 0.711 . . . . 1.96 111.616 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -110.79 114.88 28.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.905 -1.146 . . . . 2.22 107.905 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.65 HG22 HG11 ' A' ' 122' ' ' VAL . 41.5 t -107.34 115.79 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.208 -0.451 . . . . 1.97 110.055 -168.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -104.27 109.03 20.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.658 -0.497 . . . . 1.37 109.658 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -103.97 134.32 47.45 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.842 -0.617 . . . . 2.95 109.489 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -147.95 150.15 33.51 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.204 -0.295 . . . . 2.05 110.204 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.509 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 42.9 tttm -87.01 128.72 35.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.667 0.27 . . . . 2.66 111.037 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.34 127.65 30.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 1.57 110.066 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.19 94.58 5.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.927 0.87 . . . . 4.89 112.692 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t -113.47 -62.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 104.3 -2.482 . . . . 2.9 104.3 160.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.62 143.86 17.06 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 106.626 -2.59 . . . . 2.62 106.626 151.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.92 100.14 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.661 1.231 . . . . 2.76 111.12 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -156.7 -177.79 6.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.875 -1.057 . . . . 1.61 109.003 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 9.0 m-85 -128.85 154.18 46.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.715 -0.846 . . . . 1.4 108.715 -175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 60.8 m95 -100.74 104.13 15.4 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.237 -1.023 . . . . 0.75 108.237 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.609 HG23 ' CB ' ' A' ' 109' ' ' MET . 47.9 t -101.8 104.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.889 -1.05 . . . . 1.6 109.585 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 81.0 m-85 -103.16 138.64 39.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.97 110.608 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.65 HG11 HG22 ' A' ' 107' ' ' VAL . 16.6 m -107.35 153.22 8.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.944 0.402 . . . . 1.83 111.138 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -149.77 112.38 4.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.942 -0.572 . . . . 3.79 110.186 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.648 ' HA ' HG11 ' A' ' 105' ' ' VAL . 20.5 ttt180 -73.1 145.34 46.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 4.65 110.808 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.411 ' H ' HG21 ' A' ' 125' ' ' VAL . 3.2 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.153 -0.927 . . . . 2.87 110.824 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.746 0.784 . . . . 4.68 112.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.22 107.39 2.94 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.925 -0.87 . . . . 0.96 110.925 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.55 128.82 51.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 1.26 110.809 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 HD13 ' HG2' ' A' ' 46' ' ' GLU . 57.5 mt -122.26 138.89 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.228 -0.656 . . . . 1.67 109.228 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' HG2' HD11 ' A' ' 40' ' ' LEU . 62.6 tt0 -104.68 121.13 42.93 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.192 -0.67 . . . . 1.02 109.192 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.01 153.74 50.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 2.24 109.891 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.648 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 169.62 8.41 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.85 -0.34 . . . . 1.22 110.655 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.63 -22.59 8.46 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 115.313 0.885 . . . . 0.79 115.313 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.36 -21.93 38.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.756 0.778 . . . . 1.95 110.638 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.88 3.94 31.76 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.093 -0.803 . . . . 0.61 111.093 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.648 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.1 m120 -70.24 134.84 48.43 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.054 0.454 . . . . 1.64 110.705 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 62' ' ' PHE . 10.1 mt -87.24 148.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.422 -0.808 . . . . 1.58 110.015 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 32' ' ' GLN . 42.2 mt -117.69 -61.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.271 0.557 . . . . 2.1 110.516 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.8 136.89 18.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.389 0.614 . . . . 1.99 111.248 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.976 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -92.5 153.1 19.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.899 -1.046 . . . . 1.25 110.77 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -88.04 166.22 14.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.078 -0.712 . . . . 2.14 109.078 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.5 60.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.137 0.421 . . . . 1.87 112.137 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.07 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.751 0.278 . . . . 2.02 111.751 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HG2' HD13 ' A' ' 31' ' ' ILE . 6.3 tp10 -72.46 -4.86 32.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.575 0.702 . . . . 2.12 110.435 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.41 -54.12 0.62 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.486 -0.779 . . . . 1.42 112.282 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.07 -38.36 61.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.984 0.421 . . . . 2.35 111.36 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -81.78 -57.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 2.98 109.823 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.4 m -57.42 -52.35 65.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.22 -0.9 . . . . 3.86 112.032 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.73 42.77 0.92 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.625 -0.798 . . . . 2.91 111.814 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -133.46 171.74 13.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.684 -0.488 . . . . 3.64 109.684 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 16.1 t70 -105.76 130.93 22.24 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.701 -0.481 . . . . 2.1 109.701 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.976 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 50.3 Cg_exo -55.02 -20.25 22.72 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.488 2.792 . . . . 1.68 114.186 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -119.32 15.13 13.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.195 0.443 . . . . 4.08 112.195 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.778 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 23.1 mm-40 -86.23 -13.23 47.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 3.05 110.161 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.91 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.606 -0.724 . . . . 1.26 112.179 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.2 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.641 -0.423 . . . . 1.66 110.721 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 18.92 76.95 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.254 -0.738 . . . . 0.78 111.254 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -124.25 151.79 43.75 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.623 0.249 . . . . 2.37 111.084 -170.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -105.71 122.04 45.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.83 109.416 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HA ' HD12 ' A' ' 39' ' ' ILE . 84.7 t80 -54.09 -43.75 70.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.005 -0.543 . . . . 0.7 111.733 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 70.9 m-85 -77.5 -5.41 49.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 1.45 111.719 -172.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -128.37 -48.05 1.31 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.13 0.419 . . . . 4.07 112.13 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -92.88 -22.54 19.2 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.483 0.549 . . . . 2.2 112.483 -172.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.14 13.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.171 -0.612 . . . . 2.34 111.477 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.81 74.58 0.17 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.748 0.309 . . . . 1.2 111.023 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.2 -4.1 11.05 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.766 2.311 . . . . 0.98 113.64 -176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 p -113.1 18.24 18.15 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.096 -0.377 . . . . 1.41 110.641 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p -97.17 -37.64 10.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.125 164.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 59.1 t0 -59.96 102.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.207 0.527 . . . . 1.85 110.486 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.489 ' HG ' ' HH ' ' A' ' 94' ' ' TYR . 80.2 p -163.55 154.86 14.37 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.618 -0.719 . . . . 1.85 109.489 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.61 -21.41 71.97 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.6 2.2 . . . . 1.4 113.001 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.62 -17.08 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.902 0.334 . . . . 2.56 111.902 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.871 ' HE2' HG11 ' A' ' 107' ' ' VAL . 23.2 t80 -117.23 -68.92 0.88 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.825 -0.35 . . . . 4.11 110.689 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.46 -35.22 79.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 1.24 109.95 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.42 93.69 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.665 -0.698 . . . . 0.6 112.069 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 69.6 mmtt -71.4 -38.62 71.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.029 0.442 . . . . 2.58 110.406 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.76 -37.06 80.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.797 -0.638 . . . . 0.79 110.298 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.73 -20.98 32.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 1.63 110.622 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -68.88 -35.83 77.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 2.07 109.681 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.963 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -68.92 -36.67 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.538 -0.756 . . . . 0.72 111.583 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.13 -51.76 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 1.4 110.212 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.44 69.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.623 . . . . 1.48 111.162 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -65.95 -71.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.513 0.673 . . . . 2.15 110.095 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.26 -62.59 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 108.884 -1.687 . . . . 1.77 108.884 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -161.33 167.03 26.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.902 0.881 . . . . 3.83 108.674 167.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.963 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -125.59 152.79 44.64 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.8 -0.76 . . . . 3.54 111.299 -168.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.773 ' HA ' ' O ' ' A' ' 109' ' ' MET . 35.7 p30 -163.8 47.0 0.12 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.336 -1.302 . . . . 2.47 109.162 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 p -102.36 165.21 11.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.843 -1.526 . . . . 2.01 111.134 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -116.78 125.32 51.45 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.218 -0.901 . . . . 2.22 109.911 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.33 157.66 27.68 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.757 -0.461 . . . . 3.82 109.757 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.25 111.11 23.59 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.595 -0.52 . . . . 2.39 109.595 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.489 ' HH ' ' HG ' ' A' ' 72' ' ' SER . 14.3 t80 -135.87 144.07 45.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.885 -0.598 . . . . 3.62 109.408 -175.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 104' ' ' LYS . 6.0 p -105.06 155.52 18.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.013 0.435 . . . . 1.97 111.55 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -116.19 104.73 11.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.919 -0.582 . . . . 1.47 109.614 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 31.8 t70 -140.77 98.84 3.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.748 -0.66 . . . . 2.57 110.198 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HD1' ' HG2' ' A' ' 99' ' ' GLN . 65.2 t80 174.24 -71.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.675 0.61 . . . . 3.46 110.03 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.596 ' HG2' ' HD1' ' A' ' 98' ' ' TYR . 25.0 mm-40 -101.9 4.34 40.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.987 0.899 . . . . 3.41 109.319 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.5 tpp -137.99 139.4 39.64 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.114 -1.403 . . . . 3.33 107.962 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.09 144.43 94.28 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 108.972 -0.751 . . . . 2.56 108.972 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.4 90.9 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.349 2.699 . . . . 1.72 114.14 -167.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -89.85 143.73 26.54 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.133 -0.485 . . . . 1.93 110.683 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.0 OUTLIER -110.91 107.87 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.395 -0.965 . . . . 3.47 108.395 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 124' ' ' ARG . 23.6 m -129.64 163.17 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.789 0.804 . . . . 1.96 112.365 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.66 123.02 47.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.408 -1.269 . . . . 2.22 107.856 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.871 HG11 ' HE2' ' A' ' 75' ' ' PHE . 4.9 p -104.19 113.17 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.054 0.93 . . . . 1.97 109.759 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.477 ' CE1' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t-160 -104.9 104.24 13.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.976 -1.011 . . . . 1.37 108.813 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.773 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.3 pmm? -102.98 127.76 50.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.349 -0.612 . . . . 2.95 109.349 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 42.4 mtmt -137.79 164.6 28.51 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 110.228 -0.286 . . . . 2.05 110.228 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 3.9 tmtp? -94.92 149.98 20.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 2.66 110.897 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -137.37 114.56 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.313 -0.858 . . . . 1.57 109.333 173.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -87.72 32.71 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.5 0.667 . . . . 4.89 110.703 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 p -79.73 -58.34 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.492 -0.777 . . . . 2.9 109.935 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.44 20.98 5.48 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.409 -0.814 . . . . 2.62 111.136 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.21 77.25 0.33 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.57 0.7 . . . . 2.76 111.393 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 1.3 m -159.49 -171.22 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 1.61 107.51 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.542 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 78.6 m-85 -123.74 147.8 47.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 118.154 0.434 . . . . 1.4 109.847 -174.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.573 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 70.9 m95 -103.93 108.54 19.92 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.241 -1.022 . . . . 0.75 108.241 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.21 135.96 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.574 0.702 . . . . 1.6 110.437 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.547 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 98.6 m-85 -120.19 137.24 54.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.354 -0.839 . . . . 0.97 110.715 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.6 t -104.01 102.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.304 -0.862 . . . . 1.83 109.107 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -105.81 123.86 48.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.154 -0.476 . . . . 3.79 109.883 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.664 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -66.14 137.37 56.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.726 0.298 . . . . 4.65 110.818 -177.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.446 ' O ' HG11 ' A' ' 125' ' ' VAL . 3.3 p . . . . . 0 C--O 1.248 1.018 0 CA-C-N 116.35 -0.386 . . . . 2.87 110.663 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 30' ' ' ALA . 35.0 p90 . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.354 -0.61 . . . . 4.68 109.354 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -104.07 115.26 5.0 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.732 -0.746 . . . . 0.96 111.845 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -119.87 113.5 20.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 1.26 110.527 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.463 ' HB ' HG12 ' A' ' 120' ' ' VAL . 24.8 mt -120.2 146.42 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.416 -0.587 . . . . 1.67 109.416 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.657 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.3 tt0 -115.74 136.34 53.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.255 -1.016 . . . . 1.02 108.255 172.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 40' ' ' LEU . 2.0 pt? -147.95 159.32 44.0 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.729 -0.388 . . . . 2.24 110.999 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.8 p30 -102.85 167.79 9.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.308 -0.405 . . . . 1.22 110.201 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.2 -17.22 44.83 Favored Glycine 0 CA--C 1.517 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.79 113.855 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.92 -21.18 22.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.01 0.405 . . . . 1.95 111.139 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 117.09 3.49 17.51 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.418 -0.896 . . . . 0.61 113.558 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.617 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 46.1 m-80 -71.11 128.93 37.58 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.453 0.627 . . . . 1.64 109.384 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.698 HG21 ' HE2' ' A' ' 42' ' ' TYR . 18.0 mt -83.5 144.08 10.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.047 -0.524 . . . . 1.58 110.16 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -96.93 -75.47 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 2.1 110.066 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 16.9 pm0 -153.45 145.01 23.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 1.99 110.378 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.698 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.6 m-85 -90.68 156.91 17.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.142 -0.936 . . . . 1.25 109.313 170.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.591 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 58.7 t30 -70.6 156.47 39.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.85 -0.796 . . . . 2.14 108.85 171.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.21 69.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 1.87 110.707 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.84 -52.67 23.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.987 -0.551 . . . . 2.02 111.28 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.656 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 20.6 tp10 -61.41 -44.98 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 2.12 111.286 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.06 -34.82 58.14 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.33 -0.938 . . . . 1.42 113.009 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.25 -45.85 68.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 2.35 111.01 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -74.32 -55.72 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.144 -0.48 . . . . 2.98 111.307 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 m -64.26 -50.91 66.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.537 -0.302 . . . . 3.86 111.781 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.79 44.51 0.41 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.342 -0.932 . . . . 2.91 112.152 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 52' ' ' ARG . 57.5 mmt-85 -136.3 93.69 2.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.057 -0.72 . . . . 3.64 109.057 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.91 142.11 79.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.759 0.652 . . . . 2.1 112.759 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.44 114.23 1.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.135 2.557 . . . . 1.68 112.26 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 77.38 11.63 2.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.835 -1.075 . . . . 4.08 112.105 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -91.82 4.73 52.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.673 0.749 . . . . 3.05 109.056 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.696 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -110.23 14.84 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.764 -1.107 . . . . 1.26 111.935 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.43 128.22 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.451 -0.574 . . . . 1.66 109.451 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 -8.39 65.66 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.123 -1.037 . . . . 0.78 110.833 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.696 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 21.0 mttp -86.04 131.21 34.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.847 -0.797 . . . . 2.37 108.847 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.1 t-20 -88.17 112.94 23.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.122 -0.631 . . . . 0.83 109.866 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.53 ' HE1' HG23 ' A' ' 70' ' ' THR . 45.8 t80 -47.87 -64.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.361 -0.836 . . . . 0.7 111.787 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -87.96 28.09 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.192 0.442 . . . . 1.45 112.192 -169.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 38.9 ttpt -143.18 -42.43 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 4.07 111.026 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD2' HG12 ' A' ' 66' ' ' VAL . 38.9 t70 -95.15 -77.02 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 2.2 110.884 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.405 HG12 ' OD2' ' A' ' 65' ' ' ASP . 5.6 m -91.96 16.29 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.558 0.947 . . . . 2.34 113.558 -172.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -165.25 86.23 1.03 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.994 0.426 . . . . 1.2 111.153 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 98' ' ' TYR . 79.4 Cg_endo -91.07 -4.84 4.34 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.683 2.255 . . . . 0.98 114.257 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 98' ' ' TYR . 11.8 p -73.67 -13.83 61.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.267 -0.573 . . . . 1.41 109.814 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.571 HG21 ' HE1' ' A' ' 96' ' ' PHE . 11.1 m -91.49 -37.47 13.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.351 -1.295 . . . . 1.74 110.607 -145.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.36 109.96 5.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.768 0.794 . . . . 1.85 110.179 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.4 m -162.67 154.16 15.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.399 -0.819 . . . . 1.85 109.314 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.17 -35.59 91.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.688 2.259 . . . . 1.4 112.908 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.48 -16.15 60.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.248 0.462 . . . . 2.56 112.248 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.409 ' HE2' HG12 ' A' ' 107' ' ' VAL . 61.5 t80 -124.5 -74.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 4.11 110.485 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.46 -37.55 78.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 1.24 110.966 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.29 -44.69 96.33 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.894 -0.67 . . . . 0.6 112.106 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 71.9 mmtt -74.02 -32.29 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 2.58 111.024 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.461 ' O ' HD11 ' A' ' 88' ' ' LEU . 89.3 t80 -60.14 -43.41 95.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.315 0.579 . . . . 0.79 110.278 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.4 -19.6 45.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.86 -0.609 . . . . 1.63 110.338 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.27 -37.68 83.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 2.07 109.897 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.628 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.31 -44.83 41.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 0.72 111.799 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 79' ' ' PHE . 32.1 t -56.76 -50.47 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 1.4 110.945 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -12.22 60.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 1.48 112.229 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -101.26 -77.13 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.712 0.292 . . . . 2.15 110.596 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.3 -62.23 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.738 -0.744 . . . . 1.77 112.231 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -118.26 136.28 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.777 0.322 . . . . 3.83 110.552 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -104.74 123.17 47.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.261 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.727 ' HA ' ' O ' ' A' ' 109' ' ' MET . 36.9 t-20 -176.11 116.53 0.13 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.491 0.662 . . . . 2.47 110.363 173.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 13.9 t -166.0 165.15 18.16 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.718 -1.128 . . . . 2.01 109.031 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.608 ' HB3' ' HD2' ' A' ' 108' ' ' HIS . 22.6 ptm -140.0 108.64 5.91 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.335 0.588 . . . . 2.22 110.687 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -121.93 166.61 14.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.767 -0.651 . . . . 3.82 110.548 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.59 121.55 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.495 -0.557 . . . . 2.39 109.495 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -134.07 165.13 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.631 -0.713 . . . . 3.62 109.458 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -104.42 147.17 27.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.734 -0.469 . . . . 1.97 109.734 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' HE1' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -139.45 103.33 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.198 -0.601 . . . . 1.47 112.448 -169.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 7.3 t70 170.52 144.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 2.57 108.958 167.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.753 ' HA ' ' HB3' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -72.02 -42.67 66.09 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.605 -0.725 . . . . 3.46 111.578 -176.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.437 HE21 ' HD2' ' A' ' 98' ' ' TYR . 48.6 mt-30 -137.02 -5.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.037 0.754 . . . . 3.41 113.037 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.92 160.51 29.13 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.17 -0.678 . . . . 3.33 109.17 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.87 100.92 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 108.504 -0.924 . . . . 2.56 108.504 167.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -39.55 99.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.425 3.417 . . . . 1.72 113.996 -161.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.5 m -56.42 153.39 9.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.359 -0.837 . . . . 1.93 110.273 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.98 136.53 42.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.226 0.536 . . . . 3.47 110.946 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.489 HG21 ' HB ' ' A' ' 122' ' ' VAL . 10.6 p -144.4 156.2 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.381 -0.827 . . . . 1.96 110.294 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.437 ' HE3' HG12 ' A' ' 125' ' ' VAL . 29.0 ttmt -109.38 128.77 55.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.098 -1.075 . . . . 2.22 108.098 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 122' ' ' VAL . 50.3 t -119.56 114.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 109.221 -0.659 . . . . 1.97 109.221 -166.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.608 ' HD2' ' HB3' ' A' ' 91' ' ' MET . 56.5 t-80 -104.78 122.78 46.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.899 -0.591 . . . . 1.37 109.969 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.727 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.4 mpt? -100.29 147.47 25.73 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.497 -0.927 . . . . 2.95 108.497 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.59 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.8 ptmt -162.67 143.82 10.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.464 -0.569 . . . . 2.05 109.464 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.41 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 84.4 tttt -94.0 122.51 36.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.451 . . . . 2.66 111.111 -170.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -104.62 174.78 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.743 -0.662 . . . . 1.57 109.335 175.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.4 tp -121.56 -28.7 4.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.812 0.339 . . . . 4.89 110.129 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -71.34 100.24 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.424 -0.584 . . . . 2.9 109.424 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.64 -6.01 33.22 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.301 -0.952 . . . . 2.62 112.151 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 51.87 51.62 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.27 0.557 . . . . 2.76 110.099 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 p -152.59 178.98 9.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.857 -0.611 . . . . 1.61 110.568 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 2.5 m-85 -117.22 155.68 29.01 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.569 -0.9 . . . . 1.4 108.569 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.45 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 78.2 m95 -102.27 111.55 23.88 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.09 -0.707 . . . . 0.75 109.09 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.463 HG12 ' HB ' ' A' ' 31' ' ' ILE . 14.7 p -101.63 116.81 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.165 0.983 . . . . 1.6 110.396 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 32.5 m-85 -109.36 125.15 52.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.795 . . . . 0.97 110.529 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.704 HG12 HG23 ' A' ' 107' ' ' VAL . 15.3 m -109.46 140.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.127 0.489 . . . . 1.83 110.88 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -139.2 133.19 31.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 3.79 110.088 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -72.05 123.05 21.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.892 -0.41 . . . . 4.65 109.892 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.437 HG12 ' HE3' ' A' ' 106' ' ' LYS . 2.5 m . . . . . 0 C--O 1.247 0.948 0 CA-C-N 116.327 -0.397 . . . . 2.87 110.599 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.768 0.318 . . . . 4.68 110.683 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 43' ' ' ASN . . . -104.23 147.16 16.44 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.416 -0.897 . . . . 0.96 113.424 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.15 111.43 14.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.092 -0.707 . . . . 1.26 109.092 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 120' ' ' VAL . 6.9 mm -103.53 160.37 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.134 -0.691 . . . . 1.67 109.134 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 31' ' ' ILE . 63.5 tt0 -133.42 113.67 12.8 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.175 -0.328 . . . . 1.02 110.156 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' HG ' HG12 ' A' ' 120' ' ' VAL . 22.0 mt -112.63 151.98 29.5 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.351 -0.611 . . . . 2.24 109.351 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.52 168.99 8.72 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.876 -0.329 . . . . 1.22 110.249 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.92 -27.48 37.14 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.569 0.543 . . . . 0.79 114.326 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -44.03 20.09 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.508 0.654 . . . . 1.95 111.097 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.49 20.76 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.361 -0.924 . . . . 0.61 112.902 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -84.52 142.64 29.88 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.484 -0.562 . . . . 1.64 109.484 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 6.0 mt -90.91 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.982 -0.747 . . . . 1.58 108.982 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 39' ' ' ILE . 9.1 mp -118.19 -86.43 0.64 Allowed 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.134 0.492 . . . . 2.1 111.02 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -119.6 168.29 11.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.687 0.756 . . . . 1.99 111.655 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.692 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 3.3 m-85 -132.94 -167.75 1.96 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.011 -1.449 . . . . 1.25 109.337 -174.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 63.4 t30 -128.13 160.74 31.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.749 -0.834 . . . . 2.14 108.749 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.55 19.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.508 0.559 . . . . 1.87 112.508 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -95.64 -42.9 8.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.083 0.468 . . . . 2.02 110.149 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -77.5 -17.27 58.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.535 . . . . 2.12 110.555 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -82.89 -26.18 46.4 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.449 -0.882 . . . . 1.42 111.663 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -45.11 16.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 2.35 110.609 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -83.16 -62.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 2.98 111.21 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -75.76 -53.28 8.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.053 0.454 . . . . 3.86 111.382 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.21 36.59 1.32 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 2.91 111.226 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 16.9 tpp85 -123.27 110.14 14.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.56 0.219 . . . . 3.64 110.525 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.803 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 28.6 m-20 -77.74 154.6 80.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.542 -0.299 . . . . 2.1 110.508 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.692 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 36.9 Cg_endo -67.47 -9.79 26.53 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.838 2.358 . . . . 1.68 111.312 172.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HB3' ' HZ2' ' A' ' 55' ' ' LYS . 8.5 mtpm? -100.27 5.86 44.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.269 -0.878 . . . . 4.08 111.185 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.803 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 83.4 mm-40 -97.82 -60.52 1.55 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 3.05 111.75 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.832 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 2.9 m -88.27 40.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.486 0.921 . . . . 1.26 113.486 -169.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 40' ' ' LEU . 30.8 mt -91.23 120.34 40.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.466 -0.494 . . . . 1.66 109.886 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.52 33.03 58.96 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.526 -1.03 . . . . 0.78 110.526 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.832 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 35.6 mttm -121.7 135.56 54.95 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.673 -0.763 . . . . 2.37 110.009 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -80.78 112.93 18.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.803 0.335 . . . . 0.83 110.331 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 39' ' ' ILE . 71.6 t80 -57.55 -40.7 79.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.7 111.385 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.487 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 55.5 m-85 -91.05 25.63 2.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.332 -0.394 . . . . 1.45 111.712 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.79 -46.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.688 -0.405 . . . . 4.07 111.113 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.28 -78.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 2.2 111.703 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.18 36.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.982 1.373 . . . . 2.34 111.544 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -163.9 81.28 1.43 Allowed Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 113.995 -1.457 . . . . 1.2 111.071 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -97.72 8.81 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.906 2.404 . . . . 0.98 114.066 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.46 ' HB2' ' OD2' ' A' ' 97' ' ' ASP . 1.7 p -77.69 -17.97 57.12 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.949 -0.7 . . . . 1.41 110.25 170.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.1 t -96.45 -26.3 15.36 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.74 110.964 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 63' ' ' PHE . 5.7 m-20 -65.76 131.7 46.96 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.842 -0.343 . . . . 1.85 111.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.87 ' HG ' ' HH ' ' A' ' 94' ' ' TYR . 61.8 p 179.81 155.05 0.68 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 1.85 109.515 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.9 -19.2 63.97 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.353 2.035 . . . . 1.4 112.326 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.39 -24.9 18.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 2.56 111.718 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 87.0 t80 -104.34 -72.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.646 -0.422 . . . . 4.11 110.075 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -38.26 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 1.24 110.238 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.28 -34.79 90.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.86 -0.609 . . . . 0.6 112.498 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.25 -35.13 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.817 0.309 . . . . 2.58 110.464 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.59 ' O ' HG21 ' A' ' 83' ' ' VAL . 59.3 t80 -57.72 -45.82 85.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.219 -0.66 . . . . 0.79 109.219 172.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -77.75 -17.71 57.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.671 . . . . 1.63 111.241 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -61.24 -36.22 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 2.07 110.109 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.65 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -84.03 -51.36 4.01 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.161 -1.019 . . . . 0.72 111.48 172.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 79' ' ' PHE . 48.4 t -45.82 -62.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.151 0.58 . . . . 1.4 112.559 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.82 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 1.48 111.411 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -70.07 0.36 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.499 . . . . 2.15 110.537 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.99 27.5 0.18 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.223 -0.751 . . . . 1.77 111.223 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 111' ' ' LYS . 5.3 m120 67.02 107.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.559 0.744 . . . . 3.83 109.659 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.65 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 45.7 tp -149.65 148.93 29.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.63 -0.428 . . . . 3.54 111.541 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.633 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -88.63 144.44 26.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.046 -0.979 . . . . 2.47 111.688 178.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -150.1 153.37 36.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.454 -0.793 . . . . 2.01 109.874 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.8 ptm -126.35 125.39 42.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.547 -0.751 . . . . 2.22 109.734 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 32.5 p90 -144.11 165.54 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.866 0.365 . . . . 3.82 111.01 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.72 124.52 49.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.898 -0.592 . . . . 2.39 109.592 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.87 ' HH ' ' HG ' ' A' ' 72' ' ' SER . 31.0 t80 -136.38 161.61 35.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 3.62 110.534 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 103' ' ' THR . 89.1 m -106.55 136.7 45.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.211 -0.45 . . . . 1.97 110.212 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -125.34 104.73 8.63 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.222 -0.658 . . . . 1.47 109.222 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 69' ' ' CYS . 5.0 p-10 -86.17 -63.35 1.33 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.145 -0.622 . . . . 2.57 109.785 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.0 t80 47.19 55.09 8.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.761 -0.829 . . . . 3.46 108.761 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.22 -28.43 0.14 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.14 -0.937 . . . . 3.41 111.033 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.487 ' HE2' ' OG1' ' A' ' 103' ' ' THR . 33.6 ttp -67.7 163.35 21.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.234 -0.439 . . . . 3.33 110.222 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.493 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 14.8 t -55.46 146.67 42.32 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 108.383 -0.969 . . . . 2.56 108.383 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 22.5 Cg_endo -61.87 72.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.385 2.057 . . . . 1.72 113.289 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.487 ' OG1' ' HE2' ' A' ' 100' ' ' MET . 7.6 p -73.9 146.89 43.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.265 -0.425 . . . . 1.93 110.846 172.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -104.63 146.81 28.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 3.47 111.178 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.65 158.78 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.547 -0.752 . . . . 1.96 109.362 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -112.68 131.36 55.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.23 -1.026 . . . . 2.22 108.23 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.79 139.31 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.451 0.643 . . . . 1.97 110.843 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -121.59 104.22 9.48 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.594 -0.891 . . . . 1.37 108.594 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 5.1 ppp? -102.75 143.55 32.24 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 2.95 109.689 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.633 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 51.2 mtpt -149.65 146.42 27.26 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 109.708 -0.479 . . . . 2.05 109.708 -174.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.5 ' HD2' ' CB ' ' A' ' 87' ' ' ASN . 41.8 tttm -75.21 146.35 41.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.335 -0.617 . . . . 2.66 109.335 173.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -134.92 -159.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 1.57 110.088 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.28 -166.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.15 -0.685 . . . . 4.89 109.15 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.5 m 67.28 65.48 0.42 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.129 -0.693 . . . . 2.9 109.129 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.32 51.58 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.333 -0.707 . . . . 2.62 111.333 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.33 80.09 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.559 0.744 . . . . 2.76 112.684 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.82 176.06 9.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.837 -1.172 . . . . 1.61 107.837 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.588 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 80.3 m-85 -104.71 147.48 27.63 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.08 0.466 . . . . 1.4 110.121 -173.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 51.3 m95 -102.99 103.1 13.18 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.493 -0.776 . . . . 0.75 109.099 175.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -103.27 104.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.601 -1.181 . . . . 1.6 110.823 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 119' ' ' TRP . 11.6 m-85 -102.68 137.97 40.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.97 110.225 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -112.99 154.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.969 0.414 . . . . 1.83 111.894 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -165.24 153.09 11.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 3.79 109.436 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -73.26 98.66 2.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.916 -0.314 . . . . 4.65 111.791 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.401 1.063 . . . . 2.87 112.167 172.252 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 p90 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.158 -0.312 . . . . 4.68 110.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.82 119.49 6.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.508 -0.854 . . . . 0.96 112.709 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -104.8 126.18 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 1.26 109.341 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.467 ' HB ' HG11 ' A' ' 120' ' ' VAL . 51.6 mt -128.39 149.13 32.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 1.67 109.775 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.699 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.0 tt0 -112.01 134.65 53.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.987 -0.746 . . . . 1.02 108.987 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -139.67 153.41 47.28 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.136 -0.32 . . . . 2.24 110.136 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.683 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.1 p30 -103.86 168.27 9.24 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.682 -0.407 . . . . 1.22 110.576 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.588 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -57.38 -14.47 13.14 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 115.136 0.815 . . . . 0.79 115.136 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.08 -18.08 26.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.917 0.858 . . . . 1.95 110.391 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.28 26.42 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.682 -0.77 . . . . 0.61 112.012 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.683 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 92.1 m-20 -71.58 138.17 48.58 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.73 0.3 . . . . 1.64 110.807 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.493 HG12 ' HB2' ' A' ' 62' ' ' PHE . 14.0 mt -87.86 144.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.002 -0.545 . . . . 1.58 109.685 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -101.93 -63.74 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.5 0.667 . . . . 2.1 110.231 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.08 169.5 23.22 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.005 -0.998 . . . . 1.99 110.572 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.666 ' CE1' ' HB2' ' A' ' 52' ' ' ARG . 5.4 m-30 -113.91 175.94 5.25 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.113 -0.948 . . . . 1.25 109.364 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 45' ' ' ALA . 63.9 t30 -89.3 5.26 45.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.586 0.708 . . . . 2.14 110.091 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 71.47 -15.54 0.42 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.351 -1.295 . . . . 1.87 110.875 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -60.5 -32.5 71.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.585 -0.734 . . . . 2.02 111.84 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 1.075 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 8.2 tp10 -78.77 -14.66 59.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.482 0.658 . . . . 2.12 110.016 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.95 73.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.859 -0.686 . . . . 1.42 111.464 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.63 -52.16 48.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 2.35 110.836 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.522 HG22 HG21 ' A' ' 50' ' ' THR . 24.7 mt -83.82 -72.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 2.98 111.799 -170.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.522 HG21 HG22 ' A' ' 49' ' ' ILE . 11.9 t -173.73 43.24 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.049 0.928 . . . . 3.86 111.054 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 1.075 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -109.05 -119.94 4.3 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.268 -0.967 . . . . 2.91 113.673 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.666 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 24.9 mmt180 -139.21 153.46 47.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 3.64 111.539 -171.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.678 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 12.0 m-20 -81.91 155.98 70.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.495 -0.928 . . . . 2.1 108.495 163.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -29.94 85.57 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.112 1.874 . . . . 1.68 111.896 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -72.73 -22.66 60.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 4.08 111.598 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.678 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 67.4 mt-30 -81.95 -21.89 36.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.92 0.341 . . . . 3.05 111.92 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -121.54 62.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.687 0.625 . . . . 1.26 112.687 -172.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -119.26 132.49 68.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.297 -0.561 . . . . 1.66 111.058 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.2 -2.68 50.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.485 -0.864 . . . . 0.78 111.549 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 47.6 mttp -88.36 146.0 25.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.407 . . . . 2.37 110.609 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -94.25 107.24 19.2 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.785 -0.45 . . . . 0.83 109.785 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB2' HG12 ' A' ' 39' ' ' ILE . 82.2 t80 -51.39 -36.03 41.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.7 111.416 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.8 m-85 -86.16 16.06 4.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.761 0.282 . . . . 1.45 111.761 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -147.16 -45.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.423 0.527 . . . . 4.07 112.423 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.55 -78.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.137 0.421 . . . . 2.2 112.137 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' HG21 ' A' ' 66' ' ' VAL . 9.1 p -108.6 14.53 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.007 0.908 . . . . 2.34 111.367 -170.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -158.07 71.82 4.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.607 -0.724 . . . . 1.2 112.267 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.78 15.52 1.62 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.761 2.307 . . . . 0.98 112.805 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.04 -23.79 59.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.18 -0.674 . . . . 1.41 109.18 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 20.7 p -94.44 -32.04 13.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.587 -1.188 . . . . 1.74 110.52 -136.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 12.6 p-10 -77.36 82.29 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.251 1.024 . . . . 1.85 110.361 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.564 ' HG ' ' HH ' ' A' ' 94' ' ' TYR . 50.0 m -145.35 157.68 52.37 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.886 -1.052 . . . . 1.85 109.534 -175.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.87 -37.74 77.71 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.043 2.495 . . . . 1.4 113.742 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.66 14.36 25.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.428 0.529 . . . . 2.56 112.428 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' HE1' ' A' ' 92' ' ' PHE . 46.6 t80 -134.94 -73.99 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.246 -0.65 . . . . 4.11 109.246 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.699 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 66.7 t80 -63.51 -36.4 83.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.889 -0.596 . . . . 1.24 110.121 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -29.45 75.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.068 -0.586 . . . . 0.6 112.366 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 68.7 mttm -87.28 -25.87 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.943 0.401 . . . . 2.58 110.225 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' HD1' ' HE2' ' A' ' 109' ' ' MET . 79.6 t80 -62.56 -46.03 90.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.517 0.675 . . . . 0.79 109.501 169.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 30.0 mmmt -77.89 -16.74 58.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.3 -0.864 . . . . 1.63 110.481 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 40.9 tt0 -59.06 -39.97 83.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.674 . . . . 2.07 110.501 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -84.55 -45.85 5.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.519 -0.848 . . . . 0.72 112.107 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 79' ' ' PHE . 43.1 t -53.87 -52.94 30.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.662 0.385 . . . . 1.4 111.489 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.02 60.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.175 0.435 . . . . 1.48 112.175 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -98.02 -74.58 0.57 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.795 0.331 . . . . 2.15 110.81 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.03 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.001 -0.619 . . . . 1.77 111.561 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -109.82 156.74 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.475 -0.565 . . . . 3.83 109.475 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 45.6 tp -131.02 102.98 6.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 3.54 110.719 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 109' ' ' MET . 87.9 m-20 -143.76 97.98 3.16 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.783 -0.821 . . . . 2.47 108.783 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -131.16 155.72 46.53 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.113 -0.494 . . . . 2.01 111.797 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.4 ptt? -140.12 105.77 5.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 2.22 109.831 171.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HE1' ' CD2' ' A' ' 75' ' ' PHE . 25.7 p90 -127.2 167.13 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.764 -0.653 . . . . 3.82 110.739 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HG2' ' HE2' ' A' ' 106' ' ' LYS . 45.1 mt-10 -103.67 122.9 45.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.007 -0.368 . . . . 2.39 110.007 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.564 ' HH ' ' HG ' ' A' ' 72' ' ' SER . 39.5 t80 -142.15 158.4 43.79 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.533 -0.543 . . . . 3.62 109.533 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 p -104.26 156.36 17.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.51 0.672 . . . . 1.97 112.299 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.473 ' O ' ' HG3' ' A' ' 100' ' ' MET . 44.8 m-85 -121.85 112.61 18.55 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.653 -1.24 . . . . 1.47 107.653 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' HA ' ' A' ' 102' ' ' PRO . 4.5 m-20 -123.64 12.88 9.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.207 -0.451 . . . . 2.57 111.841 -166.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.85 -49.09 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 3.46 111.192 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -91.21 13.6 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 3.41 110.968 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 17.5 ptp -169.94 153.76 4.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 3.33 109.702 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 10.1 t -58.01 142.95 79.01 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.25 -1.019 . . . . 2.56 108.25 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.531 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 32.5 Cg_exo -31.65 86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.386 3.391 . . . . 1.72 114.976 -176.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 m -111.51 141.37 45.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 1.93 110.882 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -104.07 135.47 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.785 0.326 . . . . 3.47 110.399 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -127.95 166.37 25.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 1.96 110.669 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HE2' ' HG2' ' A' ' 93' ' ' GLU . 31.5 ttmt -110.81 117.02 32.28 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.346 -0.983 . . . . 2.22 108.346 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 91' ' ' MET . 80.1 t -104.11 120.58 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.068 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.42 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 12.3 t-160 -104.04 109.08 20.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.159 -0.682 . . . . 1.37 109.159 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 58.0 tpp -101.68 132.69 47.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 2.95 109.149 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 50.4 mtpt -137.62 131.57 31.75 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 121.153 -0.219 . . . . 2.05 110.498 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 81.6 tttt -90.53 123.22 34.03 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.123 0.487 . . . . 2.66 110.885 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.08 -175.24 2.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.675 -0.861 . . . . 1.57 108.675 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.42 -94.97 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.42 -0.956 . . . . 4.89 108.42 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 m 51.56 42.14 29.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.609 0.596 . . . . 2.9 112.609 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.03 79.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.758 . . . . 2.62 112.501 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.43 64.17 0.72 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.153 0.581 . . . . 2.76 111.695 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 20.4 p -139.05 163.92 31.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.095 -0.502 . . . . 1.61 110.694 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 4.9 m-85 -123.25 154.72 38.41 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.043 -1.095 . . . . 1.4 108.043 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -103.63 109.17 20.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.875 -0.787 . . . . 0.75 108.875 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 31' ' ' ILE . 14.6 p -100.71 134.35 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.682 0.753 . . . . 1.6 110.796 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.417 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 80.8 m-85 -120.83 132.62 55.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.97 110.037 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.1 t -103.17 104.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.886 -0.597 . . . . 1.83 110.061 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -103.16 110.18 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.877 -0.786 . . . . 3.79 108.877 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 105' ' ' VAL . 4.2 ptm180 -77.86 158.01 29.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.223 -0.444 . . . . 4.65 111.472 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.592 -0.718 . . . . 2.87 109.147 173.765 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.5 p90 . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 109.673 -0.491 . . . . 4.68 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 120.02 6.54 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.258 -0.972 . . . . 0.96 112.308 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.59 125.85 47.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.611 -0.515 . . . . 1.26 109.611 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.688 HG21 ' HA ' ' A' ' 42' ' ' TYR . 5.2 pt -132.17 165.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 1.67 111.991 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.538 ' HG2' HD21 ' A' ' 40' ' ' LEU . 50.3 tt0 -115.03 121.01 41.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.889 -0.596 . . . . 1.02 110.513 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -131.48 146.84 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.545 -0.539 . . . . 2.24 109.545 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.24 170.01 8.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.134 -0.321 . . . . 1.22 110.134 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.27 -23.33 12.4 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 114.306 0.482 . . . . 0.79 114.306 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.17 -21.56 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 1.95 110.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 96.51 4.9 59.22 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.151 -1.18 . . . . 0.61 110.151 -173.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -79.15 134.04 36.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.693 -0.754 . . . . 1.64 109.705 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 19.7 mt -93.02 140.24 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.924 -0.58 . . . . 1.58 110.154 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 32' ' ' GLN . 1.4 mm? -107.13 -66.48 1.02 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.144 0.497 . . . . 2.1 111.19 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -134.21 137.39 44.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.492 0.663 . . . . 1.99 111.47 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.688 ' HA ' HG21 ' A' ' 31' ' ' ILE . 3.6 m-30 -102.95 126.75 50.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.775 -1.102 . . . . 1.25 109.268 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -60.03 155.82 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.026 -0.361 . . . . 2.14 110.026 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.64 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.092 0.472 . . . . 1.87 109.874 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.27 70.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.969 -1.014 . . . . 2.02 112.61 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 38.7 tp10 -66.19 -47.96 72.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.12 110.566 -173.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.0 -10.18 72.59 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.834 -0.698 . . . . 1.42 112.503 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -93.12 -52.1 4.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.87 0.367 . . . . 2.35 110.884 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' C ' ' HG1' ' A' ' 50' ' ' THR . 31.6 mt -80.55 -72.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.394 -0.366 . . . . 2.98 110.939 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 24.5 m -153.77 106.93 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.608 -0.516 . . . . 3.86 109.608 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.528 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . 175.48 -139.75 4.87 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.067 -1.063 . . . . 2.91 112.964 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 3.0 mpt_? -124.24 174.7 7.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.706 0.289 . . . . 3.64 110.834 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.83 139.96 95.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.663 -0.699 . . . . 2.1 111.055 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.53 111.99 0.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.874 2.382 . . . . 1.68 112.497 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 81.49 11.2 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.239 -0.891 . . . . 4.08 112.545 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -94.44 22.05 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.326 0.584 . . . . 3.05 110.243 172.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.681 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -119.68 22.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.899 . . . . 1.26 111.26 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -88.51 136.61 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.878 -0.416 . . . . 1.66 109.878 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.76 11.97 84.18 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.829 -0.909 . . . . 0.78 110.829 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -118.77 141.49 48.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.69 0.281 . . . . 2.37 111.103 -173.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 23.7 t-20 -87.76 114.75 24.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.145 -0.48 . . . . 0.83 110.216 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -55.84 -35.22 66.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.963 0.411 . . . . 0.7 111.645 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.591 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 66.7 m-85 -76.48 -7.96 56.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.17 -0.468 . . . . 1.45 111.484 -174.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -136.45 -63.47 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.84 0.311 . . . . 4.07 111.84 -175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.93 -24.17 66.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.298 0.481 . . . . 2.2 112.298 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -125.89 12.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.33 -0.548 . . . . 2.34 110.969 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 171.06 85.71 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.399 -0.364 . . . . 1.2 111.434 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.0 -16.48 54.64 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.586 2.191 . . . . 0.98 113.769 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.2 m -50.4 -37.17 36.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.719 0.236 . . . . 1.41 110.901 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.591 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 10.3 m -92.82 -31.03 15.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.933 -1.031 . . . . 1.74 109.896 -135.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.56 97.13 4.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.995 -1.002 . . . . 1.85 110.16 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.5 m -164.05 152.21 11.11 Favored Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.046 -0.524 . . . . 1.85 110.019 -169.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.71 -30.33 92.1 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.278 1.985 . . . . 1.4 112.667 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HG3' ' HE2' ' A' ' 94' ' ' TYR . 9.5 pt-20 -86.14 6.37 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.271 0.471 . . . . 2.56 112.271 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.656 ' HE2' HG12 ' A' ' 107' ' ' VAL . 57.3 t80 -141.58 -71.67 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.873 -0.418 . . . . 4.11 109.873 173.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.653 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 89.0 t80 -53.75 -37.87 63.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.641 -0.709 . . . . 1.24 110.692 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -31.66 78.93 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.226 -0.512 . . . . 0.6 112.624 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -81.52 -32.67 32.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.521 0.677 . . . . 2.58 109.459 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.48 -32.15 71.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.913 -1.039 . . . . 0.79 109.588 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.653 ' HE3' ' CZ ' ' A' ' 76' ' ' TYR . 0.9 OUTLIER -88.84 -16.06 32.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.171 -0.922 . . . . 1.63 111.098 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.46 -51.33 63.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 2.07 110.573 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.35 -44.01 98.26 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.724 -0.671 . . . . 0.72 112.315 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.429 ' H ' HG21 ' A' ' 83' ' ' VAL . 23.4 t -55.85 -52.75 45.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.692 0.282 . . . . 1.4 110.869 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.7 86.81 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 116.051 -0.522 . . . . 1.48 111.196 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -66.33 -77.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 2.15 110.78 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.43 -75.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.522 -0.631 . . . . 1.77 111.522 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -97.62 147.66 24.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 3.83 110.13 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.984 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -111.21 110.4 20.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.568 -0.531 . . . . 3.54 109.568 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -175.68 91.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.974 0.892 . . . . 2.47 110.892 176.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HB ' ' HE2' ' A' ' 109' ' ' MET . 10.0 m -131.44 154.55 48.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.311 -0.859 . . . . 2.01 109.23 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.467 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 19.6 ptt? -128.27 104.08 7.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.981 0.419 . . . . 2.22 110.155 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -125.15 166.59 16.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 3.82 110.194 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.42 131.22 50.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.985 0.421 . . . . 2.39 110.537 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 50.8 t80 -136.87 159.91 40.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 3.62 109.679 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -102.97 113.63 27.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.943 0.402 . . . . 1.97 110.315 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.09 103.1 11.77 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.11 0.481 . . . . 1.47 109.801 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 100' ' ' MET . 49.5 m-20 -126.41 101.74 6.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.653 -0.703 . . . . 2.57 109.886 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -73.56 63.79 0.84 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.804 -1.184 . . . . 3.46 107.804 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 63.6 59.91 1.15 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.992 -1.004 . . . . 3.41 108.443 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 42.7 tpp -133.04 164.74 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.953 -1.021 . . . . 3.33 111.09 -168.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.1 p -59.49 151.91 58.17 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 108.747 -0.835 . . . . 2.56 108.747 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.17 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.641 2.227 . . . . 1.72 113.483 -171.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -90.71 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 1.93 110.723 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.72 120.94 41.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.967 -0.383 . . . . 3.47 109.967 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 124' ' ' ARG . 30.2 m -122.02 166.42 16.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.838 -0.619 . . . . 1.96 110.459 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 82.8 tttt -103.56 120.92 41.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.763 -0.828 . . . . 2.22 108.763 177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.656 HG12 ' HE2' ' A' ' 75' ' ' PHE . 6.5 p -106.45 115.99 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-O 122.096 0.951 . . . . 1.97 110.096 -174.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.494 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 18.7 t-160 -107.5 103.5 12.84 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.072 -0.967 . . . . 1.37 108.925 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.99 134.31 47.48 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.575 -0.45 . . . . 2.95 110.078 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HD2' ' CE1' ' A' ' 108' ' ' HIS . 8.8 mtpm? -140.65 134.75 30.87 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 120.688 0.28 . . . . 2.05 110.928 -172.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.984 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 26.0 ttpp -80.85 136.75 36.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.322 -0.399 . . . . 2.66 110.896 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.98 -173.21 3.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.403 -0.362 . . . . 1.57 111.172 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.5 -164.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.201 -0.454 . . . . 4.89 110.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.1 m 65.89 54.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.615 0.721 . . . . 2.9 110.365 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.39 -2.4 8.88 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.196 -0.911 . . . . 2.62 111.605 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.5 41.68 31.81 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.425 0.631 . . . . 2.76 110.614 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.42 -175.75 2.75 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.618 -0.719 . . . . 1.61 109.51 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.453 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 5.6 m-85 -119.6 151.69 38.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.028 -0.73 . . . . 1.4 109.028 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -102.44 108.5 19.84 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.348 -0.982 . . . . 0.75 108.348 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.553 ' CG1' HG13 ' A' ' 31' ' ' ILE . 10.9 p -101.68 137.71 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 119.801 -0.759 . . . . 1.6 110.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -114.03 125.21 53.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.436 -0.802 . . . . 0.97 110.185 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.05 114.88 48.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.378 . . . . 1.83 110.011 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -139.07 129.19 25.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.88 -0.415 . . . . 3.79 109.88 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.627 ' HA ' HG11 ' A' ' 105' ' ' VAL . 12.8 ptp180 -75.02 114.64 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.016 0.436 . . . . 4.65 110.455 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.407 ' CG2' ' HB2' ' A' ' 106' ' ' LYS . 6.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.068 -0.491 . . . . 2.87 110.43 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.816 0.341 . . . . 4.68 111.388 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.78 130.72 10.34 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.475 -0.869 . . . . 0.96 112.18 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.84 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.932 -0.395 . . . . 1.26 109.932 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 32' ' ' GLN . 9.5 mm -114.5 152.39 16.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 1.67 109.895 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.454 ' N ' HG23 ' A' ' 31' ' ' ILE . 64.4 tt0 -124.06 104.67 9.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.614 -0.513 . . . . 1.02 109.614 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CD1' HG12 ' A' ' 39' ' ' ILE . 1.9 mm? -105.47 143.62 33.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.399 -0.364 . . . . 2.24 110.277 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p30 -104.38 167.69 9.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.041 -0.264 . . . . 1.22 110.435 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.01 -22.46 35.24 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.046 0.779 . . . . 0.79 115.046 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.426 0.613 . . . . 1.95 110.35 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.84 43.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.192 -0.763 . . . . 0.61 111.192 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.0 m-20 -88.19 146.44 25.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.076 0.465 . . . . 1.64 111.416 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.684 HD12 HG12 ' A' ' 57' ' ' VAL . 10.0 mt -95.41 148.24 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 1.58 110.305 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 39' ' ' ILE . 83.1 mt -107.44 -80.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.027 -0.533 . . . . 2.1 109.76 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -116.78 136.9 52.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 1.99 111.571 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 1.026 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.4 m-30 -98.02 -175.61 3.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.892 -1.049 . . . . 1.25 110.64 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.73 161.34 20.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.626 -0.879 . . . . 2.14 108.626 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.81 -23.31 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.527 0.566 . . . . 1.87 112.527 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.79 94.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 2.02 111.078 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.3 mp0 -63.8 -27.11 68.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 2.12 111.281 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.64 -13.88 62.29 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.538 -0.839 . . . . 1.42 112.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.73 -54.48 3.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.835 0.35 . . . . 2.35 110.542 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.28 -60.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 2.98 110.124 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 3.8 m -78.73 -54.7 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.88 -0.6 . . . . 3.86 111.451 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.18 14.0 6.75 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 2.91 112.033 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HG3' ' CG1' ' A' ' 66' ' ' VAL . 19.7 mmt180 -97.69 110.09 22.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 3.64 110.005 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 15.3 m-20 -63.58 143.6 97.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.381 -0.372 . . . . 2.1 110.743 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 1.026 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 71.6 Cg_exo -52.34 -28.01 33.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.871 3.047 . . . . 1.68 114.804 -170.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -124.67 28.61 6.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.99 0.367 . . . . 4.08 111.99 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.53 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 77.0 mm-40 -94.78 0.07 54.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.255 0.55 . . . . 3.05 110.967 175.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.684 HG12 HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -93.38 -93.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.816 -0.629 . . . . 1.26 111.442 175.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 mm 54.31 99.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.427 0.691 . . . . 1.66 112.239 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.26 71.77 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.265 -1.134 . . . . 0.78 110.265 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 6.7 mmtp -111.33 121.0 44.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.708 -1.246 . . . . 2.37 109.553 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -71.24 105.38 3.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.83 110.843 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' HB2' HG12 ' A' ' 39' ' ' ILE . 85.1 t80 -54.19 -39.16 66.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.7 111.107 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.5 m-85 -82.69 30.54 0.43 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.762 -0.654 . . . . 1.45 111.213 -174.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -161.85 -42.4 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.226 -0.443 . . . . 4.07 110.575 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.94 -78.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.563 -0.289 . . . . 2.2 111.002 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 66' ' ' VAL . 2.9 t -87.62 14.91 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.299 0.571 . . . . 2.34 111.222 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -177.76 94.62 0.23 Allowed Pre-proline 0 C--O 1.222 -0.383 0 O-C-N 122.125 -0.36 . . . . 1.2 111.267 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 98' ' ' TYR . 3.9 Cg_exo -78.7 -19.89 10.96 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.419 2.079 . . . . 0.98 112.834 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -76.87 -19.68 57.17 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.646 -0.422 . . . . 1.41 110.864 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.684 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 18.4 p -73.86 -36.53 64.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.302 -0.863 . . . . 1.74 111.119 -172.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.2 96.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.85 109.895 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.5 p 175.79 158.0 0.4 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.32 -0.622 . . . . 1.85 109.32 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 58.9 Cg_exo -52.87 -32.12 55.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.801 2.334 . . . . 1.4 112.354 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.59 -59.02 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 2.56 111.255 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 28.4 m-85 -96.09 -69.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.025 -0.534 . . . . 4.11 111.357 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.576 ' HH ' ' HZ2' ' A' ' 80' ' ' LYS . 56.6 t80 -63.03 -30.39 71.56 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 1.24 111.116 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -61.44 -41.14 99.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.021 -0.609 . . . . 0.6 112.177 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -79.23 -29.72 42.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 2.58 110.121 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.462 ' HD1' ' CE ' ' A' ' 109' ' ' MET . 84.7 t80 -57.82 -40.38 79.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.335 -0.848 . . . . 0.79 110.634 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' HZ2' ' HH ' ' A' ' 76' ' ' TYR . 14.1 mmmm -95.4 -12.06 26.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.932 -0.576 . . . . 1.63 110.993 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 32.4 tt0 -68.86 -43.49 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 2.07 110.379 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' A' ' 88' ' ' LEU . . . -66.57 -43.41 92.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.695 -0.764 . . . . 0.72 112.022 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 83' ' ' VAL . 16.2 t -61.03 -49.48 84.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 1.4 110.88 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -4.64 27.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.48 112.019 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.2 m -100.53 -73.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.634 0.254 . . . . 2.15 110.782 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.91 -63.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 1.77 111.952 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.15 139.57 46.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.606 -0.516 . . . . 3.83 109.606 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.797 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -106.89 104.46 14.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.387 -0.597 . . . . 3.54 109.387 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.7 p30 -172.15 116.15 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.497 0.665 . . . . 2.47 109.868 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 21.4 m -148.36 142.23 25.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 2.01 109.887 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.0 ptm -119.92 120.1 35.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.448 -0.575 . . . . 2.22 109.448 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.457 ' CD1' ' HD1' ' A' ' 94' ' ' TYR . 4.2 p90 -140.03 157.81 45.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.421 . . . . 3.82 111.953 -172.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.505 ' OE1' ' HG3' ' A' ' 106' ' ' LYS . 5.5 mp0 -104.42 121.64 43.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 2.39 109.896 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.512 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 26.6 m-85 -142.9 165.82 26.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.36 -0.382 . . . . 3.62 110.286 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 13.5 m -107.36 144.26 34.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.39 -0.368 . . . . 1.97 110.527 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.77 106.99 15.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 1.47 109.478 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.47 111.01 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 2.57 110.829 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 68' ' ' PRO . 72.7 t80 -175.76 -79.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.484 -0.78 . . . . 3.46 109.475 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -99.55 -34.28 10.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.419 -0.586 . . . . 3.41 109.419 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.6 ttm -82.11 137.86 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.041 -1.096 . . . . 3.33 108.041 164.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -64.4 154.78 82.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.419 -0.586 . . . . 2.56 109.419 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.47 87.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.136 2.557 . . . . 1.72 114.114 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -102.97 130.48 50.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.848 -0.615 . . . . 1.93 109.952 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 22.3 pttp -103.62 124.84 49.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.401 -0.592 . . . . 3.47 109.401 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 124' ' ' ARG . 15.1 m -132.11 165.52 31.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.827 -0.624 . . . . 1.96 112.179 -171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.588 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 22.7 ttmm -104.75 111.01 23.57 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.288 -1.005 . . . . 2.22 108.288 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.63 127.75 58.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.611 -0.514 . . . . 1.97 109.611 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 12.1 t-160 -104.61 113.42 26.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.4 0.619 . . . . 1.37 109.458 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.679 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 27.3 tpp -101.13 123.54 45.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.518 -1.219 . . . . 2.95 108.772 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 63.8 pttt -150.44 146.8 26.88 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.093 -0.643 . . . . 2.05 111.512 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 48.6 tttm -87.52 140.27 29.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.087 -0.506 . . . . 2.66 110.567 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.1 -172.84 4.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.612 0.244 . . . . 1.57 110.439 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -168.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.196 -0.298 . . . . 4.89 110.196 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m 75.15 72.86 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.806 0.691 . . . . 2.9 110.094 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.38 -8.4 44.35 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.093 -0.803 . . . . 2.62 111.093 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 55.03 80.81 0.12 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.598 0.713 . . . . 2.76 111.165 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 2.6 p -156.51 -169.83 3.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.005 -0.998 . . . . 1.61 109.063 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.441 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 8.5 m-85 -119.38 152.57 36.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.332 -0.988 . . . . 1.4 108.332 -177.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.6 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 55.5 m95 -101.54 106.0 17.04 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.591 0.71 . . . . 0.75 109.148 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 108' ' ' HIS . 38.9 t -102.6 104.34 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.401 -1.272 . . . . 1.6 110.612 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.6 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 98.7 m-85 -104.79 134.08 48.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.139 -0.937 . . . . 0.97 110.253 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.48 144.9 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.585 -0.28 . . . . 1.83 110.703 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.588 ' HD2' ' HD2' ' A' ' 106' ' ' LYS . 18.5 ptpt -139.49 145.16 38.42 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.838 -0.431 . . . . 3.79 109.838 173.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.703 ' HA ' HG11 ' A' ' 105' ' ' VAL . 1.5 tmt_? -84.4 111.69 19.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.639 -0.255 . . . . 4.65 110.591 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.474 HG12 ' HE2' ' A' ' 106' ' ' LYS . 16.7 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.618 -0.706 . . . . 2.87 111.033 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.91 -0.404 . . . . 4.68 109.91 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 45' ' ' ALA . . . -104.7 130.24 10.15 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.641 -0.79 . . . . 0.96 111.302 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -135.76 104.13 5.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.172 0.51 . . . . 1.26 111.163 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.904 ' HB ' HG12 ' A' ' 120' ' ' VAL . 34.6 mt -113.07 159.74 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.079 -1.082 . . . . 1.67 108.079 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.641 HE22 HD23 ' A' ' 113' ' ' LEU . 64.6 tt0 -131.97 116.65 17.39 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.937 -0.477 . . . . 1.02 110.467 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.39 165.2 12.42 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.433 -0.58 . . . . 2.24 109.433 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -121.1 168.4 11.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.926 -0.398 . . . . 1.22 109.926 175.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.98 -24.62 35.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.415 0.526 . . . . 0.79 114.415 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.62 -21.51 55.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.95 110.83 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.84 2.65 36.8 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.807 -0.633 . . . . 0.61 111.845 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 92.6 m-20 -78.46 153.31 31.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.95 0.405 . . . . 1.64 110.864 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 60' ' ' LYS . 9.3 mt -96.87 146.88 6.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.715 -0.675 . . . . 1.58 109.674 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 40' ' ' LEU . 2.3 mm? -102.04 -46.96 4.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.629 0.728 . . . . 2.1 109.515 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.87 157.76 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.602 -1.181 . . . . 1.99 110.123 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.858 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 8.1 m-30 -110.54 177.82 4.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 1.25 110.456 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t-20 -107.36 179.25 4.3 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.292 -1.003 . . . . 2.14 108.292 172.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 -9.46 43.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.086 0.47 . . . . 1.87 109.908 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.546 ' CB ' ' HA2' ' A' ' 29' ' ' GLY . . . -55.71 -60.08 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.253 -0.885 . . . . 2.02 111.897 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -65.55 -27.15 68.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 2.12 111.22 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.2 -50.31 51.98 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.564 -0.827 . . . . 1.42 111.786 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.1 -55.19 31.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.121 0.486 . . . . 2.35 110.309 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.6 67.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.688 -1.226 . . . . 2.98 107.688 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -36.32 90.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.754 -1.566 . . . . 3.86 114.561 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -104.42 -59.29 0.68 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.325 -1.307 . . . . 2.91 110.46 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.82 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 35.3 mmt180 -149.51 168.79 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.634 0.373 . . . . 3.64 110.444 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.645 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 8.9 m-20 -90.55 141.12 26.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 2.1 109.759 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.858 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 52.8 Cg_exo -56.55 -25.88 61.15 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.193 2.595 . . . . 1.68 114.086 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -103.79 6.67 36.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.188 0.44 . . . . 4.08 112.188 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.645 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 82.9 mm-40 -102.82 6.13 39.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.069 0.461 . . . . 3.05 110.699 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 7.7 m -118.15 40.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.217 0.532 . . . . 1.26 111.606 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.01 112.25 24.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.37 -0.377 . . . . 1.66 110.64 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.21 11.72 71.32 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.964 -0.854 . . . . 0.78 110.964 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 39' ' ' ILE . 7.2 tptt -88.02 121.55 30.56 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.992 -0.604 . . . . 2.37 109.558 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 47.5 t-20 -71.78 110.99 6.68 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.442 -0.577 . . . . 0.83 109.442 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 86.6 t80 -53.98 -41.0 67.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.429 -0.805 . . . . 0.7 110.74 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 46.2 m-85 -85.86 9.48 16.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.237 -0.438 . . . . 1.45 110.803 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 48.0 tptt -124.54 -61.95 1.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.386 -0.37 . . . . 4.07 110.715 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -104.09 -22.8 13.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.17 0.433 . . . . 2.2 112.17 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.588 ' CG1' ' HG3' ' A' ' 52' ' ' ARG . 1.9 t -113.17 13.52 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.182 -0.607 . . . . 2.34 111.765 -170.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 66' ' ' VAL . . . 167.27 79.57 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.971 -0.559 . . . . 1.2 110.235 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.03 -17.15 50.95 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.751 2.301 . . . . 0.98 113.035 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.865 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.9 p -76.36 -26.66 55.92 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.486 -0.486 . . . . 1.41 110.225 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 1.9 m -80.1 -31.89 39.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.902 -1.045 . . . . 1.74 110.486 -164.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 10.5 t70 -63.75 99.23 0.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.159 -0.682 . . . . 1.85 109.159 172.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -169.56 149.46 3.68 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.723 -0.473 . . . . 1.85 109.723 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 5.3 Cg_exo -38.47 -42.79 1.8 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.742 3.628 . . . . 1.4 114.584 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.789 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.01 -53.55 4.22 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.598 -0.441 . . . . 2.56 111.19 -178.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' HB2' ' O ' ' A' ' 70' ' ' THR . 29.2 m-85 -59.63 -63.81 1.17 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.094 0.473 . . . . 4.11 110.706 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.414 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 39.6 t80 -67.47 -28.68 68.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.614 . . . . 1.24 110.097 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -63.62 -34.75 90.79 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.699 -0.682 . . . . 0.6 112.605 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.789 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 72.1 mmtt -75.09 -36.97 61.67 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.123 0.487 . . . . 2.58 109.751 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' HD12 ' A' ' 88' ' ' LEU . 82.2 t80 -59.89 -35.4 74.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.825 . . . . 0.79 110.69 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -94.52 -4.79 47.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.074 -0.512 . . . . 1.63 111.808 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -49.97 73.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.034 0.445 . . . . 2.07 110.269 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.583 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.14 -37.29 63.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.72 111.794 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.676 HG23 ' HH ' ' A' ' 118' ' ' TYR . 21.9 t -52.86 -56.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 122.971 0.508 . . . . 1.4 111.518 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.76 62.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 1.48 112.048 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.9 m -88.67 -73.2 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.381 . . . . 2.15 110.681 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.3 -72.14 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.936 -0.65 . . . . 1.77 111.521 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.76 149.09 28.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.667 -0.864 . . . . 3.83 108.667 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.583 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -116.27 101.8 9.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.18 -0.674 . . . . 3.54 109.18 178.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 109' ' ' MET . 45.9 m-80 -149.12 83.14 1.44 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.383 -0.599 . . . . 2.47 109.383 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.8 p -127.83 158.49 37.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 2.01 111.289 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.2 ptm -137.44 113.74 10.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.893 -0.594 . . . . 2.22 110.302 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.713 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 8.8 p90 -136.65 164.73 27.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 3.82 110.81 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.5 122.04 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 2.39 110.702 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.713 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 5.1 m-85 -144.21 167.03 23.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 3.62 110.089 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.0 t -103.63 154.22 19.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.268 0.556 . . . . 1.97 111.983 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -120.23 103.45 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.416 -0.957 . . . . 1.47 108.416 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 24.3 t70 -113.23 -131.37 0.32 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.586 -0.734 . . . . 2.57 109.516 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 61.7 t80 70.65 -70.23 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.434 0.694 . . . . 3.46 111.241 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -118.97 -2.14 10.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.302 0.572 . . . . 3.41 110.268 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.4 tpt -116.26 151.27 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.352 -0.84 . . . . 3.33 109.301 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.55 HG21 HG21 ' A' ' 103' ' ' THR . 9.8 t -55.98 142.45 65.05 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 108.345 -0.983 . . . . 2.56 108.345 169.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 26.7 Cg_endo -62.84 72.16 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.73 2.287 . . . . 1.72 112.662 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.55 HG21 HG21 ' A' ' 101' ' ' THR . 1.4 p -81.78 144.33 31.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.917 -0.583 . . . . 1.93 111.504 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.85 117.38 33.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.537 -0.301 . . . . 3.47 110.346 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.24 166.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.073 -0.512 . . . . 1.96 110.889 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -103.6 128.34 50.89 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.367 -0.975 . . . . 2.22 108.367 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' MET . 7.4 p -116.37 139.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 109.486 -0.561 . . . . 1.97 109.486 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 11.6 t-160 -117.2 115.67 25.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.651 -0.704 . . . . 1.37 109.166 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 86.1 mmm -100.35 126.34 46.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.201 -0.666 . . . . 2.95 109.201 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' NZ ' ' HB3' ' A' ' 110' ' ' LYS . 8.0 mtpm? -141.84 121.58 13.47 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 120.837 0.351 . . . . 2.05 111.187 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 76.5 tttt -73.17 131.42 42.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.045 -0.525 . . . . 2.66 110.824 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.21 -160.76 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.967 0.358 . . . . 1.57 111.967 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.641 HD23 HE22 ' A' ' 32' ' ' GLN . 13.7 tp 33.62 111.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.939 1.829 . . . . 4.89 115.939 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.6 m -18.23 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.406 1.691 . . . . 2.9 112.569 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.42 -8.14 0.55 Allowed Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.176 -0.92 . . . . 2.62 111.449 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 59.62 24.3 13.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.793 0.806 . . . . 2.76 110.054 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.9 p -82.67 171.57 13.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.493 -1.23 . . . . 1.61 109.466 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.676 ' HH ' HG23 ' A' ' 83' ' ' VAL . 1.6 m-85 -128.07 153.35 46.9 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.338 -0.615 . . . . 1.4 109.338 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -100.55 109.36 21.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.473 -0.936 . . . . 0.75 108.473 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.904 HG12 ' HB ' ' A' ' 31' ' ' ILE . 2.4 p -101.57 106.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 122.307 1.051 . . . . 1.6 110.517 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -103.25 136.82 42.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.651 -1.159 . . . . 0.97 109.975 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.69 147.01 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 1.83 112.02 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -149.01 154.23 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.321 -0.854 . . . . 3.79 109.457 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -100.95 121.89 42.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.018 -0.364 . . . . 4.65 110.018 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.222 -0.894 . . . . 2.87 110.521 179.083 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 109.64 -0.504 . . . . 4.68 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.24 117.2 5.74 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.115 -1.04 . . . . 0.96 112.48 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.66 104.23 14.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.696 -0.483 . . . . 1.26 109.696 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.794 ' HB ' HG11 ' A' ' 120' ' ' VAL . 37.7 mt -107.85 157.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.869 -0.605 . . . . 1.67 109.642 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.604 HE22 ' HB2' ' A' ' 113' ' ' LEU . 2.8 mt-30 -130.03 142.17 50.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.15 -0.315 . . . . 1.02 110.15 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.27 153.87 46.65 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.294 -0.632 . . . . 2.24 109.294 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.7 OUTLIER -104.41 168.4 9.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.15 -23.77 18.54 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.467 0.479 . . . . 0.79 114.205 -175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 -37.06 37.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.216 0.508 . . . . 1.95 110.528 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.54 5.0 6.69 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.639 -0.791 . . . . 0.61 112.307 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -70.72 147.15 49.35 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.564 -0.532 . . . . 1.64 109.564 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 mt -94.43 146.89 6.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.301 -0.629 . . . . 1.58 109.301 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 40' ' ' LEU . 4.0 mp -127.98 -80.46 0.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 2.1 109.8 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.5 mp0 -89.45 141.06 28.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.44 -0.8 . . . . 1.99 109.976 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.615 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -130.48 5.33 4.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.349 -0.387 . . . . 1.25 110.918 178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.92 -173.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.865 -0.607 . . . . 2.14 109.93 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.83 5.38 45.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.446 0.641 . . . . 1.87 109.495 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -77.95 -51.44 10.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.777 . . . . 2.02 111.338 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.03 -20.87 61.62 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.916 0.389 . . . . 2.12 110.913 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.45 -19.83 77.93 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.714 -0.755 . . . . 1.42 111.31 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -94.89 -16.67 22.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.202 0.525 . . . . 2.35 110.185 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 45' ' ' ALA . 50.3 mm -82.73 -63.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 2.98 111.152 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -139.92 40.88 1.98 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.161 0.981 . . . . 3.86 111.1 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.25 37.27 64.32 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.106 -0.952 . . . . 2.91 113.282 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 17.9 mmt-85 -98.6 85.67 3.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 3.64 110.985 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.605 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 6.5 m-20 -67.31 148.59 98.71 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.277 -0.874 . . . . 2.1 109.649 175.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.615 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 49.4 Cg_exo -55.5 -32.89 84.33 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.255 1.97 . . . . 1.68 111.427 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -73.35 -18.35 61.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.724 -0.671 . . . . 4.08 111.668 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.605 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 79.4 mm-40 -78.25 -26.61 47.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.713 0.264 . . . . 3.05 111.713 -175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.711 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.0 m -109.13 14.8 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.257 0.836 . . . . 1.26 113.257 -172.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 62.5 mt -83.83 133.42 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.608 -0.516 . . . . 1.66 109.608 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.14 88.5 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.211 -0.995 . . . . 0.78 110.885 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 34.8 mttm -104.88 133.03 50.38 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.126 -0.537 . . . . 2.37 109.82 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -84.34 113.31 21.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.73 -0.388 . . . . 0.83 110.138 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 66.8 t80 -54.51 -50.14 68.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.533 -0.758 . . . . 0.7 111.173 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.6 m-85 -79.76 21.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.286 0.476 . . . . 1.45 112.286 -172.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -149.92 -49.67 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.87 0.366 . . . . 4.07 111.712 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -87.19 -76.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 2.2 111.571 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -86.13 15.72 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.964 0.411 . . . . 2.34 111.491 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -171.41 96.12 0.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 121.998 -0.439 . . . . 1.2 111.835 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -89.96 -9.69 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.084 2.522 . . . . 0.98 112.898 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -83.95 -4.03 58.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.93 -0.308 . . . . 1.41 111.077 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 HG22 ' CE1' ' A' ' 62' ' ' PHE . 6.8 p -98.45 -38.74 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.064 -0.517 . . . . 1.74 111.534 -164.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 13.4 t70 -68.69 91.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.299 -0.41 . . . . 1.85 109.974 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.3 p -150.21 160.19 33.74 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 1.85 110.596 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 -43.84 53.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.927 2.418 . . . . 1.4 113.608 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -78.54 -26.0 45.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.383 0.512 . . . . 2.56 112.383 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HE2' HG12 ' A' ' 107' ' ' VAL . 67.5 t80 -105.57 -67.9 0.9 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.46 . . . . 4.11 110.894 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 89.7 t80 -64.18 -39.29 93.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.847 -0.615 . . . . 1.24 110.863 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.2 97.56 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.97 -0.634 . . . . 0.6 112.366 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -73.44 -32.21 64.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 2.58 110.606 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' O ' HG21 ' A' ' 83' ' ' VAL . 73.3 t80 -57.58 -45.87 84.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.555 0.693 . . . . 0.79 110.092 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.294 -0.866 . . . . 1.63 112.005 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 2.07 110.726 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -73.99 -44.06 31.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.312 -0.947 . . . . 0.72 111.317 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 79' ' ' PHE . 22.0 t -56.19 -55.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.248 -0.476 . . . . 1.4 111.426 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.38 83.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.285 -0.416 . . . . 1.48 112.001 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.1 m -73.52 -70.99 0.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.437 -0.347 . . . . 2.15 111.432 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.2 -79.38 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.691 -0.766 . . . . 1.77 111.843 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -92.33 149.57 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.289 -0.456 . . . . 3.83 110.786 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.759 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -121.11 120.58 35.71 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.033 -0.728 . . . . 3.54 109.033 177.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.6 p30 -159.59 123.11 3.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 2.47 109.905 173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -164.59 159.42 19.08 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.134 -0.939 . . . . 2.01 110.235 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 53.4 ttm -132.09 107.84 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.039 -0.726 . . . . 2.22 109.039 175.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -120.23 156.22 31.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 3.82 109.641 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.34 120.13 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.443 0.64 . . . . 2.39 110.254 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -138.6 165.79 26.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.09 -0.959 . . . . 3.62 109.493 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' THR . 49.2 p -104.25 154.88 19.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.858 0.361 . . . . 1.97 111.937 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.34 103.14 9.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.758 -0.83 . . . . 1.47 108.758 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 1.7 p30 -128.58 20.86 6.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.189 -0.46 . . . . 2.57 111.444 -172.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.543 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -59.76 -44.25 93.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.68 -0.691 . . . . 3.46 111.672 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -144.18 -44.77 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.691 -0.855 . . . . 3.41 108.691 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.9 ttt -71.31 151.83 43.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.855 -1.066 . . . . 3.33 108.768 170.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 p -53.68 149.8 15.08 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.514 -0.55 . . . . 2.56 109.514 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 97' ' ' ASP . 18.1 Cg_endo -59.74 80.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.454 2.103 . . . . 1.72 113.129 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.0 p -74.04 151.73 40.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.93 110.742 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 124' ' ' ARG . 10.1 mtmp? -104.62 121.19 43.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.771 0.32 . . . . 3.47 110.176 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 35.3 m -117.44 161.51 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.929 0.395 . . . . 1.96 110.683 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -116.17 113.93 23.76 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.739 -1.208 . . . . 2.22 107.739 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.601 HG12 ' HE2' ' A' ' 75' ' ' PHE . 14.8 p -106.25 142.35 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.134 0.492 . . . . 1.97 110.136 -170.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -115.35 110.98 20.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.036 -0.727 . . . . 1.37 109.036 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.7 tpp -101.84 130.78 48.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.54 -0.754 . . . . 2.95 109.258 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 15.2 ptmm? -156.83 141.57 16.91 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.007 0.432 . . . . 2.05 111.532 -177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.568 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 42.6 tttp -83.64 117.68 23.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.769 -0.651 . . . . 2.66 111.243 -172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -176.12 108.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.133 0.42 . . . . 1.57 112.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.604 ' HB2' HE22 ' A' ' 32' ' ' GLN . 38.9 tp 168.04 -109.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.943 0.897 . . . . 4.89 109.146 171.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -85.81 19.3 2.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.338 0.59 . . . . 2.9 109.677 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.83 -56.09 4.65 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.602 -0.726 . . . . 2.62 111.531 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -93.11 31.1 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.445 0.64 . . . . 2.76 111.219 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 28.8 t -146.95 142.2 27.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.384 -0.598 . . . . 1.61 109.384 173.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.568 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 13.0 m-85 -120.01 164.88 15.45 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.422 -0.808 . . . . 1.4 109.969 -167.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.563 ' HD1' ' HB1' ' A' ' 112' ' ' ALA . 73.2 m95 -102.32 108.39 19.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.905 -0.776 . . . . 0.75 108.905 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.794 HG11 ' HB ' ' A' ' 31' ' ' ILE . 4.4 p -101.33 109.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.294 1.045 . . . . 1.6 110.717 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.43 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 83.3 m-85 -102.35 124.44 47.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.244 -0.889 . . . . 0.97 109.779 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 123.93 69.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.826 0.346 . . . . 1.83 111.044 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -137.29 134.9 36.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.299 -0.63 . . . . 3.79 109.299 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 2.6 ttp180 -77.98 146.19 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.332 -0.395 . . . . 4.65 111.284 -172.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.734 -1.127 . . . . 2.87 110.687 175.669 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 120.549 0.214 . . . . 4.68 110.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 122' ' ' VAL . . . -105.35 158.27 16.01 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.785 -0.721 . . . . 0.96 112.686 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.66 112.2 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.394 -0.595 . . . . 1.26 109.394 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.921 HG22 ' HA ' ' A' ' 42' ' ' TYR . 8.9 pt -131.66 166.74 28.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.046 0.387 . . . . 1.67 112.046 -175.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -122.4 134.2 54.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.438 . . . . 1.02 110.296 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.417 HD22 HG13 ' A' ' 120' ' ' VAL . 1.7 pt? -138.79 157.62 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 2.24 110.691 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.625 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 167.76 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.002 -0.279 . . . . 1.22 110.706 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.97 -14.03 22.13 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.762 0.665 . . . . 0.79 114.762 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.471 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 26.7 t70 -86.33 -20.39 28.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.581 0.69 . . . . 1.95 110.312 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 112.19 0.59 26.73 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.588 -0.815 . . . . 0.61 111.961 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.625 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 49.5 m-80 -74.56 138.05 42.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 120.911 0.386 . . . . 1.64 110.203 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.5 mt -88.58 148.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.086 -0.709 . . . . 1.58 109.086 173.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 39' ' ' ILE . 7.8 mp -112.87 -63.56 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.26 0.552 . . . . 2.1 110.736 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -136.77 126.63 25.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.565 -0.743 . . . . 1.99 110.67 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 1.097 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 1.6 m-30 -93.04 162.27 14.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.069 -0.969 . . . . 1.25 110.572 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.38 161.51 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.564 -0.902 . . . . 2.14 108.564 166.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -12.34 59.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.795 0.331 . . . . 1.87 111.403 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.2 75.07 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.145 -0.479 . . . . 2.02 111.305 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.8 -21.37 64.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 2.12 109.892 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -68.89 -30.54 72.41 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.639 -0.71 . . . . 1.42 111.792 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -79.11 -32.57 44.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 2.35 110.207 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.88 -64.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 2.98 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.626 HG21 ' HG2' ' A' ' 52' ' ' ARG . 4.2 t -113.51 -38.62 4.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.795 0.331 . . . . 3.86 111.094 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.603 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 101.31 53.6 1.0 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.44 -0.886 . . . . 2.91 112.223 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.626 ' HG2' HG21 ' A' ' 50' ' ' THR . 14.2 mmt180 -119.14 125.74 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.595 -0.52 . . . . 3.64 109.595 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.901 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -65.81 137.62 96.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.597 -0.274 . . . . 2.1 110.783 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 1.097 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 88.7 Cg_exo -49.47 -25.25 10.23 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.836 3.024 . . . . 1.68 114.222 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -101.6 -2.13 31.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.592 0.219 . . . . 4.08 111.592 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.901 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.16 -0.88 46.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.561 0.22 . . . . 3.05 111.281 -177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.684 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.8 m -102.78 17.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.429 0.529 . . . . 1.26 112.429 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -86.62 125.7 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.799 -0.445 . . . . 1.66 109.799 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.5 1.66 90.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.065 -1.064 . . . . 0.78 110.833 -174.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.8 mptp? -94.14 118.11 31.07 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.252 -0.474 . . . . 2.37 110.184 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 36.9 t-20 -80.15 103.1 9.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.921 -0.581 . . . . 0.83 109.975 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 68.7 t80 -62.22 -13.46 28.05 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.685 -0.689 . . . . 0.7 112.16 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.518 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 80.4 m-85 -104.82 11.49 33.72 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.856 -0.527 . . . . 1.45 111.441 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 64' ' ' LYS . 13.3 tmtt? -149.48 -56.42 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.508 -0.477 . . . . 4.07 111.524 -172.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.8 -77.74 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.541 -0.299 . . . . 2.2 111.354 -167.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.2 m -78.53 16.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.451 0.538 . . . . 2.34 112.451 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -176.85 97.23 0.24 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.834 -0.621 . . . . 1.2 110.331 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -93.71 1.48 3.25 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.921 2.414 . . . . 0.98 113.447 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.5 4.11 53.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.959 -0.463 . . . . 1.41 110.069 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 9.9 p -96.75 -46.81 6.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.617 -1.174 . . . . 1.74 110.993 -167.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.47 110.72 0.92 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 1.85 110.381 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -177.18 143.85 0.55 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 1.85 108.4 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 50.0 Cg_exo -54.3 -29.11 56.08 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.645 2.23 . . . . 1.4 112.745 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 8.1 pt-20 -90.67 9.3 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 2.56 111.912 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.564 ' HE2' HG22 ' A' ' 107' ' ' VAL . 67.3 t80 -142.71 -74.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.054 -0.35 . . . . 4.11 110.054 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -65.25 -33.77 76.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.24 110.29 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -63.73 -34.97 91.39 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.832 -0.699 . . . . 0.6 111.955 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.43 -28.29 52.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.203 0.525 . . . . 2.58 110.184 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.52 -41.37 96.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.774 -0.648 . . . . 0.79 109.662 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -76.5 -20.37 57.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 1.63 110.849 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.31 -46.47 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 2.07 110.355 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.8 -41.39 83.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.72 112.214 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.62 -49.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 1.4 110.765 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.83 76.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 1.48 111.219 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.0 m -76.69 -83.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 2.15 110.713 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.57 -58.03 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.91 148.66 38.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.526 . . . . 3.83 110.293 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.6 tp -111.03 111.67 22.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.293 -0.632 . . . . 3.54 109.293 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' MET . 15.7 p30 -160.99 58.32 0.3 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.905 0.859 . . . . 2.47 109.956 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -107.12 145.47 32.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.859 -1.064 . . . . 2.01 110.296 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.5 ttp -122.17 117.88 27.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 2.22 110.319 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 42.6 p90 -138.13 163.88 30.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.298 -0.41 . . . . 3.82 110.432 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 35.1 tt0 -109.67 129.12 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.615 -0.513 . . . . 2.39 109.615 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 30.4 t80 -135.14 165.03 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.424 -0.353 . . . . 3.62 110.833 -172.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 m -105.25 137.79 42.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.772 0.32 . . . . 1.97 111.709 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.483 ' CE2' HG23 ' A' ' 105' ' ' VAL . 14.4 m-85 -113.01 108.36 17.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.02 -0.733 . . . . 1.47 109.02 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -119.67 8.23 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 2.57 110.556 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.555 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 28.8 t80 -122.79 131.26 53.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 3.46 108.325 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.555 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 28.6 mm-40 67.96 8.51 6.53 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.219 0.533 . . . . 3.41 110.218 -173.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 23.6 ttt -166.3 140.64 4.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.399 -0.963 . . . . 3.33 108.399 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.6 p -64.46 148.84 95.97 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.006 -0.738 . . . . 2.56 109.006 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.1 89.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.993 2.462 . . . . 1.72 113.374 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.8 m -109.97 154.91 22.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.907 -0.588 . . . . 1.93 110.277 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -102.84 117.94 35.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.498 -0.556 . . . . 3.47 109.498 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.757 HG13 ' HA ' ' A' ' 124' ' ' ARG . 25.0 m -122.0 163.29 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.96 110.604 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 33.6 ttpt -109.02 128.6 55.1 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.905 -0.776 . . . . 2.22 108.905 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.564 HG22 ' HE2' ' A' ' 75' ' ' PHE . 96.3 t -114.11 110.73 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 108.491 -0.929 . . . . 1.97 108.491 -171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -103.51 119.96 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.871 -0.788 . . . . 1.37 108.871 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.735 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 22.2 mmt -100.07 135.26 41.77 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.639 -0.874 . . . . 2.95 108.639 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.402 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.9 mtpp -150.94 121.93 7.65 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.895 0.379 . . . . 2.05 110.858 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.545 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 52.9 tttt -78.91 137.46 37.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.214 0.531 . . . . 2.66 111.283 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 177.06 8.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.789 -1.189 . . . . 1.57 107.789 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.4 -98.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.556 -0.858 . . . . 4.89 109.572 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.9 p 43.42 47.15 5.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.82 0.448 . . . . 2.9 112.145 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.57 13.76 49.8 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.668 -0.777 . . . . 2.62 112.519 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.1 t70 63.76 86.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.735 0.814 . . . . 2.76 111.076 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 p -164.86 157.69 16.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.237 -0.892 . . . . 1.61 109.611 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 2.6 m-85 -104.68 153.86 20.71 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.823 -0.806 . . . . 1.4 108.823 -173.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -102.12 108.78 20.3 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.484 -0.932 . . . . 0.75 108.484 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 31' ' ' ILE . 7.4 p -101.87 127.51 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.819 0.819 . . . . 1.6 110.645 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.402 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 64.1 m-85 -108.63 131.54 54.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.249 -0.887 . . . . 0.97 110.317 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.442 HG22 ' HA3' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -111.31 106.81 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.733 0.778 . . . . 1.83 111.201 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -103.23 117.19 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.678 . . . . 3.79 109.927 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.757 ' HA ' HG13 ' A' ' 105' ' ' VAL . 16.6 ptm180 -89.53 157.42 18.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.62 -0.718 . . . . 4.65 110.56 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.949 -0.548 . . . . 2.87 111.049 175.374 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 98.4 m-85 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 113.147 0.795 . . . . 4.68 113.147 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.41 104.59 2.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.357 -0.925 . . . . 0.96 111.28 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.78 123.09 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.523 0.201 . . . . 1.26 110.459 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG21 ' HA ' ' A' ' 42' ' ' TYR . 12.1 pt -125.9 160.85 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 1.67 111.102 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -119.72 115.49 24.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.391 -0.368 . . . . 1.02 110.348 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD2' ' HB ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -117.28 146.7 43.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.307 -0.627 . . . . 2.24 109.307 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.577 ' OD2' ' HB3' ' A' ' 38' ' ' ASN . 8.1 p30 -107.24 168.69 9.05 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.38 -0.528 . . . . 1.22 110.571 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -10.78 16.25 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 114.362 0.505 . . . . 0.79 114.362 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -87.33 -11.25 49.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.358 0.579 . . . . 1.95 110.342 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.27 10.49 60.81 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.484 -1.047 . . . . 0.61 110.484 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . 55.7 t30 -85.79 147.37 26.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.631 -0.785 . . . . 1.64 110.26 -174.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.782 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 3.8 mm -93.55 149.46 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.908 -0.404 . . . . 1.58 109.908 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 40' ' ' LEU . 6.2 mp -120.3 -62.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 2.1 109.781 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -136.92 131.13 32.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.685 -0.689 . . . . 1.99 110.541 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.678 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.2 m-30 -98.29 179.95 4.56 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 1.25 109.977 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -123.01 173.86 7.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.336 -0.616 . . . . 2.14 109.336 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.91 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.518 0.562 . . . . 1.87 112.518 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 28' ' ' PHE . . . -73.39 -42.92 61.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.947 0.351 . . . . 2.02 111.947 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.74 -15.52 59.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.348 -0.541 . . . . 2.12 110.411 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.28 -6.55 74.36 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.965 -0.854 . . . . 1.42 110.965 171.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.27 -48.03 5.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.314 -0.443 . . . . 2.35 110.356 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.66 -63.68 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 2.98 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -53.93 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.306 0.484 . . . . 3.86 112.306 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.22 18.29 1.34 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.434 -0.889 . . . . 2.91 113.433 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 52' ' ' ARG . 1.4 mpt_? -90.46 111.91 23.35 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.952 0.376 . . . . 3.64 110.026 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 25.7 m-20 -71.94 149.22 92.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.567 -0.531 . . . . 2.1 109.567 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 77.4 Cg_exo -49.79 -34.12 34.97 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.605 2.87 . . . . 1.68 114.304 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -106.38 17.33 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.146 0.425 . . . . 4.08 112.146 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 94.7 mt-30 -95.01 -9.28 34.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 3.05 111.074 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.782 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.7 m -104.29 21.55 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.473 0.545 . . . . 1.26 112.473 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 115.91 29.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.456 -0.498 . . . . 1.66 110.043 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.28 64.1 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.418 -1.073 . . . . 0.78 110.418 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.4 mptp? -80.6 147.57 30.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.512 -0.844 . . . . 2.37 111.196 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -107.67 113.77 27.28 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.687 -0.486 . . . . 0.83 109.687 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.706 ' HB2' HD13 ' A' ' 39' ' ' ILE . 77.4 t80 -52.89 -50.75 63.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.316 -0.402 . . . . 0.7 112.038 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.633 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.6 m-85 -76.97 5.84 7.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.043 -0.526 . . . . 1.45 112.295 -168.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 -47.32 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.151 0.426 . . . . 4.07 112.151 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -99.65 -23.77 14.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.218 0.451 . . . . 2.2 112.218 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 1.8 t -120.87 14.46 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.524 -0.47 . . . . 2.34 110.9 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.558 ' HB2' ' HG1' ' A' ' 70' ' ' THR . . . 170.84 86.44 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.89 -0.595 . . . . 1.2 110.352 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.482 ' HG2' ' CE1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -96.0 35.92 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.182 2.588 . . . . 0.98 113.582 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 17.2 p -121.73 20.58 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.8 -0.445 . . . . 1.41 109.8 171.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.558 ' HG1' ' HB2' ' A' ' 67' ' ' ALA . 37.0 m -130.14 -44.49 1.15 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.929 -1.487 . . . . 1.74 109.668 -136.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.633 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 4.5 p-10 -73.32 103.98 4.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.828 0.823 . . . . 1.85 109.393 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.526 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 64.5 m -163.93 164.59 14.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.506 -0.77 . . . . 1.85 109.579 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 6.4 Cg_endo -49.96 -31.06 25.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.072 2.514 . . . . 1.4 112.69 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.66 ' HB3' ' HE2' ' A' ' 94' ' ' TYR . 1.3 mp0 -69.86 -91.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 2.56 111.493 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HD1' ' HE2' ' A' ' 63' ' ' PHE . 45.6 t80 -60.74 -56.61 19.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.648 -0.705 . . . . 4.11 111.811 -169.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.807 ' HH ' ' HZ3' ' A' ' 80' ' ' LYS . 68.9 t80 -67.95 -38.5 82.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.789 0.328 . . . . 1.24 110.464 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -47.61 90.32 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.6 112.744 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.81 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 9.3 mmpt? -75.76 -28.72 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.931 0.365 . . . . 2.58 110.527 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -58.97 -41.61 87.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.339 0.59 . . . . 0.79 109.761 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.807 ' HZ3' ' HH ' ' A' ' 76' ' ' TYR . 14.0 mmmm -87.6 -11.07 49.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.447 -0.797 . . . . 1.63 111.306 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 6.9 tp10 -67.42 -40.14 85.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 2.07 110.567 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.945 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -71.9 -32.54 63.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.554 -0.832 . . . . 0.72 111.227 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.21 -50.86 65.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.255 -0.472 . . . . 1.4 110.673 177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.94 83.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.782 -0.644 . . . . 1.48 111.769 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 p -77.38 -71.54 0.4 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.045 0.45 . . . . 2.15 110.527 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.091 -0.575 . . . . 1.77 111.947 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.93 158.15 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 3.83 110.366 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.945 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 1.4 pt? -138.61 135.69 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.987 -0.552 . . . . 3.54 110.057 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 109' ' ' MET . 33.8 p-10 -164.01 47.94 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.445 1.117 . . . . 2.47 108.9 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -104.13 154.36 19.83 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.878 -1.51 . . . . 2.01 109.955 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -112.95 115.53 28.55 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.107 0.479 . . . . 2.22 110.359 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.36 155.47 31.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 3.82 109.199 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.33 121.88 44.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.238 0.542 . . . . 2.39 111.18 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.66 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 46.2 m-85 -126.94 167.08 16.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.676 -0.693 . . . . 3.62 111.091 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 m -106.68 139.6 40.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.885 -0.598 . . . . 1.97 110.535 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.466 ' CE2' HG11 ' A' ' 105' ' ' VAL . 13.0 m-85 -104.68 119.83 39.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.48 -0.933 . . . . 1.47 108.48 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.3 -159.75 1.02 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.289 -0.634 . . . . 2.57 109.289 -170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.482 ' CE1' ' HG2' ' A' ' 68' ' ' PRO . 90.2 t80 69.5 -76.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.981 0.512 . . . . 3.46 111.123 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -107.01 -26.69 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 3.41 109.646 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.8 tpp -84.86 139.32 31.98 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.606 -0.887 . . . . 3.33 108.606 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.6 t -65.58 136.29 96.03 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.797 -1.186 . . . . 2.56 107.797 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -43.51 91.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.3 2.666 . . . . 1.72 114.184 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.2 p -108.95 151.8 25.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.289 -0.414 . . . . 1.93 111.304 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -109.84 116.44 31.66 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.457 -0.572 . . . . 3.47 109.457 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 122' ' ' VAL . 11.3 p -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 1.96 111.248 -171.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.433 ' N ' HG23 ' A' ' 105' ' ' VAL . 39.1 ttmt -109.37 118.27 36.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.319 -0.993 . . . . 2.22 108.319 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.548 HG11 HG12 ' A' ' 120' ' ' VAL . 86.3 t -104.55 117.01 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 115.727 -0.67 . . . . 1.97 109.485 -174.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -103.9 105.24 15.38 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.37 108.786 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.2 pmm? -103.68 128.84 50.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.993 -0.549 . . . . 2.95 109.729 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 11.6 ptmm? -144.47 138.9 27.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 2.05 111.259 -174.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -71.16 128.49 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.996 -0.547 . . . . 2.66 111.939 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -115.55 93.96 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.821 -0.807 . . . . 1.57 108.821 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.83 83.88 3.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.669 0.747 . . . . 4.89 110.906 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t -141.51 26.6 1.94 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.717 -1.129 . . . . 2.9 108.534 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.27 25.15 0.42 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.055 -0.975 . . . . 2.62 112.055 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 55.93 75.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.138 0.575 . . . . 2.76 112.17 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 39.6 t -153.02 165.75 34.58 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.374 -0.973 . . . . 1.61 108.374 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -132.14 157.47 44.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.725 -0.843 . . . . 1.4 108.725 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CD1' ' HB1' ' A' ' 112' ' ' ALA . 73.8 m95 -101.22 111.35 23.54 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.861 -0.792 . . . . 0.75 108.861 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.548 HG12 HG11 ' A' ' 107' ' ' VAL . 3.5 t -102.25 119.8 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.56 0.695 . . . . 1.6 109.865 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-85 -104.57 140.63 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 0.97 111.185 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.663 HG12 HG21 ' A' ' 105' ' ' VAL . 54.1 t -104.58 104.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.073 -0.967 . . . . 1.83 110.314 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.73 105.13 13.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.956 0.408 . . . . 3.79 110.595 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -72.63 109.55 6.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.543 -0.54 . . . . 4.65 109.543 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.504 -0.76 . . . . 2.87 110.393 -178.254 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 p90 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.196 -0.298 . . . . 4.68 110.196 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.44 112.61 4.26 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.309 -0.948 . . . . 0.96 111.917 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -103.83 129.53 51.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 1.26 110.923 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.505 ' HB ' HG11 ' A' ' 120' ' ' VAL . 58.2 mt -125.7 149.82 30.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.431 -0.804 . . . . 1.67 108.999 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 31' ' ' ILE . 60.8 tt0 -115.18 122.89 47.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -134.81 156.29 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.248 0.342 . . . . 2.24 110.738 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 26.8 p30 -102.5 167.95 9.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.94 -0.304 . . . . 1.22 110.687 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.42 -2.71 3.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 114.963 0.745 . . . . 0.79 114.963 -173.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.28 -18.92 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.581 0.691 . . . . 1.95 110.81 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 114.13 15.2 8.59 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.416 -0.897 . . . . 0.61 113.254 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -86.44 135.58 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 117.125 0.463 . . . . 1.64 110.141 177.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.082 HD13 ' HB2' ' A' ' 62' ' ' PHE . 23.0 mm -89.27 149.1 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.181 -0.463 . . . . 1.58 109.938 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -121.19 -72.44 0.69 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.312 0.577 . . . . 2.1 110.177 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.4 134.19 55.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.719 -0.673 . . . . 1.99 111.666 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.541 ' HE2' HG23 ' A' ' 39' ' ' ILE . 2.3 m-85 -103.43 144.58 31.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.058 -0.974 . . . . 1.25 109.586 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 3.9 t30 -82.78 4.48 25.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.495 0.664 . . . . 2.14 109.473 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.41 -22.39 0.24 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.36 -1.291 . . . . 1.87 112.228 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -65.32 -18.67 65.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.313 0.486 . . . . 2.02 112.313 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HG3' HD12 ' A' ' 31' ' ' ILE . 2.6 tm-20 -70.39 -23.91 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.857 -0.794 . . . . 2.12 108.857 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.13 13.4 67.76 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.777 -0.725 . . . . 1.42 112.076 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.26 -44.76 71.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.163 0.506 . . . . 2.35 110.314 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.445 ' H ' HG12 ' A' ' 49' ' ' ILE . 4.1 pt -78.45 -47.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.898 -0.592 . . . . 2.98 112.153 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -61.93 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.995 0.426 . . . . 3.86 110.945 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 138.89 126.5 2.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.893 -0.67 . . . . 2.91 111.78 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 51' ' ' GLY . 26.6 mmt180 -139.1 156.12 47.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.39 -0.596 . . . . 3.64 109.39 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.5 m-20 -103.21 120.04 53.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.044 0.449 . . . . 2.1 111.311 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 26.4 Cg_exo -62.1 118.95 5.85 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.947 2.431 . . . . 1.68 112.337 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 62.6 mttp 82.29 5.38 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.851 -1.068 . . . . 4.08 112.224 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.25 -1.17 57.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.523 0.678 . . . . 3.05 109.558 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.5 m -98.88 10.29 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.143 -0.935 . . . . 1.26 111.616 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 42.8 mt -80.99 132.27 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.345 -0.613 . . . . 1.66 109.345 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.17 75.86 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.391 -0.909 . . . . 0.78 110.842 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.767 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 17.0 mttm -109.52 132.04 54.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.121 -0.696 . . . . 2.37 109.121 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.1 t-20 -90.0 102.98 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.755 -0.461 . . . . 0.83 109.755 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 1.082 ' HB2' HD13 ' A' ' 39' ' ' ILE . 70.9 t80 -49.82 -39.15 37.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.7 111.785 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.676 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m-85 -76.51 -20.5 56.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 1.45 112.435 -171.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -116.84 -30.5 5.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.215 0.45 . . . . 4.07 112.215 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -89.14 -79.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.037 0.384 . . . . 2.2 112.037 -170.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -99.77 13.96 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.699 0.762 . . . . 2.34 111.685 -169.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.3 69.91 0.81 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.665 -0.698 . . . . 1.2 111.455 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 39.4 Cg_endo -68.94 11.31 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.644 2.229 . . . . 0.98 113.688 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.8 m -79.92 -30.54 40.01 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.717 -0.475 . . . . 1.41 109.717 173.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.676 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 17.3 p -78.93 -38.56 36.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.722 -1.127 . . . . 1.74 110.383 -158.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.642 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 25.6 t70 -64.18 100.19 0.32 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.218 -0.66 . . . . 1.85 109.218 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 30.5 t -149.63 147.78 23.9 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.919 -0.582 . . . . 1.85 109.985 -171.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.38 -29.39 23.67 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.044 2.496 . . . . 1.4 112.156 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.747 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.8 pt-20 -93.65 -60.03 1.86 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.638 -0.425 . . . . 2.56 111.283 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 81.5 t80 -68.7 -52.31 32.23 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.198 -0.314 . . . . 4.11 111.564 -169.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 51.7 t80 -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 1.24 109.486 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.95 79.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.6 112.485 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 64.2 mmtt -81.91 -30.82 31.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.97 0.414 . . . . 2.58 110.159 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -65.53 -30.64 71.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.79 110.734 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 31.3 mmmt -82.79 -9.2 59.45 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.334 -0.848 . . . . 1.63 111.47 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -58.88 -33.83 70.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.489 -0.323 . . . . 2.07 111.71 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 1.029 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -88.08 -37.14 7.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.301 -0.952 . . . . 0.72 112.139 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.557 HG22 ' HH ' ' A' ' 118' ' ' TYR . 18.2 t -55.04 -46.18 77.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.893 0.477 . . . . 1.4 111.227 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -23.9 64.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 1.48 111.798 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.2 m -104.99 -81.25 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.351 0.596 . . . . 2.15 110.548 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.31 -48.6 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.886 -0.886 . . . . 1.77 110.886 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.917 ' HA ' ' HG3' ' A' ' 111' ' ' LYS . 1.4 p-10 -124.17 150.94 44.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.868 -0.666 . . . . 3.83 111.335 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 1.029 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 56.5 tp -144.29 114.96 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 3.54 109.708 174.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 109' ' ' MET . 49.2 m-20 -124.8 89.61 3.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.613 . . . . 2.47 109.667 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -124.74 165.58 17.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.159 -0.928 . . . . 2.01 111.319 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.6 ttp -136.68 111.06 8.48 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.374 -0.973 . . . . 2.22 108.374 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -121.68 163.44 19.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.482 -0.326 . . . . 3.82 110.211 -171.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -116.4 124.75 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.252 -0.647 . . . . 2.39 109.252 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -138.08 159.19 42.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.294 -0.261 . . . . 3.62 110.294 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.84 142.53 34.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.313 -0.403 . . . . 1.97 111.085 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -107.51 132.74 52.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.172 -0.467 . . . . 1.47 109.753 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 13.1 t70 -143.21 -150.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.452 -0.944 . . . . 2.57 108.452 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.454 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 68.7 t80 66.3 -82.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.759 0.424 . . . . 3.46 111.151 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -99.6 -24.18 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.262 0.553 . . . . 3.41 109.819 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 101' ' ' THR . 52.6 tpp -91.79 141.61 28.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.847 . . . . 3.33 108.996 173.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -72.38 143.17 85.18 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 108.757 -0.831 . . . . 2.56 108.757 170.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -40.41 90.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.779 2.986 . . . . 1.72 114.186 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 m -123.24 144.64 49.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 1.93 109.942 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.62 142.89 33.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.383 . . . . 3.47 110.123 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -128.78 164.52 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.06 -0.518 . . . . 1.96 110.505 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -108.72 117.88 35.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.13 -1.063 . . . . 2.22 108.13 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' A' ' 75' ' ' PHE . 11.7 p -104.59 133.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.412 0.625 . . . . 1.97 109.655 -172.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 7.7 t-160 -111.18 109.88 20.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.964 -0.754 . . . . 1.37 108.964 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 44.9 tpp -102.23 123.76 46.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.23 -0.655 . . . . 2.95 109.23 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.652 ' HZ1' ' HB3' ' A' ' 110' ' ' LYS . 8.3 mtpm? -141.81 136.43 30.63 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.588 -0.153 . . . . 2.05 110.588 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.917 ' HG3' ' HA ' ' A' ' 87' ' ' ASN . 7.7 tmtt? -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.171 0.51 . . . . 2.66 110.813 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.627 ' N ' ' HD3' ' A' ' 111' ' ' LYS . . . -146.62 160.46 42.15 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.549 -0.75 . . . . 1.57 109.913 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -103.23 -0.62 30.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.746 0.308 . . . . 4.89 110.479 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -61.78 106.47 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.505 -0.924 . . . . 2.9 108.505 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.96 -103.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.526 -1.429 . . . . 2.62 109.526 -164.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -179.07 84.54 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.775 -0.824 . . . . 2.76 108.775 167.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -166.0 -172.24 2.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.447 -0.797 . . . . 1.61 111.237 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.557 ' HH ' HG22 ' A' ' 83' ' ' VAL . 75.0 m-85 -110.86 155.32 22.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.489 -0.56 . . . . 1.4 109.489 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -103.71 107.78 18.79 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.297 -1.001 . . . . 0.75 108.297 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.505 HG11 ' HB ' ' A' ' 31' ' ' ILE . 12.5 p -100.64 131.86 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.702 0.763 . . . . 1.6 110.369 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.0 m-85 -115.2 128.82 56.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.457 -0.792 . . . . 0.97 109.84 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -104.33 102.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.193 0.521 . . . . 1.83 109.626 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -112.42 110.32 20.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 3.79 109.698 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HA ' HG12 ' A' ' 105' ' ' VAL . 5.7 ptm180 -74.6 166.55 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.535 -0.466 . . . . 4.65 110.493 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.736 -0.65 . . . . 2.87 109.81 177.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.989 -0.745 . . . . 4.68 108.989 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.47 115.56 5.24 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.332 -0.937 . . . . 0.96 112.925 -172.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.33 104.2 14.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 1.26 109.844 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.577 ' HB ' HG13 ' A' ' 120' ' ' VAL . 29.6 mt -113.09 158.23 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.818 -0.808 . . . . 1.67 108.818 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 48.9 tt0 -120.08 112.66 19.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.807 -0.558 . . . . 1.02 110.32 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.695 ' HG ' HG12 ' A' ' 120' ' ' VAL . 6.7 mt -114.05 142.92 45.58 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.895 -0.78 . . . . 2.24 108.895 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -102.71 168.96 8.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.769 -0.372 . . . . 1.22 110.275 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -50.58 -33.39 25.86 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.672 0.629 . . . . 0.79 114.672 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.04 -21.09 43.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.357 0.578 . . . . 1.95 111.45 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.3 17.36 10.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.579 -0.82 . . . . 0.61 112.75 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 7.5 m120 -83.16 147.7 27.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.372 . . . . 1.64 110.343 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.016 HD11 ' HB2' ' A' ' 62' ' ' PHE . 13.5 mm -92.76 145.31 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.703 -0.681 . . . . 1.58 110.287 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.8 mm? -97.68 -62.59 1.23 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 2.1 110.609 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -170.07 158.5 7.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.953 -1.021 . . . . 1.99 109.949 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.501 ' CE2' HG22 ' A' ' 39' ' ' ILE . 9.6 m-30 -110.94 147.74 33.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.523 -0.762 . . . . 1.25 109.376 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -80.36 -173.17 3.91 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.666 -0.494 . . . . 2.14 109.666 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -78.21 20.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.009 0.374 . . . . 1.87 112.009 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.38 -65.17 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.052 0.39 . . . . 2.02 112.052 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 27.9 tp10 -61.12 -51.02 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.682 -0.69 . . . . 2.12 111.172 -172.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.96 -3.81 81.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.082 -0.58 . . . . 1.42 112.648 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 34.7 t70 -84.2 -18.76 35.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.347 0.594 . . . . 2.35 110.204 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' C ' ' HG1' ' A' ' 50' ' ' THR . 50.9 mm -110.22 -65.18 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.57 -0.741 . . . . 2.98 111.041 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 56.9 m -155.74 -42.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.524 0.202 . . . . 3.86 111.42 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -61.15 88.04 0.04 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 115.03 0.772 . . . . 2.91 115.03 -170.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 20.0 mmm180 61.15 -176.87 0.12 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.999 0.904 . . . . 3.64 113.273 170.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 5.8 t70 -102.75 132.68 21.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 114.471 -1.24 . . . . 2.1 108.293 169.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 50.2 Cg_exo -55.29 -20.45 25.23 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.369 2.713 . . . . 1.68 114.438 -174.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 55' ' ' LYS . 1.9 mppt? -109.49 -3.49 16.96 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.037 -0.265 . . . . 4.08 111.437 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -104.08 24.56 11.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.082 0.467 . . . . 3.05 111.784 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.743 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 m -118.52 10.99 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.035 0.445 . . . . 1.26 111.319 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.73 133.33 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.653 -0.419 . . . . 1.66 110.507 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.31 72.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.265 -0.734 . . . . 0.78 111.265 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.55 148.25 47.91 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.659 -0.271 . . . . 2.37 110.526 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.865 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 8.1 t-20 -98.96 125.16 44.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.035 0.445 . . . . 0.83 111.512 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 1.016 ' HB2' HD11 ' A' ' 39' ' ' ILE . 48.5 t80 -64.72 -9.32 19.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 0.7 111.868 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.664 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 52.0 m-85 -122.65 20.55 10.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.849 0.357 . . . . 1.45 110.439 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.865 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 44.3 mmtm -150.79 -45.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 4.07 111.824 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -101.84 -79.05 0.52 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 2.2 111.389 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -84.14 15.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 2.34 112.54 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -172.64 97.06 0.36 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 1.2 109.89 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.92 19.87 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.19 2.593 . . . . 0.98 113.674 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -110.79 13.63 22.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.484 -0.486 . . . . 1.41 109.839 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.9 p -112.74 -43.73 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.943 -1.026 . . . . 1.74 111.055 -164.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.664 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -65.22 105.06 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 1.85 110.506 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 9.7 t -170.54 149.79 3.12 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 109.349 -0.612 . . . . 1.85 109.349 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 47.6 Cg_exo -39.38 -43.46 2.77 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.281 3.32 . . . . 1.4 114.98 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.38 -39.47 11.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.785 -0.366 . . . . 2.56 111.748 -176.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 70' ' ' THR . 28.3 m-85 -71.74 -69.29 0.4 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.176 0.513 . . . . 4.11 110.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.883 ' HH ' ' HZ2' ' A' ' 80' ' ' LYS . 59.8 t80 -61.66 -32.7 72.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 1.24 110.193 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -31.34 71.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.6 112.915 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 30.9 mmtp -78.05 -34.22 50.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.219 0.51 . . . . 2.58 110.836 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.58 -26.55 68.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 0.79 110.334 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.883 ' HZ2' ' HH ' ' A' ' 76' ' ' TYR . 19.5 mmmt -93.13 -6.54 47.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 1.63 112.038 -175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 6.6 mm-40 -58.14 -42.35 85.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.268 0.47 . . . . 2.07 112.268 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -76.38 -41.36 25.83 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.999 -1.096 . . . . 0.72 111.234 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.744 HG22 ' HH ' ' A' ' 118' ' ' TYR . 20.3 t -50.22 -48.15 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 123.121 0.568 . . . . 1.4 111.121 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.42 -32.35 49.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.732 -0.667 . . . . 1.48 112.502 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -90.08 -66.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.844 0.354 . . . . 2.15 110.198 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.74 34.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.749 . . . . 1.77 111.864 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.761 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 0.7 OUTLIER 65.88 105.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.277 -0.638 . . . . 3.83 109.277 -176.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 33.6 tp -143.45 159.35 42.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.132 -0.627 . . . . 3.54 111.757 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' MET . 18.9 t30 -82.05 112.83 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.036 -0.984 . . . . 2.47 111.224 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -125.27 146.48 49.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 2.01 110.157 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.563 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 21.3 ptp -116.73 129.37 56.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.839 0.352 . . . . 2.22 110.216 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 13.1 p90 -141.63 148.13 38.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.861 0.362 . . . . 3.82 110.968 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.94 116.67 30.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 2.39 109.914 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 38.7 m-85 -142.21 168.02 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.1 -0.5 . . . . 3.62 110.91 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 104' ' ' LYS . 36.2 p -102.85 156.86 17.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.968 -0.56 . . . . 1.97 111.654 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -116.27 108.96 16.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 1.47 109.194 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' MET . 7.1 p-10 -121.26 -153.75 0.56 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.943 -0.571 . . . . 2.57 110.236 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 65.8 t80 71.43 -73.81 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.959 0.503 . . . . 3.46 111.477 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.44 -26.28 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.441 0.638 . . . . 3.41 109.807 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 16.5 tpt -103.31 140.61 37.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.17 -0.923 . . . . 3.33 109.499 176.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 m -60.03 117.7 25.98 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.71 -0.848 . . . . 2.56 108.71 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -38.15 93.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.096 3.197 . . . . 1.72 114.254 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 160.48 18.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 1.93 109.611 172.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.1 ptpt -115.49 146.49 41.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 3.47 111.493 -178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.73 HG11 ' HA ' ' A' ' 124' ' ' ARG . 18.9 m -130.6 165.66 30.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.004 -0.998 . . . . 1.96 110.295 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -112.7 118.01 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.556 -0.905 . . . . 2.22 108.556 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -105.02 104.87 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 115.536 -0.756 . . . . 1.97 109.88 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.563 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 6.7 t-160 -103.79 102.81 12.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.492 -0.929 . . . . 1.37 108.492 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 5.2 ppp? -107.85 140.79 40.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.585 -0.734 . . . . 2.95 110.507 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.707 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 62.2 pttt -150.98 152.03 32.96 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.043 0.449 . . . . 2.05 111.489 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.79 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 33.2 ttpt -75.58 136.62 40.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.696 -0.684 . . . . 2.66 112.552 -172.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.512 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -130.98 107.29 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.369 -0.832 . . . . 1.57 109.312 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -74.45 1.85 10.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.341 -0.39 . . . . 4.89 111.135 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -51.89 -45.82 64.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 2.9 111.149 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.36 29.15 2.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.587 -0.816 . . . . 2.62 112.437 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.94 60.51 3.43 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.271 0.558 . . . . 2.76 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 32' ' ' GLN . 32.5 t -164.55 164.53 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.373 -0.973 . . . . 1.61 108.373 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.79 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 21.1 m-85 -104.95 156.38 18.08 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.843 -0.429 . . . . 1.4 109.843 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.512 ' HD1' ' HB1' ' A' ' 112' ' ' ALA . 62.8 m95 -101.58 106.12 17.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.398 -0.964 . . . . 0.75 108.398 172.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 33' ' ' LEU . 4.2 p -101.94 122.51 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.86 0.838 . . . . 1.6 110.473 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.707 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 94.4 m-85 -104.28 109.92 21.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.113 -0.949 . . . . 0.97 109.676 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.17 108.06 23.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.08 -0.963 . . . . 1.83 109.914 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -104.5 127.8 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 3.79 110.241 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.73 ' HA ' HG11 ' A' ' 105' ' ' VAL . 49.7 mtm-85 -70.44 127.91 34.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.006 -0.543 . . . . 4.65 109.732 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG22 ' HG3' ' A' ' 104' ' ' LYS . 3.0 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.938 -1.03 . . . . 2.87 111.326 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.233 0.197 0 N-CA-C 109.603 -0.517 . . . . 4.68 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.2 148.33 17.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.377 -0.916 . . . . 0.96 112.518 -174.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.9 105.05 5.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.842 0.353 . . . . 1.26 110.338 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.807 ' HB ' HG12 ' A' ' 120' ' ' VAL . 11.3 mm -108.67 160.83 7.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.767 -0.827 . . . . 1.67 108.767 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.444 ' NE2' HD22 ' A' ' 113' ' ' LEU . 59.2 tt0 -128.43 118.7 23.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.69 -0.485 . . . . 1.02 109.69 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HG ' HG11 ' A' ' 120' ' ' VAL . 17.1 mt -116.05 155.51 28.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.699 -0.482 . . . . 2.24 109.699 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.636 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.4 p30 -108.76 169.38 8.7 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.867 -0.333 . . . . 1.22 110.259 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.2 -20.52 6.92 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.3 0.88 . . . . 0.79 115.3 -171.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.24 -19.84 23.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.901 0.851 . . . . 1.95 110.636 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.76 6.49 23.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.762 -0.733 . . . . 0.61 112.292 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.636 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 89.7 m-20 -71.61 149.71 45.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.915 0.388 . . . . 1.64 110.486 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 62' ' ' PHE . 10.0 mt -95.4 149.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.693 -0.685 . . . . 1.58 109.37 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 40' ' ' LEU . 7.1 mp -113.49 -56.76 2.37 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.587 0.708 . . . . 2.1 109.879 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -150.77 144.27 25.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.027 -0.988 . . . . 1.99 111.142 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 1.07 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.2 m-30 -101.1 175.26 5.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.575 -1.193 . . . . 1.25 110.271 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -102.41 179.72 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.61 -0.885 . . . . 2.14 108.61 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.56 13.51 8.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.833 0.349 . . . . 1.87 110.493 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -89.92 -40.98 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 2.02 110.828 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 11.4 mp0 -59.74 -55.03 39.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 2.12 110.374 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 51' ' ' GLY . . . -61.96 -30.8 76.41 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.562 -0.744 . . . . 1.42 112.875 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.61 -33.43 74.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 2.35 110.548 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 50' ' ' THR . 44.7 mt -81.77 -62.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.776 -0.647 . . . . 2.98 109.915 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.468 HG22 HG23 ' A' ' 49' ' ' ILE . 9.4 t -179.44 131.43 0.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.157 -0.474 . . . . 3.86 110.464 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.537 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . 57.33 -157.2 13.7 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.932 -0.576 . . . . 2.91 112.808 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 4.4 mpp_? 53.95 79.85 0.12 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.755 -0.723 . . . . 3.64 111.748 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 56' ' ' GLN . 21.9 t70 -79.96 136.24 54.5 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 2.1 110.598 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 1.07 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 11.1 Cg_endo -54.5 -33.56 78.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.667 2.911 . . . . 1.68 114.123 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.94 2.02 48.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.434 . . . . 4.08 111.129 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 53' ' ' ASP . 22.4 tt0 -92.9 -8.4 43.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 3.05 110.966 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 42' ' ' TYR . 3.2 m -112.93 58.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.623 0.601 . . . . 1.26 112.623 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 40' ' ' LEU . 11.4 mt -122.39 139.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.687 -0.633 . . . . 1.66 110.031 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.13 75.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.622 -0.799 . . . . 0.78 111.191 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -114.36 139.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.147 -0.527 . . . . 2.37 110.118 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.95 113.35 20.48 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.853 -0.425 . . . . 0.83 109.853 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' HA ' HD12 ' A' ' 39' ' ' ILE . 84.2 t80 -47.21 -46.59 24.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.663 -0.699 . . . . 0.7 111.542 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 49.6 m-85 -80.22 7.77 8.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 1.45 111.614 -172.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -124.37 -50.77 1.76 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 4.07 110.991 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.44 -79.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.687 0.625 . . . . 2.2 112.687 -174.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.26 16.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.251 0.548 . . . . 2.34 111.373 -168.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HB3' ' HG1' ' A' ' 70' ' ' THR . . . -165.93 70.45 1.22 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 1.2 110.851 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.11 -6.28 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.901 2.401 . . . . 0.98 113.17 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.741 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 7.5 p -84.59 -22.15 30.13 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.415 -0.587 . . . . 1.41 109.415 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.54 ' HG1' ' HB3' ' A' ' 67' ' ' ALA . 2.2 m -79.38 -32.96 43.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.847 -1.524 . . . . 1.74 110.477 -160.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.85 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 12.1 t70 -62.9 108.58 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.7 -0.682 . . . . 1.85 109.999 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -162.95 155.78 16.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 1.85 109.496 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.94 -32.7 97.93 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.374 2.049 . . . . 1.4 111.913 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -80.44 -9.79 59.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 2.56 112.482 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' CD1' HG23 ' A' ' 70' ' ' THR . 62.0 t80 -130.05 -67.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.109 -0.37 . . . . 4.11 110.806 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -56.61 -41.53 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 1.24 110.332 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.35 -34.3 84.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.04 -0.6 . . . . 0.6 112.594 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.3 -36.95 38.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.391 . . . . 2.58 110.243 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.452 ' HD1' ' HG2' ' A' ' 109' ' ' MET . 34.9 t80 -57.4 -44.54 84.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.79 109.428 172.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -75.68 -18.91 59.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 1.63 111.781 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -38.36 82.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.827 -0.434 . . . . 2.07 109.827 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.659 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.34 -45.97 35.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.73 -0.748 . . . . 0.72 111.481 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 118' ' ' TYR . 28.1 t -50.59 -48.52 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 122.979 0.511 . . . . 1.4 111.1 176.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.4 -20.32 62.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.627 -0.715 . . . . 1.48 112.01 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -99.14 -81.86 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.878 0.37 . . . . 2.15 110.436 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.0 -60.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.826 -0.702 . . . . 1.77 111.774 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -98.72 130.84 45.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.533 . . . . 3.83 109.627 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER -115.49 104.45 11.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.914 -0.773 . . . . 3.54 108.914 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.687 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.1 p-10 -149.32 95.44 2.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.135 0.969 . . . . 2.47 110.227 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 20.9 m -142.86 145.16 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.112 -0.949 . . . . 2.01 109.894 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -120.1 117.83 28.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.061 0.458 . . . . 2.22 109.778 174.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.03 154.15 36.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.04 -0.726 . . . . 3.82 109.04 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 pt-20 -103.2 103.49 13.54 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 2.39 110.553 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -110.78 161.27 15.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.704 -1.135 . . . . 3.62 109.96 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 103' ' ' THR . 13.6 m -104.13 129.28 51.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.14 -0.482 . . . . 1.97 110.938 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -103.35 104.62 14.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 1.47 108.482 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.59 8.39 9.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 2.57 111.793 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.741 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 71.6 t80 -79.22 -82.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.555 -0.293 . . . . 3.46 110.69 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -87.37 -37.86 16.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 3.41 109.77 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.0 ttt -82.2 139.9 34.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.766 -0.827 . . . . 3.33 108.766 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.16 143.55 92.26 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 109.264 -0.643 . . . . 2.56 109.264 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -42.48 89.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.64 2.893 . . . . 1.72 114.187 -174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.8 m -108.14 145.9 33.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.977 -0.556 . . . . 1.93 110.585 175.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -103.34 104.73 14.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.143 0.497 . . . . 3.47 110.443 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 124' ' ' ARG . 27.7 m -117.15 165.51 12.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.625 -0.716 . . . . 1.96 109.973 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 35.9 ttmt -110.94 119.39 38.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.622 -0.881 . . . . 2.22 108.622 177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 91' ' ' MET . 54.9 t -105.64 127.12 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 115.408 -0.815 . . . . 1.97 108.848 -171.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 2.2 t-160 -109.97 114.45 27.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.219 -0.446 . . . . 1.37 110.31 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.687 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 4.1 mpp? -101.45 119.83 39.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.007 -0.738 . . . . 2.95 109.007 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 58.7 pttt -143.25 124.52 14.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.413 0.625 . . . . 2.05 112.227 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.56 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 42.8 tttt -57.68 126.5 27.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.664 -1.153 . . . . 2.66 111.162 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -174.79 94.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.091 0.774 . . . . 1.57 113.091 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 1.007 HD11 ' H ' ' A' ' 117' ' ' SER . 0.2 OUTLIER 177.73 -174.98 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.005 0.522 . . . . 4.89 111.431 167.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 t -77.22 77.63 3.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.529 -0.915 . . . . 2.9 108.529 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.14 -134.06 3.62 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.753 -1.213 . . . . 2.62 112.979 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -143.32 25.32 1.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 2.76 110.648 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 1.007 ' H ' HD11 ' A' ' 113' ' ' LEU . 4.3 m -98.87 167.32 10.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.943 -0.762 . . . . 1.61 108.943 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -127.13 156.99 40.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.002 0.43 . . . . 1.4 110.216 -169.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.617 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 35.9 m95 -101.02 110.63 22.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.942 -0.762 . . . . 0.75 108.942 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.807 HG12 ' HB ' ' A' ' 31' ' ' ILE . 3.5 p -103.25 107.87 23.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.512 1.149 . . . . 1.6 110.59 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.617 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 95.7 m-85 -102.78 140.72 36.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.734 -1.121 . . . . 0.97 110.697 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.87 104.15 16.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 1.83 109.744 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.99 126.01 51.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.559 . . . . 3.79 109.807 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.561 ' HA ' HG11 ' A' ' 105' ' ' VAL . 44.3 mtm180 -79.8 143.79 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.789 -0.365 . . . . 4.65 110.372 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.337 -0.84 . . . . 2.87 109.899 179.415 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 110.085 -0.339 . . . . 4.68 110.085 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.61 135.75 12.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.445 -0.883 . . . . 0.96 113.243 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.9 104.62 12.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.514 -0.55 . . . . 1.26 109.514 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 120' ' ' VAL . 60.5 mt -112.77 142.65 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.557 -0.534 . . . . 1.67 109.557 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -109.41 116.19 31.37 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.553 -0.459 . . . . 1.02 109.834 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 117' ' ' SER . 2.7 mm? -103.83 165.43 11.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.809 -1.182 . . . . 2.24 107.809 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 47.3 p30 -108.19 167.16 10.21 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 1.22 110.333 173.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -60.54 -2.12 2.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 114.403 0.521 . . . . 0.79 114.403 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -100.33 -47.33 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.534 0.667 . . . . 1.95 109.675 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.46 6.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.501 -0.772 . . . . 0.61 112.558 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -76.96 149.61 35.95 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.969 0.414 . . . . 1.64 110.43 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.721 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 12.6 mt -95.96 148.13 5.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.663 -0.699 . . . . 1.58 109.591 175.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.4 mp -115.64 -64.85 1.26 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.326 0.584 . . . . 2.1 111.945 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -150.66 158.8 44.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.219 -0.9 . . . . 1.99 110.641 -173.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.639 ' HE2' HG21 ' A' ' 39' ' ' ILE . 5.3 m-30 -121.21 -174.19 2.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.065 -0.971 . . . . 1.25 110.158 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -114.81 178.96 4.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.844 -0.799 . . . . 2.14 108.844 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.87 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 1.87 110.467 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -43.67 -63.82 0.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.847 . . . . 2.02 112.786 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -61.99 -37.9 86.57 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.796 0.331 . . . . 2.12 111.792 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.27 94.59 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.807 -0.711 . . . . 1.42 111.681 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.0 -38.17 82.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.538 0.335 . . . . 2.35 111.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 45' ' ' ALA . 48.9 mt -56.53 -60.31 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.075 0.464 . . . . 2.98 110.692 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -144.69 -42.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.139 -0.482 . . . . 3.86 111.071 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 139.64 77.47 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.395 -0.907 . . . . 2.91 112.192 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 1.2 mpt_? -118.14 119.78 35.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.822 0.344 . . . . 3.64 110.28 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.73 133.32 31.08 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 2.1 111.255 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 31.8 Cg_exo -60.37 -28.87 87.61 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.038 2.492 . . . . 1.68 112.16 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 10.9 mmpt? -79.82 -12.2 59.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.434 -0.348 . . . . 4.08 111.616 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -89.52 -24.6 21.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 3.05 111.325 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.721 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 m -98.64 16.31 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 1.26 113.462 -170.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.59 125.46 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.266 -0.574 . . . . 1.66 109.969 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 -1.77 88.37 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.289 -0.957 . . . . 0.78 110.861 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' ILE . 14.0 mptt -95.93 140.61 30.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.854 -0.673 . . . . 2.37 109.877 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 14.4 t-20 -90.34 116.87 28.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.408 -0.59 . . . . 0.83 109.408 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.634 ' HA ' HD12 ' A' ' 39' ' ' ILE . 89.0 t80 -56.24 -42.3 77.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.865 -0.607 . . . . 0.7 111.278 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.4 m-85 -82.06 1.25 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.595 . . . . 1.45 111.399 -170.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.4 mmtp -122.23 -58.32 1.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.94 0.4 . . . . 4.07 111.559 -176.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.31 -76.98 0.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.743 -0.662 . . . . 2.2 111.969 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 14.6 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.042 0.925 . . . . 2.34 111.716 -172.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -169.69 74.03 0.68 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.234 -0.893 . . . . 1.2 110.636 175.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.45 -18.24 43.74 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.151 2.567 . . . . 0.98 113.393 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.78 -8.06 59.03 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.975 -0.29 . . . . 1.41 110.513 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -86.78 -19.97 28.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 1.74 110.73 -176.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 16.8 t70 -67.93 96.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 1.85 110.285 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.634 ' HB3' ' OE1' ' A' ' 74' ' ' GLU . 74.9 m -166.11 148.58 6.28 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.85 109.477 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -53.27 -35.94 76.13 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.008 2.472 . . . . 1.4 113.294 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 72' ' ' SER . 1.4 pm0 -86.36 -7.3 58.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.053 0.39 . . . . 2.56 112.053 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.572 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 51.4 m-85 -112.56 -81.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 4.11 109.927 173.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 75.2 t80 -59.67 -37.69 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.487 -0.779 . . . . 1.24 110.555 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.24 94.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.088 -0.577 . . . . 0.6 112.136 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 67.9 mmtt -67.8 -38.15 82.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.379 . . . . 2.58 110.816 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.444 ' HZ ' ' O ' ' A' ' 34' ' ' ASP . 93.6 t80 -57.5 -42.36 82.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.79 110.614 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -85.91 -13.95 46.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.645 -0.707 . . . . 1.63 110.854 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -41.45 86.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.192 0.52 . . . . 2.07 109.699 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.885 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -70.16 -32.13 69.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.72 111.545 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.63 -51.09 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 1.4 110.354 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.47 67.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 1.48 111.677 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -93.27 -77.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 2.15 110.735 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.19 -64.8 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.62 -0.592 . . . . 1.77 111.62 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.756 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -121.99 155.56 35.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.649 -0.5 . . . . 3.83 109.649 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.885 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 2.4 tm? -135.1 104.34 5.89 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.277 -0.638 . . . . 3.54 109.277 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 110' ' ' LYS . 25.5 m-80 -133.28 93.98 3.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.805 -0.813 . . . . 2.47 108.805 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 108' ' ' HIS . 33.9 p -134.24 164.07 28.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.221 -0.899 . . . . 2.01 110.882 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.8 ptt? -132.89 109.0 9.3 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.644 -0.707 . . . . 2.22 109.66 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -104.62 155.53 18.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.012 -0.995 . . . . 3.82 109.818 -172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -117.57 111.7 19.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.047 -0.353 . . . . 2.39 110.047 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.478 ' HE1' ' HG3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -163.87 168.6 19.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 3.62 110.285 -177.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' A' ' 94' ' ' TYR . 12.4 t -102.92 153.25 20.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.161 -0.472 . . . . 1.97 110.565 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -114.9 103.24 10.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.759 -0.83 . . . . 1.47 108.759 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -114.69 112.92 23.61 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.617 -0.72 . . . . 2.57 111.078 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -174.2 -80.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 3.46 109.821 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -94.81 -41.48 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 3.41 109.433 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.2 ttp -80.9 124.96 29.54 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.708 -0.849 . . . . 3.33 108.708 171.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.8 m -56.89 120.07 35.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.619 -0.512 . . . . 2.56 109.619 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -24.33 91.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 1 C-N-CA 125.345 4.03 . . . . 1.72 114.978 -170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -108.81 144.82 36.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.896 -0.779 . . . . 1.93 108.896 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -104.16 122.43 45.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.069 0.462 . . . . 3.47 109.992 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.913 HG11 ' HA ' ' A' ' 124' ' ' ARG . 27.1 m -124.74 166.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.583 -0.735 . . . . 1.96 110.321 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -103.95 117.33 34.05 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.682 -1.229 . . . . 2.22 107.682 170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.8 p -104.21 119.36 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.899 0.856 . . . . 1.97 110.402 -170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 t-160 -103.6 105.3 15.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.006 -0.997 . . . . 1.37 109.362 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 57.5 tpp -103.9 123.54 47.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.713 -1.218 . . . . 2.95 107.713 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 13.2 ptmm? -143.39 147.07 34.07 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.959 -0.696 . . . . 2.05 111.033 -172.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.756 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 37.1 tttp -81.52 146.09 30.36 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.019 -0.537 . . . . 2.66 111.217 -171.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.77 38.47 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.518 -0.919 . . . . 1.57 108.518 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.77 -112.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.381 -0.528 . . . . 4.89 110.732 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m 52.95 37.23 23.98 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.504 0.668 . . . . 2.9 109.484 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.57 -90.7 0.55 Allowed Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.896 -1.282 . . . . 2.62 109.896 -169.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -178.22 88.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.672 -0.862 . . . . 2.76 108.672 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.0 p -135.95 -178.19 5.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.921 -0.581 . . . . 1.61 111.503 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 88' ' ' LEU . 97.1 m-85 -131.31 144.33 51.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.564 -0.532 . . . . 1.4 109.564 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 32.9 m95 -102.58 107.43 18.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.568 -0.901 . . . . 0.75 108.568 174.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.9 p -100.37 142.77 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.784 -0.766 . . . . 1.6 111.319 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.07 123.9 28.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.426 -0.807 . . . . 0.97 109.725 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.01 103.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.429 0.633 . . . . 1.83 111.31 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -104.42 121.42 43.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 3.79 109.889 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.913 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.18 140.75 55.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.834 0.35 . . . . 4.65 111.093 -179.144 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.766 -0.635 . . . . 2.87 109.518 177.223 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' ' 44' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.07 -0.345 . . . . 3.79 110.07 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.51 -32.26 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 3.43 111.176 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.89 138.14 31.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.782 0.325 . . . . 4.68 110.357 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.7 150.95 17.28 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.909 -0.662 . . . . 0.96 112.51 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.44 104.92 3.68 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.031 -0.729 . . . . 1.26 109.031 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.489 ' HB ' HG11 ' A' ' 120' ' ' VAL . 21.7 mt -116.74 156.49 17.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.1 -0.5 . . . . 1.67 109.731 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 62.6 tt0 -121.81 111.73 17.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.391 -0.596 . . . . 1.02 109.391 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -112.32 148.96 33.1 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.655 -0.498 . . . . 2.24 109.655 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -104.44 168.07 9.33 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.119 -0.233 . . . . 1.22 110.373 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.04 -7.13 29.1 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.387 -0.369 . . . . 0.79 113.891 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -89.11 -45.62 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 1.95 109.811 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 134.45 12.61 1.38 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.61 112.307 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 149.88 22.65 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.64 110.178 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 17.7 mt -94.08 145.36 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.808 -0.633 . . . . 1.58 109.781 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.4 mm? -106.52 -68.4 0.88 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.556 0.694 . . . . 2.1 110.075 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -133.89 133.29 41.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.185 -0.916 . . . . 1.99 110.656 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.942 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.7 m-30 -94.59 -176.23 3.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.635 -0.711 . . . . 1.25 110.3 171.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -118.53 165.79 13.5 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.56 -0.904 . . . . 2.14 108.56 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.752 ' HB2' HD22 ' A' ' 26' ' ' LEU . . . -76.88 19.09 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 1.87 111.332 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.33 -49.07 6.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 2.02 110.279 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' HB ' ' A' ' 50' ' ' THR . 3.6 mm-40 -69.7 -29.12 66.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.472 0.653 . . . . 2.12 110.026 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -88.26 -5.83 75.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.691 -0.766 . . . . 1.42 112.33 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.6 t70 -83.1 -60.17 2.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.771 0.319 . . . . 2.35 110.683 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' H ' HG12 ' A' ' 49' ' ' ILE . 2.8 pt -94.54 -46.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.291 -0.413 . . . . 2.98 111.93 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -70.64 -54.64 11.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.175 0.512 . . . . 3.86 110.56 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.501 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 110.47 39.61 1.46 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.765 -0.731 . . . . 2.91 112.405 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 3.1 mpt_? -118.81 98.26 6.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.59 -0.522 . . . . 3.64 109.59 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.8 m-20 -64.08 152.86 86.77 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.536 . . . . 2.1 110.559 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.942 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 48.0 Cg_exo -58.01 -18.74 37.15 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.37 2.713 . . . . 1.68 113.765 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.7 4.68 26.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.82 0.304 . . . . 4.08 111.82 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.857 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 80.9 mm-40 -90.45 -9.33 47.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.731 0.301 . . . . 3.05 111.43 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.725 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.7 m -111.87 25.73 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.986 0.736 . . . . 1.26 112.986 -171.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -89.78 126.5 42.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.248 -0.581 . . . . 1.66 110.333 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.23 87.79 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.78 110.844 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 47.3 mttm -106.73 138.79 42.25 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.072 -0.564 . . . . 2.37 110.619 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 25.8 t-20 -80.04 114.33 18.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.039 -0.528 . . . . 0.83 109.8 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.617 ' HA ' HD13 ' A' ' 39' ' ' ILE . 69.5 t80 -56.14 -43.34 78.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.961 -0.563 . . . . 0.7 111.416 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 39.6 m-85 -80.77 -6.25 58.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.457 -0.792 . . . . 1.45 112.329 -166.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.65 -45.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.448 0.536 . . . . 4.07 112.448 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.44 -23.56 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.314 -0.555 . . . . 2.2 111.833 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.93 14.01 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.116 -0.633 . . . . 2.34 110.998 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.29 74.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.904 -0.589 . . . . 1.2 110.543 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.88 13.64 1.43 Allowed 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.939 2.426 . . . . 0.98 113.698 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -97.12 -5.75 36.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.267 -0.573 . . . . 1.41 110.256 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 55.1 p -100.5 -28.87 12.68 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.61 -0.723 . . . . 1.74 111.653 -159.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.705 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 10.1 p-10 -75.29 78.49 2.39 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.591 1.186 . . . . 1.85 111.105 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.784 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 66.7 m -152.65 169.42 9.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 114.592 -1.185 . . . . 1.85 108.776 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.784 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 29.3 Cg_endo -61.99 -14.57 38.01 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.007 2.471 . . . . 1.4 114.926 -171.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.41 -34.29 13.51 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.901 -0.5 . . . . 2.56 111.554 -175.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 69.0 t80 -106.29 -69.43 0.83 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 4.11 110.459 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 63.8 t80 -60.62 -41.14 94.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 1.24 110.727 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -56.86 -49.15 73.03 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.6 112.383 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -67.48 -37.15 82.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 2.58 110.558 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.78 -40.75 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.614 . . . . 0.79 110.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -78.33 -18.59 54.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 1.63 112.229 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 35.1 mt-10 -66.12 -39.79 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.417 . . . . 2.07 110.939 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD11 ' A' ' 88' ' ' LEU . . . -69.71 -42.1 72.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.364 -0.922 . . . . 0.72 111.436 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 t -57.31 -51.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.38 . . . . 1.4 110.67 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -26.83 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.774 -0.648 . . . . 1.48 111.707 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -83.94 -77.94 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 2.15 110.172 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.87 -68.48 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.235 -0.746 . . . . 1.77 111.235 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -107.34 153.38 22.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 3.83 109.506 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 62.3 tp -118.19 126.41 52.14 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.932 -0.396 . . . . 3.54 109.932 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -166.15 94.12 0.54 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.939 0.876 . . . . 2.47 109.774 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.539 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 4.4 m -139.52 153.71 47.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.801 -1.09 . . . . 2.01 109.769 -174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 61.1 ttp -137.5 108.94 6.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.153 -0.314 . . . . 2.22 110.153 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.76 ' HE2' ' HE3' ' A' ' 109' ' ' MET . 47.1 p90 -123.76 167.29 14.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.472 -0.331 . . . . 3.82 110.76 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -102.68 132.79 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.622 -0.511 . . . . 2.39 109.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -144.21 150.84 38.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.531 . . . . 3.62 110.647 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 m -104.83 141.35 36.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.353 -0.385 . . . . 1.97 110.806 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.447 ' CE2' HG21 ' A' ' 105' ' ' VAL . 18.6 m-85 -104.63 120.81 42.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 1.47 109.832 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 99' ' ' GLN . 4.0 p30 -143.66 -156.93 0.73 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.639 -0.71 . . . . 2.57 109.527 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 58.1 t80 73.52 -24.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.152 0.581 . . . . 3.46 111.745 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.473 ' H ' ' C ' ' A' ' 97' ' ' ASP . 10.6 pt20 -158.74 -38.02 0.06 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.337 -0.616 . . . . 3.41 109.337 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 101' ' ' THR . 54.3 tpp -78.71 143.67 36.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.849 -0.797 . . . . 3.33 108.849 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 100' ' ' MET . 12.1 p -67.52 151.4 97.2 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 108.407 -0.96 . . . . 2.56 108.407 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.59 87.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.994 2.462 . . . . 1.72 113.864 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.672 HG23 ' HE ' ' A' ' 124' ' ' ARG . 85.8 m -100.78 129.89 46.73 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.457 -0.792 . . . . 1.93 110.422 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.34 114.76 29.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.48 -0.563 . . . . 3.47 109.48 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.3 m -126.95 165.88 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.784 -0.644 . . . . 1.96 111.151 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -115.19 128.09 55.95 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.499 -0.926 . . . . 2.22 108.499 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 91' ' ' MET . 98.9 t -104.51 104.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.459 -0.791 . . . . 1.97 109.201 -171.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.64 104.42 14.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.177 -0.675 . . . . 1.37 109.177 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.76 ' HE3' ' HE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -103.93 143.79 32.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.486 -0.779 . . . . 2.95 109.845 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.9 ptmt -154.31 154.24 33.04 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.466 -0.568 . . . . 2.05 109.466 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.716 ' HZ3' ' HB3' ' A' ' 111' ' ' LYS . 3.6 ttpm? -78.6 140.52 38.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.846 0.355 . . . . 2.66 111.557 -171.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -113.25 169.08 9.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.982 -0.554 . . . . 1.57 110.359 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 -6.2 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.524 -0.307 . . . . 4.89 111.525 177.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 p -61.49 -39.53 91.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.02 0.914 . . . . 2.9 109.167 170.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.02 22.21 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 108.749 -1.741 . . . . 2.62 108.749 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.27 89.8 0.06 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.474 0.637 . . . . 2.76 110.062 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 11.8 p -177.13 -170.02 0.27 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.521 -0.763 . . . . 1.61 110.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 15.9 m-85 -129.0 158.46 38.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.631 -0.877 . . . . 1.4 108.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 77.8 m95 -102.59 109.25 20.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.957 -0.757 . . . . 0.75 108.957 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 31' ' ' ILE . 7.4 p -102.5 120.85 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.887 0.851 . . . . 1.6 110.597 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.514 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 97.6 m-85 -103.61 136.53 43.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.467 -0.788 . . . . 0.97 110.992 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.48 107.76 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.078 -0.965 . . . . 1.83 110.026 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -103.65 104.42 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 3.79 110.182 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.672 ' HE ' HG23 ' A' ' 103' ' ' THR . 34.3 ttt-85 -83.55 126.9 33.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.035 -0.357 . . . . 4.65 110.035 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.125 -0.941 . . . . 2.87 111.443 -179.476 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.418 " H6'" ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.645 -0.502 . . . . 3.79 109.645 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.75 -82.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.82 0.343 . . . . 3.43 111.046 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -133.3 155.71 48.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.044 -0.354 . . . . 4.68 110.044 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.8 118.58 6.14 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.554 -0.832 . . . . 0.96 111.354 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.89 106.63 17.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.878 0.37 . . . . 1.26 110.481 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.716 ' HB ' HG12 ' A' ' 120' ' ' VAL . 20.7 mt -111.66 147.78 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.344 -0.613 . . . . 1.67 109.344 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -118.38 116.24 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.576 -0.528 . . . . 1.02 109.576 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 19.0 mt -115.71 154.12 30.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 110.276 -0.268 . . . . 2.24 110.276 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.718 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.2 p30 -112.03 167.4 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.497 -0.186 . . . . 1.22 110.497 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -19.11 50.55 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.507 0.563 . . . . 0.79 114.507 -171.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 38.7 t70 -81.38 -14.85 56.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.367 0.603 . . . . 1.95 109.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 104.53 7.82 38.91 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.502 -0.772 . . . . 0.61 112.009 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.718 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 40.1 m-80 -82.62 154.34 24.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.143 0.497 . . . . 1.64 110.483 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.749 HG23 ' HE2' ' A' ' 42' ' ' TYR . 9.1 mt -102.09 158.19 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.258 -0.883 . . . . 1.58 108.767 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.0 mp -116.77 -68.35 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.635 0.731 . . . . 2.1 109.754 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.5 151.7 40.6 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.585 -174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.749 ' HE2' HG23 ' A' ' 39' ' ' ILE . 2.7 m-85 -109.94 179.04 4.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.636 -1.166 . . . . 1.25 109.116 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -109.74 163.75 13.21 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.874 -0.787 . . . . 2.14 108.874 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.26 -7.12 44.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 1.87 111.842 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.74 -23.77 33.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.458 -0.337 . . . . 2.02 111.378 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.02 -53.14 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.268 -0.642 . . . . 2.12 109.268 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.591 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -55.76 -24.75 41.95 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.639 -0.71 . . . . 1.42 112.672 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.36 -33.36 75.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.842 0.353 . . . . 2.35 110.918 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -96.07 -69.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 2.98 110.916 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.8 m -84.29 -60.43 2.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.727 0.299 . . . . 3.86 110.281 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.591 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 119.39 40.51 0.62 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.091 -1.052 . . . . 2.91 113.121 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -92.88 119.44 32.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.165 -0.68 . . . . 3.64 109.165 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 19.6 m-20 -65.86 139.04 96.67 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 2.1 112.503 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 17.8 Cg_exo -66.98 121.56 8.77 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.691 2.261 . . . . 1.68 111.796 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 68.7 mttm 83.96 7.17 0.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.028 0.83 . . . . 4.08 112.604 171.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' HG3' HG11 ' A' ' 57' ' ' VAL . 2.6 pt20 -84.01 -16.96 42.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.909 0.862 . . . . 3.05 109.209 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.959 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.8 m -97.0 24.97 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.523 -1.217 . . . . 1.26 112.789 -170.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.41 125.71 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.732 -0.469 . . . . 1.66 109.732 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.95 5.77 88.82 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.227 -0.987 . . . . 0.78 111.102 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.959 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 39.8 mttm -98.46 139.43 34.21 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.388 . . . . 2.37 110.234 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 22.2 t-20 -86.25 111.96 20.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.761 -0.459 . . . . 0.83 109.761 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 39' ' ' ILE . 80.9 t80 -57.72 -32.63 67.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.7 111.585 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 30.0 m-85 -86.42 1.22 52.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.9 -0.591 . . . . 1.45 111.365 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -136.3 -62.55 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.327 0.492 . . . . 4.07 112.327 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.82 -24.06 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.375 0.509 . . . . 2.2 112.375 -164.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.83 13.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.215 0.45 . . . . 2.34 112.215 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.97 88.18 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.573 0.546 . . . . 1.2 110.637 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.09 29.9 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.581 2.187 . . . . 0.98 113.066 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.0 m -79.06 -30.61 44.12 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.983 -1.118 . . . . 1.41 107.983 167.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 6.8 m -96.99 -25.15 15.49 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.57 -2.105 . . . . 1.74 108.553 -119.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 11.0 p-10 -74.22 104.23 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.093 -0.958 . . . . 1.85 109.105 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' ' 76' ' ' TYR . 48.7 m -160.29 151.65 16.17 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.283 -0.871 . . . . 1.85 109.624 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.85 -31.01 87.53 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.95 2.433 . . . . 1.4 112.803 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.98 -2.36 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.343 0.497 . . . . 2.56 112.343 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -134.73 -74.33 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.888 -0.325 . . . . 4.11 110.537 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 85.8 t80 -57.54 -35.86 70.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.962 0.41 . . . . 1.24 110.171 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 81' ' ' GLU . . . -57.67 -45.69 93.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.743 -0.662 . . . . 0.6 112.048 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 72.5 mmtt -75.9 -38.68 57.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.669 0.235 . . . . 2.58 111.096 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.797 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 66.4 t80 -56.06 -40.13 73.08 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.554 0.692 . . . . 0.79 110.477 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -88.53 -16.66 32.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.292 -0.867 . . . . 1.63 111.034 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 29.3 tt0 -70.25 -35.64 73.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.154 -0.476 . . . . 2.07 110.563 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.739 ' HA3' HD11 ' A' ' 88' ' ' LEU . . . -76.37 -40.33 28.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.549 -0.834 . . . . 0.72 111.513 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.819 HG21 ' HH ' ' A' ' 118' ' ' TYR . 20.6 t -54.49 -50.35 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.832 0.349 . . . . 1.4 110.36 174.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.15 73.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.506 -0.77 . . . . 1.48 111.988 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 p -90.74 -72.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 2.15 110.959 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.75 -56.54 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.431 -0.89 . . . . 1.77 113.497 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -122.1 149.62 43.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.379 0.609 . . . . 3.83 112.055 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.739 HD11 ' HA3' ' A' ' 82' ' ' GLY . 3.9 mm? -112.8 107.61 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.108 -0.951 . . . . 3.54 109.581 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.2 p30 -169.68 110.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.989 0.9 . . . . 2.47 111.796 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.822 HG22 ' HE2' ' A' ' 109' ' ' MET . 13.8 t -166.05 158.62 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.777 -1.101 . . . . 2.01 109.413 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -127.77 119.97 26.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.127 0.489 . . . . 2.22 109.701 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.65 165.84 24.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.527 -0.545 . . . . 3.82 109.527 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 51.1 mt-10 -104.32 115.2 29.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.06 0.457 . . . . 2.39 110.423 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -118.33 152.74 35.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 3.62 109.825 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -104.01 132.09 50.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 1.97 110.594 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.845 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 79.4 m-85 -113.54 119.63 38.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.671 -0.492 . . . . 1.47 109.671 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -123.2 -147.05 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 2.57 109.629 -175.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 65.87 -85.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.044 0.537 . . . . 3.46 111.514 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.456 HE21 ' H3 ' ' A' ' 169' ' ' HC4 . 50.0 mt-30 -72.68 -51.17 20.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.45 0.643 . . . . 3.41 109.509 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.629 ' HE2' ' HB ' ' A' ' 103' ' ' THR . 47.5 ttp -93.27 130.41 39.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.338 -0.846 . . . . 3.33 109.783 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 m -52.85 117.55 11.36 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.766 -0.457 . . . . 2.56 109.766 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -20.25 92.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.552 4.168 . . . . 1.72 114.725 -169.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.629 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 25.5 m -105.52 144.45 32.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 1.93 111.184 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -103.32 117.66 35.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 3.47 110.421 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 124' ' ' ARG . 29.5 m -127.97 165.06 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.991 0.425 . . . . 1.96 111.001 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HE2' HG11 ' A' ' 125' ' ' VAL . 18.5 ttmm -104.92 129.58 53.27 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.662 -1.236 . . . . 2.22 107.662 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 121' ' ' PHE . 7.6 p -113.69 128.92 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.578 0.704 . . . . 1.97 110.096 -175.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -105.13 115.2 29.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.276 -0.875 . . . . 1.37 109.078 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.822 ' HE2' HG22 ' A' ' 90' ' ' THR . 37.0 ttp -102.99 127.22 50.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.461 -0.94 . . . . 2.95 108.461 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.8 ptmt -154.5 141.39 19.18 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.135 -0.32 . . . . 2.05 110.135 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' LEU . 31.3 ttmt -84.46 136.77 33.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.122 0.487 . . . . 2.66 111.367 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . . . -112.65 165.84 11.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.718 -0.845 . . . . 1.57 108.718 169.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.94 29.99 6.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.59 . . . . 4.89 111.139 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -76.51 79.84 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.625 -1.25 . . . . 2.9 107.625 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.31 -88.37 0.33 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.121 -1.192 . . . . 2.62 110.121 -167.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.7 83.9 0.46 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.217 -1.031 . . . . 2.76 108.217 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 p -146.42 152.27 38.77 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.683 -0.689 . . . . 1.61 109.394 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.819 ' HH ' HG21 ' A' ' 83' ' ' VAL . 1.7 m-85 -115.95 158.39 23.12 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.27 -0.641 . . . . 1.4 109.27 -170.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 83.6 m95 -101.59 110.09 22.02 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.963 -0.754 . . . . 0.75 108.963 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -102.73 110.52 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 122.029 0.918 . . . . 1.6 110.041 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.722 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 94.0 m-85 -103.93 127.91 51.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.4 -0.818 . . . . 0.97 111.17 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.28 104.8 17.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.787 0.803 . . . . 1.83 111.072 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -118.99 119.73 35.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.432 -0.803 . . . . 3.79 109.919 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HA ' HG11 ' A' ' 105' ' ' VAL . 79.3 ttt180 -68.88 135.72 51.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.987 0.423 . . . . 4.65 110.696 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.583 HG11 ' HE2' ' A' ' 106' ' ' LYS . 2.6 m . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.262 -0.875 . . . . 2.87 110.776 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.845 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 27' ' ' ALA . 3.5 tm? . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.186 -0.672 . . . . 3.79 109.186 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' N ' HD13 ' A' ' 26' ' ' LEU . . . -125.03 117.53 24.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.676 -0.693 . . . . 3.43 109.481 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -31.9 150.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.813 1.32 . . . . 4.68 113.38 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 43' ' ' ASN . . . -101.24 104.39 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.472 -0.87 . . . . 0.96 112.717 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.61 109.15 18.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.261 -0.469 . . . . 1.26 109.819 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 32' ' ' GLN . 18.9 mt -105.26 153.93 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.134 -0.691 . . . . 1.67 109.134 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.8 tt0 -113.57 110.1 19.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.686 -0.486 . . . . 1.02 109.686 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 34.9 mt -111.98 150.36 30.68 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 109.45 -0.574 . . . . 2.24 109.45 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 47.4 p30 -103.06 169.17 8.72 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.658 -0.417 . . . . 1.22 110.519 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.76 -14.67 16.34 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.357 -0.383 . . . . 0.79 113.922 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.65 -28.74 23.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.95 110.037 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.43 8.22 14.88 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.562 -0.744 . . . . 0.61 111.443 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 90.1 m-20 -76.98 149.1 35.96 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.977 0.417 . . . . 1.64 110.744 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.72 HG22 ' CE2' ' A' ' 42' ' ' TYR . 10.4 mt -92.87 153.68 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.132 -0.692 . . . . 1.58 109.132 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' O ' HG12 ' A' ' 58' ' ' ILE . 39.7 mt -122.67 -71.94 0.71 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.449 . . . . 2.1 110.189 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -125.71 136.36 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.399 0.619 . . . . 1.99 111.119 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.966 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -93.86 -176.0 3.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.936 -1.029 . . . . 1.25 111.005 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' CG ' ' HA2' ' A' ' 29' ' ' GLY . 7.8 p30 -125.05 -167.93 1.75 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.929 -1.032 . . . . 2.14 109.764 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.32 -28.35 53.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.158 0.429 . . . . 1.87 112.158 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.78 75.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 2.02 111.52 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -34.81 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.623 -0.262 . . . . 2.12 110.634 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 52' ' ' ARG . . . -61.6 -21.35 60.34 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 121.205 -0.521 . . . . 1.42 112.828 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -71.57 -28.61 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 2.35 110.436 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -91.68 81.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.733 0.778 . . . . 2.98 109.734 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 50' ' ' THR . 5.8 t -11.22 105.78 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 112.716 -2.038 . . . . 3.86 114.363 174.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.88 22.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.231 -1.349 . . . . 2.91 112.32 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HG3' ' HE1' ' A' ' 42' ' ' TYR . 6.5 mpt_? -115.16 94.8 4.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.788 0.327 . . . . 3.64 110.878 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 16.5 m-20 -88.35 148.06 41.56 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.173 -0.467 . . . . 2.1 110.442 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.966 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 40.0 Cg_exo -58.06 -34.93 99.0 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.112 2.541 . . . . 1.68 113.653 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -131.61 19.61 4.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.75 0.648 . . . . 4.08 112.75 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.627 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.19 8.57 44.27 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.454 -0.498 . . . . 3.05 110.929 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -121.19 29.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 1.26 111.863 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 40' ' ' LEU . 22.7 mt -81.35 134.28 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.635 -0.426 . . . . 1.66 110.51 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.6 29.61 74.18 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.22 -0.752 . . . . 0.78 111.22 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 39' ' ' ILE . 3.7 mtmm -126.6 125.51 42.07 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.161 -0.52 . . . . 2.37 109.76 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 38' ' ' ASN . 10.1 t-20 -73.65 114.26 11.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.874 -0.603 . . . . 0.83 111.219 -170.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.535 ' HB2' HG12 ' A' ' 39' ' ' ILE . 90.6 t80 -56.47 -48.61 76.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.485 -0.78 . . . . 0.7 111.146 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -79.94 5.25 14.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.011 -0.541 . . . . 1.45 112.111 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -137.54 -53.16 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.028 0.381 . . . . 4.07 112.028 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -96.42 -24.13 16.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.441 0.534 . . . . 2.2 112.441 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.1 t -116.07 14.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 120.12 -0.632 . . . . 2.34 110.933 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.46 87.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.055 -0.52 . . . . 1.2 110.342 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.45 -4.75 15.9 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.589 2.193 . . . . 0.98 113.683 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -80.04 -13.62 59.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.227 -0.589 . . . . 1.41 109.653 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -101.72 -4.23 26.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.821 -1.082 . . . . 1.74 110.827 -157.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.07 95.63 6.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.918 -0.401 . . . . 1.85 109.918 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.775 ' HB2' ' HD1' ' A' ' 75' ' ' PHE . 66.8 m -166.33 155.28 10.1 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.035 -0.728 . . . . 1.85 109.035 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.43 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 31.0 Cg_endo -64.51 -20.87 66.22 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.456 2.104 . . . . 1.4 112.04 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.579 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -91.79 -15.51 28.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 2.56 111.5 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.775 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 87.7 m-85 -106.75 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.287 0.565 . . . . 4.11 109.72 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.517 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 41.1 t80 -63.53 -37.4 87.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.3 -0.864 . . . . 1.24 110.321 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -62.78 -27.37 69.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.108 -0.568 . . . . 0.6 112.483 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 68.1 mmtt -80.35 -29.52 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.751 0.31 . . . . 2.58 110.555 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 64.7 t80 -68.43 -35.66 77.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.848 -0.797 . . . . 0.79 108.848 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -82.94 -3.82 57.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.63 111.239 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -53.68 -46.96 70.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.778 0.323 . . . . 2.07 111.464 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.705 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -85.12 -42.84 6.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.086 -1.054 . . . . 0.72 111.711 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 118' ' ' TYR . 21.5 t -44.3 -49.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.667 0.787 . . . . 1.4 112.031 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -42.42 38.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.862 0.465 . . . . 1.48 111.953 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -77.46 -61.91 1.83 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.386 0.612 . . . . 2.15 109.524 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.05 -54.16 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.503 -1.039 . . . . 1.77 110.503 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 137.21 2.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.286 -0.957 . . . . 3.83 109.289 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.705 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 63.1 tp -165.89 125.18 1.65 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.868 -0.333 . . . . 3.54 111.514 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.56 131.56 44.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 2.47 110.514 173.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.531 HG23 ' HE1' ' A' ' 109' ' ' MET . 12.4 t -141.66 155.35 45.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.551 -0.75 . . . . 2.01 109.888 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.4 ttp -130.27 119.35 22.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.83 -0.623 . . . . 2.22 110.512 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -130.72 155.01 47.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.085 -0.709 . . . . 3.82 109.085 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 136.41 54.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.073 0.463 . . . . 2.39 111.007 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.853 ' HD1' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -162.16 168.86 21.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.056 -0.52 . . . . 3.62 110.418 -175.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.853 ' H ' ' HD1' ' A' ' 94' ' ' TYR . 25.6 m -102.53 143.29 32.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.97 111.237 -173.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.598 ' CG ' " H6'" ' A' ' 169' ' ' HC4 . 17.4 m-85 -107.35 112.31 25.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.745 -0.835 . . . . 1.47 108.745 173.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.76 14.12 13.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.294 0.479 . . . . 2.57 112.294 -171.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.549 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 85.4 t80 -119.34 131.61 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.622 -0.51 . . . . 3.46 109.622 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.549 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 21.6 mm-40 75.51 -43.25 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.65 0.78 . . . . 3.41 110.477 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 tpt -105.88 142.03 36.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.505 -0.924 . . . . 3.33 108.505 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -62.96 141.04 97.61 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.868 -1.16 . . . . 2.56 107.868 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 51.0 Cg_exo -36.5 91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.78 2.987 . . . . 1.72 114.703 -173.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 t -108.9 146.57 33.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.903 -0.589 . . . . 1.93 109.747 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -106.51 125.02 50.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.148 0.499 . . . . 3.47 111.182 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 29.6 m -121.17 166.19 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 1.96 111.079 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 36.2 ttpt -118.64 121.47 40.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.312 -0.996 . . . . 2.22 108.312 174.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.6 103.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.905 -0.589 . . . . 1.97 109.499 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -105.55 102.13 11.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.673 -0.862 . . . . 1.37 108.673 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.653 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.44 149.81 25.83 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.863 -0.335 . . . . 2.95 110.356 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HZ1' ' HB3' ' A' ' 110' ' ' LYS . 8.8 mtpm? -146.62 147.19 30.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.203 -0.666 . . . . 2.05 109.203 -175.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 111' ' ' LYS . 1.2 tmmt? -87.18 137.48 32.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.266 0.555 . . . . 2.66 111.154 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.33 -176.12 4.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.027 -1.101 . . . . 1.57 108.027 171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.11 -93.94 0.14 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.84 -0.8 . . . . 4.89 108.84 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.6 p 42.89 38.96 1.55 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.231 0.826 . . . . 2.9 113.231 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.57 15.64 20.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.614 -0.803 . . . . 2.62 113.032 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 63.94 87.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.049 0.54 . . . . 2.76 110.507 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 p -173.74 -176.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 1.61 110.726 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.532 ' CZ ' HG21 ' A' ' 83' ' ' VAL . 42.0 m-85 -121.05 147.59 45.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.996 -0.742 . . . . 1.4 108.996 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -102.59 104.2 14.56 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.575 -0.898 . . . . 0.75 108.575 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 109' ' ' MET . 7.3 p -100.52 132.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.976 -1.011 . . . . 1.6 111.417 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.84 113.88 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.406 -0.815 . . . . 0.97 109.847 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -113.09 104.52 17.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 1.83 110.31 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 159.39 42.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.388 -0.597 . . . . 3.79 109.388 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 29.9 mtm180 -69.54 105.32 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.863 0.363 . . . . 4.65 111.107 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 106' ' ' LYS . 11.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.879 -1.055 . . . . 2.87 111.164 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.598 " H6'" ' CG ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.717 ' HG ' ' HA ' ' A' ' 45' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.918 -0.401 . . . . 3.79 109.918 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.3 -49.09 3.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 3.43 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.97 162.52 29.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 4.68 109.664 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.69 119.74 6.46 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.464 -0.874 . . . . 0.96 111.845 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.65 103.63 13.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.119 0.485 . . . . 1.26 110.093 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.747 ' HB ' HG12 ' A' ' 120' ' ' VAL . 31.5 mt -108.2 159.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.203 -1.036 . . . . 1.67 108.203 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.593 HE22 ' HB2' ' A' ' 113' ' ' LEU . 45.3 tt0 -133.42 134.16 43.28 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.618 -0.433 . . . . 1.02 110.317 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.93 161.89 38.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.977 -0.556 . . . . 2.24 110.536 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.656 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.5 p30 -103.93 169.09 8.71 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.062 -0.255 . . . . 1.22 110.741 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.65 -27.54 27.54 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 115.323 0.889 . . . . 0.79 115.323 -170.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.96 -10.39 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.818 0.809 . . . . 1.95 111.263 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.41 2.19 21.48 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.359 -0.924 . . . . 0.61 113.611 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.656 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 91.1 m-20 -71.06 126.7 30.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.191 0.496 . . . . 1.64 110.443 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.63 HG23 ' HE2' ' A' ' 42' ' ' TYR . 17.2 mt -84.06 150.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.446 . . . . 1.58 109.97 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 40' ' ' LEU . 6.9 mp -110.03 -54.22 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.249 0.547 . . . . 2.1 109.942 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -166.22 149.14 7.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.215 -0.902 . . . . 1.99 110.785 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.797 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 8.9 m-30 -98.4 -176.89 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.241 -0.891 . . . . 1.25 110.641 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -112.37 163.99 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.494 -0.928 . . . . 2.14 108.494 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.62 -27.6 17.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.87 111.474 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.717 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . . . -46.14 -54.14 9.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.152 -0.931 . . . . 2.02 112.51 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -75.25 -29.92 60.35 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.961 0.41 . . . . 2.12 110.922 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 -22.6 68.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.849 -0.691 . . . . 1.42 111.635 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -87.81 -35.07 18.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.607 0.241 . . . . 2.35 110.69 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 45' ' ' ALA . 45.9 mm -53.04 -54.03 19.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.142 0.496 . . . . 2.98 110.249 176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 t -140.08 -41.38 0.43 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 3.86 111.041 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.408 -0.901 . . . . 2.91 111.734 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -113.78 99.53 7.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.002 -0.74 . . . . 3.64 109.002 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.648 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 18.9 t70 -54.8 127.62 61.38 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.481 0.488 . . . . 2.1 110.728 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.797 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 41.7 Cg_exo -59.16 -17.64 39.92 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.583 2.855 . . . . 1.68 113.855 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -94.73 -1.83 52.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.758 0.313 . . . . 4.08 111.025 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.648 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 54.7 mm-40 -102.64 5.24 39.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.12 0.486 . . . . 3.05 110.588 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.582 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.4 m -117.27 14.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.566 . . . . 1.26 111.654 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 40.0 mt -80.26 125.73 39.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.406 -0.517 . . . . 1.66 110.407 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.3 10.52 78.81 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.843 -0.903 . . . . 0.78 110.843 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.861 ' HD3' ' HB ' ' A' ' 66' ' ' VAL . 23.3 ttmt -104.88 135.72 45.72 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.64 -0.504 . . . . 2.37 109.64 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -83.49 117.74 23.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.234 -0.439 . . . . 0.83 111.491 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.494 ' HB2' HG12 ' A' ' 39' ' ' ILE . 57.8 t80 -72.11 0.63 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.799 -0.637 . . . . 0.7 111.669 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 82.0 m-85 -116.74 -9.76 11.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.081 -0.387 . . . . 1.45 111.222 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.3 -38.47 0.76 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.73 0.641 . . . . 4.07 112.73 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.424 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 22.8 m-20 -90.43 -87.56 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.928 0.344 . . . . 2.2 111.928 -174.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.861 ' HB ' ' HD3' ' A' ' 60' ' ' LYS . 6.4 p -83.16 14.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.992 0.901 . . . . 2.34 111.616 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.77 86.23 0.46 Allowed Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.155 -0.929 . . . . 1.2 110.486 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -90.8 4.38 4.39 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.365 2.044 . . . . 0.98 113.597 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 11.4 p -84.65 -15.62 44.79 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 120.494 -0.483 . . . . 1.41 110.152 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.631 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 6.8 p -87.46 -39.68 15.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.215 -1.357 . . . . 1.74 111.048 -160.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -51.89 108.54 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.966 -0.561 . . . . 1.85 110.784 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -161.74 149.63 12.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.85 109.902 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.13 -26.25 82.29 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.379 2.053 . . . . 1.4 111.409 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 13.9 pt-20 -96.91 1.29 50.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.851 -0.613 . . . . 2.56 111.912 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' HD2' ' HE1' ' A' ' 92' ' ' PHE . 67.0 t80 -127.3 -70.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 4.11 109.597 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.596 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 64.4 t80 -61.41 -38.39 86.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 1.24 110.002 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.66 -34.98 91.41 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.054 -0.593 . . . . 0.6 112.674 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HD2' ' O ' ' A' ' 74' ' ' GLU . 92.7 mttt -80.46 -31.18 37.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.311 0.577 . . . . 2.58 110.093 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.775 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 72.8 t80 -61.27 -32.22 72.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.79 110.377 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 13.2 mmmm -95.75 -5.48 41.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 1.63 110.879 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -59.96 -52.93 63.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 2.07 110.738 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -72.85 -27.9 68.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.57 -0.824 . . . . 0.72 112.245 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.34 -54.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 1.4 110.794 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.6 70.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.576 . . . . 1.48 110.566 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.0 m -74.04 -86.05 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.7 -0.682 . . . . 2.15 110.05 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.4 -64.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.971 -0.852 . . . . 1.77 110.971 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -92.37 132.72 36.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.801 -0.7 . . . . 3.83 110.182 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.1 tm? -110.26 105.5 14.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.943 -0.762 . . . . 3.54 108.943 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' MET . 22.7 p-10 -164.41 58.03 0.15 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.625 0.726 . . . . 2.47 110.665 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -104.47 155.4 18.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.443 -0.799 . . . . 2.01 110.499 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -128.96 124.15 34.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.611 -0.722 . . . . 2.22 110.024 177.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.52 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 50.5 p90 -144.23 168.1 20.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.507 -0.315 . . . . 3.82 110.967 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -103.3 133.04 49.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.053 -0.521 . . . . 2.39 110.087 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -149.44 166.48 28.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.026 -0.731 . . . . 3.62 109.026 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -104.91 159.23 15.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.858 0.688 . . . . 1.97 112.858 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -111.26 120.6 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.219 -0.66 . . . . 1.47 109.219 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 21.5 t70 -133.92 -152.46 0.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.798 -0.816 . . . . 2.57 108.798 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.531 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 40.4 t80 71.41 -68.1 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.956 0.503 . . . . 3.46 111.753 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.439 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 2.5 pp0? -112.24 -4.43 14.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.137 0.494 . . . . 3.41 110.755 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.6 tpp -126.92 143.8 51.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.723 -0.671 . . . . 3.33 110.372 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -54.69 128.37 62.09 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.199 -1.037 . . . . 2.56 108.199 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.1 90.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.547 2.831 . . . . 1.72 113.168 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.5 158.1 16.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.174 -0.921 . . . . 1.93 110.701 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.934 ' HE2' ' HB ' ' A' ' 125' ' ' VAL . 18.1 ptmt -106.25 127.56 53.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 3.47 111.387 -175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.769 HG21 HG12 ' A' ' 122' ' ' VAL . 11.5 p -125.0 151.99 31.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.591 -0.731 . . . . 1.96 110.353 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' N ' HG23 ' A' ' 105' ' ' VAL . 82.8 tttt -110.21 119.39 39.12 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.417 -0.957 . . . . 2.22 108.417 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.9 p -112.34 129.74 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.453 0.644 . . . . 1.97 111.241 -171.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -112.71 104.59 12.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.005 -1.109 . . . . 1.37 108.005 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.775 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 9.7 ptp -103.41 129.31 50.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.273 -0.421 . . . . 2.95 110.628 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 59.6 mtpt -138.72 126.16 21.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.484 0.659 . . . . 2.05 112.651 -168.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.832 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 25.3 tttp -70.36 114.63 8.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.51 1.124 . . . . 2.66 111.498 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -177.8 93.67 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.535 0.939 . . . . 1.57 113.535 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.711 ' HB3' ' HG ' ' A' ' 117' ' ' SER . 28.7 tp 177.68 86.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.433 0.531 . . . . 4.89 112.433 165.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 m 41.68 38.78 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.598 1.186 . . . . 2.9 112.292 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.77 -123.96 1.23 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.931 -1.128 . . . . 2.62 112.012 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.02 35.29 1.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.76 111.059 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.711 ' HG ' ' HB3' ' A' ' 113' ' ' LEU . 1.5 p -100.36 135.33 41.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.95 -0.568 . . . . 1.61 109.744 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.595 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 2.0 m-85 -109.37 161.33 15.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.775 -0.454 . . . . 1.4 109.775 -169.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' MET . 88.9 m95 -100.92 114.72 28.86 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.689 -0.856 . . . . 0.75 108.689 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.747 HG12 ' HB ' ' A' ' 31' ' ' ILE . 7.3 p -100.2 115.34 41.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.128 0.966 . . . . 1.6 110.207 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.91 123.38 46.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.246 -0.888 . . . . 0.97 111.146 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.769 HG12 HG21 ' A' ' 105' ' ' VAL . 66.3 t -104.7 105.62 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.122 -0.945 . . . . 1.83 110.99 -176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -131.58 131.04 42.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.849 0.357 . . . . 3.79 110.249 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HD2' ' C ' ' A' ' 124' ' ' ARG . 7.4 ppt_? -72.88 157.41 37.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 4.65 111.661 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.934 ' HB ' ' HE2' ' A' ' 104' ' ' LYS . 25.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.67 -0.681 . . . . 2.87 109.166 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.828 -0.434 . . . . 3.79 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.7 78.24 0.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.387 -0.369 . . . . 3.43 110.125 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 55.76 -152.33 0.37 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.741 -0.663 . . . . 4.68 110.451 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -103.68 132.82 11.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.59 -0.814 . . . . 0.96 111.497 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.926 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -132.04 134.03 45.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.635 -0.506 . . . . 1.26 109.635 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 120' ' ' VAL . 4.8 mp -128.01 144.43 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.982 -0.553 . . . . 1.67 109.775 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.841 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 40.4 tt0 -104.51 118.66 37.14 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.94 -1.133 . . . . 1.02 107.94 170.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -130.1 150.14 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.43 -0.508 . . . . 2.24 110.662 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -103.43 168.39 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.862 -0.421 . . . . 1.22 109.862 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.39 -29.05 22.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.381 0.512 . . . . 0.79 114.381 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -75.2 -21.14 58.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.275 0.537 . . . . 1.95 111.324 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.14 4.44 38.43 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.898 -0.668 . . . . 0.61 111.916 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.8 m-20 -77.23 141.18 40.15 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.978 -0.378 . . . . 1.64 109.978 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.5 mt -88.75 144.77 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.263 0.554 . . . . 1.58 110.381 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.841 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -99.89 -59.29 1.74 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.264 -0.88 . . . . 2.1 110.227 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -165.13 153.06 11.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.757 -1.11 . . . . 1.99 110.027 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 1.012 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 4.7 m-30 -97.46 156.63 16.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 1.25 110.367 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.926 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 64.0 t30 -74.76 10.73 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.919 -0.582 . . . . 2.14 111.104 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 42' ' ' TYR . . . 75.72 -42.34 0.46 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.896 -1.047 . . . . 1.87 112.213 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -56.87 -24.78 54.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.555 0.576 . . . . 2.02 112.555 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.75 -18.68 64.26 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.18 0.514 . . . . 2.12 110.944 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.59 -7.6 78.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.613 -0.803 . . . . 1.42 111.861 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.57 -46.87 5.57 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 2.35 109.204 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 45' ' ' ALA . 30.8 mm -66.34 -67.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.419 -0.81 . . . . 2.98 110.714 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 m -92.71 -56.97 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.479 -0.328 . . . . 3.86 110.984 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.72 42.12 0.25 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.683 -0.77 . . . . 2.91 112.156 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mmt180 -108.29 127.89 54.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.31 -0.256 . . . . 3.64 110.31 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' CG ' ' HG2' ' A' ' 56' ' ' GLN . 12.2 t70 -65.9 132.68 94.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 2.1 110.306 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 1.012 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 7.3 Cg_exo -73.62 -12.88 24.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.986 2.457 . . . . 1.68 114.209 -172.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -130.23 -7.45 4.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.605 0.965 . . . . 4.08 113.605 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG2' ' CG ' ' A' ' 53' ' ' ASP . 77.6 mm-40 -75.23 -13.18 60.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.264 -0.575 . . . . 3.05 110.864 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.702 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.4 m -88.49 14.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.4 0.889 . . . . 1.26 113.4 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 40' ' ' LEU . 38.6 mt -81.99 131.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.177 -0.609 . . . . 1.66 110.131 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.34 26.63 72.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.011 -0.836 . . . . 0.78 111.011 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -121.5 134.46 55.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.964 -0.618 . . . . 2.37 110.177 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.4 114.66 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.79 0.329 . . . . 0.83 110.297 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.73 -40.93 69.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.7 111.389 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 72.2 m-85 -80.56 3.66 21.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.351 -0.386 . . . . 1.45 111.534 -173.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -121.84 -51.65 2.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.48 -0.563 . . . . 4.07 109.48 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -78.34 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 2.2 112.155 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 66' ' ' VAL . 2.0 t -96.22 16.38 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.794 0.33 . . . . 2.34 111.853 -168.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.99 77.2 0.74 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 121.989 -0.444 . . . . 1.2 112.014 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -97.61 28.45 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.084 2.523 . . . . 0.98 113.208 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 p -120.71 22.96 10.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.539 -0.541 . . . . 1.41 109.539 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.9 m -136.58 -44.34 0.6 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.062 -1.426 . . . . 1.74 109.41 -133.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 11.2 p-10 -68.98 119.88 13.97 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.207 -0.664 . . . . 1.85 109.207 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -168.99 161.58 7.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.78 -0.645 . . . . 1.85 109.743 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.96 -31.11 91.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.36 2.04 . . . . 1.4 112.868 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.7 -4.66 54.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 2.56 112.072 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -124.77 -70.82 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.181 -0.303 . . . . 4.11 110.181 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 93.8 t80 -60.44 -39.44 87.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 1.24 110.284 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.11 -40.19 98.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.979 -0.629 . . . . 0.6 112.219 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 74.0 mmtt -73.56 -26.14 60.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 2.58 110.32 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -67.38 -35.49 79.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.79 110.276 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -84.5 -14.89 47.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.994 -0.548 . . . . 1.63 110.98 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.484 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 49.8 mm-40 -54.48 -52.28 62.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.154 0.502 . . . . 2.07 111.016 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -72.19 -33.34 62.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.72 112.213 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG21 ' OH ' ' A' ' 118' ' ' TYR . 23.1 t -61.7 -51.61 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 1.4 110.646 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.2 -21.7 66.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.843 -0.617 . . . . 1.48 111.881 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -96.41 -77.57 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 2.15 110.875 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.49 -77.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.5 -0.64 . . . . 1.77 111.5 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.8 p30 -95.24 144.88 25.47 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.543 -0.54 . . . . 3.83 109.543 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 54.6 tp -120.18 102.63 8.64 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.714 -0.476 . . . . 3.54 109.714 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 109' ' ' MET . 39.1 m-80 -148.65 97.41 2.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.017 -0.734 . . . . 2.47 109.017 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -149.19 165.14 32.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.787 -0.642 . . . . 2.01 110.496 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 ptp -132.97 129.58 38.41 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.828 -0.623 . . . . 2.22 109.972 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.437 ' O ' HG11 ' A' ' 107' ' ' VAL . 45.5 p90 -146.51 165.25 30.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.023 -0.362 . . . . 3.82 110.023 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -109.19 122.08 46.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 2.39 110.971 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -131.83 153.84 49.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.792 -0.64 . . . . 3.62 109.885 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 m -104.76 145.62 30.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.97 110.458 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.642 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 97.9 m-85 -125.43 104.63 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.995 -0.372 . . . . 1.47 109.995 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 9.1 p-10 -135.13 115.08 13.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.473 0.654 . . . . 2.57 110.885 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -179.91 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.94 -1.027 . . . . 3.46 109.188 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -92.32 -35.87 13.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.905 -0.776 . . . . 3.41 108.905 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.28 144.17 25.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.131 -1.063 . . . . 3.33 108.131 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.59 160.31 53.64 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 109.664 -0.495 . . . . 2.56 109.664 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 50.3 Cg_exo -54.74 84.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 1.72 114.418 -171.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 p -102.13 147.7 26.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.331 -0.395 . . . . 1.93 110.291 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -121.24 130.36 53.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.007 -0.368 . . . . 3.47 110.007 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 124' ' ' ARG . 35.8 m -122.87 164.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.175 0.512 . . . . 1.96 111.658 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -104.25 111.72 24.45 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.837 -1.542 . . . . 2.22 106.837 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' MET . 14.6 p -104.27 136.64 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-O 121.329 0.585 . . . . 1.97 109.701 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -111.95 114.33 27.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.647 -0.872 . . . . 1.37 108.647 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.2 tpp -100.39 133.68 44.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.46 -0.791 . . . . 2.95 109.079 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 118' ' ' TYR . 12.2 mmmm -135.67 159.63 41.02 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.819 -0.808 . . . . 2.05 108.819 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.611 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 64.7 tttp -104.86 121.05 42.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.126 0.489 . . . . 2.66 111.657 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.605 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . . . -107.91 99.02 8.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.694 -0.685 . . . . 1.57 109.938 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.66 -19.54 62.08 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.595 -0.52 . . . . 4.89 109.595 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 m -73.34 80.81 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.543 -0.753 . . . . 2.9 110.174 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.05 9.18 13.84 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.524 -0.846 . . . . 2.62 112.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 55.95 41.34 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.896 0.379 . . . . 2.76 111.662 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -134.77 -167.14 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.514 -0.312 . . . . 1.61 110.828 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.693 ' OH ' HG21 ' A' ' 83' ' ' VAL . 82.4 m-85 -135.55 153.51 51.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.003 -0.74 . . . . 1.4 109.003 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.605 ' CD1' ' HB3' ' A' ' 112' ' ' ALA . 47.9 m95 -102.72 104.13 14.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.958 -0.756 . . . . 0.75 108.958 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 31' ' ' ILE . 11.6 p -100.34 125.66 54.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.108 0.956 . . . . 1.6 111.39 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.73 137.06 54.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.894 -1.048 . . . . 0.97 108.989 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 29' ' ' GLY . 27.0 m -104.69 141.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.093 -0.643 . . . . 1.83 111.567 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -124.23 103.54 8.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.306 -0.861 . . . . 3.79 109.257 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.545 ' HA ' HG13 ' A' ' 105' ' ' VAL . 15.0 ptm180 -75.05 120.78 21.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.506 -0.315 . . . . 4.65 110.268 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.712 1.258 . . . . 2.87 113.417 -174.025 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.642 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.611 0.243 . . . . 3.79 110.447 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.35 108.63 3.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.448 -0.342 . . . . 3.43 110.254 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 69.65 142.34 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.116 0.885 . . . . 4.68 112.137 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.42 123.49 7.88 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 0.96 110.023 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -116.79 103.94 10.84 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.966 -0.294 . . . . 1.26 110.362 -170.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 53.2 mt -108.7 114.34 46.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.971 -0.559 . . . . 1.67 109.56 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -101.45 114.34 28.26 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.624 -0.88 . . . . 1.02 108.624 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.24 160.53 34.61 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.112 -0.495 . . . . 2.24 110.632 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.4 169.88 8.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 1.22 110.574 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.28 -23.69 26.86 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 114.521 0.568 . . . . 0.79 114.521 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -37.35 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.337 0.569 . . . . 1.95 110.751 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 128.96 11.3 2.9 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.479 -0.867 . . . . 0.61 113.285 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -71.14 127.19 31.75 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.366 0.583 . . . . 1.64 109.727 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 16.2 mt -81.52 151.36 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.309 -0.626 . . . . 1.58 109.309 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.712 ' HA ' HG21 ' A' ' 58' ' ' ILE . 77.7 mt -129.82 -67.46 0.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.459 0.647 . . . . 2.1 110.115 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 63.2 mt-30 -112.61 138.38 49.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.633 -0.712 . . . . 1.99 110.347 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.823 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -118.41 -4.07 10.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.703 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.639 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 66.2 t30 63.23 172.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.538 -0.756 . . . . 2.14 110.577 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 11.2 6.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 1.87 110.882 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -92.51 -63.78 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.229 -0.442 . . . . 2.02 111.472 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.26 -43.79 83.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 2.12 110.985 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA2' ' C ' ' A' ' 51' ' ' GLY . . . -68.82 -10.06 60.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.576 -0.821 . . . . 1.42 113.148 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.15 -41.91 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.122 0.461 . . . . 2.35 110.559 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 45' ' ' ALA . 6.1 pt -85.92 -47.56 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 112.296 0.48 . . . . 2.98 112.296 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.7 p -105.82 -49.33 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.976 -0.453 . . . . 3.86 111.175 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' C ' ' HA2' ' A' ' 47' ' ' GLY . . . 139.91 -175.25 21.95 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.222 -0.751 . . . . 2.91 111.222 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.681 ' HG2' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 71.57 99.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 3.64 111.407 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.463 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 3.6 m-20 -67.97 149.4 98.2 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 108.97 -0.752 . . . . 2.1 108.97 171.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.823 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 10.3 Cg_endo -52.52 -31.78 50.43 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.788 2.325 . . . . 1.68 111.938 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -71.35 -19.13 62.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.361 -0.836 . . . . 4.08 111.46 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 15.3 mm-40 -94.97 -14.49 24.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 3.05 111.73 -171.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.685 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -111.23 18.93 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 113.033 0.753 . . . . 1.26 113.033 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.712 HG21 ' HA ' ' A' ' 40' ' ' LEU . 8.3 pt -87.51 140.09 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.438 -0.505 . . . . 1.66 110.586 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.72 10.04 71.03 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.223 -0.989 . . . . 0.78 110.901 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' O ' HG13 ' A' ' 39' ' ' ILE . 87.1 mttt -114.71 135.99 53.55 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.761 -0.459 . . . . 2.37 109.761 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 21.8 t-20 -81.62 115.78 21.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.146 -0.479 . . . . 0.83 110.021 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.668 ' HA ' HD11 ' A' ' 39' ' ' ILE . 48.1 t80 -50.73 -37.91 44.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.7 111.618 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 38.2 m-85 -90.38 15.14 11.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.382 -0.372 . . . . 1.45 111.577 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -148.66 -49.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 4.07 111.716 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.03 -21.88 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.165 0.802 . . . . 2.2 113.165 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' HG2' ' A' ' 52' ' ' ARG . 5.4 p -149.58 14.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.357 -0.937 . . . . 2.34 112.82 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -171.25 94.52 0.43 Allowed Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.043 -0.526 . . . . 1.2 111.703 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.02 -18.88 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.618 2.212 . . . . 0.98 112.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -12.03 48.78 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.142 -0.223 . . . . 1.41 111.223 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 67' ' ' ALA . 10.9 t -82.56 -27.73 31.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.697 -0.401 . . . . 1.74 110.854 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.629 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 19.1 t70 -67.05 110.36 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.217 -0.66 . . . . 1.85 109.217 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -164.12 148.94 8.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.178 -0.464 . . . . 1.85 109.791 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.81 -21.59 64.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.691 2.261 . . . . 1.4 113.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.97 -21.59 19.69 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.97 -0.292 . . . . 2.56 111.573 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 50.2 t80 -107.46 -72.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.767 0.317 . . . . 4.11 110.176 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.69 -38.9 79.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 1.24 110.132 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.04 -40.25 93.17 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.6 112.546 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.716 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 58.1 mttm -87.91 -21.95 24.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 2.58 111.426 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.646 ' O ' HG23 ' A' ' 83' ' ' VAL . 84.6 t80 -62.17 -49.65 74.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.62 -0.882 . . . . 0.79 108.62 170.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.43 -20.16 60.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.825 -1.08 . . . . 1.63 110.309 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 30.3 tt0 -57.37 -36.72 71.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 2.07 109.693 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.97 -32.62 8.84 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.611 -0.722 . . . . 0.72 112.187 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.1 t -59.9 -53.04 54.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.59 0.219 . . . . 1.4 111.59 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.83 -59.37 4.59 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.423 0.452 . . . . 1.48 111.535 -175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.2 p -167.11 29.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.306 . . . . 2.15 111.561 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.17 -10.71 19.88 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.53 -1.319 . . . . 1.77 113.069 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 63.77 124.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.409 -0.589 . . . . 3.83 109.409 -169.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD21 ' CG ' ' A' ' 118' ' ' TYR . 32.9 tp -103.67 104.19 14.2 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.655 -0.818 . . . . 3.54 111.432 -166.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.3 p-10 -165.03 104.68 0.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.497 1.142 . . . . 2.47 109.429 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -165.41 166.63 18.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.996 -1.456 . . . . 2.01 108.514 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.5 ptt? -133.25 122.22 23.61 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.072 0.463 . . . . 2.22 110.304 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -124.3 167.48 14.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.149 -0.478 . . . . 3.82 110.41 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -102.59 119.32 38.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.748 -0.464 . . . . 2.39 109.748 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -133.96 153.82 51.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 3.62 110.319 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 p -104.45 150.49 24.51 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.72 0.295 . . . . 1.97 111.295 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.44 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 53.0 m-85 -130.22 116.41 18.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.438 . . . . 1.47 110.319 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' MET . 8.0 p-10 -124.54 -158.53 0.83 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.504 -0.771 . . . . 2.57 109.238 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.502 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 67.1 t80 70.96 -74.64 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.685 0.394 . . . . 3.46 111.474 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 26.3 mm-40 -92.55 4.2 54.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.695 0.759 . . . . 3.41 110.357 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 tpt -150.0 152.0 34.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.659 -1.155 . . . . 3.33 108.243 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 100' ' ' MET . 13.7 p -63.38 147.79 94.55 Favored Pre-proline 0 N--CA 1.443 -0.809 0 N-CA-C 108.069 -1.086 . . . . 2.56 108.069 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.9 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.191 . . . . 1.72 112.649 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -99.51 149.22 23.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.931 -0.577 . . . . 1.93 110.798 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.85 118.57 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.198 -0.667 . . . . 3.47 109.198 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 124' ' ' ARG . 27.5 m -123.05 163.73 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.592 0.711 . . . . 1.96 111.616 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -110.79 114.88 28.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.905 -1.146 . . . . 2.22 107.905 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.65 HG22 HG11 ' A' ' 122' ' ' VAL . 41.5 t -107.34 115.79 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.208 -0.451 . . . . 1.97 110.055 -168.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -104.27 109.03 20.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.658 -0.497 . . . . 1.37 109.658 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -103.97 134.32 47.45 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.842 -0.617 . . . . 2.95 109.489 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -147.95 150.15 33.51 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.204 -0.295 . . . . 2.05 110.204 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.509 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 42.9 tttm -87.01 128.72 35.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.667 0.27 . . . . 2.66 111.037 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.34 127.65 30.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 1.57 110.066 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.19 94.58 5.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.927 0.87 . . . . 4.89 112.692 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t -113.47 -62.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 104.3 -2.482 . . . . 2.9 104.3 160.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.62 143.86 17.06 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 106.626 -2.59 . . . . 2.62 106.626 151.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.92 100.14 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.661 1.231 . . . . 2.76 111.12 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -156.7 -177.79 6.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.875 -1.057 . . . . 1.61 109.003 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 9.0 m-85 -128.85 154.18 46.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.715 -0.846 . . . . 1.4 108.715 -175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 60.8 m95 -100.74 104.13 15.4 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.237 -1.023 . . . . 0.75 108.237 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.609 HG23 ' CB ' ' A' ' 109' ' ' MET . 47.9 t -101.8 104.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.889 -1.05 . . . . 1.6 109.585 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 81.0 m-85 -103.16 138.64 39.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.97 110.608 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.65 HG11 HG22 ' A' ' 107' ' ' VAL . 16.6 m -107.35 153.22 8.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.944 0.402 . . . . 1.83 111.138 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -149.77 112.38 4.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.942 -0.572 . . . . 3.79 110.186 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.648 ' HA ' HG11 ' A' ' 105' ' ' VAL . 20.5 ttt180 -73.1 145.34 46.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 4.65 110.808 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.411 ' H ' HG21 ' A' ' 125' ' ' VAL . 3.2 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.153 -0.927 . . . . 2.87 110.824 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.44 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD11 ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.127 -0.694 . . . . 3.79 109.127 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' H ' HD13 ' A' ' 26' ' ' LEU . . . -75.52 59.28 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.131 0.419 . . . . 3.43 112.131 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 64.88 168.04 0.18 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.746 0.784 . . . . 4.68 112.956 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.22 107.39 2.94 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.925 -0.87 . . . . 0.96 110.925 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.55 128.82 51.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 1.26 110.809 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 HD13 ' HG2' ' A' ' 46' ' ' GLU . 57.5 mt -122.26 138.89 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.228 -0.656 . . . . 1.67 109.228 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' HG2' HD11 ' A' ' 40' ' ' LEU . 62.6 tt0 -104.68 121.13 42.93 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.192 -0.67 . . . . 1.02 109.192 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.01 153.74 50.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 2.24 109.891 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.648 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 169.62 8.41 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.85 -0.34 . . . . 1.22 110.655 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.63 -22.59 8.46 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 115.313 0.885 . . . . 0.79 115.313 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.36 -21.93 38.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.756 0.778 . . . . 1.95 110.638 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.88 3.94 31.76 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.093 -0.803 . . . . 0.61 111.093 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.648 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.1 m120 -70.24 134.84 48.43 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.054 0.454 . . . . 1.64 110.705 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 62' ' ' PHE . 10.1 mt -87.24 148.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.422 -0.808 . . . . 1.58 110.015 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 32' ' ' GLN . 42.2 mt -117.69 -61.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.271 0.557 . . . . 2.1 110.516 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.8 136.89 18.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.389 0.614 . . . . 1.99 111.248 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.976 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -92.5 153.1 19.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.899 -1.046 . . . . 1.25 110.77 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -88.04 166.22 14.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.078 -0.712 . . . . 2.14 109.078 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB2' HD12 ' A' ' 26' ' ' LEU . . . -53.46 -35.5 60.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.137 0.421 . . . . 1.87 112.137 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -63.85 -48.07 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.751 0.278 . . . . 2.02 111.751 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HG2' HD13 ' A' ' 31' ' ' ILE . 6.3 tp10 -72.46 -4.86 32.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.575 0.702 . . . . 2.12 110.435 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.41 -54.12 0.62 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.486 -0.779 . . . . 1.42 112.282 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.07 -38.36 61.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.984 0.421 . . . . 2.35 111.36 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -81.78 -57.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 2.98 109.823 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.4 m -57.42 -52.35 65.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.22 -0.9 . . . . 3.86 112.032 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.73 42.77 0.92 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.625 -0.798 . . . . 2.91 111.814 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -133.46 171.74 13.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.684 -0.488 . . . . 3.64 109.684 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.778 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 16.1 t70 -105.76 130.93 22.24 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.701 -0.481 . . . . 2.1 109.701 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.976 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 50.3 Cg_exo -55.02 -20.25 22.72 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.488 2.792 . . . . 1.68 114.186 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -119.32 15.13 13.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.195 0.443 . . . . 4.08 112.195 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.778 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 23.1 mm-40 -86.23 -13.23 47.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 3.05 110.161 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.91 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.606 -0.724 . . . . 1.26 112.179 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.2 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.641 -0.423 . . . . 1.66 110.721 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 18.92 76.95 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.254 -0.738 . . . . 0.78 111.254 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -124.25 151.79 43.75 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.623 0.249 . . . . 2.37 111.084 -170.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -105.71 122.04 45.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.83 109.416 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HA ' HD12 ' A' ' 39' ' ' ILE . 84.7 t80 -54.09 -43.75 70.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.005 -0.543 . . . . 0.7 111.733 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 70.9 m-85 -77.5 -5.41 49.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 1.45 111.719 -172.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -128.37 -48.05 1.31 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.13 0.419 . . . . 4.07 112.13 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -92.88 -22.54 19.2 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.483 0.549 . . . . 2.2 112.483 -172.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.14 13.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.171 -0.612 . . . . 2.34 111.477 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.81 74.58 0.17 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.748 0.309 . . . . 1.2 111.023 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.2 -4.1 11.05 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.766 2.311 . . . . 0.98 113.64 -176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 p -113.1 18.24 18.15 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.096 -0.377 . . . . 1.41 110.641 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p -97.17 -37.64 10.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.125 164.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 59.1 t0 -59.96 102.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.207 0.527 . . . . 1.85 110.486 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.489 ' HG ' ' HH ' ' A' ' 94' ' ' TYR . 80.2 p -163.55 154.86 14.37 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.618 -0.719 . . . . 1.85 109.489 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.61 -21.41 71.97 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.6 2.2 . . . . 1.4 113.001 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.62 -17.08 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.902 0.334 . . . . 2.56 111.902 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.871 ' HE2' HG11 ' A' ' 107' ' ' VAL . 23.2 t80 -117.23 -68.92 0.88 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.825 -0.35 . . . . 4.11 110.689 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.46 -35.22 79.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 1.24 109.95 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.42 93.69 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.665 -0.698 . . . . 0.6 112.069 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 69.6 mmtt -71.4 -38.62 71.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.029 0.442 . . . . 2.58 110.406 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.76 -37.06 80.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.797 -0.638 . . . . 0.79 110.298 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.73 -20.98 32.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 1.63 110.622 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -68.88 -35.83 77.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 2.07 109.681 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.963 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -68.92 -36.67 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.538 -0.756 . . . . 0.72 111.583 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.13 -51.76 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 1.4 110.212 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.44 69.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.623 . . . . 1.48 111.162 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -65.95 -71.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.513 0.673 . . . . 2.15 110.095 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.26 -62.59 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 108.884 -1.687 . . . . 1.77 108.884 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -161.33 167.03 26.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.902 0.881 . . . . 3.83 108.674 167.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.963 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -125.59 152.79 44.64 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.8 -0.76 . . . . 3.54 111.299 -168.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.773 ' HA ' ' O ' ' A' ' 109' ' ' MET . 35.7 p30 -163.8 47.0 0.12 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.336 -1.302 . . . . 2.47 109.162 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 p -102.36 165.21 11.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.843 -1.526 . . . . 2.01 111.134 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -116.78 125.32 51.45 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.218 -0.901 . . . . 2.22 109.911 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.33 157.66 27.68 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.757 -0.461 . . . . 3.82 109.757 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.25 111.11 23.59 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.595 -0.52 . . . . 2.39 109.595 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.489 ' HH ' ' HG ' ' A' ' 72' ' ' SER . 14.3 t80 -135.87 144.07 45.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.885 -0.598 . . . . 3.62 109.408 -175.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 104' ' ' LYS . 6.0 p -105.06 155.52 18.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.013 0.435 . . . . 1.97 111.55 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 35.8 m-85 -116.19 104.73 11.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.919 -0.582 . . . . 1.47 109.614 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 31.8 t70 -140.77 98.84 3.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.748 -0.66 . . . . 2.57 110.198 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HD1' ' HG2' ' A' ' 99' ' ' GLN . 65.2 t80 174.24 -71.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.675 0.61 . . . . 3.46 110.03 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.596 ' HG2' ' HD1' ' A' ' 98' ' ' TYR . 25.0 mm-40 -101.9 4.34 40.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.987 0.899 . . . . 3.41 109.319 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.5 tpp -137.99 139.4 39.64 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.114 -1.403 . . . . 3.33 107.962 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.09 144.43 94.28 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 108.972 -0.751 . . . . 2.56 108.972 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.4 90.9 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.349 2.699 . . . . 1.72 114.14 -167.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -89.85 143.73 26.54 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.133 -0.485 . . . . 1.93 110.683 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.0 OUTLIER -110.91 107.87 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.395 -0.965 . . . . 3.47 108.395 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 124' ' ' ARG . 23.6 m -129.64 163.17 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.789 0.804 . . . . 1.96 112.365 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.66 123.02 47.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.408 -1.269 . . . . 2.22 107.856 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.871 HG11 ' HE2' ' A' ' 75' ' ' PHE . 4.9 p -104.19 113.17 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.054 0.93 . . . . 1.97 109.759 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.477 ' CE1' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t-160 -104.9 104.24 13.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.976 -1.011 . . . . 1.37 108.813 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.773 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.3 pmm? -102.98 127.76 50.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.349 -0.612 . . . . 2.95 109.349 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 42.4 mtmt -137.79 164.6 28.51 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 110.228 -0.286 . . . . 2.05 110.228 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 3.9 tmtp? -94.92 149.98 20.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 2.66 110.897 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -137.37 114.56 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.313 -0.858 . . . . 1.57 109.333 173.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -87.72 32.71 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.5 0.667 . . . . 4.89 110.703 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 p -79.73 -58.34 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.492 -0.777 . . . . 2.9 109.935 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.44 20.98 5.48 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.409 -0.814 . . . . 2.62 111.136 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.21 77.25 0.33 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.57 0.7 . . . . 2.76 111.393 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 1.3 m -159.49 -171.22 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 1.61 107.51 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.542 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 78.6 m-85 -123.74 147.8 47.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 118.154 0.434 . . . . 1.4 109.847 -174.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.573 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 70.9 m95 -103.93 108.54 19.92 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.241 -1.022 . . . . 0.75 108.241 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.21 135.96 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.574 0.702 . . . . 1.6 110.437 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.547 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 98.6 m-85 -120.19 137.24 54.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.354 -0.839 . . . . 0.97 110.715 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.6 t -104.01 102.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.304 -0.862 . . . . 1.83 109.107 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -105.81 123.86 48.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.154 -0.476 . . . . 3.79 109.883 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.664 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -66.14 137.37 56.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.726 0.298 . . . . 4.65 110.818 -177.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.446 ' O ' HG11 ' A' ' 125' ' ' VAL . 3.3 p . . . . . 0 C--O 1.248 1.018 0 CA-C-N 116.35 -0.386 . . . . 2.87 110.663 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.445 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.734 HD22 HG13 ' A' ' 49' ' ' ILE . 68.9 mt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.107 0.479 . . . . 3.79 110.935 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.87 -56.46 2.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.93 -0.767 . . . . 3.43 108.93 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 30' ' ' ALA . 35.0 p90 173.01 170.9 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.167 -0.924 . . . . 4.68 109.354 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -104.07 115.26 5.0 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.732 -0.746 . . . . 0.96 111.845 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -119.87 113.5 20.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 1.26 110.527 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.463 ' HB ' HG12 ' A' ' 120' ' ' VAL . 24.8 mt -120.2 146.42 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.416 -0.587 . . . . 1.67 109.416 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.657 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.3 tt0 -115.74 136.34 53.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.255 -1.016 . . . . 1.02 108.255 172.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 40' ' ' LEU . 2.0 pt? -147.95 159.32 44.0 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.729 -0.388 . . . . 2.24 110.999 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.8 p30 -102.85 167.79 9.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.308 -0.405 . . . . 1.22 110.201 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.2 -17.22 44.83 Favored Glycine 0 CA--C 1.517 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.79 113.855 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.92 -21.18 22.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.01 0.405 . . . . 1.95 111.139 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 117.09 3.49 17.51 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.418 -0.896 . . . . 0.61 113.558 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.617 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 46.1 m-80 -71.11 128.93 37.58 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.453 0.627 . . . . 1.64 109.384 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.698 HG21 ' HE2' ' A' ' 42' ' ' TYR . 18.0 mt -83.5 144.08 10.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.047 -0.524 . . . . 1.58 110.16 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -96.93 -75.47 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 2.1 110.066 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 16.9 pm0 -153.45 145.01 23.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 1.99 110.378 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.698 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.6 m-85 -90.68 156.91 17.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.142 -0.936 . . . . 1.25 109.313 170.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.591 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 58.7 t30 -70.6 156.47 39.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.85 -0.796 . . . . 2.14 108.85 171.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.21 69.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 1.87 110.707 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.659 ' HB3' HD21 ' A' ' 26' ' ' LEU . . . -69.84 -52.67 23.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.987 -0.551 . . . . 2.02 111.28 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.656 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 20.6 tp10 -61.41 -44.98 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 2.12 111.286 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.06 -34.82 58.14 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.33 -0.938 . . . . 1.42 113.009 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.25 -45.85 68.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 2.35 111.01 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.734 HG13 HD22 ' A' ' 26' ' ' LEU . 38.4 mm -74.32 -55.72 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.144 -0.48 . . . . 2.98 111.307 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 m -64.26 -50.91 66.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.537 -0.302 . . . . 3.86 111.781 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.79 44.51 0.41 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.342 -0.932 . . . . 2.91 112.152 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 52' ' ' ARG . 57.5 mmt-85 -136.3 93.69 2.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.057 -0.72 . . . . 3.64 109.057 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.91 142.11 79.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.759 0.652 . . . . 2.1 112.759 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.44 114.23 1.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.135 2.557 . . . . 1.68 112.26 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 77.38 11.63 2.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.835 -1.075 . . . . 4.08 112.105 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -91.82 4.73 52.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.673 0.749 . . . . 3.05 109.056 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.696 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -110.23 14.84 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.764 -1.107 . . . . 1.26 111.935 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.43 128.22 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.451 -0.574 . . . . 1.66 109.451 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 -8.39 65.66 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.123 -1.037 . . . . 0.78 110.833 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.696 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 21.0 mttp -86.04 131.21 34.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.847 -0.797 . . . . 2.37 108.847 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.1 t-20 -88.17 112.94 23.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.122 -0.631 . . . . 0.83 109.866 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' HE1' HG23 ' A' ' 70' ' ' THR . 45.8 t80 -47.87 -64.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.361 -0.836 . . . . 0.7 111.787 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -87.96 28.09 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.192 0.442 . . . . 1.45 112.192 -169.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 38.9 ttpt -143.18 -42.43 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 4.07 111.026 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD2' HG12 ' A' ' 66' ' ' VAL . 38.9 t70 -95.15 -77.02 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 2.2 110.884 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.405 HG12 ' OD2' ' A' ' 65' ' ' ASP . 5.6 m -91.96 16.29 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.558 0.947 . . . . 2.34 113.558 -172.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -165.25 86.23 1.03 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.994 0.426 . . . . 1.2 111.153 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 98' ' ' TYR . 79.4 Cg_endo -91.07 -4.84 4.34 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.683 2.255 . . . . 0.98 114.257 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 98' ' ' TYR . 11.8 p -73.67 -13.83 61.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.267 -0.573 . . . . 1.41 109.814 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.571 HG21 ' HE1' ' A' ' 96' ' ' PHE . 11.1 m -91.49 -37.47 13.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.351 -1.295 . . . . 1.74 110.607 -145.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.36 109.96 5.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.768 0.794 . . . . 1.85 110.179 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.4 m -162.67 154.16 15.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.399 -0.819 . . . . 1.85 109.314 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.17 -35.59 91.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.688 2.259 . . . . 1.4 112.908 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.48 -16.15 60.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.248 0.462 . . . . 2.56 112.248 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.409 ' HE2' HG12 ' A' ' 107' ' ' VAL . 61.5 t80 -124.5 -74.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 4.11 110.485 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.46 -37.55 78.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 1.24 110.966 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.29 -44.69 96.33 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.894 -0.67 . . . . 0.6 112.106 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 71.9 mmtt -74.02 -32.29 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 2.58 111.024 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' O ' HD11 ' A' ' 88' ' ' LEU . 89.3 t80 -60.14 -43.41 95.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.315 0.579 . . . . 0.79 110.278 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.4 -19.6 45.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.86 -0.609 . . . . 1.63 110.338 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.27 -37.68 83.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 2.07 109.897 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.628 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.31 -44.83 41.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 0.72 111.799 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 79' ' ' PHE . 32.1 t -56.76 -50.47 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 1.4 110.945 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -12.22 60.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 1.48 112.229 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -101.26 -77.13 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.712 0.292 . . . . 2.15 110.596 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.3 -62.23 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.738 -0.744 . . . . 1.77 112.231 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -118.26 136.28 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.777 0.322 . . . . 3.83 110.552 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -104.74 123.17 47.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.179 -0.464 . . . . 3.54 110.261 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.727 ' HA ' ' O ' ' A' ' 109' ' ' MET . 36.9 t-20 -176.11 116.53 0.13 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.491 0.662 . . . . 2.47 110.363 173.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 13.9 t -166.0 165.15 18.16 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.718 -1.128 . . . . 2.01 109.031 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.608 ' HB3' ' HD2' ' A' ' 108' ' ' HIS . 22.6 ptm -140.0 108.64 5.91 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.335 0.588 . . . . 2.22 110.687 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -121.93 166.61 14.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.767 -0.651 . . . . 3.82 110.548 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.59 121.55 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.495 -0.557 . . . . 2.39 109.495 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -134.07 165.13 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.631 -0.713 . . . . 3.62 109.458 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -104.42 147.17 27.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.734 -0.469 . . . . 1.97 109.734 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' HE1' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -139.45 103.33 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.198 -0.601 . . . . 1.47 112.448 -169.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 7.3 t70 170.52 144.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 2.57 108.958 167.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.753 ' HA ' ' HB3' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -72.02 -42.67 66.09 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.605 -0.725 . . . . 3.46 111.578 -176.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.437 HE21 ' HD2' ' A' ' 98' ' ' TYR . 48.6 mt-30 -137.02 -5.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.037 0.754 . . . . 3.41 113.037 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.92 160.51 29.13 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.17 -0.678 . . . . 3.33 109.17 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.87 100.92 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 108.504 -0.924 . . . . 2.56 108.504 167.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -39.55 99.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.425 3.417 . . . . 1.72 113.996 -161.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.5 m -56.42 153.39 9.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.359 -0.837 . . . . 1.93 110.273 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.98 136.53 42.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.226 0.536 . . . . 3.47 110.946 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.489 HG21 ' HB ' ' A' ' 122' ' ' VAL . 10.6 p -144.4 156.2 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.381 -0.827 . . . . 1.96 110.294 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.437 ' HE3' HG12 ' A' ' 125' ' ' VAL . 29.0 ttmt -109.38 128.77 55.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.098 -1.075 . . . . 2.22 108.098 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 122' ' ' VAL . 50.3 t -119.56 114.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 109.221 -0.659 . . . . 1.97 109.221 -166.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.608 ' HD2' ' HB3' ' A' ' 91' ' ' MET . 56.5 t-80 -104.78 122.78 46.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.899 -0.591 . . . . 1.37 109.969 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.727 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.4 mpt? -100.29 147.47 25.73 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.497 -0.927 . . . . 2.95 108.497 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.59 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.8 ptmt -162.67 143.82 10.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.464 -0.569 . . . . 2.05 109.464 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.41 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 84.4 tttt -94.0 122.51 36.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.451 . . . . 2.66 111.111 -170.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -104.62 174.78 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.743 -0.662 . . . . 1.57 109.335 175.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.4 tp -121.56 -28.7 4.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.812 0.339 . . . . 4.89 110.129 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -71.34 100.24 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.424 -0.584 . . . . 2.9 109.424 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.64 -6.01 33.22 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.301 -0.952 . . . . 2.62 112.151 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 51.87 51.62 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.27 0.557 . . . . 2.76 110.099 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 p -152.59 178.98 9.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.857 -0.611 . . . . 1.61 110.568 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 2.5 m-85 -117.22 155.68 29.01 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.569 -0.9 . . . . 1.4 108.569 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.45 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 78.2 m95 -102.27 111.55 23.88 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.09 -0.707 . . . . 0.75 109.09 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.463 HG12 ' HB ' ' A' ' 31' ' ' ILE . 14.7 p -101.63 116.81 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.165 0.983 . . . . 1.6 110.396 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 32.5 m-85 -109.36 125.15 52.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.795 . . . . 0.97 110.529 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.704 HG12 HG23 ' A' ' 107' ' ' VAL . 15.3 m -109.46 140.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.127 0.489 . . . . 1.83 110.88 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -139.2 133.19 31.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 3.79 110.088 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -72.05 123.05 21.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.892 -0.41 . . . . 4.65 109.892 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.437 HG12 ' HE3' ' A' ' 106' ' ' LYS . 2.5 m . . . . . 0 C--O 1.247 0.948 0 CA-C-N 116.327 -0.397 . . . . 2.87 110.599 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.69 HD22 ' HB1' ' A' ' 44' ' ' ALA . 2.4 mm? . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.382 -0.229 . . . . 3.79 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.12 -77.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.597 -0.274 . . . . 3.43 111.417 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.21 170.78 9.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 4.68 110.683 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 43' ' ' ASN . . . -104.23 147.16 16.44 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.416 -0.897 . . . . 0.96 113.424 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.15 111.43 14.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.092 -0.707 . . . . 1.26 109.092 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 120' ' ' VAL . 6.9 mm -103.53 160.37 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.134 -0.691 . . . . 1.67 109.134 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 31' ' ' ILE . 63.5 tt0 -133.42 113.67 12.8 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.175 -0.328 . . . . 1.02 110.156 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' HG ' HG12 ' A' ' 120' ' ' VAL . 22.0 mt -112.63 151.98 29.5 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.351 -0.611 . . . . 2.24 109.351 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.52 168.99 8.72 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.876 -0.329 . . . . 1.22 110.249 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.92 -27.48 37.14 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.569 0.543 . . . . 0.79 114.326 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -44.03 20.09 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.508 0.654 . . . . 1.95 111.097 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.49 20.76 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.361 -0.924 . . . . 0.61 112.902 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -84.52 142.64 29.88 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.484 -0.562 . . . . 1.64 109.484 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 6.0 mt -90.91 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.982 -0.747 . . . . 1.58 108.982 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 39' ' ' ILE . 9.1 mp -118.19 -86.43 0.64 Allowed 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.134 0.492 . . . . 2.1 111.02 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -119.6 168.29 11.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.687 0.756 . . . . 1.99 111.655 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.692 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 3.3 m-85 -132.94 -167.75 1.96 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.011 -1.449 . . . . 1.25 109.337 -174.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 63.4 t30 -128.13 160.74 31.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.749 -0.834 . . . . 2.14 108.749 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.69 ' HB1' HD22 ' A' ' 26' ' ' LEU . . . -71.55 19.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.508 0.559 . . . . 1.87 112.508 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -95.64 -42.9 8.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.083 0.468 . . . . 2.02 110.149 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -77.5 -17.27 58.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.535 . . . . 2.12 110.555 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -82.89 -26.18 46.4 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.449 -0.882 . . . . 1.42 111.663 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -45.11 16.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 2.35 110.609 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -83.16 -62.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 2.98 111.21 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -75.76 -53.28 8.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.053 0.454 . . . . 3.86 111.382 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.21 36.59 1.32 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 2.91 111.226 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 16.9 tpp85 -123.27 110.14 14.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.56 0.219 . . . . 3.64 110.525 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.803 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 28.6 m-20 -77.74 154.6 80.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.542 -0.299 . . . . 2.1 110.508 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.692 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 36.9 Cg_endo -67.47 -9.79 26.53 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.838 2.358 . . . . 1.68 111.312 172.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HB3' ' HZ2' ' A' ' 55' ' ' LYS . 8.5 mtpm? -100.27 5.86 44.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.269 -0.878 . . . . 4.08 111.185 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.803 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 83.4 mm-40 -97.82 -60.52 1.55 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 3.05 111.75 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.832 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 2.9 m -88.27 40.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.486 0.921 . . . . 1.26 113.486 -169.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 40' ' ' LEU . 30.8 mt -91.23 120.34 40.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.466 -0.494 . . . . 1.66 109.886 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.52 33.03 58.96 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.526 -1.03 . . . . 0.78 110.526 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.832 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 35.6 mttm -121.7 135.56 54.95 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.673 -0.763 . . . . 2.37 110.009 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -80.78 112.93 18.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.803 0.335 . . . . 0.83 110.331 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HB2' HG12 ' A' ' 39' ' ' ILE . 71.6 t80 -57.55 -40.7 79.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.7 111.385 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.487 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 55.5 m-85 -91.05 25.63 2.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.332 -0.394 . . . . 1.45 111.712 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.79 -46.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.688 -0.405 . . . . 4.07 111.113 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.28 -78.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 2.2 111.703 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.18 36.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.982 1.373 . . . . 2.34 111.544 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -163.9 81.28 1.43 Allowed Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 113.995 -1.457 . . . . 1.2 111.071 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -97.72 8.81 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.906 2.404 . . . . 0.98 114.066 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.46 ' HB2' ' OD2' ' A' ' 97' ' ' ASP . 1.7 p -77.69 -17.97 57.12 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.949 -0.7 . . . . 1.41 110.25 170.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.1 t -96.45 -26.3 15.36 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.74 110.964 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 63' ' ' PHE . 5.7 m-20 -65.76 131.7 46.96 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.842 -0.343 . . . . 1.85 111.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.87 ' HG ' ' HH ' ' A' ' 94' ' ' TYR . 61.8 p 179.81 155.05 0.68 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 1.85 109.515 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.9 -19.2 63.97 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.353 2.035 . . . . 1.4 112.326 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.39 -24.9 18.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 2.56 111.718 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 87.0 t80 -104.34 -72.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.646 -0.422 . . . . 4.11 110.075 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -38.26 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 1.24 110.238 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.28 -34.79 90.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.86 -0.609 . . . . 0.6 112.498 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.25 -35.13 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.817 0.309 . . . . 2.58 110.464 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.59 ' O ' HG21 ' A' ' 83' ' ' VAL . 59.3 t80 -57.72 -45.82 85.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.219 -0.66 . . . . 0.79 109.219 172.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -77.75 -17.71 57.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.671 . . . . 1.63 111.241 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -61.24 -36.22 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 2.07 110.109 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.65 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -84.03 -51.36 4.01 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.161 -1.019 . . . . 0.72 111.48 172.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 79' ' ' PHE . 48.4 t -45.82 -62.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.151 0.58 . . . . 1.4 112.559 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.82 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 1.48 111.411 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -70.07 0.36 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.499 . . . . 2.15 110.537 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.99 27.5 0.18 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.223 -0.751 . . . . 1.77 111.223 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 111' ' ' LYS . 5.3 m120 67.02 107.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.559 0.744 . . . . 3.83 109.659 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.65 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 45.7 tp -149.65 148.93 29.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.63 -0.428 . . . . 3.54 111.541 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.633 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -88.63 144.44 26.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.046 -0.979 . . . . 2.47 111.688 178.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -150.1 153.37 36.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.454 -0.793 . . . . 2.01 109.874 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.8 ptm -126.35 125.39 42.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.547 -0.751 . . . . 2.22 109.734 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 32.5 p90 -144.11 165.54 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.866 0.365 . . . . 3.82 111.01 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.72 124.52 49.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.898 -0.592 . . . . 2.39 109.592 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.87 ' HH ' ' HG ' ' A' ' 72' ' ' SER . 31.0 t80 -136.38 161.61 35.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 3.62 110.534 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 103' ' ' THR . 89.1 m -106.55 136.7 45.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.211 -0.45 . . . . 1.97 110.212 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.439 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 15.8 m-85 -125.34 104.73 8.63 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.222 -0.658 . . . . 1.47 109.222 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 69' ' ' CYS . 5.0 p-10 -86.17 -63.35 1.33 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.145 -0.622 . . . . 2.57 109.785 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.428 ' HB2' ' C3 ' ' A' ' 169' ' ' HC4 . 53.0 t80 47.19 55.09 8.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.761 -0.829 . . . . 3.46 108.761 -171.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.22 -28.43 0.14 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.14 -0.937 . . . . 3.41 111.033 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.487 ' HE2' ' OG1' ' A' ' 103' ' ' THR . 33.6 ttp -67.7 163.35 21.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.234 -0.439 . . . . 3.33 110.222 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.493 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 14.8 t -55.46 146.67 42.32 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 108.383 -0.969 . . . . 2.56 108.383 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 22.5 Cg_endo -61.87 72.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.385 2.057 . . . . 1.72 113.289 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.487 ' OG1' ' HE2' ' A' ' 100' ' ' MET . 7.6 p -73.9 146.89 43.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.265 -0.425 . . . . 1.93 110.846 172.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -104.63 146.81 28.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 3.47 111.178 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.65 158.78 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.547 -0.752 . . . . 1.96 109.362 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -112.68 131.36 55.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.23 -1.026 . . . . 2.22 108.23 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.79 139.31 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.451 0.643 . . . . 1.97 110.843 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -121.59 104.22 9.48 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.594 -0.891 . . . . 1.37 108.594 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 5.1 ppp? -102.75 143.55 32.24 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 2.95 109.689 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.633 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 51.2 mtpt -149.65 146.42 27.26 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 109.708 -0.479 . . . . 2.05 109.708 -174.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.5 ' HD2' ' CB ' ' A' ' 87' ' ' ASN . 41.8 tttm -75.21 146.35 41.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.335 -0.617 . . . . 2.66 109.335 173.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -134.92 -159.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 1.57 110.088 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.28 -166.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.15 -0.685 . . . . 4.89 109.15 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.5 m 67.28 65.48 0.42 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.129 -0.693 . . . . 2.9 109.129 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.32 51.58 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.333 -0.707 . . . . 2.62 111.333 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.33 80.09 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.559 0.744 . . . . 2.76 112.684 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.82 176.06 9.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.837 -1.172 . . . . 1.61 107.837 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.588 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 80.3 m-85 -104.71 147.48 27.63 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.08 0.466 . . . . 1.4 110.121 -173.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 51.3 m95 -102.99 103.1 13.18 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.493 -0.776 . . . . 0.75 109.099 175.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -103.27 104.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.601 -1.181 . . . . 1.6 110.823 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 119' ' ' TRP . 11.6 m-85 -102.68 137.97 40.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.97 110.225 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -112.99 154.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.969 0.414 . . . . 1.83 111.894 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -165.24 153.09 11.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 3.79 109.436 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -73.26 98.66 2.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.916 -0.314 . . . . 4.65 111.791 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.401 1.063 . . . . 2.87 112.167 172.252 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.439 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.842 -0.429 . . . . 3.79 109.842 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -174.3 -76.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.844 0.354 . . . . 3.43 110.89 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -127.25 162.16 26.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.189 -0.46 . . . . 4.68 110.158 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.82 119.49 6.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.508 -0.854 . . . . 0.96 112.709 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -104.8 126.18 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 1.26 109.341 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.467 ' HB ' HG11 ' A' ' 120' ' ' VAL . 51.6 mt -128.39 149.13 32.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 1.67 109.775 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.699 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.0 tt0 -112.01 134.65 53.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.987 -0.746 . . . . 1.02 108.987 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -139.67 153.41 47.28 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.136 -0.32 . . . . 2.24 110.136 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.683 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.1 p30 -103.86 168.27 9.24 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.682 -0.407 . . . . 1.22 110.576 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.588 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -57.38 -14.47 13.14 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 115.136 0.815 . . . . 0.79 115.136 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.08 -18.08 26.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.917 0.858 . . . . 1.95 110.391 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.28 26.42 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.682 -0.77 . . . . 0.61 112.012 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.683 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 92.1 m-20 -71.58 138.17 48.58 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.73 0.3 . . . . 1.64 110.807 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.493 HG12 ' HB2' ' A' ' 62' ' ' PHE . 14.0 mt -87.86 144.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.002 -0.545 . . . . 1.58 109.685 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -101.93 -63.74 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.5 0.667 . . . . 2.1 110.231 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.08 169.5 23.22 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.005 -0.998 . . . . 1.99 110.572 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.666 ' CE1' ' HB2' ' A' ' 52' ' ' ARG . 5.4 m-30 -113.91 175.94 5.25 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.113 -0.948 . . . . 1.25 109.364 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 45' ' ' ALA . 63.9 t30 -89.3 5.26 45.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.586 0.708 . . . . 2.14 110.091 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 71.47 -15.54 0.42 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.351 -1.295 . . . . 1.87 110.875 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -60.5 -32.5 71.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.585 -0.734 . . . . 2.02 111.84 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 1.075 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 8.2 tp10 -78.77 -14.66 59.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.482 0.658 . . . . 2.12 110.016 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.95 73.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.859 -0.686 . . . . 1.42 111.464 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.63 -52.16 48.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 2.35 110.836 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.522 HG22 HG21 ' A' ' 50' ' ' THR . 24.7 mt -83.82 -72.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 2.98 111.799 -170.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.522 HG21 HG22 ' A' ' 49' ' ' ILE . 11.9 t -173.73 43.24 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.049 0.928 . . . . 3.86 111.054 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 1.075 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -109.05 -119.94 4.3 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.268 -0.967 . . . . 2.91 113.673 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.666 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 24.9 mmt180 -139.21 153.46 47.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 3.64 111.539 -171.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.678 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 12.0 m-20 -81.91 155.98 70.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.495 -0.928 . . . . 2.1 108.495 163.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -29.94 85.57 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.112 1.874 . . . . 1.68 111.896 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -72.73 -22.66 60.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 4.08 111.598 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.678 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 67.4 mt-30 -81.95 -21.89 36.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.92 0.341 . . . . 3.05 111.92 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -121.54 62.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.687 0.625 . . . . 1.26 112.687 -172.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -119.26 132.49 68.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.297 -0.561 . . . . 1.66 111.058 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.2 -2.68 50.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.485 -0.864 . . . . 0.78 111.549 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 47.6 mttp -88.36 146.0 25.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.407 . . . . 2.37 110.609 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -94.25 107.24 19.2 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.785 -0.45 . . . . 0.83 109.785 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB2' HG12 ' A' ' 39' ' ' ILE . 82.2 t80 -51.39 -36.03 41.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.7 111.416 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.8 m-85 -86.16 16.06 4.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.761 0.282 . . . . 1.45 111.761 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -147.16 -45.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.423 0.527 . . . . 4.07 112.423 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.55 -78.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.137 0.421 . . . . 2.2 112.137 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.518 ' O ' " H2'" ' A' ' 169' ' ' HC4 . 9.1 p -108.6 14.53 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.007 0.908 . . . . 2.34 111.367 -170.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HA ' ' H3 ' ' A' ' 169' ' ' HC4 . . . -158.07 71.82 4.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.607 -0.724 . . . . 1.2 112.267 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.78 15.52 1.62 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.761 2.307 . . . . 0.98 112.805 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.04 -23.79 59.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.18 -0.674 . . . . 1.41 109.18 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 20.7 p -94.44 -32.04 13.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.587 -1.188 . . . . 1.74 110.52 -136.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 12.6 p-10 -77.36 82.29 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.251 1.024 . . . . 1.85 110.361 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.564 ' HG ' ' HH ' ' A' ' 94' ' ' TYR . 50.0 m -145.35 157.68 52.37 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.886 -1.052 . . . . 1.85 109.534 -175.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.87 -37.74 77.71 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.043 2.495 . . . . 1.4 113.742 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.66 14.36 25.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.428 0.529 . . . . 2.56 112.428 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CD2' ' HE1' ' A' ' 92' ' ' PHE . 46.6 t80 -134.94 -73.99 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.246 -0.65 . . . . 4.11 109.246 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.699 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 66.7 t80 -63.51 -36.4 83.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.889 -0.596 . . . . 1.24 110.121 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -29.45 75.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.068 -0.586 . . . . 0.6 112.366 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 68.7 mttm -87.28 -25.87 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.943 0.401 . . . . 2.58 110.225 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' HD1' ' HE2' ' A' ' 109' ' ' MET . 79.6 t80 -62.56 -46.03 90.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.517 0.675 . . . . 0.79 109.501 169.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 30.0 mmmt -77.89 -16.74 58.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.3 -0.864 . . . . 1.63 110.481 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 40.9 tt0 -59.06 -39.97 83.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.674 . . . . 2.07 110.501 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -84.55 -45.85 5.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.519 -0.848 . . . . 0.72 112.107 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 79' ' ' PHE . 43.1 t -53.87 -52.94 30.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.662 0.385 . . . . 1.4 111.489 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.02 60.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.175 0.435 . . . . 1.48 112.175 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -98.02 -74.58 0.57 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.795 0.331 . . . . 2.15 110.81 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.03 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.001 -0.619 . . . . 1.77 111.561 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -109.82 156.74 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.475 -0.565 . . . . 3.83 109.475 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 45.6 tp -131.02 102.98 6.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 3.54 110.719 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 109' ' ' MET . 87.9 m-20 -143.76 97.98 3.16 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.783 -0.821 . . . . 2.47 108.783 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -131.16 155.72 46.53 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.113 -0.494 . . . . 2.01 111.797 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.4 ptt? -140.12 105.77 5.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 2.22 109.831 171.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HE1' ' CD2' ' A' ' 75' ' ' PHE . 25.7 p90 -127.2 167.13 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.764 -0.653 . . . . 3.82 110.739 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HG2' ' HE2' ' A' ' 106' ' ' LYS . 45.1 mt-10 -103.67 122.9 45.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.007 -0.368 . . . . 2.39 110.007 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.564 ' HH ' ' HG ' ' A' ' 72' ' ' SER . 39.5 t80 -142.15 158.4 43.79 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.533 -0.543 . . . . 3.62 109.533 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 p -104.26 156.36 17.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.51 0.672 . . . . 1.97 112.299 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.784 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 44.8 m-85 -121.85 112.61 18.55 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.653 -1.24 . . . . 1.47 107.653 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' HA ' ' A' ' 102' ' ' PRO . 4.5 m-20 -123.64 12.88 9.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.207 -0.451 . . . . 2.57 111.841 -166.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.437 ' HB3' ' C1 ' ' A' ' 169' ' ' HC4 . 86.2 t80 -110.85 -49.09 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 3.46 111.192 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -91.21 13.6 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 3.41 110.968 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 17.5 ptp -169.94 153.76 4.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 3.33 109.702 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 10.1 t -58.01 142.95 79.01 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.25 -1.019 . . . . 2.56 108.25 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.531 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 32.5 Cg_exo -31.65 86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.386 3.391 . . . . 1.72 114.976 -176.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 m -111.51 141.37 45.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 1.93 110.882 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -104.07 135.47 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.785 0.326 . . . . 3.47 110.399 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -127.95 166.37 25.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 1.96 110.669 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HE2' ' HG2' ' A' ' 93' ' ' GLU . 31.5 ttmt -110.81 117.02 32.28 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.346 -0.983 . . . . 2.22 108.346 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 91' ' ' MET . 80.1 t -104.11 120.58 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.068 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.42 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 12.3 t-160 -104.04 109.08 20.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.159 -0.682 . . . . 1.37 109.159 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 58.0 tpp -101.68 132.69 47.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 2.95 109.149 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 50.4 mtpt -137.62 131.57 31.75 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 121.153 -0.219 . . . . 2.05 110.498 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 81.6 tttt -90.53 123.22 34.03 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.123 0.487 . . . . 2.66 110.885 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.08 -175.24 2.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.675 -0.861 . . . . 1.57 108.675 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.42 -94.97 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.42 -0.956 . . . . 4.89 108.42 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 m 51.56 42.14 29.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.609 0.596 . . . . 2.9 112.609 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.03 79.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.758 . . . . 2.62 112.501 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.43 64.17 0.72 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.153 0.581 . . . . 2.76 111.695 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 20.4 p -139.05 163.92 31.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.095 -0.502 . . . . 1.61 110.694 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 4.9 m-85 -123.25 154.72 38.41 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.043 -1.095 . . . . 1.4 108.043 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -103.63 109.17 20.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.875 -0.787 . . . . 0.75 108.875 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 31' ' ' ILE . 14.6 p -100.71 134.35 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.682 0.753 . . . . 1.6 110.796 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.417 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 80.8 m-85 -120.83 132.62 55.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.97 110.037 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.1 t -103.17 104.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.886 -0.597 . . . . 1.83 110.061 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -103.16 110.18 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.877 -0.786 . . . . 3.79 108.877 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 105' ' ' VAL . 4.2 ptm180 -77.86 158.01 29.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.223 -0.444 . . . . 4.65 111.472 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.592 -0.718 . . . . 2.87 109.147 173.765 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.784 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.561 0.22 . . . . 3.79 110.712 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.67 -70.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.425 -0.352 . . . . 3.43 111.323 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.44 164.38 25.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.673 -0.491 . . . . 4.68 109.673 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 120.02 6.54 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.258 -0.972 . . . . 0.96 112.308 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.59 125.85 47.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.611 -0.515 . . . . 1.26 109.611 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.688 HG21 ' HA ' ' A' ' 42' ' ' TYR . 5.2 pt -132.17 165.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 1.67 111.991 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.538 ' HG2' HD21 ' A' ' 40' ' ' LEU . 50.3 tt0 -115.03 121.01 41.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.889 -0.596 . . . . 1.02 110.513 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -131.48 146.84 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.545 -0.539 . . . . 2.24 109.545 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.24 170.01 8.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.134 -0.321 . . . . 1.22 110.134 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.27 -23.33 12.4 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 114.306 0.482 . . . . 0.79 114.306 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.17 -21.56 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 1.95 110.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 96.51 4.9 59.22 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.151 -1.18 . . . . 0.61 110.151 -173.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -79.15 134.04 36.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.693 -0.754 . . . . 1.64 109.705 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 19.7 mt -93.02 140.24 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.924 -0.58 . . . . 1.58 110.154 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 32' ' ' GLN . 1.4 mm? -107.13 -66.48 1.02 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.144 0.497 . . . . 2.1 111.19 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -134.21 137.39 44.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.492 0.663 . . . . 1.99 111.47 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.688 ' HA ' HG21 ' A' ' 31' ' ' ILE . 3.6 m-30 -102.95 126.75 50.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.775 -1.102 . . . . 1.25 109.268 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -60.03 155.82 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.026 -0.361 . . . . 2.14 110.026 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.64 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.092 0.472 . . . . 1.87 109.874 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.27 70.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.969 -1.014 . . . . 2.02 112.61 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 38.7 tp10 -66.19 -47.96 72.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.12 110.566 -173.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.0 -10.18 72.59 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.834 -0.698 . . . . 1.42 112.503 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -93.12 -52.1 4.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.87 0.367 . . . . 2.35 110.884 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' C ' ' HG1' ' A' ' 50' ' ' THR . 31.6 mt -80.55 -72.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.394 -0.366 . . . . 2.98 110.939 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 24.5 m -153.77 106.93 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.608 -0.516 . . . . 3.86 109.608 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.528 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . 175.48 -139.75 4.87 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.067 -1.063 . . . . 2.91 112.964 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 3.0 mpt_? -124.24 174.7 7.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.706 0.289 . . . . 3.64 110.834 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.83 139.96 95.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.663 -0.699 . . . . 2.1 111.055 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.53 111.99 0.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.874 2.382 . . . . 1.68 112.497 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 81.49 11.2 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.239 -0.891 . . . . 4.08 112.545 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -94.44 22.05 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.326 0.584 . . . . 3.05 110.243 172.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.681 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -119.68 22.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.899 . . . . 1.26 111.26 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -88.51 136.61 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.878 -0.416 . . . . 1.66 109.878 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.76 11.97 84.18 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.829 -0.909 . . . . 0.78 110.829 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -118.77 141.49 48.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.69 0.281 . . . . 2.37 111.103 -173.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 23.7 t-20 -87.76 114.75 24.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.145 -0.48 . . . . 0.83 110.216 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -55.84 -35.22 66.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.963 0.411 . . . . 0.7 111.645 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.591 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 66.7 m-85 -76.48 -7.96 56.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.17 -0.468 . . . . 1.45 111.484 -174.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -136.45 -63.47 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.84 0.311 . . . . 4.07 111.84 -175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.93 -24.17 66.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.298 0.481 . . . . 2.2 112.298 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -125.89 12.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.33 -0.548 . . . . 2.34 110.969 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 171.06 85.71 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.399 -0.364 . . . . 1.2 111.434 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.0 -16.48 54.64 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.586 2.191 . . . . 0.98 113.769 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.2 m -50.4 -37.17 36.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.719 0.236 . . . . 1.41 110.901 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.591 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 10.3 m -92.82 -31.03 15.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.933 -1.031 . . . . 1.74 109.896 -135.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.56 97.13 4.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.995 -1.002 . . . . 1.85 110.16 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.5 m -164.05 152.21 11.11 Favored Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.046 -0.524 . . . . 1.85 110.019 -169.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.71 -30.33 92.1 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.278 1.985 . . . . 1.4 112.667 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HG3' ' HE2' ' A' ' 94' ' ' TYR . 9.5 pt-20 -86.14 6.37 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.271 0.471 . . . . 2.56 112.271 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.656 ' HE2' HG12 ' A' ' 107' ' ' VAL . 57.3 t80 -141.58 -71.67 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.873 -0.418 . . . . 4.11 109.873 173.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.653 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 89.0 t80 -53.75 -37.87 63.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.641 -0.709 . . . . 1.24 110.692 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -31.66 78.93 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.226 -0.512 . . . . 0.6 112.624 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -81.52 -32.67 32.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.521 0.677 . . . . 2.58 109.459 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.48 -32.15 71.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.913 -1.039 . . . . 0.79 109.588 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.653 ' HE3' ' CZ ' ' A' ' 76' ' ' TYR . 0.9 OUTLIER -88.84 -16.06 32.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.171 -0.922 . . . . 1.63 111.098 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.46 -51.33 63.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 2.07 110.573 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.35 -44.01 98.26 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.724 -0.671 . . . . 0.72 112.315 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.429 ' H ' HG21 ' A' ' 83' ' ' VAL . 23.4 t -55.85 -52.75 45.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.692 0.282 . . . . 1.4 110.869 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.7 86.81 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 116.051 -0.522 . . . . 1.48 111.196 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -66.33 -77.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 2.15 110.78 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.43 -75.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.522 -0.631 . . . . 1.77 111.522 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -97.62 147.66 24.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 3.83 110.13 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.984 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -111.21 110.4 20.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.568 -0.531 . . . . 3.54 109.568 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -175.68 91.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.974 0.892 . . . . 2.47 110.892 176.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HB ' ' HE2' ' A' ' 109' ' ' MET . 10.0 m -131.44 154.55 48.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.311 -0.859 . . . . 2.01 109.23 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.467 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 19.6 ptt? -128.27 104.08 7.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.981 0.419 . . . . 2.22 110.155 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -125.15 166.59 16.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 3.82 110.194 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.42 131.22 50.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.985 0.421 . . . . 2.39 110.537 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 50.8 t80 -136.87 159.91 40.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 3.62 109.679 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -102.97 113.63 27.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.943 0.402 . . . . 1.97 110.315 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.647 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 42.8 m-85 -110.09 103.1 11.77 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.11 0.481 . . . . 1.47 109.801 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 100' ' ' MET . 49.5 m-20 -126.41 101.74 6.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.653 -0.703 . . . . 2.57 109.886 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -73.56 63.79 0.84 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.804 -1.184 . . . . 3.46 107.804 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 63.6 59.91 1.15 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.992 -1.004 . . . . 3.41 108.443 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 42.7 tpp -133.04 164.74 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.953 -1.021 . . . . 3.33 111.09 -168.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.1 p -59.49 151.91 58.17 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 108.747 -0.835 . . . . 2.56 108.747 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.17 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.641 2.227 . . . . 1.72 113.483 -171.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -90.71 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 1.93 110.723 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.72 120.94 41.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.967 -0.383 . . . . 3.47 109.967 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 124' ' ' ARG . 30.2 m -122.02 166.42 16.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.838 -0.619 . . . . 1.96 110.459 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 82.8 tttt -103.56 120.92 41.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.763 -0.828 . . . . 2.22 108.763 177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG12 ' HE2' ' A' ' 75' ' ' PHE . 6.5 p -106.45 115.99 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-O 122.096 0.951 . . . . 1.97 110.096 -174.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.494 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 18.7 t-160 -107.5 103.5 12.84 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.072 -0.967 . . . . 1.37 108.925 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.99 134.31 47.48 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.575 -0.45 . . . . 2.95 110.078 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HD2' ' CE1' ' A' ' 108' ' ' HIS . 8.8 mtpm? -140.65 134.75 30.87 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 120.688 0.28 . . . . 2.05 110.928 -172.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.984 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 26.0 ttpp -80.85 136.75 36.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.322 -0.399 . . . . 2.66 110.896 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.98 -173.21 3.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.403 -0.362 . . . . 1.57 111.172 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.5 -164.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.201 -0.454 . . . . 4.89 110.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.1 m 65.89 54.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.615 0.721 . . . . 2.9 110.365 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.39 -2.4 8.88 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.196 -0.911 . . . . 2.62 111.605 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.5 41.68 31.81 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.425 0.631 . . . . 2.76 110.614 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.42 -175.75 2.75 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.618 -0.719 . . . . 1.61 109.51 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.453 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 5.6 m-85 -119.6 151.69 38.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.028 -0.73 . . . . 1.4 109.028 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -102.44 108.5 19.84 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.348 -0.982 . . . . 0.75 108.348 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.553 ' CG1' HG13 ' A' ' 31' ' ' ILE . 10.9 p -101.68 137.71 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 119.801 -0.759 . . . . 1.6 110.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -114.03 125.21 53.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.436 -0.802 . . . . 0.97 110.185 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.05 114.88 48.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.378 . . . . 1.83 110.011 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -139.07 129.19 25.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.88 -0.415 . . . . 3.79 109.88 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.627 ' HA ' HG11 ' A' ' 105' ' ' VAL . 12.8 ptp180 -75.02 114.64 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.016 0.436 . . . . 4.65 110.455 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.407 ' CG2' ' HB2' ' A' ' 106' ' ' LYS . 6.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.068 -0.491 . . . . 2.87 110.43 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.647 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.737 0.303 . . . . 3.79 110.441 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.1 103.47 4.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 116.263 -0.426 . . . . 3.43 110.218 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 64.37 -172.08 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.927 0.767 . . . . 4.68 111.388 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.78 130.72 10.34 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.475 -0.869 . . . . 0.96 112.18 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.84 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.932 -0.395 . . . . 1.26 109.932 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 32' ' ' GLN . 9.5 mm -114.5 152.39 16.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 1.67 109.895 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.454 ' N ' HG23 ' A' ' 31' ' ' ILE . 64.4 tt0 -124.06 104.67 9.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.614 -0.513 . . . . 1.02 109.614 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CD1' HG12 ' A' ' 39' ' ' ILE . 1.9 mm? -105.47 143.62 33.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.399 -0.364 . . . . 2.24 110.277 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p30 -104.38 167.69 9.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.041 -0.264 . . . . 1.22 110.435 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.01 -22.46 35.24 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.046 0.779 . . . . 0.79 115.046 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.426 0.613 . . . . 1.95 110.35 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.84 43.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.192 -0.763 . . . . 0.61 111.192 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.0 m-20 -88.19 146.44 25.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.076 0.465 . . . . 1.64 111.416 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.684 HD12 HG12 ' A' ' 57' ' ' VAL . 10.0 mt -95.41 148.24 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 1.58 110.305 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 39' ' ' ILE . 83.1 mt -107.44 -80.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.027 -0.533 . . . . 2.1 109.76 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -116.78 136.9 52.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 1.99 111.571 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 1.026 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.4 m-30 -98.02 -175.61 3.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.892 -1.049 . . . . 1.25 110.64 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.73 161.34 20.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.626 -0.879 . . . . 2.14 108.626 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 26' ' ' LEU . . . -58.81 -23.31 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.527 0.566 . . . . 1.87 112.527 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.79 94.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 2.02 111.078 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.3 mp0 -63.8 -27.11 68.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 2.12 111.281 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.64 -13.88 62.29 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.538 -0.839 . . . . 1.42 112.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.73 -54.48 3.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.835 0.35 . . . . 2.35 110.542 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.28 -60.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 2.98 110.124 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.617 HG22 " H3'" ' A' ' 169' ' ' HC4 . 3.8 m -78.73 -54.7 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.88 -0.6 . . . . 3.86 111.451 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.18 14.0 6.75 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 2.91 112.033 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HG3' ' CG1' ' A' ' 66' ' ' VAL . 19.7 mmt180 -97.69 110.09 22.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 3.64 110.005 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 15.3 m-20 -63.58 143.6 97.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.381 -0.372 . . . . 2.1 110.743 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 1.026 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 71.6 Cg_exo -52.34 -28.01 33.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.871 3.047 . . . . 1.68 114.804 -170.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -124.67 28.61 6.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.99 0.367 . . . . 4.08 111.99 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 77.0 mm-40 -94.78 0.07 54.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.255 0.55 . . . . 3.05 110.967 175.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.684 HG12 HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -93.38 -93.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.816 -0.629 . . . . 1.26 111.442 175.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 mm 54.31 99.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.427 0.691 . . . . 1.66 112.239 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.26 71.77 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.265 -1.134 . . . . 0.78 110.265 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 6.7 mmtp -111.33 121.0 44.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.708 -1.246 . . . . 2.37 109.553 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -71.24 105.38 3.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.83 110.843 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' HB2' HG12 ' A' ' 39' ' ' ILE . 85.1 t80 -54.19 -39.16 66.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.7 111.107 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.5 m-85 -82.69 30.54 0.43 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.762 -0.654 . . . . 1.45 111.213 -174.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -161.85 -42.4 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.226 -0.443 . . . . 4.07 110.575 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.94 -78.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.563 -0.289 . . . . 2.2 111.002 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 66' ' ' VAL . 2.9 t -87.62 14.91 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.299 0.571 . . . . 2.34 111.222 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -177.76 94.62 0.23 Allowed Pre-proline 0 C--O 1.222 -0.383 0 O-C-N 122.125 -0.36 . . . . 1.2 111.267 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 98' ' ' TYR . 3.9 Cg_exo -78.7 -19.89 10.96 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.419 2.079 . . . . 0.98 112.834 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -76.87 -19.68 57.17 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.646 -0.422 . . . . 1.41 110.864 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.684 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 18.4 p -73.86 -36.53 64.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.302 -0.863 . . . . 1.74 111.119 -172.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.2 96.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.85 109.895 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.5 p 175.79 158.0 0.4 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.32 -0.622 . . . . 1.85 109.32 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 58.9 Cg_exo -52.87 -32.12 55.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.801 2.334 . . . . 1.4 112.354 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.59 -59.02 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 2.56 111.255 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 28.4 m-85 -96.09 -69.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.025 -0.534 . . . . 4.11 111.357 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.576 ' HH ' ' HZ2' ' A' ' 80' ' ' LYS . 56.6 t80 -63.03 -30.39 71.56 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 1.24 111.116 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -61.44 -41.14 99.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.021 -0.609 . . . . 0.6 112.177 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -79.23 -29.72 42.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 2.58 110.121 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.462 ' HD1' ' CE ' ' A' ' 109' ' ' MET . 84.7 t80 -57.82 -40.38 79.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.335 -0.848 . . . . 0.79 110.634 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' HZ2' ' HH ' ' A' ' 76' ' ' TYR . 14.1 mmmm -95.4 -12.06 26.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.932 -0.576 . . . . 1.63 110.993 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 32.4 tt0 -68.86 -43.49 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 2.07 110.379 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' A' ' 88' ' ' LEU . . . -66.57 -43.41 92.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.695 -0.764 . . . . 0.72 112.022 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 83' ' ' VAL . 16.2 t -61.03 -49.48 84.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 1.4 110.88 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -4.64 27.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.48 112.019 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.2 m -100.53 -73.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.634 0.254 . . . . 2.15 110.782 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.91 -63.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 1.77 111.952 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.15 139.57 46.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.606 -0.516 . . . . 3.83 109.606 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.797 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -106.89 104.46 14.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.387 -0.597 . . . . 3.54 109.387 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.7 p30 -172.15 116.15 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.497 0.665 . . . . 2.47 109.868 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 21.4 m -148.36 142.23 25.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 2.01 109.887 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.0 ptm -119.92 120.1 35.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.448 -0.575 . . . . 2.22 109.448 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.457 ' CD1' ' HD1' ' A' ' 94' ' ' TYR . 4.2 p90 -140.03 157.81 45.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.421 . . . . 3.82 111.953 -172.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' OE1' ' HG3' ' A' ' 106' ' ' LYS . 5.5 mp0 -104.42 121.64 43.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 2.39 109.896 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.512 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 26.6 m-85 -142.9 165.82 26.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.36 -0.382 . . . . 3.62 110.286 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 13.5 m -107.36 144.26 34.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.39 -0.368 . . . . 1.97 110.527 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.77 106.99 15.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 1.47 109.478 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.47 111.01 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 2.57 110.829 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 68' ' ' PRO . 72.7 t80 -175.76 -79.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.484 -0.78 . . . . 3.46 109.475 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -99.55 -34.28 10.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.419 -0.586 . . . . 3.41 109.419 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.6 ttm -82.11 137.86 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.041 -1.096 . . . . 3.33 108.041 164.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -64.4 154.78 82.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.419 -0.586 . . . . 2.56 109.419 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.47 87.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.136 2.557 . . . . 1.72 114.114 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -102.97 130.48 50.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.848 -0.615 . . . . 1.93 109.952 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 22.3 pttp -103.62 124.84 49.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.401 -0.592 . . . . 3.47 109.401 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 124' ' ' ARG . 15.1 m -132.11 165.52 31.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.827 -0.624 . . . . 1.96 112.179 -171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.588 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 22.7 ttmm -104.75 111.01 23.57 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.288 -1.005 . . . . 2.22 108.288 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -104.63 127.75 58.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.611 -0.514 . . . . 1.97 109.611 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 12.1 t-160 -104.61 113.42 26.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.4 0.619 . . . . 1.37 109.458 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.679 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 27.3 tpp -101.13 123.54 45.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.518 -1.219 . . . . 2.95 108.772 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 63.8 pttt -150.44 146.8 26.88 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.093 -0.643 . . . . 2.05 111.512 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 48.6 tttm -87.52 140.27 29.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.087 -0.506 . . . . 2.66 110.567 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.1 -172.84 4.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.612 0.244 . . . . 1.57 110.439 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -168.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.196 -0.298 . . . . 4.89 110.196 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m 75.15 72.86 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.806 0.691 . . . . 2.9 110.094 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.38 -8.4 44.35 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.093 -0.803 . . . . 2.62 111.093 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 55.03 80.81 0.12 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.598 0.713 . . . . 2.76 111.165 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 2.6 p -156.51 -169.83 3.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.005 -0.998 . . . . 1.61 109.063 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.441 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 8.5 m-85 -119.38 152.57 36.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.332 -0.988 . . . . 1.4 108.332 -177.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.6 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 55.5 m95 -101.54 106.0 17.04 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.591 0.71 . . . . 0.75 109.148 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 108' ' ' HIS . 38.9 t -102.6 104.34 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.401 -1.272 . . . . 1.6 110.612 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.6 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 98.7 m-85 -104.79 134.08 48.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.139 -0.937 . . . . 0.97 110.253 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.48 144.9 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.585 -0.28 . . . . 1.83 110.703 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.588 ' HD2' ' HD2' ' A' ' 106' ' ' LYS . 18.5 ptpt -139.49 145.16 38.42 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.838 -0.431 . . . . 3.79 109.838 173.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.703 ' HA ' HG11 ' A' ' 105' ' ' VAL . 1.5 tmt_? -84.4 111.69 19.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.639 -0.255 . . . . 4.65 110.591 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.474 HG12 ' HE2' ' A' ' 106' ' ' LYS . 16.7 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.618 -0.706 . . . . 2.87 111.033 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.617 " H3'" HG22 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.446 -0.576 . . . . 3.79 109.446 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.12 -48.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 3.43 110.355 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.74 162.6 41.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 4.68 109.91 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 45' ' ' ALA . . . -104.7 130.24 10.15 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.641 -0.79 . . . . 0.96 111.302 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -135.76 104.13 5.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.172 0.51 . . . . 1.26 111.163 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.904 ' HB ' HG12 ' A' ' 120' ' ' VAL . 34.6 mt -113.07 159.74 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.079 -1.082 . . . . 1.67 108.079 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.641 HE22 HD23 ' A' ' 113' ' ' LEU . 64.6 tt0 -131.97 116.65 17.39 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.937 -0.477 . . . . 1.02 110.467 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.39 165.2 12.42 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.433 -0.58 . . . . 2.24 109.433 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -121.1 168.4 11.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.926 -0.398 . . . . 1.22 109.926 175.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.98 -24.62 35.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.415 0.526 . . . . 0.79 114.415 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.62 -21.51 55.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.95 110.83 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.84 2.65 36.8 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.807 -0.633 . . . . 0.61 111.845 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 92.6 m-20 -78.46 153.31 31.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.95 0.405 . . . . 1.64 110.864 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 60' ' ' LYS . 9.3 mt -96.87 146.88 6.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.715 -0.675 . . . . 1.58 109.674 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 40' ' ' LEU . 2.3 mm? -102.04 -46.96 4.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.629 0.728 . . . . 2.1 109.515 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.87 157.76 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.602 -1.181 . . . . 1.99 110.123 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.858 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 8.1 m-30 -110.54 177.82 4.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 1.25 110.456 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t-20 -107.36 179.25 4.3 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.292 -1.003 . . . . 2.14 108.292 172.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 -9.46 43.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.086 0.47 . . . . 1.87 109.908 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.546 ' CB ' ' HA2' ' A' ' 29' ' ' GLY . . . -55.71 -60.08 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.253 -0.885 . . . . 2.02 111.897 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -65.55 -27.15 68.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 2.12 111.22 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.2 -50.31 51.98 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.564 -0.827 . . . . 1.42 111.786 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.1 -55.19 31.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.121 0.486 . . . . 2.35 110.309 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.6 67.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.688 -1.226 . . . . 2.98 107.688 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -36.32 90.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.754 -1.566 . . . . 3.86 114.561 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -104.42 -59.29 0.68 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.325 -1.307 . . . . 2.91 110.46 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.82 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 35.3 mmt180 -149.51 168.79 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.634 0.373 . . . . 3.64 110.444 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.645 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 8.9 m-20 -90.55 141.12 26.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 2.1 109.759 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.858 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 52.8 Cg_exo -56.55 -25.88 61.15 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.193 2.595 . . . . 1.68 114.086 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -103.79 6.67 36.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.188 0.44 . . . . 4.08 112.188 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.645 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 82.9 mm-40 -102.82 6.13 39.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.069 0.461 . . . . 3.05 110.699 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 7.7 m -118.15 40.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.217 0.532 . . . . 1.26 111.606 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.01 112.25 24.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.37 -0.377 . . . . 1.66 110.64 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.21 11.72 71.32 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.964 -0.854 . . . . 0.78 110.964 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 39' ' ' ILE . 7.2 tptt -88.02 121.55 30.56 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.992 -0.604 . . . . 2.37 109.558 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 47.5 t-20 -71.78 110.99 6.68 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.442 -0.577 . . . . 0.83 109.442 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 86.6 t80 -53.98 -41.0 67.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.429 -0.805 . . . . 0.7 110.74 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 46.2 m-85 -85.86 9.48 16.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.237 -0.438 . . . . 1.45 110.803 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 48.0 tptt -124.54 -61.95 1.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.386 -0.37 . . . . 4.07 110.715 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -104.09 -22.8 13.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.17 0.433 . . . . 2.2 112.17 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.588 ' CG1' ' HG3' ' A' ' 52' ' ' ARG . 1.9 t -113.17 13.52 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.182 -0.607 . . . . 2.34 111.765 -170.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 66' ' ' VAL . . . 167.27 79.57 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.971 -0.559 . . . . 1.2 110.235 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.03 -17.15 50.95 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.751 2.301 . . . . 0.98 113.035 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.865 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.9 p -76.36 -26.66 55.92 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.486 -0.486 . . . . 1.41 110.225 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 1.9 m -80.1 -31.89 39.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.902 -1.045 . . . . 1.74 110.486 -164.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 10.5 t70 -63.75 99.23 0.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.159 -0.682 . . . . 1.85 109.159 172.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -169.56 149.46 3.68 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.723 -0.473 . . . . 1.85 109.723 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 5.3 Cg_exo -38.47 -42.79 1.8 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.742 3.628 . . . . 1.4 114.584 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.789 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.01 -53.55 4.22 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.598 -0.441 . . . . 2.56 111.19 -178.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' HB2' ' O ' ' A' ' 70' ' ' THR . 29.2 m-85 -59.63 -63.81 1.17 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.094 0.473 . . . . 4.11 110.706 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.414 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 39.6 t80 -67.47 -28.68 68.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.614 . . . . 1.24 110.097 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -63.62 -34.75 90.79 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.699 -0.682 . . . . 0.6 112.605 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.789 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 72.1 mmtt -75.09 -36.97 61.67 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.123 0.487 . . . . 2.58 109.751 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' HD12 ' A' ' 88' ' ' LEU . 82.2 t80 -59.89 -35.4 74.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.825 . . . . 0.79 110.69 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -94.52 -4.79 47.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.074 -0.512 . . . . 1.63 111.808 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -49.97 73.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.034 0.445 . . . . 2.07 110.269 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.583 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.14 -37.29 63.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.72 111.794 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.676 HG23 ' HH ' ' A' ' 118' ' ' TYR . 21.9 t -52.86 -56.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 122.971 0.508 . . . . 1.4 111.518 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.76 62.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 1.48 112.048 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.9 m -88.67 -73.2 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.381 . . . . 2.15 110.681 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.3 -72.14 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.936 -0.65 . . . . 1.77 111.521 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.76 149.09 28.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.667 -0.864 . . . . 3.83 108.667 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.583 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -116.27 101.8 9.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.18 -0.674 . . . . 3.54 109.18 178.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 109' ' ' MET . 45.9 m-80 -149.12 83.14 1.44 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.383 -0.599 . . . . 2.47 109.383 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.8 p -127.83 158.49 37.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 2.01 111.289 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.2 ptm -137.44 113.74 10.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.893 -0.594 . . . . 2.22 110.302 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.713 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 8.8 p90 -136.65 164.73 27.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 3.82 110.81 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.5 122.04 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 2.39 110.702 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.713 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 5.1 m-85 -144.21 167.03 23.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 3.62 110.089 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.0 t -103.63 154.22 19.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.268 0.556 . . . . 1.97 111.983 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -120.23 103.45 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.416 -0.957 . . . . 1.47 108.416 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 24.3 t70 -113.23 -131.37 0.32 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.586 -0.734 . . . . 2.57 109.516 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 61.7 t80 70.65 -70.23 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.434 0.694 . . . . 3.46 111.241 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -118.97 -2.14 10.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.302 0.572 . . . . 3.41 110.268 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.4 tpt -116.26 151.27 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.352 -0.84 . . . . 3.33 109.301 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.55 HG21 HG21 ' A' ' 103' ' ' THR . 9.8 t -55.98 142.45 65.05 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 108.345 -0.983 . . . . 2.56 108.345 169.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 26.7 Cg_endo -62.84 72.16 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.73 2.287 . . . . 1.72 112.662 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.55 HG21 HG21 ' A' ' 101' ' ' THR . 1.4 p -81.78 144.33 31.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.917 -0.583 . . . . 1.93 111.504 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.85 117.38 33.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.537 -0.301 . . . . 3.47 110.346 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.24 166.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.073 -0.512 . . . . 1.96 110.889 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -103.6 128.34 50.89 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.367 -0.975 . . . . 2.22 108.367 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' MET . 7.4 p -116.37 139.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 109.486 -0.561 . . . . 1.97 109.486 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 11.6 t-160 -117.2 115.67 25.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.651 -0.704 . . . . 1.37 109.166 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 86.1 mmm -100.35 126.34 46.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.201 -0.666 . . . . 2.95 109.201 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' NZ ' ' HB3' ' A' ' 110' ' ' LYS . 8.0 mtpm? -141.84 121.58 13.47 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 120.837 0.351 . . . . 2.05 111.187 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 76.5 tttt -73.17 131.42 42.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.045 -0.525 . . . . 2.66 110.824 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.21 -160.76 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.967 0.358 . . . . 1.57 111.967 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.641 HD23 HE22 ' A' ' 32' ' ' GLN . 13.7 tp 33.62 111.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.939 1.829 . . . . 4.89 115.939 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.6 m -18.23 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.406 1.691 . . . . 2.9 112.569 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.42 -8.14 0.55 Allowed Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.176 -0.92 . . . . 2.62 111.449 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 59.62 24.3 13.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.793 0.806 . . . . 2.76 110.054 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.9 p -82.67 171.57 13.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.493 -1.23 . . . . 1.61 109.466 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.676 ' HH ' HG23 ' A' ' 83' ' ' VAL . 1.6 m-85 -128.07 153.35 46.9 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.338 -0.615 . . . . 1.4 109.338 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -100.55 109.36 21.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.473 -0.936 . . . . 0.75 108.473 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.904 HG12 ' HB ' ' A' ' 31' ' ' ILE . 2.4 p -101.57 106.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 122.307 1.051 . . . . 1.6 110.517 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -103.25 136.82 42.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.651 -1.159 . . . . 0.97 109.975 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.69 147.01 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 1.83 112.02 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -149.01 154.23 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.321 -0.854 . . . . 3.79 109.457 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -100.95 121.89 42.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.018 -0.364 . . . . 4.65 110.018 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.222 -0.894 . . . . 2.87 110.521 179.083 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.802 -0.444 . . . . 3.79 109.802 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.48 -67.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.108 0.48 . . . . 3.43 110.082 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -135.16 -169.02 2.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 4.68 109.64 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.24 117.2 5.74 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.115 -1.04 . . . . 0.96 112.48 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.66 104.23 14.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.696 -0.483 . . . . 1.26 109.696 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.794 ' HB ' HG11 ' A' ' 120' ' ' VAL . 37.7 mt -107.85 157.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.869 -0.605 . . . . 1.67 109.642 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.604 HE22 ' HB2' ' A' ' 113' ' ' LEU . 2.8 mt-30 -130.03 142.17 50.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.15 -0.315 . . . . 1.02 110.15 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.27 153.87 46.65 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.294 -0.632 . . . . 2.24 109.294 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.7 OUTLIER -104.41 168.4 9.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.15 -23.77 18.54 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.467 0.479 . . . . 0.79 114.205 -175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 -37.06 37.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.216 0.508 . . . . 1.95 110.528 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.54 5.0 6.69 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.639 -0.791 . . . . 0.61 112.307 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -70.72 147.15 49.35 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.564 -0.532 . . . . 1.64 109.564 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 mt -94.43 146.89 6.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.301 -0.629 . . . . 1.58 109.301 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 40' ' ' LEU . 4.0 mp -127.98 -80.46 0.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 2.1 109.8 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.5 mp0 -89.45 141.06 28.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.44 -0.8 . . . . 1.99 109.976 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.615 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -130.48 5.33 4.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.349 -0.387 . . . . 1.25 110.918 178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.92 -173.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.865 -0.607 . . . . 2.14 109.93 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.83 5.38 45.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.446 0.641 . . . . 1.87 109.495 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -77.95 -51.44 10.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.777 . . . . 2.02 111.338 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.03 -20.87 61.62 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.916 0.389 . . . . 2.12 110.913 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.45 -19.83 77.93 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.714 -0.755 . . . . 1.42 111.31 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -94.89 -16.67 22.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.202 0.525 . . . . 2.35 110.185 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 45' ' ' ALA . 50.3 mm -82.73 -63.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 2.98 111.152 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -139.92 40.88 1.98 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.161 0.981 . . . . 3.86 111.1 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.25 37.27 64.32 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.106 -0.952 . . . . 2.91 113.282 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 17.9 mmt-85 -98.6 85.67 3.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 3.64 110.985 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.605 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 6.5 m-20 -67.31 148.59 98.71 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.277 -0.874 . . . . 2.1 109.649 175.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.615 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 49.4 Cg_exo -55.5 -32.89 84.33 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.255 1.97 . . . . 1.68 111.427 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -73.35 -18.35 61.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.724 -0.671 . . . . 4.08 111.668 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.605 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 79.4 mm-40 -78.25 -26.61 47.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.713 0.264 . . . . 3.05 111.713 -175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.711 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.0 m -109.13 14.8 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.257 0.836 . . . . 1.26 113.257 -172.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 62.5 mt -83.83 133.42 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.608 -0.516 . . . . 1.66 109.608 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.14 88.5 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.211 -0.995 . . . . 0.78 110.885 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 34.8 mttm -104.88 133.03 50.38 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.126 -0.537 . . . . 2.37 109.82 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -84.34 113.31 21.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.73 -0.388 . . . . 0.83 110.138 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 66.8 t80 -54.51 -50.14 68.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.533 -0.758 . . . . 0.7 111.173 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.6 m-85 -79.76 21.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.286 0.476 . . . . 1.45 112.286 -172.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -149.92 -49.67 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.87 0.366 . . . . 4.07 111.712 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -87.19 -76.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 2.2 111.571 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.526 ' O ' " H2'" ' A' ' 169' ' ' HC4 . 1.8 t -86.13 15.72 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.964 0.411 . . . . 2.34 111.491 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -171.41 96.12 0.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 121.998 -0.439 . . . . 1.2 111.835 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -89.96 -9.69 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.084 2.522 . . . . 0.98 112.898 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -83.95 -4.03 58.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.93 -0.308 . . . . 1.41 111.077 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 HG22 ' CE1' ' A' ' 62' ' ' PHE . 6.8 p -98.45 -38.74 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.064 -0.517 . . . . 1.74 111.534 -164.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 13.4 t70 -68.69 91.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.299 -0.41 . . . . 1.85 109.974 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.3 p -150.21 160.19 33.74 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 1.85 110.596 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 -43.84 53.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.927 2.418 . . . . 1.4 113.608 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -78.54 -26.0 45.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.383 0.512 . . . . 2.56 112.383 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HE2' HG12 ' A' ' 107' ' ' VAL . 67.5 t80 -105.57 -67.9 0.9 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.46 . . . . 4.11 110.894 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 89.7 t80 -64.18 -39.29 93.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.847 -0.615 . . . . 1.24 110.863 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.2 97.56 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.97 -0.634 . . . . 0.6 112.366 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -73.44 -32.21 64.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 2.58 110.606 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' O ' HG21 ' A' ' 83' ' ' VAL . 73.3 t80 -57.58 -45.87 84.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.555 0.693 . . . . 0.79 110.092 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.294 -0.866 . . . . 1.63 112.005 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 2.07 110.726 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -73.99 -44.06 31.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.312 -0.947 . . . . 0.72 111.317 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 79' ' ' PHE . 22.0 t -56.19 -55.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.248 -0.476 . . . . 1.4 111.426 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.38 83.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.285 -0.416 . . . . 1.48 112.001 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.1 m -73.52 -70.99 0.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.437 -0.347 . . . . 2.15 111.432 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.2 -79.38 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.691 -0.766 . . . . 1.77 111.843 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -92.33 149.57 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.289 -0.456 . . . . 3.83 110.786 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.759 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -121.11 120.58 35.71 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.033 -0.728 . . . . 3.54 109.033 177.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.6 p30 -159.59 123.11 3.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 2.47 109.905 173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -164.59 159.42 19.08 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.134 -0.939 . . . . 2.01 110.235 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 53.4 ttm -132.09 107.84 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.039 -0.726 . . . . 2.22 109.039 175.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -120.23 156.22 31.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 3.82 109.641 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.34 120.13 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.443 0.64 . . . . 2.39 110.254 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -138.6 165.79 26.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.09 -0.959 . . . . 3.62 109.493 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' THR . 49.2 p -104.25 154.88 19.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.858 0.361 . . . . 1.97 111.937 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.61 ' CD1' ' H2 ' ' A' ' 169' ' ' HC4 . 20.2 m-85 -119.34 103.14 9.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.758 -0.83 . . . . 1.47 108.758 171.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 1.7 p30 -128.58 20.86 6.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.189 -0.46 . . . . 2.57 111.444 -172.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.543 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -59.76 -44.25 93.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.68 -0.691 . . . . 3.46 111.672 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -144.18 -44.77 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.691 -0.855 . . . . 3.41 108.691 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.9 ttt -71.31 151.83 43.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.855 -1.066 . . . . 3.33 108.768 170.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 p -53.68 149.8 15.08 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.514 -0.55 . . . . 2.56 109.514 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 97' ' ' ASP . 18.1 Cg_endo -59.74 80.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.454 2.103 . . . . 1.72 113.129 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.0 p -74.04 151.73 40.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.93 110.742 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 124' ' ' ARG . 10.1 mtmp? -104.62 121.19 43.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.771 0.32 . . . . 3.47 110.176 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 35.3 m -117.44 161.51 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.929 0.395 . . . . 1.96 110.683 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -116.17 113.93 23.76 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.739 -1.208 . . . . 2.22 107.739 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.601 HG12 ' HE2' ' A' ' 75' ' ' PHE . 14.8 p -106.25 142.35 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.134 0.492 . . . . 1.97 110.136 -170.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -115.35 110.98 20.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.036 -0.727 . . . . 1.37 109.036 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.58 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.7 tpp -101.84 130.78 48.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.54 -0.754 . . . . 2.95 109.258 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 15.2 ptmm? -156.83 141.57 16.91 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.007 0.432 . . . . 2.05 111.532 -177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.568 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 42.6 tttp -83.64 117.68 23.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.769 -0.651 . . . . 2.66 111.243 -172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -176.12 108.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.133 0.42 . . . . 1.57 112.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.604 ' HB2' HE22 ' A' ' 32' ' ' GLN . 38.9 tp 168.04 -109.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.943 0.897 . . . . 4.89 109.146 171.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -85.81 19.3 2.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.338 0.59 . . . . 2.9 109.677 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.83 -56.09 4.65 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.602 -0.726 . . . . 2.62 111.531 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -93.11 31.1 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.445 0.64 . . . . 2.76 111.219 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 28.8 t -146.95 142.2 27.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.384 -0.598 . . . . 1.61 109.384 173.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.568 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 13.0 m-85 -120.01 164.88 15.45 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.422 -0.808 . . . . 1.4 109.969 -167.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.563 ' HD1' ' HB1' ' A' ' 112' ' ' ALA . 73.2 m95 -102.32 108.39 19.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.905 -0.776 . . . . 0.75 108.905 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.794 HG11 ' HB ' ' A' ' 31' ' ' ILE . 4.4 p -101.33 109.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.294 1.045 . . . . 1.6 110.717 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.43 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 83.3 m-85 -102.35 124.44 47.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.244 -0.889 . . . . 0.97 109.779 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 123.93 69.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.826 0.346 . . . . 1.83 111.044 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -137.29 134.9 36.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.299 -0.63 . . . . 3.79 109.299 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 2.6 ttp180 -77.98 146.19 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.332 -0.395 . . . . 4.65 111.284 -172.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.734 -1.127 . . . . 2.87 110.687 175.669 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.61 ' H2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.5 mm? . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.876 -0.416 . . . . 3.79 109.876 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.39 -57.89 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.583 -0.28 . . . . 3.43 111.351 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -102.73 148.45 25.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 4.68 110.479 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 122' ' ' VAL . . . -105.35 158.27 16.01 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.785 -0.721 . . . . 0.96 112.686 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.66 112.2 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.394 -0.595 . . . . 1.26 109.394 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.921 HG22 ' HA ' ' A' ' 42' ' ' TYR . 8.9 pt -131.66 166.74 28.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.046 0.387 . . . . 1.67 112.046 -175.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -122.4 134.2 54.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.438 . . . . 1.02 110.296 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.417 HD22 HG13 ' A' ' 120' ' ' VAL . 1.7 pt? -138.79 157.62 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 2.24 110.691 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.625 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 167.76 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.002 -0.279 . . . . 1.22 110.706 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.97 -14.03 22.13 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.762 0.665 . . . . 0.79 114.762 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 26.7 t70 -86.33 -20.39 28.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.581 0.69 . . . . 1.95 110.312 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 112.19 0.59 26.73 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.588 -0.815 . . . . 0.61 111.961 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.625 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 49.5 m-80 -74.56 138.05 42.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 120.911 0.386 . . . . 1.64 110.203 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.5 mt -88.58 148.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.086 -0.709 . . . . 1.58 109.086 173.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 39' ' ' ILE . 7.8 mp -112.87 -63.56 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.26 0.552 . . . . 2.1 110.736 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -136.77 126.63 25.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.565 -0.743 . . . . 1.99 110.67 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 1.097 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 1.6 m-30 -93.04 162.27 14.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.069 -0.969 . . . . 1.25 110.572 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.38 161.51 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.564 -0.902 . . . . 2.14 108.564 166.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -12.34 59.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.795 0.331 . . . . 1.87 111.403 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 26' ' ' LEU . . . -63.55 -33.2 75.07 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.145 -0.479 . . . . 2.02 111.305 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.8 -21.37 64.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 2.12 109.892 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -68.89 -30.54 72.41 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.639 -0.71 . . . . 1.42 111.792 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -79.11 -32.57 44.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 2.35 110.207 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.88 -64.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 2.98 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.626 HG21 ' HG2' ' A' ' 52' ' ' ARG . 4.2 t -113.51 -38.62 4.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.795 0.331 . . . . 3.86 111.094 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.603 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 101.31 53.6 1.0 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.44 -0.886 . . . . 2.91 112.223 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.626 ' HG2' HG21 ' A' ' 50' ' ' THR . 14.2 mmt180 -119.14 125.74 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.595 -0.52 . . . . 3.64 109.595 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.901 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -65.81 137.62 96.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.597 -0.274 . . . . 2.1 110.783 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 1.097 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 88.7 Cg_exo -49.47 -25.25 10.23 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.836 3.024 . . . . 1.68 114.222 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -101.6 -2.13 31.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.592 0.219 . . . . 4.08 111.592 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.901 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.16 -0.88 46.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.561 0.22 . . . . 3.05 111.281 -177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.684 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.8 m -102.78 17.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.429 0.529 . . . . 1.26 112.429 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -86.62 125.7 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.799 -0.445 . . . . 1.66 109.799 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.5 1.66 90.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.065 -1.064 . . . . 0.78 110.833 -174.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.8 mptp? -94.14 118.11 31.07 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.252 -0.474 . . . . 2.37 110.184 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 36.9 t-20 -80.15 103.1 9.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.921 -0.581 . . . . 0.83 109.975 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 68.7 t80 -62.22 -13.46 28.05 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.685 -0.689 . . . . 0.7 112.16 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.518 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 80.4 m-85 -104.82 11.49 33.72 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.856 -0.527 . . . . 1.45 111.441 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 64' ' ' LYS . 13.3 tmtt? -149.48 -56.42 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.508 -0.477 . . . . 4.07 111.524 -172.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.8 -77.74 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.541 -0.299 . . . . 2.2 111.354 -167.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.2 m -78.53 16.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.451 0.538 . . . . 2.34 112.451 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -176.85 97.23 0.24 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.834 -0.621 . . . . 1.2 110.331 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -93.71 1.48 3.25 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.921 2.414 . . . . 0.98 113.447 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.5 4.11 53.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.959 -0.463 . . . . 1.41 110.069 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 9.9 p -96.75 -46.81 6.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.617 -1.174 . . . . 1.74 110.993 -167.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.47 110.72 0.92 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 1.85 110.381 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -177.18 143.85 0.55 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 1.85 108.4 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 50.0 Cg_exo -54.3 -29.11 56.08 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.645 2.23 . . . . 1.4 112.745 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 8.1 pt-20 -90.67 9.3 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 2.56 111.912 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.564 ' HE2' HG22 ' A' ' 107' ' ' VAL . 67.3 t80 -142.71 -74.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.054 -0.35 . . . . 4.11 110.054 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -65.25 -33.77 76.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.24 110.29 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -63.73 -34.97 91.39 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.832 -0.699 . . . . 0.6 111.955 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.43 -28.29 52.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.203 0.525 . . . . 2.58 110.184 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.52 -41.37 96.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.774 -0.648 . . . . 0.79 109.662 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -76.5 -20.37 57.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 1.63 110.849 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.31 -46.47 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 2.07 110.355 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.8 -41.39 83.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.72 112.214 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.62 -49.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 1.4 110.765 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.83 76.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 1.48 111.219 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.0 m -76.69 -83.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 2.15 110.713 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.57 -58.03 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.91 148.66 38.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.526 . . . . 3.83 110.293 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.6 tp -111.03 111.67 22.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.293 -0.632 . . . . 3.54 109.293 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' MET . 15.7 p30 -160.99 58.32 0.3 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.905 0.859 . . . . 2.47 109.956 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -107.12 145.47 32.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.859 -1.064 . . . . 2.01 110.296 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.5 ttp -122.17 117.88 27.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 2.22 110.319 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 42.6 p90 -138.13 163.88 30.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.298 -0.41 . . . . 3.82 110.432 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 35.1 tt0 -109.67 129.12 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.615 -0.513 . . . . 2.39 109.615 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 30.4 t80 -135.14 165.03 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.424 -0.353 . . . . 3.62 110.833 -172.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 m -105.25 137.79 42.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.772 0.32 . . . . 1.97 111.709 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.483 ' CE2' HG23 ' A' ' 105' ' ' VAL . 14.4 m-85 -113.01 108.36 17.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.02 -0.733 . . . . 1.47 109.02 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -119.67 8.23 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 2.57 110.556 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.555 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 28.8 t80 -122.79 131.26 53.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 3.46 108.325 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.555 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 28.6 mm-40 67.96 8.51 6.53 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.219 0.533 . . . . 3.41 110.218 -173.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 23.6 ttt -166.3 140.64 4.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.399 -0.963 . . . . 3.33 108.399 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.6 p -64.46 148.84 95.97 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.006 -0.738 . . . . 2.56 109.006 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.1 89.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.993 2.462 . . . . 1.72 113.374 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.8 m -109.97 154.91 22.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.907 -0.588 . . . . 1.93 110.277 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -102.84 117.94 35.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.498 -0.556 . . . . 3.47 109.498 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.757 HG13 ' HA ' ' A' ' 124' ' ' ARG . 25.0 m -122.0 163.29 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.96 110.604 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 33.6 ttpt -109.02 128.6 55.1 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.905 -0.776 . . . . 2.22 108.905 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.564 HG22 ' HE2' ' A' ' 75' ' ' PHE . 96.3 t -114.11 110.73 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 108.491 -0.929 . . . . 1.97 108.491 -171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -103.51 119.96 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.871 -0.788 . . . . 1.37 108.871 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.735 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 22.2 mmt -100.07 135.26 41.77 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.639 -0.874 . . . . 2.95 108.639 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.402 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.9 mtpp -150.94 121.93 7.65 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.895 0.379 . . . . 2.05 110.858 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.545 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 52.9 tttt -78.91 137.46 37.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.214 0.531 . . . . 2.66 111.283 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 177.06 8.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.789 -1.189 . . . . 1.57 107.789 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.4 -98.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.556 -0.858 . . . . 4.89 109.572 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.9 p 43.42 47.15 5.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.82 0.448 . . . . 2.9 112.145 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.57 13.76 49.8 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.668 -0.777 . . . . 2.62 112.519 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.1 t70 63.76 86.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.735 0.814 . . . . 2.76 111.076 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 p -164.86 157.69 16.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.237 -0.892 . . . . 1.61 109.611 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 2.6 m-85 -104.68 153.86 20.71 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.823 -0.806 . . . . 1.4 108.823 -173.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -102.12 108.78 20.3 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.484 -0.932 . . . . 0.75 108.484 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 31' ' ' ILE . 7.4 p -101.87 127.51 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.819 0.819 . . . . 1.6 110.645 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.402 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 64.1 m-85 -108.63 131.54 54.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.249 -0.887 . . . . 0.97 110.317 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.442 HG22 ' HA3' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -111.31 106.81 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.733 0.778 . . . . 1.83 111.201 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -103.23 117.19 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.678 . . . . 3.79 109.927 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.757 ' HA ' HG13 ' A' ' 105' ' ' VAL . 16.6 ptm180 -89.53 157.42 18.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.62 -0.718 . . . . 4.65 110.56 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.949 -0.548 . . . . 2.87 111.049 175.374 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 26' ' ' LEU . 3.2 tm? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 111.288 0.107 . . . . 3.79 111.288 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.46 66.76 0.32 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.66 0.985 . . . . 3.43 113.66 -168.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 98.4 m-85 65.17 136.67 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.737 0.815 . . . . 4.68 113.147 172.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.41 104.59 2.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.357 -0.925 . . . . 0.96 111.28 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.78 123.09 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.523 0.201 . . . . 1.26 110.459 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG21 ' HA ' ' A' ' 42' ' ' TYR . 12.1 pt -125.9 160.85 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 1.67 111.102 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -119.72 115.49 24.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.391 -0.368 . . . . 1.02 110.348 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD2' ' HB ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -117.28 146.7 43.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.307 -0.627 . . . . 2.24 109.307 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.577 ' OD2' ' HB3' ' A' ' 38' ' ' ASN . 8.1 p30 -107.24 168.69 9.05 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.38 -0.528 . . . . 1.22 110.571 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -10.78 16.25 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 114.362 0.505 . . . . 0.79 114.362 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -87.33 -11.25 49.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.358 0.579 . . . . 1.95 110.342 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.27 10.49 60.81 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.484 -1.047 . . . . 0.61 110.484 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . 55.7 t30 -85.79 147.37 26.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.631 -0.785 . . . . 1.64 110.26 -174.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.782 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 3.8 mm -93.55 149.46 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.908 -0.404 . . . . 1.58 109.908 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 40' ' ' LEU . 6.2 mp -120.3 -62.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 2.1 109.781 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -136.92 131.13 32.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.685 -0.689 . . . . 1.99 110.541 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.678 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.2 m-30 -98.29 179.95 4.56 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 1.25 109.977 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -123.01 173.86 7.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.336 -0.616 . . . . 2.14 109.336 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.91 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.518 0.562 . . . . 1.87 112.518 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 28' ' ' PHE . . . -73.39 -42.92 61.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.947 0.351 . . . . 2.02 111.947 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.74 -15.52 59.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.348 -0.541 . . . . 2.12 110.411 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.28 -6.55 74.36 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.965 -0.854 . . . . 1.42 110.965 171.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.27 -48.03 5.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.314 -0.443 . . . . 2.35 110.356 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.66 -63.68 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 2.98 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -53.93 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.306 0.484 . . . . 3.86 112.306 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.22 18.29 1.34 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.434 -0.889 . . . . 2.91 113.433 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 52' ' ' ARG . 1.4 mpt_? -90.46 111.91 23.35 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.952 0.376 . . . . 3.64 110.026 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 25.7 m-20 -71.94 149.22 92.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.567 -0.531 . . . . 2.1 109.567 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 77.4 Cg_exo -49.79 -34.12 34.97 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.605 2.87 . . . . 1.68 114.304 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -106.38 17.33 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.146 0.425 . . . . 4.08 112.146 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 94.7 mt-30 -95.01 -9.28 34.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 3.05 111.074 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.782 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.7 m -104.29 21.55 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.473 0.545 . . . . 1.26 112.473 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 115.91 29.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.456 -0.498 . . . . 1.66 110.043 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.28 64.1 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.418 -1.073 . . . . 0.78 110.418 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.4 mptp? -80.6 147.57 30.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.512 -0.844 . . . . 2.37 111.196 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -107.67 113.77 27.28 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.687 -0.486 . . . . 0.83 109.687 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.706 ' HB2' HD13 ' A' ' 39' ' ' ILE . 77.4 t80 -52.89 -50.75 63.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.316 -0.402 . . . . 0.7 112.038 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.633 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.6 m-85 -76.97 5.84 7.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.043 -0.526 . . . . 1.45 112.295 -168.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 -47.32 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.151 0.426 . . . . 4.07 112.151 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -99.65 -23.77 14.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.218 0.451 . . . . 2.2 112.218 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 1.8 t -120.87 14.46 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.524 -0.47 . . . . 2.34 110.9 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.558 ' HB2' ' HG1' ' A' ' 70' ' ' THR . . . 170.84 86.44 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.89 -0.595 . . . . 1.2 110.352 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.482 ' HG2' ' CE1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -96.0 35.92 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.182 2.588 . . . . 0.98 113.582 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 17.2 p -121.73 20.58 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.8 -0.445 . . . . 1.41 109.8 171.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.558 ' HG1' ' HB2' ' A' ' 67' ' ' ALA . 37.0 m -130.14 -44.49 1.15 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.929 -1.487 . . . . 1.74 109.668 -136.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.633 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 4.5 p-10 -73.32 103.98 4.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.828 0.823 . . . . 1.85 109.393 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.526 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 64.5 m -163.93 164.59 14.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.506 -0.77 . . . . 1.85 109.579 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 6.4 Cg_endo -49.96 -31.06 25.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.072 2.514 . . . . 1.4 112.69 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.66 ' HB3' ' HE2' ' A' ' 94' ' ' TYR . 1.3 mp0 -69.86 -91.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 2.56 111.493 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HD1' ' HE2' ' A' ' 63' ' ' PHE . 45.6 t80 -60.74 -56.61 19.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.648 -0.705 . . . . 4.11 111.811 -169.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.807 ' HH ' ' HZ3' ' A' ' 80' ' ' LYS . 68.9 t80 -67.95 -38.5 82.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.789 0.328 . . . . 1.24 110.464 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -47.61 90.32 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.6 112.744 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.81 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 9.3 mmpt? -75.76 -28.72 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.931 0.365 . . . . 2.58 110.527 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -58.97 -41.61 87.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.339 0.59 . . . . 0.79 109.761 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.807 ' HZ3' ' HH ' ' A' ' 76' ' ' TYR . 14.0 mmmm -87.6 -11.07 49.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.447 -0.797 . . . . 1.63 111.306 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 6.9 tp10 -67.42 -40.14 85.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 2.07 110.567 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.945 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -71.9 -32.54 63.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.554 -0.832 . . . . 0.72 111.227 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.21 -50.86 65.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.255 -0.472 . . . . 1.4 110.673 177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.94 83.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.782 -0.644 . . . . 1.48 111.769 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 p -77.38 -71.54 0.4 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.045 0.45 . . . . 2.15 110.527 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.091 -0.575 . . . . 1.77 111.947 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.93 158.15 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 3.83 110.366 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.945 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 1.4 pt? -138.61 135.69 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.987 -0.552 . . . . 3.54 110.057 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 109' ' ' MET . 33.8 p-10 -164.01 47.94 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.445 1.117 . . . . 2.47 108.9 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -104.13 154.36 19.83 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.878 -1.51 . . . . 2.01 109.955 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -112.95 115.53 28.55 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.107 0.479 . . . . 2.22 110.359 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.36 155.47 31.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 3.82 109.199 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.33 121.88 44.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.238 0.542 . . . . 2.39 111.18 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.66 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 46.2 m-85 -126.94 167.08 16.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.676 -0.693 . . . . 3.62 111.091 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 m -106.68 139.6 40.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.885 -0.598 . . . . 1.97 110.535 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.466 ' CE2' HG11 ' A' ' 105' ' ' VAL . 13.0 m-85 -104.68 119.83 39.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.48 -0.933 . . . . 1.47 108.48 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.3 -159.75 1.02 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.289 -0.634 . . . . 2.57 109.289 -170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.482 ' CE1' ' HG2' ' A' ' 68' ' ' PRO . 90.2 t80 69.5 -76.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.981 0.512 . . . . 3.46 111.123 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -107.01 -26.69 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 3.41 109.646 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.8 tpp -84.86 139.32 31.98 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.606 -0.887 . . . . 3.33 108.606 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.6 t -65.58 136.29 96.03 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.797 -1.186 . . . . 2.56 107.797 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -43.51 91.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.3 2.666 . . . . 1.72 114.184 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.2 p -108.95 151.8 25.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.289 -0.414 . . . . 1.93 111.304 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -109.84 116.44 31.66 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.457 -0.572 . . . . 3.47 109.457 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 122' ' ' VAL . 11.3 p -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 1.96 111.248 -171.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.433 ' N ' HG23 ' A' ' 105' ' ' VAL . 39.1 ttmt -109.37 118.27 36.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.319 -0.993 . . . . 2.22 108.319 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.548 HG11 HG12 ' A' ' 120' ' ' VAL . 86.3 t -104.55 117.01 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 115.727 -0.67 . . . . 1.97 109.485 -174.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -103.9 105.24 15.38 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.37 108.786 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.2 pmm? -103.68 128.84 50.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.993 -0.549 . . . . 2.95 109.729 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 11.6 ptmm? -144.47 138.9 27.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 2.05 111.259 -174.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -71.16 128.49 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.996 -0.547 . . . . 2.66 111.939 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -115.55 93.96 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.821 -0.807 . . . . 1.57 108.821 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.83 83.88 3.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.669 0.747 . . . . 4.89 110.906 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t -141.51 26.6 1.94 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.717 -1.129 . . . . 2.9 108.534 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.27 25.15 0.42 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.055 -0.975 . . . . 2.62 112.055 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 55.93 75.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.138 0.575 . . . . 2.76 112.17 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 39.6 t -153.02 165.75 34.58 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.374 -0.973 . . . . 1.61 108.374 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -132.14 157.47 44.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.725 -0.843 . . . . 1.4 108.725 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CD1' ' HB1' ' A' ' 112' ' ' ALA . 73.8 m95 -101.22 111.35 23.54 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.861 -0.792 . . . . 0.75 108.861 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.548 HG12 HG11 ' A' ' 107' ' ' VAL . 3.5 t -102.25 119.8 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.56 0.695 . . . . 1.6 109.865 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-85 -104.57 140.63 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 0.97 111.185 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.663 HG12 HG21 ' A' ' 105' ' ' VAL . 54.1 t -104.58 104.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.073 -0.967 . . . . 1.83 110.314 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.73 105.13 13.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.956 0.408 . . . . 3.79 110.595 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -72.63 109.55 6.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.543 -0.54 . . . . 4.65 109.543 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.504 -0.76 . . . . 2.87 110.393 -178.254 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.016 -0.365 . . . . 3.79 110.016 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.03 -90.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.671 0.272 . . . . 3.43 111.65 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -85.2 146.81 26.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.196 -0.298 . . . . 4.68 110.196 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.44 112.61 4.26 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.309 -0.948 . . . . 0.96 111.917 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -103.83 129.53 51.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 1.26 110.923 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.505 ' HB ' HG11 ' A' ' 120' ' ' VAL . 58.2 mt -125.7 149.82 30.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.431 -0.804 . . . . 1.67 108.999 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 31' ' ' ILE . 60.8 tt0 -115.18 122.89 47.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -134.81 156.29 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.248 0.342 . . . . 2.24 110.738 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 26.8 p30 -102.5 167.95 9.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.94 -0.304 . . . . 1.22 110.687 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.42 -2.71 3.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 114.963 0.745 . . . . 0.79 114.963 -173.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.28 -18.92 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.581 0.691 . . . . 1.95 110.81 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 114.13 15.2 8.59 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.416 -0.897 . . . . 0.61 113.254 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -86.44 135.58 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 117.125 0.463 . . . . 1.64 110.141 177.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.082 HD13 ' HB2' ' A' ' 62' ' ' PHE . 23.0 mm -89.27 149.1 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.181 -0.463 . . . . 1.58 109.938 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -121.19 -72.44 0.69 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.312 0.577 . . . . 2.1 110.177 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.4 134.19 55.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.719 -0.673 . . . . 1.99 111.666 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.541 ' HE2' HG23 ' A' ' 39' ' ' ILE . 2.3 m-85 -103.43 144.58 31.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.058 -0.974 . . . . 1.25 109.586 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 3.9 t30 -82.78 4.48 25.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.495 0.664 . . . . 2.14 109.473 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.41 -22.39 0.24 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.36 -1.291 . . . . 1.87 112.228 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -65.32 -18.67 65.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.313 0.486 . . . . 2.02 112.313 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HG3' HD12 ' A' ' 31' ' ' ILE . 2.6 tm-20 -70.39 -23.91 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.857 -0.794 . . . . 2.12 108.857 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.13 13.4 67.76 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.777 -0.725 . . . . 1.42 112.076 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.26 -44.76 71.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.163 0.506 . . . . 2.35 110.314 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.445 ' H ' HG12 ' A' ' 49' ' ' ILE . 4.1 pt -78.45 -47.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.898 -0.592 . . . . 2.98 112.153 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -61.93 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.995 0.426 . . . . 3.86 110.945 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 138.89 126.5 2.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.893 -0.67 . . . . 2.91 111.78 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 51' ' ' GLY . 26.6 mmt180 -139.1 156.12 47.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.39 -0.596 . . . . 3.64 109.39 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.5 m-20 -103.21 120.04 53.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.044 0.449 . . . . 2.1 111.311 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 26.4 Cg_exo -62.1 118.95 5.85 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.947 2.431 . . . . 1.68 112.337 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 62.6 mttp 82.29 5.38 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.851 -1.068 . . . . 4.08 112.224 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.25 -1.17 57.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.523 0.678 . . . . 3.05 109.558 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.5 m -98.88 10.29 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.143 -0.935 . . . . 1.26 111.616 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 42.8 mt -80.99 132.27 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.345 -0.613 . . . . 1.66 109.345 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.17 75.86 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.391 -0.909 . . . . 0.78 110.842 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.767 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 17.0 mttm -109.52 132.04 54.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.121 -0.696 . . . . 2.37 109.121 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.1 t-20 -90.0 102.98 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.755 -0.461 . . . . 0.83 109.755 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 1.082 ' HB2' HD13 ' A' ' 39' ' ' ILE . 70.9 t80 -49.82 -39.15 37.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.7 111.785 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.676 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m-85 -76.51 -20.5 56.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 1.45 112.435 -171.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -116.84 -30.5 5.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.215 0.45 . . . . 4.07 112.215 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -89.14 -79.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.037 0.384 . . . . 2.2 112.037 -170.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -99.77 13.96 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.699 0.762 . . . . 2.34 111.685 -169.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.408 ' HA ' ' H3 ' ' A' ' 169' ' ' HC4 . . . -168.3 69.91 0.81 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.665 -0.698 . . . . 1.2 111.455 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 39.4 Cg_endo -68.94 11.31 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.644 2.229 . . . . 0.98 113.688 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.8 m -79.92 -30.54 40.01 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.717 -0.475 . . . . 1.41 109.717 173.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.676 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 17.3 p -78.93 -38.56 36.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.722 -1.127 . . . . 1.74 110.383 -158.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.642 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 25.6 t70 -64.18 100.19 0.32 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.218 -0.66 . . . . 1.85 109.218 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 30.5 t -149.63 147.78 23.9 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.919 -0.582 . . . . 1.85 109.985 -171.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.38 -29.39 23.67 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.044 2.496 . . . . 1.4 112.156 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.747 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.8 pt-20 -93.65 -60.03 1.86 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.638 -0.425 . . . . 2.56 111.283 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 81.5 t80 -68.7 -52.31 32.23 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.198 -0.314 . . . . 4.11 111.564 -169.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 51.7 t80 -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 1.24 109.486 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.95 79.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.6 112.485 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 64.2 mmtt -81.91 -30.82 31.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.97 0.414 . . . . 2.58 110.159 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -65.53 -30.64 71.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.79 110.734 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 31.3 mmmt -82.79 -9.2 59.45 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.334 -0.848 . . . . 1.63 111.47 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -58.88 -33.83 70.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.489 -0.323 . . . . 2.07 111.71 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 1.029 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -88.08 -37.14 7.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.301 -0.952 . . . . 0.72 112.139 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.557 HG22 ' HH ' ' A' ' 118' ' ' TYR . 18.2 t -55.04 -46.18 77.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.893 0.477 . . . . 1.4 111.227 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -23.9 64.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 1.48 111.798 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.2 m -104.99 -81.25 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.351 0.596 . . . . 2.15 110.548 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.31 -48.6 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.886 -0.886 . . . . 1.77 110.886 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.917 ' HA ' ' HG3' ' A' ' 111' ' ' LYS . 1.4 p-10 -124.17 150.94 44.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.868 -0.666 . . . . 3.83 111.335 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 1.029 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 56.5 tp -144.29 114.96 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 3.54 109.708 174.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 109' ' ' MET . 49.2 m-20 -124.8 89.61 3.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.613 . . . . 2.47 109.667 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -124.74 165.58 17.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.159 -0.928 . . . . 2.01 111.319 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.6 ttp -136.68 111.06 8.48 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.374 -0.973 . . . . 2.22 108.374 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -121.68 163.44 19.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.482 -0.326 . . . . 3.82 110.211 -171.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -116.4 124.75 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.252 -0.647 . . . . 2.39 109.252 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -138.08 159.19 42.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.294 -0.261 . . . . 3.62 110.294 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.84 142.53 34.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.313 -0.403 . . . . 1.97 111.085 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 12.7 m-85 -107.51 132.74 52.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.172 -0.467 . . . . 1.47 109.753 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 13.1 t70 -143.21 -150.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.452 -0.944 . . . . 2.57 108.452 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.454 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 68.7 t80 66.3 -82.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.759 0.424 . . . . 3.46 111.151 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.533 HE21 ' H3 ' ' A' ' 169' ' ' HC4 . 27.4 pt20 -99.6 -24.18 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.262 0.553 . . . . 3.41 109.819 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 101' ' ' THR . 52.6 tpp -91.79 141.61 28.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.847 . . . . 3.33 108.996 173.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -72.38 143.17 85.18 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 108.757 -0.831 . . . . 2.56 108.757 170.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -40.41 90.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.779 2.986 . . . . 1.72 114.186 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 m -123.24 144.64 49.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 1.93 109.942 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.62 142.89 33.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.383 . . . . 3.47 110.123 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -128.78 164.52 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.06 -0.518 . . . . 1.96 110.505 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -108.72 117.88 35.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.13 -1.063 . . . . 2.22 108.13 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' A' ' 75' ' ' PHE . 11.7 p -104.59 133.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.412 0.625 . . . . 1.97 109.655 -172.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 7.7 t-160 -111.18 109.88 20.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.964 -0.754 . . . . 1.37 108.964 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 44.9 tpp -102.23 123.76 46.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.23 -0.655 . . . . 2.95 109.23 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.652 ' HZ1' ' HB3' ' A' ' 110' ' ' LYS . 8.3 mtpm? -141.81 136.43 30.63 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.588 -0.153 . . . . 2.05 110.588 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.917 ' HG3' ' HA ' ' A' ' 87' ' ' ASN . 7.7 tmtt? -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.171 0.51 . . . . 2.66 110.813 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.627 ' N ' ' HD3' ' A' ' 111' ' ' LYS . . . -146.62 160.46 42.15 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.549 -0.75 . . . . 1.57 109.913 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -103.23 -0.62 30.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.746 0.308 . . . . 4.89 110.479 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -61.78 106.47 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.505 -0.924 . . . . 2.9 108.505 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.96 -103.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.526 -1.429 . . . . 2.62 109.526 -164.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -179.07 84.54 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.775 -0.824 . . . . 2.76 108.775 167.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -166.0 -172.24 2.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.447 -0.797 . . . . 1.61 111.237 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.557 ' HH ' HG22 ' A' ' 83' ' ' VAL . 75.0 m-85 -110.86 155.32 22.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.489 -0.56 . . . . 1.4 109.489 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -103.71 107.78 18.79 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.297 -1.001 . . . . 0.75 108.297 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.505 HG11 ' HB ' ' A' ' 31' ' ' ILE . 12.5 p -100.64 131.86 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.702 0.763 . . . . 1.6 110.369 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.0 m-85 -115.2 128.82 56.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.457 -0.792 . . . . 0.97 109.84 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -104.33 102.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.193 0.521 . . . . 1.83 109.626 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -112.42 110.32 20.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 3.79 109.698 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HA ' HG12 ' A' ' 105' ' ' VAL . 5.7 ptm180 -74.6 166.55 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.535 -0.466 . . . . 4.65 110.493 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.736 -0.65 . . . . 2.87 109.81 177.547 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.533 ' H3 ' HE21 ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.857 0.36 . . . . 3.79 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HA ' ' NH2' ' A' ' 124' ' ' ARG . . . -126.33 -37.36 2.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.514 . . . . 3.43 110.868 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -80.18 117.02 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.989 -0.745 . . . . 4.68 108.989 176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.47 115.56 5.24 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.332 -0.937 . . . . 0.96 112.925 -172.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.33 104.2 14.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 1.26 109.844 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.577 ' HB ' HG13 ' A' ' 120' ' ' VAL . 29.6 mt -113.09 158.23 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.818 -0.808 . . . . 1.67 108.818 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 48.9 tt0 -120.08 112.66 19.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.807 -0.558 . . . . 1.02 110.32 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.695 ' HG ' HG12 ' A' ' 120' ' ' VAL . 6.7 mt -114.05 142.92 45.58 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.895 -0.78 . . . . 2.24 108.895 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -102.71 168.96 8.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.769 -0.372 . . . . 1.22 110.275 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -50.58 -33.39 25.86 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.672 0.629 . . . . 0.79 114.672 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.04 -21.09 43.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.357 0.578 . . . . 1.95 111.45 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.3 17.36 10.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.579 -0.82 . . . . 0.61 112.75 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 7.5 m120 -83.16 147.7 27.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.372 . . . . 1.64 110.343 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.016 HD11 ' HB2' ' A' ' 62' ' ' PHE . 13.5 mm -92.76 145.31 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.703 -0.681 . . . . 1.58 110.287 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.8 mm? -97.68 -62.59 1.23 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 2.1 110.609 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -170.07 158.5 7.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.953 -1.021 . . . . 1.99 109.949 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.501 ' CE2' HG22 ' A' ' 39' ' ' ILE . 9.6 m-30 -110.94 147.74 33.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.523 -0.762 . . . . 1.25 109.376 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -80.36 -173.17 3.91 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.666 -0.494 . . . . 2.14 109.666 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -78.21 20.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.009 0.374 . . . . 1.87 112.009 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.38 -65.17 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.052 0.39 . . . . 2.02 112.052 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 27.9 tp10 -61.12 -51.02 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.682 -0.69 . . . . 2.12 111.172 -172.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.96 -3.81 81.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.082 -0.58 . . . . 1.42 112.648 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 34.7 t70 -84.2 -18.76 35.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.347 0.594 . . . . 2.35 110.204 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' C ' ' HG1' ' A' ' 50' ' ' THR . 50.9 mm -110.22 -65.18 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.57 -0.741 . . . . 2.98 111.041 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 56.9 m -155.74 -42.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.524 0.202 . . . . 3.86 111.42 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -61.15 88.04 0.04 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 115.03 0.772 . . . . 2.91 115.03 -170.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.827 ' HG2' " H3'" ' A' ' 169' ' ' HC4 . 20.0 mmm180 61.15 -176.87 0.12 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.999 0.904 . . . . 3.64 113.273 170.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 5.8 t70 -102.75 132.68 21.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 114.471 -1.24 . . . . 2.1 108.293 169.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 50.2 Cg_exo -55.29 -20.45 25.23 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.369 2.713 . . . . 1.68 114.438 -174.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 55' ' ' LYS . 1.9 mppt? -109.49 -3.49 16.96 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.037 -0.265 . . . . 4.08 111.437 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -104.08 24.56 11.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.082 0.467 . . . . 3.05 111.784 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.743 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 m -118.52 10.99 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.035 0.445 . . . . 1.26 111.319 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.73 133.33 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.653 -0.419 . . . . 1.66 110.507 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.31 72.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.265 -0.734 . . . . 0.78 111.265 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.55 148.25 47.91 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.659 -0.271 . . . . 2.37 110.526 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.865 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 8.1 t-20 -98.96 125.16 44.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.035 0.445 . . . . 0.83 111.512 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 1.016 ' HB2' HD11 ' A' ' 39' ' ' ILE . 48.5 t80 -64.72 -9.32 19.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 0.7 111.868 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.664 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 52.0 m-85 -122.65 20.55 10.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.849 0.357 . . . . 1.45 110.439 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.865 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 44.3 mmtm -150.79 -45.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 4.07 111.824 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -101.84 -79.05 0.52 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 2.2 111.389 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -84.14 15.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 2.34 112.54 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -172.64 97.06 0.36 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 1.2 109.89 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.92 19.87 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.19 2.593 . . . . 0.98 113.674 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -110.79 13.63 22.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.484 -0.486 . . . . 1.41 109.839 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.9 p -112.74 -43.73 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.943 -1.026 . . . . 1.74 111.055 -164.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.664 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -65.22 105.06 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 1.85 110.506 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 9.7 t -170.54 149.79 3.12 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 109.349 -0.612 . . . . 1.85 109.349 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 47.6 Cg_exo -39.38 -43.46 2.77 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.281 3.32 . . . . 1.4 114.98 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.38 -39.47 11.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.785 -0.366 . . . . 2.56 111.748 -176.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 70' ' ' THR . 28.3 m-85 -71.74 -69.29 0.4 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.176 0.513 . . . . 4.11 110.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.883 ' HH ' ' HZ2' ' A' ' 80' ' ' LYS . 59.8 t80 -61.66 -32.7 72.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 1.24 110.193 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -31.34 71.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.6 112.915 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 30.9 mmtp -78.05 -34.22 50.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.219 0.51 . . . . 2.58 110.836 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.58 -26.55 68.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 0.79 110.334 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.883 ' HZ2' ' HH ' ' A' ' 76' ' ' TYR . 19.5 mmmt -93.13 -6.54 47.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 1.63 112.038 -175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 6.6 mm-40 -58.14 -42.35 85.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.268 0.47 . . . . 2.07 112.268 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -76.38 -41.36 25.83 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.999 -1.096 . . . . 0.72 111.234 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.744 HG22 ' HH ' ' A' ' 118' ' ' TYR . 20.3 t -50.22 -48.15 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 123.121 0.568 . . . . 1.4 111.121 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.42 -32.35 49.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.732 -0.667 . . . . 1.48 112.502 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -90.08 -66.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.844 0.354 . . . . 2.15 110.198 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.74 34.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.749 . . . . 1.77 111.864 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.761 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 0.7 OUTLIER 65.88 105.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.277 -0.638 . . . . 3.83 109.277 -176.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 33.6 tp -143.45 159.35 42.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.132 -0.627 . . . . 3.54 111.757 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' MET . 18.9 t30 -82.05 112.83 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.036 -0.984 . . . . 2.47 111.224 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -125.27 146.48 49.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 2.01 110.157 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.563 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 21.3 ptp -116.73 129.37 56.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.839 0.352 . . . . 2.22 110.216 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 13.1 p90 -141.63 148.13 38.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.861 0.362 . . . . 3.82 110.968 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.94 116.67 30.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 2.39 109.914 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 38.7 m-85 -142.21 168.02 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.1 -0.5 . . . . 3.62 110.91 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 104' ' ' LYS . 36.2 p -102.85 156.86 17.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.968 -0.56 . . . . 1.97 111.654 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.419 ' CD1' " H6'" ' A' ' 169' ' ' HC4 . 19.8 m-85 -116.27 108.96 16.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 1.47 109.194 172.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' MET . 7.1 p-10 -121.26 -153.75 0.56 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.943 -0.571 . . . . 2.57 110.236 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 65.8 t80 71.43 -73.81 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.959 0.503 . . . . 3.46 111.477 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.44 -26.28 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.441 0.638 . . . . 3.41 109.807 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 16.5 tpt -103.31 140.61 37.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.17 -0.923 . . . . 3.33 109.499 176.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 m -60.03 117.7 25.98 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.71 -0.848 . . . . 2.56 108.71 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -38.15 93.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.096 3.197 . . . . 1.72 114.254 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 160.48 18.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 1.93 109.611 172.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.1 ptpt -115.49 146.49 41.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 3.47 111.493 -178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.73 HG11 ' HA ' ' A' ' 124' ' ' ARG . 18.9 m -130.6 165.66 30.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.004 -0.998 . . . . 1.96 110.295 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -112.7 118.01 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.556 -0.905 . . . . 2.22 108.556 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -105.02 104.87 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 115.536 -0.756 . . . . 1.97 109.88 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.563 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 6.7 t-160 -103.79 102.81 12.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.492 -0.929 . . . . 1.37 108.492 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 5.2 ppp? -107.85 140.79 40.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.585 -0.734 . . . . 2.95 110.507 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.707 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 62.2 pttt -150.98 152.03 32.96 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.043 0.449 . . . . 2.05 111.489 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.79 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 33.2 ttpt -75.58 136.62 40.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.696 -0.684 . . . . 2.66 112.552 -172.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.512 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -130.98 107.29 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.369 -0.832 . . . . 1.57 109.312 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -74.45 1.85 10.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.341 -0.39 . . . . 4.89 111.135 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -51.89 -45.82 64.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 2.9 111.149 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.36 29.15 2.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.587 -0.816 . . . . 2.62 112.437 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.94 60.51 3.43 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.271 0.558 . . . . 2.76 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 32' ' ' GLN . 32.5 t -164.55 164.53 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.373 -0.973 . . . . 1.61 108.373 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.79 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 21.1 m-85 -104.95 156.38 18.08 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.843 -0.429 . . . . 1.4 109.843 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.512 ' HD1' ' HB1' ' A' ' 112' ' ' ALA . 62.8 m95 -101.58 106.12 17.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.398 -0.964 . . . . 0.75 108.398 172.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 33' ' ' LEU . 4.2 p -101.94 122.51 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.86 0.838 . . . . 1.6 110.473 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.707 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 94.4 m-85 -104.28 109.92 21.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.113 -0.949 . . . . 0.97 109.676 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.17 108.06 23.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.08 -0.963 . . . . 1.83 109.914 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -104.5 127.8 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 3.79 110.241 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.73 ' HA ' HG11 ' A' ' 105' ' ' VAL . 49.7 mtm-85 -70.44 127.91 34.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.006 -0.543 . . . . 4.65 109.732 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG22 ' HG3' ' A' ' 104' ' ' LYS . 3.0 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.938 -1.03 . . . . 2.87 111.326 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.827 " H3'" ' HG2' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' H ' HD21 ' A' ' 26' ' ' LEU . 4.3 mm? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.406 0.146 . . . . 3.79 110.956 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 72.77 -60.43 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.822 0.701 . . . . 3.43 111.494 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -78.97 153.45 30.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.603 -0.517 . . . . 4.68 109.603 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.2 148.33 17.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.377 -0.916 . . . . 0.96 112.518 -174.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.9 105.05 5.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.842 0.353 . . . . 1.26 110.338 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.807 ' HB ' HG12 ' A' ' 120' ' ' VAL . 11.3 mm -108.67 160.83 7.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.767 -0.827 . . . . 1.67 108.767 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.444 ' NE2' HD22 ' A' ' 113' ' ' LEU . 59.2 tt0 -128.43 118.7 23.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.69 -0.485 . . . . 1.02 109.69 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HG ' HG11 ' A' ' 120' ' ' VAL . 17.1 mt -116.05 155.51 28.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.699 -0.482 . . . . 2.24 109.699 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.636 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.4 p30 -108.76 169.38 8.7 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.867 -0.333 . . . . 1.22 110.259 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.2 -20.52 6.92 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.3 0.88 . . . . 0.79 115.3 -171.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.24 -19.84 23.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.901 0.851 . . . . 1.95 110.636 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.76 6.49 23.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.762 -0.733 . . . . 0.61 112.292 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.636 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 89.7 m-20 -71.61 149.71 45.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.915 0.388 . . . . 1.64 110.486 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 62' ' ' PHE . 10.0 mt -95.4 149.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.693 -0.685 . . . . 1.58 109.37 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 40' ' ' LEU . 7.1 mp -113.49 -56.76 2.37 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.587 0.708 . . . . 2.1 109.879 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -150.77 144.27 25.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.027 -0.988 . . . . 1.99 111.142 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 1.07 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.2 m-30 -101.1 175.26 5.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.575 -1.193 . . . . 1.25 110.271 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -102.41 179.72 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.61 -0.885 . . . . 2.14 108.61 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.56 13.51 8.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.833 0.349 . . . . 1.87 110.493 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -89.92 -40.98 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 2.02 110.828 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 11.4 mp0 -59.74 -55.03 39.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 2.12 110.374 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 51' ' ' GLY . . . -61.96 -30.8 76.41 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.562 -0.744 . . . . 1.42 112.875 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.61 -33.43 74.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 2.35 110.548 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 50' ' ' THR . 44.7 mt -81.77 -62.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.776 -0.647 . . . . 2.98 109.915 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 HG22 HG23 ' A' ' 49' ' ' ILE . 9.4 t -179.44 131.43 0.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.157 -0.474 . . . . 3.86 110.464 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.537 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . 57.33 -157.2 13.7 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.932 -0.576 . . . . 2.91 112.808 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 4.4 mpp_? 53.95 79.85 0.12 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.755 -0.723 . . . . 3.64 111.748 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 56' ' ' GLN . 21.9 t70 -79.96 136.24 54.5 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 2.1 110.598 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 1.07 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 11.1 Cg_endo -54.5 -33.56 78.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.667 2.911 . . . . 1.68 114.123 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.94 2.02 48.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.434 . . . . 4.08 111.129 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 53' ' ' ASP . 22.4 tt0 -92.9 -8.4 43.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 3.05 110.966 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 42' ' ' TYR . 3.2 m -112.93 58.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.623 0.601 . . . . 1.26 112.623 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 40' ' ' LEU . 11.4 mt -122.39 139.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.687 -0.633 . . . . 1.66 110.031 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.13 75.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.622 -0.799 . . . . 0.78 111.191 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -114.36 139.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.147 -0.527 . . . . 2.37 110.118 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.95 113.35 20.48 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.853 -0.425 . . . . 0.83 109.853 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' HA ' HD12 ' A' ' 39' ' ' ILE . 84.2 t80 -47.21 -46.59 24.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.663 -0.699 . . . . 0.7 111.542 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 49.6 m-85 -80.22 7.77 8.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 1.45 111.614 -172.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -124.37 -50.77 1.76 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 4.07 110.991 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.44 -79.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.687 0.625 . . . . 2.2 112.687 -174.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.26 16.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.251 0.548 . . . . 2.34 111.373 -168.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HB3' ' HG1' ' A' ' 70' ' ' THR . . . -165.93 70.45 1.22 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 1.2 110.851 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.11 -6.28 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.901 2.401 . . . . 0.98 113.17 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.741 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 7.5 p -84.59 -22.15 30.13 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.415 -0.587 . . . . 1.41 109.415 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.54 ' HG1' ' HB3' ' A' ' 67' ' ' ALA . 2.2 m -79.38 -32.96 43.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.847 -1.524 . . . . 1.74 110.477 -160.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.85 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 12.1 t70 -62.9 108.58 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.7 -0.682 . . . . 1.85 109.999 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -162.95 155.78 16.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 1.85 109.496 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.94 -32.7 97.93 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.374 2.049 . . . . 1.4 111.913 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -80.44 -9.79 59.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 2.56 112.482 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' CD1' HG23 ' A' ' 70' ' ' THR . 62.0 t80 -130.05 -67.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.109 -0.37 . . . . 4.11 110.806 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -56.61 -41.53 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 1.24 110.332 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.35 -34.3 84.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.04 -0.6 . . . . 0.6 112.594 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.3 -36.95 38.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.391 . . . . 2.58 110.243 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.452 ' HD1' ' HG2' ' A' ' 109' ' ' MET . 34.9 t80 -57.4 -44.54 84.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.79 109.428 172.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -75.68 -18.91 59.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 1.63 111.781 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -38.36 82.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.827 -0.434 . . . . 2.07 109.827 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.659 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.34 -45.97 35.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.73 -0.748 . . . . 0.72 111.481 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 118' ' ' TYR . 28.1 t -50.59 -48.52 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 122.979 0.511 . . . . 1.4 111.1 176.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.4 -20.32 62.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.627 -0.715 . . . . 1.48 112.01 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -99.14 -81.86 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.878 0.37 . . . . 2.15 110.436 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.0 -60.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.826 -0.702 . . . . 1.77 111.774 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -98.72 130.84 45.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.533 . . . . 3.83 109.627 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER -115.49 104.45 11.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.914 -0.773 . . . . 3.54 108.914 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.687 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.1 p-10 -149.32 95.44 2.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.135 0.969 . . . . 2.47 110.227 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 20.9 m -142.86 145.16 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.112 -0.949 . . . . 2.01 109.894 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -120.1 117.83 28.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.061 0.458 . . . . 2.22 109.778 174.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.03 154.15 36.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.04 -0.726 . . . . 3.82 109.04 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 pt-20 -103.2 103.49 13.54 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 2.39 110.553 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -110.78 161.27 15.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.704 -1.135 . . . . 3.62 109.96 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 103' ' ' THR . 13.6 m -104.13 129.28 51.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.14 -0.482 . . . . 1.97 110.938 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.5 ' CD1' ' H2 ' ' A' ' 169' ' ' HC4 . 27.3 m-85 -103.35 104.62 14.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 1.47 108.482 174.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.59 8.39 9.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 2.57 111.793 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.741 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 71.6 t80 -79.22 -82.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.555 -0.293 . . . . 3.46 110.69 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -87.37 -37.86 16.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 3.41 109.77 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.0 ttt -82.2 139.9 34.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.766 -0.827 . . . . 3.33 108.766 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.16 143.55 92.26 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 109.264 -0.643 . . . . 2.56 109.264 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -42.48 89.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.64 2.893 . . . . 1.72 114.187 -174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.8 m -108.14 145.9 33.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.977 -0.556 . . . . 1.93 110.585 175.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -103.34 104.73 14.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.143 0.497 . . . . 3.47 110.443 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 124' ' ' ARG . 27.7 m -117.15 165.51 12.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.625 -0.716 . . . . 1.96 109.973 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 35.9 ttmt -110.94 119.39 38.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.622 -0.881 . . . . 2.22 108.622 177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 91' ' ' MET . 54.9 t -105.64 127.12 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 115.408 -0.815 . . . . 1.97 108.848 -171.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 2.2 t-160 -109.97 114.45 27.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.219 -0.446 . . . . 1.37 110.31 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.687 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 4.1 mpp? -101.45 119.83 39.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.007 -0.738 . . . . 2.95 109.007 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 58.7 pttt -143.25 124.52 14.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.413 0.625 . . . . 2.05 112.227 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.56 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 42.8 tttt -57.68 126.5 27.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.664 -1.153 . . . . 2.66 111.162 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB1' ' HD1' ' A' ' 119' ' ' TRP . . . -174.79 94.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.091 0.774 . . . . 1.57 113.091 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 1.007 HD11 ' H ' ' A' ' 117' ' ' SER . 0.2 OUTLIER 177.73 -174.98 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.005 0.522 . . . . 4.89 111.431 167.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 t -77.22 77.63 3.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.529 -0.915 . . . . 2.9 108.529 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.14 -134.06 3.62 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.753 -1.213 . . . . 2.62 112.979 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -143.32 25.32 1.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 2.76 110.648 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 1.007 ' H ' HD11 ' A' ' 113' ' ' LEU . 4.3 m -98.87 167.32 10.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.943 -0.762 . . . . 1.61 108.943 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.56 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -127.13 156.99 40.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.002 0.43 . . . . 1.4 110.216 -169.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.617 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 35.9 m95 -101.02 110.63 22.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.942 -0.762 . . . . 0.75 108.942 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.807 HG12 ' HB ' ' A' ' 31' ' ' ILE . 3.5 p -103.25 107.87 23.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.512 1.149 . . . . 1.6 110.59 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.617 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 95.7 m-85 -102.78 140.72 36.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.734 -1.121 . . . . 0.97 110.697 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.87 104.15 16.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 1.83 109.744 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.99 126.01 51.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.559 . . . . 3.79 109.807 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.561 ' HA ' HG11 ' A' ' 105' ' ' VAL . 44.3 mtm180 -79.8 143.79 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.789 -0.365 . . . . 4.65 110.372 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.337 -0.84 . . . . 2.87 109.899 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.5 ' H2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.556 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 31.6 tp . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.668 -0.493 . . . . 3.79 109.668 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -60.54 2.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 3.43 111.734 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -77.19 152.24 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.085 -0.339 . . . . 4.68 110.085 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.61 135.75 12.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.445 -0.883 . . . . 0.96 113.243 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.9 104.62 12.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.514 -0.55 . . . . 1.26 109.514 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 120' ' ' VAL . 60.5 mt -112.77 142.65 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.557 -0.534 . . . . 1.67 109.557 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -109.41 116.19 31.37 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.553 -0.459 . . . . 1.02 109.834 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 117' ' ' SER . 2.7 mm? -103.83 165.43 11.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.809 -1.182 . . . . 2.24 107.809 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 47.3 p30 -108.19 167.16 10.21 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 1.22 110.333 173.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -60.54 -2.12 2.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 114.403 0.521 . . . . 0.79 114.403 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -100.33 -47.33 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.534 0.667 . . . . 1.95 109.675 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.46 6.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.501 -0.772 . . . . 0.61 112.558 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -76.96 149.61 35.95 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.969 0.414 . . . . 1.64 110.43 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.721 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 12.6 mt -95.96 148.13 5.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.663 -0.699 . . . . 1.58 109.591 175.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.4 mp -115.64 -64.85 1.26 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.326 0.584 . . . . 2.1 111.945 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -150.66 158.8 44.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.219 -0.9 . . . . 1.99 110.641 -173.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.639 ' HE2' HG21 ' A' ' 39' ' ' ILE . 5.3 m-30 -121.21 -174.19 2.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.065 -0.971 . . . . 1.25 110.158 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 26' ' ' LEU . 12.9 t-20 -114.81 178.96 4.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.844 -0.799 . . . . 2.14 108.844 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.87 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 1.87 110.467 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -43.67 -63.82 0.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.847 . . . . 2.02 112.786 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -61.99 -37.9 86.57 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.796 0.331 . . . . 2.12 111.792 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.27 94.59 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.807 -0.711 . . . . 1.42 111.681 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.0 -38.17 82.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.538 0.335 . . . . 2.35 111.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 45' ' ' ALA . 48.9 mt -56.53 -60.31 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.075 0.464 . . . . 2.98 110.692 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -144.69 -42.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.139 -0.482 . . . . 3.86 111.071 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 139.64 77.47 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.395 -0.907 . . . . 2.91 112.192 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 1.2 mpt_? -118.14 119.78 35.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.822 0.344 . . . . 3.64 110.28 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.73 133.32 31.08 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 2.1 111.255 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 31.8 Cg_exo -60.37 -28.87 87.61 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.038 2.492 . . . . 1.68 112.16 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 10.9 mmpt? -79.82 -12.2 59.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.434 -0.348 . . . . 4.08 111.616 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -89.52 -24.6 21.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 3.05 111.325 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.721 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 m -98.64 16.31 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 1.26 113.462 -170.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.59 125.46 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.266 -0.574 . . . . 1.66 109.969 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 -1.77 88.37 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.289 -0.957 . . . . 0.78 110.861 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' ILE . 14.0 mptt -95.93 140.61 30.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.854 -0.673 . . . . 2.37 109.877 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 14.4 t-20 -90.34 116.87 28.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.408 -0.59 . . . . 0.83 109.408 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.634 ' HA ' HD12 ' A' ' 39' ' ' ILE . 89.0 t80 -56.24 -42.3 77.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.865 -0.607 . . . . 0.7 111.278 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.4 m-85 -82.06 1.25 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.595 . . . . 1.45 111.399 -170.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.4 mmtp -122.23 -58.32 1.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.94 0.4 . . . . 4.07 111.559 -176.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.31 -76.98 0.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.743 -0.662 . . . . 2.2 111.969 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 14.6 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.042 0.925 . . . . 2.34 111.716 -172.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 62' ' ' PHE . . . -169.69 74.03 0.68 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.234 -0.893 . . . . 1.2 110.636 175.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.45 -18.24 43.74 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.151 2.567 . . . . 0.98 113.393 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.78 -8.06 59.03 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.975 -0.29 . . . . 1.41 110.513 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -86.78 -19.97 28.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 1.74 110.73 -176.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 16.8 t70 -67.93 96.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 1.85 110.285 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.634 ' HB3' ' OE1' ' A' ' 74' ' ' GLU . 74.9 m -166.11 148.58 6.28 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.85 109.477 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -53.27 -35.94 76.13 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.008 2.472 . . . . 1.4 113.294 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 72' ' ' SER . 1.4 pm0 -86.36 -7.3 58.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.053 0.39 . . . . 2.56 112.053 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.572 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 51.4 m-85 -112.56 -81.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 4.11 109.927 173.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 75.2 t80 -59.67 -37.69 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.487 -0.779 . . . . 1.24 110.555 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.24 94.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.088 -0.577 . . . . 0.6 112.136 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 67.9 mmtt -67.8 -38.15 82.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.379 . . . . 2.58 110.816 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.444 ' HZ ' ' O ' ' A' ' 34' ' ' ASP . 93.6 t80 -57.5 -42.36 82.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.79 110.614 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -85.91 -13.95 46.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.645 -0.707 . . . . 1.63 110.854 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -41.45 86.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.192 0.52 . . . . 2.07 109.699 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.885 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -70.16 -32.13 69.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.72 111.545 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.63 -51.09 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 1.4 110.354 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.47 67.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 1.48 111.677 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -93.27 -77.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 2.15 110.735 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.19 -64.8 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.62 -0.592 . . . . 1.77 111.62 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.756 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -121.99 155.56 35.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.649 -0.5 . . . . 3.83 109.649 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.885 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 2.4 tm? -135.1 104.34 5.89 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.277 -0.638 . . . . 3.54 109.277 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 110' ' ' LYS . 25.5 m-80 -133.28 93.98 3.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.805 -0.813 . . . . 2.47 108.805 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 108' ' ' HIS . 33.9 p -134.24 164.07 28.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.221 -0.899 . . . . 2.01 110.882 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.8 ptt? -132.89 109.0 9.3 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.644 -0.707 . . . . 2.22 109.66 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -104.62 155.53 18.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.012 -0.995 . . . . 3.82 109.818 -172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -117.57 111.7 19.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.047 -0.353 . . . . 2.39 110.047 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.478 ' HE1' ' HG3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -163.87 168.6 19.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 3.62 110.285 -177.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' A' ' 94' ' ' TYR . 12.4 t -102.92 153.25 20.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.161 -0.472 . . . . 1.97 110.565 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.923 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 81.9 m-85 -114.9 103.24 10.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.759 -0.83 . . . . 1.47 108.759 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -114.69 112.92 23.61 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.617 -0.72 . . . . 2.57 111.078 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -174.2 -80.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 3.46 109.821 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -94.81 -41.48 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 3.41 109.433 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.2 ttp -80.9 124.96 29.54 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.708 -0.849 . . . . 3.33 108.708 171.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.8 m -56.89 120.07 35.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.619 -0.512 . . . . 2.56 109.619 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -24.33 91.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 1 C-N-CA 125.345 4.03 . . . . 1.72 114.978 -170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -108.81 144.82 36.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.896 -0.779 . . . . 1.93 108.896 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -104.16 122.43 45.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.069 0.462 . . . . 3.47 109.992 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.913 HG11 ' HA ' ' A' ' 124' ' ' ARG . 27.1 m -124.74 166.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.583 -0.735 . . . . 1.96 110.321 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -103.95 117.33 34.05 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.682 -1.229 . . . . 2.22 107.682 170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.8 p -104.21 119.36 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.899 0.856 . . . . 1.97 110.402 -170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 t-160 -103.6 105.3 15.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.006 -0.997 . . . . 1.37 109.362 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 57.5 tpp -103.9 123.54 47.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.713 -1.218 . . . . 2.95 107.713 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 13.2 ptmm? -143.39 147.07 34.07 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.959 -0.696 . . . . 2.05 111.033 -172.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.756 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 37.1 tttp -81.52 146.09 30.36 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.019 -0.537 . . . . 2.66 111.217 -171.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.77 38.47 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.518 -0.919 . . . . 1.57 108.518 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.77 -112.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.381 -0.528 . . . . 4.89 110.732 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m 52.95 37.23 23.98 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.504 0.668 . . . . 2.9 109.484 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.57 -90.7 0.55 Allowed Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.896 -1.282 . . . . 2.62 109.896 -169.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -178.22 88.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.672 -0.862 . . . . 2.76 108.672 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.0 p -135.95 -178.19 5.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.921 -0.581 . . . . 1.61 111.503 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 88' ' ' LEU . 97.1 m-85 -131.31 144.33 51.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.564 -0.532 . . . . 1.4 109.564 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 32.9 m95 -102.58 107.43 18.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.568 -0.901 . . . . 0.75 108.568 174.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.9 p -100.37 142.77 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.784 -0.766 . . . . 1.6 111.319 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.07 123.9 28.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.426 -0.807 . . . . 0.97 109.725 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.01 103.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.429 0.633 . . . . 1.83 111.31 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -104.42 121.42 43.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 3.79 109.889 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.913 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.18 140.75 55.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.834 0.35 . . . . 4.65 111.093 -179.144 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.766 -0.635 . . . . 2.87 109.518 177.223 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.923 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.782 0.325 . . . . 3.8500000000000001 110.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.7 150.95 17.28 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.909 -0.662 . . . . 0.84999999999999998 112.51 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.44 104.92 3.68 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.031 -0.729 . . . . 0.70999999999999996 109.031 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.513 ' HB ' HG13 ' A' ' 120' ' ' VAL . 21.7 mt -116.74 156.49 17.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.1 -0.5 . . . . 1.0800000000000001 109.731 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 62.6 tt0 -121.81 111.73 17.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.391 -0.596 . . . . 0.85999999999999999 109.391 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -112.32 148.96 33.1 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.655 -0.498 . . . . 1.6200000000000001 109.655 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -104.44 168.07 9.33 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.119 -0.233 . . . . 1.22 110.373 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.04 -7.13 29.1 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.387 -0.369 . . . . 0.79000000000000004 113.891 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -89.11 -45.62 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 1.95 109.811 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 134.45 12.61 1.38 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.53000000000000003 112.307 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -89.59 149.88 22.65 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.3 110.178 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 17.7 mt -94.08 145.36 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.808 -0.633 . . . . 0.89000000000000001 109.781 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.4 mm? -106.52 -68.4 0.88 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.556 0.694 . . . . 1.45 110.075 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -133.89 133.29 41.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.185 -0.916 . . . . 1.99 110.656 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.94 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.7 m-30 -94.59 -176.23 3.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.635 -0.711 . . . . 1.25 110.3 171.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -118.53 165.79 13.5 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.56 -0.904 . . . . 2.1299999999999999 108.56 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -76.88 19.09 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 1.48 111.332 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.33 -49.07 6.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 1.52 110.279 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 50' ' ' THR . 3.6 mm-40 -69.7 -29.12 66.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.472 0.653 . . . . 2.1200000000000001 110.026 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -88.26 -5.83 75.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.691 -0.766 . . . . 1.4199999999999999 112.33 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.6 t70 -83.1 -60.17 2.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.771 0.319 . . . . 2.3500000000000001 110.683 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' H ' HG12 ' A' ' 49' ' ' ILE . 2.8 pt -94.54 -46.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.291 -0.413 . . . . 2.5899999999999999 111.93 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -70.64 -54.64 11.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.175 0.512 . . . . 3.4100000000000001 110.56 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 110.47 39.61 1.46 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.765 -0.731 . . . . 2.3199999999999998 112.405 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 3.1 mpt_? -118.81 98.26 6.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.59 -0.522 . . . . 3.1400000000000001 109.59 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.878 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.8 m-20 -64.08 152.86 86.77 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.536 . . . . 2.1000000000000001 110.559 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.94 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 48.0 Cg_exo -58.01 -18.74 37.15 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.37 2.713 . . . . 1.6799999999999999 113.765 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.7 4.68 26.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.82 0.304 . . . . 3.6099999999999999 111.82 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.878 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 80.9 mm-40 -90.45 -9.33 47.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.731 0.301 . . . . 2.5 111.43 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.737 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.7 m -111.87 25.73 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.986 0.736 . . . . 0.96999999999999997 112.986 -171.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -89.78 126.5 42.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.248 -0.581 . . . . 1.0900000000000001 110.333 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.23 87.79 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.66000000000000003 110.844 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 47.3 mttm -106.73 138.79 42.25 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.072 -0.564 . . . . 1.8200000000000001 110.619 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 25.8 t-20 -80.04 114.33 18.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.039 -0.528 . . . . 0.71999999999999997 109.8 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.624 ' HA ' HD11 ' A' ' 39' ' ' ILE . 69.5 t80 -56.14 -43.34 78.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.961 -0.563 . . . . 0.69999999999999996 111.416 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 39.6 m-85 -80.77 -6.25 58.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 112.329 -166.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.65 -45.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.448 0.536 . . . . 3.5800000000000001 112.448 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.44 -23.56 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.314 -0.555 . . . . 2.2000000000000002 111.833 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.93 14.01 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.116 -0.633 . . . . 1.77 110.998 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.29 74.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.904 -0.589 . . . . 0.60999999999999999 110.543 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.88 13.64 1.43 Allowed 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.939 2.426 . . . . 0.81000000000000005 113.698 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -97.12 -5.75 36.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 110.256 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.602 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 55.1 p -100.5 -28.87 12.68 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.61 -0.723 . . . . 1.3300000000000001 111.653 -159.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 10.1 p-10 -75.29 78.49 2.39 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.591 1.186 . . . . 1.8500000000000001 111.105 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.792 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 66.7 m -152.65 169.42 9.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 114.592 -1.185 . . . . 1.5600000000000001 108.776 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.792 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 29.3 Cg_endo -61.99 -14.57 38.01 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.007 2.471 . . . . 1.1699999999999999 114.926 -171.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.41 -34.29 13.51 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.901 -0.5 . . . . 2.5600000000000001 111.554 -175.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 69.0 t80 -106.29 -69.43 0.83 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 3.3599999999999999 110.459 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.658 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 63.8 t80 -60.62 -41.14 94.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.79000000000000004 110.727 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -56.86 -49.15 73.03 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.59999999999999998 112.383 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -67.48 -37.15 82.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 2.0899999999999999 110.558 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.78 -40.75 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.614 . . . . 0.67000000000000004 110.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -78.33 -18.59 54.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 1.0900000000000001 112.229 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 35.1 mt-10 -66.12 -39.79 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.417 . . . . 2.0699999999999998 110.939 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -69.71 -42.1 72.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.364 -0.922 . . . . 0.71999999999999997 111.436 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 83' ' ' VAL . 35.4 t -57.31 -51.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.38 . . . . 0.84999999999999998 110.67 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -26.83 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.774 -0.648 . . . . 1.1399999999999999 111.707 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -83.94 -77.94 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.8200000000000001 110.172 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.87 -68.48 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.235 -0.746 . . . . 1.6499999999999999 111.235 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -107.34 153.38 22.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 3.5 109.506 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 62.3 tp -118.19 126.41 52.14 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.932 -0.396 . . . . 2.96 109.932 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 109' ' ' MET . 26.4 p-10 -166.15 94.12 0.54 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.939 0.876 . . . . 2.2400000000000002 109.774 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 4.4 m -139.52 153.71 47.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.801 -1.09 . . . . 1.6299999999999999 109.769 -174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 61.1 ttp -137.5 108.94 6.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.153 -0.314 . . . . 1.77 110.153 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 47.1 p90 -123.76 167.29 14.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.472 -0.331 . . . . 3.0099999999999998 110.76 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -102.68 132.79 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.622 -0.511 . . . . 2.3900000000000001 109.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -144.21 150.84 38.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.531 . . . . 3.3700000000000001 110.647 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 m -104.83 141.35 36.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.353 -0.385 . . . . 1.3999999999999999 110.806 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 105' ' ' VAL . 18.6 m-85 -104.63 120.81 42.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' MET . 4.0 p30 -143.66 -156.93 0.73 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.639 -0.71 . . . . 2.5699999999999998 109.527 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 58.1 t80 73.52 -24.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.152 0.581 . . . . 3.21 111.745 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 97' ' ' ASP . 10.6 pt20 -158.74 -38.02 0.06 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.337 -0.616 . . . . 3.23 109.337 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 101' ' ' THR . 54.3 tpp -78.71 143.67 36.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.849 -0.797 . . . . 2.8500000000000001 108.849 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.565 ' O ' ' HG3' ' A' ' 100' ' ' MET . 12.1 p -67.52 151.4 97.2 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 108.407 -0.96 . . . . 2.1200000000000001 108.407 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.59 87.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.994 2.462 . . . . 1.47 113.864 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' HE ' ' A' ' 124' ' ' ARG . 85.8 m -100.78 129.89 46.73 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.457 -0.792 . . . . 1.3999999999999999 110.422 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.34 114.76 29.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.48 -0.563 . . . . 3.0800000000000001 109.48 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.3 m -126.95 165.88 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.784 -0.644 . . . . 1.3300000000000001 111.151 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -115.19 128.09 55.95 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.499 -0.926 . . . . 1.6899999999999999 108.499 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 98.9 t -104.51 104.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.459 -0.791 . . . . 1.27 109.201 -171.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.64 104.42 14.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.177 -0.675 . . . . 1.02 109.177 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.93 143.79 32.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.486 -0.779 . . . . 2.4900000000000002 109.845 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.9 ptmt -154.31 154.24 33.04 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.466 -0.568 . . . . 1.5700000000000001 109.466 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.638 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 3.6 ttpm? -78.6 140.52 38.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.846 0.355 . . . . 2.1299999999999999 111.557 -171.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -113.25 169.08 9.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.982 -0.554 . . . . 1.5700000000000001 110.359 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' N ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 -6.2 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.524 -0.307 . . . . 4.4100000000000001 111.525 177.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 p -61.49 -39.53 91.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.02 0.914 . . . . 2.5499999999999998 109.167 170.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.02 22.21 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 108.749 -1.741 . . . . 2.6200000000000001 108.749 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.27 89.8 0.06 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.474 0.637 . . . . 2.7599999999999998 110.062 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 11.8 p -177.13 -170.02 0.27 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.521 -0.763 . . . . 1.0700000000000001 110.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 15.9 m-85 -129.0 158.46 38.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.631 -0.877 . . . . 0.85999999999999999 108.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.531 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 77.8 m95 -102.59 109.25 20.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.957 -0.757 . . . . 0.63 108.957 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.4 p -102.5 120.85 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.887 0.851 . . . . 0.91000000000000003 110.597 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.519 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 97.6 m-85 -103.61 136.53 43.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.467 -0.788 . . . . 0.79000000000000004 110.992 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.48 107.76 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.078 -0.965 . . . . 1.1799999999999999 110.026 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -103.65 104.42 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 3.3100000000000001 110.182 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.699 ' HE ' HG23 ' A' ' 103' ' ' THR . 34.3 ttt-85 -83.55 126.9 33.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.035 -0.357 . . . . 4.0300000000000002 110.035 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.125 -0.941 . . . . 2.8700000000000001 111.443 -179.476 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.0 p90 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 110.044 -0.354 . . . . 3.8500000000000001 110.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.8 118.58 6.14 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.554 -0.832 . . . . 0.84999999999999998 111.354 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.89 106.63 17.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.878 0.37 . . . . 0.70999999999999996 110.481 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' HG13 ' A' ' 120' ' ' VAL . 20.7 mt -111.66 147.78 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.344 -0.613 . . . . 1.0800000000000001 109.344 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' NE2' HD22 ' A' ' 40' ' ' LEU . 47.1 tt0 -118.38 116.24 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.576 -0.528 . . . . 0.85999999999999999 109.576 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 19.0 mt -115.71 154.12 30.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 110.276 -0.268 . . . . 1.6200000000000001 110.276 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.727 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.2 p30 -112.03 167.4 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.497 -0.186 . . . . 1.22 110.497 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -19.11 50.55 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.507 0.563 . . . . 0.79000000000000004 114.507 -171.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 38.7 t70 -81.38 -14.85 56.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.367 0.603 . . . . 1.95 109.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 104.53 7.82 38.91 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.502 -0.772 . . . . 0.53000000000000003 112.009 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.727 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 40.1 m-80 -82.62 154.34 24.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.143 0.497 . . . . 1.3 110.483 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.832 HG21 ' HE2' ' A' ' 42' ' ' TYR . 9.1 mt -102.09 158.19 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.258 -0.883 . . . . 0.89000000000000001 108.767 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.0 mp -116.77 -68.35 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.635 0.731 . . . . 1.45 109.754 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.5 151.7 40.6 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.585 -174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.832 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.7 m-85 -109.94 179.04 4.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.636 -1.166 . . . . 1.25 109.116 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 45' ' ' ALA . 31.7 p-10 -109.74 163.75 13.21 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.874 -0.787 . . . . 2.1299999999999999 108.874 169.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.26 -7.12 44.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 1.48 111.842 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . . . -82.74 -23.77 33.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.458 -0.337 . . . . 1.52 111.378 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.02 -53.14 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.268 -0.642 . . . . 2.1200000000000001 109.268 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -55.76 -24.75 41.95 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 112.672 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.36 -33.36 75.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.842 0.353 . . . . 2.3500000000000001 110.918 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -96.07 -69.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 2.5899999999999999 110.916 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.8 m -84.29 -60.43 2.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.727 0.299 . . . . 3.4100000000000001 110.281 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 119.39 40.51 0.62 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.091 -1.052 . . . . 2.3199999999999998 113.121 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -92.88 119.44 32.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.165 -0.68 . . . . 3.1400000000000001 109.165 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 19.6 m-20 -65.86 139.04 96.67 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 2.1000000000000001 112.503 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.8 Cg_exo -66.98 121.56 8.77 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.691 2.261 . . . . 1.6799999999999999 111.796 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 68.7 mttm 83.96 7.17 0.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.028 0.83 . . . . 3.6099999999999999 112.604 171.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.609 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.6 pt20 -84.01 -16.96 42.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.909 0.862 . . . . 2.5 109.209 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.957 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.8 m -97.0 24.97 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.523 -1.217 . . . . 0.96999999999999997 112.789 -170.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.41 125.71 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.732 -0.469 . . . . 1.0900000000000001 109.732 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.95 5.77 88.82 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.227 -0.987 . . . . 0.66000000000000003 111.102 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.957 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 39.8 mttm -98.46 139.43 34.21 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.388 . . . . 1.8200000000000001 110.234 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 22.2 t-20 -86.25 111.96 20.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.761 -0.459 . . . . 0.71999999999999997 109.761 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HA ' HD11 ' A' ' 39' ' ' ILE . 80.9 t80 -57.72 -32.63 67.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.585 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 30.0 m-85 -86.42 1.22 52.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.9 -0.591 . . . . 1.1599999999999999 111.365 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -136.3 -62.55 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.327 0.492 . . . . 3.5800000000000001 112.327 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.82 -24.06 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.375 0.509 . . . . 2.2000000000000002 112.375 -164.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.83 13.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.215 0.45 . . . . 1.77 112.215 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.97 88.18 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.573 0.546 . . . . 0.60999999999999999 110.637 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.09 29.9 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.581 2.187 . . . . 0.81000000000000005 113.066 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.0 m -79.06 -30.61 44.12 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.983 -1.118 . . . . 0.84999999999999998 107.983 167.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 6.8 m -96.99 -25.15 15.49 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.57 -2.105 . . . . 1.3300000000000001 108.553 -119.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 11.0 p-10 -74.22 104.23 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 109.105 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.501 ' H ' ' HB3' ' A' ' 76' ' ' TYR . 48.7 m -160.29 151.65 16.17 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.283 -0.871 . . . . 1.5600000000000001 109.624 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.85 -31.01 87.53 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.95 2.433 . . . . 1.1699999999999999 112.803 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.98 -2.36 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.343 0.497 . . . . 2.5600000000000001 112.343 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -134.73 -74.33 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.888 -0.325 . . . . 3.3599999999999999 110.537 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 85.8 t80 -57.54 -35.86 70.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.962 0.41 . . . . 0.79000000000000004 110.171 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' GLU . . . -57.67 -45.69 93.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.743 -0.662 . . . . 0.59999999999999998 112.048 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 72.5 mmtt -75.9 -38.68 57.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.669 0.235 . . . . 2.0899999999999999 111.096 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.808 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 66.4 t80 -56.06 -40.13 73.08 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.554 0.692 . . . . 0.67000000000000004 110.477 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -88.53 -16.66 32.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.292 -0.867 . . . . 1.0900000000000001 111.034 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 29.3 tt0 -70.25 -35.64 73.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.154 -0.476 . . . . 2.0699999999999998 110.563 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.731 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -76.37 -40.33 28.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.549 -0.834 . . . . 0.71999999999999997 111.513 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.6 t -54.49 -50.35 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 110.36 174.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.15 73.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.506 -0.77 . . . . 1.1399999999999999 111.988 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 p -90.74 -72.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 1.8200000000000001 110.959 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.75 -56.54 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.431 -0.89 . . . . 1.6499999999999999 113.497 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -122.1 149.62 43.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.379 0.609 . . . . 3.5 112.055 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA3' ' A' ' 82' ' ' GLY . 3.9 mm? -112.8 107.61 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.108 -0.951 . . . . 2.96 109.581 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.714 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.2 p30 -169.68 110.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.989 0.9 . . . . 2.2400000000000002 111.796 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -166.05 158.62 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.777 -1.101 . . . . 1.6299999999999999 109.413 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -127.77 119.97 26.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.127 0.489 . . . . 1.77 109.701 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.65 165.84 24.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.527 -0.545 . . . . 3.0099999999999998 109.527 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 51.1 mt-10 -104.32 115.2 29.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.06 0.457 . . . . 2.3900000000000001 110.423 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -118.33 152.74 35.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 3.3700000000000001 109.825 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -104.01 132.09 50.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 1.3999999999999999 110.594 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -113.54 119.63 38.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.671 -0.492 . . . . 1.1799999999999999 109.671 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -123.2 -147.05 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 2.5699999999999998 109.629 -175.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 99' ' ' GLN . 54.5 t80 65.87 -85.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.044 0.537 . . . . 3.21 111.514 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 50.0 mt-30 -72.68 -51.17 20.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.45 0.643 . . . . 3.23 109.509 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 47.5 ttp -93.27 130.41 39.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.338 -0.846 . . . . 2.8500000000000001 109.783 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 m -52.85 117.55 11.36 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.766 -0.457 . . . . 2.1200000000000001 109.766 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -20.25 92.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.552 4.168 . . . . 1.47 114.725 -169.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -105.52 144.45 32.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 1.3999999999999999 111.184 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -103.32 117.66 35.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 3.0800000000000001 110.421 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 124' ' ' ARG . 29.5 m -127.97 165.06 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.991 0.425 . . . . 1.3300000000000001 111.001 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.597 ' HE2' HG11 ' A' ' 125' ' ' VAL . 18.5 ttmm -104.92 129.58 53.27 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.662 -1.236 . . . . 1.6899999999999999 107.662 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 121' ' ' PHE . 7.6 p -113.69 128.92 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.578 0.704 . . . . 1.27 110.096 -175.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -105.13 115.2 29.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.276 -0.875 . . . . 1.02 109.078 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.808 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 37.0 ttp -102.99 127.22 50.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.461 -0.94 . . . . 2.4900000000000002 108.461 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.719 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.8 ptmt -154.5 141.39 19.18 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.135 -0.32 . . . . 1.5700000000000001 110.135 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' LEU . 31.3 ttmt -84.46 136.77 33.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.122 0.487 . . . . 2.1299999999999999 111.367 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -112.65 165.84 11.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.718 -0.845 . . . . 1.5700000000000001 108.718 169.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.94 29.99 6.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.59 . . . . 4.4100000000000001 111.139 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -76.51 79.84 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.625 -1.25 . . . . 2.5499999999999998 107.625 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.31 -88.37 0.33 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.121 -1.192 . . . . 2.6200000000000001 110.121 -167.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.7 83.9 0.46 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.217 -1.031 . . . . 2.7599999999999998 108.217 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 p -146.42 152.27 38.77 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.683 -0.689 . . . . 1.0700000000000001 109.394 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.477 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -115.95 158.39 23.12 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.27 -0.641 . . . . 0.85999999999999999 109.27 -170.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 83.6 m95 -101.59 110.09 22.02 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.963 -0.754 . . . . 0.63 108.963 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.741 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -102.73 110.52 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 122.029 0.918 . . . . 0.91000000000000003 110.041 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.719 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 94.0 m-85 -103.93 127.91 51.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.4 -0.818 . . . . 0.79000000000000004 111.17 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.28 104.8 17.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.787 0.803 . . . . 1.1799999999999999 111.072 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -118.99 119.73 35.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.432 -0.803 . . . . 3.3100000000000001 109.919 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.3 ttt180 -68.88 135.72 51.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.987 0.423 . . . . 4.0300000000000002 110.696 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 106' ' ' LYS . 2.6 m . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.262 -0.875 . . . . 2.8700000000000001 110.776 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 113.38 0.881 . . . . 3.8500000000000001 113.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' CG ' ' A' ' 43' ' ' ASN . . . -101.24 104.39 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.472 -0.87 . . . . 0.84999999999999998 112.717 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.61 109.15 18.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.261 -0.469 . . . . 0.70999999999999996 109.819 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 32' ' ' GLN . 18.9 mt -105.26 153.93 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.8 tt0 -113.57 110.1 19.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.686 -0.486 . . . . 0.85999999999999999 109.686 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 34.9 mt -111.98 150.36 30.68 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 109.45 -0.574 . . . . 1.6200000000000001 109.45 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 47.4 p30 -103.06 169.17 8.72 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.658 -0.417 . . . . 1.22 110.519 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.76 -14.67 16.34 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 113.922 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.65 -28.74 23.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.95 110.037 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.43 8.22 14.88 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.562 -0.744 . . . . 0.53000000000000003 111.443 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 90.1 m-20 -76.98 149.1 35.96 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.977 0.417 . . . . 1.3 110.744 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 42' ' ' TYR . 10.4 mt -92.87 153.68 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 58' ' ' ILE . 39.7 mt -122.67 -71.94 0.71 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.449 . . . . 1.45 110.189 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -125.71 136.36 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.399 0.619 . . . . 1.99 111.119 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -93.86 -176.0 3.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.936 -1.029 . . . . 1.25 111.005 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' CG ' ' HA2' ' A' ' 29' ' ' GLY . 7.8 p30 -125.05 -167.93 1.75 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.929 -1.032 . . . . 2.1299999999999999 109.764 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.32 -28.35 53.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.158 0.429 . . . . 1.48 112.158 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.78 75.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 1.52 111.52 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -34.81 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.623 -0.262 . . . . 2.1200000000000001 110.634 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 52' ' ' ARG . . . -61.6 -21.35 60.34 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 121.205 -0.521 . . . . 1.4199999999999999 112.828 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -71.57 -28.61 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 2.3500000000000001 110.436 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -91.68 81.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.733 0.778 . . . . 2.5899999999999999 109.734 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 50' ' ' THR . 5.8 t -11.22 105.78 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 112.716 -2.038 . . . . 3.4100000000000001 114.363 174.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.88 22.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.231 -1.349 . . . . 2.3199999999999998 112.32 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HG3' ' HE1' ' A' ' 42' ' ' TYR . 6.5 mpt_? -115.16 94.8 4.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.788 0.327 . . . . 3.1400000000000001 110.878 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 16.5 m-20 -88.35 148.06 41.56 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.173 -0.467 . . . . 2.1000000000000001 110.442 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.011 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 40.0 Cg_exo -58.06 -34.93 99.0 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.112 2.541 . . . . 1.6799999999999999 113.653 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -131.61 19.61 4.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.75 0.648 . . . . 3.6099999999999999 112.75 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.633 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.19 8.57 44.27 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.454 -0.498 . . . . 2.5 110.929 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -121.19 29.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.96999999999999997 111.863 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 40' ' ' LEU . 22.7 mt -81.35 134.28 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.635 -0.426 . . . . 1.0900000000000001 110.51 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.6 29.61 74.18 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.22 -0.752 . . . . 0.66000000000000003 111.22 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 39' ' ' ILE . 3.7 mtmm -126.6 125.51 42.07 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.161 -0.52 . . . . 1.8200000000000001 109.76 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' ASN . 10.1 t-20 -73.65 114.26 11.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.874 -0.603 . . . . 0.71999999999999997 111.219 -170.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 39' ' ' ILE . 90.6 t80 -56.47 -48.61 76.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.485 -0.78 . . . . 0.69999999999999996 111.146 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -79.94 5.25 14.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.011 -0.541 . . . . 1.1599999999999999 112.111 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -137.54 -53.16 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.028 0.381 . . . . 3.5800000000000001 112.028 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -96.42 -24.13 16.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.441 0.534 . . . . 2.2000000000000002 112.441 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.1 t -116.07 14.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 120.12 -0.632 . . . . 1.77 110.933 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.46 87.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.055 -0.52 . . . . 0.60999999999999999 110.342 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.45 -4.75 15.9 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.589 2.193 . . . . 0.81000000000000005 113.683 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -80.04 -13.62 59.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.227 -0.589 . . . . 0.84999999999999998 109.653 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -101.72 -4.23 26.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.821 -1.082 . . . . 1.3300000000000001 110.827 -157.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.07 95.63 6.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.918 -0.401 . . . . 1.8500000000000001 109.918 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.77 ' HB2' ' HD1' ' A' ' 75' ' ' PHE . 66.8 m -166.33 155.28 10.1 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.035 -0.728 . . . . 1.5600000000000001 109.035 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 31.0 Cg_endo -64.51 -20.87 66.22 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.456 2.104 . . . . 1.1699999999999999 112.04 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -91.79 -15.51 28.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 2.5600000000000001 111.5 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.77 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 87.7 m-85 -106.75 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.287 0.565 . . . . 3.3599999999999999 109.72 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 41.1 t80 -63.53 -37.4 87.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.3 -0.864 . . . . 0.79000000000000004 110.321 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -62.78 -27.37 69.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.108 -0.568 . . . . 0.59999999999999998 112.483 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 68.1 mmtt -80.35 -29.52 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.751 0.31 . . . . 2.0899999999999999 110.555 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 64.7 t80 -68.43 -35.66 77.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.848 -0.797 . . . . 0.67000000000000004 108.848 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -82.94 -3.82 57.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 111.239 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -53.68 -46.96 70.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.778 0.323 . . . . 2.0699999999999998 111.464 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.735 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -85.12 -42.84 6.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.086 -1.054 . . . . 0.71999999999999997 111.711 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 21.5 t -44.3 -49.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.667 0.787 . . . . 0.84999999999999998 112.031 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -42.42 38.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.862 0.465 . . . . 1.1399999999999999 111.953 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -77.46 -61.91 1.83 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.386 0.612 . . . . 1.8200000000000001 109.524 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.05 -54.16 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.503 -1.039 . . . . 1.6499999999999999 110.503 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 137.21 2.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.286 -0.957 . . . . 3.5 109.289 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.735 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 63.1 tp -165.89 125.18 1.65 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.868 -0.333 . . . . 2.96 111.514 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.56 131.56 44.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 2.2400000000000002 110.514 173.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 t -141.66 155.35 45.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.551 -0.75 . . . . 1.6299999999999999 109.888 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.4 ttp -130.27 119.35 22.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.83 -0.623 . . . . 1.77 110.512 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -130.72 155.01 47.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.085 -0.709 . . . . 3.0099999999999998 109.085 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 136.41 54.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.073 0.463 . . . . 2.3900000000000001 111.007 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.823 ' HD1' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -162.16 168.86 21.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.056 -0.52 . . . . 3.3700000000000001 110.418 -175.173 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.823 ' H ' ' HD1' ' A' ' 94' ' ' TYR . 25.6 m -102.53 143.29 32.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.3999999999999999 111.237 -173.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -107.35 112.31 25.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.745 -0.835 . . . . 1.1799999999999999 108.745 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.76 14.12 13.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.294 0.479 . . . . 2.5699999999999998 112.294 -171.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 85.4 t80 -119.34 131.61 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.622 -0.51 . . . . 3.21 109.622 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.558 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 21.6 mm-40 75.51 -43.25 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.65 0.78 . . . . 3.23 110.477 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 tpt -105.88 142.03 36.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.505 -0.924 . . . . 2.8500000000000001 108.505 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.456 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -62.96 141.04 97.61 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.868 -1.16 . . . . 2.1200000000000001 107.868 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 51.0 Cg_exo -36.5 91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.78 2.987 . . . . 1.47 114.703 -173.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 t -108.9 146.57 33.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.903 -0.589 . . . . 1.3999999999999999 109.747 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -106.51 125.02 50.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.148 0.499 . . . . 3.0800000000000001 111.182 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 29.6 m -121.17 166.19 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 1.3300000000000001 111.079 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 36.2 ttpt -118.64 121.47 40.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.312 -0.996 . . . . 1.6899999999999999 108.312 174.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.6 103.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.905 -0.589 . . . . 1.27 109.499 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -105.55 102.13 11.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.673 -0.862 . . . . 1.02 108.673 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.44 149.81 25.83 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.863 -0.335 . . . . 2.4900000000000002 110.356 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 8.8 mtpm? -146.62 147.19 30.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.203 -0.666 . . . . 1.5700000000000001 109.203 -175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 1.2 tmmt? -87.18 137.48 32.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.266 0.555 . . . . 2.1299999999999999 111.154 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -140.33 -176.12 4.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.027 -1.101 . . . . 1.5700000000000001 108.027 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.11 -93.94 0.14 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.84 -0.8 . . . . 4.4100000000000001 108.84 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.6 p 42.89 38.96 1.55 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.231 0.826 . . . . 2.5499999999999998 113.231 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.57 15.64 20.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.614 -0.803 . . . . 2.6200000000000001 113.032 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 63.94 87.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.049 0.54 . . . . 2.7599999999999998 110.507 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 p -173.74 -176.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 1.0700000000000001 110.726 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.547 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 42.0 m-85 -121.05 147.59 45.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.996 -0.742 . . . . 0.85999999999999999 108.996 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.406 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 62.6 m95 -102.59 104.2 14.56 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.575 -0.898 . . . . 0.63 108.575 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 109' ' ' MET . 7.3 p -100.52 132.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.976 -1.011 . . . . 0.91000000000000003 111.417 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.84 113.88 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.406 -0.815 . . . . 0.79000000000000004 109.847 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -113.09 104.52 17.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 1.1799999999999999 110.31 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 159.39 42.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.388 -0.597 . . . . 3.3100000000000001 109.388 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 29.9 mtm180 -69.54 105.32 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.863 0.363 . . . . 4.0300000000000002 111.107 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 106' ' ' LYS . 11.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.879 -1.055 . . . . 2.8700000000000001 111.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.664 -0.495 . . . . 3.8500000000000001 109.664 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.69 119.74 6.46 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.464 -0.874 . . . . 0.84999999999999998 111.845 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.65 103.63 13.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.119 0.485 . . . . 0.70999999999999996 110.093 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.772 ' HB ' HG13 ' A' ' 120' ' ' VAL . 31.5 mt -108.2 159.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.203 -1.036 . . . . 1.0800000000000001 108.203 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' A' ' 113' ' ' LEU . 45.3 tt0 -133.42 134.16 43.28 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.618 -0.433 . . . . 0.85999999999999999 110.317 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.93 161.89 38.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.977 -0.556 . . . . 1.6200000000000001 110.536 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.667 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.5 p30 -103.93 169.09 8.71 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.062 -0.255 . . . . 1.22 110.741 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.65 -27.54 27.54 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 115.323 0.889 . . . . 0.79000000000000004 115.323 -170.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.96 -10.39 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.818 0.809 . . . . 1.95 111.263 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.41 2.19 21.48 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.359 -0.924 . . . . 0.53000000000000003 113.611 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.667 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 91.1 m-20 -71.06 126.7 30.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.191 0.496 . . . . 1.3 110.443 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 42' ' ' TYR . 17.2 mt -84.06 150.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.446 . . . . 0.89000000000000001 109.97 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.9 mp -110.03 -54.22 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.249 0.547 . . . . 1.45 109.942 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -166.22 149.14 7.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.215 -0.902 . . . . 1.99 110.785 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.787 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 8.9 m-30 -98.4 -176.89 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.241 -0.891 . . . . 1.25 110.641 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -112.37 163.99 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.494 -0.928 . . . . 2.1299999999999999 108.494 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.62 -27.6 17.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.48 111.474 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -46.14 -54.14 9.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.152 -0.931 . . . . 1.52 112.51 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' HD11 ' A' ' 31' ' ' ILE . 16.2 mm-40 -75.25 -29.92 60.35 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.961 0.41 . . . . 2.1200000000000001 110.922 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 -22.6 68.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.849 -0.691 . . . . 1.4199999999999999 111.635 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -87.81 -35.07 18.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.607 0.241 . . . . 2.3500000000000001 110.69 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 45' ' ' ALA . 45.9 mm -53.04 -54.03 19.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.142 0.496 . . . . 2.5899999999999999 110.249 176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 51' ' ' GLY . 5.9 t -140.08 -41.38 0.43 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 3.4100000000000001 111.041 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 50' ' ' THR . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.408 -0.901 . . . . 2.3199999999999998 111.734 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -113.78 99.53 7.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.002 -0.74 . . . . 3.1400000000000001 109.002 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.664 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 18.9 t70 -54.8 127.62 61.38 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.481 0.488 . . . . 2.1000000000000001 110.728 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.787 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 41.7 Cg_exo -59.16 -17.64 39.92 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.583 2.855 . . . . 1.6799999999999999 113.855 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -94.73 -1.83 52.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.758 0.313 . . . . 3.6099999999999999 111.025 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.664 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 54.7 mm-40 -102.64 5.24 39.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.12 0.486 . . . . 2.5 110.588 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.597 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.4 m -117.27 14.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.96999999999999997 111.654 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 40.0 mt -80.26 125.73 39.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.406 -0.517 . . . . 1.0900000000000001 110.407 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.3 10.52 78.81 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.843 -0.903 . . . . 0.66000000000000003 110.843 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.889 ' HD3' ' HB ' ' A' ' 66' ' ' VAL . 23.3 ttmt -104.88 135.72 45.72 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.64 -0.504 . . . . 1.8200000000000001 109.64 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -83.49 117.74 23.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.234 -0.439 . . . . 0.71999999999999997 111.491 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 57.8 t80 -72.11 0.63 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.799 -0.637 . . . . 0.69999999999999996 111.669 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 82.0 m-85 -116.74 -9.76 11.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.081 -0.387 . . . . 1.1599999999999999 111.222 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.3 -38.47 0.76 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.73 0.641 . . . . 3.5800000000000001 112.73 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 22.8 m-20 -90.43 -87.56 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.928 0.344 . . . . 2.2000000000000002 111.928 -174.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.889 ' HB ' ' HD3' ' A' ' 60' ' ' LYS . 6.4 p -83.16 14.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.992 0.901 . . . . 1.77 111.616 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.77 86.23 0.46 Allowed Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.486 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -90.8 4.38 4.39 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.365 2.044 . . . . 0.81000000000000005 113.597 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 11.4 p -84.65 -15.62 44.79 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 120.494 -0.483 . . . . 0.84999999999999998 110.152 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 6.8 p -87.46 -39.68 15.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.215 -1.357 . . . . 1.3300000000000001 111.048 -160.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -51.89 108.54 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.966 -0.561 . . . . 1.8500000000000001 110.784 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -161.74 149.63 12.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.5600000000000001 109.902 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.13 -26.25 82.29 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.379 2.053 . . . . 1.1699999999999999 111.409 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 13.9 pt-20 -96.91 1.29 50.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.851 -0.613 . . . . 2.5600000000000001 111.912 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' HD2' ' HE1' ' A' ' 92' ' ' PHE . 67.0 t80 -127.3 -70.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 3.3599999999999999 109.597 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.604 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 64.4 t80 -61.41 -38.39 86.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 0.79000000000000004 110.002 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.66 -34.98 91.41 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.054 -0.593 . . . . 0.59999999999999998 112.674 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HD2' ' O ' ' A' ' 74' ' ' GLU . 92.7 mttt -80.46 -31.18 37.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.311 0.577 . . . . 2.0899999999999999 110.093 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.774 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 72.8 t80 -61.27 -32.22 72.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.67000000000000004 110.377 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 13.2 mmmm -95.75 -5.48 41.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 1.0900000000000001 110.879 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -59.96 -52.93 63.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 2.0699999999999998 110.738 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -72.85 -27.9 68.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.57 -0.824 . . . . 0.71999999999999997 112.245 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.34 -54.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.84999999999999998 110.794 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.6 70.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.576 . . . . 1.1399999999999999 110.566 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.0 m -74.04 -86.05 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.7 -0.682 . . . . 1.8200000000000001 110.05 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.4 -64.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.971 -0.852 . . . . 1.6499999999999999 110.971 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -92.37 132.72 36.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.801 -0.7 . . . . 3.5 110.182 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.1 tm? -110.26 105.5 14.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.943 -0.762 . . . . 2.96 108.943 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' MET . 22.7 p-10 -164.41 58.03 0.15 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.625 0.726 . . . . 2.2400000000000002 110.665 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -104.47 155.4 18.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.6299999999999999 110.499 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -128.96 124.15 34.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.611 -0.722 . . . . 1.77 110.024 177.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 50.5 p90 -144.23 168.1 20.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.507 -0.315 . . . . 3.0099999999999998 110.967 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -103.3 133.04 49.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.053 -0.521 . . . . 2.3900000000000001 110.087 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -149.44 166.48 28.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.026 -0.731 . . . . 3.3700000000000001 109.026 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -104.91 159.23 15.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.858 0.688 . . . . 1.3999999999999999 112.858 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -111.26 120.6 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.219 -0.66 . . . . 1.1799999999999999 109.219 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 21.5 t70 -133.92 -152.46 0.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.798 -0.816 . . . . 2.5699999999999998 108.798 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 40.4 t80 71.41 -68.1 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.956 0.503 . . . . 3.21 111.753 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.457 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 2.5 pp0? -112.24 -4.43 14.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.137 0.494 . . . . 3.23 110.755 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.6 tpp -126.92 143.8 51.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.723 -0.671 . . . . 2.8500000000000001 110.372 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -54.69 128.37 62.09 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.199 -1.037 . . . . 2.1200000000000001 108.199 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.1 90.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.547 2.831 . . . . 1.47 113.168 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.5 158.1 16.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.174 -0.921 . . . . 1.3999999999999999 110.701 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.957 ' HE2' ' HB ' ' A' ' 125' ' ' VAL . 18.1 ptmt -106.25 127.56 53.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 3.0800000000000001 111.387 -175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 122' ' ' VAL . 11.5 p -125.0 151.99 31.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.591 -0.731 . . . . 1.3300000000000001 110.353 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 105' ' ' VAL . 82.8 tttt -110.21 119.39 39.12 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.417 -0.957 . . . . 1.6899999999999999 108.417 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.9 p -112.34 129.74 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.453 0.644 . . . . 1.27 111.241 -171.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.71 104.59 12.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.005 -1.109 . . . . 1.02 108.005 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 9.7 ptp -103.41 129.31 50.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.273 -0.421 . . . . 2.4900000000000002 110.628 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 59.6 mtpt -138.72 126.16 21.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.484 0.659 . . . . 1.5700000000000001 112.651 -168.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 25.3 tttp -70.36 114.63 8.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.51 1.124 . . . . 2.1299999999999999 111.498 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -177.8 93.67 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.535 0.939 . . . . 1.5700000000000001 113.535 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.638 ' HB2' HE22 ' A' ' 32' ' ' GLN . 28.7 tp 177.68 86.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.433 0.531 . . . . 4.4100000000000001 112.433 165.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 m 41.68 38.78 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.598 1.186 . . . . 2.5499999999999998 112.292 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.77 -123.96 1.23 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.931 -1.128 . . . . 2.6200000000000001 112.012 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.02 35.29 1.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.7599999999999998 111.059 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 p -100.36 135.33 41.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.95 -0.568 . . . . 1.0700000000000001 109.744 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.606 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 2.0 m-85 -109.37 161.33 15.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.775 -0.454 . . . . 0.85999999999999999 109.775 -169.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 109' ' ' MET . 88.9 m95 -100.92 114.72 28.86 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.689 -0.856 . . . . 0.63 108.689 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.3 p -100.2 115.34 41.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.128 0.966 . . . . 0.91000000000000003 110.207 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.91 123.38 46.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.246 -0.888 . . . . 0.79000000000000004 111.146 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.79 HG13 HG21 ' A' ' 105' ' ' VAL . 66.3 t -104.7 105.62 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.122 -0.945 . . . . 1.1799999999999999 110.99 -176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -131.58 131.04 42.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.849 0.357 . . . . 3.3100000000000001 110.249 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.462 ' C ' ' HD2' ' A' ' 124' ' ' ARG . 7.4 ppt_? -72.88 157.41 37.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 4.0300000000000002 111.661 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.957 ' HB ' ' HE2' ' A' ' 104' ' ' LYS . 25.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.67 -0.681 . . . . 2.8700000000000001 109.166 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.619 0.247 . . . . 3.8500000000000001 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -103.68 132.82 11.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.59 -0.814 . . . . 0.84999999999999998 111.497 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -132.04 134.03 45.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.70999999999999996 109.635 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 120' ' ' VAL . 4.8 mp -128.01 144.43 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 109.775 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 40.4 tt0 -104.51 118.66 37.14 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.94 -1.133 . . . . 0.85999999999999999 107.94 170.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.4 pt? -130.1 150.14 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.43 -0.508 . . . . 1.6200000000000001 110.662 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -103.43 168.39 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.862 -0.421 . . . . 1.22 109.862 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.39 -29.05 22.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.381 0.512 . . . . 0.79000000000000004 114.381 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -75.2 -21.14 58.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.275 0.537 . . . . 1.95 111.324 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.14 4.44 38.43 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.898 -0.668 . . . . 0.53000000000000003 111.916 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.8 m-20 -77.23 141.18 40.15 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.978 -0.378 . . . . 1.3 109.978 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.5 mt -88.75 144.77 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.263 0.554 . . . . 0.89000000000000001 110.381 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -99.89 -59.29 1.74 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.264 -0.88 . . . . 1.45 110.227 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -165.13 153.06 11.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.757 -1.11 . . . . 1.99 110.027 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 4.7 m-30 -97.46 156.63 16.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 1.25 110.367 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.935 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 64.0 t30 -74.76 10.73 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.919 -0.582 . . . . 2.1299999999999999 111.104 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' TYR . . . 75.72 -42.34 0.46 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.896 -1.047 . . . . 1.48 112.213 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -56.87 -24.78 54.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.555 0.576 . . . . 1.52 112.555 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.75 -18.68 64.26 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.18 0.514 . . . . 2.1200000000000001 110.944 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.59 -7.6 78.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.613 -0.803 . . . . 1.4199999999999999 111.861 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.57 -46.87 5.57 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 2.3500000000000001 109.204 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 45' ' ' ALA . 30.8 mm -66.34 -67.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.419 -0.81 . . . . 2.5899999999999999 110.714 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 m -92.71 -56.97 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.479 -0.328 . . . . 3.4100000000000001 110.984 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.72 42.12 0.25 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.683 -0.77 . . . . 2.3199999999999998 112.156 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mmt180 -108.29 127.89 54.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.31 -0.256 . . . . 3.1400000000000001 110.31 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 56' ' ' GLN . 12.2 t70 -65.9 132.68 94.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 2.1000000000000001 110.306 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 7.3 Cg_exo -73.62 -12.88 24.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.986 2.457 . . . . 1.6799999999999999 114.209 -172.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -130.23 -7.45 4.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.605 0.965 . . . . 3.6099999999999999 113.605 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.576 ' HG2' ' CG ' ' A' ' 53' ' ' ASP . 77.6 mm-40 -75.23 -13.18 60.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.264 -0.575 . . . . 2.5 110.864 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.4 m -88.49 14.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.4 0.889 . . . . 0.96999999999999997 113.4 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' LEU . 38.6 mt -81.99 131.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.177 -0.609 . . . . 1.0900000000000001 110.131 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.34 26.63 72.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.011 -0.836 . . . . 0.66000000000000003 111.011 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -121.5 134.46 55.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.964 -0.618 . . . . 1.8200000000000001 110.177 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.4 114.66 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.79 0.329 . . . . 0.71999999999999997 110.297 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.73 -40.93 69.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.69999999999999996 111.389 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.604 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 72.2 m-85 -80.56 3.66 21.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.351 -0.386 . . . . 1.1599999999999999 111.534 -173.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -121.84 -51.65 2.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.48 -0.563 . . . . 3.5800000000000001 109.48 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -78.34 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 2.2000000000000002 112.155 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.0 t -96.22 16.38 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.794 0.33 . . . . 1.77 111.853 -168.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.99 77.2 0.74 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 121.989 -0.444 . . . . 0.60999999999999999 112.014 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -97.61 28.45 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.084 2.523 . . . . 0.81000000000000005 113.208 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.6 p -120.71 22.96 10.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.539 -0.541 . . . . 0.84999999999999998 109.539 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.9 m -136.58 -44.34 0.6 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.062 -1.426 . . . . 1.3300000000000001 109.41 -133.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 11.2 p-10 -68.98 119.88 13.97 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.207 -0.664 . . . . 1.8500000000000001 109.207 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -168.99 161.58 7.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.78 -0.645 . . . . 1.5600000000000001 109.743 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.96 -31.11 91.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.36 2.04 . . . . 1.1699999999999999 112.868 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.7 -4.66 54.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 2.5600000000000001 112.072 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -124.77 -70.82 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.181 -0.303 . . . . 3.3599999999999999 110.181 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 93.8 t80 -60.44 -39.44 87.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 0.79000000000000004 110.284 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.11 -40.19 98.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.979 -0.629 . . . . 0.59999999999999998 112.219 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 74.0 mmtt -73.56 -26.14 60.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 2.0899999999999999 110.32 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -67.38 -35.49 79.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 110.276 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -84.5 -14.89 47.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.994 -0.548 . . . . 1.0900000000000001 110.98 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 49.8 mm-40 -54.48 -52.28 62.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.154 0.502 . . . . 2.0699999999999998 111.016 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.525 ' H ' HD13 ' A' ' 88' ' ' LEU . . . -72.19 -33.34 62.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.71999999999999997 112.213 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' OH ' ' A' ' 118' ' ' TYR . 23.1 t -61.7 -51.61 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.84999999999999998 110.646 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.2 -21.7 66.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.843 -0.617 . . . . 1.1399999999999999 111.881 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -96.41 -77.57 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 1.8200000000000001 110.875 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.49 -77.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.5 -0.64 . . . . 1.6499999999999999 111.5 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.637 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.8 p30 -95.24 144.88 25.47 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.543 -0.54 . . . . 3.5 109.543 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 82' ' ' GLY . 54.6 tp -120.18 102.63 8.64 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.714 -0.476 . . . . 2.96 109.714 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 109' ' ' MET . 39.1 m-80 -148.65 97.41 2.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.017 -0.734 . . . . 2.2400000000000002 109.017 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -149.19 165.14 32.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.787 -0.642 . . . . 1.6299999999999999 110.496 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 ptp -132.97 129.58 38.41 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.828 -0.623 . . . . 1.77 109.972 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 45.5 p90 -146.51 165.25 30.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.023 -0.362 . . . . 3.0099999999999998 110.023 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -109.19 122.08 46.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 2.3900000000000001 110.971 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -131.83 153.84 49.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.792 -0.64 . . . . 3.3700000000000001 109.885 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 m -104.76 145.62 30.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.3999999999999999 110.458 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.43 104.63 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.995 -0.372 . . . . 1.1799999999999999 109.995 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 9.1 p-10 -135.13 115.08 13.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.473 0.654 . . . . 2.5699999999999998 110.885 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 63.2 t80 -179.91 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.94 -1.027 . . . . 3.21 109.188 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -92.32 -35.87 13.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.905 -0.776 . . . . 3.23 108.905 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.28 144.17 25.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.131 -1.063 . . . . 2.8500000000000001 108.131 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.59 160.31 53.64 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 109.664 -0.495 . . . . 2.1200000000000001 109.664 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 50.3 Cg_exo -54.74 84.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 1.47 114.418 -171.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 p -102.13 147.7 26.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.291 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -121.24 130.36 53.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.007 -0.368 . . . . 3.0800000000000001 110.007 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 124' ' ' ARG . 35.8 m -122.87 164.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.175 0.512 . . . . 1.3300000000000001 111.658 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -104.25 111.72 24.45 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.837 -1.542 . . . . 1.6899999999999999 106.837 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 91' ' ' MET . 14.6 p -104.27 136.64 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-O 121.329 0.585 . . . . 1.27 109.701 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -111.95 114.33 27.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.647 -0.872 . . . . 1.02 108.647 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.2 tpp -100.39 133.68 44.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.46 -0.791 . . . . 2.4900000000000002 109.079 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 118' ' ' TYR . 12.2 mmmm -135.67 159.63 41.02 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.819 -0.808 . . . . 1.5700000000000001 108.819 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 64.7 tttp -104.86 121.05 42.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.126 0.489 . . . . 2.1299999999999999 111.657 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.624 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -107.91 99.02 8.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.694 -0.685 . . . . 1.5700000000000001 109.938 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.66 -19.54 62.08 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.595 -0.52 . . . . 4.4100000000000001 109.595 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 m -73.34 80.81 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.543 -0.753 . . . . 2.5499999999999998 110.174 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.05 9.18 13.84 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.524 -0.846 . . . . 2.6200000000000001 112.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 55.95 41.34 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.896 0.379 . . . . 2.7599999999999998 111.662 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -134.77 -167.14 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.514 -0.312 . . . . 1.0700000000000001 110.828 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.702 ' OH ' HG22 ' A' ' 83' ' ' VAL . 82.4 m-85 -135.55 153.51 51.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.003 -0.74 . . . . 0.85999999999999999 109.003 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 47.9 m95 -102.72 104.13 14.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.958 -0.756 . . . . 0.63 108.958 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 31' ' ' ILE . 11.6 p -100.34 125.66 54.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.108 0.956 . . . . 0.91000000000000003 111.39 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.73 137.06 54.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.894 -1.048 . . . . 0.79000000000000004 108.989 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 29' ' ' GLY . 27.0 m -104.69 141.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.093 -0.643 . . . . 1.1799999999999999 111.567 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -124.23 103.54 8.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.306 -0.861 . . . . 3.3100000000000001 109.257 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 15.0 ptm180 -75.05 120.78 21.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.506 -0.315 . . . . 4.0300000000000002 110.268 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.712 1.258 . . . . 2.8700000000000001 113.417 -174.025 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 121.673 0.749 . . . . 3.8500000000000001 112.137 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.42 123.49 7.88 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 0.84999999999999998 110.023 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -116.79 103.94 10.84 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.966 -0.294 . . . . 0.70999999999999996 110.362 -170.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 53.2 mt -108.7 114.34 46.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.971 -0.559 . . . . 1.0800000000000001 109.56 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -101.45 114.34 28.26 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.624 -0.88 . . . . 0.85999999999999999 108.624 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.24 160.53 34.61 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.632 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.4 169.88 8.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 1.22 110.574 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.28 -23.69 26.86 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 114.521 0.568 . . . . 0.79000000000000004 114.521 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -37.35 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.337 0.569 . . . . 1.95 110.751 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 128.96 11.3 2.9 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.479 -0.867 . . . . 0.53000000000000003 113.285 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -71.14 127.19 31.75 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.366 0.583 . . . . 1.3 109.727 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 16.2 mt -81.52 151.36 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.309 -0.626 . . . . 0.89000000000000001 109.309 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 58' ' ' ILE . 77.7 mt -129.82 -67.46 0.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.459 0.647 . . . . 1.45 110.115 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 63.2 mt-30 -112.61 138.38 49.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.633 -0.712 . . . . 1.99 110.347 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.832 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -118.41 -4.07 10.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.703 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 66.2 t30 63.23 172.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.538 -0.756 . . . . 2.1299999999999999 110.577 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 11.2 6.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 1.48 110.882 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -92.51 -63.78 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.229 -0.442 . . . . 1.52 111.472 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.26 -43.79 83.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 110.985 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA2' ' C ' ' A' ' 51' ' ' GLY . . . -68.82 -10.06 60.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.576 -0.821 . . . . 1.4199999999999999 113.148 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.15 -41.91 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.122 0.461 . . . . 2.3500000000000001 110.559 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 45' ' ' ALA . 6.1 pt -85.92 -47.56 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 112.296 0.48 . . . . 2.5899999999999999 112.296 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.7 p -105.82 -49.33 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.976 -0.453 . . . . 3.4100000000000001 111.175 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' ' HA2' ' A' ' 47' ' ' GLY . . . 139.91 -175.25 21.95 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.222 -0.751 . . . . 2.3199999999999998 111.222 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.704 ' HG2' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 71.57 99.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 3.1400000000000001 111.407 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 3.6 m-20 -67.97 149.4 98.2 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 108.97 -0.752 . . . . 2.1000000000000001 108.97 171.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.832 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 10.3 Cg_endo -52.52 -31.78 50.43 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.788 2.325 . . . . 1.6799999999999999 111.938 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -71.35 -19.13 62.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.361 -0.836 . . . . 3.6099999999999999 111.46 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 15.3 mm-40 -94.97 -14.49 24.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 2.5 111.73 -171.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.694 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -111.23 18.93 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 113.033 0.753 . . . . 0.96999999999999997 113.033 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.732 HG22 ' HA ' ' A' ' 40' ' ' LEU . 8.3 pt -87.51 140.09 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.438 -0.505 . . . . 1.0900000000000001 110.586 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.72 10.04 71.03 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.223 -0.989 . . . . 0.66000000000000003 110.901 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 39' ' ' ILE . 87.1 mttt -114.71 135.99 53.55 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.761 -0.459 . . . . 1.8200000000000001 109.761 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 21.8 t-20 -81.62 115.78 21.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.146 -0.479 . . . . 0.71999999999999997 110.021 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 39' ' ' ILE . 48.1 t80 -50.73 -37.91 44.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.69999999999999996 111.618 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 38.2 m-85 -90.38 15.14 11.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.382 -0.372 . . . . 1.1599999999999999 111.577 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -148.66 -49.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 3.5800000000000001 111.716 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.03 -21.88 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.165 0.802 . . . . 2.2000000000000002 113.165 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 52' ' ' ARG . 5.4 p -149.58 14.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.357 -0.937 . . . . 1.77 112.82 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.25 94.52 0.43 Allowed Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.043 -0.526 . . . . 0.60999999999999999 111.703 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.02 -18.88 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.618 2.212 . . . . 0.81000000000000005 112.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -12.03 48.78 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.142 -0.223 . . . . 0.84999999999999998 111.223 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 67' ' ' ALA . 10.9 t -82.56 -27.73 31.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.697 -0.401 . . . . 1.3300000000000001 110.854 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 19.1 t70 -67.05 110.36 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.217 -0.66 . . . . 1.8500000000000001 109.217 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -164.12 148.94 8.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.178 -0.464 . . . . 1.5600000000000001 109.791 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.81 -21.59 64.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.691 2.261 . . . . 1.1699999999999999 113.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.97 -21.59 19.69 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.97 -0.292 . . . . 2.5600000000000001 111.573 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 50.2 t80 -107.46 -72.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.767 0.317 . . . . 3.3599999999999999 110.176 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.69 -38.9 79.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.132 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.04 -40.25 93.17 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.59999999999999998 112.546 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 58.1 mttm -87.91 -21.95 24.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 2.0899999999999999 111.426 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.678 ' O ' HG23 ' A' ' 83' ' ' VAL . 84.6 t80 -62.17 -49.65 74.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.62 -0.882 . . . . 0.67000000000000004 108.62 170.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.43 -20.16 60.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.825 -1.08 . . . . 1.0900000000000001 110.309 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 30.3 tt0 -57.37 -36.72 71.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 2.0699999999999998 109.693 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.97 -32.62 8.84 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.611 -0.722 . . . . 0.71999999999999997 112.187 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.1 t -59.9 -53.04 54.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.59 0.219 . . . . 0.84999999999999998 111.59 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.83 -59.37 4.59 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.423 0.452 . . . . 1.1399999999999999 111.535 -175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.2 p -167.11 29.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.306 . . . . 1.8200000000000001 111.561 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.17 -10.71 19.88 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.53 -1.319 . . . . 1.6499999999999999 113.069 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 63.77 124.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.409 -0.589 . . . . 3.5 109.409 -169.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 118' ' ' TYR . 32.9 tp -103.67 104.19 14.2 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.655 -0.818 . . . . 2.96 111.432 -166.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.3 p-10 -165.03 104.68 0.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.497 1.142 . . . . 2.2400000000000002 109.429 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -165.41 166.63 18.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.996 -1.456 . . . . 1.6299999999999999 108.514 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.5 ptt? -133.25 122.22 23.61 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.072 0.463 . . . . 1.77 110.304 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -124.3 167.48 14.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.149 -0.478 . . . . 3.0099999999999998 110.41 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -102.59 119.32 38.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.748 -0.464 . . . . 2.3900000000000001 109.748 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -133.96 153.82 51.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 3.3700000000000001 110.319 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 p -104.45 150.49 24.51 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.72 0.295 . . . . 1.3999999999999999 111.295 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -130.22 116.41 18.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.438 . . . . 1.1799999999999999 110.319 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' MET . 8.0 p-10 -124.54 -158.53 0.83 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.504 -0.771 . . . . 2.5699999999999998 109.238 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 67.1 t80 70.96 -74.64 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.685 0.394 . . . . 3.21 111.474 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.507 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 26.3 mm-40 -92.55 4.2 54.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.695 0.759 . . . . 3.23 110.357 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 tpt -150.0 152.0 34.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.659 -1.155 . . . . 2.8500000000000001 108.243 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 100' ' ' MET . 13.7 p -63.38 147.79 94.55 Favored Pre-proline 0 N--CA 1.443 -0.809 0 N-CA-C 108.069 -1.086 . . . . 2.1200000000000001 108.069 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.9 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.191 . . . . 1.47 112.649 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -99.51 149.22 23.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.931 -0.577 . . . . 1.3999999999999999 110.798 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -103.85 118.57 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.198 -0.667 . . . . 3.0800000000000001 109.198 174.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.5 m -123.05 163.73 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.592 0.711 . . . . 1.3300000000000001 111.616 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -110.79 114.88 28.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.905 -1.146 . . . . 1.6899999999999999 107.905 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.646 HG22 HG12 ' A' ' 122' ' ' VAL . 41.5 t -107.34 115.79 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.208 -0.451 . . . . 1.27 110.055 -168.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -104.27 109.03 20.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.658 -0.497 . . . . 1.02 109.658 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.691 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -103.97 134.32 47.45 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.842 -0.617 . . . . 2.4900000000000002 109.489 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -147.95 150.15 33.51 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.204 -0.295 . . . . 1.5700000000000001 110.204 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.515 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 42.9 tttm -87.01 128.72 35.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.667 0.27 . . . . 2.1299999999999999 111.037 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.34 127.65 30.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 1.5700000000000001 110.066 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.19 94.58 5.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.927 0.87 . . . . 4.4100000000000001 112.692 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t -113.47 -62.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 104.3 -2.482 . . . . 2.5499999999999998 104.3 160.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.62 143.86 17.06 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 106.626 -2.59 . . . . 2.6200000000000001 106.626 151.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.92 100.14 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.661 1.231 . . . . 2.7599999999999998 111.12 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -156.7 -177.79 6.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.875 -1.057 . . . . 1.0700000000000001 109.003 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.515 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 9.0 m-85 -128.85 154.18 46.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.715 -0.846 . . . . 0.85999999999999999 108.715 -175.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 60.8 m95 -100.74 104.13 15.4 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.237 -1.023 . . . . 0.63 108.237 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.617 HG22 ' CB ' ' A' ' 109' ' ' MET . 47.9 t -101.8 104.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.889 -1.05 . . . . 0.91000000000000003 109.585 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 81.0 m-85 -103.16 138.64 39.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.79000000000000004 110.608 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.646 HG12 HG22 ' A' ' 107' ' ' VAL . 16.6 m -107.35 153.22 8.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.944 0.402 . . . . 1.1799999999999999 111.138 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -149.77 112.38 4.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.942 -0.572 . . . . 3.3100000000000001 110.186 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.651 ' HA ' HG12 ' A' ' 105' ' ' VAL . 20.5 ttt180 -73.1 145.34 46.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 4.0300000000000002 110.808 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 125' ' ' VAL . 3.2 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.153 -0.927 . . . . 2.8700000000000001 110.824 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.746 0.784 . . . . 3.8500000000000001 112.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.22 107.39 2.94 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.925 -0.87 . . . . 0.84999999999999998 110.925 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.55 128.82 51.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.70999999999999996 110.809 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 46' ' ' GLU . 57.5 mt -122.26 138.89 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.228 -0.656 . . . . 1.0800000000000001 109.228 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.6 tt0 -104.68 121.13 42.93 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.192 -0.67 . . . . 0.85999999999999999 109.192 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -137.01 153.74 50.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 1.6200000000000001 109.891 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 169.62 8.41 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.85 -0.34 . . . . 1.22 110.655 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.63 -22.59 8.46 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 115.313 0.885 . . . . 0.79000000000000004 115.313 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.36 -21.93 38.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.756 0.778 . . . . 1.95 110.638 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.88 3.94 31.76 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.093 -0.803 . . . . 0.53000000000000003 111.093 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.654 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.1 m120 -70.24 134.84 48.43 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.054 0.454 . . . . 1.3 110.705 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.1 mt -87.24 148.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.422 -0.808 . . . . 0.89000000000000001 110.015 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 32' ' ' GLN . 42.2 mt -117.69 -61.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.271 0.557 . . . . 1.45 110.516 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.8 136.89 18.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.389 0.614 . . . . 1.99 111.248 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.024 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -92.5 153.1 19.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.899 -1.046 . . . . 1.25 110.77 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -88.04 166.22 14.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.5 60.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.137 0.421 . . . . 1.48 112.137 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.07 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.751 0.278 . . . . 1.52 111.751 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG2' HD11 ' A' ' 31' ' ' ILE . 6.3 tp10 -72.46 -4.86 32.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.575 0.702 . . . . 2.1200000000000001 110.435 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.41 -54.12 0.62 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.486 -0.779 . . . . 1.4199999999999999 112.282 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.07 -38.36 61.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.984 0.421 . . . . 2.3500000000000001 111.36 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -81.78 -57.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 2.5899999999999999 109.823 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.4 m -57.42 -52.35 65.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.22 -0.9 . . . . 3.4100000000000001 112.032 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.73 42.77 0.92 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.625 -0.798 . . . . 2.3199999999999998 111.814 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -133.46 171.74 13.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.684 -0.488 . . . . 3.1400000000000001 109.684 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.804 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 16.1 t70 -105.76 130.93 22.24 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.701 -0.481 . . . . 2.1000000000000001 109.701 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.024 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 50.3 Cg_exo -55.02 -20.25 22.72 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.488 2.792 . . . . 1.6799999999999999 114.186 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -119.32 15.13 13.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.195 0.443 . . . . 3.6099999999999999 112.195 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.804 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 23.1 mm-40 -86.23 -13.23 47.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 2.5 110.161 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 57' ' ' VAL . 4.6 m -89.91 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.606 -0.724 . . . . 0.96999999999999997 112.179 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.2 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.641 -0.423 . . . . 1.0900000000000001 110.721 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 18.92 76.95 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.254 -0.738 . . . . 0.66000000000000003 111.254 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -124.25 151.79 43.75 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.623 0.249 . . . . 1.8200000000000001 111.084 -170.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -105.71 122.04 45.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.71999999999999997 109.416 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.7 t80 -54.09 -43.75 70.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.005 -0.543 . . . . 0.69999999999999996 111.733 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 70.9 m-85 -77.5 -5.41 49.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 1.1599999999999999 111.719 -172.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -128.37 -48.05 1.31 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.13 0.419 . . . . 3.5800000000000001 112.13 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -92.88 -22.54 19.2 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.483 0.549 . . . . 2.2000000000000002 112.483 -172.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.14 13.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.171 -0.612 . . . . 1.77 111.477 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.81 74.58 0.17 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.748 0.309 . . . . 0.60999999999999999 111.023 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.2 -4.1 11.05 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.766 2.311 . . . . 0.81000000000000005 113.64 -176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 p -113.1 18.24 18.15 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.096 -0.377 . . . . 0.84999999999999998 110.641 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p -97.17 -37.64 10.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 1.3300000000000001 111.125 164.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 59.1 t0 -59.96 102.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.207 0.527 . . . . 1.8500000000000001 110.486 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.2 p -163.55 154.86 14.37 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.618 -0.719 . . . . 1.5600000000000001 109.489 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.61 -21.41 71.97 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.6 2.2 . . . . 1.1699999999999999 113.001 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.62 -17.08 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.902 0.334 . . . . 2.5600000000000001 111.902 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.862 ' HE2' HG11 ' A' ' 107' ' ' VAL . 23.2 t80 -117.23 -68.92 0.88 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.825 -0.35 . . . . 3.3599999999999999 110.689 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.46 -35.22 79.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.79000000000000004 109.95 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.42 93.69 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.069 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 69.6 mmtt -71.4 -38.62 71.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.029 0.442 . . . . 2.0899999999999999 110.406 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.76 -37.06 80.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.797 -0.638 . . . . 0.67000000000000004 110.298 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.73 -20.98 32.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 1.0900000000000001 110.622 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -68.88 -35.83 77.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 2.0699999999999998 109.681 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.985 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -68.92 -36.67 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.538 -0.756 . . . . 0.71999999999999997 111.583 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.13 -51.76 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.212 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.44 69.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.623 . . . . 1.1399999999999999 111.162 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -65.95 -71.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.513 0.673 . . . . 1.8200000000000001 110.095 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.26 -62.59 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 108.884 -1.687 . . . . 1.6499999999999999 108.884 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.433 HD22 ' HA ' ' A' ' 87' ' ' ASN . 2.3 m120 -161.33 167.03 26.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.902 0.881 . . . . 3.5 108.674 167.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.985 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -125.59 152.79 44.64 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.8 -0.76 . . . . 2.96 111.299 -168.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.757 ' HA ' ' O ' ' A' ' 109' ' ' MET . 35.7 p30 -163.8 47.0 0.12 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.336 -1.302 . . . . 2.2400000000000002 109.162 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 p -102.36 165.21 11.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.843 -1.526 . . . . 1.6299999999999999 111.134 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -116.78 125.32 51.45 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.218 -0.901 . . . . 1.77 109.911 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.33 157.66 27.68 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.757 -0.461 . . . . 3.0099999999999998 109.757 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.25 111.11 23.59 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.595 -0.52 . . . . 2.3900000000000001 109.595 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -135.87 144.07 45.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.885 -0.598 . . . . 3.3700000000000001 109.408 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 104' ' ' LYS . 6.0 p -105.06 155.52 18.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.013 0.435 . . . . 1.3999999999999999 111.55 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -116.19 104.73 11.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.919 -0.582 . . . . 1.1799999999999999 109.614 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 31.8 t70 -140.77 98.84 3.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.748 -0.66 . . . . 2.5699999999999998 110.198 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.61 ' HD1' ' HG2' ' A' ' 99' ' ' GLN . 65.2 t80 174.24 -71.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.675 0.61 . . . . 3.21 110.03 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG2' ' HD1' ' A' ' 98' ' ' TYR . 15.2 mm100 -101.9 4.34 40.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.987 0.899 . . . . 3.23 109.319 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.5 tpp -137.99 139.4 39.64 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.114 -1.403 . . . . 2.8500000000000001 107.962 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.09 144.43 94.28 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 108.972 -0.751 . . . . 2.1200000000000001 108.972 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.4 90.9 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.349 2.699 . . . . 1.47 114.14 -167.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -89.85 143.73 26.54 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 110.683 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -110.91 107.87 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.395 -0.965 . . . . 3.0800000000000001 108.395 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.6 m -129.64 163.17 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.789 0.804 . . . . 1.3300000000000001 112.365 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.66 123.02 47.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.408 -1.269 . . . . 1.6899999999999999 107.856 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.862 HG11 ' HE2' ' A' ' 75' ' ' PHE . 4.9 p -104.19 113.17 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.054 0.93 . . . . 1.27 109.759 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -104.9 104.24 13.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.976 -1.011 . . . . 1.02 108.813 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.757 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.3 pmm? -102.98 127.76 50.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.349 -0.612 . . . . 2.4900000000000002 109.349 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.564 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 42.4 mtmt -137.79 164.6 28.51 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 110.228 -0.286 . . . . 1.5700000000000001 110.228 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 3.9 tmtp? -94.92 149.98 20.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 2.1299999999999999 110.897 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -137.37 114.56 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.313 -0.858 . . . . 1.5700000000000001 109.333 173.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -87.72 32.71 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.5 0.667 . . . . 4.4100000000000001 110.703 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 p -79.73 -58.34 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.492 -0.777 . . . . 2.5499999999999998 109.935 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.44 20.98 5.48 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.409 -0.814 . . . . 2.6200000000000001 111.136 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.21 77.25 0.33 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.57 0.7 . . . . 2.7599999999999998 111.393 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.487 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 1.3 m -159.49 -171.22 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 1.0700000000000001 107.51 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 78.6 m-85 -123.74 147.8 47.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 118.154 0.434 . . . . 0.85999999999999999 109.847 -174.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.593 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 70.9 m95 -103.93 108.54 19.92 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.241 -1.022 . . . . 0.63 108.241 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.21 135.96 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.574 0.702 . . . . 0.91000000000000003 110.437 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.564 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 98.6 m-85 -120.19 137.24 54.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.354 -0.839 . . . . 0.79000000000000004 110.715 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.6 t -104.01 102.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.304 -0.862 . . . . 1.1799999999999999 109.107 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -105.81 123.86 48.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.154 -0.476 . . . . 3.3100000000000001 109.883 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -66.14 137.37 56.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.726 0.298 . . . . 4.0300000000000002 110.818 -177.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 105' ' ' VAL . 3.3 p . . . . . 0 C--O 1.248 1.018 0 CA-C-N 116.35 -0.386 . . . . 2.8700000000000001 110.663 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 30' ' ' ALA . 35.0 p90 . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.354 -0.61 . . . . 3.8500000000000001 109.354 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -104.07 115.26 5.0 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.732 -0.746 . . . . 0.84999999999999998 111.845 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -119.87 113.5 20.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 0.70999999999999996 110.527 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.48 ' HB ' HG13 ' A' ' 120' ' ' VAL . 24.8 mt -120.2 146.42 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.416 -0.587 . . . . 1.0800000000000001 109.416 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.3 tt0 -115.74 136.34 53.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.255 -1.016 . . . . 0.85999999999999999 108.255 172.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.0 pt? -147.95 159.32 44.0 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.729 -0.388 . . . . 1.6200000000000001 110.999 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.624 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.8 p30 -102.85 167.79 9.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.308 -0.405 . . . . 1.22 110.201 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.2 -17.22 44.83 Favored Glycine 0 CA--C 1.517 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.79000000000000004 113.855 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.92 -21.18 22.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.01 0.405 . . . . 1.95 111.139 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 117.09 3.49 17.51 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.418 -0.896 . . . . 0.53000000000000003 113.558 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 46.1 m-80 -71.11 128.93 37.58 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.453 0.627 . . . . 1.3 109.384 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.0 mt -83.5 144.08 10.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.047 -0.524 . . . . 0.89000000000000001 110.16 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -96.93 -75.47 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.45 110.066 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.528 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 16.9 pm0 -153.45 145.01 23.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 1.99 110.378 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.658 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.6 m-85 -90.68 156.91 17.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.142 -0.936 . . . . 1.25 109.313 170.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 58.7 t30 -70.6 156.47 39.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.85 -0.796 . . . . 2.1299999999999999 108.85 171.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.21 69.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 1.48 110.707 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.84 -52.67 23.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.987 -0.551 . . . . 1.52 111.28 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.685 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 20.6 tp10 -61.41 -44.98 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 2.1200000000000001 111.286 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.06 -34.82 58.14 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.33 -0.938 . . . . 1.4199999999999999 113.009 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.25 -45.85 68.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 2.3500000000000001 111.01 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -74.32 -55.72 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.144 -0.48 . . . . 2.5899999999999999 111.307 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 m -64.26 -50.91 66.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.537 -0.302 . . . . 3.4100000000000001 111.781 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.79 44.51 0.41 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.342 -0.932 . . . . 2.3199999999999998 112.152 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 52' ' ' ARG . 57.5 mmt-85 -136.3 93.69 2.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.057 -0.72 . . . . 3.1400000000000001 109.057 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.91 142.11 79.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.759 0.652 . . . . 2.1000000000000001 112.759 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.44 114.23 1.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.135 2.557 . . . . 1.6799999999999999 112.26 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 77.38 11.63 2.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.835 -1.075 . . . . 3.6099999999999999 112.105 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -91.82 4.73 52.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.673 0.749 . . . . 2.5 109.056 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.71 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -110.23 14.84 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.764 -1.107 . . . . 0.96999999999999997 111.935 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 56.3 mt -80.43 128.22 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.451 -0.574 . . . . 1.0900000000000001 109.451 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 -8.39 65.66 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.123 -1.037 . . . . 0.66000000000000003 110.833 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 21.0 mttp -86.04 131.21 34.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.847 -0.797 . . . . 1.8200000000000001 108.847 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.1 t-20 -88.17 112.94 23.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.122 -0.631 . . . . 0.71999999999999997 109.866 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' A' ' 70' ' ' THR . 45.8 t80 -47.87 -64.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.361 -0.836 . . . . 0.69999999999999996 111.787 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -87.96 28.09 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.192 0.442 . . . . 1.1599999999999999 112.192 -169.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 38.9 ttpt -143.18 -42.43 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 3.5800000000000001 111.026 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' OD2' HG13 ' A' ' 66' ' ' VAL . 38.9 t70 -95.15 -77.02 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 2.2000000000000002 110.884 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.413 HG13 ' OD2' ' A' ' 65' ' ' ASP . 5.6 m -91.96 16.29 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.558 0.947 . . . . 1.77 113.558 -172.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -165.25 86.23 1.03 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.994 0.426 . . . . 0.60999999999999999 111.153 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 98' ' ' TYR . 79.4 Cg_endo -91.07 -4.84 4.34 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.683 2.255 . . . . 0.81000000000000005 114.257 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.769 ' HB3' ' HA ' ' A' ' 98' ' ' TYR . 11.8 p -73.67 -13.83 61.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 109.814 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.582 HG23 ' HE1' ' A' ' 96' ' ' PHE . 11.1 m -91.49 -37.47 13.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.351 -1.295 . . . . 1.3300000000000001 110.607 -145.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.36 109.96 5.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.768 0.794 . . . . 1.8500000000000001 110.179 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.4 m -162.67 154.16 15.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.399 -0.819 . . . . 1.5600000000000001 109.314 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.17 -35.59 91.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.688 2.259 . . . . 1.1699999999999999 112.908 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.48 -16.15 60.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.248 0.462 . . . . 2.5600000000000001 112.248 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' HE2' HG11 ' A' ' 107' ' ' VAL . 61.5 t80 -124.5 -74.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 3.3599999999999999 110.485 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.46 -37.55 78.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 0.79000000000000004 110.966 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.29 -44.69 96.33 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.894 -0.67 . . . . 0.59999999999999998 112.106 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 71.9 mmtt -74.02 -32.29 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 2.0899999999999999 111.024 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.471 ' O ' HD11 ' A' ' 88' ' ' LEU . 89.3 t80 -60.14 -43.41 95.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.315 0.579 . . . . 0.67000000000000004 110.278 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.4 -19.6 45.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.86 -0.609 . . . . 1.0900000000000001 110.338 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.27 -37.68 83.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 2.0699999999999998 109.897 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.632 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.31 -44.83 41.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.799 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 79' ' ' PHE . 32.1 t -56.76 -50.47 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.84999999999999998 110.945 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -12.22 60.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 1.1399999999999999 112.229 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -101.26 -77.13 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.712 0.292 . . . . 1.8200000000000001 110.596 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.3 -62.23 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.738 -0.744 . . . . 1.6499999999999999 112.231 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -118.26 136.28 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.777 0.322 . . . . 3.5 110.552 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -104.74 123.17 47.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.179 -0.464 . . . . 2.96 110.261 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 36.9 t-20 -176.11 116.53 0.13 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.491 0.662 . . . . 2.2400000000000002 110.363 173.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 13.9 t -166.0 165.15 18.16 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.718 -1.128 . . . . 1.6299999999999999 109.031 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.6 ptm -140.0 108.64 5.91 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.335 0.588 . . . . 1.77 110.687 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -121.93 166.61 14.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.767 -0.651 . . . . 3.0099999999999998 110.548 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.59 121.55 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.495 -0.557 . . . . 2.3900000000000001 109.495 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -134.07 165.13 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.631 -0.713 . . . . 3.3700000000000001 109.458 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -104.42 147.17 27.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.734 -0.469 . . . . 1.3999999999999999 109.734 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HE1' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -139.45 103.33 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.198 -0.601 . . . . 1.1799999999999999 112.448 -169.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 7.3 t70 170.52 144.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 2.5699999999999998 108.958 167.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.769 ' HA ' ' HB3' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -72.02 -42.67 66.09 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.605 -0.725 . . . . 3.21 111.578 -176.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -137.02 -5.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.037 0.754 . . . . 3.23 113.037 -171.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.92 160.51 29.13 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.17 -0.678 . . . . 2.8500000000000001 109.17 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.87 100.92 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 108.504 -0.924 . . . . 2.1200000000000001 108.504 167.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -39.55 99.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.425 3.417 . . . . 1.47 113.996 -161.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.5 m -56.42 153.39 9.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.359 -0.837 . . . . 1.3999999999999999 110.273 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.98 136.53 42.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.226 0.536 . . . . 3.0800000000000001 110.946 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 122' ' ' VAL . 10.6 p -144.4 156.2 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.381 -0.827 . . . . 1.3300000000000001 110.294 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.429 ' HE3' HG11 ' A' ' 125' ' ' VAL . 29.0 ttmt -109.38 128.77 55.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.098 -1.075 . . . . 1.6899999999999999 108.098 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 122' ' ' VAL . 50.3 t -119.56 114.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 109.221 -0.659 . . . . 1.27 109.221 -166.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 90' ' ' THR . 73.4 t60 -104.78 122.78 46.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.899 -0.591 . . . . 1.02 109.969 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.4 mpt? -100.29 147.47 25.73 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.497 -0.927 . . . . 2.4900000000000002 108.497 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.612 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.8 ptmt -162.67 143.82 10.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.464 -0.569 . . . . 1.5700000000000001 109.464 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 84.4 tttt -94.0 122.51 36.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.451 . . . . 2.1299999999999999 111.111 -170.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.478 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -104.62 174.78 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.743 -0.662 . . . . 1.5700000000000001 109.335 175.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.4 tp -121.56 -28.7 4.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.812 0.339 . . . . 4.4100000000000001 110.129 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -71.34 100.24 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.424 -0.584 . . . . 2.5499999999999998 109.424 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.64 -6.01 33.22 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.301 -0.952 . . . . 2.6200000000000001 112.151 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 51.87 51.62 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.27 0.557 . . . . 2.7599999999999998 110.099 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.4 p -152.59 178.98 9.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.857 -0.611 . . . . 1.0700000000000001 110.568 -172.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 2.5 m-85 -117.22 155.68 29.01 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.569 -0.9 . . . . 0.85999999999999999 108.569 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.478 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 78.2 m95 -102.27 111.55 23.88 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.09 -0.707 . . . . 0.63 109.09 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.48 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.7 p -101.63 116.81 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.165 0.983 . . . . 0.91000000000000003 110.396 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.612 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 32.5 m-85 -109.36 125.15 52.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.795 . . . . 0.79000000000000004 110.529 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 107' ' ' VAL . 15.3 m -109.46 140.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.127 0.489 . . . . 1.1799999999999999 110.88 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -139.2 133.19 31.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 3.3100000000000001 110.088 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -72.05 123.05 21.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.892 -0.41 . . . . 4.0300000000000002 109.892 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 ' HE3' ' A' ' 106' ' ' LYS . 2.5 m . . . . . 0 C--O 1.247 0.948 0 CA-C-N 116.327 -0.397 . . . . 2.8700000000000001 110.599 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.768 0.318 . . . . 3.8500000000000001 110.683 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 43' ' ' ASN . . . -104.23 147.16 16.44 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.416 -0.897 . . . . 0.84999999999999998 113.424 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.15 111.43 14.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.092 -0.707 . . . . 0.70999999999999996 109.092 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 120' ' ' VAL . 6.9 mm -103.53 160.37 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' HG22 ' A' ' 31' ' ' ILE . 63.5 tt0 -133.42 113.67 12.8 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.175 -0.328 . . . . 0.85999999999999999 110.156 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.553 ' HG ' HG11 ' A' ' 120' ' ' VAL . 22.0 mt -112.63 151.98 29.5 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.351 -0.611 . . . . 1.6200000000000001 109.351 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.52 168.99 8.72 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.876 -0.329 . . . . 1.22 110.249 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.92 -27.48 37.14 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.569 0.543 . . . . 0.79000000000000004 114.326 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -44.03 20.09 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.508 0.654 . . . . 1.95 111.097 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.49 20.76 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.361 -0.924 . . . . 0.53000000000000003 112.902 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -84.52 142.64 29.88 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.484 -0.562 . . . . 1.3 109.484 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 6.0 mt -90.91 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.982 -0.747 . . . . 0.89000000000000001 108.982 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 58' ' ' ILE . 9.1 mp -118.19 -86.43 0.64 Allowed 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.134 0.492 . . . . 1.45 111.02 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -119.6 168.29 11.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.687 0.756 . . . . 1.99 111.655 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.767 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 3.3 m-85 -132.94 -167.75 1.96 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.011 -1.449 . . . . 1.25 109.337 -174.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 63.4 t30 -128.13 160.74 31.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.749 -0.834 . . . . 2.1299999999999999 108.749 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.55 19.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.508 0.559 . . . . 1.48 112.508 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.64 -42.9 8.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.083 0.468 . . . . 1.52 110.149 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 42' ' ' TYR . 16.4 mm-40 -77.5 -17.27 58.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.555 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -82.89 -26.18 46.4 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.449 -0.882 . . . . 1.4199999999999999 111.663 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -45.11 16.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 2.3500000000000001 110.609 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -83.16 -62.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 2.5899999999999999 111.21 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -75.76 -53.28 8.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.053 0.454 . . . . 3.4100000000000001 111.382 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.21 36.59 1.32 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 2.3199999999999998 111.226 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.467 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 16.9 tpp85 -123.27 110.14 14.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.56 0.219 . . . . 3.1400000000000001 110.525 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 28.6 m-20 -77.74 154.6 80.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.542 -0.299 . . . . 2.1000000000000001 110.508 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 36.9 Cg_endo -67.47 -9.79 26.53 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.838 2.358 . . . . 1.6799999999999999 111.312 172.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.27 5.86 44.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.269 -0.878 . . . . 3.6099999999999999 111.185 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 83.4 mm-40 -97.82 -60.52 1.55 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 2.5 111.75 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.852 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 2.9 m -88.27 40.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.486 0.921 . . . . 0.96999999999999997 113.486 -169.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 40' ' ' LEU . 30.8 mt -91.23 120.34 40.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.466 -0.494 . . . . 1.0900000000000001 109.886 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.52 33.03 58.96 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.526 -1.03 . . . . 0.66000000000000003 110.526 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.852 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 35.6 mttm -121.7 135.56 54.95 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.673 -0.763 . . . . 1.8200000000000001 110.009 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -80.78 112.93 18.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.803 0.335 . . . . 0.71999999999999997 110.331 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 39' ' ' ILE . 71.6 t80 -57.55 -40.7 79.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.69999999999999996 111.385 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.496 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 55.5 m-85 -91.05 25.63 2.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.332 -0.394 . . . . 1.1599999999999999 111.712 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.79 -46.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.688 -0.405 . . . . 3.5800000000000001 111.113 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.28 -78.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 2.2000000000000002 111.703 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.18 36.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.982 1.373 . . . . 1.77 111.544 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -163.9 81.28 1.43 Allowed Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 113.995 -1.457 . . . . 0.60999999999999999 111.071 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -97.72 8.81 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.906 2.404 . . . . 0.81000000000000005 114.066 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 97' ' ' ASP . 1.7 p -77.69 -17.97 57.12 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.949 -0.7 . . . . 0.84999999999999998 110.25 170.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.1 t -96.45 -26.3 15.36 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.3300000000000001 110.964 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 63' ' ' PHE . 5.7 m-20 -65.76 131.7 46.96 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.842 -0.343 . . . . 1.8500000000000001 111.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.8 p 179.81 155.05 0.68 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 109.515 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.9 -19.2 63.97 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.353 2.035 . . . . 1.1699999999999999 112.326 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 8.0 pt-20 -92.39 -24.9 18.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 2.5600000000000001 111.718 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 87.0 t80 -104.34 -72.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.646 -0.422 . . . . 3.3599999999999999 110.075 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -38.26 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.79000000000000004 110.238 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.28 -34.79 90.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.86 -0.609 . . . . 0.59999999999999998 112.498 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.25 -35.13 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.817 0.309 . . . . 2.0899999999999999 110.464 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.591 ' O ' HG23 ' A' ' 83' ' ' VAL . 59.3 t80 -57.72 -45.82 85.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.219 -0.66 . . . . 0.67000000000000004 109.219 172.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -77.75 -17.71 57.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.671 . . . . 1.0900000000000001 111.241 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -61.24 -36.22 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.109 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.661 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -84.03 -51.36 4.01 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.161 -1.019 . . . . 0.71999999999999997 111.48 172.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.598 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 48.4 t -45.82 -62.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.151 0.58 . . . . 0.84999999999999998 112.559 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.82 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 1.1399999999999999 111.411 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -70.07 0.36 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.499 . . . . 1.8200000000000001 110.537 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.99 27.5 0.18 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.223 -0.751 . . . . 1.6499999999999999 111.223 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 111' ' ' LYS . 19.6 m-20 67.02 107.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.559 0.744 . . . . 3.5 109.659 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.661 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 45.7 tp -149.65 148.93 29.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.63 -0.428 . . . . 2.96 111.541 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -88.63 144.44 26.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.046 -0.979 . . . . 2.2400000000000002 111.688 178.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -150.1 153.37 36.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.454 -0.793 . . . . 1.6299999999999999 109.874 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.8 ptm -126.35 125.39 42.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.547 -0.751 . . . . 1.77 109.734 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 32.5 p90 -144.11 165.54 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.866 0.365 . . . . 3.0099999999999998 111.01 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.72 124.52 49.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.898 -0.592 . . . . 2.3900000000000001 109.592 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -136.38 161.61 35.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 3.3700000000000001 110.534 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 89.1 m -106.55 136.7 45.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 110.212 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -125.34 104.73 8.63 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.222 -0.658 . . . . 1.1799999999999999 109.222 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 69' ' ' CYS . 5.0 p-10 -86.17 -63.35 1.33 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.145 -0.622 . . . . 2.5699999999999998 109.785 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.0 t80 47.19 55.09 8.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.761 -0.829 . . . . 3.21 108.761 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.22 -28.43 0.14 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.14 -0.937 . . . . 3.23 111.033 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 33.6 ttp -67.7 163.35 21.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.234 -0.439 . . . . 2.8500000000000001 110.222 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 14.8 t -55.46 146.67 42.32 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 108.383 -0.969 . . . . 2.1200000000000001 108.383 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 22.5 Cg_endo -61.87 72.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.385 2.057 . . . . 1.47 113.289 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.48 HG23 HG23 ' A' ' 101' ' ' THR . 7.6 p -73.9 146.89 43.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.265 -0.425 . . . . 1.3999999999999999 110.846 172.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -104.63 146.81 28.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 3.0800000000000001 111.178 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 106' ' ' LYS . 7.7 p -142.65 158.78 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.547 -0.752 . . . . 1.3300000000000001 109.362 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 105' ' ' VAL . 38.1 ttmt -112.68 131.36 55.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.23 -1.026 . . . . 1.6899999999999999 108.23 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.79 139.31 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.451 0.643 . . . . 1.27 110.843 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -121.59 104.22 9.48 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.594 -0.891 . . . . 1.02 108.594 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 5.1 ppp? -102.75 143.55 32.24 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 2.4900000000000002 109.689 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 51.2 mtpt -149.65 146.42 27.26 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 109.708 -0.479 . . . . 1.5700000000000001 109.708 -174.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HD2' ' CB ' ' A' ' 87' ' ' ASN . 41.8 tttm -75.21 146.35 41.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.335 -0.617 . . . . 2.1299999999999999 109.335 173.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -134.92 -159.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 1.5700000000000001 110.088 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.28 -166.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.15 -0.685 . . . . 4.4100000000000001 109.15 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.5 m 67.28 65.48 0.42 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.129 -0.693 . . . . 2.5499999999999998 109.129 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.32 51.58 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.333 -0.707 . . . . 2.6200000000000001 111.333 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.33 80.09 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.559 0.744 . . . . 2.7599999999999998 112.684 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.82 176.06 9.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.837 -1.172 . . . . 1.0700000000000001 107.837 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 80.3 m-85 -104.71 147.48 27.63 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.08 0.466 . . . . 0.85999999999999999 110.121 -173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 51.3 m95 -102.99 103.1 13.18 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.493 -0.776 . . . . 0.63 109.099 175.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -103.27 104.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.601 -1.181 . . . . 0.91000000000000003 110.823 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 119' ' ' TRP . 11.6 m-85 -102.68 137.97 40.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.79000000000000004 110.225 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -112.99 154.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.969 0.414 . . . . 1.1799999999999999 111.894 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -165.24 153.09 11.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 3.3100000000000001 109.436 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -73.26 98.66 2.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.916 -0.314 . . . . 4.0300000000000002 111.791 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.401 1.063 . . . . 2.8700000000000001 112.167 172.252 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 p90 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.158 -0.312 . . . . 3.8500000000000001 110.158 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.82 119.49 6.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.508 -0.854 . . . . 0.84999999999999998 112.709 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -104.8 126.18 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 0.70999999999999996 109.341 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.484 ' HB ' HG13 ' A' ' 120' ' ' VAL . 51.6 mt -128.39 149.13 32.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 1.0800000000000001 109.775 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.0 tt0 -112.01 134.65 53.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.987 -0.746 . . . . 0.85999999999999999 108.987 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD21 ' SD ' ' A' ' 109' ' ' MET . 2.6 pt? -139.67 153.41 47.28 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.136 -0.32 . . . . 1.6200000000000001 110.136 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.691 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.1 p30 -103.86 168.27 9.24 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.682 -0.407 . . . . 1.22 110.576 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -57.38 -14.47 13.14 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 115.136 0.815 . . . . 0.79000000000000004 115.136 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.08 -18.08 26.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.917 0.858 . . . . 1.95 110.391 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.28 26.42 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.682 -0.77 . . . . 0.53000000000000003 112.012 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.691 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 92.1 m-20 -71.58 138.17 48.58 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.73 0.3 . . . . 1.3 110.807 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 62' ' ' PHE . 14.0 mt -87.86 144.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.002 -0.545 . . . . 0.89000000000000001 109.685 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -101.93 -63.74 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.5 0.667 . . . . 1.45 110.231 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.08 169.5 23.22 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.005 -0.998 . . . . 1.99 110.572 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 52' ' ' ARG . 5.4 m-30 -113.91 175.94 5.25 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.113 -0.948 . . . . 1.25 109.364 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' ALA . 63.9 t30 -89.3 5.26 45.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.586 0.708 . . . . 2.1299999999999999 110.091 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 71.47 -15.54 0.42 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.351 -1.295 . . . . 1.48 110.875 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -60.5 -32.5 71.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.585 -0.734 . . . . 1.52 111.84 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.093 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 8.2 tp10 -78.77 -14.66 59.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.482 0.658 . . . . 2.1200000000000001 110.016 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.95 73.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.859 -0.686 . . . . 1.4199999999999999 111.464 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.63 -52.16 48.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 2.3500000000000001 110.836 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 HG22 ' A' ' 50' ' ' THR . 24.7 mt -83.82 -72.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 2.5899999999999999 111.799 -170.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 49' ' ' ILE . 11.9 t -173.73 43.24 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.049 0.928 . . . . 3.4100000000000001 111.054 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 1.093 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -109.05 -119.94 4.3 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.268 -0.967 . . . . 2.3199999999999998 113.673 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 24.9 mmt180 -139.21 153.46 47.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 3.1400000000000001 111.539 -171.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.694 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 12.0 m-20 -81.91 155.98 70.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.495 -0.928 . . . . 2.1000000000000001 108.495 163.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -29.94 85.57 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.112 1.874 . . . . 1.6799999999999999 111.896 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -72.73 -22.66 60.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 3.6099999999999999 111.598 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.694 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 67.4 mt-30 -81.95 -21.89 36.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.92 0.341 . . . . 2.5 111.92 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -121.54 62.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.687 0.625 . . . . 0.96999999999999997 112.687 -172.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -119.26 132.49 68.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.297 -0.561 . . . . 1.0900000000000001 111.058 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.2 -2.68 50.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.485 -0.864 . . . . 0.66000000000000003 111.549 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 47.6 mttp -88.36 146.0 25.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.407 . . . . 1.8200000000000001 110.609 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -94.25 107.24 19.2 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.785 -0.45 . . . . 0.71999999999999997 109.785 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 82.2 t80 -51.39 -36.03 41.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.69999999999999996 111.416 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.8 m-85 -86.16 16.06 4.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.761 0.282 . . . . 1.1599999999999999 111.761 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -147.16 -45.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.423 0.527 . . . . 3.5800000000000001 112.423 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.55 -78.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.137 0.421 . . . . 2.2000000000000002 112.137 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.1 p -108.6 14.53 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.007 0.908 . . . . 1.77 111.367 -170.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -158.07 71.82 4.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.607 -0.724 . . . . 0.60999999999999999 112.267 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.78 15.52 1.62 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.761 2.307 . . . . 0.81000000000000005 112.805 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.04 -23.79 59.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.18 -0.674 . . . . 0.84999999999999998 109.18 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 20.7 p -94.44 -32.04 13.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.587 -1.188 . . . . 1.3300000000000001 110.52 -136.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.715 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 12.6 p-10 -77.36 82.29 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.251 1.024 . . . . 1.8500000000000001 110.361 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -145.35 157.68 52.37 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.886 -1.052 . . . . 1.5600000000000001 109.534 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.87 -37.74 77.71 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.043 2.495 . . . . 1.1699999999999999 113.742 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.66 14.36 25.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.428 0.529 . . . . 2.5600000000000001 112.428 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.425 ' CD2' ' HE1' ' A' ' 92' ' ' PHE . 46.6 t80 -134.94 -73.99 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.246 -0.65 . . . . 3.3599999999999999 109.246 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 66.7 t80 -63.51 -36.4 83.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.889 -0.596 . . . . 0.79000000000000004 110.121 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -29.45 75.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.068 -0.586 . . . . 0.59999999999999998 112.366 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 68.7 mttm -87.28 -25.87 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.943 0.401 . . . . 2.0899999999999999 110.225 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 83' ' ' VAL . 79.6 t80 -62.56 -46.03 90.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.517 0.675 . . . . 0.67000000000000004 109.501 169.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 30.0 mmmt -77.89 -16.74 58.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.3 -0.864 . . . . 1.0900000000000001 110.481 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 40.9 tt0 -59.06 -39.97 83.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.674 . . . . 2.0699999999999998 110.501 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -84.55 -45.85 5.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.519 -0.848 . . . . 0.71999999999999997 112.107 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 79' ' ' PHE . 43.1 t -53.87 -52.94 30.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.662 0.385 . . . . 0.84999999999999998 111.489 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.02 60.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.175 0.435 . . . . 1.1399999999999999 112.175 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -98.02 -74.58 0.57 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.795 0.331 . . . . 1.8200000000000001 110.81 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.03 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.001 -0.619 . . . . 1.6499999999999999 111.561 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -109.82 156.74 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.475 -0.565 . . . . 3.5 109.475 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 45.6 tp -131.02 102.98 6.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 2.96 110.719 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 109' ' ' MET . 87.9 m-20 -143.76 97.98 3.16 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.783 -0.821 . . . . 2.2400000000000002 108.783 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -131.16 155.72 46.53 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.113 -0.494 . . . . 1.6299999999999999 111.797 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.4 ptt? -140.12 105.77 5.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 1.77 109.831 171.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HE1' ' CD2' ' A' ' 75' ' ' PHE . 25.7 p90 -127.2 167.13 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.764 -0.653 . . . . 3.0099999999999998 110.739 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 106' ' ' LYS . 45.1 mt-10 -103.67 122.9 45.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.007 -0.368 . . . . 2.3900000000000001 110.007 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -142.15 158.4 43.79 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.533 -0.543 . . . . 3.3700000000000001 109.533 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 104' ' ' LYS . 40.5 p -104.26 156.36 17.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.51 0.672 . . . . 1.3999999999999999 112.299 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.487 ' O ' ' HG3' ' A' ' 100' ' ' MET . 44.8 m-85 -121.85 112.61 18.55 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.653 -1.24 . . . . 1.1799999999999999 107.653 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 102' ' ' PRO . 4.5 m-20 -123.64 12.88 9.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.841 -166.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.85 -49.09 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 3.21 111.192 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.21 13.6 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 3.23 110.968 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 17.5 ptp -169.94 153.76 4.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 2.8500000000000001 109.702 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 10.1 t -58.01 142.95 79.01 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.25 -1.019 . . . . 2.1200000000000001 108.25 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.468 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 32.5 Cg_exo -31.65 86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.386 3.391 . . . . 1.47 114.976 -176.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 m -111.51 141.37 45.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 1.3999999999999999 110.882 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 95' ' ' THR . 22.2 ttmm -104.07 135.47 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.785 0.326 . . . . 3.0800000000000001 110.399 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -127.95 166.37 25.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 1.3300000000000001 110.669 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 93' ' ' GLU . 31.5 ttmt -110.81 117.02 32.28 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.346 -0.983 . . . . 1.6899999999999999 108.346 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 80.1 t -104.11 120.58 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.073 -0.512 . . . . 1.27 110.068 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 6.8 t60 -104.04 109.08 20.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.159 -0.682 . . . . 1.02 109.159 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 58.0 tpp -101.68 132.69 47.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 2.4900000000000002 109.149 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 50.4 mtpt -137.62 131.57 31.75 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 121.153 -0.219 . . . . 1.5700000000000001 110.498 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 81.6 tttt -90.53 123.22 34.03 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.123 0.487 . . . . 2.1299999999999999 110.885 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.08 -175.24 2.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.675 -0.861 . . . . 1.5700000000000001 108.675 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.42 -94.97 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.42 -0.956 . . . . 4.4100000000000001 108.42 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 m 51.56 42.14 29.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.609 0.596 . . . . 2.5499999999999998 112.609 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.03 79.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.758 . . . . 2.6200000000000001 112.501 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.43 64.17 0.72 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.153 0.581 . . . . 2.7599999999999998 111.695 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 20.4 p -139.05 163.92 31.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.095 -0.502 . . . . 1.0700000000000001 110.694 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 4.9 m-85 -123.25 154.72 38.41 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.043 -1.095 . . . . 0.85999999999999999 108.043 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -103.63 109.17 20.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.875 -0.787 . . . . 0.63 108.875 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.484 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.6 p -100.71 134.35 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.682 0.753 . . . . 0.91000000000000003 110.796 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.423 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 80.8 m-85 -120.83 132.62 55.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.79000000000000004 110.037 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.1 t -103.17 104.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.886 -0.597 . . . . 1.1799999999999999 110.061 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -103.16 110.18 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.877 -0.786 . . . . 3.3100000000000001 108.877 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 105' ' ' VAL . 4.2 ptm180 -77.86 158.01 29.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.223 -0.444 . . . . 4.0300000000000002 111.472 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.592 -0.718 . . . . 2.8700000000000001 109.147 173.765 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.5 p90 . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 109.673 -0.491 . . . . 3.8500000000000001 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 120.02 6.54 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.258 -0.972 . . . . 0.84999999999999998 112.308 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.59 125.85 47.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.611 -0.515 . . . . 0.70999999999999996 109.611 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 42' ' ' TYR . 5.2 pt -132.17 165.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 1.0800000000000001 111.991 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.536 ' HG2' HD23 ' A' ' 40' ' ' LEU . 50.3 tt0 -115.03 121.01 41.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.889 -0.596 . . . . 0.85999999999999999 110.513 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.9 pt? -131.48 146.84 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.545 -0.539 . . . . 1.6200000000000001 109.545 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.24 170.01 8.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.134 -0.321 . . . . 1.22 110.134 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.27 -23.33 12.4 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 114.306 0.482 . . . . 0.79000000000000004 114.306 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.17 -21.56 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 1.95 110.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 96.51 4.9 59.22 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.151 -1.18 . . . . 0.53000000000000003 110.151 -173.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -79.15 134.04 36.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.693 -0.754 . . . . 1.3 109.705 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 19.7 mt -93.02 140.24 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.924 -0.58 . . . . 0.89000000000000001 110.154 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 ' HG2' ' A' ' 32' ' ' GLN . 1.4 mm? -107.13 -66.48 1.02 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.144 0.497 . . . . 1.45 111.19 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -134.21 137.39 44.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.492 0.663 . . . . 1.99 111.47 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.725 ' HA ' HG22 ' A' ' 31' ' ' ILE . 3.6 m-30 -102.95 126.75 50.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.775 -1.102 . . . . 1.25 109.268 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -60.03 155.82 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.026 -0.361 . . . . 2.1299999999999999 110.026 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.64 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.092 0.472 . . . . 1.48 109.874 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.27 70.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.969 -1.014 . . . . 1.52 112.61 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 38.7 tp10 -66.19 -47.96 72.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.1200000000000001 110.566 -173.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.0 -10.18 72.59 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.834 -0.698 . . . . 1.4199999999999999 112.503 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -93.12 -52.1 4.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.87 0.367 . . . . 2.3500000000000001 110.884 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.6 mt -80.55 -72.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.394 -0.366 . . . . 2.5899999999999999 110.939 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.5 m -153.77 106.93 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.608 -0.516 . . . . 3.4100000000000001 109.608 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . 175.48 -139.75 4.87 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.067 -1.063 . . . . 2.3199999999999998 112.964 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 3.0 mpt_? -124.24 174.7 7.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.706 0.289 . . . . 3.1400000000000001 110.834 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.83 139.96 95.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.663 -0.699 . . . . 2.1000000000000001 111.055 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.53 111.99 0.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.874 2.382 . . . . 1.6799999999999999 112.497 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 81.49 11.2 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.239 -0.891 . . . . 3.6099999999999999 112.545 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -94.44 22.05 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.326 0.584 . . . . 2.5 110.243 172.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.692 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -119.68 22.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.899 . . . . 0.96999999999999997 111.26 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -88.51 136.61 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.878 -0.416 . . . . 1.0900000000000001 109.878 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.76 11.97 84.18 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.829 -0.909 . . . . 0.66000000000000003 110.829 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 65' ' ' ASP . 26.5 mttm -118.77 141.49 48.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.69 0.281 . . . . 1.8200000000000001 111.103 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 23.7 t-20 -87.76 114.75 24.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.145 -0.48 . . . . 0.71999999999999997 110.216 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -55.84 -35.22 66.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.963 0.411 . . . . 0.69999999999999996 111.645 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 66.7 m-85 -76.48 -7.96 56.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.17 -0.468 . . . . 1.1599999999999999 111.484 -174.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -136.45 -63.47 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.84 0.311 . . . . 3.5800000000000001 111.84 -175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 5.3 m-20 -66.93 -24.17 66.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.298 0.481 . . . . 2.2000000000000002 112.298 -173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -125.89 12.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.33 -0.548 . . . . 1.77 110.969 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 171.06 85.71 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.399 -0.364 . . . . 0.60999999999999999 111.434 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.0 -16.48 54.64 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.586 2.191 . . . . 0.81000000000000005 113.769 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.2 m -50.4 -37.17 36.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.719 0.236 . . . . 0.84999999999999998 110.901 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 10.3 m -92.82 -31.03 15.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.933 -1.031 . . . . 1.3300000000000001 109.896 -135.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.56 97.13 4.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.995 -1.002 . . . . 1.8500000000000001 110.16 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.5 m -164.05 152.21 11.11 Favored Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.046 -0.524 . . . . 1.5600000000000001 110.019 -169.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.71 -30.33 92.1 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.278 1.985 . . . . 1.1699999999999999 112.667 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HG3' ' HE2' ' A' ' 94' ' ' TYR . 9.5 pt-20 -86.14 6.37 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.271 0.471 . . . . 2.5600000000000001 112.271 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.682 ' HE2' HG11 ' A' ' 107' ' ' VAL . 57.3 t80 -141.58 -71.67 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.873 -0.418 . . . . 3.3599999999999999 109.873 173.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.663 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 89.0 t80 -53.75 -37.87 63.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.79000000000000004 110.692 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -31.66 78.93 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.226 -0.512 . . . . 0.59999999999999998 112.624 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -81.52 -32.67 32.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.521 0.677 . . . . 2.0899999999999999 109.459 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.48 -32.15 71.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.913 -1.039 . . . . 0.67000000000000004 109.588 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HE3' ' CZ ' ' A' ' 76' ' ' TYR . 0.9 OUTLIER -88.84 -16.06 32.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.171 -0.922 . . . . 1.0900000000000001 111.098 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.46 -51.33 63.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 2.0699999999999998 110.573 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.35 -44.01 98.26 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.724 -0.671 . . . . 0.71999999999999997 112.315 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 83' ' ' VAL . 23.4 t -55.85 -52.75 45.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.692 0.282 . . . . 0.84999999999999998 110.869 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.7 86.81 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 116.051 -0.522 . . . . 1.1399999999999999 111.196 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -66.33 -77.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 1.8200000000000001 110.78 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.43 -75.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.522 -0.631 . . . . 1.6499999999999999 111.522 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.62 147.66 24.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 3.5 110.13 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.002 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -111.21 110.4 20.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.568 -0.531 . . . . 2.96 109.568 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' MET . 24.0 p-10 -175.68 91.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.974 0.892 . . . . 2.2400000000000002 110.892 176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 91' ' ' MET . 10.0 m -131.44 154.55 48.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.311 -0.859 . . . . 1.6299999999999999 109.23 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.428 ' N ' HG22 ' A' ' 90' ' ' THR . 19.6 ptt? -128.27 104.08 7.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.981 0.419 . . . . 1.77 110.155 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -125.15 166.59 16.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 3.0099999999999998 110.194 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.42 131.22 50.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.985 0.421 . . . . 2.3900000000000001 110.537 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 50.8 t80 -136.87 159.91 40.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 3.3700000000000001 109.679 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -102.97 113.63 27.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.943 0.402 . . . . 1.3999999999999999 110.315 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.09 103.1 11.77 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.11 0.481 . . . . 1.1799999999999999 109.801 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 100' ' ' MET . 49.5 m-20 -126.41 101.74 6.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.653 -0.703 . . . . 2.5699999999999998 109.886 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -73.56 63.79 0.84 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.804 -1.184 . . . . 3.21 107.804 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 63.6 59.91 1.15 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.992 -1.004 . . . . 3.23 108.443 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.506 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 42.7 tpp -133.04 164.74 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.953 -1.021 . . . . 2.8500000000000001 111.09 -168.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.1 p -59.49 151.91 58.17 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 108.747 -0.835 . . . . 2.1200000000000001 108.747 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.17 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.641 2.227 . . . . 1.47 113.483 -171.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -90.71 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 1.3999999999999999 110.723 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.72 120.94 41.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.967 -0.383 . . . . 3.0800000000000001 109.967 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.2 m -122.02 166.42 16.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.838 -0.619 . . . . 1.3300000000000001 110.459 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 82.8 tttt -103.56 120.92 41.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.763 -0.828 . . . . 1.6899999999999999 108.763 177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.682 HG11 ' HE2' ' A' ' 75' ' ' PHE . 6.5 p -106.45 115.99 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-O 122.096 0.951 . . . . 1.27 110.096 -174.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.5 103.5 12.84 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.072 -0.967 . . . . 1.02 108.925 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.99 134.31 47.48 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.575 -0.45 . . . . 2.4900000000000002 110.078 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -140.65 134.75 30.87 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 120.688 0.28 . . . . 1.5700000000000001 110.928 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 1.002 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 26.0 ttpp -80.85 136.75 36.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.322 -0.399 . . . . 2.1299999999999999 110.896 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.98 -173.21 3.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.403 -0.362 . . . . 1.5700000000000001 111.172 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.5 -164.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.201 -0.454 . . . . 4.4100000000000001 110.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.1 m 65.89 54.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.615 0.721 . . . . 2.5499999999999998 110.365 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.39 -2.4 8.88 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.196 -0.911 . . . . 2.6200000000000001 111.605 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.5 41.68 31.81 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.425 0.631 . . . . 2.7599999999999998 110.614 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.42 -175.75 2.75 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.51 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.456 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 5.6 m-85 -119.6 151.69 38.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.028 -0.73 . . . . 0.85999999999999999 109.028 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -102.44 108.5 19.84 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.348 -0.982 . . . . 0.63 108.348 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' A' ' 31' ' ' ILE . 10.9 p -101.68 137.71 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 119.801 -0.759 . . . . 0.91000000000000003 110.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -114.03 125.21 53.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.436 -0.802 . . . . 0.79000000000000004 110.185 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.05 114.88 48.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.378 . . . . 1.1799999999999999 110.011 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -139.07 129.19 25.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.88 -0.415 . . . . 3.3100000000000001 109.88 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.8 ptp180 -75.02 114.64 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.016 0.436 . . . . 4.0300000000000002 110.455 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 106' ' ' LYS . 6.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.068 -0.491 . . . . 2.8700000000000001 110.43 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' VAL . 95.1 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.816 0.341 . . . . 3.8500000000000001 111.388 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.78 130.72 10.34 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.475 -0.869 . . . . 0.84999999999999998 112.18 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.84 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.932 -0.395 . . . . 0.70999999999999996 109.932 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 32' ' ' GLN . 9.5 mm -114.5 152.39 16.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 1.0800000000000001 109.895 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 31' ' ' ILE . 64.4 tt0 -124.06 104.67 9.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.614 -0.513 . . . . 0.85999999999999999 109.614 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.522 ' CD1' HG12 ' A' ' 39' ' ' ILE . 1.9 mm? -105.47 143.62 33.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.399 -0.364 . . . . 1.6200000000000001 110.277 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p30 -104.38 167.69 9.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.041 -0.264 . . . . 1.22 110.435 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.01 -22.46 35.24 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.046 0.779 . . . . 0.79000000000000004 115.046 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.426 0.613 . . . . 1.95 110.35 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.84 43.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.192 -0.763 . . . . 0.53000000000000003 111.192 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.0 m-20 -88.19 146.44 25.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.076 0.465 . . . . 1.3 111.416 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.698 HD12 HG11 ' A' ' 57' ' ' VAL . 10.0 mt -95.41 148.24 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.89000000000000001 110.305 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.454 ' N ' HG22 ' A' ' 39' ' ' ILE . 83.1 mt -107.44 -80.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.027 -0.533 . . . . 1.45 109.76 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -116.78 136.9 52.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 1.99 111.571 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.4 m-30 -98.02 -175.61 3.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.892 -1.049 . . . . 1.25 110.64 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.73 161.34 20.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.626 -0.879 . . . . 2.1299999999999999 108.626 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.81 -23.31 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.527 0.566 . . . . 1.48 112.527 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.79 94.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 1.52 111.078 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.3 mp0 -63.8 -27.11 68.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 2.1200000000000001 111.281 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.64 -13.88 62.29 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.538 -0.839 . . . . 1.4199999999999999 112.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.73 -54.48 3.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.542 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.28 -60.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 2.5899999999999999 110.124 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 3.8 m -78.73 -54.7 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.88 -0.6 . . . . 3.4100000000000001 111.451 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.18 14.0 6.75 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 2.3199999999999998 112.033 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 66' ' ' VAL . 19.7 mmt180 -97.69 110.09 22.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 3.1400000000000001 110.005 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.575 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 15.3 m-20 -63.58 143.6 97.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.381 -0.372 . . . . 2.1000000000000001 110.743 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 71.6 Cg_exo -52.34 -28.01 33.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.871 3.047 . . . . 1.6799999999999999 114.804 -170.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -124.67 28.61 6.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.99 0.367 . . . . 3.6099999999999999 111.99 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.575 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 77.0 mm-40 -94.78 0.07 54.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.255 0.55 . . . . 2.5 110.967 175.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -93.38 -93.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.816 -0.629 . . . . 0.96999999999999997 111.442 175.161 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.8 mm 54.31 99.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.427 0.691 . . . . 1.0900000000000001 112.239 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.26 71.77 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.265 -1.134 . . . . 0.66000000000000003 110.265 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 6.7 mmtp -111.33 121.0 44.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.708 -1.246 . . . . 1.8200000000000001 109.553 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -71.24 105.38 3.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.71999999999999997 110.843 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HB2' HG12 ' A' ' 39' ' ' ILE . 85.1 t80 -54.19 -39.16 66.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.69999999999999996 111.107 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.5 m-85 -82.69 30.54 0.43 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 111.213 -174.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -161.85 -42.4 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.226 -0.443 . . . . 3.5800000000000001 110.575 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.94 -78.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.563 -0.289 . . . . 2.2000000000000002 111.002 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.9 t -87.62 14.91 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.299 0.571 . . . . 1.77 111.222 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -177.76 94.62 0.23 Allowed Pre-proline 0 C--O 1.222 -0.383 0 O-C-N 122.125 -0.36 . . . . 0.60999999999999999 111.267 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 98' ' ' TYR . 3.9 Cg_exo -78.7 -19.89 10.96 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.419 2.079 . . . . 0.81000000000000005 112.834 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -76.87 -19.68 57.17 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.646 -0.422 . . . . 0.84999999999999998 110.864 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.69 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 18.4 p -73.86 -36.53 64.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.302 -0.863 . . . . 1.3300000000000001 111.119 -172.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 11.0 t70 -62.2 96.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.8500000000000001 109.895 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.5 p 175.79 158.0 0.4 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.32 -0.622 . . . . 1.5600000000000001 109.32 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.592 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 58.9 Cg_exo -52.87 -32.12 55.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.801 2.334 . . . . 1.1699999999999999 112.354 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.59 -59.02 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 2.5600000000000001 111.255 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.69 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 28.4 m-85 -96.09 -69.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.025 -0.534 . . . . 3.3599999999999999 111.357 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.03 -30.39 71.56 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.79000000000000004 111.116 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -61.44 -41.14 99.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.021 -0.609 . . . . 0.59999999999999998 112.177 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -79.23 -29.72 42.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 2.0899999999999999 110.121 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' HE1' ' A' ' 109' ' ' MET . 84.7 t80 -57.82 -40.38 79.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.335 -0.848 . . . . 0.67000000000000004 110.634 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.4 -12.06 26.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.993 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 32.4 tt0 -68.86 -43.49 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 110.379 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.57 -43.41 92.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.695 -0.764 . . . . 0.71999999999999997 112.022 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 t -61.03 -49.48 84.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.84999999999999998 110.88 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -4.64 27.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 112.019 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.2 m -100.53 -73.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.634 0.254 . . . . 1.8200000000000001 110.782 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.91 -63.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 1.6499999999999999 111.952 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.15 139.57 46.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.606 -0.516 . . . . 3.5 109.606 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -106.89 104.46 14.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.387 -0.597 . . . . 2.96 109.387 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.686 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.7 p30 -172.15 116.15 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.497 0.665 . . . . 2.2400000000000002 109.868 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.4 m -148.36 142.23 25.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 1.6299999999999999 109.887 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.0 ptm -119.92 120.1 35.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.448 -0.575 . . . . 1.77 109.448 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' CD1' ' HD1' ' A' ' 94' ' ' TYR . 4.2 p90 -140.03 157.81 45.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.421 . . . . 3.0099999999999998 111.953 -172.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 106' ' ' LYS . 5.5 mp0 -104.42 121.64 43.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 2.3900000000000001 109.896 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 26.6 m-85 -142.9 165.82 26.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.286 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 13.5 m -107.36 144.26 34.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.39 -0.368 . . . . 1.3999999999999999 110.527 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.77 106.99 15.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 1.1799999999999999 109.478 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.47 111.01 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 2.5699999999999998 110.829 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 68' ' ' PRO . 72.7 t80 -175.76 -79.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.484 -0.78 . . . . 3.21 109.475 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -99.55 -34.28 10.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.419 -0.586 . . . . 3.23 109.419 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.6 ttm -82.11 137.86 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.041 -1.096 . . . . 2.8500000000000001 108.041 164.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -64.4 154.78 82.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.419 -0.586 . . . . 2.1200000000000001 109.419 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.47 87.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.136 2.557 . . . . 1.47 114.114 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -102.97 130.48 50.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.848 -0.615 . . . . 1.3999999999999999 109.952 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 22.3 pttp -103.62 124.84 49.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.401 -0.592 . . . . 3.0800000000000001 109.401 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 124' ' ' ARG . 15.1 m -132.11 165.52 31.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 112.179 -171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 22.7 ttmm -104.75 111.01 23.57 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.288 -1.005 . . . . 1.6899999999999999 108.288 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 122' ' ' VAL . 59.8 t -104.63 127.75 58.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.611 -0.514 . . . . 1.27 109.611 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 10.7 t60 -104.61 113.42 26.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.4 0.619 . . . . 1.02 109.458 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.686 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 27.3 tpp -101.13 123.54 45.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.518 -1.219 . . . . 2.4900000000000002 108.772 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 63.8 pttt -150.44 146.8 26.88 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.093 -0.643 . . . . 1.5700000000000001 111.512 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 48.6 tttm -87.52 140.27 29.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.567 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.1 -172.84 4.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.612 0.244 . . . . 1.5700000000000001 110.439 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -168.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.196 -0.298 . . . . 4.4100000000000001 110.196 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m 75.15 72.86 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.806 0.691 . . . . 2.5499999999999998 110.094 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.38 -8.4 44.35 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.093 -0.803 . . . . 2.6200000000000001 111.093 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 55.03 80.81 0.12 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.598 0.713 . . . . 2.7599999999999998 111.165 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 2.6 p -156.51 -169.83 3.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.005 -0.998 . . . . 1.0700000000000001 109.063 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 8.5 m-85 -119.38 152.57 36.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.332 -0.988 . . . . 0.85999999999999999 108.332 -177.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 55.5 m95 -101.54 106.0 17.04 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.591 0.71 . . . . 0.63 109.148 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 108' ' ' HIS . 38.9 t -102.6 104.34 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.401 -1.272 . . . . 0.91000000000000003 110.612 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 98.7 m-85 -104.79 134.08 48.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.139 -0.937 . . . . 0.79000000000000004 110.253 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -113.48 144.9 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.585 -0.28 . . . . 1.1799999999999999 110.703 -176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 106' ' ' LYS . 18.5 ptpt -139.49 145.16 38.42 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.838 -0.431 . . . . 3.3100000000000001 109.838 173.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.716 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.5 tmt_? -84.4 111.69 19.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.639 -0.255 . . . . 4.0300000000000002 110.591 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.494 HG11 ' HE2' ' A' ' 106' ' ' LYS . 16.7 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.618 -0.706 . . . . 2.8700000000000001 111.033 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.91 -0.404 . . . . 3.8500000000000001 109.91 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 45' ' ' ALA . . . -104.7 130.24 10.15 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.641 -0.79 . . . . 0.84999999999999998 111.302 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -135.76 104.13 5.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.172 0.51 . . . . 0.70999999999999996 111.163 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.924 ' HB ' HG13 ' A' ' 120' ' ' VAL . 34.6 mt -113.07 159.74 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.079 -1.082 . . . . 1.0800000000000001 108.079 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' HG22 ' A' ' 31' ' ' ILE . 10.1 tt0 -131.97 116.65 17.39 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.937 -0.477 . . . . 0.85999999999999999 110.467 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.39 165.2 12.42 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.433 -0.58 . . . . 1.6200000000000001 109.433 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -121.1 168.4 11.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.926 -0.398 . . . . 1.22 109.926 175.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.98 -24.62 35.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.415 0.526 . . . . 0.79000000000000004 114.415 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.62 -21.51 55.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.95 110.83 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.84 2.65 36.8 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.807 -0.633 . . . . 0.53000000000000003 111.845 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 92.6 m-20 -78.46 153.31 31.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.95 0.405 . . . . 1.3 110.864 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 60' ' ' LYS . 9.3 mt -96.87 146.88 6.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.715 -0.675 . . . . 0.89000000000000001 109.674 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -102.04 -46.96 4.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.629 0.728 . . . . 1.45 109.515 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -170.87 157.76 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.602 -1.181 . . . . 1.99 110.123 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.909 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 8.1 m-30 -110.54 177.82 4.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 1.25 110.456 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t-20 -107.36 179.25 4.3 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.292 -1.003 . . . . 2.1299999999999999 108.292 172.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 -9.46 43.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.086 0.47 . . . . 1.48 109.908 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' CB ' ' HA2' ' A' ' 29' ' ' GLY . . . -55.71 -60.08 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.253 -0.885 . . . . 1.52 111.897 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.6 mp0 -65.55 -27.15 68.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 2.1200000000000001 111.22 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.2 -50.31 51.98 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.564 -0.827 . . . . 1.4199999999999999 111.786 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.1 -55.19 31.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.121 0.486 . . . . 2.3500000000000001 110.309 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.6 67.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.688 -1.226 . . . . 2.5899999999999999 107.688 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 18.9 m -36.32 90.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.754 -1.566 . . . . 3.4100000000000001 114.561 -169.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -104.42 -59.29 0.68 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.325 -1.307 . . . . 2.3199999999999998 110.46 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.909 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 35.3 mmt180 -149.51 168.79 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.634 0.373 . . . . 3.1400000000000001 110.444 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.682 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 8.9 m-20 -90.55 141.12 26.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 2.1000000000000001 109.759 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.769 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 52.8 Cg_exo -56.55 -25.88 61.15 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.193 2.595 . . . . 1.6799999999999999 114.086 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -103.79 6.67 36.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.188 0.44 . . . . 3.6099999999999999 112.188 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 82.9 mm-40 -102.82 6.13 39.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.069 0.461 . . . . 2.5 110.699 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 7.7 m -118.15 40.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.217 0.532 . . . . 0.96999999999999997 111.606 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.01 112.25 24.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.37 -0.377 . . . . 1.0900000000000001 110.64 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.21 11.72 71.32 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.964 -0.854 . . . . 0.66000000000000003 110.964 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.57 ' O ' HG13 ' A' ' 39' ' ' ILE . 7.2 tptt -88.02 121.55 30.56 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.992 -0.604 . . . . 1.8200000000000001 109.558 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 47.5 t-20 -71.78 110.99 6.68 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.442 -0.577 . . . . 0.71999999999999997 109.442 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 86.6 t80 -53.98 -41.0 67.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.429 -0.805 . . . . 0.69999999999999996 110.74 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 46.2 m-85 -85.86 9.48 16.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.237 -0.438 . . . . 1.1599999999999999 110.803 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 48.0 tptt -124.54 -61.95 1.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.386 -0.37 . . . . 3.5800000000000001 110.715 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -104.09 -22.8 13.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.17 0.433 . . . . 2.2000000000000002 112.17 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 52' ' ' ARG . 1.9 t -113.17 13.52 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.182 -0.607 . . . . 1.77 111.765 -170.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 167.27 79.57 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.971 -0.559 . . . . 0.60999999999999999 110.235 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.03 -17.15 50.95 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.751 2.301 . . . . 0.81000000000000005 113.035 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.893 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.9 p -76.36 -26.66 55.92 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.486 -0.486 . . . . 0.84999999999999998 110.225 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 1.9 m -80.1 -31.89 39.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.902 -1.045 . . . . 1.3300000000000001 110.486 -164.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 10.5 t70 -63.75 99.23 0.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.159 -0.682 . . . . 1.8500000000000001 109.159 172.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 8.8 t -169.56 149.46 3.68 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.723 -0.473 . . . . 1.5600000000000001 109.723 -175.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 5.3 Cg_exo -38.47 -42.79 1.8 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.742 3.628 . . . . 1.1699999999999999 114.584 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.799 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.01 -53.55 4.22 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.598 -0.441 . . . . 2.5600000000000001 111.19 -178.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 70' ' ' THR . 29.2 m-85 -59.63 -63.81 1.17 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.094 0.473 . . . . 3.3599999999999999 110.706 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 39.6 t80 -67.47 -28.68 68.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.614 . . . . 0.79000000000000004 110.097 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -63.62 -34.75 90.79 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.699 -0.682 . . . . 0.59999999999999998 112.605 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 72.1 mmtt -75.09 -36.97 61.67 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.123 0.487 . . . . 2.0899999999999999 109.751 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' O ' HD11 ' A' ' 88' ' ' LEU . 82.2 t80 -59.89 -35.4 74.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.825 . . . . 0.67000000000000004 110.69 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -94.52 -4.79 47.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.074 -0.512 . . . . 1.0900000000000001 111.808 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -49.97 73.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.034 0.445 . . . . 2.0699999999999998 110.269 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.14 -37.29 63.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.71999999999999997 111.794 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' OH ' ' A' ' 118' ' ' TYR . 21.9 t -52.86 -56.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 122.971 0.508 . . . . 0.84999999999999998 111.518 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.76 62.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 1.1399999999999999 112.048 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.9 m -88.67 -73.2 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.381 . . . . 1.8200000000000001 110.681 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.3 -72.14 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.936 -0.65 . . . . 1.6499999999999999 111.521 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.76 149.09 28.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.667 -0.864 . . . . 3.5 108.667 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -116.27 101.8 9.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.18 -0.674 . . . . 2.96 109.18 178.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 45.9 m-80 -149.12 83.14 1.44 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.383 -0.599 . . . . 2.2400000000000002 109.383 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.8 p -127.83 158.49 37.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 1.6299999999999999 111.289 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.2 ptm -137.44 113.74 10.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.893 -0.594 . . . . 1.77 110.302 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.714 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 8.8 p90 -136.65 164.73 27.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 3.0099999999999998 110.81 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.5 122.04 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 2.3900000000000001 110.702 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.714 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 5.1 m-85 -144.21 167.03 23.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 3.3700000000000001 110.089 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.0 t -103.63 154.22 19.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.268 0.556 . . . . 1.3999999999999999 111.983 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -120.23 103.45 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.416 -0.957 . . . . 1.1799999999999999 108.416 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 24.3 t70 -113.23 -131.37 0.32 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.586 -0.734 . . . . 2.5699999999999998 109.516 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 61.7 t80 70.65 -70.23 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.434 0.694 . . . . 3.21 111.241 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -118.97 -2.14 10.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.302 0.572 . . . . 3.23 110.268 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.4 tpt -116.26 151.27 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.352 -0.84 . . . . 2.8500000000000001 109.301 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 103' ' ' THR . 9.8 t -55.98 142.45 65.05 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 108.345 -0.983 . . . . 2.1200000000000001 108.345 169.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 26.7 Cg_endo -62.84 72.16 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.73 2.287 . . . . 1.47 112.662 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 101' ' ' THR . 1.4 p -81.78 144.33 31.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.917 -0.583 . . . . 1.3999999999999999 111.504 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.85 117.38 33.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.537 -0.301 . . . . 3.0800000000000001 110.346 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.24 166.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.073 -0.512 . . . . 1.3300000000000001 110.889 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -103.6 128.34 50.89 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.367 -0.975 . . . . 1.6899999999999999 108.367 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' MET . 7.4 p -116.37 139.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 109.486 -0.561 . . . . 1.27 109.486 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -117.2 115.67 25.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.651 -0.704 . . . . 1.02 109.166 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 86.1 mmm -100.35 126.34 46.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.201 -0.666 . . . . 2.4900000000000002 109.201 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.0 mtpm? -141.84 121.58 13.47 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 120.837 0.351 . . . . 1.5700000000000001 111.187 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 76.5 tttt -73.17 131.42 42.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.045 -0.525 . . . . 2.1299999999999999 110.824 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.21 -160.76 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.967 0.358 . . . . 1.5700000000000001 111.967 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.413 HD23 HE22 ' A' ' 32' ' ' GLN . 13.7 tp 33.62 111.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.939 1.829 . . . . 4.4100000000000001 115.939 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.6 m -18.23 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.406 1.691 . . . . 2.5499999999999998 112.569 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.42 -8.14 0.55 Allowed Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.176 -0.92 . . . . 2.6200000000000001 111.449 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 59.62 24.3 13.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.793 0.806 . . . . 2.7599999999999998 110.054 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.9 p -82.67 171.57 13.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.493 -1.23 . . . . 1.0700000000000001 109.466 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.556 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.6 m-85 -128.07 153.35 46.9 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.338 -0.615 . . . . 0.85999999999999999 109.338 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -100.55 109.36 21.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.473 -0.936 . . . . 0.63 108.473 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.924 HG13 ' HB ' ' A' ' 31' ' ' ILE . 2.4 p -101.57 106.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 122.307 1.051 . . . . 0.91000000000000003 110.517 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -103.25 136.82 42.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.651 -1.159 . . . . 0.79000000000000004 109.975 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.69 147.01 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 1.1799999999999999 112.02 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -149.01 154.23 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.321 -0.854 . . . . 3.3100000000000001 109.457 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -100.95 121.89 42.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.018 -0.364 . . . . 4.0300000000000002 110.018 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.222 -0.894 . . . . 2.8700000000000001 110.521 179.083 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 109.64 -0.504 . . . . 3.8500000000000001 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.24 117.2 5.74 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 112.48 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.66 104.23 14.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.696 -0.483 . . . . 0.70999999999999996 109.696 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 120' ' ' VAL . 37.7 mt -107.85 157.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.869 -0.605 . . . . 1.0800000000000001 109.642 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.65 HE22 ' HB2' ' A' ' 113' ' ' LEU . 2.8 mt-30 -130.03 142.17 50.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.15 -0.315 . . . . 0.85999999999999999 110.15 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -140.27 153.87 46.65 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.294 -0.632 . . . . 1.6200000000000001 109.294 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.7 OUTLIER -104.41 168.4 9.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.15 -23.77 18.54 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.467 0.479 . . . . 0.79000000000000004 114.205 -175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 -37.06 37.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.216 0.508 . . . . 1.95 110.528 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.54 5.0 6.69 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.639 -0.791 . . . . 0.53000000000000003 112.307 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -70.72 147.15 49.35 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.564 -0.532 . . . . 1.3 109.564 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 mt -94.43 146.89 6.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.301 -0.629 . . . . 0.89000000000000001 109.301 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 40' ' ' LEU . 4.0 mp -127.98 -80.46 0.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 1.45 109.8 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.5 mp0 -89.45 141.06 28.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.44 -0.8 . . . . 1.99 109.976 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -130.48 5.33 4.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.349 -0.387 . . . . 1.25 110.918 178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.92 -173.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.865 -0.607 . . . . 2.1299999999999999 109.93 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.83 5.38 45.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.446 0.641 . . . . 1.48 109.495 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -77.95 -51.44 10.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.777 . . . . 1.52 111.338 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.03 -20.87 61.62 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.916 0.389 . . . . 2.1200000000000001 110.913 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.45 -19.83 77.93 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.714 -0.755 . . . . 1.4199999999999999 111.31 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -94.89 -16.67 22.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.202 0.525 . . . . 2.3500000000000001 110.185 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 45' ' ' ALA . 50.3 mm -82.73 -63.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 2.5899999999999999 111.152 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -139.92 40.88 1.98 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.161 0.981 . . . . 3.4100000000000001 111.1 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.25 37.27 64.32 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.106 -0.952 . . . . 2.3199999999999998 113.282 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 17.9 mmt-85 -98.6 85.67 3.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 3.1400000000000001 110.985 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 6.5 m-20 -67.31 148.59 98.71 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.277 -0.874 . . . . 2.1000000000000001 109.649 175.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 49.4 Cg_exo -55.5 -32.89 84.33 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.255 1.97 . . . . 1.6799999999999999 111.427 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -73.35 -18.35 61.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.724 -0.671 . . . . 3.6099999999999999 111.668 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 79.4 mm-40 -78.25 -26.61 47.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.713 0.264 . . . . 2.5 111.713 -175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.0 m -109.13 14.8 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.257 0.836 . . . . 0.96999999999999997 113.257 -172.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 62.5 mt -83.83 133.42 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.608 -0.516 . . . . 1.0900000000000001 109.608 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.14 88.5 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.211 -0.995 . . . . 0.66000000000000003 110.885 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 34.8 mttm -104.88 133.03 50.38 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.126 -0.537 . . . . 1.8200000000000001 109.82 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -84.34 113.31 21.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.73 -0.388 . . . . 0.71999999999999997 110.138 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 66.8 t80 -54.51 -50.14 68.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.533 -0.758 . . . . 0.69999999999999996 111.173 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.6 m-85 -79.76 21.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.286 0.476 . . . . 1.1599999999999999 112.286 -172.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -149.92 -49.67 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.87 0.366 . . . . 3.5800000000000001 111.712 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -87.19 -76.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 2.2000000000000002 111.571 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -86.13 15.72 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.964 0.411 . . . . 1.77 111.491 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.41 96.12 0.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 121.998 -0.439 . . . . 0.60999999999999999 111.835 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -89.96 -9.69 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.084 2.522 . . . . 0.81000000000000005 112.898 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -83.95 -4.03 58.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.84999999999999998 111.077 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.489 HG21 ' CE1' ' A' ' 62' ' ' PHE . 6.8 p -98.45 -38.74 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.064 -0.517 . . . . 1.3300000000000001 111.534 -164.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 13.4 t70 -68.69 91.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.299 -0.41 . . . . 1.8500000000000001 109.974 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.3 p -150.21 160.19 33.74 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 1.5600000000000001 110.596 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 -43.84 53.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.927 2.418 . . . . 1.1699999999999999 113.608 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -78.54 -26.0 45.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.383 0.512 . . . . 2.5600000000000001 112.383 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HE2' HG11 ' A' ' 107' ' ' VAL . 67.5 t80 -105.57 -67.9 0.9 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.46 . . . . 3.3599999999999999 110.894 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 89.7 t80 -64.18 -39.29 93.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 110.863 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.2 97.56 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.97 -0.634 . . . . 0.59999999999999998 112.366 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 50.5 mmtt -73.44 -32.21 64.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 2.0899999999999999 110.606 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.3 t80 -57.58 -45.87 84.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.555 0.693 . . . . 0.67000000000000004 110.092 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.294 -0.866 . . . . 1.0900000000000001 112.005 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 2.0699999999999998 110.726 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.769 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -73.99 -44.06 31.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.312 -0.947 . . . . 0.71999999999999997 111.317 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' PHE . 22.0 t -56.19 -55.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.248 -0.476 . . . . 0.84999999999999998 111.426 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.38 83.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.285 -0.416 . . . . 1.1399999999999999 112.001 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.1 m -73.52 -70.99 0.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.437 -0.347 . . . . 1.8200000000000001 111.432 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.2 -79.38 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.691 -0.766 . . . . 1.6499999999999999 111.843 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 19.9 p30 -92.33 149.57 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.289 -0.456 . . . . 3.5 110.786 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -121.11 120.58 35.71 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.033 -0.728 . . . . 2.96 109.033 177.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.6 p30 -159.59 123.11 3.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 2.2400000000000002 109.905 173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -164.59 159.42 19.08 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.134 -0.939 . . . . 1.6299999999999999 110.235 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 53.4 ttm -132.09 107.84 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.039 -0.726 . . . . 1.77 109.039 175.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -120.23 156.22 31.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 3.0099999999999998 109.641 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.34 120.13 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.443 0.64 . . . . 2.3900000000000001 110.254 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -138.6 165.79 26.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.09 -0.959 . . . . 3.3700000000000001 109.493 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' THR . 49.2 p -104.25 154.88 19.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.858 0.361 . . . . 1.3999999999999999 111.937 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.34 103.14 9.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.758 -0.83 . . . . 1.1799999999999999 108.758 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 1.7 p30 -128.58 20.86 6.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.189 -0.46 . . . . 2.5699999999999998 111.444 -172.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.584 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -59.76 -44.25 93.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.68 -0.691 . . . . 3.21 111.672 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -144.18 -44.77 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.691 -0.855 . . . . 3.23 108.691 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.9 ttt -71.31 151.83 43.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.855 -1.066 . . . . 2.8500000000000001 108.768 170.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 p -53.68 149.8 15.08 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.514 -0.55 . . . . 2.1200000000000001 109.514 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 97' ' ' ASP . 18.1 Cg_endo -59.74 80.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.454 2.103 . . . . 1.47 113.129 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.0 p -74.04 151.73 40.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.3999999999999999 110.742 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 124' ' ' ARG . 10.1 mtmp? -104.62 121.19 43.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.771 0.32 . . . . 3.0800000000000001 110.176 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 35.3 m -117.44 161.51 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.929 0.395 . . . . 1.3300000000000001 110.683 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -116.17 113.93 23.76 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.739 -1.208 . . . . 1.6899999999999999 107.739 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 75' ' ' PHE . 14.8 p -106.25 142.35 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.134 0.492 . . . . 1.27 110.136 -170.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -115.35 110.98 20.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.036 -0.727 . . . . 1.02 109.036 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.7 tpp -101.84 130.78 48.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.54 -0.754 . . . . 2.4900000000000002 109.258 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 15.2 ptmm? -156.83 141.57 16.91 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.007 0.432 . . . . 1.5700000000000001 111.532 -177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 42.6 tttp -83.64 117.68 23.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.769 -0.651 . . . . 2.1299999999999999 111.243 -172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -176.12 108.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.133 0.42 . . . . 1.5700000000000001 112.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.65 ' HB2' HE22 ' A' ' 32' ' ' GLN . 38.9 tp 168.04 -109.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.943 0.897 . . . . 4.4100000000000001 109.146 171.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -85.81 19.3 2.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.338 0.59 . . . . 2.5499999999999998 109.677 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.83 -56.09 4.65 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.602 -0.726 . . . . 2.6200000000000001 111.531 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -93.11 31.1 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.445 0.64 . . . . 2.7599999999999998 111.219 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 28.8 t -146.95 142.2 27.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.384 -0.598 . . . . 1.0700000000000001 109.384 173.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.547 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 13.0 m-85 -120.01 164.88 15.45 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.422 -0.808 . . . . 0.85999999999999999 109.969 -167.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.575 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 73.2 m95 -102.32 108.39 19.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.905 -0.776 . . . . 0.63 108.905 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 31' ' ' ILE . 4.4 p -101.33 109.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.294 1.045 . . . . 0.91000000000000003 110.717 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.448 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 83.3 m-85 -102.35 124.44 47.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.244 -0.889 . . . . 0.79000000000000004 109.779 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 123.93 69.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.826 0.346 . . . . 1.1799999999999999 111.044 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -137.29 134.9 36.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.299 -0.63 . . . . 3.3100000000000001 109.299 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 2.6 ttp180 -77.98 146.19 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.332 -0.395 . . . . 4.0300000000000002 111.284 -172.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.734 -1.127 . . . . 2.8700000000000001 110.687 175.669 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 120.549 0.214 . . . . 3.8500000000000001 110.479 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA3' HG23 ' A' ' 122' ' ' VAL . . . -105.35 158.27 16.01 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.785 -0.721 . . . . 0.84999999999999998 112.686 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.66 112.2 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.394 -0.595 . . . . 0.70999999999999996 109.394 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.938 HG22 ' HA ' ' A' ' 42' ' ' TYR . 8.9 pt -131.66 166.74 28.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.046 0.387 . . . . 1.0800000000000001 112.046 -175.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -122.4 134.2 54.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.438 . . . . 0.85999999999999999 110.296 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.7 pt? -138.79 157.62 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.691 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 167.76 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.002 -0.279 . . . . 1.22 110.706 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.97 -14.03 22.13 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.762 0.665 . . . . 0.79000000000000004 114.762 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 26.7 t70 -86.33 -20.39 28.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.581 0.69 . . . . 1.95 110.312 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 112.19 0.59 26.73 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.588 -0.815 . . . . 0.53000000000000003 111.961 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.632 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 49.5 m-80 -74.56 138.05 42.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 120.911 0.386 . . . . 1.3 110.203 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.5 mt -88.58 148.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.086 -0.709 . . . . 0.89000000000000001 109.086 173.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 7.8 mp -112.87 -63.56 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.26 0.552 . . . . 1.45 110.736 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -136.77 126.63 25.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.565 -0.743 . . . . 1.99 110.67 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.074 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 1.6 m-30 -93.04 162.27 14.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.069 -0.969 . . . . 1.25 110.572 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.38 161.51 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.564 -0.902 . . . . 2.1299999999999999 108.564 166.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -12.34 59.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.795 0.331 . . . . 1.48 111.403 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.2 75.07 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.145 -0.479 . . . . 1.52 111.305 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.8 -21.37 64.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 2.1200000000000001 109.892 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -68.89 -30.54 72.41 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 111.792 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -79.11 -32.57 44.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 2.3500000000000001 110.207 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.88 -64.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 2.5899999999999999 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 52' ' ' ARG . 4.2 t -113.51 -38.62 4.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.795 0.331 . . . . 3.4100000000000001 111.094 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 101.31 53.6 1.0 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.44 -0.886 . . . . 2.3199999999999998 112.223 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.67 ' HG2' HG23 ' A' ' 50' ' ' THR . 14.2 mmt180 -119.14 125.74 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.595 -0.52 . . . . 3.1400000000000001 109.595 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.928 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -65.81 137.62 96.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.597 -0.274 . . . . 2.1000000000000001 110.783 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.074 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 88.7 Cg_exo -49.47 -25.25 10.23 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.836 3.024 . . . . 1.6799999999999999 114.222 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -101.6 -2.13 31.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.592 0.219 . . . . 3.6099999999999999 111.592 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.928 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.16 -0.88 46.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.561 0.22 . . . . 2.5 111.281 -177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.8 m -102.78 17.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.429 0.529 . . . . 0.96999999999999997 112.429 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -86.62 125.7 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.799 -0.445 . . . . 1.0900000000000001 109.799 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.5 1.66 90.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.065 -1.064 . . . . 0.66000000000000003 110.833 -174.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.8 mptp? -94.14 118.11 31.07 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.252 -0.474 . . . . 1.8200000000000001 110.184 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 36.9 t-20 -80.15 103.1 9.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.921 -0.581 . . . . 0.71999999999999997 109.975 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 68.7 t80 -62.22 -13.46 28.05 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 112.16 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 80.4 m-85 -104.82 11.49 33.72 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.856 -0.527 . . . . 1.1599999999999999 111.441 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 64' ' ' LYS . 13.3 tmtt? -149.48 -56.42 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.508 -0.477 . . . . 3.5800000000000001 111.524 -172.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.8 -77.74 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.541 -0.299 . . . . 2.2000000000000002 111.354 -167.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.2 m -78.53 16.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.451 0.538 . . . . 1.77 112.451 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -176.85 97.23 0.24 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.60999999999999999 110.331 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -93.71 1.48 3.25 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 113.447 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.5 4.11 53.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.959 -0.463 . . . . 0.84999999999999998 110.069 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 9.9 p -96.75 -46.81 6.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.617 -1.174 . . . . 1.3300000000000001 110.993 -167.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.47 110.72 0.92 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 1.8500000000000001 110.381 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -177.18 143.85 0.55 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 1.5600000000000001 108.4 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 50.0 Cg_exo -54.3 -29.11 56.08 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.645 2.23 . . . . 1.1699999999999999 112.745 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 8.1 pt-20 -90.67 9.3 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 2.5600000000000001 111.912 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 107' ' ' VAL . 67.3 t80 -142.71 -74.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.054 -0.35 . . . . 3.3599999999999999 110.054 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -65.25 -33.77 76.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 0.79000000000000004 110.29 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -63.73 -34.97 91.39 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.832 -0.699 . . . . 0.59999999999999998 111.955 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.43 -28.29 52.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.203 0.525 . . . . 2.0899999999999999 110.184 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.52 -41.37 96.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 109.662 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -76.5 -20.37 57.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 1.0900000000000001 110.849 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.31 -46.47 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 2.0699999999999998 110.355 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.8 -41.39 83.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.71999999999999997 112.214 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.62 -49.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.84999999999999998 110.765 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.83 76.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 1.1399999999999999 111.219 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.0 m -76.69 -83.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 1.8200000000000001 110.713 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.57 -58.03 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.0 -0.84 . . . . 1.6499999999999999 111.0 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.91 148.66 38.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.526 . . . . 3.5 110.293 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.6 tp -111.03 111.67 22.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.293 -0.632 . . . . 2.96 109.293 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 109' ' ' MET . 15.7 p30 -160.99 58.32 0.3 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.905 0.859 . . . . 2.2400000000000002 109.956 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -107.12 145.47 32.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.859 -1.064 . . . . 1.6299999999999999 110.296 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.5 ttp -122.17 117.88 27.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 1.77 110.319 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 42.6 p90 -138.13 163.88 30.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.298 -0.41 . . . . 3.0099999999999998 110.432 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 35.1 tt0 -109.67 129.12 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.615 -0.513 . . . . 2.3900000000000001 109.615 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.517 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 30.4 t80 -135.14 165.03 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.424 -0.353 . . . . 3.3700000000000001 110.833 -172.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 m -105.25 137.79 42.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.772 0.32 . . . . 1.3999999999999999 111.709 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 105' ' ' VAL . 14.4 m-85 -113.01 108.36 17.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.02 -0.733 . . . . 1.1799999999999999 109.02 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -119.67 8.23 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 2.5699999999999998 110.556 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 28.8 t80 -122.79 131.26 53.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 3.21 108.325 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.56 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 28.6 mm-40 67.96 8.51 6.53 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.219 0.533 . . . . 3.23 110.218 -173.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 23.6 ttt -166.3 140.64 4.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.399 -0.963 . . . . 2.8500000000000001 108.399 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.6 p -64.46 148.84 95.97 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.006 -0.738 . . . . 2.1200000000000001 109.006 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.1 89.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.993 2.462 . . . . 1.47 113.374 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 104' ' ' LYS . 3.8 m -109.97 154.91 22.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.907 -0.588 . . . . 1.3999999999999999 110.277 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 103' ' ' THR . 48.1 mmtm -102.84 117.94 35.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.498 -0.556 . . . . 3.0800000000000001 109.498 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 124' ' ' ARG . 25.0 m -122.0 163.29 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.3300000000000001 110.604 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 33.6 ttpt -109.02 128.6 55.1 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.905 -0.776 . . . . 1.6899999999999999 108.905 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 75' ' ' PHE . 96.3 t -114.11 110.73 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 108.491 -0.929 . . . . 1.27 108.491 -171.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -103.51 119.96 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.871 -0.788 . . . . 1.02 108.871 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.739 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 22.2 mmt -100.07 135.26 41.77 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.639 -0.874 . . . . 2.4900000000000002 108.639 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -150.94 121.93 7.65 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.895 0.379 . . . . 1.5700000000000001 110.858 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 52.9 tttt -78.91 137.46 37.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.214 0.531 . . . . 2.1299999999999999 111.283 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 177.06 8.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.789 -1.189 . . . . 1.5700000000000001 107.789 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.4 -98.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.556 -0.858 . . . . 4.4100000000000001 109.572 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.9 p 43.42 47.15 5.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.82 0.448 . . . . 2.5499999999999998 112.145 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.57 13.76 49.8 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.668 -0.777 . . . . 2.6200000000000001 112.519 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.1 t70 63.76 86.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.735 0.814 . . . . 2.7599999999999998 111.076 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 p -164.86 157.69 16.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.237 -0.892 . . . . 1.0700000000000001 109.611 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 2.6 m-85 -104.68 153.86 20.71 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.823 -0.806 . . . . 0.85999999999999999 108.823 -173.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -102.12 108.78 20.3 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.484 -0.932 . . . . 0.63 108.484 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.767 HG13 HG13 ' A' ' 31' ' ' ILE . 7.4 p -101.87 127.51 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.819 0.819 . . . . 0.91000000000000003 110.645 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -108.63 131.54 54.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.249 -0.887 . . . . 0.79000000000000004 110.317 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.449 HG23 ' HA3' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -111.31 106.81 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.733 0.778 . . . . 1.1799999999999999 111.201 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -103.23 117.19 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.678 . . . . 3.3100000000000001 109.927 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.781 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.6 ptm180 -89.53 157.42 18.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.62 -0.718 . . . . 4.0300000000000002 110.56 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.949 -0.548 . . . . 2.8700000000000001 111.049 175.374 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 98.4 m-85 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 113.147 0.795 . . . . 3.8500000000000001 113.147 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.41 104.59 2.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.357 -0.925 . . . . 0.84999999999999998 111.28 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -140.78 123.09 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.523 0.201 . . . . 0.70999999999999996 110.459 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 42' ' ' TYR . 12.1 pt -125.9 160.85 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 1.0800000000000001 111.102 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -119.72 115.49 24.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.391 -0.368 . . . . 0.85999999999999999 110.348 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD12 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -117.28 146.7 43.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.307 -0.627 . . . . 1.6200000000000001 109.307 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 38' ' ' ASN . 8.1 p30 -107.24 168.69 9.05 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.38 -0.528 . . . . 1.22 110.571 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -10.78 16.25 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 114.362 0.505 . . . . 0.79000000000000004 114.362 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -87.33 -11.25 49.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.358 0.579 . . . . 1.95 110.342 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.27 10.49 60.81 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.484 -1.047 . . . . 0.53000000000000003 110.484 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . 55.7 t30 -85.79 147.37 26.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.631 -0.785 . . . . 1.3 110.26 -174.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.798 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 3.8 mm -93.55 149.46 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.908 -0.404 . . . . 0.89000000000000001 109.908 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -120.3 -62.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 1.45 109.781 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -136.92 131.13 32.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.685 -0.689 . . . . 1.99 110.541 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.752 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.2 m-30 -98.29 179.95 4.56 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 1.25 109.977 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 58.1 t30 -123.01 173.86 7.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.336 -0.616 . . . . 2.1299999999999999 109.336 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.91 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.518 0.562 . . . . 1.48 112.518 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' PHE . . . -73.39 -42.92 61.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.947 0.351 . . . . 1.52 111.947 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.74 -15.52 59.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.348 -0.541 . . . . 2.1200000000000001 110.411 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.28 -6.55 74.36 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.965 -0.854 . . . . 1.4199999999999999 110.965 171.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.27 -48.03 5.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.314 -0.443 . . . . 2.3500000000000001 110.356 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.66 -63.68 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -53.93 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.306 0.484 . . . . 3.4100000000000001 112.306 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.22 18.29 1.34 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.434 -0.889 . . . . 2.3199999999999998 113.433 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -90.46 111.91 23.35 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.952 0.376 . . . . 3.1400000000000001 110.026 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.559 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 25.7 m-20 -71.94 149.22 92.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.567 -0.531 . . . . 2.1000000000000001 109.567 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 77.4 Cg_exo -49.79 -34.12 34.97 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.605 2.87 . . . . 1.6799999999999999 114.304 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -106.38 17.33 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.146 0.425 . . . . 3.6099999999999999 112.146 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 94.7 mt-30 -95.01 -9.28 34.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 2.5 111.074 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.798 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.7 m -104.29 21.55 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.473 0.545 . . . . 0.96999999999999997 112.473 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 115.91 29.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.456 -0.498 . . . . 1.0900000000000001 110.043 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.28 64.1 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.418 -1.073 . . . . 0.66000000000000003 110.418 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.4 mptp? -80.6 147.57 30.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.512 -0.844 . . . . 1.8200000000000001 111.196 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -107.67 113.77 27.28 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.687 -0.486 . . . . 0.71999999999999997 109.687 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.717 ' HB2' HD11 ' A' ' 39' ' ' ILE . 77.4 t80 -52.89 -50.75 63.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.316 -0.402 . . . . 0.69999999999999996 112.038 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.6 m-85 -76.97 5.84 7.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.043 -0.526 . . . . 1.1599999999999999 112.295 -168.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 -47.32 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.151 0.426 . . . . 3.5800000000000001 112.151 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -99.65 -23.77 14.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.218 0.451 . . . . 2.2000000000000002 112.218 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.8 t -120.87 14.46 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.524 -0.47 . . . . 1.77 110.9 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 170.84 86.44 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.89 -0.595 . . . . 0.60999999999999999 110.352 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HG2' ' CE1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -96.0 35.92 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.182 2.588 . . . . 0.81000000000000005 113.582 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 17.2 p -121.73 20.58 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.8 -0.445 . . . . 0.84999999999999998 109.8 171.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -130.14 -44.49 1.15 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.929 -1.487 . . . . 1.3300000000000001 109.668 -136.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 4.5 p-10 -73.32 103.98 4.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.828 0.823 . . . . 1.8500000000000001 109.393 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 64.5 m -163.93 164.59 14.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.506 -0.77 . . . . 1.5600000000000001 109.579 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 6.4 Cg_endo -49.96 -31.06 25.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.072 2.514 . . . . 1.1699999999999999 112.69 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HB3' ' HE2' ' A' ' 94' ' ' TYR . 1.3 mp0 -69.86 -91.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 2.5600000000000001 111.493 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HD1' ' HE2' ' A' ' 63' ' ' PHE . 45.6 t80 -60.74 -56.61 19.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.648 -0.705 . . . . 3.3599999999999999 111.811 -169.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 68.9 t80 -67.95 -38.5 82.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 110.464 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -47.61 90.32 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.59999999999999998 112.744 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.817 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.3 mmpt? -75.76 -28.72 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.931 0.365 . . . . 2.0899999999999999 110.527 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -58.97 -41.61 87.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.339 0.59 . . . . 0.67000000000000004 109.761 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.6 -11.07 49.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.447 -0.797 . . . . 1.0900000000000001 111.306 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 6.9 tp10 -67.42 -40.14 85.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 2.0699999999999998 110.567 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.954 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -71.9 -32.54 63.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.554 -0.832 . . . . 0.71999999999999997 111.227 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 83' ' ' VAL . 20.1 t -66.21 -50.86 65.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.255 -0.472 . . . . 0.84999999999999998 110.673 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.94 83.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.782 -0.644 . . . . 1.1399999999999999 111.769 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 p -77.38 -71.54 0.4 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.045 0.45 . . . . 1.8200000000000001 110.527 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.091 -0.575 . . . . 1.6499999999999999 111.947 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.93 158.15 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 3.5 110.366 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.954 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 1.4 pt? -138.61 135.69 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.987 -0.552 . . . . 2.96 110.057 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 109' ' ' MET . 33.8 p-10 -164.01 47.94 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.445 1.117 . . . . 2.2400000000000002 108.9 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -104.13 154.36 19.83 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.878 -1.51 . . . . 1.6299999999999999 109.955 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -112.95 115.53 28.55 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.107 0.479 . . . . 1.77 110.359 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.36 155.47 31.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 3.0099999999999998 109.199 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.33 121.88 44.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.238 0.542 . . . . 2.3900000000000001 111.18 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.645 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 46.2 m-85 -126.94 167.08 16.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.676 -0.693 . . . . 3.3700000000000001 111.091 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 m -106.68 139.6 40.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.885 -0.598 . . . . 1.3999999999999999 110.535 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CE2' HG11 ' A' ' 105' ' ' VAL . 13.0 m-85 -104.68 119.83 39.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.48 -0.933 . . . . 1.1799999999999999 108.48 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.3 -159.75 1.02 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.289 -0.634 . . . . 2.5699999999999998 109.289 -170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' CE1' ' HG2' ' A' ' 68' ' ' PRO . 90.2 t80 69.5 -76.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.981 0.512 . . . . 3.21 111.123 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -107.01 -26.69 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 3.23 109.646 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.8 tpp -84.86 139.32 31.98 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.606 -0.887 . . . . 2.8500000000000001 108.606 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.6 t -65.58 136.29 96.03 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.797 -1.186 . . . . 2.1200000000000001 107.797 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -43.51 91.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.3 2.666 . . . . 1.47 114.184 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.2 p -108.95 151.8 25.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.289 -0.414 . . . . 1.3999999999999999 111.304 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -109.84 116.44 31.66 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.457 -0.572 . . . . 3.0800000000000001 109.457 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 122' ' ' VAL . 11.3 p -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 1.3300000000000001 111.248 -171.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 105' ' ' VAL . 39.1 ttmt -109.37 118.27 36.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.319 -0.993 . . . . 1.6899999999999999 108.319 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 120' ' ' VAL . 86.3 t -104.55 117.01 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 115.727 -0.67 . . . . 1.27 109.485 -174.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -103.9 105.24 15.38 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.02 108.786 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.2 pmm? -103.68 128.84 50.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.993 -0.549 . . . . 2.4900000000000002 109.729 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 11.6 ptmm? -144.47 138.9 27.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 1.5700000000000001 111.259 -174.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.402 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 13.6 tttt -71.16 128.49 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.996 -0.547 . . . . 2.1299999999999999 111.939 -172.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -115.55 93.96 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.821 -0.807 . . . . 1.5700000000000001 108.821 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.83 83.88 3.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.669 0.747 . . . . 4.4100000000000001 110.906 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t -141.51 26.6 1.94 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.717 -1.129 . . . . 2.5499999999999998 108.534 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.27 25.15 0.42 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.055 -0.975 . . . . 2.6200000000000001 112.055 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 55.93 75.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.138 0.575 . . . . 2.7599999999999998 112.17 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 39.6 t -153.02 165.75 34.58 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.374 -0.973 . . . . 1.0700000000000001 108.374 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.7 m-85 -132.14 157.47 44.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.725 -0.843 . . . . 0.85999999999999999 108.725 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 73.8 m95 -101.22 111.35 23.54 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.861 -0.792 . . . . 0.63 108.861 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 107' ' ' VAL . 3.5 t -102.25 119.8 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.56 0.695 . . . . 0.91000000000000003 109.865 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-85 -104.57 140.63 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 0.79000000000000004 111.185 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 105' ' ' VAL . 54.1 t -104.58 104.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.073 -0.967 . . . . 1.1799999999999999 110.314 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.73 105.13 13.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.956 0.408 . . . . 3.3100000000000001 110.595 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -72.63 109.55 6.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.543 -0.54 . . . . 4.0300000000000002 109.543 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.504 -0.76 . . . . 2.8700000000000001 110.393 -178.254 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 p90 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.196 -0.298 . . . . 3.8500000000000001 110.196 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.44 112.61 4.26 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.309 -0.948 . . . . 0.84999999999999998 111.917 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -103.83 129.53 51.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.70999999999999996 110.923 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.528 ' HB ' HG13 ' A' ' 120' ' ' VAL . 58.2 mt -125.7 149.82 30.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.431 -0.804 . . . . 1.0800000000000001 108.999 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 31' ' ' ILE . 60.8 tt0 -115.18 122.89 47.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.115 -0.698 . . . . 0.85999999999999999 109.115 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD22 ' CG1' ' A' ' 120' ' ' VAL . 1.9 pt? -134.81 156.29 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.248 0.342 . . . . 1.6200000000000001 110.738 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 26.8 p30 -102.5 167.95 9.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.94 -0.304 . . . . 1.22 110.687 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.42 -2.71 3.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 114.963 0.745 . . . . 0.79000000000000004 114.963 -173.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.28 -18.92 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.581 0.691 . . . . 1.95 110.81 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 114.13 15.2 8.59 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.416 -0.897 . . . . 0.53000000000000003 113.254 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.7 m-20 -86.44 135.58 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 117.125 0.463 . . . . 1.3 110.141 177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 62' ' ' PHE . 23.0 mm -89.27 149.1 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.181 -0.463 . . . . 0.89000000000000001 109.938 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -121.19 -72.44 0.69 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.312 0.577 . . . . 1.45 110.177 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.4 134.19 55.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.719 -0.673 . . . . 1.99 111.666 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.547 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.3 m-85 -103.43 144.58 31.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.058 -0.974 . . . . 1.25 109.586 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 3.9 t30 -82.78 4.48 25.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.495 0.664 . . . . 2.1299999999999999 109.473 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.41 -22.39 0.24 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.36 -1.291 . . . . 1.48 112.228 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -65.32 -18.67 65.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.313 0.486 . . . . 1.52 112.313 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' HD11 ' A' ' 31' ' ' ILE . 2.6 tm-20 -70.39 -23.91 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.857 -0.794 . . . . 2.1200000000000001 108.857 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.13 13.4 67.76 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.777 -0.725 . . . . 1.4199999999999999 112.076 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.26 -44.76 71.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.163 0.506 . . . . 2.3500000000000001 110.314 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 49' ' ' ILE . 4.1 pt -78.45 -47.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.898 -0.592 . . . . 2.5899999999999999 112.153 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -61.93 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.995 0.426 . . . . 3.4100000000000001 110.945 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 138.89 126.5 2.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.893 -0.67 . . . . 2.3199999999999998 111.78 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 51' ' ' GLY . 26.6 mmt180 -139.1 156.12 47.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.39 -0.596 . . . . 3.1400000000000001 109.39 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.5 m-20 -103.21 120.04 53.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.044 0.449 . . . . 2.1000000000000001 111.311 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 26.4 Cg_exo -62.1 118.95 5.85 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.947 2.431 . . . . 1.6799999999999999 112.337 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 62.6 mttp 82.29 5.38 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.851 -1.068 . . . . 3.6099999999999999 112.224 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.25 -1.17 57.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.523 0.678 . . . . 2.5 109.558 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.795 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.5 m -98.88 10.29 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.143 -0.935 . . . . 0.96999999999999997 111.616 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 42.8 mt -80.99 132.27 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.345 -0.613 . . . . 1.0900000000000001 109.345 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.17 75.86 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.391 -0.909 . . . . 0.66000000000000003 110.842 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 17.0 mttm -109.52 132.04 54.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.121 -0.696 . . . . 1.8200000000000001 109.121 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.1 t-20 -90.0 102.98 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.755 -0.461 . . . . 0.71999999999999997 109.755 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.025 ' HB2' HD11 ' A' ' 39' ' ' ILE . 70.9 t80 -49.82 -39.15 37.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.69999999999999996 111.785 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.677 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m-85 -76.51 -20.5 56.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 1.1599999999999999 112.435 -171.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -116.84 -30.5 5.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.215 0.45 . . . . 3.5800000000000001 112.215 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -89.14 -79.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.037 0.384 . . . . 2.2000000000000002 112.037 -170.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 p -99.77 13.96 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.699 0.762 . . . . 1.77 111.685 -169.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.3 69.91 0.81 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.455 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 39.4 Cg_endo -68.94 11.31 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.644 2.229 . . . . 0.81000000000000005 113.688 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.8 m -79.92 -30.54 40.01 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.84999999999999998 109.717 173.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.677 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 17.3 p -78.93 -38.56 36.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.722 -1.127 . . . . 1.3300000000000001 110.383 -158.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 25.6 t70 -64.18 100.19 0.32 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.218 -0.66 . . . . 1.8500000000000001 109.218 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 30.5 t -149.63 147.78 23.9 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.919 -0.582 . . . . 1.5600000000000001 109.985 -171.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.38 -29.39 23.67 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.044 2.496 . . . . 1.1699999999999999 112.156 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.8 pt-20 -93.65 -60.03 1.86 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.638 -0.425 . . . . 2.5600000000000001 111.283 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 81.5 t80 -68.7 -52.31 32.23 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.198 -0.314 . . . . 3.3599999999999999 111.564 -169.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 51.7 t80 -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.79000000000000004 109.486 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.95 79.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.485 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 64.2 mmtt -81.91 -30.82 31.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.97 0.414 . . . . 2.0899999999999999 110.159 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -65.53 -30.64 71.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.67000000000000004 110.734 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 31.3 mmmt -82.79 -9.2 59.45 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.334 -0.848 . . . . 1.0900000000000001 111.47 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -58.88 -33.83 70.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.489 -0.323 . . . . 2.0699999999999998 111.71 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 1.058 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -88.08 -37.14 7.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.301 -0.952 . . . . 0.71999999999999997 112.139 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.04 -46.18 77.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.893 0.477 . . . . 0.84999999999999998 111.227 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -23.9 64.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 1.1399999999999999 111.798 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.2 m -104.99 -81.25 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.351 0.596 . . . . 1.8200000000000001 110.548 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.31 -48.6 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.886 -0.886 . . . . 1.6499999999999999 110.886 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.936 ' HA ' ' HG3' ' A' ' 111' ' ' LYS . 1.4 p-10 -124.17 150.94 44.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.868 -0.666 . . . . 3.5 111.335 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.058 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 56.5 tp -144.29 114.96 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 2.96 109.708 174.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 109' ' ' MET . 49.2 m-20 -124.8 89.61 3.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.613 . . . . 2.2400000000000002 109.667 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -124.74 165.58 17.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.159 -0.928 . . . . 1.6299999999999999 111.319 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.6 ttp -136.68 111.06 8.48 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.374 -0.973 . . . . 1.77 108.374 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -121.68 163.44 19.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.482 -0.326 . . . . 3.0099999999999998 110.211 -171.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -116.4 124.75 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.252 -0.647 . . . . 2.3900000000000001 109.252 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -138.08 159.19 42.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.294 -0.261 . . . . 3.3700000000000001 110.294 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.84 142.53 34.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.313 -0.403 . . . . 1.3999999999999999 111.085 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -107.51 132.74 52.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.172 -0.467 . . . . 1.1799999999999999 109.753 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 100' ' ' MET . 13.1 t70 -143.21 -150.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.452 -0.944 . . . . 2.5699999999999998 108.452 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.7 t80 66.3 -82.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.759 0.424 . . . . 3.21 111.151 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -99.6 -24.18 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.262 0.553 . . . . 3.23 109.819 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 101' ' ' THR . 52.6 tpp -91.79 141.61 28.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.847 . . . . 2.8500000000000001 108.996 173.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -72.38 143.17 85.18 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 108.757 -0.831 . . . . 2.1200000000000001 108.757 170.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -40.41 90.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.779 2.986 . . . . 1.47 114.186 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 m -123.24 144.64 49.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 1.3999999999999999 109.942 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.62 142.89 33.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.383 . . . . 3.0800000000000001 110.123 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -128.78 164.52 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.06 -0.518 . . . . 1.3300000000000001 110.505 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -108.72 117.88 35.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.13 -1.063 . . . . 1.6899999999999999 108.13 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.418 HG11 ' HE2' ' A' ' 75' ' ' PHE . 11.7 p -104.59 133.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.412 0.625 . . . . 1.27 109.655 -172.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.7 OUTLIER -111.18 109.88 20.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.964 -0.754 . . . . 1.02 108.964 -177.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 44.9 tpp -102.23 123.76 46.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.23 -0.655 . . . . 2.4900000000000002 109.23 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -141.81 136.43 30.63 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.588 -0.153 . . . . 1.5700000000000001 110.588 -174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.936 ' HG3' ' HA ' ' A' ' 87' ' ' ASN . 7.7 tmtt? -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.171 0.51 . . . . 2.1299999999999999 110.813 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.635 ' N ' ' HD3' ' A' ' 111' ' ' LYS . . . -146.62 160.46 42.15 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.549 -0.75 . . . . 1.5700000000000001 109.913 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -103.23 -0.62 30.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.746 0.308 . . . . 4.4100000000000001 110.479 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -61.78 106.47 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.505 -0.924 . . . . 2.5499999999999998 108.505 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.96 -103.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.526 -1.429 . . . . 2.6200000000000001 109.526 -164.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -179.07 84.54 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.775 -0.824 . . . . 2.7599999999999998 108.775 167.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 2.6 p -166.0 -172.24 2.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.447 -0.797 . . . . 1.0700000000000001 111.237 -171.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 75.0 m-85 -110.86 155.32 22.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.489 -0.56 . . . . 0.85999999999999999 109.489 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -103.71 107.78 18.79 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.297 -1.001 . . . . 0.63 108.297 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.528 HG13 ' HB ' ' A' ' 31' ' ' ILE . 12.5 p -100.64 131.86 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.702 0.763 . . . . 0.91000000000000003 110.369 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.0 m-85 -115.2 128.82 56.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.457 -0.792 . . . . 0.79000000000000004 109.84 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -104.33 102.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.193 0.521 . . . . 1.1799999999999999 109.626 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -112.42 110.32 20.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 3.3100000000000001 109.698 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 5.7 ptm180 -74.6 166.55 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.535 -0.466 . . . . 4.0300000000000002 110.493 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.736 -0.65 . . . . 2.8700000000000001 109.81 177.547 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.989 -0.745 . . . . 3.8500000000000001 108.989 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -102.47 115.56 5.24 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.332 -0.937 . . . . 0.84999999999999998 112.925 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' A' ' 43' ' ' ASN . . . -104.33 104.2 14.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 109.844 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 120' ' ' VAL . 29.6 mt -113.09 158.23 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.818 -0.808 . . . . 1.0800000000000001 108.818 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 48.9 tt0 -120.08 112.66 19.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.807 -0.558 . . . . 0.85999999999999999 110.32 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.677 ' HG ' HG11 ' A' ' 120' ' ' VAL . 6.7 mt -114.05 142.92 45.58 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.895 -0.78 . . . . 1.6200000000000001 108.895 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -102.71 168.96 8.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.769 -0.372 . . . . 1.22 110.275 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -50.58 -33.39 25.86 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.672 0.629 . . . . 0.79000000000000004 114.672 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.04 -21.09 43.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.357 0.578 . . . . 1.95 111.45 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.3 17.36 10.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.579 -0.82 . . . . 0.53000000000000003 112.75 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 79.2 m-20 -83.16 147.7 27.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.372 . . . . 1.3 110.343 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.033 HD11 ' HB2' ' A' ' 62' ' ' PHE . 13.5 mm -92.76 145.31 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.703 -0.681 . . . . 0.89000000000000001 110.287 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.8 mm? -97.68 -62.59 1.23 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 1.45 110.609 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -170.07 158.5 7.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.953 -1.021 . . . . 1.99 109.949 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.532 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 9.6 m-30 -110.94 147.74 33.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.523 -0.762 . . . . 1.25 109.376 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 30' ' ' ALA . 28.5 p-10 -80.36 -173.17 3.91 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.666 -0.494 . . . . 2.1299999999999999 109.666 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -78.21 20.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.009 0.374 . . . . 1.48 112.009 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . . . -97.38 -65.17 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.052 0.39 . . . . 1.52 112.052 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 27.9 tp10 -61.12 -51.02 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.682 -0.69 . . . . 2.1200000000000001 111.172 -172.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.96 -3.81 81.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.082 -0.58 . . . . 1.4199999999999999 112.648 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 34.7 t70 -84.2 -18.76 35.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.347 0.594 . . . . 2.3500000000000001 110.204 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -110.22 -65.18 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.57 -0.741 . . . . 2.5899999999999999 111.041 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.9 m -155.74 -42.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.524 0.202 . . . . 3.4100000000000001 111.42 -174.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -61.15 88.04 0.04 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 115.03 0.772 . . . . 2.3199999999999998 115.03 -170.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 20.0 mmm180 61.15 -176.87 0.12 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.999 0.904 . . . . 3.1400000000000001 113.273 170.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 5.8 t70 -102.75 132.68 21.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 114.471 -1.24 . . . . 2.1000000000000001 108.293 169.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 50.2 Cg_exo -55.29 -20.45 25.23 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.369 2.713 . . . . 1.6799999999999999 114.438 -174.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 1.9 mppt? -109.49 -3.49 16.96 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.037 -0.265 . . . . 3.6099999999999999 111.437 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -104.08 24.56 11.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.082 0.467 . . . . 2.5 111.784 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.76 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 m -118.52 10.99 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.035 0.445 . . . . 0.96999999999999997 111.319 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.73 133.33 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.653 -0.419 . . . . 1.0900000000000001 110.507 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.31 72.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.265 -0.734 . . . . 0.66000000000000003 111.265 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.55 148.25 47.91 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.659 -0.271 . . . . 1.8200000000000001 110.526 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 8.1 t-20 -98.96 125.16 44.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.035 0.445 . . . . 0.71999999999999997 111.512 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.033 ' HB2' HD11 ' A' ' 39' ' ' ILE . 48.5 t80 -64.72 -9.32 19.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 0.69999999999999996 111.868 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 52.0 m-85 -122.65 20.55 10.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.849 0.357 . . . . 1.1599999999999999 110.439 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 44.3 mmtm -150.79 -45.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 3.5800000000000001 111.824 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -101.84 -79.05 0.52 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 2.2000000000000002 111.389 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 HG12 ' A' ' 57' ' ' VAL . 14.7 m -84.14 15.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 1.77 112.54 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -172.64 97.06 0.36 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.60999999999999999 109.89 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.92 19.87 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.19 2.593 . . . . 0.81000000000000005 113.674 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -110.79 13.63 22.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.484 -0.486 . . . . 0.84999999999999998 109.839 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.9 p -112.74 -43.73 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.943 -1.026 . . . . 1.3300000000000001 111.055 -164.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -65.22 105.06 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 1.8500000000000001 110.506 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.602 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 9.7 t -170.54 149.79 3.12 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 109.349 -0.612 . . . . 1.5600000000000001 109.349 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 47.6 Cg_exo -39.38 -43.46 2.77 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.281 3.32 . . . . 1.1699999999999999 114.98 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.674 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.38 -39.47 11.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.785 -0.366 . . . . 2.5600000000000001 111.748 -176.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 70' ' ' THR . 28.3 m-85 -71.74 -69.29 0.4 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.176 0.513 . . . . 3.3599999999999999 110.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.8 t80 -61.66 -32.7 72.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.79000000000000004 110.193 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -59.83 -31.34 71.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 112.915 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 30.9 mmtp -78.05 -34.22 50.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.219 0.51 . . . . 2.0899999999999999 110.836 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.58 -26.55 68.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 0.67000000000000004 110.334 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 19.5 mmmt -93.13 -6.54 47.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 1.0900000000000001 112.038 -175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 6.6 mm-40 -58.14 -42.35 85.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.268 0.47 . . . . 2.0699999999999998 112.268 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -76.38 -41.36 25.83 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.999 -1.096 . . . . 0.71999999999999997 111.234 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.43 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.3 t -50.22 -48.15 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 123.121 0.568 . . . . 0.84999999999999998 111.121 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.42 -32.35 49.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.732 -0.667 . . . . 1.1399999999999999 112.502 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -90.08 -66.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.844 0.354 . . . . 1.8200000000000001 110.198 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.74 34.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.749 . . . . 1.6499999999999999 111.864 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.793 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 2.4 m-20 65.88 105.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.277 -0.638 . . . . 3.5 109.277 -176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.464 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 33.6 tp -143.45 159.35 42.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.132 -0.627 . . . . 2.96 111.757 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 109' ' ' MET . 18.9 t30 -82.05 112.83 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.036 -0.984 . . . . 2.2400000000000002 111.224 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -125.27 146.48 49.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 1.6299999999999999 110.157 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.3 ptp -116.73 129.37 56.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.839 0.352 . . . . 1.77 110.216 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 13.1 p90 -141.63 148.13 38.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.861 0.362 . . . . 3.0099999999999998 110.968 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.94 116.67 30.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 2.3900000000000001 109.914 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 38.7 m-85 -142.21 168.02 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.1 -0.5 . . . . 3.3700000000000001 110.91 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 104' ' ' LYS . 36.2 p -102.85 156.86 17.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.968 -0.56 . . . . 1.3999999999999999 111.654 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -116.27 108.96 16.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 1.1799999999999999 109.194 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' MET . 7.1 p-10 -121.26 -153.75 0.56 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.943 -0.571 . . . . 2.5699999999999998 110.236 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 65.8 t80 71.43 -73.81 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.959 0.503 . . . . 3.21 111.477 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.44 -26.28 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.441 0.638 . . . . 3.23 109.807 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 16.5 tpt -103.31 140.61 37.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.17 -0.923 . . . . 2.8500000000000001 109.499 176.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 m -60.03 117.7 25.98 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.71 -0.848 . . . . 2.1200000000000001 108.71 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -38.15 93.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.096 3.197 . . . . 1.47 114.254 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 160.48 18.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 109.611 172.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.1 ptpt -115.49 146.49 41.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 3.0800000000000001 111.493 -178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 124' ' ' ARG . 18.9 m -130.6 165.66 30.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.004 -0.998 . . . . 1.3300000000000001 110.295 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -112.7 118.01 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.556 -0.905 . . . . 1.6899999999999999 108.556 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -105.02 104.87 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.88 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -103.79 102.81 12.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.492 -0.929 . . . . 1.02 108.492 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 5.2 ppp? -107.85 140.79 40.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.585 -0.734 . . . . 2.4900000000000002 110.507 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.724 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 62.2 pttt -150.98 152.03 32.96 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.043 0.449 . . . . 1.5700000000000001 111.489 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.793 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 33.2 ttpt -75.58 136.62 40.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.696 -0.684 . . . . 2.1299999999999999 112.552 -172.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -130.98 107.29 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.369 -0.832 . . . . 1.5700000000000001 109.312 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -74.45 1.85 10.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.341 -0.39 . . . . 4.4100000000000001 111.135 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -51.89 -45.82 64.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 2.5499999999999998 111.149 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.36 29.15 2.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.587 -0.816 . . . . 2.6200000000000001 112.437 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.94 60.51 3.43 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.271 0.558 . . . . 2.7599999999999998 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.44 ' OG ' ' HG2' ' A' ' 32' ' ' GLN . 32.5 t -164.55 164.53 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.373 -0.973 . . . . 1.0700000000000001 108.373 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.762 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 21.1 m-85 -104.95 156.38 18.08 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.843 -0.429 . . . . 0.85999999999999999 109.843 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 62.8 m95 -101.58 106.12 17.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.398 -0.964 . . . . 0.63 108.398 172.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.677 HG11 ' HG ' ' A' ' 33' ' ' LEU . 4.2 p -101.94 122.51 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.86 0.838 . . . . 0.91000000000000003 110.473 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.724 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 94.4 m-85 -104.28 109.92 21.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.113 -0.949 . . . . 0.79000000000000004 109.676 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.17 108.06 23.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.08 -0.963 . . . . 1.1799999999999999 109.914 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -104.5 127.8 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 3.3100000000000001 110.241 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.728 ' HA ' HG12 ' A' ' 105' ' ' VAL . 49.7 mtm-85 -70.44 127.91 34.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.006 -0.543 . . . . 4.0300000000000002 109.732 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 104' ' ' LYS . 3.0 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.938 -1.03 . . . . 2.8700000000000001 111.326 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.233 0.197 0 N-CA-C 109.603 -0.517 . . . . 3.8500000000000001 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.2 148.33 17.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.377 -0.916 . . . . 0.84999999999999998 112.518 -174.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' HD22 ' A' ' 43' ' ' ASN . . . -138.9 105.05 5.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.842 0.353 . . . . 0.70999999999999996 110.338 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.837 ' HB ' HG13 ' A' ' 120' ' ' VAL . 11.3 mm -108.67 160.83 7.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.767 -0.827 . . . . 1.0800000000000001 108.767 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 31' ' ' ILE . 59.2 tt0 -128.43 118.7 23.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.69 -0.485 . . . . 0.85999999999999999 109.69 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 120' ' ' VAL . 17.1 mt -116.05 155.51 28.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.699 -0.482 . . . . 1.6200000000000001 109.699 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.4 p30 -108.76 169.38 8.7 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.867 -0.333 . . . . 1.22 110.259 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.2 -20.52 6.92 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.3 0.88 . . . . 0.79000000000000004 115.3 -171.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.24 -19.84 23.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.901 0.851 . . . . 1.95 110.636 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.76 6.49 23.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.762 -0.733 . . . . 0.53000000000000003 112.292 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.645 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 89.7 m-20 -71.61 149.71 45.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.915 0.388 . . . . 1.3 110.486 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.0 mt -95.4 149.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.693 -0.685 . . . . 0.89000000000000001 109.37 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.1 mp -113.49 -56.76 2.37 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.45 109.879 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -150.77 144.27 25.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.027 -0.988 . . . . 1.99 111.142 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.067 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.2 m-30 -101.1 175.26 5.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.575 -1.193 . . . . 1.25 110.271 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.44 HD22 ' HB3' ' A' ' 30' ' ' ALA . 18.2 t-20 -102.41 179.72 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.61 -0.885 . . . . 2.1299999999999999 108.61 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -86.56 13.51 8.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.833 0.349 . . . . 1.48 110.493 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -89.92 -40.98 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 1.52 110.828 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 11.4 mp0 -59.74 -55.03 39.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 2.1200000000000001 110.374 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 51' ' ' GLY . . . -61.96 -30.8 76.41 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.562 -0.744 . . . . 1.4199999999999999 112.875 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.4 t70 -62.61 -33.43 74.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 2.3500000000000001 110.548 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.494 HG22 HG22 ' A' ' 50' ' ' THR . 44.7 mt -81.77 -62.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.776 -0.647 . . . . 2.5899999999999999 109.915 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 49' ' ' ILE . 9.4 t -179.44 131.43 0.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.157 -0.474 . . . . 3.4100000000000001 110.464 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . 57.33 -157.2 13.7 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.932 -0.576 . . . . 2.3199999999999998 112.808 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 4.4 mpp_? 53.95 79.85 0.12 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.755 -0.723 . . . . 3.1400000000000001 111.748 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' A' ' 56' ' ' GLN . 21.9 t70 -79.96 136.24 54.5 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 2.1000000000000001 110.598 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.067 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 11.1 Cg_endo -54.5 -33.56 78.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.667 2.911 . . . . 1.6799999999999999 114.123 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.94 2.02 48.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.434 . . . . 3.6099999999999999 111.129 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' CB ' ' HB3' ' A' ' 53' ' ' ASP . 22.4 tt0 -92.9 -8.4 43.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 2.5 110.966 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG21 ' CD2' ' A' ' 42' ' ' TYR . 3.2 m -112.93 58.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.623 0.601 . . . . 0.96999999999999997 112.623 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 40' ' ' LEU . 11.4 mt -122.39 139.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.687 -0.633 . . . . 1.0900000000000001 110.031 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.13 75.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.622 -0.799 . . . . 0.66000000000000003 111.191 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -114.36 139.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.147 -0.527 . . . . 1.8200000000000001 110.118 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.95 113.35 20.48 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.853 -0.425 . . . . 0.71999999999999997 109.853 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.2 t80 -47.21 -46.59 24.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.663 -0.699 . . . . 0.69999999999999996 111.542 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.862 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 49.6 m-85 -80.22 7.77 8.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 1.1599999999999999 111.614 -172.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -124.37 -50.77 1.76 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 3.5800000000000001 110.991 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.44 -79.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.687 0.625 . . . . 2.2000000000000002 112.687 -174.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.26 16.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.251 0.548 . . . . 1.77 111.373 -168.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB1' ' OG1' ' A' ' 70' ' ' THR . . . -165.93 70.45 1.22 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.60999999999999999 110.851 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.11 -6.28 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.901 2.401 . . . . 0.81000000000000005 113.17 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 7.5 p -84.59 -22.15 30.13 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.415 -0.587 . . . . 0.84999999999999998 109.415 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.556 ' OG1' ' HB1' ' A' ' 67' ' ' ALA . 2.2 m -79.38 -32.96 43.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.847 -1.524 . . . . 1.3300000000000001 110.477 -160.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.862 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 12.1 t70 -62.9 108.58 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.7 -0.682 . . . . 1.8500000000000001 109.999 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -162.95 155.78 16.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 1.5600000000000001 109.496 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.94 -32.7 97.93 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.374 2.049 . . . . 1.1699999999999999 111.913 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -80.44 -9.79 59.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 2.5600000000000001 112.482 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' A' ' 70' ' ' THR . 62.0 t80 -130.05 -67.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.109 -0.37 . . . . 3.3599999999999999 110.806 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -56.61 -41.53 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.79000000000000004 110.332 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.35 -34.3 84.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.04 -0.6 . . . . 0.59999999999999998 112.594 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.3 -36.95 38.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.391 . . . . 2.0899999999999999 110.243 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' HD1' ' HG2' ' A' ' 109' ' ' MET . 34.9 t80 -57.4 -44.54 84.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.67000000000000004 109.428 172.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -75.68 -18.91 59.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 1.0900000000000001 111.781 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -38.36 82.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.827 -0.434 . . . . 2.0699999999999998 109.827 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.682 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.34 -45.97 35.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.73 -0.748 . . . . 0.71999999999999997 111.481 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' PHE . 28.1 t -50.59 -48.52 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 122.979 0.511 . . . . 0.84999999999999998 111.1 176.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.4 -20.32 62.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.627 -0.715 . . . . 1.1399999999999999 112.01 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -99.14 -81.86 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.878 0.37 . . . . 1.8200000000000001 110.436 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.0 -60.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.826 -0.702 . . . . 1.6499999999999999 111.774 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -98.72 130.84 45.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.533 . . . . 3.5 109.627 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.682 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER -115.49 104.45 11.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.914 -0.773 . . . . 2.96 108.914 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.1 p-10 -149.32 95.44 2.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.135 0.969 . . . . 2.2400000000000002 110.227 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.9 m -142.86 145.16 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.112 -0.949 . . . . 1.6299999999999999 109.894 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -120.1 117.83 28.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.061 0.458 . . . . 1.77 109.778 174.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.03 154.15 36.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.04 -0.726 . . . . 3.0099999999999998 109.04 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 pt-20 -103.2 103.49 13.54 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 2.3900000000000001 110.553 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -110.78 161.27 15.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.704 -1.135 . . . . 3.3700000000000001 109.96 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' THR . 13.6 m -104.13 129.28 51.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.14 -0.482 . . . . 1.3999999999999999 110.938 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -103.35 104.62 14.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 1.1799999999999999 108.482 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.59 8.39 9.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 2.5699999999999998 111.793 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 71.6 t80 -79.22 -82.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.555 -0.293 . . . . 3.21 110.69 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -87.37 -37.86 16.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 3.23 109.77 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.0 ttt -82.2 139.9 34.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.766 -0.827 . . . . 2.8500000000000001 108.766 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.16 143.55 92.26 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 109.264 -0.643 . . . . 2.1200000000000001 109.264 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -42.48 89.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.64 2.893 . . . . 1.47 114.187 -174.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.8 m -108.14 145.9 33.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.977 -0.556 . . . . 1.3999999999999999 110.585 175.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -103.34 104.73 14.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.143 0.497 . . . . 3.0800000000000001 110.443 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.7 m -117.15 165.51 12.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.625 -0.716 . . . . 1.3300000000000001 109.973 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 35.9 ttmt -110.94 119.39 38.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.622 -0.881 . . . . 1.6899999999999999 108.622 177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 91' ' ' MET . 54.9 t -105.64 127.12 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 115.408 -0.815 . . . . 1.27 108.848 -171.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 2.2 t-160 -109.97 114.45 27.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.31 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 4.1 mpp? -101.45 119.83 39.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.007 -0.738 . . . . 2.4900000000000002 109.007 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 58.7 pttt -143.25 124.52 14.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.413 0.625 . . . . 1.5700000000000001 112.227 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 42.8 tttt -57.68 126.5 27.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.664 -1.153 . . . . 2.1299999999999999 111.162 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -174.79 94.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.091 0.774 . . . . 1.5700000000000001 113.091 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.021 HD11 ' H ' ' A' ' 117' ' ' SER . 0.2 OUTLIER 177.73 -174.98 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.005 0.522 . . . . 4.4100000000000001 111.431 167.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 t -77.22 77.63 3.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.529 -0.915 . . . . 2.5499999999999998 108.529 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.14 -134.06 3.62 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.753 -1.213 . . . . 2.6200000000000001 112.979 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -143.32 25.32 1.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 2.7599999999999998 110.648 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 1.021 ' H ' HD11 ' A' ' 113' ' ' LEU . 4.3 m -98.87 167.32 10.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.943 -0.762 . . . . 1.0700000000000001 108.943 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -127.13 156.99 40.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.002 0.43 . . . . 0.85999999999999999 110.216 -169.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.627 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 35.9 m95 -101.02 110.63 22.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.942 -0.762 . . . . 0.63 108.942 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 31' ' ' ILE . 3.5 p -103.25 107.87 23.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.512 1.149 . . . . 0.91000000000000003 110.59 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.627 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 95.7 m-85 -102.78 140.72 36.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.734 -1.121 . . . . 0.79000000000000004 110.697 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.87 104.15 16.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 1.1799999999999999 109.744 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.99 126.01 51.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.559 . . . . 3.3100000000000001 109.807 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HA ' HG12 ' A' ' 105' ' ' VAL . 44.3 mtm180 -79.8 143.79 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.789 -0.365 . . . . 4.0300000000000002 110.372 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.337 -0.84 . . . . 2.8700000000000001 109.899 179.415 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 110.085 -0.339 . . . . 3.8500000000000001 110.085 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.61 135.75 12.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.445 -0.883 . . . . 0.84999999999999998 113.243 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.9 104.62 12.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.514 -0.55 . . . . 0.70999999999999996 109.514 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 120' ' ' VAL . 60.5 mt -112.77 142.65 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.557 -0.534 . . . . 1.0800000000000001 109.557 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -109.41 116.19 31.37 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.553 -0.459 . . . . 0.85999999999999999 109.834 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 117' ' ' SER . 2.7 mm? -103.83 165.43 11.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.809 -1.182 . . . . 1.6200000000000001 107.809 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 47.3 p30 -108.19 167.16 10.21 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 1.22 110.333 173.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -60.54 -2.12 2.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 114.403 0.521 . . . . 0.79000000000000004 114.403 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -100.33 -47.33 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.534 0.667 . . . . 1.95 109.675 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.46 6.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.501 -0.772 . . . . 0.53000000000000003 112.558 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -76.96 149.61 35.95 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.969 0.414 . . . . 1.3 110.43 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 12.6 mt -95.96 148.13 5.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.663 -0.699 . . . . 0.89000000000000001 109.591 175.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 8.4 mp -115.64 -64.85 1.26 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.326 0.584 . . . . 1.45 111.945 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -150.66 158.8 44.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.219 -0.9 . . . . 1.99 110.641 -173.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 39' ' ' ILE . 5.3 m-30 -121.21 -174.19 2.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.065 -0.971 . . . . 1.25 110.158 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -114.81 178.96 4.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.844 -0.799 . . . . 2.1299999999999999 108.844 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.87 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 1.48 110.467 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -43.67 -63.82 0.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.847 . . . . 1.52 112.786 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -61.99 -37.9 86.57 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.796 0.331 . . . . 2.1200000000000001 111.792 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.27 94.59 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.807 -0.711 . . . . 1.4199999999999999 111.681 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.0 -38.17 82.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.538 0.335 . . . . 2.3500000000000001 111.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 45' ' ' ALA . 48.9 mt -56.53 -60.31 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.075 0.464 . . . . 2.5899999999999999 110.692 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 51' ' ' GLY . 8.8 t -144.69 -42.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.139 -0.482 . . . . 3.4100000000000001 111.071 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 50' ' ' THR . . . 139.64 77.47 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.395 -0.907 . . . . 2.3199999999999998 112.192 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 1.2 mpt_? -118.14 119.78 35.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.822 0.344 . . . . 3.1400000000000001 110.28 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.73 133.32 31.08 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 2.1000000000000001 111.255 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 31.8 Cg_exo -60.37 -28.87 87.61 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.038 2.492 . . . . 1.6799999999999999 112.16 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 10.9 mmpt? -79.82 -12.2 59.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.434 -0.348 . . . . 3.6099999999999999 111.616 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -89.52 -24.6 21.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 2.5 111.325 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.734 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 m -98.64 16.31 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.96999999999999997 113.462 -170.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.59 125.46 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.266 -0.574 . . . . 1.0900000000000001 109.969 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 -1.77 88.37 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.289 -0.957 . . . . 0.66000000000000003 110.861 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' ILE . 14.0 mptt -95.93 140.61 30.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.854 -0.673 . . . . 1.8200000000000001 109.877 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 14.4 t-20 -90.34 116.87 28.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.408 -0.59 . . . . 0.71999999999999997 109.408 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' HA ' HD11 ' A' ' 39' ' ' ILE . 89.0 t80 -56.24 -42.3 77.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.865 -0.607 . . . . 0.69999999999999996 111.278 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.4 m-85 -82.06 1.25 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.595 . . . . 1.1599999999999999 111.399 -170.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.4 mmtp -122.23 -58.32 1.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.94 0.4 . . . . 3.5800000000000001 111.559 -176.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.31 -76.98 0.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.743 -0.662 . . . . 2.2000000000000002 111.969 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 14.6 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.042 0.925 . . . . 1.77 111.716 -172.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -169.69 74.03 0.68 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.234 -0.893 . . . . 0.60999999999999999 110.636 175.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.45 -18.24 43.74 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.151 2.567 . . . . 0.81000000000000005 113.393 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.78 -8.06 59.03 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.975 -0.29 . . . . 0.84999999999999998 110.513 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -86.78 -19.97 28.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 1.3300000000000001 110.73 -176.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 16.8 t70 -67.93 96.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 1.8500000000000001 110.285 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' ' OE1' ' A' ' 74' ' ' GLU . 74.9 m -166.11 148.58 6.28 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.5600000000000001 109.477 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -53.27 -35.94 76.13 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.008 2.472 . . . . 1.1699999999999999 113.294 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 72' ' ' SER . 1.4 pm0 -86.36 -7.3 58.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.053 0.39 . . . . 2.5600000000000001 112.053 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 51.4 m-85 -112.56 -81.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 3.3599999999999999 109.927 173.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 75.2 t80 -59.67 -37.69 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.487 -0.779 . . . . 0.79000000000000004 110.555 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.24 94.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.088 -0.577 . . . . 0.59999999999999998 112.136 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 67.9 mmtt -67.8 -38.15 82.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.379 . . . . 2.0899999999999999 110.816 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 34' ' ' ASP . 93.6 t80 -57.5 -42.36 82.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.67000000000000004 110.614 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -85.91 -13.95 46.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.645 -0.707 . . . . 1.0900000000000001 110.854 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -41.45 86.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.192 0.52 . . . . 2.0699999999999998 109.699 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.892 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -70.16 -32.13 69.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.71999999999999997 111.545 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.63 -51.09 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.84999999999999998 110.354 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.47 67.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 1.1399999999999999 111.677 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -93.27 -77.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 1.8200000000000001 110.735 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.19 -64.8 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.62 -0.592 . . . . 1.6499999999999999 111.62 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.781 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -121.99 155.56 35.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.649 -0.5 . . . . 3.5 109.649 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.892 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 2.4 tm? -135.1 104.34 5.89 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.277 -0.638 . . . . 2.96 109.277 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 110' ' ' LYS . 25.5 m-80 -133.28 93.98 3.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.805 -0.813 . . . . 2.2400000000000002 108.805 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.9 p -134.24 164.07 28.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.221 -0.899 . . . . 1.6299999999999999 110.882 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.8 ptt? -132.89 109.0 9.3 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.644 -0.707 . . . . 1.77 109.66 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -104.62 155.53 18.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.012 -0.995 . . . . 3.0099999999999998 109.818 -172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -117.57 111.7 19.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.047 -0.353 . . . . 2.3900000000000001 110.047 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.503 ' HE1' ' HG3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -163.87 168.6 19.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 3.3700000000000001 110.285 -177.266 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.4 ' H ' ' HD2' ' A' ' 94' ' ' TYR . 12.4 t -102.92 153.25 20.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.161 -0.472 . . . . 1.3999999999999999 110.565 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -114.9 103.24 10.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.759 -0.83 . . . . 1.1799999999999999 108.759 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -114.69 112.92 23.61 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.617 -0.72 . . . . 2.5699999999999998 111.078 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -174.2 -80.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 3.21 109.821 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -94.81 -41.48 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 3.23 109.433 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.2 ttp -80.9 124.96 29.54 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.708 -0.849 . . . . 2.8500000000000001 108.708 171.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.8 m -56.89 120.07 35.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.619 -0.512 . . . . 2.1200000000000001 109.619 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -24.33 91.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 1 C-N-CA 125.345 4.03 . . . . 1.47 114.978 -170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -108.81 144.82 36.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.896 -0.779 . . . . 1.3999999999999999 108.896 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -104.16 122.43 45.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.069 0.462 . . . . 3.0800000000000001 109.992 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.1 m -124.74 166.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.583 -0.735 . . . . 1.3300000000000001 110.321 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -103.95 117.33 34.05 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.682 -1.229 . . . . 1.6899999999999999 107.682 170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.8 p -104.21 119.36 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.899 0.856 . . . . 1.27 110.402 -170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.1 t60 -103.6 105.3 15.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.006 -0.997 . . . . 1.02 109.362 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 57.5 tpp -103.9 123.54 47.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.713 -1.218 . . . . 2.4900000000000002 107.713 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.526 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 13.2 ptmm? -143.39 147.07 34.07 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.959 -0.696 . . . . 1.5700000000000001 111.033 -172.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.781 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 37.1 tttp -81.52 146.09 30.36 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.019 -0.537 . . . . 2.1299999999999999 111.217 -171.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.77 38.47 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.518 -0.919 . . . . 1.5700000000000001 108.518 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.77 -112.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.381 -0.528 . . . . 4.4100000000000001 110.732 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m 52.95 37.23 23.98 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.504 0.668 . . . . 2.5499999999999998 109.484 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.57 -90.7 0.55 Allowed Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.896 -1.282 . . . . 2.6200000000000001 109.896 -169.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -178.22 88.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.672 -0.862 . . . . 2.7599999999999998 108.672 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.0 p -135.95 -178.19 5.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.921 -0.581 . . . . 1.0700000000000001 111.503 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 88' ' ' LEU . 97.1 m-85 -131.31 144.33 51.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.564 -0.532 . . . . 0.85999999999999999 109.564 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 32.9 m95 -102.58 107.43 18.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.568 -0.901 . . . . 0.63 108.568 174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.9 p -100.37 142.77 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.784 -0.766 . . . . 0.91000000000000003 111.319 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.07 123.9 28.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.426 -0.807 . . . . 0.79000000000000004 109.725 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.01 103.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.429 0.633 . . . . 1.1799999999999999 111.31 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -104.42 121.42 43.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 3.3100000000000001 109.889 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.914 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.18 140.75 55.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.834 0.35 . . . . 4.0300000000000002 111.093 -179.144 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.766 -0.635 . . . . 2.8700000000000001 109.518 177.223 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 44' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.07 -0.345 . . . . 3.3399999999999999 110.07 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.51 -32.26 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 2.8999999999999999 111.176 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.89 138.14 31.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.782 0.325 . . . . 3.8500000000000001 110.357 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.7 150.95 17.28 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.909 -0.662 . . . . 0.84999999999999998 112.51 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.44 104.92 3.68 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.031 -0.729 . . . . 0.70999999999999996 109.031 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.513 ' HB ' HG13 ' A' ' 120' ' ' VAL . 21.7 mt -116.74 156.49 17.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.1 -0.5 . . . . 1.0800000000000001 109.731 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 62.6 tt0 -121.81 111.73 17.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.391 -0.596 . . . . 0.85999999999999999 109.391 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -112.32 148.96 33.1 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.655 -0.498 . . . . 1.6200000000000001 109.655 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -104.44 168.07 9.33 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.119 -0.233 . . . . 1.22 110.373 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.04 -7.13 29.1 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.387 -0.369 . . . . 0.79000000000000004 113.891 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -89.11 -45.62 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 1.95 109.811 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 134.45 12.61 1.38 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.53000000000000003 112.307 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -89.59 149.88 22.65 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.3 110.178 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 17.7 mt -94.08 145.36 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.808 -0.633 . . . . 0.89000000000000001 109.781 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.4 mm? -106.52 -68.4 0.88 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.556 0.694 . . . . 1.45 110.075 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -133.89 133.29 41.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.185 -0.916 . . . . 1.99 110.656 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.94 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.7 m-30 -94.59 -176.23 3.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.635 -0.711 . . . . 1.25 110.3 171.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -118.53 165.79 13.5 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.56 -0.904 . . . . 2.1299999999999999 108.56 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.719 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -76.88 19.09 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 1.48 111.332 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.33 -49.07 6.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 1.52 110.279 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 50' ' ' THR . 3.6 mm-40 -69.7 -29.12 66.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.472 0.653 . . . . 2.1200000000000001 110.026 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -88.26 -5.83 75.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.691 -0.766 . . . . 1.4199999999999999 112.33 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.6 t70 -83.1 -60.17 2.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.771 0.319 . . . . 2.3500000000000001 110.683 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' H ' HG12 ' A' ' 49' ' ' ILE . 2.8 pt -94.54 -46.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.291 -0.413 . . . . 2.5899999999999999 111.93 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -70.64 -54.64 11.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.175 0.512 . . . . 3.4100000000000001 110.56 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 110.47 39.61 1.46 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.765 -0.731 . . . . 2.3199999999999998 112.405 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 3.1 mpt_? -118.81 98.26 6.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.59 -0.522 . . . . 3.1400000000000001 109.59 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.878 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.8 m-20 -64.08 152.86 86.77 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.536 . . . . 2.1000000000000001 110.559 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.94 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 48.0 Cg_exo -58.01 -18.74 37.15 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.37 2.713 . . . . 1.6799999999999999 113.765 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.7 4.68 26.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.82 0.304 . . . . 3.6099999999999999 111.82 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.878 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 80.9 mm-40 -90.45 -9.33 47.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.731 0.301 . . . . 2.5 111.43 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.737 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.7 m -111.87 25.73 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.986 0.736 . . . . 0.96999999999999997 112.986 -171.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -89.78 126.5 42.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.248 -0.581 . . . . 1.0900000000000001 110.333 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.23 87.79 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.66000000000000003 110.844 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 47.3 mttm -106.73 138.79 42.25 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.072 -0.564 . . . . 1.8200000000000001 110.619 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 25.8 t-20 -80.04 114.33 18.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.039 -0.528 . . . . 0.71999999999999997 109.8 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.624 ' HA ' HD11 ' A' ' 39' ' ' ILE . 69.5 t80 -56.14 -43.34 78.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.961 -0.563 . . . . 0.69999999999999996 111.416 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 39.6 m-85 -80.77 -6.25 58.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 112.329 -166.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.65 -45.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.448 0.536 . . . . 3.5800000000000001 112.448 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.44 -23.56 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.314 -0.555 . . . . 2.2000000000000002 111.833 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.93 14.01 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.116 -0.633 . . . . 1.77 110.998 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.29 74.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.904 -0.589 . . . . 0.60999999999999999 110.543 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.88 13.64 1.43 Allowed 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.939 2.426 . . . . 0.81000000000000005 113.698 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -97.12 -5.75 36.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 110.256 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.602 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 55.1 p -100.5 -28.87 12.68 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.61 -0.723 . . . . 1.3300000000000001 111.653 -159.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 10.1 p-10 -75.29 78.49 2.39 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.591 1.186 . . . . 1.8500000000000001 111.105 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.792 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 66.7 m -152.65 169.42 9.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 114.592 -1.185 . . . . 1.5600000000000001 108.776 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.792 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 29.3 Cg_endo -61.99 -14.57 38.01 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.007 2.471 . . . . 1.1699999999999999 114.926 -171.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.41 -34.29 13.51 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.901 -0.5 . . . . 2.5600000000000001 111.554 -175.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 69.0 t80 -106.29 -69.43 0.83 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 3.3599999999999999 110.459 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.658 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 63.8 t80 -60.62 -41.14 94.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.79000000000000004 110.727 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -56.86 -49.15 73.03 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.59999999999999998 112.383 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -67.48 -37.15 82.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 2.0899999999999999 110.558 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.78 -40.75 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.614 . . . . 0.67000000000000004 110.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -78.33 -18.59 54.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 1.0900000000000001 112.229 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 35.1 mt-10 -66.12 -39.79 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.417 . . . . 2.0699999999999998 110.939 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -69.71 -42.1 72.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.364 -0.922 . . . . 0.71999999999999997 111.436 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 83' ' ' VAL . 35.4 t -57.31 -51.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.38 . . . . 0.84999999999999998 110.67 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -26.83 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.774 -0.648 . . . . 1.1399999999999999 111.707 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -83.94 -77.94 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.8200000000000001 110.172 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.87 -68.48 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.235 -0.746 . . . . 1.6499999999999999 111.235 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -107.34 153.38 22.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 3.5 109.506 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 62.3 tp -118.19 126.41 52.14 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.932 -0.396 . . . . 2.96 109.932 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 109' ' ' MET . 26.4 p-10 -166.15 94.12 0.54 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.939 0.876 . . . . 2.2400000000000002 109.774 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 4.4 m -139.52 153.71 47.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.801 -1.09 . . . . 1.6299999999999999 109.769 -174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 61.1 ttp -137.5 108.94 6.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.153 -0.314 . . . . 1.77 110.153 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 47.1 p90 -123.76 167.29 14.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.472 -0.331 . . . . 3.0099999999999998 110.76 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -102.68 132.79 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.622 -0.511 . . . . 2.3900000000000001 109.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -144.21 150.84 38.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.531 . . . . 3.3700000000000001 110.647 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 m -104.83 141.35 36.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.353 -0.385 . . . . 1.3999999999999999 110.806 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 105' ' ' VAL . 18.6 m-85 -104.63 120.81 42.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' MET . 4.0 p30 -143.66 -156.93 0.73 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.639 -0.71 . . . . 2.5699999999999998 109.527 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 58.1 t80 73.52 -24.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.152 0.581 . . . . 3.21 111.745 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 97' ' ' ASP . 10.6 pt20 -158.74 -38.02 0.06 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.337 -0.616 . . . . 3.23 109.337 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 101' ' ' THR . 54.3 tpp -78.71 143.67 36.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.849 -0.797 . . . . 2.8500000000000001 108.849 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.565 ' O ' ' HG3' ' A' ' 100' ' ' MET . 12.1 p -67.52 151.4 97.2 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 108.407 -0.96 . . . . 2.1200000000000001 108.407 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.59 87.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.994 2.462 . . . . 1.47 113.864 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' HE ' ' A' ' 124' ' ' ARG . 85.8 m -100.78 129.89 46.73 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.457 -0.792 . . . . 1.3999999999999999 110.422 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.34 114.76 29.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.48 -0.563 . . . . 3.0800000000000001 109.48 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.3 m -126.95 165.88 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.784 -0.644 . . . . 1.3300000000000001 111.151 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -115.19 128.09 55.95 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.499 -0.926 . . . . 1.6899999999999999 108.499 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 98.9 t -104.51 104.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.459 -0.791 . . . . 1.27 109.201 -171.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.64 104.42 14.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.177 -0.675 . . . . 1.02 109.177 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.93 143.79 32.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.486 -0.779 . . . . 2.4900000000000002 109.845 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.9 ptmt -154.31 154.24 33.04 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.466 -0.568 . . . . 1.5700000000000001 109.466 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.638 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 3.6 ttpm? -78.6 140.52 38.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.846 0.355 . . . . 2.1299999999999999 111.557 -171.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -113.25 169.08 9.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.982 -0.554 . . . . 1.5700000000000001 110.359 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' N ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 -6.2 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.524 -0.307 . . . . 4.4100000000000001 111.525 177.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 p -61.49 -39.53 91.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.02 0.914 . . . . 2.5499999999999998 109.167 170.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.02 22.21 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 108.749 -1.741 . . . . 2.6200000000000001 108.749 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.27 89.8 0.06 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.474 0.637 . . . . 2.7599999999999998 110.062 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 11.8 p -177.13 -170.02 0.27 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.521 -0.763 . . . . 1.0700000000000001 110.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 15.9 m-85 -129.0 158.46 38.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.631 -0.877 . . . . 0.85999999999999999 108.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.531 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 77.8 m95 -102.59 109.25 20.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.957 -0.757 . . . . 0.63 108.957 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.4 p -102.5 120.85 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.887 0.851 . . . . 0.91000000000000003 110.597 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.519 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 97.6 m-85 -103.61 136.53 43.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.467 -0.788 . . . . 0.79000000000000004 110.992 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.48 107.76 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.078 -0.965 . . . . 1.1799999999999999 110.026 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -103.65 104.42 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 3.3100000000000001 110.182 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.699 ' HE ' HG23 ' A' ' 103' ' ' THR . 34.3 ttt-85 -83.55 126.9 33.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.035 -0.357 . . . . 4.0300000000000002 110.035 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.125 -0.941 . . . . 2.8700000000000001 111.443 -179.476 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.432 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.645 -0.502 . . . . 3.3399999999999999 109.645 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.75 -82.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.82 0.343 . . . . 2.8999999999999999 111.046 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -133.3 155.71 48.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.044 -0.354 . . . . 3.8500000000000001 110.044 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.8 118.58 6.14 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.554 -0.832 . . . . 0.84999999999999998 111.354 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.89 106.63 17.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.878 0.37 . . . . 0.70999999999999996 110.481 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' HG13 ' A' ' 120' ' ' VAL . 20.7 mt -111.66 147.78 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.344 -0.613 . . . . 1.0800000000000001 109.344 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' NE2' HD22 ' A' ' 40' ' ' LEU . 47.1 tt0 -118.38 116.24 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.576 -0.528 . . . . 0.85999999999999999 109.576 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 19.0 mt -115.71 154.12 30.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 110.276 -0.268 . . . . 1.6200000000000001 110.276 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.727 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.2 p30 -112.03 167.4 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.497 -0.186 . . . . 1.22 110.497 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -19.11 50.55 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.507 0.563 . . . . 0.79000000000000004 114.507 -171.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 38.7 t70 -81.38 -14.85 56.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.367 0.603 . . . . 1.95 109.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 104.53 7.82 38.91 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.502 -0.772 . . . . 0.53000000000000003 112.009 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.727 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 40.1 m-80 -82.62 154.34 24.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.143 0.497 . . . . 1.3 110.483 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.832 HG21 ' HE2' ' A' ' 42' ' ' TYR . 9.1 mt -102.09 158.19 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.258 -0.883 . . . . 0.89000000000000001 108.767 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.0 mp -116.77 -68.35 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.635 0.731 . . . . 1.45 109.754 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.5 151.7 40.6 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.585 -174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.832 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.7 m-85 -109.94 179.04 4.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.636 -1.166 . . . . 1.25 109.116 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 45' ' ' ALA . 31.7 p-10 -109.74 163.75 13.21 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.874 -0.787 . . . . 2.1299999999999999 108.874 169.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.26 -7.12 44.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 1.48 111.842 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . . . -82.74 -23.77 33.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.458 -0.337 . . . . 1.52 111.378 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.02 -53.14 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.268 -0.642 . . . . 2.1200000000000001 109.268 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -55.76 -24.75 41.95 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 112.672 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.36 -33.36 75.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.842 0.353 . . . . 2.3500000000000001 110.918 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -96.07 -69.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 2.5899999999999999 110.916 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.8 m -84.29 -60.43 2.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.727 0.299 . . . . 3.4100000000000001 110.281 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 119.39 40.51 0.62 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.091 -1.052 . . . . 2.3199999999999998 113.121 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -92.88 119.44 32.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.165 -0.68 . . . . 3.1400000000000001 109.165 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 19.6 m-20 -65.86 139.04 96.67 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 2.1000000000000001 112.503 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.8 Cg_exo -66.98 121.56 8.77 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.691 2.261 . . . . 1.6799999999999999 111.796 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 68.7 mttm 83.96 7.17 0.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.028 0.83 . . . . 3.6099999999999999 112.604 171.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.609 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.6 pt20 -84.01 -16.96 42.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.909 0.862 . . . . 2.5 109.209 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.957 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.8 m -97.0 24.97 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.523 -1.217 . . . . 0.96999999999999997 112.789 -170.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.41 125.71 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.732 -0.469 . . . . 1.0900000000000001 109.732 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.95 5.77 88.82 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.227 -0.987 . . . . 0.66000000000000003 111.102 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.957 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 39.8 mttm -98.46 139.43 34.21 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.388 . . . . 1.8200000000000001 110.234 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 22.2 t-20 -86.25 111.96 20.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.761 -0.459 . . . . 0.71999999999999997 109.761 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HA ' HD11 ' A' ' 39' ' ' ILE . 80.9 t80 -57.72 -32.63 67.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.585 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 30.0 m-85 -86.42 1.22 52.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.9 -0.591 . . . . 1.1599999999999999 111.365 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -136.3 -62.55 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.327 0.492 . . . . 3.5800000000000001 112.327 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.82 -24.06 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.375 0.509 . . . . 2.2000000000000002 112.375 -164.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.83 13.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.215 0.45 . . . . 1.77 112.215 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.97 88.18 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.573 0.546 . . . . 0.60999999999999999 110.637 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.09 29.9 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.581 2.187 . . . . 0.81000000000000005 113.066 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.0 m -79.06 -30.61 44.12 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.983 -1.118 . . . . 0.84999999999999998 107.983 167.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 6.8 m -96.99 -25.15 15.49 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.57 -2.105 . . . . 1.3300000000000001 108.553 -119.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 11.0 p-10 -74.22 104.23 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 109.105 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.501 ' H ' ' HB3' ' A' ' 76' ' ' TYR . 48.7 m -160.29 151.65 16.17 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.283 -0.871 . . . . 1.5600000000000001 109.624 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.85 -31.01 87.53 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.95 2.433 . . . . 1.1699999999999999 112.803 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.98 -2.36 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.343 0.497 . . . . 2.5600000000000001 112.343 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -134.73 -74.33 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.888 -0.325 . . . . 3.3599999999999999 110.537 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 85.8 t80 -57.54 -35.86 70.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.962 0.41 . . . . 0.79000000000000004 110.171 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' GLU . . . -57.67 -45.69 93.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.743 -0.662 . . . . 0.59999999999999998 112.048 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 72.5 mmtt -75.9 -38.68 57.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.669 0.235 . . . . 2.0899999999999999 111.096 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.808 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 66.4 t80 -56.06 -40.13 73.08 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.554 0.692 . . . . 0.67000000000000004 110.477 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -88.53 -16.66 32.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.292 -0.867 . . . . 1.0900000000000001 111.034 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 29.3 tt0 -70.25 -35.64 73.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.154 -0.476 . . . . 2.0699999999999998 110.563 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.731 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -76.37 -40.33 28.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.549 -0.834 . . . . 0.71999999999999997 111.513 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.6 t -54.49 -50.35 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 110.36 174.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.15 73.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.506 -0.77 . . . . 1.1399999999999999 111.988 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 p -90.74 -72.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 1.8200000000000001 110.959 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.75 -56.54 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.431 -0.89 . . . . 1.6499999999999999 113.497 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -122.1 149.62 43.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.379 0.609 . . . . 3.5 112.055 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA3' ' A' ' 82' ' ' GLY . 3.9 mm? -112.8 107.61 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.108 -0.951 . . . . 2.96 109.581 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.714 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.2 p30 -169.68 110.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.989 0.9 . . . . 2.2400000000000002 111.796 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -166.05 158.62 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.777 -1.101 . . . . 1.6299999999999999 109.413 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -127.77 119.97 26.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.127 0.489 . . . . 1.77 109.701 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.65 165.84 24.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.527 -0.545 . . . . 3.0099999999999998 109.527 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 51.1 mt-10 -104.32 115.2 29.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.06 0.457 . . . . 2.3900000000000001 110.423 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -118.33 152.74 35.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 3.3700000000000001 109.825 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -104.01 132.09 50.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 1.3999999999999999 110.594 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.848 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 79.4 m-85 -113.54 119.63 38.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.671 -0.492 . . . . 1.1799999999999999 109.671 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -123.2 -147.05 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 2.5699999999999998 109.629 -175.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 99' ' ' GLN . 54.5 t80 65.87 -85.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.044 0.537 . . . . 3.21 111.514 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.401 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 57.9 mt-30 -72.68 -51.17 20.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.45 0.643 . . . . 3.23 109.509 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.475 ' HE2' " H5'" ' A' ' 169' ' ' HC4 . 47.5 ttp -93.27 130.41 39.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.338 -0.846 . . . . 2.8500000000000001 109.783 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 m -52.85 117.55 11.36 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.766 -0.457 . . . . 2.1200000000000001 109.766 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -20.25 92.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.552 4.168 . . . . 1.47 114.725 -169.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -105.52 144.45 32.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 1.3999999999999999 111.184 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -103.32 117.66 35.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 3.0800000000000001 110.421 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 124' ' ' ARG . 29.5 m -127.97 165.06 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.991 0.425 . . . . 1.3300000000000001 111.001 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.597 ' HE2' HG11 ' A' ' 125' ' ' VAL . 18.5 ttmm -104.92 129.58 53.27 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.662 -1.236 . . . . 1.6899999999999999 107.662 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 121' ' ' PHE . 7.6 p -113.69 128.92 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.578 0.704 . . . . 1.27 110.096 -175.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -105.13 115.2 29.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.276 -0.875 . . . . 1.02 109.078 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.808 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 37.0 ttp -102.99 127.22 50.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.461 -0.94 . . . . 2.4900000000000002 108.461 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.719 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.8 ptmt -154.5 141.39 19.18 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.135 -0.32 . . . . 1.5700000000000001 110.135 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' LEU . 31.3 ttmt -84.46 136.77 33.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.122 0.487 . . . . 2.1299999999999999 111.367 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -112.65 165.84 11.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.718 -0.845 . . . . 1.5700000000000001 108.718 169.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.94 29.99 6.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.59 . . . . 4.4100000000000001 111.139 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -76.51 79.84 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.625 -1.25 . . . . 2.5499999999999998 107.625 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.31 -88.37 0.33 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.121 -1.192 . . . . 2.6200000000000001 110.121 -167.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.7 83.9 0.46 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.217 -1.031 . . . . 2.7599999999999998 108.217 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 p -146.42 152.27 38.77 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.683 -0.689 . . . . 1.0700000000000001 109.394 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.477 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -115.95 158.39 23.12 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.27 -0.641 . . . . 0.85999999999999999 109.27 -170.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 83.6 m95 -101.59 110.09 22.02 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.963 -0.754 . . . . 0.63 108.963 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.741 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -102.73 110.52 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 122.029 0.918 . . . . 0.91000000000000003 110.041 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.719 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 94.0 m-85 -103.93 127.91 51.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.4 -0.818 . . . . 0.79000000000000004 111.17 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.28 104.8 17.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.787 0.803 . . . . 1.1799999999999999 111.072 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -118.99 119.73 35.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.432 -0.803 . . . . 3.3100000000000001 109.919 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.3 ttt180 -68.88 135.72 51.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.987 0.423 . . . . 4.0300000000000002 110.696 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 106' ' ' LYS . 2.6 m . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.262 -0.875 . . . . 2.8700000000000001 110.776 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.848 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.569 HD13 ' N ' ' A' ' 27' ' ' ALA . 3.5 tm? . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.186 -0.672 . . . . 3.3399999999999999 109.186 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.569 ' N ' HD13 ' A' ' 26' ' ' LEU . . . -125.03 117.53 24.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.676 -0.693 . . . . 2.8999999999999999 109.481 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -31.9 150.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.813 1.32 . . . . 3.8500000000000001 113.38 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' CG ' ' A' ' 43' ' ' ASN . . . -101.24 104.39 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.472 -0.87 . . . . 0.84999999999999998 112.717 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.61 109.15 18.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.261 -0.469 . . . . 0.70999999999999996 109.819 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 32' ' ' GLN . 18.9 mt -105.26 153.93 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.8 tt0 -113.57 110.1 19.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.686 -0.486 . . . . 0.85999999999999999 109.686 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 34.9 mt -111.98 150.36 30.68 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 109.45 -0.574 . . . . 1.6200000000000001 109.45 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 47.4 p30 -103.06 169.17 8.72 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.658 -0.417 . . . . 1.22 110.519 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.76 -14.67 16.34 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 113.922 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.65 -28.74 23.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.95 110.037 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.43 8.22 14.88 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.562 -0.744 . . . . 0.53000000000000003 111.443 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 90.1 m-20 -76.98 149.1 35.96 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.977 0.417 . . . . 1.3 110.744 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 42' ' ' TYR . 10.4 mt -92.87 153.68 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 58' ' ' ILE . 39.7 mt -122.67 -71.94 0.71 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.449 . . . . 1.45 110.189 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -125.71 136.36 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.399 0.619 . . . . 1.99 111.119 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -93.86 -176.0 3.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.936 -1.029 . . . . 1.25 111.005 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' CG ' ' HA2' ' A' ' 29' ' ' GLY . 7.8 p30 -125.05 -167.93 1.75 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.929 -1.032 . . . . 2.1299999999999999 109.764 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.32 -28.35 53.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.158 0.429 . . . . 1.48 112.158 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.78 75.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 1.52 111.52 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -34.81 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.623 -0.262 . . . . 2.1200000000000001 110.634 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 52' ' ' ARG . . . -61.6 -21.35 60.34 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 121.205 -0.521 . . . . 1.4199999999999999 112.828 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -71.57 -28.61 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 2.3500000000000001 110.436 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -91.68 81.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.733 0.778 . . . . 2.5899999999999999 109.734 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 50' ' ' THR . 5.8 t -11.22 105.78 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 112.716 -2.038 . . . . 3.4100000000000001 114.363 174.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.88 22.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.231 -1.349 . . . . 2.3199999999999998 112.32 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HG3' ' HE1' ' A' ' 42' ' ' TYR . 6.5 mpt_? -115.16 94.8 4.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.788 0.327 . . . . 3.1400000000000001 110.878 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 16.5 m-20 -88.35 148.06 41.56 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.173 -0.467 . . . . 2.1000000000000001 110.442 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.011 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 40.0 Cg_exo -58.06 -34.93 99.0 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.112 2.541 . . . . 1.6799999999999999 113.653 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -131.61 19.61 4.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.75 0.648 . . . . 3.6099999999999999 112.75 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.633 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.19 8.57 44.27 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.454 -0.498 . . . . 2.5 110.929 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -121.19 29.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.96999999999999997 111.863 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 40' ' ' LEU . 22.7 mt -81.35 134.28 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.635 -0.426 . . . . 1.0900000000000001 110.51 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.6 29.61 74.18 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.22 -0.752 . . . . 0.66000000000000003 111.22 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 39' ' ' ILE . 3.7 mtmm -126.6 125.51 42.07 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.161 -0.52 . . . . 1.8200000000000001 109.76 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' ASN . 10.1 t-20 -73.65 114.26 11.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.874 -0.603 . . . . 0.71999999999999997 111.219 -170.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 39' ' ' ILE . 90.6 t80 -56.47 -48.61 76.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.485 -0.78 . . . . 0.69999999999999996 111.146 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -79.94 5.25 14.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.011 -0.541 . . . . 1.1599999999999999 112.111 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -137.54 -53.16 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.028 0.381 . . . . 3.5800000000000001 112.028 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -96.42 -24.13 16.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.441 0.534 . . . . 2.2000000000000002 112.441 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.1 t -116.07 14.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 120.12 -0.632 . . . . 1.77 110.933 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.46 87.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.055 -0.52 . . . . 0.60999999999999999 110.342 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.45 -4.75 15.9 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.589 2.193 . . . . 0.81000000000000005 113.683 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -80.04 -13.62 59.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.227 -0.589 . . . . 0.84999999999999998 109.653 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -101.72 -4.23 26.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.821 -1.082 . . . . 1.3300000000000001 110.827 -157.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.07 95.63 6.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.918 -0.401 . . . . 1.8500000000000001 109.918 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.77 ' HB2' ' HD1' ' A' ' 75' ' ' PHE . 66.8 m -166.33 155.28 10.1 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.035 -0.728 . . . . 1.5600000000000001 109.035 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 31.0 Cg_endo -64.51 -20.87 66.22 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.456 2.104 . . . . 1.1699999999999999 112.04 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -91.79 -15.51 28.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 2.5600000000000001 111.5 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.77 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 87.7 m-85 -106.75 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.287 0.565 . . . . 3.3599999999999999 109.72 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 41.1 t80 -63.53 -37.4 87.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.3 -0.864 . . . . 0.79000000000000004 110.321 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -62.78 -27.37 69.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.108 -0.568 . . . . 0.59999999999999998 112.483 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 68.1 mmtt -80.35 -29.52 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.751 0.31 . . . . 2.0899999999999999 110.555 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 64.7 t80 -68.43 -35.66 77.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.848 -0.797 . . . . 0.67000000000000004 108.848 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -82.94 -3.82 57.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 111.239 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -53.68 -46.96 70.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.778 0.323 . . . . 2.0699999999999998 111.464 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.735 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -85.12 -42.84 6.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.086 -1.054 . . . . 0.71999999999999997 111.711 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 21.5 t -44.3 -49.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.667 0.787 . . . . 0.84999999999999998 112.031 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -42.42 38.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.862 0.465 . . . . 1.1399999999999999 111.953 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -77.46 -61.91 1.83 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.386 0.612 . . . . 1.8200000000000001 109.524 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.05 -54.16 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.503 -1.039 . . . . 1.6499999999999999 110.503 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 137.21 2.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.286 -0.957 . . . . 3.5 109.289 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.735 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 63.1 tp -165.89 125.18 1.65 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.868 -0.333 . . . . 2.96 111.514 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.56 131.56 44.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 2.2400000000000002 110.514 173.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 t -141.66 155.35 45.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.551 -0.75 . . . . 1.6299999999999999 109.888 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.4 ttp -130.27 119.35 22.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.83 -0.623 . . . . 1.77 110.512 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -130.72 155.01 47.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.085 -0.709 . . . . 3.0099999999999998 109.085 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 136.41 54.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.073 0.463 . . . . 2.3900000000000001 111.007 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.823 ' HD1' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -162.16 168.86 21.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.056 -0.52 . . . . 3.3700000000000001 110.418 -175.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.823 ' H ' ' HD1' ' A' ' 94' ' ' TYR . 25.6 m -102.53 143.29 32.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.3999999999999999 111.237 -173.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.611 ' CG ' " H6'" ' A' ' 169' ' ' HC4 . 17.4 m-85 -107.35 112.31 25.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.745 -0.835 . . . . 1.1799999999999999 108.745 173.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.76 14.12 13.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.294 0.479 . . . . 2.5699999999999998 112.294 -171.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 85.4 t80 -119.34 131.61 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.622 -0.51 . . . . 3.21 109.622 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.558 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 21.6 mm-40 75.51 -43.25 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.65 0.78 . . . . 3.23 110.477 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 tpt -105.88 142.03 36.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.505 -0.924 . . . . 2.8500000000000001 108.505 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.456 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -62.96 141.04 97.61 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.868 -1.16 . . . . 2.1200000000000001 107.868 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 51.0 Cg_exo -36.5 91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.78 2.987 . . . . 1.47 114.703 -173.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 t -108.9 146.57 33.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.903 -0.589 . . . . 1.3999999999999999 109.747 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -106.51 125.02 50.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.148 0.499 . . . . 3.0800000000000001 111.182 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 29.6 m -121.17 166.19 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 1.3300000000000001 111.079 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 36.2 ttpt -118.64 121.47 40.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.312 -0.996 . . . . 1.6899999999999999 108.312 174.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.6 103.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.905 -0.589 . . . . 1.27 109.499 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -105.55 102.13 11.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.673 -0.862 . . . . 1.02 108.673 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.44 149.81 25.83 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.863 -0.335 . . . . 2.4900000000000002 110.356 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 8.8 mtpm? -146.62 147.19 30.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.203 -0.666 . . . . 1.5700000000000001 109.203 -175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 1.2 tmmt? -87.18 137.48 32.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.266 0.555 . . . . 2.1299999999999999 111.154 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -140.33 -176.12 4.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.027 -1.101 . . . . 1.5700000000000001 108.027 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.11 -93.94 0.14 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.84 -0.8 . . . . 4.4100000000000001 108.84 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.6 p 42.89 38.96 1.55 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.231 0.826 . . . . 2.5499999999999998 113.231 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.57 15.64 20.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.614 -0.803 . . . . 2.6200000000000001 113.032 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 63.94 87.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.049 0.54 . . . . 2.7599999999999998 110.507 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 p -173.74 -176.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 1.0700000000000001 110.726 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.547 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 42.0 m-85 -121.05 147.59 45.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.996 -0.742 . . . . 0.85999999999999999 108.996 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.406 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 62.6 m95 -102.59 104.2 14.56 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.575 -0.898 . . . . 0.63 108.575 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 109' ' ' MET . 7.3 p -100.52 132.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.976 -1.011 . . . . 0.91000000000000003 111.417 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.84 113.88 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.406 -0.815 . . . . 0.79000000000000004 109.847 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -113.09 104.52 17.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 1.1799999999999999 110.31 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 159.39 42.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.388 -0.597 . . . . 3.3100000000000001 109.388 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 29.9 mtm180 -69.54 105.32 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.863 0.363 . . . . 4.0300000000000002 111.107 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 106' ' ' LYS . 11.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.879 -1.055 . . . . 2.8700000000000001 111.164 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.611 " H6'" ' CG ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.709 ' HG ' ' HA ' ' A' ' 45' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.918 -0.401 . . . . 3.3399999999999999 109.918 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.3 -49.09 3.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 2.8999999999999999 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.97 162.52 29.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 3.8500000000000001 109.664 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.69 119.74 6.46 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.464 -0.874 . . . . 0.84999999999999998 111.845 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.65 103.63 13.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.119 0.485 . . . . 0.70999999999999996 110.093 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.772 ' HB ' HG13 ' A' ' 120' ' ' VAL . 31.5 mt -108.2 159.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.203 -1.036 . . . . 1.0800000000000001 108.203 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' A' ' 113' ' ' LEU . 45.3 tt0 -133.42 134.16 43.28 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.618 -0.433 . . . . 0.85999999999999999 110.317 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.93 161.89 38.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.977 -0.556 . . . . 1.6200000000000001 110.536 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.667 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.5 p30 -103.93 169.09 8.71 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.062 -0.255 . . . . 1.22 110.741 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.65 -27.54 27.54 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 115.323 0.889 . . . . 0.79000000000000004 115.323 -170.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.96 -10.39 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.818 0.809 . . . . 1.95 111.263 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.41 2.19 21.48 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.359 -0.924 . . . . 0.53000000000000003 113.611 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.667 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 91.1 m-20 -71.06 126.7 30.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.191 0.496 . . . . 1.3 110.443 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 42' ' ' TYR . 17.2 mt -84.06 150.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.446 . . . . 0.89000000000000001 109.97 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.9 mp -110.03 -54.22 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.249 0.547 . . . . 1.45 109.942 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -166.22 149.14 7.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.215 -0.902 . . . . 1.99 110.785 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.787 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 8.9 m-30 -98.4 -176.89 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.241 -0.891 . . . . 1.25 110.641 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -112.37 163.99 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.494 -0.928 . . . . 2.1299999999999999 108.494 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.62 -27.6 17.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.48 111.474 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.709 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . . . -46.14 -54.14 9.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.152 -0.931 . . . . 1.52 112.51 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' HD11 ' A' ' 31' ' ' ILE . 16.2 mm-40 -75.25 -29.92 60.35 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.961 0.41 . . . . 2.1200000000000001 110.922 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 -22.6 68.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.849 -0.691 . . . . 1.4199999999999999 111.635 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -87.81 -35.07 18.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.607 0.241 . . . . 2.3500000000000001 110.69 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 45' ' ' ALA . 45.9 mm -53.04 -54.03 19.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.142 0.496 . . . . 2.5899999999999999 110.249 176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 51' ' ' GLY . 5.9 t -140.08 -41.38 0.43 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 3.4100000000000001 111.041 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 50' ' ' THR . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.408 -0.901 . . . . 2.3199999999999998 111.734 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -113.78 99.53 7.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.002 -0.74 . . . . 3.1400000000000001 109.002 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.664 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 18.9 t70 -54.8 127.62 61.38 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.481 0.488 . . . . 2.1000000000000001 110.728 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.787 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 41.7 Cg_exo -59.16 -17.64 39.92 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.583 2.855 . . . . 1.6799999999999999 113.855 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -94.73 -1.83 52.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.758 0.313 . . . . 3.6099999999999999 111.025 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.664 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 54.7 mm-40 -102.64 5.24 39.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.12 0.486 . . . . 2.5 110.588 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.597 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.4 m -117.27 14.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.96999999999999997 111.654 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 40.0 mt -80.26 125.73 39.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.406 -0.517 . . . . 1.0900000000000001 110.407 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.3 10.52 78.81 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.843 -0.903 . . . . 0.66000000000000003 110.843 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.889 ' HD3' ' HB ' ' A' ' 66' ' ' VAL . 23.3 ttmt -104.88 135.72 45.72 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.64 -0.504 . . . . 1.8200000000000001 109.64 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -83.49 117.74 23.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.234 -0.439 . . . . 0.71999999999999997 111.491 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 57.8 t80 -72.11 0.63 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.799 -0.637 . . . . 0.69999999999999996 111.669 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 82.0 m-85 -116.74 -9.76 11.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.081 -0.387 . . . . 1.1599999999999999 111.222 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.3 -38.47 0.76 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.73 0.641 . . . . 3.5800000000000001 112.73 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 22.8 m-20 -90.43 -87.56 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.928 0.344 . . . . 2.2000000000000002 111.928 -174.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.889 ' HB ' ' HD3' ' A' ' 60' ' ' LYS . 6.4 p -83.16 14.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.992 0.901 . . . . 1.77 111.616 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.77 86.23 0.46 Allowed Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.486 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -90.8 4.38 4.39 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.365 2.044 . . . . 0.81000000000000005 113.597 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 11.4 p -84.65 -15.62 44.79 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 120.494 -0.483 . . . . 0.84999999999999998 110.152 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 6.8 p -87.46 -39.68 15.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.215 -1.357 . . . . 1.3300000000000001 111.048 -160.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -51.89 108.54 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.966 -0.561 . . . . 1.8500000000000001 110.784 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -161.74 149.63 12.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.5600000000000001 109.902 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.13 -26.25 82.29 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.379 2.053 . . . . 1.1699999999999999 111.409 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 13.9 pt-20 -96.91 1.29 50.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.851 -0.613 . . . . 2.5600000000000001 111.912 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' HD2' ' HE1' ' A' ' 92' ' ' PHE . 67.0 t80 -127.3 -70.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 3.3599999999999999 109.597 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.604 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 64.4 t80 -61.41 -38.39 86.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 0.79000000000000004 110.002 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.66 -34.98 91.41 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.054 -0.593 . . . . 0.59999999999999998 112.674 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HD2' ' O ' ' A' ' 74' ' ' GLU . 92.7 mttt -80.46 -31.18 37.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.311 0.577 . . . . 2.0899999999999999 110.093 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.774 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 72.8 t80 -61.27 -32.22 72.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.67000000000000004 110.377 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 13.2 mmmm -95.75 -5.48 41.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 1.0900000000000001 110.879 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -59.96 -52.93 63.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 2.0699999999999998 110.738 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -72.85 -27.9 68.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.57 -0.824 . . . . 0.71999999999999997 112.245 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.34 -54.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.84999999999999998 110.794 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.6 70.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.576 . . . . 1.1399999999999999 110.566 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.0 m -74.04 -86.05 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.7 -0.682 . . . . 1.8200000000000001 110.05 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.4 -64.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.971 -0.852 . . . . 1.6499999999999999 110.971 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -92.37 132.72 36.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.801 -0.7 . . . . 3.5 110.182 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.1 tm? -110.26 105.5 14.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.943 -0.762 . . . . 2.96 108.943 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' MET . 22.7 p-10 -164.41 58.03 0.15 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.625 0.726 . . . . 2.2400000000000002 110.665 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -104.47 155.4 18.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.6299999999999999 110.499 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -128.96 124.15 34.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.611 -0.722 . . . . 1.77 110.024 177.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 50.5 p90 -144.23 168.1 20.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.507 -0.315 . . . . 3.0099999999999998 110.967 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -103.3 133.04 49.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.053 -0.521 . . . . 2.3900000000000001 110.087 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -149.44 166.48 28.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.026 -0.731 . . . . 3.3700000000000001 109.026 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -104.91 159.23 15.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.858 0.688 . . . . 1.3999999999999999 112.858 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -111.26 120.6 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.219 -0.66 . . . . 1.1799999999999999 109.219 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 21.5 t70 -133.92 -152.46 0.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.798 -0.816 . . . . 2.5699999999999998 108.798 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 40.4 t80 71.41 -68.1 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.956 0.503 . . . . 3.21 111.753 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.457 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 2.5 pp0? -112.24 -4.43 14.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.137 0.494 . . . . 3.23 110.755 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.6 tpp -126.92 143.8 51.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.723 -0.671 . . . . 2.8500000000000001 110.372 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -54.69 128.37 62.09 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.199 -1.037 . . . . 2.1200000000000001 108.199 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.1 90.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.547 2.831 . . . . 1.47 113.168 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.5 158.1 16.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.174 -0.921 . . . . 1.3999999999999999 110.701 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.957 ' HE2' ' HB ' ' A' ' 125' ' ' VAL . 18.1 ptmt -106.25 127.56 53.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 3.0800000000000001 111.387 -175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 122' ' ' VAL . 11.5 p -125.0 151.99 31.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.591 -0.731 . . . . 1.3300000000000001 110.353 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 105' ' ' VAL . 82.8 tttt -110.21 119.39 39.12 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.417 -0.957 . . . . 1.6899999999999999 108.417 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.9 p -112.34 129.74 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.453 0.644 . . . . 1.27 111.241 -171.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -112.71 104.59 12.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.005 -1.109 . . . . 1.02 108.005 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 9.7 ptp -103.41 129.31 50.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.273 -0.421 . . . . 2.4900000000000002 110.628 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 59.6 mtpt -138.72 126.16 21.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.484 0.659 . . . . 1.5700000000000001 112.651 -168.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 25.3 tttp -70.36 114.63 8.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.51 1.124 . . . . 2.1299999999999999 111.498 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -177.8 93.67 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.535 0.939 . . . . 1.5700000000000001 113.535 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.638 ' HB2' HE22 ' A' ' 32' ' ' GLN . 28.7 tp 177.68 86.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.433 0.531 . . . . 4.4100000000000001 112.433 165.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 m 41.68 38.78 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.598 1.186 . . . . 2.5499999999999998 112.292 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.77 -123.96 1.23 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.931 -1.128 . . . . 2.6200000000000001 112.012 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.02 35.29 1.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.7599999999999998 111.059 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 p -100.36 135.33 41.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.95 -0.568 . . . . 1.0700000000000001 109.744 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.606 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 2.0 m-85 -109.37 161.33 15.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.775 -0.454 . . . . 0.85999999999999999 109.775 -169.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 109' ' ' MET . 88.9 m95 -100.92 114.72 28.86 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.689 -0.856 . . . . 0.63 108.689 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.3 p -100.2 115.34 41.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.128 0.966 . . . . 0.91000000000000003 110.207 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.91 123.38 46.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.246 -0.888 . . . . 0.79000000000000004 111.146 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG13 HG21 ' A' ' 105' ' ' VAL . 66.3 t -104.7 105.62 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.122 -0.945 . . . . 1.1799999999999999 110.99 -176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -131.58 131.04 42.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.849 0.357 . . . . 3.3100000000000001 110.249 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.462 ' C ' ' HD2' ' A' ' 124' ' ' ARG . 7.4 ppt_? -72.88 157.41 37.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 4.0300000000000002 111.661 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.957 ' HB ' ' HE2' ' A' ' 104' ' ' LYS . 25.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.67 -0.681 . . . . 2.8700000000000001 109.166 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.828 -0.434 . . . . 3.3399999999999999 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.7 78.24 0.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.387 -0.369 . . . . 2.8999999999999999 110.125 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 55.76 -152.33 0.37 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.741 -0.663 . . . . 3.8500000000000001 110.451 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -103.68 132.82 11.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.59 -0.814 . . . . 0.84999999999999998 111.497 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -132.04 134.03 45.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.70999999999999996 109.635 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 120' ' ' VAL . 4.8 mp -128.01 144.43 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 109.775 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 40.4 tt0 -104.51 118.66 37.14 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.94 -1.133 . . . . 0.85999999999999999 107.94 170.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.4 pt? -130.1 150.14 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.43 -0.508 . . . . 1.6200000000000001 110.662 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -103.43 168.39 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.862 -0.421 . . . . 1.22 109.862 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.39 -29.05 22.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.381 0.512 . . . . 0.79000000000000004 114.381 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -75.2 -21.14 58.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.275 0.537 . . . . 1.95 111.324 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.14 4.44 38.43 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.898 -0.668 . . . . 0.53000000000000003 111.916 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.8 m-20 -77.23 141.18 40.15 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.978 -0.378 . . . . 1.3 109.978 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.5 mt -88.75 144.77 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.263 0.554 . . . . 0.89000000000000001 110.381 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -99.89 -59.29 1.74 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.264 -0.88 . . . . 1.45 110.227 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -165.13 153.06 11.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.757 -1.11 . . . . 1.99 110.027 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 4.7 m-30 -97.46 156.63 16.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 1.25 110.367 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.935 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 64.0 t30 -74.76 10.73 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.919 -0.582 . . . . 2.1299999999999999 111.104 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' TYR . . . 75.72 -42.34 0.46 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.896 -1.047 . . . . 1.48 112.213 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -56.87 -24.78 54.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.555 0.576 . . . . 1.52 112.555 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.75 -18.68 64.26 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.18 0.514 . . . . 2.1200000000000001 110.944 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.59 -7.6 78.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.613 -0.803 . . . . 1.4199999999999999 111.861 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.57 -46.87 5.57 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 2.3500000000000001 109.204 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 45' ' ' ALA . 30.8 mm -66.34 -67.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.419 -0.81 . . . . 2.5899999999999999 110.714 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 m -92.71 -56.97 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.479 -0.328 . . . . 3.4100000000000001 110.984 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.72 42.12 0.25 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.683 -0.77 . . . . 2.3199999999999998 112.156 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mmt180 -108.29 127.89 54.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.31 -0.256 . . . . 3.1400000000000001 110.31 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 56' ' ' GLN . 12.2 t70 -65.9 132.68 94.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 2.1000000000000001 110.306 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 7.3 Cg_exo -73.62 -12.88 24.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.986 2.457 . . . . 1.6799999999999999 114.209 -172.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -130.23 -7.45 4.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.605 0.965 . . . . 3.6099999999999999 113.605 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.576 ' HG2' ' CG ' ' A' ' 53' ' ' ASP . 77.6 mm-40 -75.23 -13.18 60.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.264 -0.575 . . . . 2.5 110.864 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.4 m -88.49 14.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.4 0.889 . . . . 0.96999999999999997 113.4 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' LEU . 38.6 mt -81.99 131.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.177 -0.609 . . . . 1.0900000000000001 110.131 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.34 26.63 72.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.011 -0.836 . . . . 0.66000000000000003 111.011 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -121.5 134.46 55.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.964 -0.618 . . . . 1.8200000000000001 110.177 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.4 114.66 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.79 0.329 . . . . 0.71999999999999997 110.297 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.73 -40.93 69.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.69999999999999996 111.389 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.604 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 72.2 m-85 -80.56 3.66 21.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.351 -0.386 . . . . 1.1599999999999999 111.534 -173.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -121.84 -51.65 2.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.48 -0.563 . . . . 3.5800000000000001 109.48 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -78.34 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 2.2000000000000002 112.155 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.0 t -96.22 16.38 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.794 0.33 . . . . 1.77 111.853 -168.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.99 77.2 0.74 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 121.989 -0.444 . . . . 0.60999999999999999 112.014 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -97.61 28.45 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.084 2.523 . . . . 0.81000000000000005 113.208 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.6 p -120.71 22.96 10.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.539 -0.541 . . . . 0.84999999999999998 109.539 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.9 m -136.58 -44.34 0.6 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.062 -1.426 . . . . 1.3300000000000001 109.41 -133.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 11.2 p-10 -68.98 119.88 13.97 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.207 -0.664 . . . . 1.8500000000000001 109.207 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -168.99 161.58 7.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.78 -0.645 . . . . 1.5600000000000001 109.743 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.96 -31.11 91.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.36 2.04 . . . . 1.1699999999999999 112.868 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.7 -4.66 54.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 2.5600000000000001 112.072 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -124.77 -70.82 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.181 -0.303 . . . . 3.3599999999999999 110.181 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 93.8 t80 -60.44 -39.44 87.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 0.79000000000000004 110.284 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.11 -40.19 98.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.979 -0.629 . . . . 0.59999999999999998 112.219 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 74.0 mmtt -73.56 -26.14 60.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 2.0899999999999999 110.32 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -67.38 -35.49 79.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 110.276 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -84.5 -14.89 47.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.994 -0.548 . . . . 1.0900000000000001 110.98 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 49.8 mm-40 -54.48 -52.28 62.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.154 0.502 . . . . 2.0699999999999998 111.016 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.525 ' H ' HD13 ' A' ' 88' ' ' LEU . . . -72.19 -33.34 62.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.71999999999999997 112.213 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' OH ' ' A' ' 118' ' ' TYR . 23.1 t -61.7 -51.61 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.84999999999999998 110.646 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.2 -21.7 66.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.843 -0.617 . . . . 1.1399999999999999 111.881 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -96.41 -77.57 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 1.8200000000000001 110.875 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.49 -77.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.5 -0.64 . . . . 1.6499999999999999 111.5 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.637 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.8 p30 -95.24 144.88 25.47 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.543 -0.54 . . . . 3.5 109.543 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 82' ' ' GLY . 54.6 tp -120.18 102.63 8.64 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.714 -0.476 . . . . 2.96 109.714 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 109' ' ' MET . 39.1 m-80 -148.65 97.41 2.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.017 -0.734 . . . . 2.2400000000000002 109.017 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -149.19 165.14 32.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.787 -0.642 . . . . 1.6299999999999999 110.496 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 ptp -132.97 129.58 38.41 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.828 -0.623 . . . . 1.77 109.972 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 45.5 p90 -146.51 165.25 30.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.023 -0.362 . . . . 3.0099999999999998 110.023 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -109.19 122.08 46.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 2.3900000000000001 110.971 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -131.83 153.84 49.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.792 -0.64 . . . . 3.3700000000000001 109.885 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 m -104.76 145.62 30.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.3999999999999999 110.458 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.648 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 97.9 m-85 -125.43 104.63 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.995 -0.372 . . . . 1.1799999999999999 109.995 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 9.1 p-10 -135.13 115.08 13.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.473 0.654 . . . . 2.5699999999999998 110.885 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 63.2 t80 -179.91 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.94 -1.027 . . . . 3.21 109.188 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -92.32 -35.87 13.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.905 -0.776 . . . . 3.23 108.905 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.28 144.17 25.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.131 -1.063 . . . . 2.8500000000000001 108.131 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.59 160.31 53.64 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 109.664 -0.495 . . . . 2.1200000000000001 109.664 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 50.3 Cg_exo -54.74 84.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 1.47 114.418 -171.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 p -102.13 147.7 26.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.291 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -121.24 130.36 53.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.007 -0.368 . . . . 3.0800000000000001 110.007 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 124' ' ' ARG . 35.8 m -122.87 164.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.175 0.512 . . . . 1.3300000000000001 111.658 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -104.25 111.72 24.45 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.837 -1.542 . . . . 1.6899999999999999 106.837 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 91' ' ' MET . 14.6 p -104.27 136.64 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-O 121.329 0.585 . . . . 1.27 109.701 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -111.95 114.33 27.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.647 -0.872 . . . . 1.02 108.647 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.2 tpp -100.39 133.68 44.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.46 -0.791 . . . . 2.4900000000000002 109.079 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 118' ' ' TYR . 12.2 mmmm -135.67 159.63 41.02 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.819 -0.808 . . . . 1.5700000000000001 108.819 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 64.7 tttp -104.86 121.05 42.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.126 0.489 . . . . 2.1299999999999999 111.657 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.624 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -107.91 99.02 8.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.694 -0.685 . . . . 1.5700000000000001 109.938 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.66 -19.54 62.08 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.595 -0.52 . . . . 4.4100000000000001 109.595 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 m -73.34 80.81 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.543 -0.753 . . . . 2.5499999999999998 110.174 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.05 9.18 13.84 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.524 -0.846 . . . . 2.6200000000000001 112.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 55.95 41.34 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.896 0.379 . . . . 2.7599999999999998 111.662 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -134.77 -167.14 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.514 -0.312 . . . . 1.0700000000000001 110.828 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.702 ' OH ' HG22 ' A' ' 83' ' ' VAL . 82.4 m-85 -135.55 153.51 51.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.003 -0.74 . . . . 0.85999999999999999 109.003 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 47.9 m95 -102.72 104.13 14.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.958 -0.756 . . . . 0.63 108.958 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 31' ' ' ILE . 11.6 p -100.34 125.66 54.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.108 0.956 . . . . 0.91000000000000003 111.39 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.73 137.06 54.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.894 -1.048 . . . . 0.79000000000000004 108.989 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 29' ' ' GLY . 27.0 m -104.69 141.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.093 -0.643 . . . . 1.1799999999999999 111.567 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -124.23 103.54 8.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.306 -0.861 . . . . 3.3100000000000001 109.257 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 15.0 ptm180 -75.05 120.78 21.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.506 -0.315 . . . . 4.0300000000000002 110.268 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.712 1.258 . . . . 2.8700000000000001 113.417 -174.025 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.648 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.433 HD22 ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.611 0.243 . . . . 3.3399999999999999 110.447 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.35 108.63 3.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.448 -0.342 . . . . 2.8999999999999999 110.254 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 69.65 142.34 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.116 0.885 . . . . 3.8500000000000001 112.137 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.42 123.49 7.88 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 0.84999999999999998 110.023 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -116.79 103.94 10.84 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.966 -0.294 . . . . 0.70999999999999996 110.362 -170.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 53.2 mt -108.7 114.34 46.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.971 -0.559 . . . . 1.0800000000000001 109.56 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -101.45 114.34 28.26 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.624 -0.88 . . . . 0.85999999999999999 108.624 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.24 160.53 34.61 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.632 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.4 169.88 8.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 1.22 110.574 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.28 -23.69 26.86 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 114.521 0.568 . . . . 0.79000000000000004 114.521 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -37.35 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.337 0.569 . . . . 1.95 110.751 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 128.96 11.3 2.9 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.479 -0.867 . . . . 0.53000000000000003 113.285 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -71.14 127.19 31.75 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.366 0.583 . . . . 1.3 109.727 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 16.2 mt -81.52 151.36 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.309 -0.626 . . . . 0.89000000000000001 109.309 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 58' ' ' ILE . 77.7 mt -129.82 -67.46 0.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.459 0.647 . . . . 1.45 110.115 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 63.2 mt-30 -112.61 138.38 49.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.633 -0.712 . . . . 1.99 110.347 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.832 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -118.41 -4.07 10.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.703 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 66.2 t30 63.23 172.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.538 -0.756 . . . . 2.1299999999999999 110.577 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 11.2 6.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 1.48 110.882 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -92.51 -63.78 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.229 -0.442 . . . . 1.52 111.472 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.26 -43.79 83.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 110.985 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA2' ' C ' ' A' ' 51' ' ' GLY . . . -68.82 -10.06 60.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.576 -0.821 . . . . 1.4199999999999999 113.148 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.15 -41.91 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.122 0.461 . . . . 2.3500000000000001 110.559 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 45' ' ' ALA . 6.1 pt -85.92 -47.56 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 112.296 0.48 . . . . 2.5899999999999999 112.296 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.7 p -105.82 -49.33 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.976 -0.453 . . . . 3.4100000000000001 111.175 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' ' HA2' ' A' ' 47' ' ' GLY . . . 139.91 -175.25 21.95 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.222 -0.751 . . . . 2.3199999999999998 111.222 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.704 ' HG2' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 71.57 99.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 3.1400000000000001 111.407 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 3.6 m-20 -67.97 149.4 98.2 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 108.97 -0.752 . . . . 2.1000000000000001 108.97 171.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.832 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 10.3 Cg_endo -52.52 -31.78 50.43 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.788 2.325 . . . . 1.6799999999999999 111.938 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -71.35 -19.13 62.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.361 -0.836 . . . . 3.6099999999999999 111.46 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 15.3 mm-40 -94.97 -14.49 24.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 2.5 111.73 -171.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.694 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -111.23 18.93 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 113.033 0.753 . . . . 0.96999999999999997 113.033 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.732 HG22 ' HA ' ' A' ' 40' ' ' LEU . 8.3 pt -87.51 140.09 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.438 -0.505 . . . . 1.0900000000000001 110.586 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.72 10.04 71.03 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.223 -0.989 . . . . 0.66000000000000003 110.901 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 39' ' ' ILE . 87.1 mttt -114.71 135.99 53.55 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.761 -0.459 . . . . 1.8200000000000001 109.761 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 21.8 t-20 -81.62 115.78 21.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.146 -0.479 . . . . 0.71999999999999997 110.021 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 39' ' ' ILE . 48.1 t80 -50.73 -37.91 44.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.69999999999999996 111.618 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 38.2 m-85 -90.38 15.14 11.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.382 -0.372 . . . . 1.1599999999999999 111.577 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -148.66 -49.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 3.5800000000000001 111.716 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.03 -21.88 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.165 0.802 . . . . 2.2000000000000002 113.165 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 52' ' ' ARG . 5.4 p -149.58 14.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.357 -0.937 . . . . 1.77 112.82 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.25 94.52 0.43 Allowed Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.043 -0.526 . . . . 0.60999999999999999 111.703 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.02 -18.88 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.618 2.212 . . . . 0.81000000000000005 112.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -12.03 48.78 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.142 -0.223 . . . . 0.84999999999999998 111.223 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 67' ' ' ALA . 10.9 t -82.56 -27.73 31.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.697 -0.401 . . . . 1.3300000000000001 110.854 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 19.1 t70 -67.05 110.36 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.217 -0.66 . . . . 1.8500000000000001 109.217 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -164.12 148.94 8.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.178 -0.464 . . . . 1.5600000000000001 109.791 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.81 -21.59 64.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.691 2.261 . . . . 1.1699999999999999 113.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.97 -21.59 19.69 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.97 -0.292 . . . . 2.5600000000000001 111.573 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 50.2 t80 -107.46 -72.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.767 0.317 . . . . 3.3599999999999999 110.176 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.69 -38.9 79.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.132 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.04 -40.25 93.17 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.59999999999999998 112.546 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 58.1 mttm -87.91 -21.95 24.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 2.0899999999999999 111.426 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.678 ' O ' HG23 ' A' ' 83' ' ' VAL . 84.6 t80 -62.17 -49.65 74.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.62 -0.882 . . . . 0.67000000000000004 108.62 170.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.43 -20.16 60.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.825 -1.08 . . . . 1.0900000000000001 110.309 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 30.3 tt0 -57.37 -36.72 71.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 2.0699999999999998 109.693 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.97 -32.62 8.84 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.611 -0.722 . . . . 0.71999999999999997 112.187 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.1 t -59.9 -53.04 54.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.59 0.219 . . . . 0.84999999999999998 111.59 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.83 -59.37 4.59 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.423 0.452 . . . . 1.1399999999999999 111.535 -175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.2 p -167.11 29.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.306 . . . . 1.8200000000000001 111.561 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.17 -10.71 19.88 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.53 -1.319 . . . . 1.6499999999999999 113.069 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 63.77 124.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.409 -0.589 . . . . 3.5 109.409 -169.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 118' ' ' TYR . 32.9 tp -103.67 104.19 14.2 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.655 -0.818 . . . . 2.96 111.432 -166.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.3 p-10 -165.03 104.68 0.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.497 1.142 . . . . 2.2400000000000002 109.429 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -165.41 166.63 18.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.996 -1.456 . . . . 1.6299999999999999 108.514 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.5 ptt? -133.25 122.22 23.61 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.072 0.463 . . . . 1.77 110.304 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -124.3 167.48 14.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.149 -0.478 . . . . 3.0099999999999998 110.41 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -102.59 119.32 38.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.748 -0.464 . . . . 2.3900000000000001 109.748 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -133.96 153.82 51.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 3.3700000000000001 110.319 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 p -104.45 150.49 24.51 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.72 0.295 . . . . 1.3999999999999999 111.295 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.442 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 53.0 m-85 -130.22 116.41 18.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.438 . . . . 1.1799999999999999 110.319 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' MET . 8.0 p-10 -124.54 -158.53 0.83 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.504 -0.771 . . . . 2.5699999999999998 109.238 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 67.1 t80 70.96 -74.64 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.685 0.394 . . . . 3.21 111.474 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.507 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 26.3 mm-40 -92.55 4.2 54.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.695 0.759 . . . . 3.23 110.357 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 tpt -150.0 152.0 34.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.659 -1.155 . . . . 2.8500000000000001 108.243 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 100' ' ' MET . 13.7 p -63.38 147.79 94.55 Favored Pre-proline 0 N--CA 1.443 -0.809 0 N-CA-C 108.069 -1.086 . . . . 2.1200000000000001 108.069 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.9 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.191 . . . . 1.47 112.649 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -99.51 149.22 23.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.931 -0.577 . . . . 1.3999999999999999 110.798 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -103.85 118.57 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.198 -0.667 . . . . 3.0800000000000001 109.198 174.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.5 m -123.05 163.73 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.592 0.711 . . . . 1.3300000000000001 111.616 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -110.79 114.88 28.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.905 -1.146 . . . . 1.6899999999999999 107.905 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.646 HG22 HG12 ' A' ' 122' ' ' VAL . 41.5 t -107.34 115.79 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.208 -0.451 . . . . 1.27 110.055 -168.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -104.27 109.03 20.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.658 -0.497 . . . . 1.02 109.658 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.691 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -103.97 134.32 47.45 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.842 -0.617 . . . . 2.4900000000000002 109.489 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -147.95 150.15 33.51 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.204 -0.295 . . . . 1.5700000000000001 110.204 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.515 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 42.9 tttm -87.01 128.72 35.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.667 0.27 . . . . 2.1299999999999999 111.037 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.34 127.65 30.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 1.5700000000000001 110.066 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.19 94.58 5.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.927 0.87 . . . . 4.4100000000000001 112.692 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t -113.47 -62.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 104.3 -2.482 . . . . 2.5499999999999998 104.3 160.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.62 143.86 17.06 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 106.626 -2.59 . . . . 2.6200000000000001 106.626 151.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.92 100.14 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.661 1.231 . . . . 2.7599999999999998 111.12 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -156.7 -177.79 6.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.875 -1.057 . . . . 1.0700000000000001 109.003 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.515 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 9.0 m-85 -128.85 154.18 46.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.715 -0.846 . . . . 0.85999999999999999 108.715 -175.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 60.8 m95 -100.74 104.13 15.4 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.237 -1.023 . . . . 0.63 108.237 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.617 HG22 ' CB ' ' A' ' 109' ' ' MET . 47.9 t -101.8 104.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.889 -1.05 . . . . 0.91000000000000003 109.585 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 81.0 m-85 -103.16 138.64 39.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.79000000000000004 110.608 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.646 HG12 HG22 ' A' ' 107' ' ' VAL . 16.6 m -107.35 153.22 8.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.944 0.402 . . . . 1.1799999999999999 111.138 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -149.77 112.38 4.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.942 -0.572 . . . . 3.3100000000000001 110.186 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.651 ' HA ' HG12 ' A' ' 105' ' ' VAL . 20.5 ttt180 -73.1 145.34 46.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 4.0300000000000002 110.808 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 125' ' ' VAL . 3.2 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.153 -0.927 . . . . 2.8700000000000001 110.824 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.442 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.127 -0.694 . . . . 3.3399999999999999 109.127 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' H ' HD13 ' A' ' 26' ' ' LEU . . . -75.52 59.28 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.131 0.419 . . . . 2.8999999999999999 112.131 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 64.88 168.04 0.18 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.746 0.784 . . . . 3.8500000000000001 112.956 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.22 107.39 2.94 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.925 -0.87 . . . . 0.84999999999999998 110.925 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.55 128.82 51.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.70999999999999996 110.809 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 46' ' ' GLU . 57.5 mt -122.26 138.89 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.228 -0.656 . . . . 1.0800000000000001 109.228 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.6 tt0 -104.68 121.13 42.93 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.192 -0.67 . . . . 0.85999999999999999 109.192 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -137.01 153.74 50.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 1.6200000000000001 109.891 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 169.62 8.41 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.85 -0.34 . . . . 1.22 110.655 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.63 -22.59 8.46 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 115.313 0.885 . . . . 0.79000000000000004 115.313 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.36 -21.93 38.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.756 0.778 . . . . 1.95 110.638 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.88 3.94 31.76 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.093 -0.803 . . . . 0.53000000000000003 111.093 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.654 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.1 m120 -70.24 134.84 48.43 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.054 0.454 . . . . 1.3 110.705 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.1 mt -87.24 148.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.422 -0.808 . . . . 0.89000000000000001 110.015 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 32' ' ' GLN . 42.2 mt -117.69 -61.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.271 0.557 . . . . 1.45 110.516 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.8 136.89 18.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.389 0.614 . . . . 1.99 111.248 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.024 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -92.5 153.1 19.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.899 -1.046 . . . . 1.25 110.77 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -88.04 166.22 14.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' HB3' HD11 ' A' ' 26' ' ' LEU . . . -53.46 -35.5 60.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.137 0.421 . . . . 1.48 112.137 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 26' ' ' LEU . . . -63.85 -48.07 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.751 0.278 . . . . 1.52 111.751 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG2' HD11 ' A' ' 31' ' ' ILE . 6.3 tp10 -72.46 -4.86 32.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.575 0.702 . . . . 2.1200000000000001 110.435 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.41 -54.12 0.62 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.486 -0.779 . . . . 1.4199999999999999 112.282 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.07 -38.36 61.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.984 0.421 . . . . 2.3500000000000001 111.36 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -81.78 -57.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 2.5899999999999999 109.823 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.4 m -57.42 -52.35 65.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.22 -0.9 . . . . 3.4100000000000001 112.032 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.73 42.77 0.92 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.625 -0.798 . . . . 2.3199999999999998 111.814 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -133.46 171.74 13.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.684 -0.488 . . . . 3.1400000000000001 109.684 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.804 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 16.1 t70 -105.76 130.93 22.24 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.701 -0.481 . . . . 2.1000000000000001 109.701 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.024 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 50.3 Cg_exo -55.02 -20.25 22.72 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.488 2.792 . . . . 1.6799999999999999 114.186 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -119.32 15.13 13.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.195 0.443 . . . . 3.6099999999999999 112.195 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.804 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 23.1 mm-40 -86.23 -13.23 47.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 2.5 110.161 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 57' ' ' VAL . 4.6 m -89.91 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.606 -0.724 . . . . 0.96999999999999997 112.179 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.2 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.641 -0.423 . . . . 1.0900000000000001 110.721 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 18.92 76.95 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.254 -0.738 . . . . 0.66000000000000003 111.254 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -124.25 151.79 43.75 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.623 0.249 . . . . 1.8200000000000001 111.084 -170.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -105.71 122.04 45.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.71999999999999997 109.416 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.7 t80 -54.09 -43.75 70.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.005 -0.543 . . . . 0.69999999999999996 111.733 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 70.9 m-85 -77.5 -5.41 49.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 1.1599999999999999 111.719 -172.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -128.37 -48.05 1.31 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.13 0.419 . . . . 3.5800000000000001 112.13 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -92.88 -22.54 19.2 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.483 0.549 . . . . 2.2000000000000002 112.483 -172.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.14 13.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.171 -0.612 . . . . 1.77 111.477 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.81 74.58 0.17 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.748 0.309 . . . . 0.60999999999999999 111.023 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.2 -4.1 11.05 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.766 2.311 . . . . 0.81000000000000005 113.64 -176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 p -113.1 18.24 18.15 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.096 -0.377 . . . . 0.84999999999999998 110.641 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p -97.17 -37.64 10.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 1.3300000000000001 111.125 164.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 59.1 t0 -59.96 102.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.207 0.527 . . . . 1.8500000000000001 110.486 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.2 p -163.55 154.86 14.37 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.618 -0.719 . . . . 1.5600000000000001 109.489 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.61 -21.41 71.97 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.6 2.2 . . . . 1.1699999999999999 113.001 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.62 -17.08 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.902 0.334 . . . . 2.5600000000000001 111.902 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.862 ' HE2' HG11 ' A' ' 107' ' ' VAL . 23.2 t80 -117.23 -68.92 0.88 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.825 -0.35 . . . . 3.3599999999999999 110.689 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.46 -35.22 79.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.79000000000000004 109.95 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.42 93.69 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.069 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 69.6 mmtt -71.4 -38.62 71.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.029 0.442 . . . . 2.0899999999999999 110.406 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.76 -37.06 80.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.797 -0.638 . . . . 0.67000000000000004 110.298 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.73 -20.98 32.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 1.0900000000000001 110.622 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -68.88 -35.83 77.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 2.0699999999999998 109.681 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.985 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -68.92 -36.67 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.538 -0.756 . . . . 0.71999999999999997 111.583 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.13 -51.76 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.212 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.44 69.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.623 . . . . 1.1399999999999999 111.162 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -65.95 -71.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.513 0.673 . . . . 1.8200000000000001 110.095 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.26 -62.59 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 108.884 -1.687 . . . . 1.6499999999999999 108.884 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.433 HD22 ' HA ' ' A' ' 87' ' ' ASN . 2.3 m120 -161.33 167.03 26.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.902 0.881 . . . . 3.5 108.674 167.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.985 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -125.59 152.79 44.64 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.8 -0.76 . . . . 2.96 111.299 -168.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.757 ' HA ' ' O ' ' A' ' 109' ' ' MET . 35.7 p30 -163.8 47.0 0.12 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.336 -1.302 . . . . 2.2400000000000002 109.162 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 p -102.36 165.21 11.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.843 -1.526 . . . . 1.6299999999999999 111.134 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -116.78 125.32 51.45 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.218 -0.901 . . . . 1.77 109.911 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.33 157.66 27.68 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.757 -0.461 . . . . 3.0099999999999998 109.757 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.25 111.11 23.59 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.595 -0.52 . . . . 2.3900000000000001 109.595 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -135.87 144.07 45.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.885 -0.598 . . . . 3.3700000000000001 109.408 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 104' ' ' LYS . 6.0 p -105.06 155.52 18.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.013 0.435 . . . . 1.3999999999999999 111.55 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 35.8 m-85 -116.19 104.73 11.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.919 -0.582 . . . . 1.1799999999999999 109.614 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 31.8 t70 -140.77 98.84 3.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.748 -0.66 . . . . 2.5699999999999998 110.198 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.61 ' HD1' ' HG2' ' A' ' 99' ' ' GLN . 65.2 t80 174.24 -71.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.675 0.61 . . . . 3.21 110.03 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG2' ' HD1' ' A' ' 98' ' ' TYR . 15.2 mm100 -101.9 4.34 40.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.987 0.899 . . . . 3.23 109.319 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.5 tpp -137.99 139.4 39.64 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.114 -1.403 . . . . 2.8500000000000001 107.962 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.09 144.43 94.28 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 108.972 -0.751 . . . . 2.1200000000000001 108.972 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.4 90.9 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.349 2.699 . . . . 1.47 114.14 -167.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -89.85 143.73 26.54 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 110.683 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -110.91 107.87 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.395 -0.965 . . . . 3.0800000000000001 108.395 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.6 m -129.64 163.17 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.789 0.804 . . . . 1.3300000000000001 112.365 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.66 123.02 47.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.408 -1.269 . . . . 1.6899999999999999 107.856 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.862 HG11 ' HE2' ' A' ' 75' ' ' PHE . 4.9 p -104.19 113.17 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.054 0.93 . . . . 1.27 109.759 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -104.9 104.24 13.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.976 -1.011 . . . . 1.02 108.813 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.757 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.3 pmm? -102.98 127.76 50.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.349 -0.612 . . . . 2.4900000000000002 109.349 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.564 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 42.4 mtmt -137.79 164.6 28.51 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 110.228 -0.286 . . . . 1.5700000000000001 110.228 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 3.9 tmtp? -94.92 149.98 20.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 2.1299999999999999 110.897 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -137.37 114.56 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.313 -0.858 . . . . 1.5700000000000001 109.333 173.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -87.72 32.71 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.5 0.667 . . . . 4.4100000000000001 110.703 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 p -79.73 -58.34 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.492 -0.777 . . . . 2.5499999999999998 109.935 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.44 20.98 5.48 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.409 -0.814 . . . . 2.6200000000000001 111.136 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.21 77.25 0.33 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.57 0.7 . . . . 2.7599999999999998 111.393 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.487 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 1.3 m -159.49 -171.22 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 1.0700000000000001 107.51 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 78.6 m-85 -123.74 147.8 47.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 118.154 0.434 . . . . 0.85999999999999999 109.847 -174.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.593 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 70.9 m95 -103.93 108.54 19.92 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.241 -1.022 . . . . 0.63 108.241 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.21 135.96 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.574 0.702 . . . . 0.91000000000000003 110.437 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.564 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 98.6 m-85 -120.19 137.24 54.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.354 -0.839 . . . . 0.79000000000000004 110.715 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.6 t -104.01 102.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.304 -0.862 . . . . 1.1799999999999999 109.107 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -105.81 123.86 48.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.154 -0.476 . . . . 3.3100000000000001 109.883 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -66.14 137.37 56.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.726 0.298 . . . . 4.0300000000000002 110.818 -177.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 105' ' ' VAL . 3.3 p . . . . . 0 C--O 1.248 1.018 0 CA-C-N 116.35 -0.386 . . . . 2.8700000000000001 110.663 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.441 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.745 HD21 HG13 ' A' ' 49' ' ' ILE . 68.9 mt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.107 0.479 . . . . 3.3399999999999999 110.935 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.87 -56.46 2.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.93 -0.767 . . . . 2.8999999999999999 108.93 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 30' ' ' ALA . 35.0 p90 173.01 170.9 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.167 -0.924 . . . . 3.8500000000000001 109.354 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -104.07 115.26 5.0 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.732 -0.746 . . . . 0.84999999999999998 111.845 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -119.87 113.5 20.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 0.70999999999999996 110.527 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.48 ' HB ' HG13 ' A' ' 120' ' ' VAL . 24.8 mt -120.2 146.42 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.416 -0.587 . . . . 1.0800000000000001 109.416 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.3 tt0 -115.74 136.34 53.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.255 -1.016 . . . . 0.85999999999999999 108.255 172.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.0 pt? -147.95 159.32 44.0 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.729 -0.388 . . . . 1.6200000000000001 110.999 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.624 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.8 p30 -102.85 167.79 9.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.308 -0.405 . . . . 1.22 110.201 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.2 -17.22 44.83 Favored Glycine 0 CA--C 1.517 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.79000000000000004 113.855 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.92 -21.18 22.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.01 0.405 . . . . 1.95 111.139 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 117.09 3.49 17.51 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.418 -0.896 . . . . 0.53000000000000003 113.558 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 46.1 m-80 -71.11 128.93 37.58 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.453 0.627 . . . . 1.3 109.384 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.0 mt -83.5 144.08 10.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.047 -0.524 . . . . 0.89000000000000001 110.16 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -96.93 -75.47 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.45 110.066 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.528 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 16.9 pm0 -153.45 145.01 23.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 1.99 110.378 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.658 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.6 m-85 -90.68 156.91 17.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.142 -0.936 . . . . 1.25 109.313 170.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 58.7 t30 -70.6 156.47 39.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.85 -0.796 . . . . 2.1299999999999999 108.85 171.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.21 69.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 1.48 110.707 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 26' ' ' LEU . . . -69.84 -52.67 23.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.987 -0.551 . . . . 1.52 111.28 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.685 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 20.6 tp10 -61.41 -44.98 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 2.1200000000000001 111.286 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.06 -34.82 58.14 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.33 -0.938 . . . . 1.4199999999999999 113.009 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.25 -45.85 68.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 2.3500000000000001 111.01 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.745 HG13 HD21 ' A' ' 26' ' ' LEU . 38.4 mm -74.32 -55.72 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.144 -0.48 . . . . 2.5899999999999999 111.307 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 m -64.26 -50.91 66.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.537 -0.302 . . . . 3.4100000000000001 111.781 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.79 44.51 0.41 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.342 -0.932 . . . . 2.3199999999999998 112.152 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 52' ' ' ARG . 57.5 mmt-85 -136.3 93.69 2.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.057 -0.72 . . . . 3.1400000000000001 109.057 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.91 142.11 79.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.759 0.652 . . . . 2.1000000000000001 112.759 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.44 114.23 1.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.135 2.557 . . . . 1.6799999999999999 112.26 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 77.38 11.63 2.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.835 -1.075 . . . . 3.6099999999999999 112.105 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -91.82 4.73 52.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.673 0.749 . . . . 2.5 109.056 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.71 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -110.23 14.84 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.764 -1.107 . . . . 0.96999999999999997 111.935 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 56.3 mt -80.43 128.22 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.451 -0.574 . . . . 1.0900000000000001 109.451 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 -8.39 65.66 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.123 -1.037 . . . . 0.66000000000000003 110.833 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 21.0 mttp -86.04 131.21 34.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.847 -0.797 . . . . 1.8200000000000001 108.847 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.1 t-20 -88.17 112.94 23.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.122 -0.631 . . . . 0.71999999999999997 109.866 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' A' ' 70' ' ' THR . 45.8 t80 -47.87 -64.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.361 -0.836 . . . . 0.69999999999999996 111.787 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -87.96 28.09 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.192 0.442 . . . . 1.1599999999999999 112.192 -169.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 38.9 ttpt -143.18 -42.43 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 3.5800000000000001 111.026 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' OD2' HG13 ' A' ' 66' ' ' VAL . 38.9 t70 -95.15 -77.02 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 2.2000000000000002 110.884 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.413 HG13 ' OD2' ' A' ' 65' ' ' ASP . 5.6 m -91.96 16.29 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.558 0.947 . . . . 1.77 113.558 -172.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -165.25 86.23 1.03 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.994 0.426 . . . . 0.60999999999999999 111.153 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 98' ' ' TYR . 79.4 Cg_endo -91.07 -4.84 4.34 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.683 2.255 . . . . 0.81000000000000005 114.257 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.769 ' HB3' ' HA ' ' A' ' 98' ' ' TYR . 11.8 p -73.67 -13.83 61.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 109.814 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.582 HG23 ' HE1' ' A' ' 96' ' ' PHE . 11.1 m -91.49 -37.47 13.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.351 -1.295 . . . . 1.3300000000000001 110.607 -145.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.36 109.96 5.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.768 0.794 . . . . 1.8500000000000001 110.179 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.4 m -162.67 154.16 15.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.399 -0.819 . . . . 1.5600000000000001 109.314 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.17 -35.59 91.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.688 2.259 . . . . 1.1699999999999999 112.908 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.48 -16.15 60.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.248 0.462 . . . . 2.5600000000000001 112.248 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.432 ' HE2' HG11 ' A' ' 107' ' ' VAL . 61.5 t80 -124.5 -74.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 3.3599999999999999 110.485 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.46 -37.55 78.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 0.79000000000000004 110.966 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.29 -44.69 96.33 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.894 -0.67 . . . . 0.59999999999999998 112.106 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 71.9 mmtt -74.02 -32.29 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 2.0899999999999999 111.024 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.471 ' O ' HD11 ' A' ' 88' ' ' LEU . 89.3 t80 -60.14 -43.41 95.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.315 0.579 . . . . 0.67000000000000004 110.278 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.4 -19.6 45.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.86 -0.609 . . . . 1.0900000000000001 110.338 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.27 -37.68 83.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 2.0699999999999998 109.897 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.632 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.31 -44.83 41.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.799 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 79' ' ' PHE . 32.1 t -56.76 -50.47 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.84999999999999998 110.945 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -12.22 60.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 1.1399999999999999 112.229 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -101.26 -77.13 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.712 0.292 . . . . 1.8200000000000001 110.596 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.3 -62.23 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.738 -0.744 . . . . 1.6499999999999999 112.231 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -118.26 136.28 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.777 0.322 . . . . 3.5 110.552 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -104.74 123.17 47.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.179 -0.464 . . . . 2.96 110.261 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 36.9 t-20 -176.11 116.53 0.13 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.491 0.662 . . . . 2.2400000000000002 110.363 173.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 13.9 t -166.0 165.15 18.16 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.718 -1.128 . . . . 1.6299999999999999 109.031 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.6 ptm -140.0 108.64 5.91 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.335 0.588 . . . . 1.77 110.687 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -121.93 166.61 14.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.767 -0.651 . . . . 3.0099999999999998 110.548 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.59 121.55 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.495 -0.557 . . . . 2.3900000000000001 109.495 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -134.07 165.13 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.631 -0.713 . . . . 3.3700000000000001 109.458 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -104.42 147.17 27.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.734 -0.469 . . . . 1.3999999999999999 109.734 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HE1' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -139.45 103.33 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.198 -0.601 . . . . 1.1799999999999999 112.448 -169.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 7.3 t70 170.52 144.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 2.5699999999999998 108.958 167.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.769 ' HA ' ' HB3' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -72.02 -42.67 66.09 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.605 -0.725 . . . . 3.21 111.578 -176.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -137.02 -5.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.037 0.754 . . . . 3.23 113.037 -171.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.92 160.51 29.13 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.17 -0.678 . . . . 2.8500000000000001 109.17 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.87 100.92 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 108.504 -0.924 . . . . 2.1200000000000001 108.504 167.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -39.55 99.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.425 3.417 . . . . 1.47 113.996 -161.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.5 m -56.42 153.39 9.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.359 -0.837 . . . . 1.3999999999999999 110.273 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.98 136.53 42.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.226 0.536 . . . . 3.0800000000000001 110.946 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 122' ' ' VAL . 10.6 p -144.4 156.2 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.381 -0.827 . . . . 1.3300000000000001 110.294 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.429 ' HE3' HG11 ' A' ' 125' ' ' VAL . 29.0 ttmt -109.38 128.77 55.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.098 -1.075 . . . . 1.6899999999999999 108.098 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 122' ' ' VAL . 50.3 t -119.56 114.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 109.221 -0.659 . . . . 1.27 109.221 -166.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 90' ' ' THR . 73.4 t60 -104.78 122.78 46.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.899 -0.591 . . . . 1.02 109.969 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.4 mpt? -100.29 147.47 25.73 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.497 -0.927 . . . . 2.4900000000000002 108.497 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.612 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.8 ptmt -162.67 143.82 10.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.464 -0.569 . . . . 1.5700000000000001 109.464 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 84.4 tttt -94.0 122.51 36.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.451 . . . . 2.1299999999999999 111.111 -170.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.478 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -104.62 174.78 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.743 -0.662 . . . . 1.5700000000000001 109.335 175.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.4 tp -121.56 -28.7 4.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.812 0.339 . . . . 4.4100000000000001 110.129 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -71.34 100.24 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.424 -0.584 . . . . 2.5499999999999998 109.424 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.64 -6.01 33.22 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.301 -0.952 . . . . 2.6200000000000001 112.151 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 51.87 51.62 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.27 0.557 . . . . 2.7599999999999998 110.099 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.4 p -152.59 178.98 9.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.857 -0.611 . . . . 1.0700000000000001 110.568 -172.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 2.5 m-85 -117.22 155.68 29.01 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.569 -0.9 . . . . 0.85999999999999999 108.569 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.478 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 78.2 m95 -102.27 111.55 23.88 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.09 -0.707 . . . . 0.63 109.09 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.48 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.7 p -101.63 116.81 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.165 0.983 . . . . 0.91000000000000003 110.396 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.612 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 32.5 m-85 -109.36 125.15 52.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.795 . . . . 0.79000000000000004 110.529 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 107' ' ' VAL . 15.3 m -109.46 140.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.127 0.489 . . . . 1.1799999999999999 110.88 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -139.2 133.19 31.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 3.3100000000000001 110.088 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -72.05 123.05 21.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.892 -0.41 . . . . 4.0300000000000002 109.892 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 ' HE3' ' A' ' 106' ' ' LYS . 2.5 m . . . . . 0 C--O 1.247 0.948 0 CA-C-N 116.327 -0.397 . . . . 2.8700000000000001 110.599 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 44' ' ' ALA . 2.4 mm? . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.382 -0.229 . . . . 3.3399999999999999 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.12 -77.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.597 -0.274 . . . . 2.8999999999999999 111.417 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.21 170.78 9.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 3.8500000000000001 110.683 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 43' ' ' ASN . . . -104.23 147.16 16.44 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.416 -0.897 . . . . 0.84999999999999998 113.424 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.15 111.43 14.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.092 -0.707 . . . . 0.70999999999999996 109.092 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 120' ' ' VAL . 6.9 mm -103.53 160.37 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' HG22 ' A' ' 31' ' ' ILE . 63.5 tt0 -133.42 113.67 12.8 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.175 -0.328 . . . . 0.85999999999999999 110.156 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.553 ' HG ' HG11 ' A' ' 120' ' ' VAL . 22.0 mt -112.63 151.98 29.5 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.351 -0.611 . . . . 1.6200000000000001 109.351 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.52 168.99 8.72 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.876 -0.329 . . . . 1.22 110.249 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.92 -27.48 37.14 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.569 0.543 . . . . 0.79000000000000004 114.326 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -44.03 20.09 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.508 0.654 . . . . 1.95 111.097 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.49 20.76 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.361 -0.924 . . . . 0.53000000000000003 112.902 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -84.52 142.64 29.88 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.484 -0.562 . . . . 1.3 109.484 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 6.0 mt -90.91 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.982 -0.747 . . . . 0.89000000000000001 108.982 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 58' ' ' ILE . 9.1 mp -118.19 -86.43 0.64 Allowed 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.134 0.492 . . . . 1.45 111.02 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -119.6 168.29 11.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.687 0.756 . . . . 1.99 111.655 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.767 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 3.3 m-85 -132.94 -167.75 1.96 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.011 -1.449 . . . . 1.25 109.337 -174.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 63.4 t30 -128.13 160.74 31.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.749 -0.834 . . . . 2.1299999999999999 108.749 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.671 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -71.55 19.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.508 0.559 . . . . 1.48 112.508 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.64 -42.9 8.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.083 0.468 . . . . 1.52 110.149 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 42' ' ' TYR . 16.4 mm-40 -77.5 -17.27 58.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.555 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -82.89 -26.18 46.4 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.449 -0.882 . . . . 1.4199999999999999 111.663 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -45.11 16.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 2.3500000000000001 110.609 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -83.16 -62.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 2.5899999999999999 111.21 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -75.76 -53.28 8.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.053 0.454 . . . . 3.4100000000000001 111.382 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.21 36.59 1.32 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 2.3199999999999998 111.226 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.467 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 16.9 tpp85 -123.27 110.14 14.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.56 0.219 . . . . 3.1400000000000001 110.525 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 28.6 m-20 -77.74 154.6 80.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.542 -0.299 . . . . 2.1000000000000001 110.508 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 36.9 Cg_endo -67.47 -9.79 26.53 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.838 2.358 . . . . 1.6799999999999999 111.312 172.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.27 5.86 44.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.269 -0.878 . . . . 3.6099999999999999 111.185 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 83.4 mm-40 -97.82 -60.52 1.55 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 2.5 111.75 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.852 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 2.9 m -88.27 40.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.486 0.921 . . . . 0.96999999999999997 113.486 -169.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 40' ' ' LEU . 30.8 mt -91.23 120.34 40.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.466 -0.494 . . . . 1.0900000000000001 109.886 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.52 33.03 58.96 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.526 -1.03 . . . . 0.66000000000000003 110.526 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.852 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 35.6 mttm -121.7 135.56 54.95 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.673 -0.763 . . . . 1.8200000000000001 110.009 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -80.78 112.93 18.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.803 0.335 . . . . 0.71999999999999997 110.331 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 39' ' ' ILE . 71.6 t80 -57.55 -40.7 79.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.69999999999999996 111.385 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.496 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 55.5 m-85 -91.05 25.63 2.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.332 -0.394 . . . . 1.1599999999999999 111.712 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.79 -46.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.688 -0.405 . . . . 3.5800000000000001 111.113 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.28 -78.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 2.2000000000000002 111.703 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.18 36.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.982 1.373 . . . . 1.77 111.544 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -163.9 81.28 1.43 Allowed Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 113.995 -1.457 . . . . 0.60999999999999999 111.071 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -97.72 8.81 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.906 2.404 . . . . 0.81000000000000005 114.066 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 97' ' ' ASP . 1.7 p -77.69 -17.97 57.12 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.949 -0.7 . . . . 0.84999999999999998 110.25 170.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.1 t -96.45 -26.3 15.36 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.3300000000000001 110.964 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 63' ' ' PHE . 5.7 m-20 -65.76 131.7 46.96 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.842 -0.343 . . . . 1.8500000000000001 111.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.8 p 179.81 155.05 0.68 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 109.515 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.9 -19.2 63.97 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.353 2.035 . . . . 1.1699999999999999 112.326 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 8.0 pt-20 -92.39 -24.9 18.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 2.5600000000000001 111.718 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 87.0 t80 -104.34 -72.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.646 -0.422 . . . . 3.3599999999999999 110.075 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -38.26 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.79000000000000004 110.238 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.28 -34.79 90.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.86 -0.609 . . . . 0.59999999999999998 112.498 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.25 -35.13 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.817 0.309 . . . . 2.0899999999999999 110.464 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.591 ' O ' HG23 ' A' ' 83' ' ' VAL . 59.3 t80 -57.72 -45.82 85.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.219 -0.66 . . . . 0.67000000000000004 109.219 172.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -77.75 -17.71 57.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.671 . . . . 1.0900000000000001 111.241 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -61.24 -36.22 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.109 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.661 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -84.03 -51.36 4.01 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.161 -1.019 . . . . 0.71999999999999997 111.48 172.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.598 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 48.4 t -45.82 -62.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.151 0.58 . . . . 0.84999999999999998 112.559 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.82 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 1.1399999999999999 111.411 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -70.07 0.36 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.499 . . . . 1.8200000000000001 110.537 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.99 27.5 0.18 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.223 -0.751 . . . . 1.6499999999999999 111.223 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 111' ' ' LYS . 19.6 m-20 67.02 107.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.559 0.744 . . . . 3.5 109.659 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.661 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 45.7 tp -149.65 148.93 29.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.63 -0.428 . . . . 2.96 111.541 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -88.63 144.44 26.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.046 -0.979 . . . . 2.2400000000000002 111.688 178.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -150.1 153.37 36.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.454 -0.793 . . . . 1.6299999999999999 109.874 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.8 ptm -126.35 125.39 42.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.547 -0.751 . . . . 1.77 109.734 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 32.5 p90 -144.11 165.54 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.866 0.365 . . . . 3.0099999999999998 111.01 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.72 124.52 49.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.898 -0.592 . . . . 2.3900000000000001 109.592 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -136.38 161.61 35.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 3.3700000000000001 110.534 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 89.1 m -106.55 136.7 45.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 110.212 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.443 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 15.8 m-85 -125.34 104.73 8.63 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.222 -0.658 . . . . 1.1799999999999999 109.222 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 69' ' ' CYS . 5.0 p-10 -86.17 -63.35 1.33 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.145 -0.622 . . . . 2.5699999999999998 109.785 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.435 ' HB2' ' C3 ' ' A' ' 169' ' ' HC4 . 53.0 t80 47.19 55.09 8.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.761 -0.829 . . . . 3.21 108.761 -171.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.22 -28.43 0.14 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.14 -0.937 . . . . 3.23 111.033 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 33.6 ttp -67.7 163.35 21.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.234 -0.439 . . . . 2.8500000000000001 110.222 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 14.8 t -55.46 146.67 42.32 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 108.383 -0.969 . . . . 2.1200000000000001 108.383 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 22.5 Cg_endo -61.87 72.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.385 2.057 . . . . 1.47 113.289 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.48 HG23 HG23 ' A' ' 101' ' ' THR . 7.6 p -73.9 146.89 43.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.265 -0.425 . . . . 1.3999999999999999 110.846 172.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -104.63 146.81 28.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 3.0800000000000001 111.178 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 106' ' ' LYS . 7.7 p -142.65 158.78 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.547 -0.752 . . . . 1.3300000000000001 109.362 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 105' ' ' VAL . 38.1 ttmt -112.68 131.36 55.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.23 -1.026 . . . . 1.6899999999999999 108.23 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.79 139.31 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.451 0.643 . . . . 1.27 110.843 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -121.59 104.22 9.48 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.594 -0.891 . . . . 1.02 108.594 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 5.1 ppp? -102.75 143.55 32.24 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 2.4900000000000002 109.689 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 51.2 mtpt -149.65 146.42 27.26 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 109.708 -0.479 . . . . 1.5700000000000001 109.708 -174.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HD2' ' CB ' ' A' ' 87' ' ' ASN . 41.8 tttm -75.21 146.35 41.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.335 -0.617 . . . . 2.1299999999999999 109.335 173.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -134.92 -159.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 1.5700000000000001 110.088 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.28 -166.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.15 -0.685 . . . . 4.4100000000000001 109.15 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.5 m 67.28 65.48 0.42 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.129 -0.693 . . . . 2.5499999999999998 109.129 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.32 51.58 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.333 -0.707 . . . . 2.6200000000000001 111.333 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.33 80.09 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.559 0.744 . . . . 2.7599999999999998 112.684 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.82 176.06 9.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.837 -1.172 . . . . 1.0700000000000001 107.837 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 80.3 m-85 -104.71 147.48 27.63 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.08 0.466 . . . . 0.85999999999999999 110.121 -173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 51.3 m95 -102.99 103.1 13.18 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.493 -0.776 . . . . 0.63 109.099 175.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -103.27 104.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.601 -1.181 . . . . 0.91000000000000003 110.823 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 119' ' ' TRP . 11.6 m-85 -102.68 137.97 40.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.79000000000000004 110.225 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -112.99 154.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.969 0.414 . . . . 1.1799999999999999 111.894 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -165.24 153.09 11.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 3.3100000000000001 109.436 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -73.26 98.66 2.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.916 -0.314 . . . . 4.0300000000000002 111.791 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.401 1.063 . . . . 2.8700000000000001 112.167 172.252 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.443 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.842 -0.429 . . . . 3.3399999999999999 109.842 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -174.3 -76.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.844 0.354 . . . . 2.8999999999999999 110.89 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -127.25 162.16 26.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.189 -0.46 . . . . 3.8500000000000001 110.158 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.82 119.49 6.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.508 -0.854 . . . . 0.84999999999999998 112.709 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -104.8 126.18 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 0.70999999999999996 109.341 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.484 ' HB ' HG13 ' A' ' 120' ' ' VAL . 51.6 mt -128.39 149.13 32.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 1.0800000000000001 109.775 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.0 tt0 -112.01 134.65 53.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.987 -0.746 . . . . 0.85999999999999999 108.987 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD21 ' SD ' ' A' ' 109' ' ' MET . 2.6 pt? -139.67 153.41 47.28 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.136 -0.32 . . . . 1.6200000000000001 110.136 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.691 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.1 p30 -103.86 168.27 9.24 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.682 -0.407 . . . . 1.22 110.576 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -57.38 -14.47 13.14 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 115.136 0.815 . . . . 0.79000000000000004 115.136 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.08 -18.08 26.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.917 0.858 . . . . 1.95 110.391 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.28 26.42 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.682 -0.77 . . . . 0.53000000000000003 112.012 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.691 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 92.1 m-20 -71.58 138.17 48.58 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.73 0.3 . . . . 1.3 110.807 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 62' ' ' PHE . 14.0 mt -87.86 144.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.002 -0.545 . . . . 0.89000000000000001 109.685 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -101.93 -63.74 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.5 0.667 . . . . 1.45 110.231 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.08 169.5 23.22 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.005 -0.998 . . . . 1.99 110.572 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 52' ' ' ARG . 5.4 m-30 -113.91 175.94 5.25 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.113 -0.948 . . . . 1.25 109.364 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' ALA . 63.9 t30 -89.3 5.26 45.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.586 0.708 . . . . 2.1299999999999999 110.091 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 71.47 -15.54 0.42 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.351 -1.295 . . . . 1.48 110.875 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -60.5 -32.5 71.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.585 -0.734 . . . . 1.52 111.84 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.093 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 8.2 tp10 -78.77 -14.66 59.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.482 0.658 . . . . 2.1200000000000001 110.016 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.95 73.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.859 -0.686 . . . . 1.4199999999999999 111.464 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.63 -52.16 48.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 2.3500000000000001 110.836 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 HG22 ' A' ' 50' ' ' THR . 24.7 mt -83.82 -72.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 2.5899999999999999 111.799 -170.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 49' ' ' ILE . 11.9 t -173.73 43.24 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.049 0.928 . . . . 3.4100000000000001 111.054 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 1.093 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -109.05 -119.94 4.3 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.268 -0.967 . . . . 2.3199999999999998 113.673 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 24.9 mmt180 -139.21 153.46 47.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 3.1400000000000001 111.539 -171.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.694 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 12.0 m-20 -81.91 155.98 70.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.495 -0.928 . . . . 2.1000000000000001 108.495 163.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -29.94 85.57 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.112 1.874 . . . . 1.6799999999999999 111.896 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -72.73 -22.66 60.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 3.6099999999999999 111.598 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.694 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 67.4 mt-30 -81.95 -21.89 36.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.92 0.341 . . . . 2.5 111.92 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -121.54 62.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.687 0.625 . . . . 0.96999999999999997 112.687 -172.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -119.26 132.49 68.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.297 -0.561 . . . . 1.0900000000000001 111.058 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.2 -2.68 50.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.485 -0.864 . . . . 0.66000000000000003 111.549 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 47.6 mttp -88.36 146.0 25.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.407 . . . . 1.8200000000000001 110.609 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -94.25 107.24 19.2 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.785 -0.45 . . . . 0.71999999999999997 109.785 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 82.2 t80 -51.39 -36.03 41.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.69999999999999996 111.416 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.8 m-85 -86.16 16.06 4.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.761 0.282 . . . . 1.1599999999999999 111.761 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -147.16 -45.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.423 0.527 . . . . 3.5800000000000001 112.423 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.55 -78.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.137 0.421 . . . . 2.2000000000000002 112.137 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.53 ' O ' " H2'" ' A' ' 169' ' ' HC4 . 9.1 p -108.6 14.53 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.007 0.908 . . . . 1.77 111.367 -170.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.55 ' HA ' ' H3 ' ' A' ' 169' ' ' HC4 . . . -158.07 71.82 4.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.607 -0.724 . . . . 0.60999999999999999 112.267 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.78 15.52 1.62 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.761 2.307 . . . . 0.81000000000000005 112.805 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.04 -23.79 59.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.18 -0.674 . . . . 0.84999999999999998 109.18 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 20.7 p -94.44 -32.04 13.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.587 -1.188 . . . . 1.3300000000000001 110.52 -136.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.715 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 12.6 p-10 -77.36 82.29 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.251 1.024 . . . . 1.8500000000000001 110.361 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -145.35 157.68 52.37 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.886 -1.052 . . . . 1.5600000000000001 109.534 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.87 -37.74 77.71 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.043 2.495 . . . . 1.1699999999999999 113.742 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.66 14.36 25.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.428 0.529 . . . . 2.5600000000000001 112.428 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.425 ' CD2' ' HE1' ' A' ' 92' ' ' PHE . 46.6 t80 -134.94 -73.99 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.246 -0.65 . . . . 3.3599999999999999 109.246 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 66.7 t80 -63.51 -36.4 83.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.889 -0.596 . . . . 0.79000000000000004 110.121 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -29.45 75.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.068 -0.586 . . . . 0.59999999999999998 112.366 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 68.7 mttm -87.28 -25.87 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.943 0.401 . . . . 2.0899999999999999 110.225 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 83' ' ' VAL . 79.6 t80 -62.56 -46.03 90.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.517 0.675 . . . . 0.67000000000000004 109.501 169.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 30.0 mmmt -77.89 -16.74 58.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.3 -0.864 . . . . 1.0900000000000001 110.481 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 40.9 tt0 -59.06 -39.97 83.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.674 . . . . 2.0699999999999998 110.501 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -84.55 -45.85 5.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.519 -0.848 . . . . 0.71999999999999997 112.107 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 79' ' ' PHE . 43.1 t -53.87 -52.94 30.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.662 0.385 . . . . 0.84999999999999998 111.489 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.02 60.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.175 0.435 . . . . 1.1399999999999999 112.175 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -98.02 -74.58 0.57 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.795 0.331 . . . . 1.8200000000000001 110.81 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.03 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.001 -0.619 . . . . 1.6499999999999999 111.561 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -109.82 156.74 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.475 -0.565 . . . . 3.5 109.475 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 45.6 tp -131.02 102.98 6.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 2.96 110.719 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 109' ' ' MET . 87.9 m-20 -143.76 97.98 3.16 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.783 -0.821 . . . . 2.2400000000000002 108.783 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -131.16 155.72 46.53 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.113 -0.494 . . . . 1.6299999999999999 111.797 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.4 ptt? -140.12 105.77 5.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 1.77 109.831 171.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HE1' ' CD2' ' A' ' 75' ' ' PHE . 25.7 p90 -127.2 167.13 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.764 -0.653 . . . . 3.0099999999999998 110.739 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 106' ' ' LYS . 45.1 mt-10 -103.67 122.9 45.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.007 -0.368 . . . . 2.3900000000000001 110.007 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -142.15 158.4 43.79 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.533 -0.543 . . . . 3.3700000000000001 109.533 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 104' ' ' LYS . 40.5 p -104.26 156.36 17.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.51 0.672 . . . . 1.3999999999999999 112.299 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.787 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 44.8 m-85 -121.85 112.61 18.55 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.653 -1.24 . . . . 1.1799999999999999 107.653 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 102' ' ' PRO . 4.5 m-20 -123.64 12.88 9.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.841 -166.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' C1 ' ' A' ' 169' ' ' HC4 . 86.2 t80 -110.85 -49.09 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 3.21 111.192 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.21 13.6 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 3.23 110.968 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 17.5 ptp -169.94 153.76 4.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 2.8500000000000001 109.702 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 10.1 t -58.01 142.95 79.01 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.25 -1.019 . . . . 2.1200000000000001 108.25 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 32.5 Cg_exo -31.65 86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.386 3.391 . . . . 1.47 114.976 -176.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 m -111.51 141.37 45.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 1.3999999999999999 110.882 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 95' ' ' THR . 22.2 ttmm -104.07 135.47 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.785 0.326 . . . . 3.0800000000000001 110.399 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -127.95 166.37 25.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 1.3300000000000001 110.669 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 93' ' ' GLU . 31.5 ttmt -110.81 117.02 32.28 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.346 -0.983 . . . . 1.6899999999999999 108.346 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 80.1 t -104.11 120.58 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.073 -0.512 . . . . 1.27 110.068 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 6.8 t60 -104.04 109.08 20.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.159 -0.682 . . . . 1.02 109.159 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 58.0 tpp -101.68 132.69 47.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 2.4900000000000002 109.149 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 50.4 mtpt -137.62 131.57 31.75 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 121.153 -0.219 . . . . 1.5700000000000001 110.498 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 81.6 tttt -90.53 123.22 34.03 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.123 0.487 . . . . 2.1299999999999999 110.885 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.08 -175.24 2.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.675 -0.861 . . . . 1.5700000000000001 108.675 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.42 -94.97 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.42 -0.956 . . . . 4.4100000000000001 108.42 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 m 51.56 42.14 29.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.609 0.596 . . . . 2.5499999999999998 112.609 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.03 79.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.758 . . . . 2.6200000000000001 112.501 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.43 64.17 0.72 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.153 0.581 . . . . 2.7599999999999998 111.695 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 20.4 p -139.05 163.92 31.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.095 -0.502 . . . . 1.0700000000000001 110.694 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 4.9 m-85 -123.25 154.72 38.41 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.043 -1.095 . . . . 0.85999999999999999 108.043 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -103.63 109.17 20.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.875 -0.787 . . . . 0.63 108.875 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.484 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.6 p -100.71 134.35 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.682 0.753 . . . . 0.91000000000000003 110.796 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.423 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 80.8 m-85 -120.83 132.62 55.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.79000000000000004 110.037 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.1 t -103.17 104.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.886 -0.597 . . . . 1.1799999999999999 110.061 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -103.16 110.18 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.877 -0.786 . . . . 3.3100000000000001 108.877 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 105' ' ' VAL . 4.2 ptm180 -77.86 158.01 29.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.223 -0.444 . . . . 4.0300000000000002 111.472 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.592 -0.718 . . . . 2.8700000000000001 109.147 173.765 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.787 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.561 0.22 . . . . 3.3399999999999999 110.712 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.67 -70.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.425 -0.352 . . . . 2.8999999999999999 111.323 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.44 164.38 25.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.673 -0.491 . . . . 3.8500000000000001 109.673 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 120.02 6.54 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.258 -0.972 . . . . 0.84999999999999998 112.308 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.59 125.85 47.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.611 -0.515 . . . . 0.70999999999999996 109.611 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 42' ' ' TYR . 5.2 pt -132.17 165.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 1.0800000000000001 111.991 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.536 ' HG2' HD23 ' A' ' 40' ' ' LEU . 50.3 tt0 -115.03 121.01 41.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.889 -0.596 . . . . 0.85999999999999999 110.513 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.9 pt? -131.48 146.84 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.545 -0.539 . . . . 1.6200000000000001 109.545 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.24 170.01 8.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.134 -0.321 . . . . 1.22 110.134 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.27 -23.33 12.4 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 114.306 0.482 . . . . 0.79000000000000004 114.306 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.17 -21.56 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 1.95 110.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 96.51 4.9 59.22 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.151 -1.18 . . . . 0.53000000000000003 110.151 -173.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -79.15 134.04 36.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.693 -0.754 . . . . 1.3 109.705 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 19.7 mt -93.02 140.24 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.924 -0.58 . . . . 0.89000000000000001 110.154 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 ' HG2' ' A' ' 32' ' ' GLN . 1.4 mm? -107.13 -66.48 1.02 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.144 0.497 . . . . 1.45 111.19 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -134.21 137.39 44.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.492 0.663 . . . . 1.99 111.47 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.725 ' HA ' HG22 ' A' ' 31' ' ' ILE . 3.6 m-30 -102.95 126.75 50.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.775 -1.102 . . . . 1.25 109.268 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -60.03 155.82 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.026 -0.361 . . . . 2.1299999999999999 110.026 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.64 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.092 0.472 . . . . 1.48 109.874 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.27 70.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.969 -1.014 . . . . 1.52 112.61 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 38.7 tp10 -66.19 -47.96 72.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.1200000000000001 110.566 -173.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.0 -10.18 72.59 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.834 -0.698 . . . . 1.4199999999999999 112.503 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -93.12 -52.1 4.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.87 0.367 . . . . 2.3500000000000001 110.884 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.6 mt -80.55 -72.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.394 -0.366 . . . . 2.5899999999999999 110.939 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.5 m -153.77 106.93 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.608 -0.516 . . . . 3.4100000000000001 109.608 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . 175.48 -139.75 4.87 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.067 -1.063 . . . . 2.3199999999999998 112.964 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 3.0 mpt_? -124.24 174.7 7.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.706 0.289 . . . . 3.1400000000000001 110.834 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.83 139.96 95.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.663 -0.699 . . . . 2.1000000000000001 111.055 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.53 111.99 0.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.874 2.382 . . . . 1.6799999999999999 112.497 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 81.49 11.2 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.239 -0.891 . . . . 3.6099999999999999 112.545 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -94.44 22.05 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.326 0.584 . . . . 2.5 110.243 172.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.692 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -119.68 22.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.899 . . . . 0.96999999999999997 111.26 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -88.51 136.61 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.878 -0.416 . . . . 1.0900000000000001 109.878 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.76 11.97 84.18 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.829 -0.909 . . . . 0.66000000000000003 110.829 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 65' ' ' ASP . 26.5 mttm -118.77 141.49 48.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.69 0.281 . . . . 1.8200000000000001 111.103 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 23.7 t-20 -87.76 114.75 24.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.145 -0.48 . . . . 0.71999999999999997 110.216 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -55.84 -35.22 66.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.963 0.411 . . . . 0.69999999999999996 111.645 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 66.7 m-85 -76.48 -7.96 56.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.17 -0.468 . . . . 1.1599999999999999 111.484 -174.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -136.45 -63.47 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.84 0.311 . . . . 3.5800000000000001 111.84 -175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 5.3 m-20 -66.93 -24.17 66.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.298 0.481 . . . . 2.2000000000000002 112.298 -173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -125.89 12.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.33 -0.548 . . . . 1.77 110.969 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 171.06 85.71 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.399 -0.364 . . . . 0.60999999999999999 111.434 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.0 -16.48 54.64 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.586 2.191 . . . . 0.81000000000000005 113.769 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.2 m -50.4 -37.17 36.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.719 0.236 . . . . 0.84999999999999998 110.901 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 10.3 m -92.82 -31.03 15.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.933 -1.031 . . . . 1.3300000000000001 109.896 -135.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.56 97.13 4.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.995 -1.002 . . . . 1.8500000000000001 110.16 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.5 m -164.05 152.21 11.11 Favored Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.046 -0.524 . . . . 1.5600000000000001 110.019 -169.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.71 -30.33 92.1 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.278 1.985 . . . . 1.1699999999999999 112.667 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HG3' ' HE2' ' A' ' 94' ' ' TYR . 9.5 pt-20 -86.14 6.37 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.271 0.471 . . . . 2.5600000000000001 112.271 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.682 ' HE2' HG11 ' A' ' 107' ' ' VAL . 57.3 t80 -141.58 -71.67 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.873 -0.418 . . . . 3.3599999999999999 109.873 173.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.663 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 89.0 t80 -53.75 -37.87 63.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.79000000000000004 110.692 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -31.66 78.93 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.226 -0.512 . . . . 0.59999999999999998 112.624 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -81.52 -32.67 32.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.521 0.677 . . . . 2.0899999999999999 109.459 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.48 -32.15 71.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.913 -1.039 . . . . 0.67000000000000004 109.588 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HE3' ' CZ ' ' A' ' 76' ' ' TYR . 0.9 OUTLIER -88.84 -16.06 32.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.171 -0.922 . . . . 1.0900000000000001 111.098 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.46 -51.33 63.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 2.0699999999999998 110.573 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.35 -44.01 98.26 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.724 -0.671 . . . . 0.71999999999999997 112.315 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 83' ' ' VAL . 23.4 t -55.85 -52.75 45.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.692 0.282 . . . . 0.84999999999999998 110.869 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.7 86.81 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 116.051 -0.522 . . . . 1.1399999999999999 111.196 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -66.33 -77.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 1.8200000000000001 110.78 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.43 -75.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.522 -0.631 . . . . 1.6499999999999999 111.522 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.62 147.66 24.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 3.5 110.13 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.002 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -111.21 110.4 20.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.568 -0.531 . . . . 2.96 109.568 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' MET . 24.0 p-10 -175.68 91.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.974 0.892 . . . . 2.2400000000000002 110.892 176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 91' ' ' MET . 10.0 m -131.44 154.55 48.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.311 -0.859 . . . . 1.6299999999999999 109.23 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.428 ' N ' HG22 ' A' ' 90' ' ' THR . 19.6 ptt? -128.27 104.08 7.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.981 0.419 . . . . 1.77 110.155 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -125.15 166.59 16.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 3.0099999999999998 110.194 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.42 131.22 50.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.985 0.421 . . . . 2.3900000000000001 110.537 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 50.8 t80 -136.87 159.91 40.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 3.3700000000000001 109.679 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -102.97 113.63 27.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.943 0.402 . . . . 1.3999999999999999 110.315 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.667 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 42.8 m-85 -110.09 103.1 11.77 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.11 0.481 . . . . 1.1799999999999999 109.801 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 100' ' ' MET . 49.5 m-20 -126.41 101.74 6.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.653 -0.703 . . . . 2.5699999999999998 109.886 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.447 ' HD1' ' H3 ' ' A' ' 169' ' ' HC4 . 10.8 t80 -73.56 63.79 0.84 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.804 -1.184 . . . . 3.21 107.804 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 63.6 59.91 1.15 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.992 -1.004 . . . . 3.23 108.443 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.506 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 42.7 tpp -133.04 164.74 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.953 -1.021 . . . . 2.8500000000000001 111.09 -168.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.1 p -59.49 151.91 58.17 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 108.747 -0.835 . . . . 2.1200000000000001 108.747 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.17 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.641 2.227 . . . . 1.47 113.483 -171.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -90.71 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 1.3999999999999999 110.723 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.72 120.94 41.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.967 -0.383 . . . . 3.0800000000000001 109.967 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.2 m -122.02 166.42 16.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.838 -0.619 . . . . 1.3300000000000001 110.459 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 82.8 tttt -103.56 120.92 41.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.763 -0.828 . . . . 1.6899999999999999 108.763 177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.682 HG11 ' HE2' ' A' ' 75' ' ' PHE . 6.5 p -106.45 115.99 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-O 122.096 0.951 . . . . 1.27 110.096 -174.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.5 103.5 12.84 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.072 -0.967 . . . . 1.02 108.925 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.99 134.31 47.48 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.575 -0.45 . . . . 2.4900000000000002 110.078 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -140.65 134.75 30.87 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 120.688 0.28 . . . . 1.5700000000000001 110.928 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 1.002 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 26.0 ttpp -80.85 136.75 36.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.322 -0.399 . . . . 2.1299999999999999 110.896 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.98 -173.21 3.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.403 -0.362 . . . . 1.5700000000000001 111.172 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.5 -164.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.201 -0.454 . . . . 4.4100000000000001 110.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.1 m 65.89 54.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.615 0.721 . . . . 2.5499999999999998 110.365 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.39 -2.4 8.88 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.196 -0.911 . . . . 2.6200000000000001 111.605 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.5 41.68 31.81 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.425 0.631 . . . . 2.7599999999999998 110.614 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.42 -175.75 2.75 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.51 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.456 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 5.6 m-85 -119.6 151.69 38.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.028 -0.73 . . . . 0.85999999999999999 109.028 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -102.44 108.5 19.84 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.348 -0.982 . . . . 0.63 108.348 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' A' ' 31' ' ' ILE . 10.9 p -101.68 137.71 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 119.801 -0.759 . . . . 0.91000000000000003 110.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -114.03 125.21 53.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.436 -0.802 . . . . 0.79000000000000004 110.185 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.05 114.88 48.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.378 . . . . 1.1799999999999999 110.011 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -139.07 129.19 25.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.88 -0.415 . . . . 3.3100000000000001 109.88 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.8 ptp180 -75.02 114.64 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.016 0.436 . . . . 4.0300000000000002 110.455 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 106' ' ' LYS . 6.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.068 -0.491 . . . . 2.8700000000000001 110.43 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.667 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.737 0.303 . . . . 3.3399999999999999 110.441 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.1 103.47 4.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 116.263 -0.426 . . . . 2.8999999999999999 110.218 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' VAL . 95.1 m-85 64.37 -172.08 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.927 0.767 . . . . 3.8500000000000001 111.388 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.78 130.72 10.34 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.475 -0.869 . . . . 0.84999999999999998 112.18 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.84 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.932 -0.395 . . . . 0.70999999999999996 109.932 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 32' ' ' GLN . 9.5 mm -114.5 152.39 16.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 1.0800000000000001 109.895 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 31' ' ' ILE . 64.4 tt0 -124.06 104.67 9.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.614 -0.513 . . . . 0.85999999999999999 109.614 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.522 ' CD1' HG12 ' A' ' 39' ' ' ILE . 1.9 mm? -105.47 143.62 33.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.399 -0.364 . . . . 1.6200000000000001 110.277 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p30 -104.38 167.69 9.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.041 -0.264 . . . . 1.22 110.435 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.01 -22.46 35.24 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.046 0.779 . . . . 0.79000000000000004 115.046 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.426 0.613 . . . . 1.95 110.35 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.84 43.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.192 -0.763 . . . . 0.53000000000000003 111.192 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.0 m-20 -88.19 146.44 25.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.076 0.465 . . . . 1.3 111.416 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.698 HD12 HG11 ' A' ' 57' ' ' VAL . 10.0 mt -95.41 148.24 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.89000000000000001 110.305 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.454 ' N ' HG22 ' A' ' 39' ' ' ILE . 83.1 mt -107.44 -80.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.027 -0.533 . . . . 1.45 109.76 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -116.78 136.9 52.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 1.99 111.571 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.4 m-30 -98.02 -175.61 3.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.892 -1.049 . . . . 1.25 110.64 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.73 161.34 20.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.626 -0.879 . . . . 2.1299999999999999 108.626 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -58.81 -23.31 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.527 0.566 . . . . 1.48 112.527 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.79 94.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 1.52 111.078 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.3 mp0 -63.8 -27.11 68.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 2.1200000000000001 111.281 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.64 -13.88 62.29 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.538 -0.839 . . . . 1.4199999999999999 112.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.73 -54.48 3.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.542 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.28 -60.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 2.5899999999999999 110.124 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.633 HG21 " H3'" ' A' ' 169' ' ' HC4 . 3.8 m -78.73 -54.7 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.88 -0.6 . . . . 3.4100000000000001 111.451 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.18 14.0 6.75 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 2.3199999999999998 112.033 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 66' ' ' VAL . 19.7 mmt180 -97.69 110.09 22.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 3.1400000000000001 110.005 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.575 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 15.3 m-20 -63.58 143.6 97.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.381 -0.372 . . . . 2.1000000000000001 110.743 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 71.6 Cg_exo -52.34 -28.01 33.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.871 3.047 . . . . 1.6799999999999999 114.804 -170.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -124.67 28.61 6.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.99 0.367 . . . . 3.6099999999999999 111.99 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.575 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 77.0 mm-40 -94.78 0.07 54.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.255 0.55 . . . . 2.5 110.967 175.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -93.38 -93.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.816 -0.629 . . . . 0.96999999999999997 111.442 175.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.8 mm 54.31 99.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.427 0.691 . . . . 1.0900000000000001 112.239 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.26 71.77 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.265 -1.134 . . . . 0.66000000000000003 110.265 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 6.7 mmtp -111.33 121.0 44.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.708 -1.246 . . . . 1.8200000000000001 109.553 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -71.24 105.38 3.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.71999999999999997 110.843 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HB2' HG12 ' A' ' 39' ' ' ILE . 85.1 t80 -54.19 -39.16 66.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.69999999999999996 111.107 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.5 m-85 -82.69 30.54 0.43 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 111.213 -174.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -161.85 -42.4 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.226 -0.443 . . . . 3.5800000000000001 110.575 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.94 -78.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.563 -0.289 . . . . 2.2000000000000002 111.002 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.9 t -87.62 14.91 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.299 0.571 . . . . 1.77 111.222 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -177.76 94.62 0.23 Allowed Pre-proline 0 C--O 1.222 -0.383 0 O-C-N 122.125 -0.36 . . . . 0.60999999999999999 111.267 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 98' ' ' TYR . 3.9 Cg_exo -78.7 -19.89 10.96 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.419 2.079 . . . . 0.81000000000000005 112.834 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -76.87 -19.68 57.17 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.646 -0.422 . . . . 0.84999999999999998 110.864 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.69 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 18.4 p -73.86 -36.53 64.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.302 -0.863 . . . . 1.3300000000000001 111.119 -172.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 11.0 t70 -62.2 96.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.8500000000000001 109.895 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.5 p 175.79 158.0 0.4 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.32 -0.622 . . . . 1.5600000000000001 109.32 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.592 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 58.9 Cg_exo -52.87 -32.12 55.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.801 2.334 . . . . 1.1699999999999999 112.354 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.59 -59.02 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 2.5600000000000001 111.255 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.69 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 28.4 m-85 -96.09 -69.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.025 -0.534 . . . . 3.3599999999999999 111.357 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.03 -30.39 71.56 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.79000000000000004 111.116 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -61.44 -41.14 99.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.021 -0.609 . . . . 0.59999999999999998 112.177 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -79.23 -29.72 42.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 2.0899999999999999 110.121 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' HE1' ' A' ' 109' ' ' MET . 84.7 t80 -57.82 -40.38 79.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.335 -0.848 . . . . 0.67000000000000004 110.634 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.4 -12.06 26.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.993 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 32.4 tt0 -68.86 -43.49 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 110.379 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.57 -43.41 92.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.695 -0.764 . . . . 0.71999999999999997 112.022 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 t -61.03 -49.48 84.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.84999999999999998 110.88 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -4.64 27.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 112.019 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.2 m -100.53 -73.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.634 0.254 . . . . 1.8200000000000001 110.782 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.91 -63.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 1.6499999999999999 111.952 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.15 139.57 46.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.606 -0.516 . . . . 3.5 109.606 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -106.89 104.46 14.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.387 -0.597 . . . . 2.96 109.387 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.686 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.7 p30 -172.15 116.15 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.497 0.665 . . . . 2.2400000000000002 109.868 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.4 m -148.36 142.23 25.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 1.6299999999999999 109.887 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.0 ptm -119.92 120.1 35.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.448 -0.575 . . . . 1.77 109.448 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' CD1' ' HD1' ' A' ' 94' ' ' TYR . 4.2 p90 -140.03 157.81 45.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.421 . . . . 3.0099999999999998 111.953 -172.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 106' ' ' LYS . 5.5 mp0 -104.42 121.64 43.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 2.3900000000000001 109.896 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 26.6 m-85 -142.9 165.82 26.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.286 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 13.5 m -107.36 144.26 34.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.39 -0.368 . . . . 1.3999999999999999 110.527 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.77 106.99 15.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 1.1799999999999999 109.478 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.47 111.01 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 2.5699999999999998 110.829 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 68' ' ' PRO . 72.7 t80 -175.76 -79.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.484 -0.78 . . . . 3.21 109.475 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -99.55 -34.28 10.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.419 -0.586 . . . . 3.23 109.419 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.6 ttm -82.11 137.86 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.041 -1.096 . . . . 2.8500000000000001 108.041 164.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -64.4 154.78 82.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.419 -0.586 . . . . 2.1200000000000001 109.419 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.47 87.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.136 2.557 . . . . 1.47 114.114 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -102.97 130.48 50.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.848 -0.615 . . . . 1.3999999999999999 109.952 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 22.3 pttp -103.62 124.84 49.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.401 -0.592 . . . . 3.0800000000000001 109.401 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 124' ' ' ARG . 15.1 m -132.11 165.52 31.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 112.179 -171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 22.7 ttmm -104.75 111.01 23.57 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.288 -1.005 . . . . 1.6899999999999999 108.288 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 122' ' ' VAL . 59.8 t -104.63 127.75 58.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.611 -0.514 . . . . 1.27 109.611 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 10.7 t60 -104.61 113.42 26.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.4 0.619 . . . . 1.02 109.458 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.686 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 27.3 tpp -101.13 123.54 45.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.518 -1.219 . . . . 2.4900000000000002 108.772 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 63.8 pttt -150.44 146.8 26.88 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.093 -0.643 . . . . 1.5700000000000001 111.512 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 48.6 tttm -87.52 140.27 29.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.567 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.1 -172.84 4.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.612 0.244 . . . . 1.5700000000000001 110.439 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -168.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.196 -0.298 . . . . 4.4100000000000001 110.196 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m 75.15 72.86 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.806 0.691 . . . . 2.5499999999999998 110.094 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.38 -8.4 44.35 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.093 -0.803 . . . . 2.6200000000000001 111.093 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 55.03 80.81 0.12 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.598 0.713 . . . . 2.7599999999999998 111.165 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 2.6 p -156.51 -169.83 3.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.005 -0.998 . . . . 1.0700000000000001 109.063 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 8.5 m-85 -119.38 152.57 36.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.332 -0.988 . . . . 0.85999999999999999 108.332 -177.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 55.5 m95 -101.54 106.0 17.04 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.591 0.71 . . . . 0.63 109.148 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 108' ' ' HIS . 38.9 t -102.6 104.34 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.401 -1.272 . . . . 0.91000000000000003 110.612 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 98.7 m-85 -104.79 134.08 48.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.139 -0.937 . . . . 0.79000000000000004 110.253 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -113.48 144.9 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.585 -0.28 . . . . 1.1799999999999999 110.703 -176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 106' ' ' LYS . 18.5 ptpt -139.49 145.16 38.42 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.838 -0.431 . . . . 3.3100000000000001 109.838 173.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.716 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.5 tmt_? -84.4 111.69 19.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.639 -0.255 . . . . 4.0300000000000002 110.591 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.494 HG11 ' HE2' ' A' ' 106' ' ' LYS . 16.7 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.618 -0.706 . . . . 2.8700000000000001 111.033 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.633 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.446 -0.576 . . . . 3.3399999999999999 109.446 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.12 -48.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 2.8999999999999999 110.355 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.74 162.6 41.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 3.8500000000000001 109.91 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 45' ' ' ALA . . . -104.7 130.24 10.15 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.641 -0.79 . . . . 0.84999999999999998 111.302 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -135.76 104.13 5.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.172 0.51 . . . . 0.70999999999999996 111.163 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.924 ' HB ' HG13 ' A' ' 120' ' ' VAL . 34.6 mt -113.07 159.74 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.079 -1.082 . . . . 1.0800000000000001 108.079 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' HG22 ' A' ' 31' ' ' ILE . 10.1 tt0 -131.97 116.65 17.39 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.937 -0.477 . . . . 0.85999999999999999 110.467 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.39 165.2 12.42 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.433 -0.58 . . . . 1.6200000000000001 109.433 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -121.1 168.4 11.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.926 -0.398 . . . . 1.22 109.926 175.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.98 -24.62 35.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.415 0.526 . . . . 0.79000000000000004 114.415 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.62 -21.51 55.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.95 110.83 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.84 2.65 36.8 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.807 -0.633 . . . . 0.53000000000000003 111.845 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 92.6 m-20 -78.46 153.31 31.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.95 0.405 . . . . 1.3 110.864 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 60' ' ' LYS . 9.3 mt -96.87 146.88 6.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.715 -0.675 . . . . 0.89000000000000001 109.674 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -102.04 -46.96 4.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.629 0.728 . . . . 1.45 109.515 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -170.87 157.76 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.602 -1.181 . . . . 1.99 110.123 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.909 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 8.1 m-30 -110.54 177.82 4.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 1.25 110.456 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t-20 -107.36 179.25 4.3 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.292 -1.003 . . . . 2.1299999999999999 108.292 172.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 -9.46 43.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.086 0.47 . . . . 1.48 109.908 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' CB ' ' HA2' ' A' ' 29' ' ' GLY . . . -55.71 -60.08 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.253 -0.885 . . . . 1.52 111.897 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.6 mp0 -65.55 -27.15 68.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 2.1200000000000001 111.22 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.2 -50.31 51.98 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.564 -0.827 . . . . 1.4199999999999999 111.786 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.1 -55.19 31.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.121 0.486 . . . . 2.3500000000000001 110.309 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.6 67.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.688 -1.226 . . . . 2.5899999999999999 107.688 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 18.9 m -36.32 90.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.754 -1.566 . . . . 3.4100000000000001 114.561 -169.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -104.42 -59.29 0.68 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.325 -1.307 . . . . 2.3199999999999998 110.46 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.909 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 35.3 mmt180 -149.51 168.79 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.634 0.373 . . . . 3.1400000000000001 110.444 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.682 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 8.9 m-20 -90.55 141.12 26.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 2.1000000000000001 109.759 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.769 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 52.8 Cg_exo -56.55 -25.88 61.15 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.193 2.595 . . . . 1.6799999999999999 114.086 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -103.79 6.67 36.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.188 0.44 . . . . 3.6099999999999999 112.188 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 82.9 mm-40 -102.82 6.13 39.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.069 0.461 . . . . 2.5 110.699 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 7.7 m -118.15 40.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.217 0.532 . . . . 0.96999999999999997 111.606 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.01 112.25 24.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.37 -0.377 . . . . 1.0900000000000001 110.64 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.21 11.72 71.32 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.964 -0.854 . . . . 0.66000000000000003 110.964 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.57 ' O ' HG13 ' A' ' 39' ' ' ILE . 7.2 tptt -88.02 121.55 30.56 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.992 -0.604 . . . . 1.8200000000000001 109.558 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 47.5 t-20 -71.78 110.99 6.68 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.442 -0.577 . . . . 0.71999999999999997 109.442 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 86.6 t80 -53.98 -41.0 67.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.429 -0.805 . . . . 0.69999999999999996 110.74 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 46.2 m-85 -85.86 9.48 16.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.237 -0.438 . . . . 1.1599999999999999 110.803 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 48.0 tptt -124.54 -61.95 1.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.386 -0.37 . . . . 3.5800000000000001 110.715 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -104.09 -22.8 13.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.17 0.433 . . . . 2.2000000000000002 112.17 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 52' ' ' ARG . 1.9 t -113.17 13.52 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.182 -0.607 . . . . 1.77 111.765 -170.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 167.27 79.57 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.971 -0.559 . . . . 0.60999999999999999 110.235 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.03 -17.15 50.95 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.751 2.301 . . . . 0.81000000000000005 113.035 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.893 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.9 p -76.36 -26.66 55.92 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.486 -0.486 . . . . 0.84999999999999998 110.225 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 1.9 m -80.1 -31.89 39.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.902 -1.045 . . . . 1.3300000000000001 110.486 -164.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 10.5 t70 -63.75 99.23 0.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.159 -0.682 . . . . 1.8500000000000001 109.159 172.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 8.8 t -169.56 149.46 3.68 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.723 -0.473 . . . . 1.5600000000000001 109.723 -175.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 5.3 Cg_exo -38.47 -42.79 1.8 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.742 3.628 . . . . 1.1699999999999999 114.584 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.799 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.01 -53.55 4.22 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.598 -0.441 . . . . 2.5600000000000001 111.19 -178.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 70' ' ' THR . 29.2 m-85 -59.63 -63.81 1.17 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.094 0.473 . . . . 3.3599999999999999 110.706 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 39.6 t80 -67.47 -28.68 68.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.614 . . . . 0.79000000000000004 110.097 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -63.62 -34.75 90.79 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.699 -0.682 . . . . 0.59999999999999998 112.605 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 72.1 mmtt -75.09 -36.97 61.67 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.123 0.487 . . . . 2.0899999999999999 109.751 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' O ' HD11 ' A' ' 88' ' ' LEU . 82.2 t80 -59.89 -35.4 74.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.825 . . . . 0.67000000000000004 110.69 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -94.52 -4.79 47.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.074 -0.512 . . . . 1.0900000000000001 111.808 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -49.97 73.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.034 0.445 . . . . 2.0699999999999998 110.269 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.14 -37.29 63.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.71999999999999997 111.794 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' OH ' ' A' ' 118' ' ' TYR . 21.9 t -52.86 -56.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 122.971 0.508 . . . . 0.84999999999999998 111.518 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.76 62.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 1.1399999999999999 112.048 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.9 m -88.67 -73.2 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.381 . . . . 1.8200000000000001 110.681 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.3 -72.14 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.936 -0.65 . . . . 1.6499999999999999 111.521 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.76 149.09 28.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.667 -0.864 . . . . 3.5 108.667 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -116.27 101.8 9.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.18 -0.674 . . . . 2.96 109.18 178.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 45.9 m-80 -149.12 83.14 1.44 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.383 -0.599 . . . . 2.2400000000000002 109.383 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.8 p -127.83 158.49 37.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 1.6299999999999999 111.289 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.2 ptm -137.44 113.74 10.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.893 -0.594 . . . . 1.77 110.302 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.714 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 8.8 p90 -136.65 164.73 27.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 3.0099999999999998 110.81 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.5 122.04 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 2.3900000000000001 110.702 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.714 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 5.1 m-85 -144.21 167.03 23.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 3.3700000000000001 110.089 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.0 t -103.63 154.22 19.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.268 0.556 . . . . 1.3999999999999999 111.983 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.407 ' CD1' " H6'" ' A' ' 169' ' ' HC4 . 67.7 m-85 -120.23 103.45 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.416 -0.957 . . . . 1.1799999999999999 108.416 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 24.3 t70 -113.23 -131.37 0.32 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.586 -0.734 . . . . 2.5699999999999998 109.516 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 61.7 t80 70.65 -70.23 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.434 0.694 . . . . 3.21 111.241 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -118.97 -2.14 10.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.302 0.572 . . . . 3.23 110.268 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.4 tpt -116.26 151.27 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.352 -0.84 . . . . 2.8500000000000001 109.301 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 103' ' ' THR . 9.8 t -55.98 142.45 65.05 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 108.345 -0.983 . . . . 2.1200000000000001 108.345 169.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 26.7 Cg_endo -62.84 72.16 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.73 2.287 . . . . 1.47 112.662 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 101' ' ' THR . 1.4 p -81.78 144.33 31.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.917 -0.583 . . . . 1.3999999999999999 111.504 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.85 117.38 33.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.537 -0.301 . . . . 3.0800000000000001 110.346 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.24 166.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.073 -0.512 . . . . 1.3300000000000001 110.889 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -103.6 128.34 50.89 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.367 -0.975 . . . . 1.6899999999999999 108.367 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' MET . 7.4 p -116.37 139.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 109.486 -0.561 . . . . 1.27 109.486 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -117.2 115.67 25.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.651 -0.704 . . . . 1.02 109.166 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 86.1 mmm -100.35 126.34 46.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.201 -0.666 . . . . 2.4900000000000002 109.201 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.0 mtpm? -141.84 121.58 13.47 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 120.837 0.351 . . . . 1.5700000000000001 111.187 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 76.5 tttt -73.17 131.42 42.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.045 -0.525 . . . . 2.1299999999999999 110.824 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.21 -160.76 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.967 0.358 . . . . 1.5700000000000001 111.967 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.413 HD23 HE22 ' A' ' 32' ' ' GLN . 13.7 tp 33.62 111.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.939 1.829 . . . . 4.4100000000000001 115.939 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.6 m -18.23 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.406 1.691 . . . . 2.5499999999999998 112.569 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.42 -8.14 0.55 Allowed Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.176 -0.92 . . . . 2.6200000000000001 111.449 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 59.62 24.3 13.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.793 0.806 . . . . 2.7599999999999998 110.054 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.9 p -82.67 171.57 13.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.493 -1.23 . . . . 1.0700000000000001 109.466 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.556 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.6 m-85 -128.07 153.35 46.9 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.338 -0.615 . . . . 0.85999999999999999 109.338 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -100.55 109.36 21.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.473 -0.936 . . . . 0.63 108.473 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.924 HG13 ' HB ' ' A' ' 31' ' ' ILE . 2.4 p -101.57 106.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 122.307 1.051 . . . . 0.91000000000000003 110.517 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -103.25 136.82 42.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.651 -1.159 . . . . 0.79000000000000004 109.975 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.69 147.01 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 1.1799999999999999 112.02 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -149.01 154.23 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.321 -0.854 . . . . 3.3100000000000001 109.457 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -100.95 121.89 42.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.018 -0.364 . . . . 4.0300000000000002 110.018 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.222 -0.894 . . . . 2.8700000000000001 110.521 179.083 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.407 " H6'" ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.802 -0.444 . . . . 3.3399999999999999 109.802 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.48 -67.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.108 0.48 . . . . 2.8999999999999999 110.082 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -135.16 -169.02 2.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 3.8500000000000001 109.64 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.24 117.2 5.74 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 112.48 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.66 104.23 14.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.696 -0.483 . . . . 0.70999999999999996 109.696 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 120' ' ' VAL . 37.7 mt -107.85 157.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.869 -0.605 . . . . 1.0800000000000001 109.642 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.65 HE22 ' HB2' ' A' ' 113' ' ' LEU . 2.8 mt-30 -130.03 142.17 50.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.15 -0.315 . . . . 0.85999999999999999 110.15 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -140.27 153.87 46.65 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.294 -0.632 . . . . 1.6200000000000001 109.294 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.7 OUTLIER -104.41 168.4 9.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.15 -23.77 18.54 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.467 0.479 . . . . 0.79000000000000004 114.205 -175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 -37.06 37.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.216 0.508 . . . . 1.95 110.528 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.54 5.0 6.69 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.639 -0.791 . . . . 0.53000000000000003 112.307 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -70.72 147.15 49.35 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.564 -0.532 . . . . 1.3 109.564 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 mt -94.43 146.89 6.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.301 -0.629 . . . . 0.89000000000000001 109.301 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 40' ' ' LEU . 4.0 mp -127.98 -80.46 0.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 1.45 109.8 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.5 mp0 -89.45 141.06 28.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.44 -0.8 . . . . 1.99 109.976 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -130.48 5.33 4.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.349 -0.387 . . . . 1.25 110.918 178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.92 -173.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.865 -0.607 . . . . 2.1299999999999999 109.93 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.83 5.38 45.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.446 0.641 . . . . 1.48 109.495 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -77.95 -51.44 10.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.777 . . . . 1.52 111.338 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.03 -20.87 61.62 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.916 0.389 . . . . 2.1200000000000001 110.913 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.45 -19.83 77.93 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.714 -0.755 . . . . 1.4199999999999999 111.31 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -94.89 -16.67 22.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.202 0.525 . . . . 2.3500000000000001 110.185 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 45' ' ' ALA . 50.3 mm -82.73 -63.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 2.5899999999999999 111.152 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -139.92 40.88 1.98 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.161 0.981 . . . . 3.4100000000000001 111.1 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.25 37.27 64.32 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.106 -0.952 . . . . 2.3199999999999998 113.282 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 17.9 mmt-85 -98.6 85.67 3.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 3.1400000000000001 110.985 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 6.5 m-20 -67.31 148.59 98.71 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.277 -0.874 . . . . 2.1000000000000001 109.649 175.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 49.4 Cg_exo -55.5 -32.89 84.33 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.255 1.97 . . . . 1.6799999999999999 111.427 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -73.35 -18.35 61.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.724 -0.671 . . . . 3.6099999999999999 111.668 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 79.4 mm-40 -78.25 -26.61 47.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.713 0.264 . . . . 2.5 111.713 -175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.0 m -109.13 14.8 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.257 0.836 . . . . 0.96999999999999997 113.257 -172.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 62.5 mt -83.83 133.42 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.608 -0.516 . . . . 1.0900000000000001 109.608 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.14 88.5 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.211 -0.995 . . . . 0.66000000000000003 110.885 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 34.8 mttm -104.88 133.03 50.38 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.126 -0.537 . . . . 1.8200000000000001 109.82 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -84.34 113.31 21.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.73 -0.388 . . . . 0.71999999999999997 110.138 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 66.8 t80 -54.51 -50.14 68.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.533 -0.758 . . . . 0.69999999999999996 111.173 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.6 m-85 -79.76 21.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.286 0.476 . . . . 1.1599999999999999 112.286 -172.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -149.92 -49.67 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.87 0.366 . . . . 3.5800000000000001 111.712 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -87.19 -76.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 2.2000000000000002 111.571 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' O ' " H2'" ' A' ' 169' ' ' HC4 . 1.8 t -86.13 15.72 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.964 0.411 . . . . 1.77 111.491 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.41 96.12 0.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 121.998 -0.439 . . . . 0.60999999999999999 111.835 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -89.96 -9.69 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.084 2.522 . . . . 0.81000000000000005 112.898 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -83.95 -4.03 58.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.84999999999999998 111.077 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.489 HG21 ' CE1' ' A' ' 62' ' ' PHE . 6.8 p -98.45 -38.74 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.064 -0.517 . . . . 1.3300000000000001 111.534 -164.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 13.4 t70 -68.69 91.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.299 -0.41 . . . . 1.8500000000000001 109.974 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.3 p -150.21 160.19 33.74 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 1.5600000000000001 110.596 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 -43.84 53.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.927 2.418 . . . . 1.1699999999999999 113.608 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -78.54 -26.0 45.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.383 0.512 . . . . 2.5600000000000001 112.383 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HE2' HG11 ' A' ' 107' ' ' VAL . 67.5 t80 -105.57 -67.9 0.9 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.46 . . . . 3.3599999999999999 110.894 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 89.7 t80 -64.18 -39.29 93.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 110.863 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.2 97.56 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.97 -0.634 . . . . 0.59999999999999998 112.366 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 50.5 mmtt -73.44 -32.21 64.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 2.0899999999999999 110.606 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.3 t80 -57.58 -45.87 84.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.555 0.693 . . . . 0.67000000000000004 110.092 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.294 -0.866 . . . . 1.0900000000000001 112.005 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 2.0699999999999998 110.726 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.769 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -73.99 -44.06 31.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.312 -0.947 . . . . 0.71999999999999997 111.317 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' PHE . 22.0 t -56.19 -55.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.248 -0.476 . . . . 0.84999999999999998 111.426 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.38 83.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.285 -0.416 . . . . 1.1399999999999999 112.001 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.1 m -73.52 -70.99 0.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.437 -0.347 . . . . 1.8200000000000001 111.432 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.2 -79.38 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.691 -0.766 . . . . 1.6499999999999999 111.843 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 19.9 p30 -92.33 149.57 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.289 -0.456 . . . . 3.5 110.786 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -121.11 120.58 35.71 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.033 -0.728 . . . . 2.96 109.033 177.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.6 p30 -159.59 123.11 3.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 2.2400000000000002 109.905 173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -164.59 159.42 19.08 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.134 -0.939 . . . . 1.6299999999999999 110.235 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 53.4 ttm -132.09 107.84 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.039 -0.726 . . . . 1.77 109.039 175.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -120.23 156.22 31.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 3.0099999999999998 109.641 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.34 120.13 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.443 0.64 . . . . 2.3900000000000001 110.254 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -138.6 165.79 26.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.09 -0.959 . . . . 3.3700000000000001 109.493 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' THR . 49.2 p -104.25 154.88 19.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.858 0.361 . . . . 1.3999999999999999 111.937 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CD1' ' H2 ' ' A' ' 169' ' ' HC4 . 20.2 m-85 -119.34 103.14 9.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.758 -0.83 . . . . 1.1799999999999999 108.758 171.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 1.7 p30 -128.58 20.86 6.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.189 -0.46 . . . . 2.5699999999999998 111.444 -172.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.584 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -59.76 -44.25 93.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.68 -0.691 . . . . 3.21 111.672 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -144.18 -44.77 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.691 -0.855 . . . . 3.23 108.691 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.9 ttt -71.31 151.83 43.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.855 -1.066 . . . . 2.8500000000000001 108.768 170.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 p -53.68 149.8 15.08 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.514 -0.55 . . . . 2.1200000000000001 109.514 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 97' ' ' ASP . 18.1 Cg_endo -59.74 80.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.454 2.103 . . . . 1.47 113.129 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.0 p -74.04 151.73 40.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.3999999999999999 110.742 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 124' ' ' ARG . 10.1 mtmp? -104.62 121.19 43.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.771 0.32 . . . . 3.0800000000000001 110.176 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 35.3 m -117.44 161.51 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.929 0.395 . . . . 1.3300000000000001 110.683 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -116.17 113.93 23.76 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.739 -1.208 . . . . 1.6899999999999999 107.739 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 75' ' ' PHE . 14.8 p -106.25 142.35 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.134 0.492 . . . . 1.27 110.136 -170.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -115.35 110.98 20.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.036 -0.727 . . . . 1.02 109.036 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.7 tpp -101.84 130.78 48.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.54 -0.754 . . . . 2.4900000000000002 109.258 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 15.2 ptmm? -156.83 141.57 16.91 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.007 0.432 . . . . 1.5700000000000001 111.532 -177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 42.6 tttp -83.64 117.68 23.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.769 -0.651 . . . . 2.1299999999999999 111.243 -172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -176.12 108.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.133 0.42 . . . . 1.5700000000000001 112.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.65 ' HB2' HE22 ' A' ' 32' ' ' GLN . 38.9 tp 168.04 -109.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.943 0.897 . . . . 4.4100000000000001 109.146 171.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -85.81 19.3 2.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.338 0.59 . . . . 2.5499999999999998 109.677 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.83 -56.09 4.65 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.602 -0.726 . . . . 2.6200000000000001 111.531 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -93.11 31.1 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.445 0.64 . . . . 2.7599999999999998 111.219 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 28.8 t -146.95 142.2 27.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.384 -0.598 . . . . 1.0700000000000001 109.384 173.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.547 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 13.0 m-85 -120.01 164.88 15.45 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.422 -0.808 . . . . 0.85999999999999999 109.969 -167.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.575 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 73.2 m95 -102.32 108.39 19.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.905 -0.776 . . . . 0.63 108.905 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 31' ' ' ILE . 4.4 p -101.33 109.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.294 1.045 . . . . 0.91000000000000003 110.717 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.448 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 83.3 m-85 -102.35 124.44 47.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.244 -0.889 . . . . 0.79000000000000004 109.779 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 123.93 69.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.826 0.346 . . . . 1.1799999999999999 111.044 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -137.29 134.9 36.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.299 -0.63 . . . . 3.3100000000000001 109.299 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 2.6 ttp180 -77.98 146.19 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.332 -0.395 . . . . 4.0300000000000002 111.284 -172.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.734 -1.127 . . . . 2.8700000000000001 110.687 175.669 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.596 ' H2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.5 mm? . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.876 -0.416 . . . . 3.3399999999999999 109.876 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.39 -57.89 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.583 -0.28 . . . . 2.8999999999999999 111.351 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -102.73 148.45 25.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 3.8500000000000001 110.479 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA3' HG23 ' A' ' 122' ' ' VAL . . . -105.35 158.27 16.01 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.785 -0.721 . . . . 0.84999999999999998 112.686 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.66 112.2 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.394 -0.595 . . . . 0.70999999999999996 109.394 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.938 HG22 ' HA ' ' A' ' 42' ' ' TYR . 8.9 pt -131.66 166.74 28.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.046 0.387 . . . . 1.0800000000000001 112.046 -175.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -122.4 134.2 54.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.438 . . . . 0.85999999999999999 110.296 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.7 pt? -138.79 157.62 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.691 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 167.76 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.002 -0.279 . . . . 1.22 110.706 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.97 -14.03 22.13 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.762 0.665 . . . . 0.79000000000000004 114.762 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 26.7 t70 -86.33 -20.39 28.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.581 0.69 . . . . 1.95 110.312 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 112.19 0.59 26.73 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.588 -0.815 . . . . 0.53000000000000003 111.961 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.632 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 49.5 m-80 -74.56 138.05 42.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 120.911 0.386 . . . . 1.3 110.203 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.5 mt -88.58 148.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.086 -0.709 . . . . 0.89000000000000001 109.086 173.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 7.8 mp -112.87 -63.56 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.26 0.552 . . . . 1.45 110.736 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -136.77 126.63 25.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.565 -0.743 . . . . 1.99 110.67 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.074 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 1.6 m-30 -93.04 162.27 14.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.069 -0.969 . . . . 1.25 110.572 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.38 161.51 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.564 -0.902 . . . . 2.1299999999999999 108.564 166.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -12.34 59.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.795 0.331 . . . . 1.48 111.403 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 26' ' ' LEU . . . -63.55 -33.2 75.07 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.145 -0.479 . . . . 1.52 111.305 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.8 -21.37 64.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 2.1200000000000001 109.892 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -68.89 -30.54 72.41 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 111.792 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -79.11 -32.57 44.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 2.3500000000000001 110.207 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.88 -64.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 2.5899999999999999 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 52' ' ' ARG . 4.2 t -113.51 -38.62 4.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.795 0.331 . . . . 3.4100000000000001 111.094 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 101.31 53.6 1.0 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.44 -0.886 . . . . 2.3199999999999998 112.223 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.67 ' HG2' HG23 ' A' ' 50' ' ' THR . 14.2 mmt180 -119.14 125.74 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.595 -0.52 . . . . 3.1400000000000001 109.595 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.928 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -65.81 137.62 96.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.597 -0.274 . . . . 2.1000000000000001 110.783 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.074 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 88.7 Cg_exo -49.47 -25.25 10.23 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.836 3.024 . . . . 1.6799999999999999 114.222 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -101.6 -2.13 31.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.592 0.219 . . . . 3.6099999999999999 111.592 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.928 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.16 -0.88 46.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.561 0.22 . . . . 2.5 111.281 -177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.8 m -102.78 17.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.429 0.529 . . . . 0.96999999999999997 112.429 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -86.62 125.7 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.799 -0.445 . . . . 1.0900000000000001 109.799 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.5 1.66 90.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.065 -1.064 . . . . 0.66000000000000003 110.833 -174.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.8 mptp? -94.14 118.11 31.07 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.252 -0.474 . . . . 1.8200000000000001 110.184 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 36.9 t-20 -80.15 103.1 9.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.921 -0.581 . . . . 0.71999999999999997 109.975 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 68.7 t80 -62.22 -13.46 28.05 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 112.16 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 80.4 m-85 -104.82 11.49 33.72 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.856 -0.527 . . . . 1.1599999999999999 111.441 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 64' ' ' LYS . 13.3 tmtt? -149.48 -56.42 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.508 -0.477 . . . . 3.5800000000000001 111.524 -172.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.8 -77.74 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.541 -0.299 . . . . 2.2000000000000002 111.354 -167.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.2 m -78.53 16.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.451 0.538 . . . . 1.77 112.451 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -176.85 97.23 0.24 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.60999999999999999 110.331 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -93.71 1.48 3.25 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 113.447 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.5 4.11 53.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.959 -0.463 . . . . 0.84999999999999998 110.069 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 9.9 p -96.75 -46.81 6.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.617 -1.174 . . . . 1.3300000000000001 110.993 -167.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.47 110.72 0.92 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 1.8500000000000001 110.381 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -177.18 143.85 0.55 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 1.5600000000000001 108.4 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 50.0 Cg_exo -54.3 -29.11 56.08 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.645 2.23 . . . . 1.1699999999999999 112.745 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 8.1 pt-20 -90.67 9.3 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 2.5600000000000001 111.912 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 107' ' ' VAL . 67.3 t80 -142.71 -74.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.054 -0.35 . . . . 3.3599999999999999 110.054 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -65.25 -33.77 76.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 0.79000000000000004 110.29 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -63.73 -34.97 91.39 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.832 -0.699 . . . . 0.59999999999999998 111.955 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.43 -28.29 52.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.203 0.525 . . . . 2.0899999999999999 110.184 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.52 -41.37 96.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 109.662 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -76.5 -20.37 57.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 1.0900000000000001 110.849 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.31 -46.47 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 2.0699999999999998 110.355 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.8 -41.39 83.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.71999999999999997 112.214 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.62 -49.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.84999999999999998 110.765 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.83 76.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 1.1399999999999999 111.219 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.0 m -76.69 -83.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 1.8200000000000001 110.713 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.57 -58.03 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.0 -0.84 . . . . 1.6499999999999999 111.0 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.91 148.66 38.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.526 . . . . 3.5 110.293 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.6 tp -111.03 111.67 22.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.293 -0.632 . . . . 2.96 109.293 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 109' ' ' MET . 15.7 p30 -160.99 58.32 0.3 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.905 0.859 . . . . 2.2400000000000002 109.956 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -107.12 145.47 32.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.859 -1.064 . . . . 1.6299999999999999 110.296 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.5 ttp -122.17 117.88 27.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 1.77 110.319 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 42.6 p90 -138.13 163.88 30.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.298 -0.41 . . . . 3.0099999999999998 110.432 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 35.1 tt0 -109.67 129.12 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.615 -0.513 . . . . 2.3900000000000001 109.615 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.517 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 30.4 t80 -135.14 165.03 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.424 -0.353 . . . . 3.3700000000000001 110.833 -172.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 m -105.25 137.79 42.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.772 0.32 . . . . 1.3999999999999999 111.709 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 105' ' ' VAL . 14.4 m-85 -113.01 108.36 17.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.02 -0.733 . . . . 1.1799999999999999 109.02 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -119.67 8.23 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 2.5699999999999998 110.556 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 28.8 t80 -122.79 131.26 53.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 3.21 108.325 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.56 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 28.6 mm-40 67.96 8.51 6.53 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.219 0.533 . . . . 3.23 110.218 -173.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 23.6 ttt -166.3 140.64 4.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.399 -0.963 . . . . 2.8500000000000001 108.399 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.6 p -64.46 148.84 95.97 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.006 -0.738 . . . . 2.1200000000000001 109.006 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.1 89.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.993 2.462 . . . . 1.47 113.374 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 104' ' ' LYS . 3.8 m -109.97 154.91 22.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.907 -0.588 . . . . 1.3999999999999999 110.277 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 103' ' ' THR . 48.1 mmtm -102.84 117.94 35.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.498 -0.556 . . . . 3.0800000000000001 109.498 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 124' ' ' ARG . 25.0 m -122.0 163.29 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.3300000000000001 110.604 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 33.6 ttpt -109.02 128.6 55.1 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.905 -0.776 . . . . 1.6899999999999999 108.905 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 75' ' ' PHE . 96.3 t -114.11 110.73 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 108.491 -0.929 . . . . 1.27 108.491 -171.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -103.51 119.96 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.871 -0.788 . . . . 1.02 108.871 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.739 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 22.2 mmt -100.07 135.26 41.77 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.639 -0.874 . . . . 2.4900000000000002 108.639 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -150.94 121.93 7.65 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.895 0.379 . . . . 1.5700000000000001 110.858 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 52.9 tttt -78.91 137.46 37.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.214 0.531 . . . . 2.1299999999999999 111.283 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 177.06 8.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.789 -1.189 . . . . 1.5700000000000001 107.789 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.4 -98.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.556 -0.858 . . . . 4.4100000000000001 109.572 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.9 p 43.42 47.15 5.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.82 0.448 . . . . 2.5499999999999998 112.145 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.57 13.76 49.8 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.668 -0.777 . . . . 2.6200000000000001 112.519 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.1 t70 63.76 86.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.735 0.814 . . . . 2.7599999999999998 111.076 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 p -164.86 157.69 16.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.237 -0.892 . . . . 1.0700000000000001 109.611 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 2.6 m-85 -104.68 153.86 20.71 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.823 -0.806 . . . . 0.85999999999999999 108.823 -173.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -102.12 108.78 20.3 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.484 -0.932 . . . . 0.63 108.484 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.767 HG13 HG13 ' A' ' 31' ' ' ILE . 7.4 p -101.87 127.51 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.819 0.819 . . . . 0.91000000000000003 110.645 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -108.63 131.54 54.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.249 -0.887 . . . . 0.79000000000000004 110.317 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.449 HG23 ' HA3' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -111.31 106.81 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.733 0.778 . . . . 1.1799999999999999 111.201 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -103.23 117.19 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.678 . . . . 3.3100000000000001 109.927 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.781 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.6 ptm180 -89.53 157.42 18.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.62 -0.718 . . . . 4.0300000000000002 110.56 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.949 -0.548 . . . . 2.8700000000000001 111.049 175.374 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 26' ' ' LEU . 3.2 tm? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 111.288 0.107 . . . . 3.3399999999999999 111.288 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.46 66.76 0.32 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.66 0.985 . . . . 2.8999999999999999 113.66 -168.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 98.4 m-85 65.17 136.67 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.737 0.815 . . . . 3.8500000000000001 113.147 172.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.41 104.59 2.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.357 -0.925 . . . . 0.84999999999999998 111.28 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -140.78 123.09 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.523 0.201 . . . . 0.70999999999999996 110.459 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 42' ' ' TYR . 12.1 pt -125.9 160.85 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 1.0800000000000001 111.102 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -119.72 115.49 24.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.391 -0.368 . . . . 0.85999999999999999 110.348 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD12 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -117.28 146.7 43.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.307 -0.627 . . . . 1.6200000000000001 109.307 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 38' ' ' ASN . 8.1 p30 -107.24 168.69 9.05 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.38 -0.528 . . . . 1.22 110.571 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -10.78 16.25 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 114.362 0.505 . . . . 0.79000000000000004 114.362 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -87.33 -11.25 49.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.358 0.579 . . . . 1.95 110.342 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.27 10.49 60.81 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.484 -1.047 . . . . 0.53000000000000003 110.484 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . 55.7 t30 -85.79 147.37 26.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.631 -0.785 . . . . 1.3 110.26 -174.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.798 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 3.8 mm -93.55 149.46 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.908 -0.404 . . . . 0.89000000000000001 109.908 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -120.3 -62.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 1.45 109.781 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -136.92 131.13 32.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.685 -0.689 . . . . 1.99 110.541 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.752 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.2 m-30 -98.29 179.95 4.56 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 1.25 109.977 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 58.1 t30 -123.01 173.86 7.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.336 -0.616 . . . . 2.1299999999999999 109.336 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.91 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.518 0.562 . . . . 1.48 112.518 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' PHE . . . -73.39 -42.92 61.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.947 0.351 . . . . 1.52 111.947 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.74 -15.52 59.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.348 -0.541 . . . . 2.1200000000000001 110.411 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.28 -6.55 74.36 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.965 -0.854 . . . . 1.4199999999999999 110.965 171.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.27 -48.03 5.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.314 -0.443 . . . . 2.3500000000000001 110.356 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.66 -63.68 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -53.93 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.306 0.484 . . . . 3.4100000000000001 112.306 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.22 18.29 1.34 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.434 -0.889 . . . . 2.3199999999999998 113.433 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -90.46 111.91 23.35 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.952 0.376 . . . . 3.1400000000000001 110.026 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 25.7 m-20 -71.94 149.22 92.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.567 -0.531 . . . . 2.1000000000000001 109.567 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 77.4 Cg_exo -49.79 -34.12 34.97 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.605 2.87 . . . . 1.6799999999999999 114.304 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -106.38 17.33 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.146 0.425 . . . . 3.6099999999999999 112.146 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 94.7 mt-30 -95.01 -9.28 34.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 2.5 111.074 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.798 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.7 m -104.29 21.55 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.473 0.545 . . . . 0.96999999999999997 112.473 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 115.91 29.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.456 -0.498 . . . . 1.0900000000000001 110.043 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.28 64.1 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.418 -1.073 . . . . 0.66000000000000003 110.418 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.4 mptp? -80.6 147.57 30.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.512 -0.844 . . . . 1.8200000000000001 111.196 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -107.67 113.77 27.28 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.687 -0.486 . . . . 0.71999999999999997 109.687 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.717 ' HB2' HD11 ' A' ' 39' ' ' ILE . 77.4 t80 -52.89 -50.75 63.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.316 -0.402 . . . . 0.69999999999999996 112.038 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.6 m-85 -76.97 5.84 7.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.043 -0.526 . . . . 1.1599999999999999 112.295 -168.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 -47.32 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.151 0.426 . . . . 3.5800000000000001 112.151 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -99.65 -23.77 14.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.218 0.451 . . . . 2.2000000000000002 112.218 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.8 t -120.87 14.46 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.524 -0.47 . . . . 1.77 110.9 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 170.84 86.44 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.89 -0.595 . . . . 0.60999999999999999 110.352 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HG2' ' CE1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -96.0 35.92 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.182 2.588 . . . . 0.81000000000000005 113.582 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 17.2 p -121.73 20.58 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.8 -0.445 . . . . 0.84999999999999998 109.8 171.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -130.14 -44.49 1.15 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.929 -1.487 . . . . 1.3300000000000001 109.668 -136.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 4.5 p-10 -73.32 103.98 4.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.828 0.823 . . . . 1.8500000000000001 109.393 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 64.5 m -163.93 164.59 14.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.506 -0.77 . . . . 1.5600000000000001 109.579 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 6.4 Cg_endo -49.96 -31.06 25.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.072 2.514 . . . . 1.1699999999999999 112.69 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HB3' ' HE2' ' A' ' 94' ' ' TYR . 1.3 mp0 -69.86 -91.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 2.5600000000000001 111.493 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HD1' ' HE2' ' A' ' 63' ' ' PHE . 45.6 t80 -60.74 -56.61 19.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.648 -0.705 . . . . 3.3599999999999999 111.811 -169.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 68.9 t80 -67.95 -38.5 82.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 110.464 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -47.61 90.32 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.59999999999999998 112.744 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.817 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.3 mmpt? -75.76 -28.72 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.931 0.365 . . . . 2.0899999999999999 110.527 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -58.97 -41.61 87.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.339 0.59 . . . . 0.67000000000000004 109.761 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.6 -11.07 49.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.447 -0.797 . . . . 1.0900000000000001 111.306 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 6.9 tp10 -67.42 -40.14 85.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 2.0699999999999998 110.567 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.954 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -71.9 -32.54 63.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.554 -0.832 . . . . 0.71999999999999997 111.227 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 83' ' ' VAL . 20.1 t -66.21 -50.86 65.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.255 -0.472 . . . . 0.84999999999999998 110.673 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.94 83.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.782 -0.644 . . . . 1.1399999999999999 111.769 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 p -77.38 -71.54 0.4 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.045 0.45 . . . . 1.8200000000000001 110.527 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.091 -0.575 . . . . 1.6499999999999999 111.947 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.93 158.15 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 3.5 110.366 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.954 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 1.4 pt? -138.61 135.69 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.987 -0.552 . . . . 2.96 110.057 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 109' ' ' MET . 33.8 p-10 -164.01 47.94 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.445 1.117 . . . . 2.2400000000000002 108.9 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -104.13 154.36 19.83 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.878 -1.51 . . . . 1.6299999999999999 109.955 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -112.95 115.53 28.55 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.107 0.479 . . . . 1.77 110.359 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.36 155.47 31.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 3.0099999999999998 109.199 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.33 121.88 44.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.238 0.542 . . . . 2.3900000000000001 111.18 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.645 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 46.2 m-85 -126.94 167.08 16.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.676 -0.693 . . . . 3.3700000000000001 111.091 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 m -106.68 139.6 40.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.885 -0.598 . . . . 1.3999999999999999 110.535 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CE2' HG11 ' A' ' 105' ' ' VAL . 13.0 m-85 -104.68 119.83 39.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.48 -0.933 . . . . 1.1799999999999999 108.48 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.3 -159.75 1.02 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.289 -0.634 . . . . 2.5699999999999998 109.289 -170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' CE1' ' HG2' ' A' ' 68' ' ' PRO . 90.2 t80 69.5 -76.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.981 0.512 . . . . 3.21 111.123 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -107.01 -26.69 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 3.23 109.646 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.8 tpp -84.86 139.32 31.98 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.606 -0.887 . . . . 2.8500000000000001 108.606 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.6 t -65.58 136.29 96.03 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.797 -1.186 . . . . 2.1200000000000001 107.797 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -43.51 91.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.3 2.666 . . . . 1.47 114.184 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.2 p -108.95 151.8 25.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.289 -0.414 . . . . 1.3999999999999999 111.304 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -109.84 116.44 31.66 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.457 -0.572 . . . . 3.0800000000000001 109.457 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 122' ' ' VAL . 11.3 p -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 1.3300000000000001 111.248 -171.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 105' ' ' VAL . 39.1 ttmt -109.37 118.27 36.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.319 -0.993 . . . . 1.6899999999999999 108.319 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 120' ' ' VAL . 86.3 t -104.55 117.01 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 115.727 -0.67 . . . . 1.27 109.485 -174.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -103.9 105.24 15.38 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.02 108.786 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.2 pmm? -103.68 128.84 50.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.993 -0.549 . . . . 2.4900000000000002 109.729 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 11.6 ptmm? -144.47 138.9 27.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 1.5700000000000001 111.259 -174.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.402 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 13.6 tttt -71.16 128.49 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.996 -0.547 . . . . 2.1299999999999999 111.939 -172.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -115.55 93.96 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.821 -0.807 . . . . 1.5700000000000001 108.821 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.83 83.88 3.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.669 0.747 . . . . 4.4100000000000001 110.906 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t -141.51 26.6 1.94 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.717 -1.129 . . . . 2.5499999999999998 108.534 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.27 25.15 0.42 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.055 -0.975 . . . . 2.6200000000000001 112.055 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 55.93 75.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.138 0.575 . . . . 2.7599999999999998 112.17 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 39.6 t -153.02 165.75 34.58 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.374 -0.973 . . . . 1.0700000000000001 108.374 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.7 m-85 -132.14 157.47 44.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.725 -0.843 . . . . 0.85999999999999999 108.725 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 73.8 m95 -101.22 111.35 23.54 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.861 -0.792 . . . . 0.63 108.861 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 107' ' ' VAL . 3.5 t -102.25 119.8 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.56 0.695 . . . . 0.91000000000000003 109.865 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-85 -104.57 140.63 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 0.79000000000000004 111.185 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 105' ' ' VAL . 54.1 t -104.58 104.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.073 -0.967 . . . . 1.1799999999999999 110.314 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.73 105.13 13.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.956 0.408 . . . . 3.3100000000000001 110.595 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -72.63 109.55 6.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.543 -0.54 . . . . 4.0300000000000002 109.543 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.504 -0.76 . . . . 2.8700000000000001 110.393 -178.254 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.016 -0.365 . . . . 3.3399999999999999 110.016 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.03 -90.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.671 0.272 . . . . 2.8999999999999999 111.65 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -85.2 146.81 26.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.196 -0.298 . . . . 3.8500000000000001 110.196 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.44 112.61 4.26 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.309 -0.948 . . . . 0.84999999999999998 111.917 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -103.83 129.53 51.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.70999999999999996 110.923 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.528 ' HB ' HG13 ' A' ' 120' ' ' VAL . 58.2 mt -125.7 149.82 30.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.431 -0.804 . . . . 1.0800000000000001 108.999 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 31' ' ' ILE . 60.8 tt0 -115.18 122.89 47.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.115 -0.698 . . . . 0.85999999999999999 109.115 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD22 ' CG1' ' A' ' 120' ' ' VAL . 1.9 pt? -134.81 156.29 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.248 0.342 . . . . 1.6200000000000001 110.738 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 26.8 p30 -102.5 167.95 9.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.94 -0.304 . . . . 1.22 110.687 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.42 -2.71 3.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 114.963 0.745 . . . . 0.79000000000000004 114.963 -173.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.28 -18.92 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.581 0.691 . . . . 1.95 110.81 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 114.13 15.2 8.59 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.416 -0.897 . . . . 0.53000000000000003 113.254 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.7 m-20 -86.44 135.58 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 117.125 0.463 . . . . 1.3 110.141 177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 62' ' ' PHE . 23.0 mm -89.27 149.1 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.181 -0.463 . . . . 0.89000000000000001 109.938 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -121.19 -72.44 0.69 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.312 0.577 . . . . 1.45 110.177 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -121.4 134.19 55.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.719 -0.673 . . . . 1.99 111.666 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.547 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.3 m-85 -103.43 144.58 31.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.058 -0.974 . . . . 1.25 109.586 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 3.9 t30 -82.78 4.48 25.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.495 0.664 . . . . 2.1299999999999999 109.473 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.41 -22.39 0.24 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.36 -1.291 . . . . 1.48 112.228 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -65.32 -18.67 65.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.313 0.486 . . . . 1.52 112.313 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' HD11 ' A' ' 31' ' ' ILE . 2.6 tm-20 -70.39 -23.91 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.857 -0.794 . . . . 2.1200000000000001 108.857 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.13 13.4 67.76 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.777 -0.725 . . . . 1.4199999999999999 112.076 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.26 -44.76 71.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.163 0.506 . . . . 2.3500000000000001 110.314 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 49' ' ' ILE . 4.1 pt -78.45 -47.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.898 -0.592 . . . . 2.5899999999999999 112.153 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -61.93 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.995 0.426 . . . . 3.4100000000000001 110.945 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 138.89 126.5 2.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.893 -0.67 . . . . 2.3199999999999998 111.78 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 51' ' ' GLY . 26.6 mmt180 -139.1 156.12 47.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.39 -0.596 . . . . 3.1400000000000001 109.39 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.5 m-20 -103.21 120.04 53.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.044 0.449 . . . . 2.1000000000000001 111.311 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 26.4 Cg_exo -62.1 118.95 5.85 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.947 2.431 . . . . 1.6799999999999999 112.337 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 62.6 mttp 82.29 5.38 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.851 -1.068 . . . . 3.6099999999999999 112.224 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.25 -1.17 57.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.523 0.678 . . . . 2.5 109.558 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.795 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.5 m -98.88 10.29 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.143 -0.935 . . . . 0.96999999999999997 111.616 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 42.8 mt -80.99 132.27 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.345 -0.613 . . . . 1.0900000000000001 109.345 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.17 75.86 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.391 -0.909 . . . . 0.66000000000000003 110.842 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 17.0 mttm -109.52 132.04 54.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.121 -0.696 . . . . 1.8200000000000001 109.121 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.1 t-20 -90.0 102.98 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.755 -0.461 . . . . 0.71999999999999997 109.755 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.025 ' HB2' HD11 ' A' ' 39' ' ' ILE . 70.9 t80 -49.82 -39.15 37.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.69999999999999996 111.785 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.677 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m-85 -76.51 -20.5 56.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 1.1599999999999999 112.435 -171.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -116.84 -30.5 5.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.215 0.45 . . . . 3.5800000000000001 112.215 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -89.14 -79.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.037 0.384 . . . . 2.2000000000000002 112.037 -170.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 p -99.77 13.96 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.699 0.762 . . . . 1.77 111.685 -169.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.3 69.91 0.81 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.455 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 39.4 Cg_endo -68.94 11.31 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.644 2.229 . . . . 0.81000000000000005 113.688 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.8 m -79.92 -30.54 40.01 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.84999999999999998 109.717 173.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.677 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 17.3 p -78.93 -38.56 36.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.722 -1.127 . . . . 1.3300000000000001 110.383 -158.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 25.6 t70 -64.18 100.19 0.32 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.218 -0.66 . . . . 1.8500000000000001 109.218 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 30.5 t -149.63 147.78 23.9 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.919 -0.582 . . . . 1.5600000000000001 109.985 -171.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.38 -29.39 23.67 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.044 2.496 . . . . 1.1699999999999999 112.156 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.8 pt-20 -93.65 -60.03 1.86 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.638 -0.425 . . . . 2.5600000000000001 111.283 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 81.5 t80 -68.7 -52.31 32.23 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.198 -0.314 . . . . 3.3599999999999999 111.564 -169.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 51.7 t80 -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.79000000000000004 109.486 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.95 79.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.485 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 64.2 mmtt -81.91 -30.82 31.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.97 0.414 . . . . 2.0899999999999999 110.159 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -65.53 -30.64 71.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.67000000000000004 110.734 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 31.3 mmmt -82.79 -9.2 59.45 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.334 -0.848 . . . . 1.0900000000000001 111.47 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -58.88 -33.83 70.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.489 -0.323 . . . . 2.0699999999999998 111.71 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 1.058 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -88.08 -37.14 7.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.301 -0.952 . . . . 0.71999999999999997 112.139 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.04 -46.18 77.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.893 0.477 . . . . 0.84999999999999998 111.227 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -23.9 64.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 1.1399999999999999 111.798 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.2 m -104.99 -81.25 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.351 0.596 . . . . 1.8200000000000001 110.548 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.31 -48.6 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.886 -0.886 . . . . 1.6499999999999999 110.886 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.936 ' HA ' ' HG3' ' A' ' 111' ' ' LYS . 1.4 p-10 -124.17 150.94 44.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.868 -0.666 . . . . 3.5 111.335 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.058 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 56.5 tp -144.29 114.96 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 2.96 109.708 174.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 109' ' ' MET . 49.2 m-20 -124.8 89.61 3.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.613 . . . . 2.2400000000000002 109.667 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -124.74 165.58 17.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.159 -0.928 . . . . 1.6299999999999999 111.319 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.6 ttp -136.68 111.06 8.48 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.374 -0.973 . . . . 1.77 108.374 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -121.68 163.44 19.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.482 -0.326 . . . . 3.0099999999999998 110.211 -171.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -116.4 124.75 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.252 -0.647 . . . . 2.3900000000000001 109.252 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -138.08 159.19 42.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.294 -0.261 . . . . 3.3700000000000001 110.294 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.84 142.53 34.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.313 -0.403 . . . . 1.3999999999999999 111.085 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 12.7 m-85 -107.51 132.74 52.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.172 -0.467 . . . . 1.1799999999999999 109.753 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 100' ' ' MET . 13.1 t70 -143.21 -150.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.452 -0.944 . . . . 2.5699999999999998 108.452 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.7 t80 66.3 -82.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.759 0.424 . . . . 3.21 111.151 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -99.6 -24.18 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.262 0.553 . . . . 3.23 109.819 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 101' ' ' THR . 52.6 tpp -91.79 141.61 28.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.847 . . . . 2.8500000000000001 108.996 173.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -72.38 143.17 85.18 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 108.757 -0.831 . . . . 2.1200000000000001 108.757 170.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -40.41 90.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.779 2.986 . . . . 1.47 114.186 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 m -123.24 144.64 49.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 1.3999999999999999 109.942 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.62 142.89 33.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.383 . . . . 3.0800000000000001 110.123 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -128.78 164.52 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.06 -0.518 . . . . 1.3300000000000001 110.505 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -108.72 117.88 35.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.13 -1.063 . . . . 1.6899999999999999 108.13 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.418 HG11 ' HE2' ' A' ' 75' ' ' PHE . 11.7 p -104.59 133.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.412 0.625 . . . . 1.27 109.655 -172.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.7 OUTLIER -111.18 109.88 20.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.964 -0.754 . . . . 1.02 108.964 -177.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 44.9 tpp -102.23 123.76 46.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.23 -0.655 . . . . 2.4900000000000002 109.23 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -141.81 136.43 30.63 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.588 -0.153 . . . . 1.5700000000000001 110.588 -174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.936 ' HG3' ' HA ' ' A' ' 87' ' ' ASN . 7.7 tmtt? -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.171 0.51 . . . . 2.1299999999999999 110.813 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.635 ' N ' ' HD3' ' A' ' 111' ' ' LYS . . . -146.62 160.46 42.15 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.549 -0.75 . . . . 1.5700000000000001 109.913 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -103.23 -0.62 30.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.746 0.308 . . . . 4.4100000000000001 110.479 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -61.78 106.47 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.505 -0.924 . . . . 2.5499999999999998 108.505 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.96 -103.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.526 -1.429 . . . . 2.6200000000000001 109.526 -164.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -179.07 84.54 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.775 -0.824 . . . . 2.7599999999999998 108.775 167.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 2.6 p -166.0 -172.24 2.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.447 -0.797 . . . . 1.0700000000000001 111.237 -171.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 75.0 m-85 -110.86 155.32 22.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.489 -0.56 . . . . 0.85999999999999999 109.489 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -103.71 107.78 18.79 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.297 -1.001 . . . . 0.63 108.297 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.528 HG13 ' HB ' ' A' ' 31' ' ' ILE . 12.5 p -100.64 131.86 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.702 0.763 . . . . 0.91000000000000003 110.369 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.0 m-85 -115.2 128.82 56.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.457 -0.792 . . . . 0.79000000000000004 109.84 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -104.33 102.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.193 0.521 . . . . 1.1799999999999999 109.626 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -112.42 110.32 20.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 3.3100000000000001 109.698 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 5.7 ptm180 -74.6 166.55 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.535 -0.466 . . . . 4.0300000000000002 110.493 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.736 -0.65 . . . . 2.8700000000000001 109.81 177.547 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.462 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.857 0.36 . . . . 3.3399999999999999 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HA ' ' NH2' ' A' ' 124' ' ' ARG . . . -126.33 -37.36 2.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.514 . . . . 2.8999999999999999 110.868 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -80.18 117.02 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.989 -0.745 . . . . 3.8500000000000001 108.989 176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -102.47 115.56 5.24 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.332 -0.937 . . . . 0.84999999999999998 112.925 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' A' ' 43' ' ' ASN . . . -104.33 104.2 14.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 109.844 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 120' ' ' VAL . 29.6 mt -113.09 158.23 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.818 -0.808 . . . . 1.0800000000000001 108.818 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 48.9 tt0 -120.08 112.66 19.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.807 -0.558 . . . . 0.85999999999999999 110.32 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.677 ' HG ' HG11 ' A' ' 120' ' ' VAL . 6.7 mt -114.05 142.92 45.58 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.895 -0.78 . . . . 1.6200000000000001 108.895 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -102.71 168.96 8.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.769 -0.372 . . . . 1.22 110.275 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -50.58 -33.39 25.86 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.672 0.629 . . . . 0.79000000000000004 114.672 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.04 -21.09 43.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.357 0.578 . . . . 1.95 111.45 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.3 17.36 10.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.579 -0.82 . . . . 0.53000000000000003 112.75 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 79.2 m-20 -83.16 147.7 27.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.372 . . . . 1.3 110.343 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.033 HD11 ' HB2' ' A' ' 62' ' ' PHE . 13.5 mm -92.76 145.31 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.703 -0.681 . . . . 0.89000000000000001 110.287 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.8 mm? -97.68 -62.59 1.23 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 1.45 110.609 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -170.07 158.5 7.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.953 -1.021 . . . . 1.99 109.949 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 9.6 m-30 -110.94 147.74 33.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.523 -0.762 . . . . 1.25 109.376 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 30' ' ' ALA . 28.5 p-10 -80.36 -173.17 3.91 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.666 -0.494 . . . . 2.1299999999999999 109.666 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -78.21 20.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.009 0.374 . . . . 1.48 112.009 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . . . -97.38 -65.17 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.052 0.39 . . . . 1.52 112.052 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 27.9 tp10 -61.12 -51.02 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.682 -0.69 . . . . 2.1200000000000001 111.172 -172.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.96 -3.81 81.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.082 -0.58 . . . . 1.4199999999999999 112.648 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 34.7 t70 -84.2 -18.76 35.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.347 0.594 . . . . 2.3500000000000001 110.204 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -110.22 -65.18 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.57 -0.741 . . . . 2.5899999999999999 111.041 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.9 m -155.74 -42.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.524 0.202 . . . . 3.4100000000000001 111.42 -174.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -61.15 88.04 0.04 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 115.03 0.772 . . . . 2.3199999999999998 115.03 -170.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.85 ' HG2' " H3'" ' A' ' 169' ' ' HC4 . 20.0 mmm180 61.15 -176.87 0.12 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.999 0.904 . . . . 3.1400000000000001 113.273 170.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 5.8 t70 -102.75 132.68 21.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 114.471 -1.24 . . . . 2.1000000000000001 108.293 169.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 50.2 Cg_exo -55.29 -20.45 25.23 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.369 2.713 . . . . 1.6799999999999999 114.438 -174.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 1.9 mppt? -109.49 -3.49 16.96 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.037 -0.265 . . . . 3.6099999999999999 111.437 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -104.08 24.56 11.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.082 0.467 . . . . 2.5 111.784 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.76 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 m -118.52 10.99 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.035 0.445 . . . . 0.96999999999999997 111.319 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.73 133.33 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.653 -0.419 . . . . 1.0900000000000001 110.507 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.31 72.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.265 -0.734 . . . . 0.66000000000000003 111.265 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.55 148.25 47.91 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.659 -0.271 . . . . 1.8200000000000001 110.526 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 8.1 t-20 -98.96 125.16 44.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.035 0.445 . . . . 0.71999999999999997 111.512 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.033 ' HB2' HD11 ' A' ' 39' ' ' ILE . 48.5 t80 -64.72 -9.32 19.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 0.69999999999999996 111.868 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 52.0 m-85 -122.65 20.55 10.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.849 0.357 . . . . 1.1599999999999999 110.439 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 44.3 mmtm -150.79 -45.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 3.5800000000000001 111.824 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -101.84 -79.05 0.52 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 2.2000000000000002 111.389 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 HG12 ' A' ' 57' ' ' VAL . 14.7 m -84.14 15.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 1.77 112.54 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -172.64 97.06 0.36 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.60999999999999999 109.89 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.92 19.87 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.19 2.593 . . . . 0.81000000000000005 113.674 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -110.79 13.63 22.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.484 -0.486 . . . . 0.84999999999999998 109.839 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.9 p -112.74 -43.73 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.943 -1.026 . . . . 1.3300000000000001 111.055 -164.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -65.22 105.06 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 1.8500000000000001 110.506 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.602 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 9.7 t -170.54 149.79 3.12 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 109.349 -0.612 . . . . 1.5600000000000001 109.349 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 47.6 Cg_exo -39.38 -43.46 2.77 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.281 3.32 . . . . 1.1699999999999999 114.98 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.674 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.38 -39.47 11.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.785 -0.366 . . . . 2.5600000000000001 111.748 -176.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 70' ' ' THR . 28.3 m-85 -71.74 -69.29 0.4 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.176 0.513 . . . . 3.3599999999999999 110.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.8 t80 -61.66 -32.7 72.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.79000000000000004 110.193 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -59.83 -31.34 71.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 112.915 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 30.9 mmtp -78.05 -34.22 50.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.219 0.51 . . . . 2.0899999999999999 110.836 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.58 -26.55 68.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 0.67000000000000004 110.334 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 19.5 mmmt -93.13 -6.54 47.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 1.0900000000000001 112.038 -175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 6.6 mm-40 -58.14 -42.35 85.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.268 0.47 . . . . 2.0699999999999998 112.268 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -76.38 -41.36 25.83 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.999 -1.096 . . . . 0.71999999999999997 111.234 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.43 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.3 t -50.22 -48.15 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 123.121 0.568 . . . . 0.84999999999999998 111.121 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.42 -32.35 49.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.732 -0.667 . . . . 1.1399999999999999 112.502 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -90.08 -66.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.844 0.354 . . . . 1.8200000000000001 110.198 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.74 34.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.749 . . . . 1.6499999999999999 111.864 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.793 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 2.4 m-20 65.88 105.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.277 -0.638 . . . . 3.5 109.277 -176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.464 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 33.6 tp -143.45 159.35 42.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.132 -0.627 . . . . 2.96 111.757 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 109' ' ' MET . 18.9 t30 -82.05 112.83 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.036 -0.984 . . . . 2.2400000000000002 111.224 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -125.27 146.48 49.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 1.6299999999999999 110.157 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.3 ptp -116.73 129.37 56.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.839 0.352 . . . . 1.77 110.216 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 13.1 p90 -141.63 148.13 38.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.861 0.362 . . . . 3.0099999999999998 110.968 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.94 116.67 30.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 2.3900000000000001 109.914 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 38.7 m-85 -142.21 168.02 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.1 -0.5 . . . . 3.3700000000000001 110.91 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 104' ' ' LYS . 36.2 p -102.85 156.86 17.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.968 -0.56 . . . . 1.3999999999999999 111.654 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.428 ' CD1' " H6'" ' A' ' 169' ' ' HC4 . 19.8 m-85 -116.27 108.96 16.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 1.1799999999999999 109.194 172.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' MET . 7.1 p-10 -121.26 -153.75 0.56 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.943 -0.571 . . . . 2.5699999999999998 110.236 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 65.8 t80 71.43 -73.81 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.959 0.503 . . . . 3.21 111.477 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.44 -26.28 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.441 0.638 . . . . 3.23 109.807 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 16.5 tpt -103.31 140.61 37.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.17 -0.923 . . . . 2.8500000000000001 109.499 176.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 m -60.03 117.7 25.98 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.71 -0.848 . . . . 2.1200000000000001 108.71 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -38.15 93.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.096 3.197 . . . . 1.47 114.254 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 160.48 18.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 109.611 172.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.1 ptpt -115.49 146.49 41.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 3.0800000000000001 111.493 -178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 124' ' ' ARG . 18.9 m -130.6 165.66 30.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.004 -0.998 . . . . 1.3300000000000001 110.295 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -112.7 118.01 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.556 -0.905 . . . . 1.6899999999999999 108.556 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -105.02 104.87 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.88 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -103.79 102.81 12.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.492 -0.929 . . . . 1.02 108.492 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 5.2 ppp? -107.85 140.79 40.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.585 -0.734 . . . . 2.4900000000000002 110.507 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.724 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 62.2 pttt -150.98 152.03 32.96 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.043 0.449 . . . . 1.5700000000000001 111.489 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.793 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 33.2 ttpt -75.58 136.62 40.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.696 -0.684 . . . . 2.1299999999999999 112.552 -172.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -130.98 107.29 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.369 -0.832 . . . . 1.5700000000000001 109.312 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -74.45 1.85 10.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.341 -0.39 . . . . 4.4100000000000001 111.135 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -51.89 -45.82 64.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 2.5499999999999998 111.149 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.36 29.15 2.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.587 -0.816 . . . . 2.6200000000000001 112.437 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.94 60.51 3.43 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.271 0.558 . . . . 2.7599999999999998 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.44 ' OG ' ' HG2' ' A' ' 32' ' ' GLN . 32.5 t -164.55 164.53 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.373 -0.973 . . . . 1.0700000000000001 108.373 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.762 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 21.1 m-85 -104.95 156.38 18.08 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.843 -0.429 . . . . 0.85999999999999999 109.843 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 62.8 m95 -101.58 106.12 17.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.398 -0.964 . . . . 0.63 108.398 172.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.677 HG11 ' HG ' ' A' ' 33' ' ' LEU . 4.2 p -101.94 122.51 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.86 0.838 . . . . 0.91000000000000003 110.473 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.724 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 94.4 m-85 -104.28 109.92 21.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.113 -0.949 . . . . 0.79000000000000004 109.676 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.17 108.06 23.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.08 -0.963 . . . . 1.1799999999999999 109.914 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -104.5 127.8 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 3.3100000000000001 110.241 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.728 ' HA ' HG12 ' A' ' 105' ' ' VAL . 49.7 mtm-85 -70.44 127.91 34.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.006 -0.543 . . . . 4.0300000000000002 109.732 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 104' ' ' LYS . 3.0 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.938 -1.03 . . . . 2.8700000000000001 111.326 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.85 " H3'" ' HG2' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.406 0.146 . . . . 3.3399999999999999 110.956 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 72.77 -60.43 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.822 0.701 . . . . 2.8999999999999999 111.494 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -78.97 153.45 30.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.603 -0.517 . . . . 3.8500000000000001 109.603 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.2 148.33 17.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.377 -0.916 . . . . 0.84999999999999998 112.518 -174.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' HD22 ' A' ' 43' ' ' ASN . . . -138.9 105.05 5.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.842 0.353 . . . . 0.70999999999999996 110.338 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.837 ' HB ' HG13 ' A' ' 120' ' ' VAL . 11.3 mm -108.67 160.83 7.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.767 -0.827 . . . . 1.0800000000000001 108.767 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 31' ' ' ILE . 59.2 tt0 -128.43 118.7 23.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.69 -0.485 . . . . 0.85999999999999999 109.69 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 120' ' ' VAL . 17.1 mt -116.05 155.51 28.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.699 -0.482 . . . . 1.6200000000000001 109.699 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.4 p30 -108.76 169.38 8.7 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.867 -0.333 . . . . 1.22 110.259 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.2 -20.52 6.92 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.3 0.88 . . . . 0.79000000000000004 115.3 -171.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.24 -19.84 23.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.901 0.851 . . . . 1.95 110.636 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.76 6.49 23.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.762 -0.733 . . . . 0.53000000000000003 112.292 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.645 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 89.7 m-20 -71.61 149.71 45.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.915 0.388 . . . . 1.3 110.486 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.0 mt -95.4 149.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.693 -0.685 . . . . 0.89000000000000001 109.37 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.1 mp -113.49 -56.76 2.37 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.45 109.879 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -150.77 144.27 25.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.027 -0.988 . . . . 1.99 111.142 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.067 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.2 m-30 -101.1 175.26 5.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.575 -1.193 . . . . 1.25 110.271 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.44 HD22 ' HB3' ' A' ' 30' ' ' ALA . 18.2 t-20 -102.41 179.72 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.61 -0.885 . . . . 2.1299999999999999 108.61 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -86.56 13.51 8.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.833 0.349 . . . . 1.48 110.493 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -89.92 -40.98 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 1.52 110.828 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 11.4 mp0 -59.74 -55.03 39.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 2.1200000000000001 110.374 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 51' ' ' GLY . . . -61.96 -30.8 76.41 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.562 -0.744 . . . . 1.4199999999999999 112.875 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.4 t70 -62.61 -33.43 74.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 2.3500000000000001 110.548 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.494 HG22 HG22 ' A' ' 50' ' ' THR . 44.7 mt -81.77 -62.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.776 -0.647 . . . . 2.5899999999999999 109.915 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 49' ' ' ILE . 9.4 t -179.44 131.43 0.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.157 -0.474 . . . . 3.4100000000000001 110.464 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . 57.33 -157.2 13.7 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.932 -0.576 . . . . 2.3199999999999998 112.808 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 4.4 mpp_? 53.95 79.85 0.12 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.755 -0.723 . . . . 3.1400000000000001 111.748 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' A' ' 56' ' ' GLN . 21.9 t70 -79.96 136.24 54.5 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 2.1000000000000001 110.598 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.067 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 11.1 Cg_endo -54.5 -33.56 78.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.667 2.911 . . . . 1.6799999999999999 114.123 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.94 2.02 48.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.434 . . . . 3.6099999999999999 111.129 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' CB ' ' HB3' ' A' ' 53' ' ' ASP . 22.4 tt0 -92.9 -8.4 43.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 2.5 110.966 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG21 ' CD2' ' A' ' 42' ' ' TYR . 3.2 m -112.93 58.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.623 0.601 . . . . 0.96999999999999997 112.623 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 40' ' ' LEU . 11.4 mt -122.39 139.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.687 -0.633 . . . . 1.0900000000000001 110.031 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.13 75.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.622 -0.799 . . . . 0.66000000000000003 111.191 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -114.36 139.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.147 -0.527 . . . . 1.8200000000000001 110.118 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.95 113.35 20.48 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.853 -0.425 . . . . 0.71999999999999997 109.853 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.2 t80 -47.21 -46.59 24.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.663 -0.699 . . . . 0.69999999999999996 111.542 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.862 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 49.6 m-85 -80.22 7.77 8.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 1.1599999999999999 111.614 -172.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -124.37 -50.77 1.76 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 3.5800000000000001 110.991 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.44 -79.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.687 0.625 . . . . 2.2000000000000002 112.687 -174.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.26 16.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.251 0.548 . . . . 1.77 111.373 -168.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB1' ' OG1' ' A' ' 70' ' ' THR . . . -165.93 70.45 1.22 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.60999999999999999 110.851 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.11 -6.28 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.901 2.401 . . . . 0.81000000000000005 113.17 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 7.5 p -84.59 -22.15 30.13 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.415 -0.587 . . . . 0.84999999999999998 109.415 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 ' OG1' ' HB1' ' A' ' 67' ' ' ALA . 2.2 m -79.38 -32.96 43.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.847 -1.524 . . . . 1.3300000000000001 110.477 -160.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.862 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 12.1 t70 -62.9 108.58 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.7 -0.682 . . . . 1.8500000000000001 109.999 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -162.95 155.78 16.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 1.5600000000000001 109.496 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.94 -32.7 97.93 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.374 2.049 . . . . 1.1699999999999999 111.913 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -80.44 -9.79 59.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 2.5600000000000001 112.482 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' A' ' 70' ' ' THR . 62.0 t80 -130.05 -67.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.109 -0.37 . . . . 3.3599999999999999 110.806 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -56.61 -41.53 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.79000000000000004 110.332 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.35 -34.3 84.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.04 -0.6 . . . . 0.59999999999999998 112.594 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.3 -36.95 38.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.391 . . . . 2.0899999999999999 110.243 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' HD1' ' HG2' ' A' ' 109' ' ' MET . 34.9 t80 -57.4 -44.54 84.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.67000000000000004 109.428 172.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -75.68 -18.91 59.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 1.0900000000000001 111.781 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -38.36 82.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.827 -0.434 . . . . 2.0699999999999998 109.827 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.682 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.34 -45.97 35.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.73 -0.748 . . . . 0.71999999999999997 111.481 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' PHE . 28.1 t -50.59 -48.52 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 122.979 0.511 . . . . 0.84999999999999998 111.1 176.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.4 -20.32 62.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.627 -0.715 . . . . 1.1399999999999999 112.01 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -99.14 -81.86 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.878 0.37 . . . . 1.8200000000000001 110.436 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.0 -60.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.826 -0.702 . . . . 1.6499999999999999 111.774 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -98.72 130.84 45.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.533 . . . . 3.5 109.627 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.682 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER -115.49 104.45 11.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.914 -0.773 . . . . 2.96 108.914 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.1 p-10 -149.32 95.44 2.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.135 0.969 . . . . 2.2400000000000002 110.227 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.9 m -142.86 145.16 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.112 -0.949 . . . . 1.6299999999999999 109.894 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -120.1 117.83 28.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.061 0.458 . . . . 1.77 109.778 174.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.03 154.15 36.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.04 -0.726 . . . . 3.0099999999999998 109.04 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 pt-20 -103.2 103.49 13.54 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 2.3900000000000001 110.553 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -110.78 161.27 15.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.704 -1.135 . . . . 3.3700000000000001 109.96 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' THR . 13.6 m -104.13 129.28 51.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.14 -0.482 . . . . 1.3999999999999999 110.938 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' CD1' ' H2 ' ' A' ' 169' ' ' HC4 . 27.3 m-85 -103.35 104.62 14.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 1.1799999999999999 108.482 174.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.59 8.39 9.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 2.5699999999999998 111.793 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 71.6 t80 -79.22 -82.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.555 -0.293 . . . . 3.21 110.69 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -87.37 -37.86 16.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 3.23 109.77 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.0 ttt -82.2 139.9 34.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.766 -0.827 . . . . 2.8500000000000001 108.766 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.16 143.55 92.26 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 109.264 -0.643 . . . . 2.1200000000000001 109.264 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -42.48 89.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.64 2.893 . . . . 1.47 114.187 -174.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.8 m -108.14 145.9 33.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.977 -0.556 . . . . 1.3999999999999999 110.585 175.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -103.34 104.73 14.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.143 0.497 . . . . 3.0800000000000001 110.443 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.7 m -117.15 165.51 12.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.625 -0.716 . . . . 1.3300000000000001 109.973 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 35.9 ttmt -110.94 119.39 38.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.622 -0.881 . . . . 1.6899999999999999 108.622 177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 91' ' ' MET . 54.9 t -105.64 127.12 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 115.408 -0.815 . . . . 1.27 108.848 -171.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 2.2 t-160 -109.97 114.45 27.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.31 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 4.1 mpp? -101.45 119.83 39.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.007 -0.738 . . . . 2.4900000000000002 109.007 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 58.7 pttt -143.25 124.52 14.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.413 0.625 . . . . 1.5700000000000001 112.227 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 42.8 tttt -57.68 126.5 27.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.664 -1.153 . . . . 2.1299999999999999 111.162 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -174.79 94.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.091 0.774 . . . . 1.5700000000000001 113.091 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.021 HD11 ' H ' ' A' ' 117' ' ' SER . 0.2 OUTLIER 177.73 -174.98 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.005 0.522 . . . . 4.4100000000000001 111.431 167.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 t -77.22 77.63 3.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.529 -0.915 . . . . 2.5499999999999998 108.529 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.14 -134.06 3.62 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.753 -1.213 . . . . 2.6200000000000001 112.979 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -143.32 25.32 1.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 2.7599999999999998 110.648 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 1.021 ' H ' HD11 ' A' ' 113' ' ' LEU . 4.3 m -98.87 167.32 10.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.943 -0.762 . . . . 1.0700000000000001 108.943 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -127.13 156.99 40.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.002 0.43 . . . . 0.85999999999999999 110.216 -169.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.627 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 35.9 m95 -101.02 110.63 22.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.942 -0.762 . . . . 0.63 108.942 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 31' ' ' ILE . 3.5 p -103.25 107.87 23.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.512 1.149 . . . . 0.91000000000000003 110.59 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.627 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 95.7 m-85 -102.78 140.72 36.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.734 -1.121 . . . . 0.79000000000000004 110.697 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.87 104.15 16.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 1.1799999999999999 109.744 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.99 126.01 51.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.559 . . . . 3.3100000000000001 109.807 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HA ' HG12 ' A' ' 105' ' ' VAL . 44.3 mtm180 -79.8 143.79 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.789 -0.365 . . . . 4.0300000000000002 110.372 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.337 -0.84 . . . . 2.8700000000000001 109.899 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.504 " H3'" ' HE ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 31.6 tp . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.668 -0.493 . . . . 3.3399999999999999 109.668 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -60.54 2.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 2.8999999999999999 111.734 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -77.19 152.24 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.085 -0.339 . . . . 3.8500000000000001 110.085 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.61 135.75 12.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.445 -0.883 . . . . 0.84999999999999998 113.243 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.9 104.62 12.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.514 -0.55 . . . . 0.70999999999999996 109.514 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 120' ' ' VAL . 60.5 mt -112.77 142.65 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.557 -0.534 . . . . 1.0800000000000001 109.557 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -109.41 116.19 31.37 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.553 -0.459 . . . . 0.85999999999999999 109.834 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 117' ' ' SER . 2.7 mm? -103.83 165.43 11.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.809 -1.182 . . . . 1.6200000000000001 107.809 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 47.3 p30 -108.19 167.16 10.21 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 1.22 110.333 173.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -60.54 -2.12 2.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 114.403 0.521 . . . . 0.79000000000000004 114.403 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -100.33 -47.33 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.534 0.667 . . . . 1.95 109.675 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.46 6.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.501 -0.772 . . . . 0.53000000000000003 112.558 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -76.96 149.61 35.95 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.969 0.414 . . . . 1.3 110.43 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 12.6 mt -95.96 148.13 5.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.663 -0.699 . . . . 0.89000000000000001 109.591 175.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 8.4 mp -115.64 -64.85 1.26 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.326 0.584 . . . . 1.45 111.945 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -150.66 158.8 44.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.219 -0.9 . . . . 1.99 110.641 -173.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 39' ' ' ILE . 5.3 m-30 -121.21 -174.19 2.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.065 -0.971 . . . . 1.25 110.158 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 26' ' ' LEU . 12.9 t-20 -114.81 178.96 4.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.844 -0.799 . . . . 2.1299999999999999 108.844 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.87 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 1.48 110.467 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -43.67 -63.82 0.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.847 . . . . 1.52 112.786 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -61.99 -37.9 86.57 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.796 0.331 . . . . 2.1200000000000001 111.792 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.27 94.59 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.807 -0.711 . . . . 1.4199999999999999 111.681 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.0 -38.17 82.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.538 0.335 . . . . 2.3500000000000001 111.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 45' ' ' ALA . 48.9 mt -56.53 -60.31 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.075 0.464 . . . . 2.5899999999999999 110.692 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 51' ' ' GLY . 8.8 t -144.69 -42.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.139 -0.482 . . . . 3.4100000000000001 111.071 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 50' ' ' THR . . . 139.64 77.47 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.395 -0.907 . . . . 2.3199999999999998 112.192 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 1.2 mpt_? -118.14 119.78 35.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.822 0.344 . . . . 3.1400000000000001 110.28 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.73 133.32 31.08 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 2.1000000000000001 111.255 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 31.8 Cg_exo -60.37 -28.87 87.61 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.038 2.492 . . . . 1.6799999999999999 112.16 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 10.9 mmpt? -79.82 -12.2 59.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.434 -0.348 . . . . 3.6099999999999999 111.616 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -89.52 -24.6 21.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 2.5 111.325 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.734 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 m -98.64 16.31 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.96999999999999997 113.462 -170.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.59 125.46 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.266 -0.574 . . . . 1.0900000000000001 109.969 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 -1.77 88.37 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.289 -0.957 . . . . 0.66000000000000003 110.861 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' ILE . 14.0 mptt -95.93 140.61 30.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.854 -0.673 . . . . 1.8200000000000001 109.877 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 14.4 t-20 -90.34 116.87 28.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.408 -0.59 . . . . 0.71999999999999997 109.408 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' HA ' HD11 ' A' ' 39' ' ' ILE . 89.0 t80 -56.24 -42.3 77.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.865 -0.607 . . . . 0.69999999999999996 111.278 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.4 m-85 -82.06 1.25 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.595 . . . . 1.1599999999999999 111.399 -170.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.4 mmtp -122.23 -58.32 1.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.94 0.4 . . . . 3.5800000000000001 111.559 -176.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.31 -76.98 0.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.743 -0.662 . . . . 2.2000000000000002 111.969 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 14.6 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.042 0.925 . . . . 1.77 111.716 -172.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -169.69 74.03 0.68 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.234 -0.893 . . . . 0.60999999999999999 110.636 175.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.45 -18.24 43.74 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.151 2.567 . . . . 0.81000000000000005 113.393 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.78 -8.06 59.03 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.975 -0.29 . . . . 0.84999999999999998 110.513 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -86.78 -19.97 28.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 1.3300000000000001 110.73 -176.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 16.8 t70 -67.93 96.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 1.8500000000000001 110.285 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' ' OE1' ' A' ' 74' ' ' GLU . 74.9 m -166.11 148.58 6.28 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.5600000000000001 109.477 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -53.27 -35.94 76.13 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.008 2.472 . . . . 1.1699999999999999 113.294 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 72' ' ' SER . 1.4 pm0 -86.36 -7.3 58.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.053 0.39 . . . . 2.5600000000000001 112.053 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 51.4 m-85 -112.56 -81.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 3.3599999999999999 109.927 173.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 75.2 t80 -59.67 -37.69 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.487 -0.779 . . . . 0.79000000000000004 110.555 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.24 94.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.088 -0.577 . . . . 0.59999999999999998 112.136 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 67.9 mmtt -67.8 -38.15 82.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.379 . . . . 2.0899999999999999 110.816 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 34' ' ' ASP . 93.6 t80 -57.5 -42.36 82.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.67000000000000004 110.614 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -85.91 -13.95 46.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.645 -0.707 . . . . 1.0900000000000001 110.854 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -41.45 86.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.192 0.52 . . . . 2.0699999999999998 109.699 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.892 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -70.16 -32.13 69.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.71999999999999997 111.545 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.63 -51.09 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.84999999999999998 110.354 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.47 67.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 1.1399999999999999 111.677 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -93.27 -77.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 1.8200000000000001 110.735 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.19 -64.8 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.62 -0.592 . . . . 1.6499999999999999 111.62 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.781 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -121.99 155.56 35.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.649 -0.5 . . . . 3.5 109.649 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.892 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 2.4 tm? -135.1 104.34 5.89 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.277 -0.638 . . . . 2.96 109.277 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 110' ' ' LYS . 25.5 m-80 -133.28 93.98 3.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.805 -0.813 . . . . 2.2400000000000002 108.805 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.9 p -134.24 164.07 28.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.221 -0.899 . . . . 1.6299999999999999 110.882 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.8 ptt? -132.89 109.0 9.3 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.644 -0.707 . . . . 1.77 109.66 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -104.62 155.53 18.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.012 -0.995 . . . . 3.0099999999999998 109.818 -172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -117.57 111.7 19.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.047 -0.353 . . . . 2.3900000000000001 110.047 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.503 ' HE1' ' HG3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -163.87 168.6 19.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 3.3700000000000001 110.285 -177.266 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.4 ' H ' ' HD2' ' A' ' 94' ' ' TYR . 12.4 t -102.92 153.25 20.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.161 -0.472 . . . . 1.3999999999999999 110.565 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.925 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 81.9 m-85 -114.9 103.24 10.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.759 -0.83 . . . . 1.1799999999999999 108.759 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -114.69 112.92 23.61 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.617 -0.72 . . . . 2.5699999999999998 111.078 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -174.2 -80.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 3.21 109.821 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.471 ' NE2' " H2'" ' A' ' 169' ' ' HC4 . 12.4 pt20 -94.81 -41.48 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 3.23 109.433 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.2 ttp -80.9 124.96 29.54 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.708 -0.849 . . . . 2.8500000000000001 108.708 171.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.8 m -56.89 120.07 35.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.619 -0.512 . . . . 2.1200000000000001 109.619 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -24.33 91.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 1 C-N-CA 125.345 4.03 . . . . 1.47 114.978 -170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -108.81 144.82 36.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.896 -0.779 . . . . 1.3999999999999999 108.896 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -104.16 122.43 45.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.069 0.462 . . . . 3.0800000000000001 109.992 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.1 m -124.74 166.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.583 -0.735 . . . . 1.3300000000000001 110.321 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -103.95 117.33 34.05 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.682 -1.229 . . . . 1.6899999999999999 107.682 170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.8 p -104.21 119.36 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.899 0.856 . . . . 1.27 110.402 -170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.1 t60 -103.6 105.3 15.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.006 -0.997 . . . . 1.02 109.362 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 57.5 tpp -103.9 123.54 47.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.713 -1.218 . . . . 2.4900000000000002 107.713 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.526 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 13.2 ptmm? -143.39 147.07 34.07 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.959 -0.696 . . . . 1.5700000000000001 111.033 -172.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.781 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 37.1 tttp -81.52 146.09 30.36 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.019 -0.537 . . . . 2.1299999999999999 111.217 -171.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.77 38.47 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.518 -0.919 . . . . 1.5700000000000001 108.518 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.77 -112.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.381 -0.528 . . . . 4.4100000000000001 110.732 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m 52.95 37.23 23.98 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.504 0.668 . . . . 2.5499999999999998 109.484 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.57 -90.7 0.55 Allowed Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.896 -1.282 . . . . 2.6200000000000001 109.896 -169.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -178.22 88.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.672 -0.862 . . . . 2.7599999999999998 108.672 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.0 p -135.95 -178.19 5.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.921 -0.581 . . . . 1.0700000000000001 111.503 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 88' ' ' LEU . 97.1 m-85 -131.31 144.33 51.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.564 -0.532 . . . . 0.85999999999999999 109.564 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 32.9 m95 -102.58 107.43 18.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.568 -0.901 . . . . 0.63 108.568 174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.9 p -100.37 142.77 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.784 -0.766 . . . . 0.91000000000000003 111.319 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.07 123.9 28.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.426 -0.807 . . . . 0.79000000000000004 109.725 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.01 103.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.429 0.633 . . . . 1.1799999999999999 111.31 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -104.42 121.42 43.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 3.3100000000000001 109.889 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.914 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.18 140.75 55.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.834 0.35 . . . . 4.0300000000000002 111.093 -179.144 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.766 -0.635 . . . . 2.8700000000000001 109.518 177.223 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.925 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.782 0.325 . . . . 3.8500000000000001 110.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.7 150.95 17.28 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.909 -0.662 . . . . 0.84999999999999998 112.51 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.44 104.92 3.68 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.031 -0.729 . . . . 0.70999999999999996 109.031 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.513 ' HB ' HG13 ' A' ' 120' ' ' VAL . 21.7 mt -116.74 156.49 17.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.1 -0.5 . . . . 1.0800000000000001 109.731 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 62.6 tt0 -121.81 111.73 17.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.391 -0.596 . . . . 0.85999999999999999 109.391 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -112.32 148.96 33.1 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.655 -0.498 . . . . 1.6200000000000001 109.655 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -104.44 168.07 9.33 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.119 -0.233 . . . . 1.22 110.373 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.04 -7.13 29.1 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.387 -0.369 . . . . 0.79000000000000004 113.891 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -89.11 -45.62 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 1.95 109.811 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 134.45 12.61 1.38 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.53000000000000003 112.307 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 149.88 22.65 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.3 110.178 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 17.7 mt -94.08 145.36 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.808 -0.633 . . . . 0.89000000000000001 109.781 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.4 mm? -106.52 -68.4 0.88 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.556 0.694 . . . . 1.45 110.075 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -133.89 133.29 41.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.185 -0.916 . . . . 1.99 110.656 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.94 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.7 m-30 -94.59 -176.23 3.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.635 -0.711 . . . . 1.25 110.3 171.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -118.53 165.79 13.5 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.56 -0.904 . . . . 2.1299999999999999 108.56 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -76.88 19.09 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 1.48 111.332 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.33 -49.07 6.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 1.52 110.279 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 50' ' ' THR . 3.6 mm-40 -69.7 -29.12 66.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.472 0.653 . . . . 2.1200000000000001 110.026 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -88.26 -5.83 75.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.691 -0.766 . . . . 1.4199999999999999 112.33 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.6 t70 -83.1 -60.17 2.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.771 0.319 . . . . 2.3500000000000001 110.683 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' H ' HG12 ' A' ' 49' ' ' ILE . 2.8 pt -94.54 -46.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.291 -0.413 . . . . 2.5899999999999999 111.93 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -70.64 -54.64 11.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.175 0.512 . . . . 3.4100000000000001 110.56 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 110.47 39.61 1.46 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.765 -0.731 . . . . 2.3199999999999998 112.405 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 3.1 mpt_? -118.81 98.26 6.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.59 -0.522 . . . . 3.1400000000000001 109.59 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.878 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.8 m-20 -64.08 152.86 86.77 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.536 . . . . 2.1000000000000001 110.559 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.94 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 48.0 Cg_exo -58.01 -18.74 37.15 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.37 2.713 . . . . 1.6799999999999999 113.765 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.7 4.68 26.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.82 0.304 . . . . 3.6099999999999999 111.82 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.878 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 80.9 mm-40 -90.45 -9.33 47.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.731 0.301 . . . . 2.5 111.43 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.737 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.7 m -111.87 25.73 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.986 0.736 . . . . 0.96999999999999997 112.986 -171.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -89.78 126.5 42.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.248 -0.581 . . . . 1.0900000000000001 110.333 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.23 87.79 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.66000000000000003 110.844 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 47.3 mttm -106.73 138.79 42.25 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.072 -0.564 . . . . 1.8200000000000001 110.619 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 25.8 t-20 -80.04 114.33 18.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.039 -0.528 . . . . 0.71999999999999997 109.8 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.624 ' HA ' HD11 ' A' ' 39' ' ' ILE . 69.5 t80 -56.14 -43.34 78.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.961 -0.563 . . . . 0.69999999999999996 111.416 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 39.6 m-85 -80.77 -6.25 58.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 112.329 -166.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.65 -45.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.448 0.536 . . . . 3.5800000000000001 112.448 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.44 -23.56 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.314 -0.555 . . . . 2.2000000000000002 111.833 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.93 14.01 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.116 -0.633 . . . . 1.77 110.998 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.29 74.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.904 -0.589 . . . . 0.60999999999999999 110.543 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.88 13.64 1.43 Allowed 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.939 2.426 . . . . 0.81000000000000005 113.698 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -97.12 -5.75 36.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 110.256 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.602 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 55.1 p -100.5 -28.87 12.68 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.61 -0.723 . . . . 1.3300000000000001 111.653 -159.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 10.1 p-10 -75.29 78.49 2.39 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.591 1.186 . . . . 1.8500000000000001 111.105 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.792 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 66.7 m -152.65 169.42 9.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 114.592 -1.185 . . . . 1.5600000000000001 108.776 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.792 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 29.3 Cg_endo -61.99 -14.57 38.01 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.007 2.471 . . . . 1.1699999999999999 114.926 -171.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.41 -34.29 13.51 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.901 -0.5 . . . . 2.5600000000000001 111.554 -175.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 69.0 t80 -106.29 -69.43 0.83 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 3.3599999999999999 110.459 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.658 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 63.8 t80 -60.62 -41.14 94.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.79000000000000004 110.727 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -56.86 -49.15 73.03 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.59999999999999998 112.383 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -67.48 -37.15 82.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 2.0899999999999999 110.558 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.78 -40.75 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.614 . . . . 0.67000000000000004 110.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -78.33 -18.59 54.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 1.0900000000000001 112.229 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 35.1 mt-10 -66.12 -39.79 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.417 . . . . 2.0699999999999998 110.939 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -69.71 -42.1 72.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.364 -0.922 . . . . 0.71999999999999997 111.436 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 83' ' ' VAL . 35.4 t -57.31 -51.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.38 . . . . 0.84999999999999998 110.67 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -26.83 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.774 -0.648 . . . . 1.1399999999999999 111.707 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -83.94 -77.94 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.8200000000000001 110.172 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.87 -68.48 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.235 -0.746 . . . . 1.6499999999999999 111.235 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -107.34 153.38 22.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 3.5 109.506 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 62.3 tp -118.19 126.41 52.14 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.932 -0.396 . . . . 2.96 109.932 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -166.15 94.12 0.54 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.939 0.876 . . . . 2.2400000000000002 109.774 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 4.4 m -139.52 153.71 47.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.801 -1.09 . . . . 1.6299999999999999 109.769 -174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 61.1 ttp -137.5 108.94 6.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.153 -0.314 . . . . 1.77 110.153 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 47.1 p90 -123.76 167.29 14.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.472 -0.331 . . . . 3.0099999999999998 110.76 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -102.68 132.79 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.622 -0.511 . . . . 2.3900000000000001 109.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -144.21 150.84 38.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.531 . . . . 3.3700000000000001 110.647 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 m -104.83 141.35 36.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.353 -0.385 . . . . 1.3999999999999999 110.806 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 105' ' ' VAL . 18.6 m-85 -104.63 120.81 42.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' MET . 4.0 p30 -143.66 -156.93 0.73 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.639 -0.71 . . . . 2.5699999999999998 109.527 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 58.1 t80 73.52 -24.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.152 0.581 . . . . 3.21 111.745 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 97' ' ' ASP . 10.6 pt20 -158.74 -38.02 0.06 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.337 -0.616 . . . . 3.23 109.337 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 101' ' ' THR . 54.3 tpp -78.71 143.67 36.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.849 -0.797 . . . . 2.8500000000000001 108.849 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.565 ' O ' ' HG3' ' A' ' 100' ' ' MET . 12.1 p -67.52 151.4 97.2 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 108.407 -0.96 . . . . 2.1200000000000001 108.407 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.59 87.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.994 2.462 . . . . 1.47 113.864 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' HE ' ' A' ' 124' ' ' ARG . 85.8 m -100.78 129.89 46.73 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.457 -0.792 . . . . 1.3999999999999999 110.422 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.34 114.76 29.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.48 -0.563 . . . . 3.0800000000000001 109.48 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.3 m -126.95 165.88 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.784 -0.644 . . . . 1.3300000000000001 111.151 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -115.19 128.09 55.95 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.499 -0.926 . . . . 1.6899999999999999 108.499 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 98.9 t -104.51 104.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.459 -0.791 . . . . 1.27 109.201 -171.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.64 104.42 14.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.177 -0.675 . . . . 1.02 109.177 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.93 143.79 32.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.486 -0.779 . . . . 2.4900000000000002 109.845 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.9 ptmt -154.31 154.24 33.04 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.466 -0.568 . . . . 1.5700000000000001 109.466 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.638 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 3.6 ttpm? -78.6 140.52 38.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.846 0.355 . . . . 2.1299999999999999 111.557 -171.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -113.25 169.08 9.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.982 -0.554 . . . . 1.5700000000000001 110.359 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' N ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 -6.2 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.524 -0.307 . . . . 4.4100000000000001 111.525 177.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 p -61.49 -39.53 91.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.02 0.914 . . . . 2.5499999999999998 109.167 170.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.02 22.21 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 108.749 -1.741 . . . . 2.6200000000000001 108.749 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.27 89.8 0.06 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.474 0.637 . . . . 2.7599999999999998 110.062 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 11.8 p -177.13 -170.02 0.27 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.521 -0.763 . . . . 1.0700000000000001 110.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 15.9 m-85 -129.0 158.46 38.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.631 -0.877 . . . . 0.85999999999999999 108.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.531 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 77.8 m95 -102.59 109.25 20.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.957 -0.757 . . . . 0.63 108.957 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.4 p -102.5 120.85 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.887 0.851 . . . . 0.91000000000000003 110.597 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.519 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 97.6 m-85 -103.61 136.53 43.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.467 -0.788 . . . . 0.79000000000000004 110.992 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.48 107.76 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.078 -0.965 . . . . 1.1799999999999999 110.026 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -103.65 104.42 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 3.3100000000000001 110.182 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.699 ' HE ' HG23 ' A' ' 103' ' ' THR . 34.3 ttt-85 -83.55 126.9 33.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.035 -0.357 . . . . 4.0300000000000002 110.035 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.125 -0.941 . . . . 2.8700000000000001 111.443 -179.476 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.0 p90 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 110.044 -0.354 . . . . 3.8500000000000001 110.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.8 118.58 6.14 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.554 -0.832 . . . . 0.84999999999999998 111.354 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.89 106.63 17.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.878 0.37 . . . . 0.70999999999999996 110.481 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' HG13 ' A' ' 120' ' ' VAL . 20.7 mt -111.66 147.78 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.344 -0.613 . . . . 1.0800000000000001 109.344 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' NE2' HD22 ' A' ' 40' ' ' LEU . 47.1 tt0 -118.38 116.24 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.576 -0.528 . . . . 0.85999999999999999 109.576 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 19.0 mt -115.71 154.12 30.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 110.276 -0.268 . . . . 1.6200000000000001 110.276 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.727 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.2 p30 -112.03 167.4 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.497 -0.186 . . . . 1.22 110.497 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -19.11 50.55 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.507 0.563 . . . . 0.79000000000000004 114.507 -171.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 38.7 t70 -81.38 -14.85 56.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.367 0.603 . . . . 1.95 109.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 104.53 7.82 38.91 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.502 -0.772 . . . . 0.53000000000000003 112.009 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.727 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 40.1 m-80 -82.62 154.34 24.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.143 0.497 . . . . 1.3 110.483 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.832 HG21 ' HE2' ' A' ' 42' ' ' TYR . 9.1 mt -102.09 158.19 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.258 -0.883 . . . . 0.89000000000000001 108.767 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.0 mp -116.77 -68.35 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.635 0.731 . . . . 1.45 109.754 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.5 151.7 40.6 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.585 -174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.832 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.7 m-85 -109.94 179.04 4.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.636 -1.166 . . . . 1.25 109.116 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 45' ' ' ALA . 31.7 p-10 -109.74 163.75 13.21 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.874 -0.787 . . . . 2.1299999999999999 108.874 169.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.26 -7.12 44.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 1.48 111.842 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . . . -82.74 -23.77 33.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.458 -0.337 . . . . 1.52 111.378 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.02 -53.14 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.268 -0.642 . . . . 2.1200000000000001 109.268 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -55.76 -24.75 41.95 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 112.672 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.36 -33.36 75.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.842 0.353 . . . . 2.3500000000000001 110.918 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -96.07 -69.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 2.5899999999999999 110.916 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.8 m -84.29 -60.43 2.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.727 0.299 . . . . 3.4100000000000001 110.281 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 119.39 40.51 0.62 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.091 -1.052 . . . . 2.3199999999999998 113.121 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -92.88 119.44 32.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.165 -0.68 . . . . 3.1400000000000001 109.165 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 19.6 m-20 -65.86 139.04 96.67 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 2.1000000000000001 112.503 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.8 Cg_exo -66.98 121.56 8.77 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.691 2.261 . . . . 1.6799999999999999 111.796 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 68.7 mttm 83.96 7.17 0.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.028 0.83 . . . . 3.6099999999999999 112.604 171.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.609 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.6 pt20 -84.01 -16.96 42.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.909 0.862 . . . . 2.5 109.209 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.957 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.8 m -97.0 24.97 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.523 -1.217 . . . . 0.96999999999999997 112.789 -170.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.41 125.71 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.732 -0.469 . . . . 1.0900000000000001 109.732 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.95 5.77 88.82 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.227 -0.987 . . . . 0.66000000000000003 111.102 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.957 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 39.8 mttm -98.46 139.43 34.21 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.388 . . . . 1.8200000000000001 110.234 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 22.2 t-20 -86.25 111.96 20.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.761 -0.459 . . . . 0.71999999999999997 109.761 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HA ' HD11 ' A' ' 39' ' ' ILE . 80.9 t80 -57.72 -32.63 67.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.585 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 30.0 m-85 -86.42 1.22 52.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.9 -0.591 . . . . 1.1599999999999999 111.365 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -136.3 -62.55 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.327 0.492 . . . . 3.5800000000000001 112.327 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.82 -24.06 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.375 0.509 . . . . 2.2000000000000002 112.375 -164.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.83 13.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.215 0.45 . . . . 1.77 112.215 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.97 88.18 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.573 0.546 . . . . 0.60999999999999999 110.637 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.09 29.9 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.581 2.187 . . . . 0.81000000000000005 113.066 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.0 m -79.06 -30.61 44.12 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.983 -1.118 . . . . 0.84999999999999998 107.983 167.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 6.8 m -96.99 -25.15 15.49 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.57 -2.105 . . . . 1.3300000000000001 108.553 -119.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 11.0 p-10 -74.22 104.23 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 109.105 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.501 ' H ' ' HB3' ' A' ' 76' ' ' TYR . 48.7 m -160.29 151.65 16.17 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.283 -0.871 . . . . 1.5600000000000001 109.624 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.85 -31.01 87.53 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.95 2.433 . . . . 1.1699999999999999 112.803 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.98 -2.36 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.343 0.497 . . . . 2.5600000000000001 112.343 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -134.73 -74.33 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.888 -0.325 . . . . 3.3599999999999999 110.537 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 85.8 t80 -57.54 -35.86 70.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.962 0.41 . . . . 0.79000000000000004 110.171 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' GLU . . . -57.67 -45.69 93.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.743 -0.662 . . . . 0.59999999999999998 112.048 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 72.5 mmtt -75.9 -38.68 57.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.669 0.235 . . . . 2.0899999999999999 111.096 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.808 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 66.4 t80 -56.06 -40.13 73.08 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.554 0.692 . . . . 0.67000000000000004 110.477 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -88.53 -16.66 32.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.292 -0.867 . . . . 1.0900000000000001 111.034 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 29.3 tt0 -70.25 -35.64 73.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.154 -0.476 . . . . 2.0699999999999998 110.563 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.731 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -76.37 -40.33 28.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.549 -0.834 . . . . 0.71999999999999997 111.513 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.6 t -54.49 -50.35 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 110.36 174.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.15 73.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.506 -0.77 . . . . 1.1399999999999999 111.988 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 p -90.74 -72.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 1.8200000000000001 110.959 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.75 -56.54 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.431 -0.89 . . . . 1.6499999999999999 113.497 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -122.1 149.62 43.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.379 0.609 . . . . 3.5 112.055 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA3' ' A' ' 82' ' ' GLY . 3.9 mm? -112.8 107.61 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.108 -0.951 . . . . 2.96 109.581 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.714 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.2 p30 -169.68 110.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.989 0.9 . . . . 2.2400000000000002 111.796 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -166.05 158.62 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.777 -1.101 . . . . 1.6299999999999999 109.413 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -127.77 119.97 26.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.127 0.489 . . . . 1.77 109.701 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.65 165.84 24.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.527 -0.545 . . . . 3.0099999999999998 109.527 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 51.1 mt-10 -104.32 115.2 29.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.06 0.457 . . . . 2.3900000000000001 110.423 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -118.33 152.74 35.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 3.3700000000000001 109.825 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -104.01 132.09 50.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 1.3999999999999999 110.594 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -113.54 119.63 38.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.671 -0.492 . . . . 1.1799999999999999 109.671 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -123.2 -147.05 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 2.5699999999999998 109.629 -175.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 99' ' ' GLN . 54.5 t80 65.87 -85.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.044 0.537 . . . . 3.21 111.514 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 50.0 mt-30 -72.68 -51.17 20.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.45 0.643 . . . . 3.23 109.509 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 47.5 ttp -93.27 130.41 39.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.338 -0.846 . . . . 2.8500000000000001 109.783 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 m -52.85 117.55 11.36 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.766 -0.457 . . . . 2.1200000000000001 109.766 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -20.25 92.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.552 4.168 . . . . 1.47 114.725 -169.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -105.52 144.45 32.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 1.3999999999999999 111.184 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -103.32 117.66 35.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 3.0800000000000001 110.421 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 124' ' ' ARG . 29.5 m -127.97 165.06 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.991 0.425 . . . . 1.3300000000000001 111.001 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.597 ' HE2' HG11 ' A' ' 125' ' ' VAL . 18.5 ttmm -104.92 129.58 53.27 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.662 -1.236 . . . . 1.6899999999999999 107.662 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 121' ' ' PHE . 7.6 p -113.69 128.92 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.578 0.704 . . . . 1.27 110.096 -175.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -105.13 115.2 29.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.276 -0.875 . . . . 1.02 109.078 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.808 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 37.0 ttp -102.99 127.22 50.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.461 -0.94 . . . . 2.4900000000000002 108.461 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.719 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.8 ptmt -154.5 141.39 19.18 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.135 -0.32 . . . . 1.5700000000000001 110.135 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' LEU . 31.3 ttmt -84.46 136.77 33.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.122 0.487 . . . . 2.1299999999999999 111.367 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -112.65 165.84 11.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.718 -0.845 . . . . 1.5700000000000001 108.718 169.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.94 29.99 6.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.59 . . . . 4.4100000000000001 111.139 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -76.51 79.84 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.625 -1.25 . . . . 2.5499999999999998 107.625 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.31 -88.37 0.33 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.121 -1.192 . . . . 2.6200000000000001 110.121 -167.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.7 83.9 0.46 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.217 -1.031 . . . . 2.7599999999999998 108.217 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 p -146.42 152.27 38.77 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.683 -0.689 . . . . 1.0700000000000001 109.394 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.477 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -115.95 158.39 23.12 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.27 -0.641 . . . . 0.85999999999999999 109.27 -170.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 83.6 m95 -101.59 110.09 22.02 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.963 -0.754 . . . . 0.63 108.963 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.741 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -102.73 110.52 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 122.029 0.918 . . . . 0.91000000000000003 110.041 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.719 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 94.0 m-85 -103.93 127.91 51.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.4 -0.818 . . . . 0.79000000000000004 111.17 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.28 104.8 17.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.787 0.803 . . . . 1.1799999999999999 111.072 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -118.99 119.73 35.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.432 -0.803 . . . . 3.3100000000000001 109.919 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.3 ttt180 -68.88 135.72 51.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.987 0.423 . . . . 4.0300000000000002 110.696 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 106' ' ' LYS . 2.6 m . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.262 -0.875 . . . . 2.8700000000000001 110.776 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 113.38 0.881 . . . . 3.8500000000000001 113.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' CG ' ' A' ' 43' ' ' ASN . . . -101.24 104.39 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.472 -0.87 . . . . 0.84999999999999998 112.717 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.61 109.15 18.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.261 -0.469 . . . . 0.70999999999999996 109.819 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 32' ' ' GLN . 18.9 mt -105.26 153.93 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.8 tt0 -113.57 110.1 19.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.686 -0.486 . . . . 0.85999999999999999 109.686 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 34.9 mt -111.98 150.36 30.68 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 109.45 -0.574 . . . . 1.6200000000000001 109.45 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 47.4 p30 -103.06 169.17 8.72 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.658 -0.417 . . . . 1.22 110.519 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.76 -14.67 16.34 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 113.922 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.65 -28.74 23.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.95 110.037 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.43 8.22 14.88 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.562 -0.744 . . . . 0.53000000000000003 111.443 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 90.1 m-20 -76.98 149.1 35.96 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.977 0.417 . . . . 1.3 110.744 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 42' ' ' TYR . 10.4 mt -92.87 153.68 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 58' ' ' ILE . 39.7 mt -122.67 -71.94 0.71 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.449 . . . . 1.45 110.189 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -125.71 136.36 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.399 0.619 . . . . 1.99 111.119 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -93.86 -176.0 3.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.936 -1.029 . . . . 1.25 111.005 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' CG ' ' HA2' ' A' ' 29' ' ' GLY . 7.8 p30 -125.05 -167.93 1.75 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.929 -1.032 . . . . 2.1299999999999999 109.764 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.32 -28.35 53.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.158 0.429 . . . . 1.48 112.158 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.78 75.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 1.52 111.52 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -34.81 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.623 -0.262 . . . . 2.1200000000000001 110.634 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 52' ' ' ARG . . . -61.6 -21.35 60.34 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 121.205 -0.521 . . . . 1.4199999999999999 112.828 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -71.57 -28.61 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 2.3500000000000001 110.436 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -91.68 81.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.733 0.778 . . . . 2.5899999999999999 109.734 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 50' ' ' THR . 5.8 t -11.22 105.78 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 112.716 -2.038 . . . . 3.4100000000000001 114.363 174.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.88 22.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.231 -1.349 . . . . 2.3199999999999998 112.32 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HG3' ' HE1' ' A' ' 42' ' ' TYR . 6.5 mpt_? -115.16 94.8 4.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.788 0.327 . . . . 3.1400000000000001 110.878 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 16.5 m-20 -88.35 148.06 41.56 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.173 -0.467 . . . . 2.1000000000000001 110.442 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.011 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 40.0 Cg_exo -58.06 -34.93 99.0 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.112 2.541 . . . . 1.6799999999999999 113.653 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -131.61 19.61 4.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.75 0.648 . . . . 3.6099999999999999 112.75 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.633 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.19 8.57 44.27 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.454 -0.498 . . . . 2.5 110.929 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -121.19 29.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.96999999999999997 111.863 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 40' ' ' LEU . 22.7 mt -81.35 134.28 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.635 -0.426 . . . . 1.0900000000000001 110.51 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.6 29.61 74.18 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.22 -0.752 . . . . 0.66000000000000003 111.22 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 39' ' ' ILE . 3.7 mtmm -126.6 125.51 42.07 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.161 -0.52 . . . . 1.8200000000000001 109.76 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' ASN . 10.1 t-20 -73.65 114.26 11.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.874 -0.603 . . . . 0.71999999999999997 111.219 -170.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 39' ' ' ILE . 90.6 t80 -56.47 -48.61 76.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.485 -0.78 . . . . 0.69999999999999996 111.146 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -79.94 5.25 14.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.011 -0.541 . . . . 1.1599999999999999 112.111 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -137.54 -53.16 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.028 0.381 . . . . 3.5800000000000001 112.028 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -96.42 -24.13 16.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.441 0.534 . . . . 2.2000000000000002 112.441 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.1 t -116.07 14.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 120.12 -0.632 . . . . 1.77 110.933 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.46 87.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.055 -0.52 . . . . 0.60999999999999999 110.342 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.45 -4.75 15.9 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.589 2.193 . . . . 0.81000000000000005 113.683 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -80.04 -13.62 59.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.227 -0.589 . . . . 0.84999999999999998 109.653 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -101.72 -4.23 26.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.821 -1.082 . . . . 1.3300000000000001 110.827 -157.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.07 95.63 6.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.918 -0.401 . . . . 1.8500000000000001 109.918 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.77 ' HB2' ' HD1' ' A' ' 75' ' ' PHE . 66.8 m -166.33 155.28 10.1 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.035 -0.728 . . . . 1.5600000000000001 109.035 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 31.0 Cg_endo -64.51 -20.87 66.22 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.456 2.104 . . . . 1.1699999999999999 112.04 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -91.79 -15.51 28.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 2.5600000000000001 111.5 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.77 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 87.7 m-85 -106.75 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.287 0.565 . . . . 3.3599999999999999 109.72 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 41.1 t80 -63.53 -37.4 87.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.3 -0.864 . . . . 0.79000000000000004 110.321 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -62.78 -27.37 69.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.108 -0.568 . . . . 0.59999999999999998 112.483 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 68.1 mmtt -80.35 -29.52 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.751 0.31 . . . . 2.0899999999999999 110.555 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 64.7 t80 -68.43 -35.66 77.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.848 -0.797 . . . . 0.67000000000000004 108.848 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -82.94 -3.82 57.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 111.239 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -53.68 -46.96 70.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.778 0.323 . . . . 2.0699999999999998 111.464 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.735 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -85.12 -42.84 6.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.086 -1.054 . . . . 0.71999999999999997 111.711 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 21.5 t -44.3 -49.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.667 0.787 . . . . 0.84999999999999998 112.031 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -42.42 38.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.862 0.465 . . . . 1.1399999999999999 111.953 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -77.46 -61.91 1.83 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.386 0.612 . . . . 1.8200000000000001 109.524 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.05 -54.16 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.503 -1.039 . . . . 1.6499999999999999 110.503 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 137.21 2.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.286 -0.957 . . . . 3.5 109.289 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.735 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 63.1 tp -165.89 125.18 1.65 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.868 -0.333 . . . . 2.96 111.514 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.56 131.56 44.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 2.2400000000000002 110.514 173.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 t -141.66 155.35 45.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.551 -0.75 . . . . 1.6299999999999999 109.888 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.4 ttp -130.27 119.35 22.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.83 -0.623 . . . . 1.77 110.512 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -130.72 155.01 47.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.085 -0.709 . . . . 3.0099999999999998 109.085 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 136.41 54.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.073 0.463 . . . . 2.3900000000000001 111.007 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.823 ' HD1' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -162.16 168.86 21.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.056 -0.52 . . . . 3.3700000000000001 110.418 -175.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.823 ' H ' ' HD1' ' A' ' 94' ' ' TYR . 25.6 m -102.53 143.29 32.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.3999999999999999 111.237 -173.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -107.35 112.31 25.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.745 -0.835 . . . . 1.1799999999999999 108.745 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.76 14.12 13.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.294 0.479 . . . . 2.5699999999999998 112.294 -171.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 85.4 t80 -119.34 131.61 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.622 -0.51 . . . . 3.21 109.622 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.558 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 21.6 mm-40 75.51 -43.25 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.65 0.78 . . . . 3.23 110.477 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 tpt -105.88 142.03 36.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.505 -0.924 . . . . 2.8500000000000001 108.505 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.456 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -62.96 141.04 97.61 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.868 -1.16 . . . . 2.1200000000000001 107.868 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 51.0 Cg_exo -36.5 91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.78 2.987 . . . . 1.47 114.703 -173.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 t -108.9 146.57 33.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.903 -0.589 . . . . 1.3999999999999999 109.747 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -106.51 125.02 50.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.148 0.499 . . . . 3.0800000000000001 111.182 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 29.6 m -121.17 166.19 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 1.3300000000000001 111.079 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 36.2 ttpt -118.64 121.47 40.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.312 -0.996 . . . . 1.6899999999999999 108.312 174.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.6 103.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.905 -0.589 . . . . 1.27 109.499 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -105.55 102.13 11.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.673 -0.862 . . . . 1.02 108.673 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.44 149.81 25.83 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.863 -0.335 . . . . 2.4900000000000002 110.356 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 8.8 mtpm? -146.62 147.19 30.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.203 -0.666 . . . . 1.5700000000000001 109.203 -175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 1.2 tmmt? -87.18 137.48 32.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.266 0.555 . . . . 2.1299999999999999 111.154 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -140.33 -176.12 4.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.027 -1.101 . . . . 1.5700000000000001 108.027 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.11 -93.94 0.14 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.84 -0.8 . . . . 4.4100000000000001 108.84 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.6 p 42.89 38.96 1.55 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.231 0.826 . . . . 2.5499999999999998 113.231 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.57 15.64 20.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.614 -0.803 . . . . 2.6200000000000001 113.032 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 63.94 87.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.049 0.54 . . . . 2.7599999999999998 110.507 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 p -173.74 -176.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 1.0700000000000001 110.726 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.547 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 42.0 m-85 -121.05 147.59 45.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.996 -0.742 . . . . 0.85999999999999999 108.996 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.406 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 62.6 m95 -102.59 104.2 14.56 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.575 -0.898 . . . . 0.63 108.575 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 109' ' ' MET . 7.3 p -100.52 132.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.976 -1.011 . . . . 0.91000000000000003 111.417 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.84 113.88 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.406 -0.815 . . . . 0.79000000000000004 109.847 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -113.09 104.52 17.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 1.1799999999999999 110.31 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 159.39 42.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.388 -0.597 . . . . 3.3100000000000001 109.388 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 29.9 mtm180 -69.54 105.32 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.863 0.363 . . . . 4.0300000000000002 111.107 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 106' ' ' LYS . 11.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.879 -1.055 . . . . 2.8700000000000001 111.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.664 -0.495 . . . . 3.8500000000000001 109.664 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.69 119.74 6.46 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.464 -0.874 . . . . 0.84999999999999998 111.845 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.65 103.63 13.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.119 0.485 . . . . 0.70999999999999996 110.093 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.772 ' HB ' HG13 ' A' ' 120' ' ' VAL . 31.5 mt -108.2 159.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.203 -1.036 . . . . 1.0800000000000001 108.203 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' A' ' 113' ' ' LEU . 45.3 tt0 -133.42 134.16 43.28 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.618 -0.433 . . . . 0.85999999999999999 110.317 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.93 161.89 38.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.977 -0.556 . . . . 1.6200000000000001 110.536 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.667 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.5 p30 -103.93 169.09 8.71 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.062 -0.255 . . . . 1.22 110.741 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.65 -27.54 27.54 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 115.323 0.889 . . . . 0.79000000000000004 115.323 -170.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.96 -10.39 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.818 0.809 . . . . 1.95 111.263 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.41 2.19 21.48 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.359 -0.924 . . . . 0.53000000000000003 113.611 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.667 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 91.1 m-20 -71.06 126.7 30.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.191 0.496 . . . . 1.3 110.443 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 42' ' ' TYR . 17.2 mt -84.06 150.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.446 . . . . 0.89000000000000001 109.97 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.9 mp -110.03 -54.22 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.249 0.547 . . . . 1.45 109.942 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -166.22 149.14 7.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.215 -0.902 . . . . 1.99 110.785 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.787 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 8.9 m-30 -98.4 -176.89 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.241 -0.891 . . . . 1.25 110.641 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -112.37 163.99 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.494 -0.928 . . . . 2.1299999999999999 108.494 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.62 -27.6 17.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.48 111.474 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -46.14 -54.14 9.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.152 -0.931 . . . . 1.52 112.51 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' HD11 ' A' ' 31' ' ' ILE . 16.2 mm-40 -75.25 -29.92 60.35 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.961 0.41 . . . . 2.1200000000000001 110.922 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 -22.6 68.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.849 -0.691 . . . . 1.4199999999999999 111.635 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -87.81 -35.07 18.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.607 0.241 . . . . 2.3500000000000001 110.69 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 45' ' ' ALA . 45.9 mm -53.04 -54.03 19.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.142 0.496 . . . . 2.5899999999999999 110.249 176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 51' ' ' GLY . 5.9 t -140.08 -41.38 0.43 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 3.4100000000000001 111.041 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 50' ' ' THR . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.408 -0.901 . . . . 2.3199999999999998 111.734 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -113.78 99.53 7.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.002 -0.74 . . . . 3.1400000000000001 109.002 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.664 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 18.9 t70 -54.8 127.62 61.38 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.481 0.488 . . . . 2.1000000000000001 110.728 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.787 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 41.7 Cg_exo -59.16 -17.64 39.92 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.583 2.855 . . . . 1.6799999999999999 113.855 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -94.73 -1.83 52.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.758 0.313 . . . . 3.6099999999999999 111.025 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.664 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 54.7 mm-40 -102.64 5.24 39.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.12 0.486 . . . . 2.5 110.588 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.597 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.4 m -117.27 14.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.96999999999999997 111.654 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 40.0 mt -80.26 125.73 39.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.406 -0.517 . . . . 1.0900000000000001 110.407 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.3 10.52 78.81 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.843 -0.903 . . . . 0.66000000000000003 110.843 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.889 ' HD3' ' HB ' ' A' ' 66' ' ' VAL . 23.3 ttmt -104.88 135.72 45.72 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.64 -0.504 . . . . 1.8200000000000001 109.64 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -83.49 117.74 23.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.234 -0.439 . . . . 0.71999999999999997 111.491 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 57.8 t80 -72.11 0.63 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.799 -0.637 . . . . 0.69999999999999996 111.669 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 82.0 m-85 -116.74 -9.76 11.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.081 -0.387 . . . . 1.1599999999999999 111.222 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.3 -38.47 0.76 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.73 0.641 . . . . 3.5800000000000001 112.73 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 22.8 m-20 -90.43 -87.56 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.928 0.344 . . . . 2.2000000000000002 111.928 -174.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.889 ' HB ' ' HD3' ' A' ' 60' ' ' LYS . 6.4 p -83.16 14.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.992 0.901 . . . . 1.77 111.616 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.77 86.23 0.46 Allowed Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.486 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -90.8 4.38 4.39 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.365 2.044 . . . . 0.81000000000000005 113.597 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 11.4 p -84.65 -15.62 44.79 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 120.494 -0.483 . . . . 0.84999999999999998 110.152 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 6.8 p -87.46 -39.68 15.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.215 -1.357 . . . . 1.3300000000000001 111.048 -160.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -51.89 108.54 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.966 -0.561 . . . . 1.8500000000000001 110.784 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -161.74 149.63 12.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.5600000000000001 109.902 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.13 -26.25 82.29 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.379 2.053 . . . . 1.1699999999999999 111.409 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 13.9 pt-20 -96.91 1.29 50.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.851 -0.613 . . . . 2.5600000000000001 111.912 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' HD2' ' HE1' ' A' ' 92' ' ' PHE . 67.0 t80 -127.3 -70.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 3.3599999999999999 109.597 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.604 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 64.4 t80 -61.41 -38.39 86.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 0.79000000000000004 110.002 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.66 -34.98 91.41 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.054 -0.593 . . . . 0.59999999999999998 112.674 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HD2' ' O ' ' A' ' 74' ' ' GLU . 92.7 mttt -80.46 -31.18 37.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.311 0.577 . . . . 2.0899999999999999 110.093 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.774 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 72.8 t80 -61.27 -32.22 72.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.67000000000000004 110.377 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 13.2 mmmm -95.75 -5.48 41.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 1.0900000000000001 110.879 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -59.96 -52.93 63.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 2.0699999999999998 110.738 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -72.85 -27.9 68.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.57 -0.824 . . . . 0.71999999999999997 112.245 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.34 -54.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.84999999999999998 110.794 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.6 70.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.576 . . . . 1.1399999999999999 110.566 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.0 m -74.04 -86.05 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.7 -0.682 . . . . 1.8200000000000001 110.05 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.4 -64.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.971 -0.852 . . . . 1.6499999999999999 110.971 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -92.37 132.72 36.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.801 -0.7 . . . . 3.5 110.182 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.1 tm? -110.26 105.5 14.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.943 -0.762 . . . . 2.96 108.943 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' MET . 22.7 p-10 -164.41 58.03 0.15 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.625 0.726 . . . . 2.2400000000000002 110.665 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -104.47 155.4 18.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.6299999999999999 110.499 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -128.96 124.15 34.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.611 -0.722 . . . . 1.77 110.024 177.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 50.5 p90 -144.23 168.1 20.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.507 -0.315 . . . . 3.0099999999999998 110.967 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -103.3 133.04 49.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.053 -0.521 . . . . 2.3900000000000001 110.087 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -149.44 166.48 28.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.026 -0.731 . . . . 3.3700000000000001 109.026 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -104.91 159.23 15.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.858 0.688 . . . . 1.3999999999999999 112.858 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -111.26 120.6 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.219 -0.66 . . . . 1.1799999999999999 109.219 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 21.5 t70 -133.92 -152.46 0.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.798 -0.816 . . . . 2.5699999999999998 108.798 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 40.4 t80 71.41 -68.1 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.956 0.503 . . . . 3.21 111.753 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.457 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 2.5 pp0? -112.24 -4.43 14.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.137 0.494 . . . . 3.23 110.755 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.6 tpp -126.92 143.8 51.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.723 -0.671 . . . . 2.8500000000000001 110.372 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -54.69 128.37 62.09 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.199 -1.037 . . . . 2.1200000000000001 108.199 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.1 90.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.547 2.831 . . . . 1.47 113.168 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.5 158.1 16.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.174 -0.921 . . . . 1.3999999999999999 110.701 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.957 ' HE2' ' HB ' ' A' ' 125' ' ' VAL . 18.1 ptmt -106.25 127.56 53.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 3.0800000000000001 111.387 -175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 122' ' ' VAL . 11.5 p -125.0 151.99 31.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.591 -0.731 . . . . 1.3300000000000001 110.353 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 105' ' ' VAL . 82.8 tttt -110.21 119.39 39.12 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.417 -0.957 . . . . 1.6899999999999999 108.417 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.9 p -112.34 129.74 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.453 0.644 . . . . 1.27 111.241 -171.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -112.71 104.59 12.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.005 -1.109 . . . . 1.02 108.005 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 9.7 ptp -103.41 129.31 50.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.273 -0.421 . . . . 2.4900000000000002 110.628 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 59.6 mtpt -138.72 126.16 21.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.484 0.659 . . . . 1.5700000000000001 112.651 -168.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 25.3 tttp -70.36 114.63 8.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.51 1.124 . . . . 2.1299999999999999 111.498 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -177.8 93.67 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.535 0.939 . . . . 1.5700000000000001 113.535 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.638 ' HB2' HE22 ' A' ' 32' ' ' GLN . 28.7 tp 177.68 86.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.433 0.531 . . . . 4.4100000000000001 112.433 165.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 m 41.68 38.78 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.598 1.186 . . . . 2.5499999999999998 112.292 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.77 -123.96 1.23 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.931 -1.128 . . . . 2.6200000000000001 112.012 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.02 35.29 1.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.7599999999999998 111.059 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 p -100.36 135.33 41.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.95 -0.568 . . . . 1.0700000000000001 109.744 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.606 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 2.0 m-85 -109.37 161.33 15.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.775 -0.454 . . . . 0.85999999999999999 109.775 -169.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 109' ' ' MET . 88.9 m95 -100.92 114.72 28.86 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.689 -0.856 . . . . 0.63 108.689 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.3 p -100.2 115.34 41.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.128 0.966 . . . . 0.91000000000000003 110.207 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.91 123.38 46.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.246 -0.888 . . . . 0.79000000000000004 111.146 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.79 HG13 HG21 ' A' ' 105' ' ' VAL . 66.3 t -104.7 105.62 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.122 -0.945 . . . . 1.1799999999999999 110.99 -176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -131.58 131.04 42.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.849 0.357 . . . . 3.3100000000000001 110.249 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.462 ' C ' ' HD2' ' A' ' 124' ' ' ARG . 7.4 ppt_? -72.88 157.41 37.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 4.0300000000000002 111.661 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.957 ' HB ' ' HE2' ' A' ' 104' ' ' LYS . 25.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.67 -0.681 . . . . 2.8700000000000001 109.166 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.619 0.247 . . . . 3.8500000000000001 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -103.68 132.82 11.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.59 -0.814 . . . . 0.84999999999999998 111.497 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -132.04 134.03 45.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.70999999999999996 109.635 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 120' ' ' VAL . 4.8 mp -128.01 144.43 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 109.775 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 40.4 tt0 -104.51 118.66 37.14 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.94 -1.133 . . . . 0.85999999999999999 107.94 170.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.4 pt? -130.1 150.14 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.43 -0.508 . . . . 1.6200000000000001 110.662 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -103.43 168.39 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.862 -0.421 . . . . 1.22 109.862 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.39 -29.05 22.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.381 0.512 . . . . 0.79000000000000004 114.381 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -75.2 -21.14 58.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.275 0.537 . . . . 1.95 111.324 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.14 4.44 38.43 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.898 -0.668 . . . . 0.53000000000000003 111.916 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.8 m-20 -77.23 141.18 40.15 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.978 -0.378 . . . . 1.3 109.978 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.5 mt -88.75 144.77 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.263 0.554 . . . . 0.89000000000000001 110.381 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -99.89 -59.29 1.74 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.264 -0.88 . . . . 1.45 110.227 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -165.13 153.06 11.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.757 -1.11 . . . . 1.99 110.027 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 4.7 m-30 -97.46 156.63 16.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 1.25 110.367 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.935 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 64.0 t30 -74.76 10.73 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.919 -0.582 . . . . 2.1299999999999999 111.104 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' TYR . . . 75.72 -42.34 0.46 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.896 -1.047 . . . . 1.48 112.213 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -56.87 -24.78 54.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.555 0.576 . . . . 1.52 112.555 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.75 -18.68 64.26 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.18 0.514 . . . . 2.1200000000000001 110.944 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.59 -7.6 78.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.613 -0.803 . . . . 1.4199999999999999 111.861 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.57 -46.87 5.57 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 2.3500000000000001 109.204 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 45' ' ' ALA . 30.8 mm -66.34 -67.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.419 -0.81 . . . . 2.5899999999999999 110.714 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 m -92.71 -56.97 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.479 -0.328 . . . . 3.4100000000000001 110.984 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.72 42.12 0.25 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.683 -0.77 . . . . 2.3199999999999998 112.156 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mmt180 -108.29 127.89 54.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.31 -0.256 . . . . 3.1400000000000001 110.31 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 56' ' ' GLN . 12.2 t70 -65.9 132.68 94.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 2.1000000000000001 110.306 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 7.3 Cg_exo -73.62 -12.88 24.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.986 2.457 . . . . 1.6799999999999999 114.209 -172.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -130.23 -7.45 4.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.605 0.965 . . . . 3.6099999999999999 113.605 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.576 ' HG2' ' CG ' ' A' ' 53' ' ' ASP . 77.6 mm-40 -75.23 -13.18 60.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.264 -0.575 . . . . 2.5 110.864 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.4 m -88.49 14.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.4 0.889 . . . . 0.96999999999999997 113.4 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' LEU . 38.6 mt -81.99 131.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.177 -0.609 . . . . 1.0900000000000001 110.131 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.34 26.63 72.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.011 -0.836 . . . . 0.66000000000000003 111.011 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -121.5 134.46 55.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.964 -0.618 . . . . 1.8200000000000001 110.177 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.4 114.66 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.79 0.329 . . . . 0.71999999999999997 110.297 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.73 -40.93 69.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.69999999999999996 111.389 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.604 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 72.2 m-85 -80.56 3.66 21.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.351 -0.386 . . . . 1.1599999999999999 111.534 -173.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -121.84 -51.65 2.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.48 -0.563 . . . . 3.5800000000000001 109.48 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -78.34 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 2.2000000000000002 112.155 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.0 t -96.22 16.38 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.794 0.33 . . . . 1.77 111.853 -168.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.99 77.2 0.74 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 121.989 -0.444 . . . . 0.60999999999999999 112.014 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -97.61 28.45 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.084 2.523 . . . . 0.81000000000000005 113.208 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.6 p -120.71 22.96 10.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.539 -0.541 . . . . 0.84999999999999998 109.539 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.9 m -136.58 -44.34 0.6 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.062 -1.426 . . . . 1.3300000000000001 109.41 -133.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 11.2 p-10 -68.98 119.88 13.97 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.207 -0.664 . . . . 1.8500000000000001 109.207 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -168.99 161.58 7.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.78 -0.645 . . . . 1.5600000000000001 109.743 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.96 -31.11 91.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.36 2.04 . . . . 1.1699999999999999 112.868 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.7 -4.66 54.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 2.5600000000000001 112.072 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -124.77 -70.82 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.181 -0.303 . . . . 3.3599999999999999 110.181 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 93.8 t80 -60.44 -39.44 87.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 0.79000000000000004 110.284 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.11 -40.19 98.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.979 -0.629 . . . . 0.59999999999999998 112.219 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 74.0 mmtt -73.56 -26.14 60.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 2.0899999999999999 110.32 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -67.38 -35.49 79.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 110.276 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -84.5 -14.89 47.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.994 -0.548 . . . . 1.0900000000000001 110.98 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 49.8 mm-40 -54.48 -52.28 62.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.154 0.502 . . . . 2.0699999999999998 111.016 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.525 ' H ' HD13 ' A' ' 88' ' ' LEU . . . -72.19 -33.34 62.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.71999999999999997 112.213 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' OH ' ' A' ' 118' ' ' TYR . 23.1 t -61.7 -51.61 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.84999999999999998 110.646 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.2 -21.7 66.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.843 -0.617 . . . . 1.1399999999999999 111.881 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -96.41 -77.57 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 1.8200000000000001 110.875 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.49 -77.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.5 -0.64 . . . . 1.6499999999999999 111.5 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.637 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.8 p30 -95.24 144.88 25.47 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.543 -0.54 . . . . 3.5 109.543 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 82' ' ' GLY . 54.6 tp -120.18 102.63 8.64 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.714 -0.476 . . . . 2.96 109.714 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 109' ' ' MET . 39.1 m-80 -148.65 97.41 2.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.017 -0.734 . . . . 2.2400000000000002 109.017 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -149.19 165.14 32.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.787 -0.642 . . . . 1.6299999999999999 110.496 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 ptp -132.97 129.58 38.41 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.828 -0.623 . . . . 1.77 109.972 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 45.5 p90 -146.51 165.25 30.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.023 -0.362 . . . . 3.0099999999999998 110.023 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -109.19 122.08 46.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 2.3900000000000001 110.971 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -131.83 153.84 49.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.792 -0.64 . . . . 3.3700000000000001 109.885 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 m -104.76 145.62 30.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.3999999999999999 110.458 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.43 104.63 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.995 -0.372 . . . . 1.1799999999999999 109.995 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 9.1 p-10 -135.13 115.08 13.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.473 0.654 . . . . 2.5699999999999998 110.885 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 63.2 t80 -179.91 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.94 -1.027 . . . . 3.21 109.188 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -92.32 -35.87 13.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.905 -0.776 . . . . 3.23 108.905 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.28 144.17 25.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.131 -1.063 . . . . 2.8500000000000001 108.131 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.59 160.31 53.64 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 109.664 -0.495 . . . . 2.1200000000000001 109.664 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 50.3 Cg_exo -54.74 84.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 1.47 114.418 -171.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 p -102.13 147.7 26.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.291 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -121.24 130.36 53.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.007 -0.368 . . . . 3.0800000000000001 110.007 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 124' ' ' ARG . 35.8 m -122.87 164.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.175 0.512 . . . . 1.3300000000000001 111.658 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -104.25 111.72 24.45 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.837 -1.542 . . . . 1.6899999999999999 106.837 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 91' ' ' MET . 14.6 p -104.27 136.64 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-O 121.329 0.585 . . . . 1.27 109.701 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -111.95 114.33 27.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.647 -0.872 . . . . 1.02 108.647 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.2 tpp -100.39 133.68 44.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.46 -0.791 . . . . 2.4900000000000002 109.079 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 118' ' ' TYR . 12.2 mmmm -135.67 159.63 41.02 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.819 -0.808 . . . . 1.5700000000000001 108.819 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 64.7 tttp -104.86 121.05 42.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.126 0.489 . . . . 2.1299999999999999 111.657 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.624 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -107.91 99.02 8.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.694 -0.685 . . . . 1.5700000000000001 109.938 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.66 -19.54 62.08 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.595 -0.52 . . . . 4.4100000000000001 109.595 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 m -73.34 80.81 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.543 -0.753 . . . . 2.5499999999999998 110.174 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.05 9.18 13.84 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.524 -0.846 . . . . 2.6200000000000001 112.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 55.95 41.34 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.896 0.379 . . . . 2.7599999999999998 111.662 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -134.77 -167.14 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.514 -0.312 . . . . 1.0700000000000001 110.828 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.702 ' OH ' HG22 ' A' ' 83' ' ' VAL . 82.4 m-85 -135.55 153.51 51.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.003 -0.74 . . . . 0.85999999999999999 109.003 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 47.9 m95 -102.72 104.13 14.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.958 -0.756 . . . . 0.63 108.958 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 31' ' ' ILE . 11.6 p -100.34 125.66 54.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.108 0.956 . . . . 0.91000000000000003 111.39 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.73 137.06 54.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.894 -1.048 . . . . 0.79000000000000004 108.989 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 29' ' ' GLY . 27.0 m -104.69 141.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.093 -0.643 . . . . 1.1799999999999999 111.567 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -124.23 103.54 8.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.306 -0.861 . . . . 3.3100000000000001 109.257 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 15.0 ptm180 -75.05 120.78 21.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.506 -0.315 . . . . 4.0300000000000002 110.268 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.712 1.258 . . . . 2.8700000000000001 113.417 -174.025 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 121.673 0.749 . . . . 3.8500000000000001 112.137 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.42 123.49 7.88 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 0.84999999999999998 110.023 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -116.79 103.94 10.84 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.966 -0.294 . . . . 0.70999999999999996 110.362 -170.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 53.2 mt -108.7 114.34 46.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.971 -0.559 . . . . 1.0800000000000001 109.56 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -101.45 114.34 28.26 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.624 -0.88 . . . . 0.85999999999999999 108.624 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.24 160.53 34.61 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.632 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.4 169.88 8.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 1.22 110.574 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.28 -23.69 26.86 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 114.521 0.568 . . . . 0.79000000000000004 114.521 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -37.35 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.337 0.569 . . . . 1.95 110.751 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 128.96 11.3 2.9 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.479 -0.867 . . . . 0.53000000000000003 113.285 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -71.14 127.19 31.75 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.366 0.583 . . . . 1.3 109.727 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 16.2 mt -81.52 151.36 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.309 -0.626 . . . . 0.89000000000000001 109.309 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 58' ' ' ILE . 77.7 mt -129.82 -67.46 0.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.459 0.647 . . . . 1.45 110.115 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 63.2 mt-30 -112.61 138.38 49.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.633 -0.712 . . . . 1.99 110.347 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.832 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -118.41 -4.07 10.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.703 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 66.2 t30 63.23 172.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.538 -0.756 . . . . 2.1299999999999999 110.577 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 11.2 6.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 1.48 110.882 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -92.51 -63.78 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.229 -0.442 . . . . 1.52 111.472 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.26 -43.79 83.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 110.985 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA2' ' C ' ' A' ' 51' ' ' GLY . . . -68.82 -10.06 60.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.576 -0.821 . . . . 1.4199999999999999 113.148 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.15 -41.91 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.122 0.461 . . . . 2.3500000000000001 110.559 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 45' ' ' ALA . 6.1 pt -85.92 -47.56 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 112.296 0.48 . . . . 2.5899999999999999 112.296 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.7 p -105.82 -49.33 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.976 -0.453 . . . . 3.4100000000000001 111.175 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' ' HA2' ' A' ' 47' ' ' GLY . . . 139.91 -175.25 21.95 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.222 -0.751 . . . . 2.3199999999999998 111.222 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.704 ' HG2' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 71.57 99.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 3.1400000000000001 111.407 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 3.6 m-20 -67.97 149.4 98.2 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 108.97 -0.752 . . . . 2.1000000000000001 108.97 171.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.832 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 10.3 Cg_endo -52.52 -31.78 50.43 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.788 2.325 . . . . 1.6799999999999999 111.938 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -71.35 -19.13 62.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.361 -0.836 . . . . 3.6099999999999999 111.46 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 15.3 mm-40 -94.97 -14.49 24.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 2.5 111.73 -171.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.694 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -111.23 18.93 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 113.033 0.753 . . . . 0.96999999999999997 113.033 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.732 HG22 ' HA ' ' A' ' 40' ' ' LEU . 8.3 pt -87.51 140.09 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.438 -0.505 . . . . 1.0900000000000001 110.586 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.72 10.04 71.03 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.223 -0.989 . . . . 0.66000000000000003 110.901 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 39' ' ' ILE . 87.1 mttt -114.71 135.99 53.55 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.761 -0.459 . . . . 1.8200000000000001 109.761 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 21.8 t-20 -81.62 115.78 21.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.146 -0.479 . . . . 0.71999999999999997 110.021 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 39' ' ' ILE . 48.1 t80 -50.73 -37.91 44.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.69999999999999996 111.618 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 38.2 m-85 -90.38 15.14 11.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.382 -0.372 . . . . 1.1599999999999999 111.577 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -148.66 -49.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 3.5800000000000001 111.716 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.03 -21.88 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.165 0.802 . . . . 2.2000000000000002 113.165 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 52' ' ' ARG . 5.4 p -149.58 14.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.357 -0.937 . . . . 1.77 112.82 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.25 94.52 0.43 Allowed Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.043 -0.526 . . . . 0.60999999999999999 111.703 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.02 -18.88 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.618 2.212 . . . . 0.81000000000000005 112.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -12.03 48.78 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.142 -0.223 . . . . 0.84999999999999998 111.223 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 67' ' ' ALA . 10.9 t -82.56 -27.73 31.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.697 -0.401 . . . . 1.3300000000000001 110.854 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 19.1 t70 -67.05 110.36 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.217 -0.66 . . . . 1.8500000000000001 109.217 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -164.12 148.94 8.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.178 -0.464 . . . . 1.5600000000000001 109.791 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.81 -21.59 64.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.691 2.261 . . . . 1.1699999999999999 113.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.97 -21.59 19.69 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.97 -0.292 . . . . 2.5600000000000001 111.573 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 50.2 t80 -107.46 -72.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.767 0.317 . . . . 3.3599999999999999 110.176 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.69 -38.9 79.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.132 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.04 -40.25 93.17 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.59999999999999998 112.546 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 58.1 mttm -87.91 -21.95 24.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 2.0899999999999999 111.426 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.678 ' O ' HG23 ' A' ' 83' ' ' VAL . 84.6 t80 -62.17 -49.65 74.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.62 -0.882 . . . . 0.67000000000000004 108.62 170.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.43 -20.16 60.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.825 -1.08 . . . . 1.0900000000000001 110.309 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 30.3 tt0 -57.37 -36.72 71.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 2.0699999999999998 109.693 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.97 -32.62 8.84 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.611 -0.722 . . . . 0.71999999999999997 112.187 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.1 t -59.9 -53.04 54.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.59 0.219 . . . . 0.84999999999999998 111.59 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.83 -59.37 4.59 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.423 0.452 . . . . 1.1399999999999999 111.535 -175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.2 p -167.11 29.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.306 . . . . 1.8200000000000001 111.561 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.17 -10.71 19.88 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.53 -1.319 . . . . 1.6499999999999999 113.069 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 63.77 124.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.409 -0.589 . . . . 3.5 109.409 -169.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 118' ' ' TYR . 32.9 tp -103.67 104.19 14.2 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.655 -0.818 . . . . 2.96 111.432 -166.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.3 p-10 -165.03 104.68 0.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.497 1.142 . . . . 2.2400000000000002 109.429 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -165.41 166.63 18.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.996 -1.456 . . . . 1.6299999999999999 108.514 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.5 ptt? -133.25 122.22 23.61 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.072 0.463 . . . . 1.77 110.304 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -124.3 167.48 14.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.149 -0.478 . . . . 3.0099999999999998 110.41 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -102.59 119.32 38.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.748 -0.464 . . . . 2.3900000000000001 109.748 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -133.96 153.82 51.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 3.3700000000000001 110.319 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 p -104.45 150.49 24.51 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.72 0.295 . . . . 1.3999999999999999 111.295 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -130.22 116.41 18.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.438 . . . . 1.1799999999999999 110.319 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' MET . 8.0 p-10 -124.54 -158.53 0.83 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.504 -0.771 . . . . 2.5699999999999998 109.238 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 67.1 t80 70.96 -74.64 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.685 0.394 . . . . 3.21 111.474 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.507 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 26.3 mm-40 -92.55 4.2 54.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.695 0.759 . . . . 3.23 110.357 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 tpt -150.0 152.0 34.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.659 -1.155 . . . . 2.8500000000000001 108.243 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 100' ' ' MET . 13.7 p -63.38 147.79 94.55 Favored Pre-proline 0 N--CA 1.443 -0.809 0 N-CA-C 108.069 -1.086 . . . . 2.1200000000000001 108.069 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.9 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.191 . . . . 1.47 112.649 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -99.51 149.22 23.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.931 -0.577 . . . . 1.3999999999999999 110.798 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -103.85 118.57 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.198 -0.667 . . . . 3.0800000000000001 109.198 174.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.5 m -123.05 163.73 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.592 0.711 . . . . 1.3300000000000001 111.616 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -110.79 114.88 28.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.905 -1.146 . . . . 1.6899999999999999 107.905 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.646 HG22 HG12 ' A' ' 122' ' ' VAL . 41.5 t -107.34 115.79 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.208 -0.451 . . . . 1.27 110.055 -168.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -104.27 109.03 20.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.658 -0.497 . . . . 1.02 109.658 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.691 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -103.97 134.32 47.45 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.842 -0.617 . . . . 2.4900000000000002 109.489 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -147.95 150.15 33.51 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.204 -0.295 . . . . 1.5700000000000001 110.204 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.515 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 42.9 tttm -87.01 128.72 35.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.667 0.27 . . . . 2.1299999999999999 111.037 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.34 127.65 30.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 1.5700000000000001 110.066 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.19 94.58 5.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.927 0.87 . . . . 4.4100000000000001 112.692 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t -113.47 -62.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 104.3 -2.482 . . . . 2.5499999999999998 104.3 160.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.62 143.86 17.06 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 106.626 -2.59 . . . . 2.6200000000000001 106.626 151.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.92 100.14 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.661 1.231 . . . . 2.7599999999999998 111.12 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -156.7 -177.79 6.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.875 -1.057 . . . . 1.0700000000000001 109.003 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.515 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 9.0 m-85 -128.85 154.18 46.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.715 -0.846 . . . . 0.85999999999999999 108.715 -175.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 60.8 m95 -100.74 104.13 15.4 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.237 -1.023 . . . . 0.63 108.237 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.617 HG22 ' CB ' ' A' ' 109' ' ' MET . 47.9 t -101.8 104.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.889 -1.05 . . . . 0.91000000000000003 109.585 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 81.0 m-85 -103.16 138.64 39.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.79000000000000004 110.608 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.646 HG12 HG22 ' A' ' 107' ' ' VAL . 16.6 m -107.35 153.22 8.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.944 0.402 . . . . 1.1799999999999999 111.138 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -149.77 112.38 4.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.942 -0.572 . . . . 3.3100000000000001 110.186 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.651 ' HA ' HG12 ' A' ' 105' ' ' VAL . 20.5 ttt180 -73.1 145.34 46.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 4.0300000000000002 110.808 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 125' ' ' VAL . 3.2 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.153 -0.927 . . . . 2.8700000000000001 110.824 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.746 0.784 . . . . 3.8500000000000001 112.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.22 107.39 2.94 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.925 -0.87 . . . . 0.84999999999999998 110.925 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.55 128.82 51.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.70999999999999996 110.809 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 46' ' ' GLU . 57.5 mt -122.26 138.89 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.228 -0.656 . . . . 1.0800000000000001 109.228 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.6 tt0 -104.68 121.13 42.93 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.192 -0.67 . . . . 0.85999999999999999 109.192 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -137.01 153.74 50.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 1.6200000000000001 109.891 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 169.62 8.41 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.85 -0.34 . . . . 1.22 110.655 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.63 -22.59 8.46 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 115.313 0.885 . . . . 0.79000000000000004 115.313 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.36 -21.93 38.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.756 0.778 . . . . 1.95 110.638 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.88 3.94 31.76 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.093 -0.803 . . . . 0.53000000000000003 111.093 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.654 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.1 m120 -70.24 134.84 48.43 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.054 0.454 . . . . 1.3 110.705 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.1 mt -87.24 148.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.422 -0.808 . . . . 0.89000000000000001 110.015 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 32' ' ' GLN . 42.2 mt -117.69 -61.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.271 0.557 . . . . 1.45 110.516 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.8 136.89 18.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.389 0.614 . . . . 1.99 111.248 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.024 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -92.5 153.1 19.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.899 -1.046 . . . . 1.25 110.77 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -88.04 166.22 14.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.5 60.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.137 0.421 . . . . 1.48 112.137 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.07 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.751 0.278 . . . . 1.52 111.751 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG2' HD11 ' A' ' 31' ' ' ILE . 6.3 tp10 -72.46 -4.86 32.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.575 0.702 . . . . 2.1200000000000001 110.435 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.41 -54.12 0.62 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.486 -0.779 . . . . 1.4199999999999999 112.282 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.07 -38.36 61.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.984 0.421 . . . . 2.3500000000000001 111.36 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -81.78 -57.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 2.5899999999999999 109.823 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.4 m -57.42 -52.35 65.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.22 -0.9 . . . . 3.4100000000000001 112.032 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.73 42.77 0.92 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.625 -0.798 . . . . 2.3199999999999998 111.814 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -133.46 171.74 13.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.684 -0.488 . . . . 3.1400000000000001 109.684 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.804 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 16.1 t70 -105.76 130.93 22.24 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.701 -0.481 . . . . 2.1000000000000001 109.701 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.024 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 50.3 Cg_exo -55.02 -20.25 22.72 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.488 2.792 . . . . 1.6799999999999999 114.186 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -119.32 15.13 13.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.195 0.443 . . . . 3.6099999999999999 112.195 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.804 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 23.1 mm-40 -86.23 -13.23 47.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 2.5 110.161 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 57' ' ' VAL . 4.6 m -89.91 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.606 -0.724 . . . . 0.96999999999999997 112.179 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.2 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.641 -0.423 . . . . 1.0900000000000001 110.721 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 18.92 76.95 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.254 -0.738 . . . . 0.66000000000000003 111.254 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -124.25 151.79 43.75 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.623 0.249 . . . . 1.8200000000000001 111.084 -170.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -105.71 122.04 45.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.71999999999999997 109.416 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.7 t80 -54.09 -43.75 70.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.005 -0.543 . . . . 0.69999999999999996 111.733 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 70.9 m-85 -77.5 -5.41 49.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 1.1599999999999999 111.719 -172.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -128.37 -48.05 1.31 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.13 0.419 . . . . 3.5800000000000001 112.13 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -92.88 -22.54 19.2 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.483 0.549 . . . . 2.2000000000000002 112.483 -172.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.14 13.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.171 -0.612 . . . . 1.77 111.477 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.81 74.58 0.17 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.748 0.309 . . . . 0.60999999999999999 111.023 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.2 -4.1 11.05 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.766 2.311 . . . . 0.81000000000000005 113.64 -176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 p -113.1 18.24 18.15 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.096 -0.377 . . . . 0.84999999999999998 110.641 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p -97.17 -37.64 10.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 1.3300000000000001 111.125 164.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 59.1 t0 -59.96 102.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.207 0.527 . . . . 1.8500000000000001 110.486 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.2 p -163.55 154.86 14.37 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.618 -0.719 . . . . 1.5600000000000001 109.489 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.61 -21.41 71.97 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.6 2.2 . . . . 1.1699999999999999 113.001 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.62 -17.08 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.902 0.334 . . . . 2.5600000000000001 111.902 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.862 ' HE2' HG11 ' A' ' 107' ' ' VAL . 23.2 t80 -117.23 -68.92 0.88 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.825 -0.35 . . . . 3.3599999999999999 110.689 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.46 -35.22 79.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.79000000000000004 109.95 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.42 93.69 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.069 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 69.6 mmtt -71.4 -38.62 71.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.029 0.442 . . . . 2.0899999999999999 110.406 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.76 -37.06 80.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.797 -0.638 . . . . 0.67000000000000004 110.298 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.73 -20.98 32.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 1.0900000000000001 110.622 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -68.88 -35.83 77.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 2.0699999999999998 109.681 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.985 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -68.92 -36.67 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.538 -0.756 . . . . 0.71999999999999997 111.583 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.13 -51.76 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.212 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.44 69.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.623 . . . . 1.1399999999999999 111.162 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -65.95 -71.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.513 0.673 . . . . 1.8200000000000001 110.095 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.26 -62.59 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 108.884 -1.687 . . . . 1.6499999999999999 108.884 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.433 HD22 ' HA ' ' A' ' 87' ' ' ASN . 2.3 m120 -161.33 167.03 26.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.902 0.881 . . . . 3.5 108.674 167.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.985 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -125.59 152.79 44.64 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.8 -0.76 . . . . 2.96 111.299 -168.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.757 ' HA ' ' O ' ' A' ' 109' ' ' MET . 35.7 p30 -163.8 47.0 0.12 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.336 -1.302 . . . . 2.2400000000000002 109.162 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 p -102.36 165.21 11.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.843 -1.526 . . . . 1.6299999999999999 111.134 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -116.78 125.32 51.45 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.218 -0.901 . . . . 1.77 109.911 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.33 157.66 27.68 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.757 -0.461 . . . . 3.0099999999999998 109.757 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.25 111.11 23.59 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.595 -0.52 . . . . 2.3900000000000001 109.595 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -135.87 144.07 45.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.885 -0.598 . . . . 3.3700000000000001 109.408 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 104' ' ' LYS . 6.0 p -105.06 155.52 18.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.013 0.435 . . . . 1.3999999999999999 111.55 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -116.19 104.73 11.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.919 -0.582 . . . . 1.1799999999999999 109.614 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 31.8 t70 -140.77 98.84 3.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.748 -0.66 . . . . 2.5699999999999998 110.198 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.61 ' HD1' ' HG2' ' A' ' 99' ' ' GLN . 65.2 t80 174.24 -71.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.675 0.61 . . . . 3.21 110.03 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG2' ' HD1' ' A' ' 98' ' ' TYR . 25.0 mm-40 -101.9 4.34 40.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.987 0.899 . . . . 3.23 109.319 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.5 tpp -137.99 139.4 39.64 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.114 -1.403 . . . . 2.8500000000000001 107.962 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.09 144.43 94.28 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 108.972 -0.751 . . . . 2.1200000000000001 108.972 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.4 90.9 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.349 2.699 . . . . 1.47 114.14 -167.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -89.85 143.73 26.54 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 110.683 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -110.91 107.87 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.395 -0.965 . . . . 3.0800000000000001 108.395 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.6 m -129.64 163.17 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.789 0.804 . . . . 1.3300000000000001 112.365 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.66 123.02 47.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.408 -1.269 . . . . 1.6899999999999999 107.856 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.862 HG11 ' HE2' ' A' ' 75' ' ' PHE . 4.9 p -104.19 113.17 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.054 0.93 . . . . 1.27 109.759 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.492 ' CE1' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t-160 -104.9 104.24 13.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.976 -1.011 . . . . 1.02 108.813 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.757 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.3 pmm? -102.98 127.76 50.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.349 -0.612 . . . . 2.4900000000000002 109.349 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.564 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 42.4 mtmt -137.79 164.6 28.51 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 110.228 -0.286 . . . . 1.5700000000000001 110.228 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 3.9 tmtp? -94.92 149.98 20.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 2.1299999999999999 110.897 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -137.37 114.56 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.313 -0.858 . . . . 1.5700000000000001 109.333 173.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -87.72 32.71 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.5 0.667 . . . . 4.4100000000000001 110.703 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 p -79.73 -58.34 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.492 -0.777 . . . . 2.5499999999999998 109.935 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.44 20.98 5.48 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.409 -0.814 . . . . 2.6200000000000001 111.136 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.21 77.25 0.33 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.57 0.7 . . . . 2.7599999999999998 111.393 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.487 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 1.3 m -159.49 -171.22 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 1.0700000000000001 107.51 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 78.6 m-85 -123.74 147.8 47.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 118.154 0.434 . . . . 0.85999999999999999 109.847 -174.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.593 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 70.9 m95 -103.93 108.54 19.92 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.241 -1.022 . . . . 0.63 108.241 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.21 135.96 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.574 0.702 . . . . 0.91000000000000003 110.437 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.564 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 98.6 m-85 -120.19 137.24 54.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.354 -0.839 . . . . 0.79000000000000004 110.715 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.6 t -104.01 102.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.304 -0.862 . . . . 1.1799999999999999 109.107 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -105.81 123.86 48.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.154 -0.476 . . . . 3.3100000000000001 109.883 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -66.14 137.37 56.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.726 0.298 . . . . 4.0300000000000002 110.818 -177.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 105' ' ' VAL . 3.3 p . . . . . 0 C--O 1.248 1.018 0 CA-C-N 116.35 -0.386 . . . . 2.8700000000000001 110.663 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 30' ' ' ALA . 35.0 p90 . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.354 -0.61 . . . . 3.8500000000000001 109.354 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -104.07 115.26 5.0 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.732 -0.746 . . . . 0.84999999999999998 111.845 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -119.87 113.5 20.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 0.70999999999999996 110.527 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.48 ' HB ' HG13 ' A' ' 120' ' ' VAL . 24.8 mt -120.2 146.42 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.416 -0.587 . . . . 1.0800000000000001 109.416 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.3 tt0 -115.74 136.34 53.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.255 -1.016 . . . . 0.85999999999999999 108.255 172.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.0 pt? -147.95 159.32 44.0 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.729 -0.388 . . . . 1.6200000000000001 110.999 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.624 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.8 p30 -102.85 167.79 9.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.308 -0.405 . . . . 1.22 110.201 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.2 -17.22 44.83 Favored Glycine 0 CA--C 1.517 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.79000000000000004 113.855 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.92 -21.18 22.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.01 0.405 . . . . 1.95 111.139 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 117.09 3.49 17.51 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.418 -0.896 . . . . 0.53000000000000003 113.558 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 46.1 m-80 -71.11 128.93 37.58 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.453 0.627 . . . . 1.3 109.384 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.0 mt -83.5 144.08 10.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.047 -0.524 . . . . 0.89000000000000001 110.16 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -96.93 -75.47 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.45 110.066 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.528 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 16.9 pm0 -153.45 145.01 23.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 1.99 110.378 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.658 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.6 m-85 -90.68 156.91 17.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.142 -0.936 . . . . 1.25 109.313 170.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 58.7 t30 -70.6 156.47 39.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.85 -0.796 . . . . 2.1299999999999999 108.85 171.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.21 69.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 1.48 110.707 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.84 -52.67 23.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.987 -0.551 . . . . 1.52 111.28 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.685 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 20.6 tp10 -61.41 -44.98 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 2.1200000000000001 111.286 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.06 -34.82 58.14 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.33 -0.938 . . . . 1.4199999999999999 113.009 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.25 -45.85 68.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 2.3500000000000001 111.01 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -74.32 -55.72 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.144 -0.48 . . . . 2.5899999999999999 111.307 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 m -64.26 -50.91 66.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.537 -0.302 . . . . 3.4100000000000001 111.781 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.79 44.51 0.41 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.342 -0.932 . . . . 2.3199999999999998 112.152 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 52' ' ' ARG . 57.5 mmt-85 -136.3 93.69 2.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.057 -0.72 . . . . 3.1400000000000001 109.057 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.91 142.11 79.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.759 0.652 . . . . 2.1000000000000001 112.759 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.44 114.23 1.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.135 2.557 . . . . 1.6799999999999999 112.26 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 77.38 11.63 2.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.835 -1.075 . . . . 3.6099999999999999 112.105 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -91.82 4.73 52.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.673 0.749 . . . . 2.5 109.056 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.71 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -110.23 14.84 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.764 -1.107 . . . . 0.96999999999999997 111.935 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 56.3 mt -80.43 128.22 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.451 -0.574 . . . . 1.0900000000000001 109.451 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 -8.39 65.66 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.123 -1.037 . . . . 0.66000000000000003 110.833 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 21.0 mttp -86.04 131.21 34.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.847 -0.797 . . . . 1.8200000000000001 108.847 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.1 t-20 -88.17 112.94 23.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.122 -0.631 . . . . 0.71999999999999997 109.866 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' A' ' 70' ' ' THR . 45.8 t80 -47.87 -64.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.361 -0.836 . . . . 0.69999999999999996 111.787 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -87.96 28.09 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.192 0.442 . . . . 1.1599999999999999 112.192 -169.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 38.9 ttpt -143.18 -42.43 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 3.5800000000000001 111.026 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' OD2' HG13 ' A' ' 66' ' ' VAL . 38.9 t70 -95.15 -77.02 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 2.2000000000000002 110.884 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.413 HG13 ' OD2' ' A' ' 65' ' ' ASP . 5.6 m -91.96 16.29 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.558 0.947 . . . . 1.77 113.558 -172.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -165.25 86.23 1.03 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.994 0.426 . . . . 0.60999999999999999 111.153 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 98' ' ' TYR . 79.4 Cg_endo -91.07 -4.84 4.34 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.683 2.255 . . . . 0.81000000000000005 114.257 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.769 ' HB3' ' HA ' ' A' ' 98' ' ' TYR . 11.8 p -73.67 -13.83 61.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 109.814 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.582 HG23 ' HE1' ' A' ' 96' ' ' PHE . 11.1 m -91.49 -37.47 13.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.351 -1.295 . . . . 1.3300000000000001 110.607 -145.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.36 109.96 5.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.768 0.794 . . . . 1.8500000000000001 110.179 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.4 m -162.67 154.16 15.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.399 -0.819 . . . . 1.5600000000000001 109.314 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.17 -35.59 91.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.688 2.259 . . . . 1.1699999999999999 112.908 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.48 -16.15 60.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.248 0.462 . . . . 2.5600000000000001 112.248 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' HE2' HG11 ' A' ' 107' ' ' VAL . 61.5 t80 -124.5 -74.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 3.3599999999999999 110.485 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.46 -37.55 78.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 0.79000000000000004 110.966 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.29 -44.69 96.33 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.894 -0.67 . . . . 0.59999999999999998 112.106 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 71.9 mmtt -74.02 -32.29 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 2.0899999999999999 111.024 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.471 ' O ' HD11 ' A' ' 88' ' ' LEU . 89.3 t80 -60.14 -43.41 95.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.315 0.579 . . . . 0.67000000000000004 110.278 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.4 -19.6 45.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.86 -0.609 . . . . 1.0900000000000001 110.338 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.27 -37.68 83.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 2.0699999999999998 109.897 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.632 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.31 -44.83 41.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.799 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 79' ' ' PHE . 32.1 t -56.76 -50.47 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.84999999999999998 110.945 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -12.22 60.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 1.1399999999999999 112.229 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -101.26 -77.13 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.712 0.292 . . . . 1.8200000000000001 110.596 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.3 -62.23 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.738 -0.744 . . . . 1.6499999999999999 112.231 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -118.26 136.28 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.777 0.322 . . . . 3.5 110.552 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -104.74 123.17 47.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.179 -0.464 . . . . 2.96 110.261 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 36.9 t-20 -176.11 116.53 0.13 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.491 0.662 . . . . 2.2400000000000002 110.363 173.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 13.9 t -166.0 165.15 18.16 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.718 -1.128 . . . . 1.6299999999999999 109.031 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.61 ' HB3' ' HD2' ' A' ' 108' ' ' HIS . 22.6 ptm -140.0 108.64 5.91 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.335 0.588 . . . . 1.77 110.687 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -121.93 166.61 14.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.767 -0.651 . . . . 3.0099999999999998 110.548 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.59 121.55 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.495 -0.557 . . . . 2.3900000000000001 109.495 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -134.07 165.13 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.631 -0.713 . . . . 3.3700000000000001 109.458 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -104.42 147.17 27.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.734 -0.469 . . . . 1.3999999999999999 109.734 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HE1' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -139.45 103.33 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.198 -0.601 . . . . 1.1799999999999999 112.448 -169.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 7.3 t70 170.52 144.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 2.5699999999999998 108.958 167.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.769 ' HA ' ' HB3' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -72.02 -42.67 66.09 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.605 -0.725 . . . . 3.21 111.578 -176.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.466 HE21 ' HD2' ' A' ' 98' ' ' TYR . 48.6 mt-30 -137.02 -5.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.037 0.754 . . . . 3.23 113.037 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.92 160.51 29.13 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.17 -0.678 . . . . 2.8500000000000001 109.17 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.87 100.92 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 108.504 -0.924 . . . . 2.1200000000000001 108.504 167.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -39.55 99.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.425 3.417 . . . . 1.47 113.996 -161.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.5 m -56.42 153.39 9.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.359 -0.837 . . . . 1.3999999999999999 110.273 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.98 136.53 42.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.226 0.536 . . . . 3.0800000000000001 110.946 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 122' ' ' VAL . 10.6 p -144.4 156.2 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.381 -0.827 . . . . 1.3300000000000001 110.294 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.429 ' HE3' HG11 ' A' ' 125' ' ' VAL . 29.0 ttmt -109.38 128.77 55.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.098 -1.075 . . . . 1.6899999999999999 108.098 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 122' ' ' VAL . 50.3 t -119.56 114.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 109.221 -0.659 . . . . 1.27 109.221 -166.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 91' ' ' MET . 56.5 t-80 -104.78 122.78 46.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.899 -0.591 . . . . 1.02 109.969 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.4 mpt? -100.29 147.47 25.73 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.497 -0.927 . . . . 2.4900000000000002 108.497 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.612 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.8 ptmt -162.67 143.82 10.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.464 -0.569 . . . . 1.5700000000000001 109.464 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 84.4 tttt -94.0 122.51 36.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.451 . . . . 2.1299999999999999 111.111 -170.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.478 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -104.62 174.78 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.743 -0.662 . . . . 1.5700000000000001 109.335 175.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.4 tp -121.56 -28.7 4.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.812 0.339 . . . . 4.4100000000000001 110.129 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -71.34 100.24 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.424 -0.584 . . . . 2.5499999999999998 109.424 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.64 -6.01 33.22 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.301 -0.952 . . . . 2.6200000000000001 112.151 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 51.87 51.62 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.27 0.557 . . . . 2.7599999999999998 110.099 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.4 p -152.59 178.98 9.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.857 -0.611 . . . . 1.0700000000000001 110.568 -172.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 2.5 m-85 -117.22 155.68 29.01 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.569 -0.9 . . . . 0.85999999999999999 108.569 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.478 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 78.2 m95 -102.27 111.55 23.88 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.09 -0.707 . . . . 0.63 109.09 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.48 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.7 p -101.63 116.81 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.165 0.983 . . . . 0.91000000000000003 110.396 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.612 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 32.5 m-85 -109.36 125.15 52.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.795 . . . . 0.79000000000000004 110.529 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 107' ' ' VAL . 15.3 m -109.46 140.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.127 0.489 . . . . 1.1799999999999999 110.88 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -139.2 133.19 31.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 3.3100000000000001 110.088 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -72.05 123.05 21.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.892 -0.41 . . . . 4.0300000000000002 109.892 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 ' HE3' ' A' ' 106' ' ' LYS . 2.5 m . . . . . 0 C--O 1.247 0.948 0 CA-C-N 116.327 -0.397 . . . . 2.8700000000000001 110.599 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.768 0.318 . . . . 3.8500000000000001 110.683 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 43' ' ' ASN . . . -104.23 147.16 16.44 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.416 -0.897 . . . . 0.84999999999999998 113.424 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.15 111.43 14.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.092 -0.707 . . . . 0.70999999999999996 109.092 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 120' ' ' VAL . 6.9 mm -103.53 160.37 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' HG22 ' A' ' 31' ' ' ILE . 63.5 tt0 -133.42 113.67 12.8 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.175 -0.328 . . . . 0.85999999999999999 110.156 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.553 ' HG ' HG11 ' A' ' 120' ' ' VAL . 22.0 mt -112.63 151.98 29.5 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.351 -0.611 . . . . 1.6200000000000001 109.351 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.52 168.99 8.72 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.876 -0.329 . . . . 1.22 110.249 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.92 -27.48 37.14 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.569 0.543 . . . . 0.79000000000000004 114.326 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -44.03 20.09 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.508 0.654 . . . . 1.95 111.097 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.49 20.76 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.361 -0.924 . . . . 0.53000000000000003 112.902 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -84.52 142.64 29.88 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.484 -0.562 . . . . 1.3 109.484 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 6.0 mt -90.91 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.982 -0.747 . . . . 0.89000000000000001 108.982 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 58' ' ' ILE . 9.1 mp -118.19 -86.43 0.64 Allowed 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.134 0.492 . . . . 1.45 111.02 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -119.6 168.29 11.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.687 0.756 . . . . 1.99 111.655 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.767 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 3.3 m-85 -132.94 -167.75 1.96 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.011 -1.449 . . . . 1.25 109.337 -174.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 63.4 t30 -128.13 160.74 31.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.749 -0.834 . . . . 2.1299999999999999 108.749 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.55 19.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.508 0.559 . . . . 1.48 112.508 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.64 -42.9 8.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.083 0.468 . . . . 1.52 110.149 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 42' ' ' TYR . 16.4 mm-40 -77.5 -17.27 58.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.555 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -82.89 -26.18 46.4 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.449 -0.882 . . . . 1.4199999999999999 111.663 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -45.11 16.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 2.3500000000000001 110.609 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -83.16 -62.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 2.5899999999999999 111.21 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -75.76 -53.28 8.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.053 0.454 . . . . 3.4100000000000001 111.382 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.21 36.59 1.32 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 2.3199999999999998 111.226 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.467 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 16.9 tpp85 -123.27 110.14 14.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.56 0.219 . . . . 3.1400000000000001 110.525 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 28.6 m-20 -77.74 154.6 80.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.542 -0.299 . . . . 2.1000000000000001 110.508 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 36.9 Cg_endo -67.47 -9.79 26.53 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.838 2.358 . . . . 1.6799999999999999 111.312 172.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.27 5.86 44.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.269 -0.878 . . . . 3.6099999999999999 111.185 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 83.4 mm-40 -97.82 -60.52 1.55 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 2.5 111.75 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.852 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 2.9 m -88.27 40.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.486 0.921 . . . . 0.96999999999999997 113.486 -169.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 40' ' ' LEU . 30.8 mt -91.23 120.34 40.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.466 -0.494 . . . . 1.0900000000000001 109.886 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.52 33.03 58.96 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.526 -1.03 . . . . 0.66000000000000003 110.526 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.852 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 35.6 mttm -121.7 135.56 54.95 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.673 -0.763 . . . . 1.8200000000000001 110.009 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -80.78 112.93 18.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.803 0.335 . . . . 0.71999999999999997 110.331 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 39' ' ' ILE . 71.6 t80 -57.55 -40.7 79.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.69999999999999996 111.385 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.496 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 55.5 m-85 -91.05 25.63 2.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.332 -0.394 . . . . 1.1599999999999999 111.712 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.79 -46.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.688 -0.405 . . . . 3.5800000000000001 111.113 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.28 -78.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 2.2000000000000002 111.703 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.18 36.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.982 1.373 . . . . 1.77 111.544 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -163.9 81.28 1.43 Allowed Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 113.995 -1.457 . . . . 0.60999999999999999 111.071 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -97.72 8.81 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.906 2.404 . . . . 0.81000000000000005 114.066 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 97' ' ' ASP . 1.7 p -77.69 -17.97 57.12 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.949 -0.7 . . . . 0.84999999999999998 110.25 170.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.1 t -96.45 -26.3 15.36 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.3300000000000001 110.964 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 63' ' ' PHE . 5.7 m-20 -65.76 131.7 46.96 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.842 -0.343 . . . . 1.8500000000000001 111.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.8 p 179.81 155.05 0.68 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 109.515 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.9 -19.2 63.97 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.353 2.035 . . . . 1.1699999999999999 112.326 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 8.0 pt-20 -92.39 -24.9 18.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 2.5600000000000001 111.718 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 87.0 t80 -104.34 -72.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.646 -0.422 . . . . 3.3599999999999999 110.075 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -38.26 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.79000000000000004 110.238 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.28 -34.79 90.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.86 -0.609 . . . . 0.59999999999999998 112.498 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.25 -35.13 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.817 0.309 . . . . 2.0899999999999999 110.464 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.591 ' O ' HG23 ' A' ' 83' ' ' VAL . 59.3 t80 -57.72 -45.82 85.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.219 -0.66 . . . . 0.67000000000000004 109.219 172.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -77.75 -17.71 57.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.671 . . . . 1.0900000000000001 111.241 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -61.24 -36.22 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.109 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.661 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -84.03 -51.36 4.01 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.161 -1.019 . . . . 0.71999999999999997 111.48 172.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.598 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 48.4 t -45.82 -62.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.151 0.58 . . . . 0.84999999999999998 112.559 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.82 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 1.1399999999999999 111.411 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -70.07 0.36 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.499 . . . . 1.8200000000000001 110.537 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.99 27.5 0.18 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.223 -0.751 . . . . 1.6499999999999999 111.223 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 111' ' ' LYS . 5.3 m120 67.02 107.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.559 0.744 . . . . 3.5 109.659 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.661 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 45.7 tp -149.65 148.93 29.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.63 -0.428 . . . . 2.96 111.541 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -88.63 144.44 26.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.046 -0.979 . . . . 2.2400000000000002 111.688 178.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -150.1 153.37 36.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.454 -0.793 . . . . 1.6299999999999999 109.874 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.8 ptm -126.35 125.39 42.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.547 -0.751 . . . . 1.77 109.734 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 32.5 p90 -144.11 165.54 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.866 0.365 . . . . 3.0099999999999998 111.01 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.72 124.52 49.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.898 -0.592 . . . . 2.3900000000000001 109.592 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -136.38 161.61 35.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 3.3700000000000001 110.534 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 89.1 m -106.55 136.7 45.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 110.212 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -125.34 104.73 8.63 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.222 -0.658 . . . . 1.1799999999999999 109.222 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 69' ' ' CYS . 5.0 p-10 -86.17 -63.35 1.33 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.145 -0.622 . . . . 2.5699999999999998 109.785 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.0 t80 47.19 55.09 8.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.761 -0.829 . . . . 3.21 108.761 -171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.22 -28.43 0.14 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.14 -0.937 . . . . 3.23 111.033 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 33.6 ttp -67.7 163.35 21.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.234 -0.439 . . . . 2.8500000000000001 110.222 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 14.8 t -55.46 146.67 42.32 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 108.383 -0.969 . . . . 2.1200000000000001 108.383 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 22.5 Cg_endo -61.87 72.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.385 2.057 . . . . 1.47 113.289 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.48 HG23 HG23 ' A' ' 101' ' ' THR . 7.6 p -73.9 146.89 43.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.265 -0.425 . . . . 1.3999999999999999 110.846 172.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -104.63 146.81 28.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 3.0800000000000001 111.178 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 106' ' ' LYS . 7.7 p -142.65 158.78 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.547 -0.752 . . . . 1.3300000000000001 109.362 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 105' ' ' VAL . 38.1 ttmt -112.68 131.36 55.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.23 -1.026 . . . . 1.6899999999999999 108.23 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.79 139.31 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.451 0.643 . . . . 1.27 110.843 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -121.59 104.22 9.48 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.594 -0.891 . . . . 1.02 108.594 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 5.1 ppp? -102.75 143.55 32.24 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 2.4900000000000002 109.689 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 51.2 mtpt -149.65 146.42 27.26 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 109.708 -0.479 . . . . 1.5700000000000001 109.708 -174.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HD2' ' CB ' ' A' ' 87' ' ' ASN . 41.8 tttm -75.21 146.35 41.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.335 -0.617 . . . . 2.1299999999999999 109.335 173.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -134.92 -159.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 1.5700000000000001 110.088 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.28 -166.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.15 -0.685 . . . . 4.4100000000000001 109.15 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.5 m 67.28 65.48 0.42 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.129 -0.693 . . . . 2.5499999999999998 109.129 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.32 51.58 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.333 -0.707 . . . . 2.6200000000000001 111.333 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.33 80.09 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.559 0.744 . . . . 2.7599999999999998 112.684 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.82 176.06 9.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.837 -1.172 . . . . 1.0700000000000001 107.837 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 80.3 m-85 -104.71 147.48 27.63 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.08 0.466 . . . . 0.85999999999999999 110.121 -173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 51.3 m95 -102.99 103.1 13.18 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.493 -0.776 . . . . 0.63 109.099 175.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -103.27 104.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.601 -1.181 . . . . 0.91000000000000003 110.823 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 119' ' ' TRP . 11.6 m-85 -102.68 137.97 40.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.79000000000000004 110.225 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -112.99 154.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.969 0.414 . . . . 1.1799999999999999 111.894 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -165.24 153.09 11.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 3.3100000000000001 109.436 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -73.26 98.66 2.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.916 -0.314 . . . . 4.0300000000000002 111.791 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.401 1.063 . . . . 2.8700000000000001 112.167 172.252 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 p90 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.158 -0.312 . . . . 3.8500000000000001 110.158 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.82 119.49 6.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.508 -0.854 . . . . 0.84999999999999998 112.709 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -104.8 126.18 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 0.70999999999999996 109.341 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.484 ' HB ' HG13 ' A' ' 120' ' ' VAL . 51.6 mt -128.39 149.13 32.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 1.0800000000000001 109.775 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.0 tt0 -112.01 134.65 53.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.987 -0.746 . . . . 0.85999999999999999 108.987 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD21 ' SD ' ' A' ' 109' ' ' MET . 2.6 pt? -139.67 153.41 47.28 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.136 -0.32 . . . . 1.6200000000000001 110.136 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.691 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.1 p30 -103.86 168.27 9.24 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.682 -0.407 . . . . 1.22 110.576 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -57.38 -14.47 13.14 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 115.136 0.815 . . . . 0.79000000000000004 115.136 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.08 -18.08 26.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.917 0.858 . . . . 1.95 110.391 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.28 26.42 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.682 -0.77 . . . . 0.53000000000000003 112.012 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.691 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 92.1 m-20 -71.58 138.17 48.58 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.73 0.3 . . . . 1.3 110.807 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 62' ' ' PHE . 14.0 mt -87.86 144.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.002 -0.545 . . . . 0.89000000000000001 109.685 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -101.93 -63.74 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.5 0.667 . . . . 1.45 110.231 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.08 169.5 23.22 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.005 -0.998 . . . . 1.99 110.572 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 52' ' ' ARG . 5.4 m-30 -113.91 175.94 5.25 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.113 -0.948 . . . . 1.25 109.364 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' ALA . 63.9 t30 -89.3 5.26 45.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.586 0.708 . . . . 2.1299999999999999 110.091 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 71.47 -15.54 0.42 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.351 -1.295 . . . . 1.48 110.875 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -60.5 -32.5 71.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.585 -0.734 . . . . 1.52 111.84 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.093 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 8.2 tp10 -78.77 -14.66 59.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.482 0.658 . . . . 2.1200000000000001 110.016 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.95 73.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.859 -0.686 . . . . 1.4199999999999999 111.464 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.63 -52.16 48.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 2.3500000000000001 110.836 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 HG22 ' A' ' 50' ' ' THR . 24.7 mt -83.82 -72.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 2.5899999999999999 111.799 -170.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 49' ' ' ILE . 11.9 t -173.73 43.24 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.049 0.928 . . . . 3.4100000000000001 111.054 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 1.093 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -109.05 -119.94 4.3 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.268 -0.967 . . . . 2.3199999999999998 113.673 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 24.9 mmt180 -139.21 153.46 47.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 3.1400000000000001 111.539 -171.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.694 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 12.0 m-20 -81.91 155.98 70.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.495 -0.928 . . . . 2.1000000000000001 108.495 163.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -29.94 85.57 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.112 1.874 . . . . 1.6799999999999999 111.896 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -72.73 -22.66 60.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 3.6099999999999999 111.598 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.694 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 67.4 mt-30 -81.95 -21.89 36.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.92 0.341 . . . . 2.5 111.92 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -121.54 62.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.687 0.625 . . . . 0.96999999999999997 112.687 -172.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -119.26 132.49 68.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.297 -0.561 . . . . 1.0900000000000001 111.058 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.2 -2.68 50.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.485 -0.864 . . . . 0.66000000000000003 111.549 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 47.6 mttp -88.36 146.0 25.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.407 . . . . 1.8200000000000001 110.609 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -94.25 107.24 19.2 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.785 -0.45 . . . . 0.71999999999999997 109.785 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 82.2 t80 -51.39 -36.03 41.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.69999999999999996 111.416 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.8 m-85 -86.16 16.06 4.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.761 0.282 . . . . 1.1599999999999999 111.761 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -147.16 -45.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.423 0.527 . . . . 3.5800000000000001 112.423 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.55 -78.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.137 0.421 . . . . 2.2000000000000002 112.137 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.1 p -108.6 14.53 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.007 0.908 . . . . 1.77 111.367 -170.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -158.07 71.82 4.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.607 -0.724 . . . . 0.60999999999999999 112.267 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.78 15.52 1.62 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.761 2.307 . . . . 0.81000000000000005 112.805 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.04 -23.79 59.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.18 -0.674 . . . . 0.84999999999999998 109.18 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 20.7 p -94.44 -32.04 13.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.587 -1.188 . . . . 1.3300000000000001 110.52 -136.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.715 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 12.6 p-10 -77.36 82.29 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.251 1.024 . . . . 1.8500000000000001 110.361 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -145.35 157.68 52.37 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.886 -1.052 . . . . 1.5600000000000001 109.534 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.87 -37.74 77.71 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.043 2.495 . . . . 1.1699999999999999 113.742 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.66 14.36 25.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.428 0.529 . . . . 2.5600000000000001 112.428 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.425 ' CD2' ' HE1' ' A' ' 92' ' ' PHE . 46.6 t80 -134.94 -73.99 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.246 -0.65 . . . . 3.3599999999999999 109.246 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 66.7 t80 -63.51 -36.4 83.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.889 -0.596 . . . . 0.79000000000000004 110.121 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -29.45 75.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.068 -0.586 . . . . 0.59999999999999998 112.366 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 68.7 mttm -87.28 -25.87 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.943 0.401 . . . . 2.0899999999999999 110.225 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 83' ' ' VAL . 79.6 t80 -62.56 -46.03 90.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.517 0.675 . . . . 0.67000000000000004 109.501 169.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 30.0 mmmt -77.89 -16.74 58.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.3 -0.864 . . . . 1.0900000000000001 110.481 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 40.9 tt0 -59.06 -39.97 83.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.674 . . . . 2.0699999999999998 110.501 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -84.55 -45.85 5.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.519 -0.848 . . . . 0.71999999999999997 112.107 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 79' ' ' PHE . 43.1 t -53.87 -52.94 30.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.662 0.385 . . . . 0.84999999999999998 111.489 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.02 60.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.175 0.435 . . . . 1.1399999999999999 112.175 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -98.02 -74.58 0.57 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.795 0.331 . . . . 1.8200000000000001 110.81 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.03 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.001 -0.619 . . . . 1.6499999999999999 111.561 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -109.82 156.74 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.475 -0.565 . . . . 3.5 109.475 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 45.6 tp -131.02 102.98 6.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 2.96 110.719 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 109' ' ' MET . 87.9 m-20 -143.76 97.98 3.16 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.783 -0.821 . . . . 2.2400000000000002 108.783 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -131.16 155.72 46.53 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.113 -0.494 . . . . 1.6299999999999999 111.797 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.4 ptt? -140.12 105.77 5.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 1.77 109.831 171.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HE1' ' CD2' ' A' ' 75' ' ' PHE . 25.7 p90 -127.2 167.13 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.764 -0.653 . . . . 3.0099999999999998 110.739 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 106' ' ' LYS . 45.1 mt-10 -103.67 122.9 45.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.007 -0.368 . . . . 2.3900000000000001 110.007 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -142.15 158.4 43.79 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.533 -0.543 . . . . 3.3700000000000001 109.533 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 104' ' ' LYS . 40.5 p -104.26 156.36 17.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.51 0.672 . . . . 1.3999999999999999 112.299 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.487 ' O ' ' HG3' ' A' ' 100' ' ' MET . 44.8 m-85 -121.85 112.61 18.55 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.653 -1.24 . . . . 1.1799999999999999 107.653 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 102' ' ' PRO . 4.5 m-20 -123.64 12.88 9.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.841 -166.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.85 -49.09 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 3.21 111.192 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -91.21 13.6 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 3.23 110.968 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 17.5 ptp -169.94 153.76 4.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 2.8500000000000001 109.702 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 10.1 t -58.01 142.95 79.01 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.25 -1.019 . . . . 2.1200000000000001 108.25 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.468 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 32.5 Cg_exo -31.65 86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.386 3.391 . . . . 1.47 114.976 -176.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 m -111.51 141.37 45.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 1.3999999999999999 110.882 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 95' ' ' THR . 22.2 ttmm -104.07 135.47 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.785 0.326 . . . . 3.0800000000000001 110.399 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -127.95 166.37 25.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 1.3300000000000001 110.669 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 93' ' ' GLU . 31.5 ttmt -110.81 117.02 32.28 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.346 -0.983 . . . . 1.6899999999999999 108.346 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 80.1 t -104.11 120.58 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.073 -0.512 . . . . 1.27 110.068 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.431 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 12.3 t-160 -104.04 109.08 20.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.159 -0.682 . . . . 1.02 109.159 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 58.0 tpp -101.68 132.69 47.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 2.4900000000000002 109.149 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 50.4 mtpt -137.62 131.57 31.75 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 121.153 -0.219 . . . . 1.5700000000000001 110.498 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 81.6 tttt -90.53 123.22 34.03 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.123 0.487 . . . . 2.1299999999999999 110.885 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.08 -175.24 2.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.675 -0.861 . . . . 1.5700000000000001 108.675 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.42 -94.97 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.42 -0.956 . . . . 4.4100000000000001 108.42 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 m 51.56 42.14 29.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.609 0.596 . . . . 2.5499999999999998 112.609 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.03 79.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.758 . . . . 2.6200000000000001 112.501 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.43 64.17 0.72 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.153 0.581 . . . . 2.7599999999999998 111.695 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 20.4 p -139.05 163.92 31.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.095 -0.502 . . . . 1.0700000000000001 110.694 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 4.9 m-85 -123.25 154.72 38.41 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.043 -1.095 . . . . 0.85999999999999999 108.043 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -103.63 109.17 20.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.875 -0.787 . . . . 0.63 108.875 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.484 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.6 p -100.71 134.35 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.682 0.753 . . . . 0.91000000000000003 110.796 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.423 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 80.8 m-85 -120.83 132.62 55.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.79000000000000004 110.037 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.1 t -103.17 104.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.886 -0.597 . . . . 1.1799999999999999 110.061 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -103.16 110.18 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.877 -0.786 . . . . 3.3100000000000001 108.877 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 105' ' ' VAL . 4.2 ptm180 -77.86 158.01 29.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.223 -0.444 . . . . 4.0300000000000002 111.472 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.592 -0.718 . . . . 2.8700000000000001 109.147 173.765 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.5 p90 . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 109.673 -0.491 . . . . 3.8500000000000001 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 120.02 6.54 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.258 -0.972 . . . . 0.84999999999999998 112.308 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.59 125.85 47.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.611 -0.515 . . . . 0.70999999999999996 109.611 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 42' ' ' TYR . 5.2 pt -132.17 165.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 1.0800000000000001 111.991 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.536 ' HG2' HD23 ' A' ' 40' ' ' LEU . 50.3 tt0 -115.03 121.01 41.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.889 -0.596 . . . . 0.85999999999999999 110.513 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.9 pt? -131.48 146.84 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.545 -0.539 . . . . 1.6200000000000001 109.545 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.24 170.01 8.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.134 -0.321 . . . . 1.22 110.134 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.27 -23.33 12.4 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 114.306 0.482 . . . . 0.79000000000000004 114.306 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.17 -21.56 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 1.95 110.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 96.51 4.9 59.22 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.151 -1.18 . . . . 0.53000000000000003 110.151 -173.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -79.15 134.04 36.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.693 -0.754 . . . . 1.3 109.705 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 19.7 mt -93.02 140.24 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.924 -0.58 . . . . 0.89000000000000001 110.154 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 ' HG2' ' A' ' 32' ' ' GLN . 1.4 mm? -107.13 -66.48 1.02 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.144 0.497 . . . . 1.45 111.19 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -134.21 137.39 44.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.492 0.663 . . . . 1.99 111.47 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.725 ' HA ' HG22 ' A' ' 31' ' ' ILE . 3.6 m-30 -102.95 126.75 50.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.775 -1.102 . . . . 1.25 109.268 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -60.03 155.82 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.026 -0.361 . . . . 2.1299999999999999 110.026 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.64 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.092 0.472 . . . . 1.48 109.874 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.27 70.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.969 -1.014 . . . . 1.52 112.61 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 38.7 tp10 -66.19 -47.96 72.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.1200000000000001 110.566 -173.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.0 -10.18 72.59 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.834 -0.698 . . . . 1.4199999999999999 112.503 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -93.12 -52.1 4.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.87 0.367 . . . . 2.3500000000000001 110.884 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.6 mt -80.55 -72.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.394 -0.366 . . . . 2.5899999999999999 110.939 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.5 m -153.77 106.93 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.608 -0.516 . . . . 3.4100000000000001 109.608 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . 175.48 -139.75 4.87 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.067 -1.063 . . . . 2.3199999999999998 112.964 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 3.0 mpt_? -124.24 174.7 7.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.706 0.289 . . . . 3.1400000000000001 110.834 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.83 139.96 95.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.663 -0.699 . . . . 2.1000000000000001 111.055 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.53 111.99 0.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.874 2.382 . . . . 1.6799999999999999 112.497 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 81.49 11.2 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.239 -0.891 . . . . 3.6099999999999999 112.545 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -94.44 22.05 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.326 0.584 . . . . 2.5 110.243 172.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.692 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -119.68 22.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.899 . . . . 0.96999999999999997 111.26 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -88.51 136.61 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.878 -0.416 . . . . 1.0900000000000001 109.878 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.76 11.97 84.18 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.829 -0.909 . . . . 0.66000000000000003 110.829 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 65' ' ' ASP . 26.5 mttm -118.77 141.49 48.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.69 0.281 . . . . 1.8200000000000001 111.103 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 23.7 t-20 -87.76 114.75 24.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.145 -0.48 . . . . 0.71999999999999997 110.216 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -55.84 -35.22 66.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.963 0.411 . . . . 0.69999999999999996 111.645 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 66.7 m-85 -76.48 -7.96 56.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.17 -0.468 . . . . 1.1599999999999999 111.484 -174.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -136.45 -63.47 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.84 0.311 . . . . 3.5800000000000001 111.84 -175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 5.3 m-20 -66.93 -24.17 66.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.298 0.481 . . . . 2.2000000000000002 112.298 -173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -125.89 12.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.33 -0.548 . . . . 1.77 110.969 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 171.06 85.71 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.399 -0.364 . . . . 0.60999999999999999 111.434 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.0 -16.48 54.64 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.586 2.191 . . . . 0.81000000000000005 113.769 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.2 m -50.4 -37.17 36.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.719 0.236 . . . . 0.84999999999999998 110.901 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 10.3 m -92.82 -31.03 15.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.933 -1.031 . . . . 1.3300000000000001 109.896 -135.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.56 97.13 4.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.995 -1.002 . . . . 1.8500000000000001 110.16 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.5 m -164.05 152.21 11.11 Favored Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.046 -0.524 . . . . 1.5600000000000001 110.019 -169.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.71 -30.33 92.1 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.278 1.985 . . . . 1.1699999999999999 112.667 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HG3' ' HE2' ' A' ' 94' ' ' TYR . 9.5 pt-20 -86.14 6.37 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.271 0.471 . . . . 2.5600000000000001 112.271 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.682 ' HE2' HG11 ' A' ' 107' ' ' VAL . 57.3 t80 -141.58 -71.67 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.873 -0.418 . . . . 3.3599999999999999 109.873 173.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.663 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 89.0 t80 -53.75 -37.87 63.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.79000000000000004 110.692 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -31.66 78.93 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.226 -0.512 . . . . 0.59999999999999998 112.624 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -81.52 -32.67 32.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.521 0.677 . . . . 2.0899999999999999 109.459 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.48 -32.15 71.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.913 -1.039 . . . . 0.67000000000000004 109.588 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HE3' ' CZ ' ' A' ' 76' ' ' TYR . 0.9 OUTLIER -88.84 -16.06 32.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.171 -0.922 . . . . 1.0900000000000001 111.098 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.46 -51.33 63.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 2.0699999999999998 110.573 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.35 -44.01 98.26 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.724 -0.671 . . . . 0.71999999999999997 112.315 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 83' ' ' VAL . 23.4 t -55.85 -52.75 45.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.692 0.282 . . . . 0.84999999999999998 110.869 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.7 86.81 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 116.051 -0.522 . . . . 1.1399999999999999 111.196 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -66.33 -77.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 1.8200000000000001 110.78 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.43 -75.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.522 -0.631 . . . . 1.6499999999999999 111.522 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -97.62 147.66 24.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 3.5 110.13 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.002 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -111.21 110.4 20.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.568 -0.531 . . . . 2.96 109.568 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -175.68 91.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.974 0.892 . . . . 2.2400000000000002 110.892 176.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 91' ' ' MET . 10.0 m -131.44 154.55 48.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.311 -0.859 . . . . 1.6299999999999999 109.23 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.473 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 19.6 ptt? -128.27 104.08 7.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.981 0.419 . . . . 1.77 110.155 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -125.15 166.59 16.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 3.0099999999999998 110.194 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.42 131.22 50.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.985 0.421 . . . . 2.3900000000000001 110.537 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 50.8 t80 -136.87 159.91 40.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 3.3700000000000001 109.679 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -102.97 113.63 27.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.943 0.402 . . . . 1.3999999999999999 110.315 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.09 103.1 11.77 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.11 0.481 . . . . 1.1799999999999999 109.801 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 100' ' ' MET . 49.5 m-20 -126.41 101.74 6.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.653 -0.703 . . . . 2.5699999999999998 109.886 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -73.56 63.79 0.84 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.804 -1.184 . . . . 3.21 107.804 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 63.6 59.91 1.15 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.992 -1.004 . . . . 3.23 108.443 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.506 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 42.7 tpp -133.04 164.74 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.953 -1.021 . . . . 2.8500000000000001 111.09 -168.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.1 p -59.49 151.91 58.17 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 108.747 -0.835 . . . . 2.1200000000000001 108.747 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.17 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.641 2.227 . . . . 1.47 113.483 -171.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -90.71 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 1.3999999999999999 110.723 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.72 120.94 41.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.967 -0.383 . . . . 3.0800000000000001 109.967 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.2 m -122.02 166.42 16.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.838 -0.619 . . . . 1.3300000000000001 110.459 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 82.8 tttt -103.56 120.92 41.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.763 -0.828 . . . . 1.6899999999999999 108.763 177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.682 HG11 ' HE2' ' A' ' 75' ' ' PHE . 6.5 p -106.45 115.99 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-O 122.096 0.951 . . . . 1.27 110.096 -174.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.501 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 18.7 t-160 -107.5 103.5 12.84 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.072 -0.967 . . . . 1.02 108.925 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.99 134.31 47.48 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.575 -0.45 . . . . 2.4900000000000002 110.078 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.501 ' HD2' ' CE1' ' A' ' 108' ' ' HIS . 8.8 mtpm? -140.65 134.75 30.87 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 120.688 0.28 . . . . 1.5700000000000001 110.928 -172.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 1.002 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 26.0 ttpp -80.85 136.75 36.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.322 -0.399 . . . . 2.1299999999999999 110.896 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.98 -173.21 3.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.403 -0.362 . . . . 1.5700000000000001 111.172 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.5 -164.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.201 -0.454 . . . . 4.4100000000000001 110.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.1 m 65.89 54.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.615 0.721 . . . . 2.5499999999999998 110.365 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.39 -2.4 8.88 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.196 -0.911 . . . . 2.6200000000000001 111.605 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.5 41.68 31.81 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.425 0.631 . . . . 2.7599999999999998 110.614 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.42 -175.75 2.75 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.51 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.456 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 5.6 m-85 -119.6 151.69 38.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.028 -0.73 . . . . 0.85999999999999999 109.028 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -102.44 108.5 19.84 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.348 -0.982 . . . . 0.63 108.348 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' A' ' 31' ' ' ILE . 10.9 p -101.68 137.71 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 119.801 -0.759 . . . . 0.91000000000000003 110.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -114.03 125.21 53.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.436 -0.802 . . . . 0.79000000000000004 110.185 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.05 114.88 48.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.378 . . . . 1.1799999999999999 110.011 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -139.07 129.19 25.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.88 -0.415 . . . . 3.3100000000000001 109.88 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.8 ptp180 -75.02 114.64 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.016 0.436 . . . . 4.0300000000000002 110.455 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 106' ' ' LYS . 6.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.068 -0.491 . . . . 2.8700000000000001 110.43 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' VAL . 95.1 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.816 0.341 . . . . 3.8500000000000001 111.388 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.78 130.72 10.34 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.475 -0.869 . . . . 0.84999999999999998 112.18 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.84 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.932 -0.395 . . . . 0.70999999999999996 109.932 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 32' ' ' GLN . 9.5 mm -114.5 152.39 16.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 1.0800000000000001 109.895 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 31' ' ' ILE . 64.4 tt0 -124.06 104.67 9.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.614 -0.513 . . . . 0.85999999999999999 109.614 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.522 ' CD1' HG12 ' A' ' 39' ' ' ILE . 1.9 mm? -105.47 143.62 33.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.399 -0.364 . . . . 1.6200000000000001 110.277 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p30 -104.38 167.69 9.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.041 -0.264 . . . . 1.22 110.435 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.01 -22.46 35.24 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.046 0.779 . . . . 0.79000000000000004 115.046 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.426 0.613 . . . . 1.95 110.35 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.84 43.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.192 -0.763 . . . . 0.53000000000000003 111.192 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.0 m-20 -88.19 146.44 25.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.076 0.465 . . . . 1.3 111.416 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.698 HD12 HG11 ' A' ' 57' ' ' VAL . 10.0 mt -95.41 148.24 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.89000000000000001 110.305 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.454 ' N ' HG22 ' A' ' 39' ' ' ILE . 83.1 mt -107.44 -80.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.027 -0.533 . . . . 1.45 109.76 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -116.78 136.9 52.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 1.99 111.571 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.4 m-30 -98.02 -175.61 3.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.892 -1.049 . . . . 1.25 110.64 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.73 161.34 20.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.626 -0.879 . . . . 2.1299999999999999 108.626 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.81 -23.31 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.527 0.566 . . . . 1.48 112.527 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.79 94.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 1.52 111.078 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.3 mp0 -63.8 -27.11 68.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 2.1200000000000001 111.281 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.64 -13.88 62.29 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.538 -0.839 . . . . 1.4199999999999999 112.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.73 -54.48 3.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.542 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.28 -60.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 2.5899999999999999 110.124 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 3.8 m -78.73 -54.7 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.88 -0.6 . . . . 3.4100000000000001 111.451 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.18 14.0 6.75 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 2.3199999999999998 112.033 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 66' ' ' VAL . 19.7 mmt180 -97.69 110.09 22.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 3.1400000000000001 110.005 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.575 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 15.3 m-20 -63.58 143.6 97.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.381 -0.372 . . . . 2.1000000000000001 110.743 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 71.6 Cg_exo -52.34 -28.01 33.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.871 3.047 . . . . 1.6799999999999999 114.804 -170.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -124.67 28.61 6.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.99 0.367 . . . . 3.6099999999999999 111.99 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.575 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 77.0 mm-40 -94.78 0.07 54.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.255 0.55 . . . . 2.5 110.967 175.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -93.38 -93.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.816 -0.629 . . . . 0.96999999999999997 111.442 175.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.8 mm 54.31 99.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.427 0.691 . . . . 1.0900000000000001 112.239 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.26 71.77 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.265 -1.134 . . . . 0.66000000000000003 110.265 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 6.7 mmtp -111.33 121.0 44.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.708 -1.246 . . . . 1.8200000000000001 109.553 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -71.24 105.38 3.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.71999999999999997 110.843 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HB2' HG12 ' A' ' 39' ' ' ILE . 85.1 t80 -54.19 -39.16 66.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.69999999999999996 111.107 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.5 m-85 -82.69 30.54 0.43 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 111.213 -174.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -161.85 -42.4 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.226 -0.443 . . . . 3.5800000000000001 110.575 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.94 -78.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.563 -0.289 . . . . 2.2000000000000002 111.002 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.9 t -87.62 14.91 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.299 0.571 . . . . 1.77 111.222 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -177.76 94.62 0.23 Allowed Pre-proline 0 C--O 1.222 -0.383 0 O-C-N 122.125 -0.36 . . . . 0.60999999999999999 111.267 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 98' ' ' TYR . 3.9 Cg_exo -78.7 -19.89 10.96 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.419 2.079 . . . . 0.81000000000000005 112.834 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -76.87 -19.68 57.17 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.646 -0.422 . . . . 0.84999999999999998 110.864 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.69 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 18.4 p -73.86 -36.53 64.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.302 -0.863 . . . . 1.3300000000000001 111.119 -172.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 11.0 t70 -62.2 96.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.8500000000000001 109.895 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.5 p 175.79 158.0 0.4 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.32 -0.622 . . . . 1.5600000000000001 109.32 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.592 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 58.9 Cg_exo -52.87 -32.12 55.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.801 2.334 . . . . 1.1699999999999999 112.354 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.59 -59.02 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 2.5600000000000001 111.255 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.69 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 28.4 m-85 -96.09 -69.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.025 -0.534 . . . . 3.3599999999999999 111.357 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.03 -30.39 71.56 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.79000000000000004 111.116 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -61.44 -41.14 99.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.021 -0.609 . . . . 0.59999999999999998 112.177 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -79.23 -29.72 42.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 2.0899999999999999 110.121 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' HE1' ' A' ' 109' ' ' MET . 84.7 t80 -57.82 -40.38 79.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.335 -0.848 . . . . 0.67000000000000004 110.634 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.4 -12.06 26.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.993 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 32.4 tt0 -68.86 -43.49 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 110.379 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.57 -43.41 92.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.695 -0.764 . . . . 0.71999999999999997 112.022 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 t -61.03 -49.48 84.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.84999999999999998 110.88 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -4.64 27.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 112.019 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.2 m -100.53 -73.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.634 0.254 . . . . 1.8200000000000001 110.782 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.91 -63.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 1.6499999999999999 111.952 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.15 139.57 46.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.606 -0.516 . . . . 3.5 109.606 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -106.89 104.46 14.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.387 -0.597 . . . . 2.96 109.387 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.686 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.7 p30 -172.15 116.15 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.497 0.665 . . . . 2.2400000000000002 109.868 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.4 m -148.36 142.23 25.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 1.6299999999999999 109.887 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.0 ptm -119.92 120.1 35.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.448 -0.575 . . . . 1.77 109.448 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' CD1' ' HD1' ' A' ' 94' ' ' TYR . 4.2 p90 -140.03 157.81 45.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.421 . . . . 3.0099999999999998 111.953 -172.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 106' ' ' LYS . 5.5 mp0 -104.42 121.64 43.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 2.3900000000000001 109.896 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 26.6 m-85 -142.9 165.82 26.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.286 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 13.5 m -107.36 144.26 34.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.39 -0.368 . . . . 1.3999999999999999 110.527 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.77 106.99 15.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 1.1799999999999999 109.478 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.47 111.01 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 2.5699999999999998 110.829 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 68' ' ' PRO . 72.7 t80 -175.76 -79.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.484 -0.78 . . . . 3.21 109.475 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -99.55 -34.28 10.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.419 -0.586 . . . . 3.23 109.419 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.6 ttm -82.11 137.86 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.041 -1.096 . . . . 2.8500000000000001 108.041 164.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -64.4 154.78 82.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.419 -0.586 . . . . 2.1200000000000001 109.419 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.47 87.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.136 2.557 . . . . 1.47 114.114 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -102.97 130.48 50.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.848 -0.615 . . . . 1.3999999999999999 109.952 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 22.3 pttp -103.62 124.84 49.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.401 -0.592 . . . . 3.0800000000000001 109.401 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 124' ' ' ARG . 15.1 m -132.11 165.52 31.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 112.179 -171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 22.7 ttmm -104.75 111.01 23.57 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.288 -1.005 . . . . 1.6899999999999999 108.288 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 122' ' ' VAL . 59.8 t -104.63 127.75 58.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.611 -0.514 . . . . 1.27 109.611 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 12.1 t-160 -104.61 113.42 26.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.4 0.619 . . . . 1.02 109.458 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.686 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 27.3 tpp -101.13 123.54 45.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.518 -1.219 . . . . 2.4900000000000002 108.772 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 63.8 pttt -150.44 146.8 26.88 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.093 -0.643 . . . . 1.5700000000000001 111.512 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 48.6 tttm -87.52 140.27 29.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.567 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.1 -172.84 4.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.612 0.244 . . . . 1.5700000000000001 110.439 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -168.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.196 -0.298 . . . . 4.4100000000000001 110.196 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m 75.15 72.86 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.806 0.691 . . . . 2.5499999999999998 110.094 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.38 -8.4 44.35 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.093 -0.803 . . . . 2.6200000000000001 111.093 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 55.03 80.81 0.12 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.598 0.713 . . . . 2.7599999999999998 111.165 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 2.6 p -156.51 -169.83 3.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.005 -0.998 . . . . 1.0700000000000001 109.063 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 8.5 m-85 -119.38 152.57 36.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.332 -0.988 . . . . 0.85999999999999999 108.332 -177.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 55.5 m95 -101.54 106.0 17.04 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.591 0.71 . . . . 0.63 109.148 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 108' ' ' HIS . 38.9 t -102.6 104.34 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.401 -1.272 . . . . 0.91000000000000003 110.612 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 98.7 m-85 -104.79 134.08 48.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.139 -0.937 . . . . 0.79000000000000004 110.253 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -113.48 144.9 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.585 -0.28 . . . . 1.1799999999999999 110.703 -176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 106' ' ' LYS . 18.5 ptpt -139.49 145.16 38.42 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.838 -0.431 . . . . 3.3100000000000001 109.838 173.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.716 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.5 tmt_? -84.4 111.69 19.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.639 -0.255 . . . . 4.0300000000000002 110.591 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.494 HG11 ' HE2' ' A' ' 106' ' ' LYS . 16.7 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.618 -0.706 . . . . 2.8700000000000001 111.033 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.91 -0.404 . . . . 3.8500000000000001 109.91 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 45' ' ' ALA . . . -104.7 130.24 10.15 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.641 -0.79 . . . . 0.84999999999999998 111.302 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -135.76 104.13 5.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.172 0.51 . . . . 0.70999999999999996 111.163 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.924 ' HB ' HG13 ' A' ' 120' ' ' VAL . 34.6 mt -113.07 159.74 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.079 -1.082 . . . . 1.0800000000000001 108.079 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.646 HE22 HD23 ' A' ' 113' ' ' LEU . 64.6 tt0 -131.97 116.65 17.39 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.937 -0.477 . . . . 0.85999999999999999 110.467 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.39 165.2 12.42 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.433 -0.58 . . . . 1.6200000000000001 109.433 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -121.1 168.4 11.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.926 -0.398 . . . . 1.22 109.926 175.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.98 -24.62 35.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.415 0.526 . . . . 0.79000000000000004 114.415 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.62 -21.51 55.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.95 110.83 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.84 2.65 36.8 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.807 -0.633 . . . . 0.53000000000000003 111.845 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 92.6 m-20 -78.46 153.31 31.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.95 0.405 . . . . 1.3 110.864 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 60' ' ' LYS . 9.3 mt -96.87 146.88 6.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.715 -0.675 . . . . 0.89000000000000001 109.674 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -102.04 -46.96 4.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.629 0.728 . . . . 1.45 109.515 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.87 157.76 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.602 -1.181 . . . . 1.99 110.123 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.909 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 8.1 m-30 -110.54 177.82 4.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 1.25 110.456 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t-20 -107.36 179.25 4.3 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.292 -1.003 . . . . 2.1299999999999999 108.292 172.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 -9.46 43.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.086 0.47 . . . . 1.48 109.908 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' CB ' ' HA2' ' A' ' 29' ' ' GLY . . . -55.71 -60.08 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.253 -0.885 . . . . 1.52 111.897 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.6 mp0 -65.55 -27.15 68.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 2.1200000000000001 111.22 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.2 -50.31 51.98 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.564 -0.827 . . . . 1.4199999999999999 111.786 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.1 -55.19 31.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.121 0.486 . . . . 2.3500000000000001 110.309 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.6 67.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.688 -1.226 . . . . 2.5899999999999999 107.688 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 18.9 m -36.32 90.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.754 -1.566 . . . . 3.4100000000000001 114.561 -169.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -104.42 -59.29 0.68 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.325 -1.307 . . . . 2.3199999999999998 110.46 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.909 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 35.3 mmt180 -149.51 168.79 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.634 0.373 . . . . 3.1400000000000001 110.444 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.682 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 8.9 m-20 -90.55 141.12 26.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 2.1000000000000001 109.759 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.769 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 52.8 Cg_exo -56.55 -25.88 61.15 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.193 2.595 . . . . 1.6799999999999999 114.086 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -103.79 6.67 36.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.188 0.44 . . . . 3.6099999999999999 112.188 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 82.9 mm-40 -102.82 6.13 39.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.069 0.461 . . . . 2.5 110.699 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 7.7 m -118.15 40.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.217 0.532 . . . . 0.96999999999999997 111.606 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.01 112.25 24.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.37 -0.377 . . . . 1.0900000000000001 110.64 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.21 11.72 71.32 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.964 -0.854 . . . . 0.66000000000000003 110.964 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.57 ' O ' HG13 ' A' ' 39' ' ' ILE . 7.2 tptt -88.02 121.55 30.56 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.992 -0.604 . . . . 1.8200000000000001 109.558 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 47.5 t-20 -71.78 110.99 6.68 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.442 -0.577 . . . . 0.71999999999999997 109.442 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 86.6 t80 -53.98 -41.0 67.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.429 -0.805 . . . . 0.69999999999999996 110.74 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 46.2 m-85 -85.86 9.48 16.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.237 -0.438 . . . . 1.1599999999999999 110.803 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 48.0 tptt -124.54 -61.95 1.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.386 -0.37 . . . . 3.5800000000000001 110.715 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -104.09 -22.8 13.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.17 0.433 . . . . 2.2000000000000002 112.17 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 52' ' ' ARG . 1.9 t -113.17 13.52 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.182 -0.607 . . . . 1.77 111.765 -170.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 167.27 79.57 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.971 -0.559 . . . . 0.60999999999999999 110.235 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.03 -17.15 50.95 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.751 2.301 . . . . 0.81000000000000005 113.035 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.893 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.9 p -76.36 -26.66 55.92 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.486 -0.486 . . . . 0.84999999999999998 110.225 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 1.9 m -80.1 -31.89 39.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.902 -1.045 . . . . 1.3300000000000001 110.486 -164.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 10.5 t70 -63.75 99.23 0.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.159 -0.682 . . . . 1.8500000000000001 109.159 172.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 8.8 t -169.56 149.46 3.68 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.723 -0.473 . . . . 1.5600000000000001 109.723 -175.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 5.3 Cg_exo -38.47 -42.79 1.8 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.742 3.628 . . . . 1.1699999999999999 114.584 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.799 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.01 -53.55 4.22 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.598 -0.441 . . . . 2.5600000000000001 111.19 -178.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 70' ' ' THR . 29.2 m-85 -59.63 -63.81 1.17 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.094 0.473 . . . . 3.3599999999999999 110.706 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 39.6 t80 -67.47 -28.68 68.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.614 . . . . 0.79000000000000004 110.097 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -63.62 -34.75 90.79 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.699 -0.682 . . . . 0.59999999999999998 112.605 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 72.1 mmtt -75.09 -36.97 61.67 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.123 0.487 . . . . 2.0899999999999999 109.751 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' O ' HD11 ' A' ' 88' ' ' LEU . 82.2 t80 -59.89 -35.4 74.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.825 . . . . 0.67000000000000004 110.69 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -94.52 -4.79 47.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.074 -0.512 . . . . 1.0900000000000001 111.808 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -49.97 73.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.034 0.445 . . . . 2.0699999999999998 110.269 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.14 -37.29 63.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.71999999999999997 111.794 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' OH ' ' A' ' 118' ' ' TYR . 21.9 t -52.86 -56.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 122.971 0.508 . . . . 0.84999999999999998 111.518 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.76 62.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 1.1399999999999999 112.048 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.9 m -88.67 -73.2 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.381 . . . . 1.8200000000000001 110.681 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.3 -72.14 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.936 -0.65 . . . . 1.6499999999999999 111.521 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.76 149.09 28.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.667 -0.864 . . . . 3.5 108.667 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -116.27 101.8 9.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.18 -0.674 . . . . 2.96 109.18 178.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 45.9 m-80 -149.12 83.14 1.44 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.383 -0.599 . . . . 2.2400000000000002 109.383 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.8 p -127.83 158.49 37.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 1.6299999999999999 111.289 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.2 ptm -137.44 113.74 10.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.893 -0.594 . . . . 1.77 110.302 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.714 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 8.8 p90 -136.65 164.73 27.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 3.0099999999999998 110.81 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.5 122.04 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 2.3900000000000001 110.702 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.714 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 5.1 m-85 -144.21 167.03 23.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 3.3700000000000001 110.089 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.0 t -103.63 154.22 19.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.268 0.556 . . . . 1.3999999999999999 111.983 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -120.23 103.45 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.416 -0.957 . . . . 1.1799999999999999 108.416 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 24.3 t70 -113.23 -131.37 0.32 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.586 -0.734 . . . . 2.5699999999999998 109.516 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 61.7 t80 70.65 -70.23 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.434 0.694 . . . . 3.21 111.241 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -118.97 -2.14 10.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.302 0.572 . . . . 3.23 110.268 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.4 tpt -116.26 151.27 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.352 -0.84 . . . . 2.8500000000000001 109.301 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 103' ' ' THR . 9.8 t -55.98 142.45 65.05 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 108.345 -0.983 . . . . 2.1200000000000001 108.345 169.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 26.7 Cg_endo -62.84 72.16 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.73 2.287 . . . . 1.47 112.662 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 101' ' ' THR . 1.4 p -81.78 144.33 31.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.917 -0.583 . . . . 1.3999999999999999 111.504 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.85 117.38 33.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.537 -0.301 . . . . 3.0800000000000001 110.346 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.24 166.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.073 -0.512 . . . . 1.3300000000000001 110.889 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -103.6 128.34 50.89 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.367 -0.975 . . . . 1.6899999999999999 108.367 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' MET . 7.4 p -116.37 139.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 109.486 -0.561 . . . . 1.27 109.486 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 11.6 t-160 -117.2 115.67 25.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.651 -0.704 . . . . 1.02 109.166 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 86.1 mmm -100.35 126.34 46.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.201 -0.666 . . . . 2.4900000000000002 109.201 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.0 mtpm? -141.84 121.58 13.47 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 120.837 0.351 . . . . 1.5700000000000001 111.187 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 76.5 tttt -73.17 131.42 42.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.045 -0.525 . . . . 2.1299999999999999 110.824 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.21 -160.76 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.967 0.358 . . . . 1.5700000000000001 111.967 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.646 HD23 HE22 ' A' ' 32' ' ' GLN . 13.7 tp 33.62 111.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.939 1.829 . . . . 4.4100000000000001 115.939 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.6 m -18.23 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.406 1.691 . . . . 2.5499999999999998 112.569 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.42 -8.14 0.55 Allowed Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.176 -0.92 . . . . 2.6200000000000001 111.449 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 59.62 24.3 13.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.793 0.806 . . . . 2.7599999999999998 110.054 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.9 p -82.67 171.57 13.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.493 -1.23 . . . . 1.0700000000000001 109.466 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.556 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.6 m-85 -128.07 153.35 46.9 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.338 -0.615 . . . . 0.85999999999999999 109.338 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -100.55 109.36 21.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.473 -0.936 . . . . 0.63 108.473 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.924 HG13 ' HB ' ' A' ' 31' ' ' ILE . 2.4 p -101.57 106.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 122.307 1.051 . . . . 0.91000000000000003 110.517 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -103.25 136.82 42.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.651 -1.159 . . . . 0.79000000000000004 109.975 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.69 147.01 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 1.1799999999999999 112.02 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -149.01 154.23 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.321 -0.854 . . . . 3.3100000000000001 109.457 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -100.95 121.89 42.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.018 -0.364 . . . . 4.0300000000000002 110.018 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.222 -0.894 . . . . 2.8700000000000001 110.521 179.083 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 109.64 -0.504 . . . . 3.8500000000000001 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.24 117.2 5.74 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 112.48 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.66 104.23 14.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.696 -0.483 . . . . 0.70999999999999996 109.696 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 120' ' ' VAL . 37.7 mt -107.85 157.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.869 -0.605 . . . . 1.0800000000000001 109.642 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.65 HE22 ' HB2' ' A' ' 113' ' ' LEU . 2.8 mt-30 -130.03 142.17 50.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.15 -0.315 . . . . 0.85999999999999999 110.15 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -140.27 153.87 46.65 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.294 -0.632 . . . . 1.6200000000000001 109.294 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.7 OUTLIER -104.41 168.4 9.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.15 -23.77 18.54 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.467 0.479 . . . . 0.79000000000000004 114.205 -175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 -37.06 37.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.216 0.508 . . . . 1.95 110.528 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.54 5.0 6.69 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.639 -0.791 . . . . 0.53000000000000003 112.307 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -70.72 147.15 49.35 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.564 -0.532 . . . . 1.3 109.564 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 mt -94.43 146.89 6.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.301 -0.629 . . . . 0.89000000000000001 109.301 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 40' ' ' LEU . 4.0 mp -127.98 -80.46 0.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 1.45 109.8 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.5 mp0 -89.45 141.06 28.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.44 -0.8 . . . . 1.99 109.976 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -130.48 5.33 4.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.349 -0.387 . . . . 1.25 110.918 178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.92 -173.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.865 -0.607 . . . . 2.1299999999999999 109.93 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.83 5.38 45.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.446 0.641 . . . . 1.48 109.495 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -77.95 -51.44 10.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.777 . . . . 1.52 111.338 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.03 -20.87 61.62 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.916 0.389 . . . . 2.1200000000000001 110.913 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.45 -19.83 77.93 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.714 -0.755 . . . . 1.4199999999999999 111.31 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -94.89 -16.67 22.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.202 0.525 . . . . 2.3500000000000001 110.185 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 45' ' ' ALA . 50.3 mm -82.73 -63.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 2.5899999999999999 111.152 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -139.92 40.88 1.98 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.161 0.981 . . . . 3.4100000000000001 111.1 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.25 37.27 64.32 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.106 -0.952 . . . . 2.3199999999999998 113.282 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 17.9 mmt-85 -98.6 85.67 3.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 3.1400000000000001 110.985 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 6.5 m-20 -67.31 148.59 98.71 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.277 -0.874 . . . . 2.1000000000000001 109.649 175.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 49.4 Cg_exo -55.5 -32.89 84.33 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.255 1.97 . . . . 1.6799999999999999 111.427 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -73.35 -18.35 61.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.724 -0.671 . . . . 3.6099999999999999 111.668 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 79.4 mm-40 -78.25 -26.61 47.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.713 0.264 . . . . 2.5 111.713 -175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.0 m -109.13 14.8 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.257 0.836 . . . . 0.96999999999999997 113.257 -172.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 62.5 mt -83.83 133.42 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.608 -0.516 . . . . 1.0900000000000001 109.608 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.14 88.5 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.211 -0.995 . . . . 0.66000000000000003 110.885 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 34.8 mttm -104.88 133.03 50.38 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.126 -0.537 . . . . 1.8200000000000001 109.82 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -84.34 113.31 21.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.73 -0.388 . . . . 0.71999999999999997 110.138 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 66.8 t80 -54.51 -50.14 68.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.533 -0.758 . . . . 0.69999999999999996 111.173 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.6 m-85 -79.76 21.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.286 0.476 . . . . 1.1599999999999999 112.286 -172.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -149.92 -49.67 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.87 0.366 . . . . 3.5800000000000001 111.712 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -87.19 -76.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 2.2000000000000002 111.571 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -86.13 15.72 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.964 0.411 . . . . 1.77 111.491 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.41 96.12 0.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 121.998 -0.439 . . . . 0.60999999999999999 111.835 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -89.96 -9.69 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.084 2.522 . . . . 0.81000000000000005 112.898 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -83.95 -4.03 58.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.84999999999999998 111.077 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.489 HG21 ' CE1' ' A' ' 62' ' ' PHE . 6.8 p -98.45 -38.74 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.064 -0.517 . . . . 1.3300000000000001 111.534 -164.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 13.4 t70 -68.69 91.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.299 -0.41 . . . . 1.8500000000000001 109.974 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.3 p -150.21 160.19 33.74 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 1.5600000000000001 110.596 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 -43.84 53.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.927 2.418 . . . . 1.1699999999999999 113.608 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -78.54 -26.0 45.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.383 0.512 . . . . 2.5600000000000001 112.383 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HE2' HG11 ' A' ' 107' ' ' VAL . 67.5 t80 -105.57 -67.9 0.9 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.46 . . . . 3.3599999999999999 110.894 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 89.7 t80 -64.18 -39.29 93.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 110.863 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.2 97.56 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.97 -0.634 . . . . 0.59999999999999998 112.366 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 50.5 mmtt -73.44 -32.21 64.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 2.0899999999999999 110.606 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.3 t80 -57.58 -45.87 84.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.555 0.693 . . . . 0.67000000000000004 110.092 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.294 -0.866 . . . . 1.0900000000000001 112.005 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 2.0699999999999998 110.726 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.769 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -73.99 -44.06 31.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.312 -0.947 . . . . 0.71999999999999997 111.317 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' PHE . 22.0 t -56.19 -55.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.248 -0.476 . . . . 0.84999999999999998 111.426 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.38 83.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.285 -0.416 . . . . 1.1399999999999999 112.001 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.1 m -73.52 -70.99 0.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.437 -0.347 . . . . 1.8200000000000001 111.432 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.2 -79.38 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.691 -0.766 . . . . 1.6499999999999999 111.843 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -92.33 149.57 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.289 -0.456 . . . . 3.5 110.786 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -121.11 120.58 35.71 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.033 -0.728 . . . . 2.96 109.033 177.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.6 p30 -159.59 123.11 3.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 2.2400000000000002 109.905 173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -164.59 159.42 19.08 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.134 -0.939 . . . . 1.6299999999999999 110.235 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 53.4 ttm -132.09 107.84 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.039 -0.726 . . . . 1.77 109.039 175.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -120.23 156.22 31.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 3.0099999999999998 109.641 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.34 120.13 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.443 0.64 . . . . 2.3900000000000001 110.254 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -138.6 165.79 26.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.09 -0.959 . . . . 3.3700000000000001 109.493 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' THR . 49.2 p -104.25 154.88 19.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.858 0.361 . . . . 1.3999999999999999 111.937 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.34 103.14 9.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.758 -0.83 . . . . 1.1799999999999999 108.758 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 1.7 p30 -128.58 20.86 6.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.189 -0.46 . . . . 2.5699999999999998 111.444 -172.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.584 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -59.76 -44.25 93.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.68 -0.691 . . . . 3.21 111.672 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -144.18 -44.77 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.691 -0.855 . . . . 3.23 108.691 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.9 ttt -71.31 151.83 43.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.855 -1.066 . . . . 2.8500000000000001 108.768 170.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 p -53.68 149.8 15.08 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.514 -0.55 . . . . 2.1200000000000001 109.514 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 97' ' ' ASP . 18.1 Cg_endo -59.74 80.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.454 2.103 . . . . 1.47 113.129 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.0 p -74.04 151.73 40.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.3999999999999999 110.742 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 124' ' ' ARG . 10.1 mtmp? -104.62 121.19 43.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.771 0.32 . . . . 3.0800000000000001 110.176 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 35.3 m -117.44 161.51 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.929 0.395 . . . . 1.3300000000000001 110.683 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -116.17 113.93 23.76 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.739 -1.208 . . . . 1.6899999999999999 107.739 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 75' ' ' PHE . 14.8 p -106.25 142.35 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.134 0.492 . . . . 1.27 110.136 -170.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -115.35 110.98 20.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.036 -0.727 . . . . 1.02 109.036 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.7 tpp -101.84 130.78 48.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.54 -0.754 . . . . 2.4900000000000002 109.258 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 15.2 ptmm? -156.83 141.57 16.91 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.007 0.432 . . . . 1.5700000000000001 111.532 -177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 42.6 tttp -83.64 117.68 23.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.769 -0.651 . . . . 2.1299999999999999 111.243 -172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -176.12 108.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.133 0.42 . . . . 1.5700000000000001 112.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.65 ' HB2' HE22 ' A' ' 32' ' ' GLN . 38.9 tp 168.04 -109.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.943 0.897 . . . . 4.4100000000000001 109.146 171.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -85.81 19.3 2.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.338 0.59 . . . . 2.5499999999999998 109.677 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.83 -56.09 4.65 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.602 -0.726 . . . . 2.6200000000000001 111.531 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -93.11 31.1 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.445 0.64 . . . . 2.7599999999999998 111.219 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 28.8 t -146.95 142.2 27.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.384 -0.598 . . . . 1.0700000000000001 109.384 173.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.547 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 13.0 m-85 -120.01 164.88 15.45 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.422 -0.808 . . . . 0.85999999999999999 109.969 -167.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.575 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 73.2 m95 -102.32 108.39 19.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.905 -0.776 . . . . 0.63 108.905 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 31' ' ' ILE . 4.4 p -101.33 109.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.294 1.045 . . . . 0.91000000000000003 110.717 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.448 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 83.3 m-85 -102.35 124.44 47.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.244 -0.889 . . . . 0.79000000000000004 109.779 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 123.93 69.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.826 0.346 . . . . 1.1799999999999999 111.044 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -137.29 134.9 36.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.299 -0.63 . . . . 3.3100000000000001 109.299 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 2.6 ttp180 -77.98 146.19 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.332 -0.395 . . . . 4.0300000000000002 111.284 -172.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.734 -1.127 . . . . 2.8700000000000001 110.687 175.669 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 120.549 0.214 . . . . 3.8500000000000001 110.479 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA3' HG23 ' A' ' 122' ' ' VAL . . . -105.35 158.27 16.01 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.785 -0.721 . . . . 0.84999999999999998 112.686 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.66 112.2 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.394 -0.595 . . . . 0.70999999999999996 109.394 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.938 HG22 ' HA ' ' A' ' 42' ' ' TYR . 8.9 pt -131.66 166.74 28.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.046 0.387 . . . . 1.0800000000000001 112.046 -175.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -122.4 134.2 54.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.438 . . . . 0.85999999999999999 110.296 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.7 pt? -138.79 157.62 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.691 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 167.76 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.002 -0.279 . . . . 1.22 110.706 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.97 -14.03 22.13 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.762 0.665 . . . . 0.79000000000000004 114.762 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 26.7 t70 -86.33 -20.39 28.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.581 0.69 . . . . 1.95 110.312 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 112.19 0.59 26.73 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.588 -0.815 . . . . 0.53000000000000003 111.961 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.632 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 49.5 m-80 -74.56 138.05 42.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 120.911 0.386 . . . . 1.3 110.203 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.5 mt -88.58 148.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.086 -0.709 . . . . 0.89000000000000001 109.086 173.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 7.8 mp -112.87 -63.56 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.26 0.552 . . . . 1.45 110.736 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -136.77 126.63 25.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.565 -0.743 . . . . 1.99 110.67 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.074 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 1.6 m-30 -93.04 162.27 14.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.069 -0.969 . . . . 1.25 110.572 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.38 161.51 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.564 -0.902 . . . . 2.1299999999999999 108.564 166.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -12.34 59.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.795 0.331 . . . . 1.48 111.403 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.2 75.07 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.145 -0.479 . . . . 1.52 111.305 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.8 -21.37 64.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 2.1200000000000001 109.892 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -68.89 -30.54 72.41 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 111.792 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -79.11 -32.57 44.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 2.3500000000000001 110.207 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.88 -64.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 2.5899999999999999 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 52' ' ' ARG . 4.2 t -113.51 -38.62 4.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.795 0.331 . . . . 3.4100000000000001 111.094 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 101.31 53.6 1.0 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.44 -0.886 . . . . 2.3199999999999998 112.223 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.67 ' HG2' HG23 ' A' ' 50' ' ' THR . 14.2 mmt180 -119.14 125.74 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.595 -0.52 . . . . 3.1400000000000001 109.595 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.928 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -65.81 137.62 96.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.597 -0.274 . . . . 2.1000000000000001 110.783 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.074 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 88.7 Cg_exo -49.47 -25.25 10.23 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.836 3.024 . . . . 1.6799999999999999 114.222 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -101.6 -2.13 31.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.592 0.219 . . . . 3.6099999999999999 111.592 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.928 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.16 -0.88 46.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.561 0.22 . . . . 2.5 111.281 -177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.8 m -102.78 17.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.429 0.529 . . . . 0.96999999999999997 112.429 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -86.62 125.7 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.799 -0.445 . . . . 1.0900000000000001 109.799 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.5 1.66 90.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.065 -1.064 . . . . 0.66000000000000003 110.833 -174.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.8 mptp? -94.14 118.11 31.07 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.252 -0.474 . . . . 1.8200000000000001 110.184 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 36.9 t-20 -80.15 103.1 9.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.921 -0.581 . . . . 0.71999999999999997 109.975 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 68.7 t80 -62.22 -13.46 28.05 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 112.16 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 80.4 m-85 -104.82 11.49 33.72 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.856 -0.527 . . . . 1.1599999999999999 111.441 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 64' ' ' LYS . 13.3 tmtt? -149.48 -56.42 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.508 -0.477 . . . . 3.5800000000000001 111.524 -172.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.8 -77.74 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.541 -0.299 . . . . 2.2000000000000002 111.354 -167.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.2 m -78.53 16.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.451 0.538 . . . . 1.77 112.451 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -176.85 97.23 0.24 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.60999999999999999 110.331 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -93.71 1.48 3.25 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 113.447 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.5 4.11 53.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.959 -0.463 . . . . 0.84999999999999998 110.069 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 9.9 p -96.75 -46.81 6.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.617 -1.174 . . . . 1.3300000000000001 110.993 -167.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.47 110.72 0.92 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 1.8500000000000001 110.381 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -177.18 143.85 0.55 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 1.5600000000000001 108.4 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 50.0 Cg_exo -54.3 -29.11 56.08 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.645 2.23 . . . . 1.1699999999999999 112.745 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 8.1 pt-20 -90.67 9.3 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 2.5600000000000001 111.912 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 107' ' ' VAL . 67.3 t80 -142.71 -74.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.054 -0.35 . . . . 3.3599999999999999 110.054 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -65.25 -33.77 76.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 0.79000000000000004 110.29 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -63.73 -34.97 91.39 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.832 -0.699 . . . . 0.59999999999999998 111.955 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.43 -28.29 52.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.203 0.525 . . . . 2.0899999999999999 110.184 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.52 -41.37 96.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 109.662 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -76.5 -20.37 57.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 1.0900000000000001 110.849 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.31 -46.47 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 2.0699999999999998 110.355 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.8 -41.39 83.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.71999999999999997 112.214 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.62 -49.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.84999999999999998 110.765 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.83 76.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 1.1399999999999999 111.219 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.0 m -76.69 -83.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 1.8200000000000001 110.713 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.57 -58.03 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.0 -0.84 . . . . 1.6499999999999999 111.0 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.91 148.66 38.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.526 . . . . 3.5 110.293 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.6 tp -111.03 111.67 22.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.293 -0.632 . . . . 2.96 109.293 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 109' ' ' MET . 15.7 p30 -160.99 58.32 0.3 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.905 0.859 . . . . 2.2400000000000002 109.956 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -107.12 145.47 32.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.859 -1.064 . . . . 1.6299999999999999 110.296 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.5 ttp -122.17 117.88 27.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 1.77 110.319 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 42.6 p90 -138.13 163.88 30.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.298 -0.41 . . . . 3.0099999999999998 110.432 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 35.1 tt0 -109.67 129.12 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.615 -0.513 . . . . 2.3900000000000001 109.615 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.517 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 30.4 t80 -135.14 165.03 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.424 -0.353 . . . . 3.3700000000000001 110.833 -172.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 m -105.25 137.79 42.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.772 0.32 . . . . 1.3999999999999999 111.709 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 105' ' ' VAL . 14.4 m-85 -113.01 108.36 17.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.02 -0.733 . . . . 1.1799999999999999 109.02 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -119.67 8.23 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 2.5699999999999998 110.556 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 28.8 t80 -122.79 131.26 53.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 3.21 108.325 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.56 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 28.6 mm-40 67.96 8.51 6.53 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.219 0.533 . . . . 3.23 110.218 -173.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 23.6 ttt -166.3 140.64 4.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.399 -0.963 . . . . 2.8500000000000001 108.399 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.6 p -64.46 148.84 95.97 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.006 -0.738 . . . . 2.1200000000000001 109.006 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.1 89.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.993 2.462 . . . . 1.47 113.374 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 104' ' ' LYS . 3.8 m -109.97 154.91 22.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.907 -0.588 . . . . 1.3999999999999999 110.277 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 103' ' ' THR . 48.1 mmtm -102.84 117.94 35.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.498 -0.556 . . . . 3.0800000000000001 109.498 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 124' ' ' ARG . 25.0 m -122.0 163.29 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.3300000000000001 110.604 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 33.6 ttpt -109.02 128.6 55.1 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.905 -0.776 . . . . 1.6899999999999999 108.905 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 75' ' ' PHE . 96.3 t -114.11 110.73 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 108.491 -0.929 . . . . 1.27 108.491 -171.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -103.51 119.96 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.871 -0.788 . . . . 1.02 108.871 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.739 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 22.2 mmt -100.07 135.26 41.77 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.639 -0.874 . . . . 2.4900000000000002 108.639 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -150.94 121.93 7.65 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.895 0.379 . . . . 1.5700000000000001 110.858 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 52.9 tttt -78.91 137.46 37.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.214 0.531 . . . . 2.1299999999999999 111.283 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 177.06 8.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.789 -1.189 . . . . 1.5700000000000001 107.789 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.4 -98.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.556 -0.858 . . . . 4.4100000000000001 109.572 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.9 p 43.42 47.15 5.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.82 0.448 . . . . 2.5499999999999998 112.145 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.57 13.76 49.8 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.668 -0.777 . . . . 2.6200000000000001 112.519 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.1 t70 63.76 86.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.735 0.814 . . . . 2.7599999999999998 111.076 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 p -164.86 157.69 16.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.237 -0.892 . . . . 1.0700000000000001 109.611 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 2.6 m-85 -104.68 153.86 20.71 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.823 -0.806 . . . . 0.85999999999999999 108.823 -173.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -102.12 108.78 20.3 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.484 -0.932 . . . . 0.63 108.484 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.767 HG13 HG13 ' A' ' 31' ' ' ILE . 7.4 p -101.87 127.51 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.819 0.819 . . . . 0.91000000000000003 110.645 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -108.63 131.54 54.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.249 -0.887 . . . . 0.79000000000000004 110.317 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.449 HG23 ' HA3' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -111.31 106.81 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.733 0.778 . . . . 1.1799999999999999 111.201 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -103.23 117.19 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.678 . . . . 3.3100000000000001 109.927 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.781 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.6 ptm180 -89.53 157.42 18.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.62 -0.718 . . . . 4.0300000000000002 110.56 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.949 -0.548 . . . . 2.8700000000000001 111.049 175.374 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 98.4 m-85 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 113.147 0.795 . . . . 3.8500000000000001 113.147 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.41 104.59 2.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.357 -0.925 . . . . 0.84999999999999998 111.28 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -140.78 123.09 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.523 0.201 . . . . 0.70999999999999996 110.459 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 42' ' ' TYR . 12.1 pt -125.9 160.85 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 1.0800000000000001 111.102 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -119.72 115.49 24.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.391 -0.368 . . . . 0.85999999999999999 110.348 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD12 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -117.28 146.7 43.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.307 -0.627 . . . . 1.6200000000000001 109.307 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 38' ' ' ASN . 8.1 p30 -107.24 168.69 9.05 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.38 -0.528 . . . . 1.22 110.571 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -10.78 16.25 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 114.362 0.505 . . . . 0.79000000000000004 114.362 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -87.33 -11.25 49.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.358 0.579 . . . . 1.95 110.342 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.27 10.49 60.81 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.484 -1.047 . . . . 0.53000000000000003 110.484 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . 55.7 t30 -85.79 147.37 26.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.631 -0.785 . . . . 1.3 110.26 -174.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.798 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 3.8 mm -93.55 149.46 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.908 -0.404 . . . . 0.89000000000000001 109.908 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -120.3 -62.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 1.45 109.781 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -136.92 131.13 32.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.685 -0.689 . . . . 1.99 110.541 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.752 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.2 m-30 -98.29 179.95 4.56 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 1.25 109.977 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 58.1 t30 -123.01 173.86 7.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.336 -0.616 . . . . 2.1299999999999999 109.336 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.91 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.518 0.562 . . . . 1.48 112.518 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' PHE . . . -73.39 -42.92 61.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.947 0.351 . . . . 1.52 111.947 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.74 -15.52 59.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.348 -0.541 . . . . 2.1200000000000001 110.411 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.28 -6.55 74.36 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.965 -0.854 . . . . 1.4199999999999999 110.965 171.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.27 -48.03 5.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.314 -0.443 . . . . 2.3500000000000001 110.356 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.66 -63.68 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -53.93 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.306 0.484 . . . . 3.4100000000000001 112.306 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.22 18.29 1.34 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.434 -0.889 . . . . 2.3199999999999998 113.433 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -90.46 111.91 23.35 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.952 0.376 . . . . 3.1400000000000001 110.026 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.559 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 25.7 m-20 -71.94 149.22 92.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.567 -0.531 . . . . 2.1000000000000001 109.567 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 77.4 Cg_exo -49.79 -34.12 34.97 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.605 2.87 . . . . 1.6799999999999999 114.304 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -106.38 17.33 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.146 0.425 . . . . 3.6099999999999999 112.146 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 94.7 mt-30 -95.01 -9.28 34.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 2.5 111.074 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.798 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.7 m -104.29 21.55 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.473 0.545 . . . . 0.96999999999999997 112.473 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 115.91 29.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.456 -0.498 . . . . 1.0900000000000001 110.043 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.28 64.1 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.418 -1.073 . . . . 0.66000000000000003 110.418 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.4 mptp? -80.6 147.57 30.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.512 -0.844 . . . . 1.8200000000000001 111.196 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -107.67 113.77 27.28 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.687 -0.486 . . . . 0.71999999999999997 109.687 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.717 ' HB2' HD11 ' A' ' 39' ' ' ILE . 77.4 t80 -52.89 -50.75 63.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.316 -0.402 . . . . 0.69999999999999996 112.038 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.6 m-85 -76.97 5.84 7.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.043 -0.526 . . . . 1.1599999999999999 112.295 -168.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 -47.32 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.151 0.426 . . . . 3.5800000000000001 112.151 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -99.65 -23.77 14.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.218 0.451 . . . . 2.2000000000000002 112.218 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.8 t -120.87 14.46 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.524 -0.47 . . . . 1.77 110.9 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 170.84 86.44 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.89 -0.595 . . . . 0.60999999999999999 110.352 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HG2' ' CE1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -96.0 35.92 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.182 2.588 . . . . 0.81000000000000005 113.582 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 17.2 p -121.73 20.58 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.8 -0.445 . . . . 0.84999999999999998 109.8 171.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -130.14 -44.49 1.15 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.929 -1.487 . . . . 1.3300000000000001 109.668 -136.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 4.5 p-10 -73.32 103.98 4.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.828 0.823 . . . . 1.8500000000000001 109.393 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 64.5 m -163.93 164.59 14.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.506 -0.77 . . . . 1.5600000000000001 109.579 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 6.4 Cg_endo -49.96 -31.06 25.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.072 2.514 . . . . 1.1699999999999999 112.69 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HB3' ' HE2' ' A' ' 94' ' ' TYR . 1.3 mp0 -69.86 -91.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 2.5600000000000001 111.493 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HD1' ' HE2' ' A' ' 63' ' ' PHE . 45.6 t80 -60.74 -56.61 19.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.648 -0.705 . . . . 3.3599999999999999 111.811 -169.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 68.9 t80 -67.95 -38.5 82.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 110.464 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -47.61 90.32 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.59999999999999998 112.744 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.817 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.3 mmpt? -75.76 -28.72 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.931 0.365 . . . . 2.0899999999999999 110.527 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -58.97 -41.61 87.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.339 0.59 . . . . 0.67000000000000004 109.761 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.6 -11.07 49.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.447 -0.797 . . . . 1.0900000000000001 111.306 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 6.9 tp10 -67.42 -40.14 85.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 2.0699999999999998 110.567 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.954 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -71.9 -32.54 63.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.554 -0.832 . . . . 0.71999999999999997 111.227 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 83' ' ' VAL . 20.1 t -66.21 -50.86 65.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.255 -0.472 . . . . 0.84999999999999998 110.673 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.94 83.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.782 -0.644 . . . . 1.1399999999999999 111.769 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 p -77.38 -71.54 0.4 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.045 0.45 . . . . 1.8200000000000001 110.527 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.091 -0.575 . . . . 1.6499999999999999 111.947 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.93 158.15 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 3.5 110.366 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.954 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 1.4 pt? -138.61 135.69 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.987 -0.552 . . . . 2.96 110.057 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 109' ' ' MET . 33.8 p-10 -164.01 47.94 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.445 1.117 . . . . 2.2400000000000002 108.9 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -104.13 154.36 19.83 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.878 -1.51 . . . . 1.6299999999999999 109.955 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -112.95 115.53 28.55 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.107 0.479 . . . . 1.77 110.359 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.36 155.47 31.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 3.0099999999999998 109.199 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.33 121.88 44.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.238 0.542 . . . . 2.3900000000000001 111.18 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.645 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 46.2 m-85 -126.94 167.08 16.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.676 -0.693 . . . . 3.3700000000000001 111.091 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 m -106.68 139.6 40.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.885 -0.598 . . . . 1.3999999999999999 110.535 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CE2' HG11 ' A' ' 105' ' ' VAL . 13.0 m-85 -104.68 119.83 39.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.48 -0.933 . . . . 1.1799999999999999 108.48 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.3 -159.75 1.02 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.289 -0.634 . . . . 2.5699999999999998 109.289 -170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' CE1' ' HG2' ' A' ' 68' ' ' PRO . 90.2 t80 69.5 -76.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.981 0.512 . . . . 3.21 111.123 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -107.01 -26.69 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 3.23 109.646 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.8 tpp -84.86 139.32 31.98 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.606 -0.887 . . . . 2.8500000000000001 108.606 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.6 t -65.58 136.29 96.03 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.797 -1.186 . . . . 2.1200000000000001 107.797 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -43.51 91.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.3 2.666 . . . . 1.47 114.184 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.2 p -108.95 151.8 25.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.289 -0.414 . . . . 1.3999999999999999 111.304 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -109.84 116.44 31.66 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.457 -0.572 . . . . 3.0800000000000001 109.457 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 122' ' ' VAL . 11.3 p -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 1.3300000000000001 111.248 -171.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 105' ' ' VAL . 39.1 ttmt -109.37 118.27 36.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.319 -0.993 . . . . 1.6899999999999999 108.319 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 120' ' ' VAL . 86.3 t -104.55 117.01 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 115.727 -0.67 . . . . 1.27 109.485 -174.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -103.9 105.24 15.38 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.02 108.786 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.2 pmm? -103.68 128.84 50.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.993 -0.549 . . . . 2.4900000000000002 109.729 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 11.6 ptmm? -144.47 138.9 27.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 1.5700000000000001 111.259 -174.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.402 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 13.6 tttt -71.16 128.49 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.996 -0.547 . . . . 2.1299999999999999 111.939 -172.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -115.55 93.96 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.821 -0.807 . . . . 1.5700000000000001 108.821 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.83 83.88 3.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.669 0.747 . . . . 4.4100000000000001 110.906 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t -141.51 26.6 1.94 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.717 -1.129 . . . . 2.5499999999999998 108.534 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.27 25.15 0.42 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.055 -0.975 . . . . 2.6200000000000001 112.055 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 55.93 75.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.138 0.575 . . . . 2.7599999999999998 112.17 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 39.6 t -153.02 165.75 34.58 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.374 -0.973 . . . . 1.0700000000000001 108.374 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.7 m-85 -132.14 157.47 44.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.725 -0.843 . . . . 0.85999999999999999 108.725 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 73.8 m95 -101.22 111.35 23.54 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.861 -0.792 . . . . 0.63 108.861 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 107' ' ' VAL . 3.5 t -102.25 119.8 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.56 0.695 . . . . 0.91000000000000003 109.865 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-85 -104.57 140.63 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 0.79000000000000004 111.185 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 105' ' ' VAL . 54.1 t -104.58 104.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.073 -0.967 . . . . 1.1799999999999999 110.314 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.73 105.13 13.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.956 0.408 . . . . 3.3100000000000001 110.595 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -72.63 109.55 6.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.543 -0.54 . . . . 4.0300000000000002 109.543 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.504 -0.76 . . . . 2.8700000000000001 110.393 -178.254 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 p90 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.196 -0.298 . . . . 3.8500000000000001 110.196 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.44 112.61 4.26 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.309 -0.948 . . . . 0.84999999999999998 111.917 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -103.83 129.53 51.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.70999999999999996 110.923 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.528 ' HB ' HG13 ' A' ' 120' ' ' VAL . 58.2 mt -125.7 149.82 30.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.431 -0.804 . . . . 1.0800000000000001 108.999 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 31' ' ' ILE . 60.8 tt0 -115.18 122.89 47.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.115 -0.698 . . . . 0.85999999999999999 109.115 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD22 ' CG1' ' A' ' 120' ' ' VAL . 1.9 pt? -134.81 156.29 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.248 0.342 . . . . 1.6200000000000001 110.738 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 26.8 p30 -102.5 167.95 9.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.94 -0.304 . . . . 1.22 110.687 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.42 -2.71 3.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 114.963 0.745 . . . . 0.79000000000000004 114.963 -173.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.28 -18.92 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.581 0.691 . . . . 1.95 110.81 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 114.13 15.2 8.59 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.416 -0.897 . . . . 0.53000000000000003 113.254 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -86.44 135.58 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 117.125 0.463 . . . . 1.3 110.141 177.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 62' ' ' PHE . 23.0 mm -89.27 149.1 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.181 -0.463 . . . . 0.89000000000000001 109.938 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -121.19 -72.44 0.69 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.312 0.577 . . . . 1.45 110.177 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.4 134.19 55.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.719 -0.673 . . . . 1.99 111.666 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.547 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.3 m-85 -103.43 144.58 31.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.058 -0.974 . . . . 1.25 109.586 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 3.9 t30 -82.78 4.48 25.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.495 0.664 . . . . 2.1299999999999999 109.473 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.41 -22.39 0.24 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.36 -1.291 . . . . 1.48 112.228 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -65.32 -18.67 65.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.313 0.486 . . . . 1.52 112.313 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' HD11 ' A' ' 31' ' ' ILE . 2.6 tm-20 -70.39 -23.91 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.857 -0.794 . . . . 2.1200000000000001 108.857 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.13 13.4 67.76 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.777 -0.725 . . . . 1.4199999999999999 112.076 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.26 -44.76 71.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.163 0.506 . . . . 2.3500000000000001 110.314 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 49' ' ' ILE . 4.1 pt -78.45 -47.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.898 -0.592 . . . . 2.5899999999999999 112.153 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -61.93 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.995 0.426 . . . . 3.4100000000000001 110.945 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 138.89 126.5 2.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.893 -0.67 . . . . 2.3199999999999998 111.78 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 51' ' ' GLY . 26.6 mmt180 -139.1 156.12 47.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.39 -0.596 . . . . 3.1400000000000001 109.39 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.5 m-20 -103.21 120.04 53.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.044 0.449 . . . . 2.1000000000000001 111.311 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 26.4 Cg_exo -62.1 118.95 5.85 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.947 2.431 . . . . 1.6799999999999999 112.337 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 62.6 mttp 82.29 5.38 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.851 -1.068 . . . . 3.6099999999999999 112.224 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.25 -1.17 57.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.523 0.678 . . . . 2.5 109.558 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.795 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.5 m -98.88 10.29 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.143 -0.935 . . . . 0.96999999999999997 111.616 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 42.8 mt -80.99 132.27 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.345 -0.613 . . . . 1.0900000000000001 109.345 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.17 75.86 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.391 -0.909 . . . . 0.66000000000000003 110.842 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 17.0 mttm -109.52 132.04 54.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.121 -0.696 . . . . 1.8200000000000001 109.121 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.1 t-20 -90.0 102.98 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.755 -0.461 . . . . 0.71999999999999997 109.755 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.025 ' HB2' HD11 ' A' ' 39' ' ' ILE . 70.9 t80 -49.82 -39.15 37.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.69999999999999996 111.785 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.677 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m-85 -76.51 -20.5 56.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 1.1599999999999999 112.435 -171.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -116.84 -30.5 5.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.215 0.45 . . . . 3.5800000000000001 112.215 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -89.14 -79.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.037 0.384 . . . . 2.2000000000000002 112.037 -170.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 p -99.77 13.96 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.699 0.762 . . . . 1.77 111.685 -169.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.3 69.91 0.81 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.455 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 39.4 Cg_endo -68.94 11.31 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.644 2.229 . . . . 0.81000000000000005 113.688 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.8 m -79.92 -30.54 40.01 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.84999999999999998 109.717 173.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.677 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 17.3 p -78.93 -38.56 36.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.722 -1.127 . . . . 1.3300000000000001 110.383 -158.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 25.6 t70 -64.18 100.19 0.32 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.218 -0.66 . . . . 1.8500000000000001 109.218 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 30.5 t -149.63 147.78 23.9 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.919 -0.582 . . . . 1.5600000000000001 109.985 -171.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.38 -29.39 23.67 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.044 2.496 . . . . 1.1699999999999999 112.156 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.8 pt-20 -93.65 -60.03 1.86 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.638 -0.425 . . . . 2.5600000000000001 111.283 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 81.5 t80 -68.7 -52.31 32.23 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.198 -0.314 . . . . 3.3599999999999999 111.564 -169.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 51.7 t80 -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.79000000000000004 109.486 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.95 79.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.485 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 64.2 mmtt -81.91 -30.82 31.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.97 0.414 . . . . 2.0899999999999999 110.159 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -65.53 -30.64 71.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.67000000000000004 110.734 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 31.3 mmmt -82.79 -9.2 59.45 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.334 -0.848 . . . . 1.0900000000000001 111.47 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -58.88 -33.83 70.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.489 -0.323 . . . . 2.0699999999999998 111.71 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 1.058 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -88.08 -37.14 7.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.301 -0.952 . . . . 0.71999999999999997 112.139 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.04 -46.18 77.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.893 0.477 . . . . 0.84999999999999998 111.227 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -23.9 64.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 1.1399999999999999 111.798 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.2 m -104.99 -81.25 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.351 0.596 . . . . 1.8200000000000001 110.548 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.31 -48.6 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.886 -0.886 . . . . 1.6499999999999999 110.886 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.936 ' HA ' ' HG3' ' A' ' 111' ' ' LYS . 1.4 p-10 -124.17 150.94 44.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.868 -0.666 . . . . 3.5 111.335 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.058 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 56.5 tp -144.29 114.96 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 2.96 109.708 174.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 109' ' ' MET . 49.2 m-20 -124.8 89.61 3.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.613 . . . . 2.2400000000000002 109.667 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -124.74 165.58 17.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.159 -0.928 . . . . 1.6299999999999999 111.319 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.6 ttp -136.68 111.06 8.48 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.374 -0.973 . . . . 1.77 108.374 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -121.68 163.44 19.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.482 -0.326 . . . . 3.0099999999999998 110.211 -171.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -116.4 124.75 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.252 -0.647 . . . . 2.3900000000000001 109.252 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -138.08 159.19 42.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.294 -0.261 . . . . 3.3700000000000001 110.294 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.84 142.53 34.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.313 -0.403 . . . . 1.3999999999999999 111.085 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -107.51 132.74 52.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.172 -0.467 . . . . 1.1799999999999999 109.753 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 100' ' ' MET . 13.1 t70 -143.21 -150.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.452 -0.944 . . . . 2.5699999999999998 108.452 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.7 t80 66.3 -82.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.759 0.424 . . . . 3.21 111.151 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -99.6 -24.18 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.262 0.553 . . . . 3.23 109.819 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 101' ' ' THR . 52.6 tpp -91.79 141.61 28.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.847 . . . . 2.8500000000000001 108.996 173.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -72.38 143.17 85.18 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 108.757 -0.831 . . . . 2.1200000000000001 108.757 170.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -40.41 90.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.779 2.986 . . . . 1.47 114.186 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 m -123.24 144.64 49.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 1.3999999999999999 109.942 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.62 142.89 33.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.383 . . . . 3.0800000000000001 110.123 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -128.78 164.52 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.06 -0.518 . . . . 1.3300000000000001 110.505 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -108.72 117.88 35.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.13 -1.063 . . . . 1.6899999999999999 108.13 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.418 HG11 ' HE2' ' A' ' 75' ' ' PHE . 11.7 p -104.59 133.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.412 0.625 . . . . 1.27 109.655 -172.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 7.7 t-160 -111.18 109.88 20.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.964 -0.754 . . . . 1.02 108.964 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 44.9 tpp -102.23 123.76 46.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.23 -0.655 . . . . 2.4900000000000002 109.23 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -141.81 136.43 30.63 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.588 -0.153 . . . . 1.5700000000000001 110.588 -174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.936 ' HG3' ' HA ' ' A' ' 87' ' ' ASN . 7.7 tmtt? -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.171 0.51 . . . . 2.1299999999999999 110.813 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.635 ' N ' ' HD3' ' A' ' 111' ' ' LYS . . . -146.62 160.46 42.15 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.549 -0.75 . . . . 1.5700000000000001 109.913 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -103.23 -0.62 30.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.746 0.308 . . . . 4.4100000000000001 110.479 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -61.78 106.47 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.505 -0.924 . . . . 2.5499999999999998 108.505 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.96 -103.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.526 -1.429 . . . . 2.6200000000000001 109.526 -164.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -179.07 84.54 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.775 -0.824 . . . . 2.7599999999999998 108.775 167.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 2.6 p -166.0 -172.24 2.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.447 -0.797 . . . . 1.0700000000000001 111.237 -171.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 75.0 m-85 -110.86 155.32 22.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.489 -0.56 . . . . 0.85999999999999999 109.489 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -103.71 107.78 18.79 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.297 -1.001 . . . . 0.63 108.297 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.528 HG13 ' HB ' ' A' ' 31' ' ' ILE . 12.5 p -100.64 131.86 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.702 0.763 . . . . 0.91000000000000003 110.369 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.0 m-85 -115.2 128.82 56.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.457 -0.792 . . . . 0.79000000000000004 109.84 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -104.33 102.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.193 0.521 . . . . 1.1799999999999999 109.626 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -112.42 110.32 20.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 3.3100000000000001 109.698 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 5.7 ptm180 -74.6 166.55 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.535 -0.466 . . . . 4.0300000000000002 110.493 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.736 -0.65 . . . . 2.8700000000000001 109.81 177.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.989 -0.745 . . . . 3.8500000000000001 108.989 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -102.47 115.56 5.24 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.332 -0.937 . . . . 0.84999999999999998 112.925 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' A' ' 43' ' ' ASN . . . -104.33 104.2 14.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 109.844 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 120' ' ' VAL . 29.6 mt -113.09 158.23 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.818 -0.808 . . . . 1.0800000000000001 108.818 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 48.9 tt0 -120.08 112.66 19.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.807 -0.558 . . . . 0.85999999999999999 110.32 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.677 ' HG ' HG11 ' A' ' 120' ' ' VAL . 6.7 mt -114.05 142.92 45.58 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.895 -0.78 . . . . 1.6200000000000001 108.895 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -102.71 168.96 8.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.769 -0.372 . . . . 1.22 110.275 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -50.58 -33.39 25.86 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.672 0.629 . . . . 0.79000000000000004 114.672 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.04 -21.09 43.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.357 0.578 . . . . 1.95 111.45 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.3 17.36 10.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.579 -0.82 . . . . 0.53000000000000003 112.75 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 7.5 m120 -83.16 147.7 27.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.372 . . . . 1.3 110.343 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.033 HD11 ' HB2' ' A' ' 62' ' ' PHE . 13.5 mm -92.76 145.31 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.703 -0.681 . . . . 0.89000000000000001 110.287 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.8 mm? -97.68 -62.59 1.23 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 1.45 110.609 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -170.07 158.5 7.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.953 -1.021 . . . . 1.99 109.949 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.532 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 9.6 m-30 -110.94 147.74 33.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.523 -0.762 . . . . 1.25 109.376 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 30' ' ' ALA . 28.5 p-10 -80.36 -173.17 3.91 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.666 -0.494 . . . . 2.1299999999999999 109.666 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -78.21 20.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.009 0.374 . . . . 1.48 112.009 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . . . -97.38 -65.17 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.052 0.39 . . . . 1.52 112.052 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 27.9 tp10 -61.12 -51.02 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.682 -0.69 . . . . 2.1200000000000001 111.172 -172.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.96 -3.81 81.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.082 -0.58 . . . . 1.4199999999999999 112.648 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 34.7 t70 -84.2 -18.76 35.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.347 0.594 . . . . 2.3500000000000001 110.204 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -110.22 -65.18 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.57 -0.741 . . . . 2.5899999999999999 111.041 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.9 m -155.74 -42.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.524 0.202 . . . . 3.4100000000000001 111.42 -174.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -61.15 88.04 0.04 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 115.03 0.772 . . . . 2.3199999999999998 115.03 -170.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 20.0 mmm180 61.15 -176.87 0.12 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.999 0.904 . . . . 3.1400000000000001 113.273 170.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 5.8 t70 -102.75 132.68 21.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 114.471 -1.24 . . . . 2.1000000000000001 108.293 169.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 50.2 Cg_exo -55.29 -20.45 25.23 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.369 2.713 . . . . 1.6799999999999999 114.438 -174.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 1.9 mppt? -109.49 -3.49 16.96 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.037 -0.265 . . . . 3.6099999999999999 111.437 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -104.08 24.56 11.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.082 0.467 . . . . 2.5 111.784 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.76 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 m -118.52 10.99 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.035 0.445 . . . . 0.96999999999999997 111.319 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.73 133.33 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.653 -0.419 . . . . 1.0900000000000001 110.507 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.31 72.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.265 -0.734 . . . . 0.66000000000000003 111.265 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.55 148.25 47.91 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.659 -0.271 . . . . 1.8200000000000001 110.526 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 8.1 t-20 -98.96 125.16 44.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.035 0.445 . . . . 0.71999999999999997 111.512 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.033 ' HB2' HD11 ' A' ' 39' ' ' ILE . 48.5 t80 -64.72 -9.32 19.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 0.69999999999999996 111.868 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 52.0 m-85 -122.65 20.55 10.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.849 0.357 . . . . 1.1599999999999999 110.439 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 44.3 mmtm -150.79 -45.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 3.5800000000000001 111.824 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -101.84 -79.05 0.52 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 2.2000000000000002 111.389 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 HG12 ' A' ' 57' ' ' VAL . 14.7 m -84.14 15.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 1.77 112.54 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -172.64 97.06 0.36 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.60999999999999999 109.89 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.92 19.87 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.19 2.593 . . . . 0.81000000000000005 113.674 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -110.79 13.63 22.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.484 -0.486 . . . . 0.84999999999999998 109.839 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.9 p -112.74 -43.73 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.943 -1.026 . . . . 1.3300000000000001 111.055 -164.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -65.22 105.06 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 1.8500000000000001 110.506 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.602 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 9.7 t -170.54 149.79 3.12 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 109.349 -0.612 . . . . 1.5600000000000001 109.349 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 47.6 Cg_exo -39.38 -43.46 2.77 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.281 3.32 . . . . 1.1699999999999999 114.98 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.674 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.38 -39.47 11.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.785 -0.366 . . . . 2.5600000000000001 111.748 -176.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 70' ' ' THR . 28.3 m-85 -71.74 -69.29 0.4 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.176 0.513 . . . . 3.3599999999999999 110.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.8 t80 -61.66 -32.7 72.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.79000000000000004 110.193 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -59.83 -31.34 71.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 112.915 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 30.9 mmtp -78.05 -34.22 50.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.219 0.51 . . . . 2.0899999999999999 110.836 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.58 -26.55 68.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 0.67000000000000004 110.334 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 19.5 mmmt -93.13 -6.54 47.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 1.0900000000000001 112.038 -175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 6.6 mm-40 -58.14 -42.35 85.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.268 0.47 . . . . 2.0699999999999998 112.268 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -76.38 -41.36 25.83 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.999 -1.096 . . . . 0.71999999999999997 111.234 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.43 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.3 t -50.22 -48.15 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 123.121 0.568 . . . . 0.84999999999999998 111.121 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.42 -32.35 49.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.732 -0.667 . . . . 1.1399999999999999 112.502 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -90.08 -66.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.844 0.354 . . . . 1.8200000000000001 110.198 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.74 34.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.749 . . . . 1.6499999999999999 111.864 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.793 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 0.7 OUTLIER 65.88 105.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.277 -0.638 . . . . 3.5 109.277 -176.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.464 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 33.6 tp -143.45 159.35 42.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.132 -0.627 . . . . 2.96 111.757 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 109' ' ' MET . 18.9 t30 -82.05 112.83 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.036 -0.984 . . . . 2.2400000000000002 111.224 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -125.27 146.48 49.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 1.6299999999999999 110.157 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.572 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 21.3 ptp -116.73 129.37 56.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.839 0.352 . . . . 1.77 110.216 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 13.1 p90 -141.63 148.13 38.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.861 0.362 . . . . 3.0099999999999998 110.968 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.94 116.67 30.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 2.3900000000000001 109.914 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 38.7 m-85 -142.21 168.02 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.1 -0.5 . . . . 3.3700000000000001 110.91 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 104' ' ' LYS . 36.2 p -102.85 156.86 17.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.968 -0.56 . . . . 1.3999999999999999 111.654 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -116.27 108.96 16.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 1.1799999999999999 109.194 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' MET . 7.1 p-10 -121.26 -153.75 0.56 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.943 -0.571 . . . . 2.5699999999999998 110.236 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 65.8 t80 71.43 -73.81 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.959 0.503 . . . . 3.21 111.477 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.44 -26.28 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.441 0.638 . . . . 3.23 109.807 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 16.5 tpt -103.31 140.61 37.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.17 -0.923 . . . . 2.8500000000000001 109.499 176.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 m -60.03 117.7 25.98 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.71 -0.848 . . . . 2.1200000000000001 108.71 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -38.15 93.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.096 3.197 . . . . 1.47 114.254 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 160.48 18.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 109.611 172.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.1 ptpt -115.49 146.49 41.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 3.0800000000000001 111.493 -178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 124' ' ' ARG . 18.9 m -130.6 165.66 30.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.004 -0.998 . . . . 1.3300000000000001 110.295 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -112.7 118.01 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.556 -0.905 . . . . 1.6899999999999999 108.556 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -105.02 104.87 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.88 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.572 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 6.7 t-160 -103.79 102.81 12.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.492 -0.929 . . . . 1.02 108.492 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 5.2 ppp? -107.85 140.79 40.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.585 -0.734 . . . . 2.4900000000000002 110.507 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.724 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 62.2 pttt -150.98 152.03 32.96 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.043 0.449 . . . . 1.5700000000000001 111.489 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.793 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 33.2 ttpt -75.58 136.62 40.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.696 -0.684 . . . . 2.1299999999999999 112.552 -172.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -130.98 107.29 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.369 -0.832 . . . . 1.5700000000000001 109.312 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -74.45 1.85 10.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.341 -0.39 . . . . 4.4100000000000001 111.135 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -51.89 -45.82 64.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 2.5499999999999998 111.149 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.36 29.15 2.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.587 -0.816 . . . . 2.6200000000000001 112.437 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.94 60.51 3.43 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.271 0.558 . . . . 2.7599999999999998 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.44 ' OG ' ' HG2' ' A' ' 32' ' ' GLN . 32.5 t -164.55 164.53 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.373 -0.973 . . . . 1.0700000000000001 108.373 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.762 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 21.1 m-85 -104.95 156.38 18.08 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.843 -0.429 . . . . 0.85999999999999999 109.843 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 62.8 m95 -101.58 106.12 17.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.398 -0.964 . . . . 0.63 108.398 172.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.677 HG11 ' HG ' ' A' ' 33' ' ' LEU . 4.2 p -101.94 122.51 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.86 0.838 . . . . 0.91000000000000003 110.473 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.724 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 94.4 m-85 -104.28 109.92 21.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.113 -0.949 . . . . 0.79000000000000004 109.676 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.17 108.06 23.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.08 -0.963 . . . . 1.1799999999999999 109.914 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -104.5 127.8 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 3.3100000000000001 110.241 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.728 ' HA ' HG12 ' A' ' 105' ' ' VAL . 49.7 mtm-85 -70.44 127.91 34.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.006 -0.543 . . . . 4.0300000000000002 109.732 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 104' ' ' LYS . 3.0 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.938 -1.03 . . . . 2.8700000000000001 111.326 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.233 0.197 0 N-CA-C 109.603 -0.517 . . . . 3.8500000000000001 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.2 148.33 17.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.377 -0.916 . . . . 0.84999999999999998 112.518 -174.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' HD22 ' A' ' 43' ' ' ASN . . . -138.9 105.05 5.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.842 0.353 . . . . 0.70999999999999996 110.338 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.837 ' HB ' HG13 ' A' ' 120' ' ' VAL . 11.3 mm -108.67 160.83 7.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.767 -0.827 . . . . 1.0800000000000001 108.767 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 31' ' ' ILE . 59.2 tt0 -128.43 118.7 23.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.69 -0.485 . . . . 0.85999999999999999 109.69 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 120' ' ' VAL . 17.1 mt -116.05 155.51 28.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.699 -0.482 . . . . 1.6200000000000001 109.699 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.4 p30 -108.76 169.38 8.7 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.867 -0.333 . . . . 1.22 110.259 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.2 -20.52 6.92 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.3 0.88 . . . . 0.79000000000000004 115.3 -171.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.24 -19.84 23.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.901 0.851 . . . . 1.95 110.636 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.76 6.49 23.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.762 -0.733 . . . . 0.53000000000000003 112.292 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.645 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 89.7 m-20 -71.61 149.71 45.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.915 0.388 . . . . 1.3 110.486 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.0 mt -95.4 149.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.693 -0.685 . . . . 0.89000000000000001 109.37 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.1 mp -113.49 -56.76 2.37 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.45 109.879 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -150.77 144.27 25.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.027 -0.988 . . . . 1.99 111.142 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.067 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.2 m-30 -101.1 175.26 5.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.575 -1.193 . . . . 1.25 110.271 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.44 HD22 ' HB3' ' A' ' 30' ' ' ALA . 18.2 t-20 -102.41 179.72 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.61 -0.885 . . . . 2.1299999999999999 108.61 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -86.56 13.51 8.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.833 0.349 . . . . 1.48 110.493 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -89.92 -40.98 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 1.52 110.828 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 11.4 mp0 -59.74 -55.03 39.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 2.1200000000000001 110.374 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 51' ' ' GLY . . . -61.96 -30.8 76.41 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.562 -0.744 . . . . 1.4199999999999999 112.875 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.4 t70 -62.61 -33.43 74.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 2.3500000000000001 110.548 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.494 HG22 HG22 ' A' ' 50' ' ' THR . 44.7 mt -81.77 -62.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.776 -0.647 . . . . 2.5899999999999999 109.915 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 49' ' ' ILE . 9.4 t -179.44 131.43 0.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.157 -0.474 . . . . 3.4100000000000001 110.464 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . 57.33 -157.2 13.7 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.932 -0.576 . . . . 2.3199999999999998 112.808 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 4.4 mpp_? 53.95 79.85 0.12 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.755 -0.723 . . . . 3.1400000000000001 111.748 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' A' ' 56' ' ' GLN . 21.9 t70 -79.96 136.24 54.5 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 2.1000000000000001 110.598 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.067 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 11.1 Cg_endo -54.5 -33.56 78.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.667 2.911 . . . . 1.6799999999999999 114.123 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.94 2.02 48.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.434 . . . . 3.6099999999999999 111.129 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' CB ' ' HB3' ' A' ' 53' ' ' ASP . 22.4 tt0 -92.9 -8.4 43.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 2.5 110.966 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG21 ' CD2' ' A' ' 42' ' ' TYR . 3.2 m -112.93 58.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.623 0.601 . . . . 0.96999999999999997 112.623 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 40' ' ' LEU . 11.4 mt -122.39 139.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.687 -0.633 . . . . 1.0900000000000001 110.031 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.13 75.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.622 -0.799 . . . . 0.66000000000000003 111.191 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -114.36 139.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.147 -0.527 . . . . 1.8200000000000001 110.118 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.95 113.35 20.48 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.853 -0.425 . . . . 0.71999999999999997 109.853 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.2 t80 -47.21 -46.59 24.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.663 -0.699 . . . . 0.69999999999999996 111.542 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.862 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 49.6 m-85 -80.22 7.77 8.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 1.1599999999999999 111.614 -172.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -124.37 -50.77 1.76 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 3.5800000000000001 110.991 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.44 -79.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.687 0.625 . . . . 2.2000000000000002 112.687 -174.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.26 16.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.251 0.548 . . . . 1.77 111.373 -168.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB1' ' OG1' ' A' ' 70' ' ' THR . . . -165.93 70.45 1.22 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.60999999999999999 110.851 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.11 -6.28 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.901 2.401 . . . . 0.81000000000000005 113.17 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 7.5 p -84.59 -22.15 30.13 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.415 -0.587 . . . . 0.84999999999999998 109.415 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.556 ' OG1' ' HB1' ' A' ' 67' ' ' ALA . 2.2 m -79.38 -32.96 43.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.847 -1.524 . . . . 1.3300000000000001 110.477 -160.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.862 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 12.1 t70 -62.9 108.58 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.7 -0.682 . . . . 1.8500000000000001 109.999 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -162.95 155.78 16.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 1.5600000000000001 109.496 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.94 -32.7 97.93 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.374 2.049 . . . . 1.1699999999999999 111.913 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -80.44 -9.79 59.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 2.5600000000000001 112.482 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' A' ' 70' ' ' THR . 62.0 t80 -130.05 -67.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.109 -0.37 . . . . 3.3599999999999999 110.806 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -56.61 -41.53 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.79000000000000004 110.332 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.35 -34.3 84.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.04 -0.6 . . . . 0.59999999999999998 112.594 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.3 -36.95 38.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.391 . . . . 2.0899999999999999 110.243 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' HD1' ' HG2' ' A' ' 109' ' ' MET . 34.9 t80 -57.4 -44.54 84.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.67000000000000004 109.428 172.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -75.68 -18.91 59.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 1.0900000000000001 111.781 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -38.36 82.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.827 -0.434 . . . . 2.0699999999999998 109.827 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.682 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.34 -45.97 35.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.73 -0.748 . . . . 0.71999999999999997 111.481 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' PHE . 28.1 t -50.59 -48.52 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 122.979 0.511 . . . . 0.84999999999999998 111.1 176.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.4 -20.32 62.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.627 -0.715 . . . . 1.1399999999999999 112.01 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -99.14 -81.86 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.878 0.37 . . . . 1.8200000000000001 110.436 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.0 -60.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.826 -0.702 . . . . 1.6499999999999999 111.774 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -98.72 130.84 45.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.533 . . . . 3.5 109.627 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.682 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER -115.49 104.45 11.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.914 -0.773 . . . . 2.96 108.914 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.1 p-10 -149.32 95.44 2.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.135 0.969 . . . . 2.2400000000000002 110.227 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.9 m -142.86 145.16 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.112 -0.949 . . . . 1.6299999999999999 109.894 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -120.1 117.83 28.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.061 0.458 . . . . 1.77 109.778 174.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.03 154.15 36.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.04 -0.726 . . . . 3.0099999999999998 109.04 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 pt-20 -103.2 103.49 13.54 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 2.3900000000000001 110.553 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -110.78 161.27 15.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.704 -1.135 . . . . 3.3700000000000001 109.96 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' THR . 13.6 m -104.13 129.28 51.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.14 -0.482 . . . . 1.3999999999999999 110.938 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -103.35 104.62 14.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 1.1799999999999999 108.482 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.59 8.39 9.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 2.5699999999999998 111.793 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 71.6 t80 -79.22 -82.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.555 -0.293 . . . . 3.21 110.69 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -87.37 -37.86 16.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 3.23 109.77 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.0 ttt -82.2 139.9 34.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.766 -0.827 . . . . 2.8500000000000001 108.766 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.16 143.55 92.26 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 109.264 -0.643 . . . . 2.1200000000000001 109.264 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -42.48 89.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.64 2.893 . . . . 1.47 114.187 -174.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.8 m -108.14 145.9 33.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.977 -0.556 . . . . 1.3999999999999999 110.585 175.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -103.34 104.73 14.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.143 0.497 . . . . 3.0800000000000001 110.443 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.7 m -117.15 165.51 12.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.625 -0.716 . . . . 1.3300000000000001 109.973 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 35.9 ttmt -110.94 119.39 38.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.622 -0.881 . . . . 1.6899999999999999 108.622 177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 91' ' ' MET . 54.9 t -105.64 127.12 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 115.408 -0.815 . . . . 1.27 108.848 -171.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 2.2 t-160 -109.97 114.45 27.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.31 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 4.1 mpp? -101.45 119.83 39.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.007 -0.738 . . . . 2.4900000000000002 109.007 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 58.7 pttt -143.25 124.52 14.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.413 0.625 . . . . 1.5700000000000001 112.227 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 42.8 tttt -57.68 126.5 27.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.664 -1.153 . . . . 2.1299999999999999 111.162 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -174.79 94.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.091 0.774 . . . . 1.5700000000000001 113.091 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.021 HD11 ' H ' ' A' ' 117' ' ' SER . 0.2 OUTLIER 177.73 -174.98 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.005 0.522 . . . . 4.4100000000000001 111.431 167.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 t -77.22 77.63 3.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.529 -0.915 . . . . 2.5499999999999998 108.529 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.14 -134.06 3.62 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.753 -1.213 . . . . 2.6200000000000001 112.979 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -143.32 25.32 1.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 2.7599999999999998 110.648 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 1.021 ' H ' HD11 ' A' ' 113' ' ' LEU . 4.3 m -98.87 167.32 10.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.943 -0.762 . . . . 1.0700000000000001 108.943 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -127.13 156.99 40.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.002 0.43 . . . . 0.85999999999999999 110.216 -169.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.627 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 35.9 m95 -101.02 110.63 22.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.942 -0.762 . . . . 0.63 108.942 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 31' ' ' ILE . 3.5 p -103.25 107.87 23.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.512 1.149 . . . . 0.91000000000000003 110.59 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.627 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 95.7 m-85 -102.78 140.72 36.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.734 -1.121 . . . . 0.79000000000000004 110.697 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.87 104.15 16.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 1.1799999999999999 109.744 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.99 126.01 51.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.559 . . . . 3.3100000000000001 109.807 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HA ' HG12 ' A' ' 105' ' ' VAL . 44.3 mtm180 -79.8 143.79 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.789 -0.365 . . . . 4.0300000000000002 110.372 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.337 -0.84 . . . . 2.8700000000000001 109.899 179.415 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 110.085 -0.339 . . . . 3.8500000000000001 110.085 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.61 135.75 12.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.445 -0.883 . . . . 0.84999999999999998 113.243 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.9 104.62 12.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.514 -0.55 . . . . 0.70999999999999996 109.514 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 120' ' ' VAL . 60.5 mt -112.77 142.65 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.557 -0.534 . . . . 1.0800000000000001 109.557 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -109.41 116.19 31.37 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.553 -0.459 . . . . 0.85999999999999999 109.834 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 117' ' ' SER . 2.7 mm? -103.83 165.43 11.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.809 -1.182 . . . . 1.6200000000000001 107.809 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 47.3 p30 -108.19 167.16 10.21 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 1.22 110.333 173.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -60.54 -2.12 2.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 114.403 0.521 . . . . 0.79000000000000004 114.403 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -100.33 -47.33 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.534 0.667 . . . . 1.95 109.675 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.46 6.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.501 -0.772 . . . . 0.53000000000000003 112.558 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -76.96 149.61 35.95 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.969 0.414 . . . . 1.3 110.43 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 12.6 mt -95.96 148.13 5.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.663 -0.699 . . . . 0.89000000000000001 109.591 175.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 8.4 mp -115.64 -64.85 1.26 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.326 0.584 . . . . 1.45 111.945 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -150.66 158.8 44.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.219 -0.9 . . . . 1.99 110.641 -173.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 39' ' ' ILE . 5.3 m-30 -121.21 -174.19 2.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.065 -0.971 . . . . 1.25 110.158 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -114.81 178.96 4.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.844 -0.799 . . . . 2.1299999999999999 108.844 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.87 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 1.48 110.467 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -43.67 -63.82 0.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.847 . . . . 1.52 112.786 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -61.99 -37.9 86.57 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.796 0.331 . . . . 2.1200000000000001 111.792 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.27 94.59 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.807 -0.711 . . . . 1.4199999999999999 111.681 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.0 -38.17 82.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.538 0.335 . . . . 2.3500000000000001 111.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 45' ' ' ALA . 48.9 mt -56.53 -60.31 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.075 0.464 . . . . 2.5899999999999999 110.692 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 51' ' ' GLY . 8.8 t -144.69 -42.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.139 -0.482 . . . . 3.4100000000000001 111.071 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 50' ' ' THR . . . 139.64 77.47 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.395 -0.907 . . . . 2.3199999999999998 112.192 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 1.2 mpt_? -118.14 119.78 35.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.822 0.344 . . . . 3.1400000000000001 110.28 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.73 133.32 31.08 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 2.1000000000000001 111.255 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 31.8 Cg_exo -60.37 -28.87 87.61 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.038 2.492 . . . . 1.6799999999999999 112.16 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 10.9 mmpt? -79.82 -12.2 59.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.434 -0.348 . . . . 3.6099999999999999 111.616 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -89.52 -24.6 21.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 2.5 111.325 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.734 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 m -98.64 16.31 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.96999999999999997 113.462 -170.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.59 125.46 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.266 -0.574 . . . . 1.0900000000000001 109.969 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 -1.77 88.37 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.289 -0.957 . . . . 0.66000000000000003 110.861 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' ILE . 14.0 mptt -95.93 140.61 30.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.854 -0.673 . . . . 1.8200000000000001 109.877 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 14.4 t-20 -90.34 116.87 28.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.408 -0.59 . . . . 0.71999999999999997 109.408 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' HA ' HD11 ' A' ' 39' ' ' ILE . 89.0 t80 -56.24 -42.3 77.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.865 -0.607 . . . . 0.69999999999999996 111.278 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.4 m-85 -82.06 1.25 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.595 . . . . 1.1599999999999999 111.399 -170.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.4 mmtp -122.23 -58.32 1.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.94 0.4 . . . . 3.5800000000000001 111.559 -176.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.31 -76.98 0.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.743 -0.662 . . . . 2.2000000000000002 111.969 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 14.6 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.042 0.925 . . . . 1.77 111.716 -172.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -169.69 74.03 0.68 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.234 -0.893 . . . . 0.60999999999999999 110.636 175.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.45 -18.24 43.74 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.151 2.567 . . . . 0.81000000000000005 113.393 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.78 -8.06 59.03 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.975 -0.29 . . . . 0.84999999999999998 110.513 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -86.78 -19.97 28.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 1.3300000000000001 110.73 -176.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 16.8 t70 -67.93 96.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 1.8500000000000001 110.285 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' ' OE1' ' A' ' 74' ' ' GLU . 74.9 m -166.11 148.58 6.28 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.5600000000000001 109.477 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -53.27 -35.94 76.13 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.008 2.472 . . . . 1.1699999999999999 113.294 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 72' ' ' SER . 1.4 pm0 -86.36 -7.3 58.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.053 0.39 . . . . 2.5600000000000001 112.053 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 51.4 m-85 -112.56 -81.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 3.3599999999999999 109.927 173.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 75.2 t80 -59.67 -37.69 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.487 -0.779 . . . . 0.79000000000000004 110.555 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.24 94.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.088 -0.577 . . . . 0.59999999999999998 112.136 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 67.9 mmtt -67.8 -38.15 82.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.379 . . . . 2.0899999999999999 110.816 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 34' ' ' ASP . 93.6 t80 -57.5 -42.36 82.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.67000000000000004 110.614 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -85.91 -13.95 46.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.645 -0.707 . . . . 1.0900000000000001 110.854 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -41.45 86.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.192 0.52 . . . . 2.0699999999999998 109.699 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.892 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -70.16 -32.13 69.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.71999999999999997 111.545 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.63 -51.09 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.84999999999999998 110.354 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.47 67.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 1.1399999999999999 111.677 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -93.27 -77.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 1.8200000000000001 110.735 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.19 -64.8 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.62 -0.592 . . . . 1.6499999999999999 111.62 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.781 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -121.99 155.56 35.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.649 -0.5 . . . . 3.5 109.649 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.892 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 2.4 tm? -135.1 104.34 5.89 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.277 -0.638 . . . . 2.96 109.277 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 110' ' ' LYS . 25.5 m-80 -133.28 93.98 3.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.805 -0.813 . . . . 2.2400000000000002 108.805 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.425 ' O ' ' HD2' ' A' ' 108' ' ' HIS . 33.9 p -134.24 164.07 28.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.221 -0.899 . . . . 1.6299999999999999 110.882 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.8 ptt? -132.89 109.0 9.3 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.644 -0.707 . . . . 1.77 109.66 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -104.62 155.53 18.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.012 -0.995 . . . . 3.0099999999999998 109.818 -172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -117.57 111.7 19.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.047 -0.353 . . . . 2.3900000000000001 110.047 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.503 ' HE1' ' HG3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -163.87 168.6 19.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 3.3700000000000001 110.285 -177.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.4 ' H ' ' HD2' ' A' ' 94' ' ' TYR . 12.4 t -102.92 153.25 20.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.161 -0.472 . . . . 1.3999999999999999 110.565 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -114.9 103.24 10.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.759 -0.83 . . . . 1.1799999999999999 108.759 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -114.69 112.92 23.61 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.617 -0.72 . . . . 2.5699999999999998 111.078 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -174.2 -80.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 3.21 109.821 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -94.81 -41.48 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 3.23 109.433 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.2 ttp -80.9 124.96 29.54 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.708 -0.849 . . . . 2.8500000000000001 108.708 171.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.8 m -56.89 120.07 35.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.619 -0.512 . . . . 2.1200000000000001 109.619 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -24.33 91.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 1 C-N-CA 125.345 4.03 . . . . 1.47 114.978 -170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -108.81 144.82 36.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.896 -0.779 . . . . 1.3999999999999999 108.896 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -104.16 122.43 45.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.069 0.462 . . . . 3.0800000000000001 109.992 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.1 m -124.74 166.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.583 -0.735 . . . . 1.3300000000000001 110.321 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -103.95 117.33 34.05 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.682 -1.229 . . . . 1.6899999999999999 107.682 170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.8 p -104.21 119.36 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.899 0.856 . . . . 1.27 110.402 -170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 t-160 -103.6 105.3 15.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.006 -0.997 . . . . 1.02 109.362 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 57.5 tpp -103.9 123.54 47.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.713 -1.218 . . . . 2.4900000000000002 107.713 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.526 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 13.2 ptmm? -143.39 147.07 34.07 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.959 -0.696 . . . . 1.5700000000000001 111.033 -172.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.781 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 37.1 tttp -81.52 146.09 30.36 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.019 -0.537 . . . . 2.1299999999999999 111.217 -171.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.77 38.47 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.518 -0.919 . . . . 1.5700000000000001 108.518 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.77 -112.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.381 -0.528 . . . . 4.4100000000000001 110.732 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m 52.95 37.23 23.98 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.504 0.668 . . . . 2.5499999999999998 109.484 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.57 -90.7 0.55 Allowed Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.896 -1.282 . . . . 2.6200000000000001 109.896 -169.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -178.22 88.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.672 -0.862 . . . . 2.7599999999999998 108.672 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.0 p -135.95 -178.19 5.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.921 -0.581 . . . . 1.0700000000000001 111.503 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 88' ' ' LEU . 97.1 m-85 -131.31 144.33 51.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.564 -0.532 . . . . 0.85999999999999999 109.564 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 32.9 m95 -102.58 107.43 18.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.568 -0.901 . . . . 0.63 108.568 174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.9 p -100.37 142.77 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.784 -0.766 . . . . 0.91000000000000003 111.319 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.07 123.9 28.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.426 -0.807 . . . . 0.79000000000000004 109.725 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.01 103.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.429 0.633 . . . . 1.1799999999999999 111.31 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -104.42 121.42 43.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 3.3100000000000001 109.889 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.914 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.18 140.75 55.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.834 0.35 . . . . 4.0300000000000002 111.093 -179.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.766 -0.635 . . . . 2.8700000000000001 109.518 177.223 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 44' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.07 -0.345 . . . . 3.3399999999999999 110.07 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.51 -32.26 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 2.8999999999999999 111.176 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.89 138.14 31.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.782 0.325 . . . . 3.8500000000000001 110.357 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.7 150.95 17.28 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.909 -0.662 . . . . 0.84999999999999998 112.51 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.44 104.92 3.68 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.031 -0.729 . . . . 0.70999999999999996 109.031 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.513 ' HB ' HG13 ' A' ' 120' ' ' VAL . 21.7 mt -116.74 156.49 17.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.1 -0.5 . . . . 1.0800000000000001 109.731 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 62.6 tt0 -121.81 111.73 17.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.391 -0.596 . . . . 0.85999999999999999 109.391 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -112.32 148.96 33.1 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.655 -0.498 . . . . 1.6200000000000001 109.655 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -104.44 168.07 9.33 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.119 -0.233 . . . . 1.22 110.373 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.04 -7.13 29.1 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.387 -0.369 . . . . 0.79000000000000004 113.891 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -89.11 -45.62 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 1.95 109.811 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 134.45 12.61 1.38 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.53000000000000003 112.307 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 149.88 22.65 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.845 0.355 . . . . 1.3 110.178 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 17.7 mt -94.08 145.36 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.808 -0.633 . . . . 0.89000000000000001 109.781 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.4 mm? -106.52 -68.4 0.88 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.556 0.694 . . . . 1.45 110.075 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -133.89 133.29 41.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.185 -0.916 . . . . 1.99 110.656 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.94 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.7 m-30 -94.59 -176.23 3.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.635 -0.711 . . . . 1.25 110.3 171.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -118.53 165.79 13.5 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.56 -0.904 . . . . 2.1299999999999999 108.56 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.719 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -76.88 19.09 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 1.48 111.332 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.33 -49.07 6.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 1.52 110.279 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 50' ' ' THR . 3.6 mm-40 -69.7 -29.12 66.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.472 0.653 . . . . 2.1200000000000001 110.026 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -88.26 -5.83 75.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.691 -0.766 . . . . 1.4199999999999999 112.33 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.6 t70 -83.1 -60.17 2.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.771 0.319 . . . . 2.3500000000000001 110.683 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' H ' HG12 ' A' ' 49' ' ' ILE . 2.8 pt -94.54 -46.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.291 -0.413 . . . . 2.5899999999999999 111.93 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -70.64 -54.64 11.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.175 0.512 . . . . 3.4100000000000001 110.56 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 110.47 39.61 1.46 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.765 -0.731 . . . . 2.3199999999999998 112.405 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 3.1 mpt_? -118.81 98.26 6.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.59 -0.522 . . . . 3.1400000000000001 109.59 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.878 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.8 m-20 -64.08 152.86 86.77 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.536 . . . . 2.1000000000000001 110.559 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.94 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 48.0 Cg_exo -58.01 -18.74 37.15 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.37 2.713 . . . . 1.6799999999999999 113.765 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.7 4.68 26.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.82 0.304 . . . . 3.6099999999999999 111.82 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.878 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 80.9 mm-40 -90.45 -9.33 47.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.731 0.301 . . . . 2.5 111.43 -176.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.737 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.7 m -111.87 25.73 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.986 0.736 . . . . 0.96999999999999997 112.986 -171.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -89.78 126.5 42.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.248 -0.581 . . . . 1.0900000000000001 110.333 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.23 87.79 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.66000000000000003 110.844 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 47.3 mttm -106.73 138.79 42.25 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.072 -0.564 . . . . 1.8200000000000001 110.619 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 25.8 t-20 -80.04 114.33 18.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.039 -0.528 . . . . 0.71999999999999997 109.8 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.624 ' HA ' HD11 ' A' ' 39' ' ' ILE . 69.5 t80 -56.14 -43.34 78.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.961 -0.563 . . . . 0.69999999999999996 111.416 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 39.6 m-85 -80.77 -6.25 58.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 112.329 -166.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.65 -45.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.448 0.536 . . . . 3.5800000000000001 112.448 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.44 -23.56 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.314 -0.555 . . . . 2.2000000000000002 111.833 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.93 14.01 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.116 -0.633 . . . . 1.77 110.998 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.29 74.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.904 -0.589 . . . . 0.60999999999999999 110.543 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.88 13.64 1.43 Allowed 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.939 2.426 . . . . 0.81000000000000005 113.698 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -97.12 -5.75 36.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 110.256 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.602 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 55.1 p -100.5 -28.87 12.68 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.61 -0.723 . . . . 1.3300000000000001 111.653 -159.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 10.1 p-10 -75.29 78.49 2.39 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.591 1.186 . . . . 1.8500000000000001 111.105 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.792 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 66.7 m -152.65 169.42 9.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 114.592 -1.185 . . . . 1.5600000000000001 108.776 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.792 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 29.3 Cg_endo -61.99 -14.57 38.01 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.007 2.471 . . . . 1.1699999999999999 114.926 -171.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.41 -34.29 13.51 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.901 -0.5 . . . . 2.5600000000000001 111.554 -175.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 69.0 t80 -106.29 -69.43 0.83 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 3.3599999999999999 110.459 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.658 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 63.8 t80 -60.62 -41.14 94.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.79000000000000004 110.727 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -56.86 -49.15 73.03 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.59999999999999998 112.383 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -67.48 -37.15 82.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 2.0899999999999999 110.558 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -57.78 -40.75 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.614 . . . . 0.67000000000000004 110.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -78.33 -18.59 54.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 1.0900000000000001 112.229 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 35.1 mt-10 -66.12 -39.79 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.417 . . . . 2.0699999999999998 110.939 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -69.71 -42.1 72.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.364 -0.922 . . . . 0.71999999999999997 111.436 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 83' ' ' VAL . 35.4 t -57.31 -51.6 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.38 . . . . 0.84999999999999998 110.67 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -26.83 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.774 -0.648 . . . . 1.1399999999999999 111.707 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -83.94 -77.94 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.8200000000000001 110.172 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.87 -68.48 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.235 -0.746 . . . . 1.6499999999999999 111.235 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -107.34 153.38 22.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 3.5 109.506 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 62.3 tp -118.19 126.41 52.14 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.932 -0.396 . . . . 2.96 109.932 -175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -166.15 94.12 0.54 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.939 0.876 . . . . 2.2400000000000002 109.774 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 4.4 m -139.52 153.71 47.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.801 -1.09 . . . . 1.6299999999999999 109.769 -174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 61.1 ttp -137.5 108.94 6.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.153 -0.314 . . . . 1.77 110.153 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 47.1 p90 -123.76 167.29 14.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.472 -0.331 . . . . 3.0099999999999998 110.76 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -102.68 132.79 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.622 -0.511 . . . . 2.3900000000000001 109.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -144.21 150.84 38.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.531 . . . . 3.3700000000000001 110.647 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 m -104.83 141.35 36.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.353 -0.385 . . . . 1.3999999999999999 110.806 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 105' ' ' VAL . 18.6 m-85 -104.63 120.81 42.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' MET . 4.0 p30 -143.66 -156.93 0.73 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.639 -0.71 . . . . 2.5699999999999998 109.527 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 58.1 t80 73.52 -24.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.152 0.581 . . . . 3.21 111.745 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 97' ' ' ASP . 10.6 pt20 -158.74 -38.02 0.06 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.337 -0.616 . . . . 3.23 109.337 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 101' ' ' THR . 54.3 tpp -78.71 143.67 36.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.849 -0.797 . . . . 2.8500000000000001 108.849 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.565 ' O ' ' HG3' ' A' ' 100' ' ' MET . 12.1 p -67.52 151.4 97.2 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 108.407 -0.96 . . . . 2.1200000000000001 108.407 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.59 87.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.994 2.462 . . . . 1.47 113.864 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' HE ' ' A' ' 124' ' ' ARG . 85.8 m -100.78 129.89 46.73 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.457 -0.792 . . . . 1.3999999999999999 110.422 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.34 114.76 29.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.48 -0.563 . . . . 3.0800000000000001 109.48 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.3 m -126.95 165.88 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.784 -0.644 . . . . 1.3300000000000001 111.151 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -115.19 128.09 55.95 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.499 -0.926 . . . . 1.6899999999999999 108.499 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 98.9 t -104.51 104.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.459 -0.791 . . . . 1.27 109.201 -171.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.64 104.42 14.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.177 -0.675 . . . . 1.02 109.177 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.93 143.79 32.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.486 -0.779 . . . . 2.4900000000000002 109.845 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.9 ptmt -154.31 154.24 33.04 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.466 -0.568 . . . . 1.5700000000000001 109.466 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.638 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 3.6 ttpm? -78.6 140.52 38.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.846 0.355 . . . . 2.1299999999999999 111.557 -171.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -113.25 169.08 9.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.982 -0.554 . . . . 1.5700000000000001 110.359 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' N ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 -6.2 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.524 -0.307 . . . . 4.4100000000000001 111.525 177.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 p -61.49 -39.53 91.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 122.02 0.914 . . . . 2.5499999999999998 109.167 170.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.02 22.21 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 108.749 -1.741 . . . . 2.6200000000000001 108.749 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.27 89.8 0.06 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.474 0.637 . . . . 2.7599999999999998 110.062 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 11.8 p -177.13 -170.02 0.27 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.521 -0.763 . . . . 1.0700000000000001 110.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 15.9 m-85 -129.0 158.46 38.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.631 -0.877 . . . . 0.85999999999999999 108.631 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.531 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 77.8 m95 -102.59 109.25 20.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.957 -0.757 . . . . 0.63 108.957 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.4 p -102.5 120.85 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.887 0.851 . . . . 0.91000000000000003 110.597 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.519 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 97.6 m-85 -103.61 136.53 43.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.467 -0.788 . . . . 0.79000000000000004 110.992 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -104.48 107.76 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.078 -0.965 . . . . 1.1799999999999999 110.026 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -103.65 104.42 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 3.3100000000000001 110.182 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.699 ' HE ' HG23 ' A' ' 103' ' ' THR . 34.3 ttt-85 -83.55 126.9 33.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.035 -0.357 . . . . 4.0300000000000002 110.035 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.125 -0.941 . . . . 2.8700000000000001 111.443 -179.476 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.432 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.645 -0.502 . . . . 3.3399999999999999 109.645 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.75 -82.26 0.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.82 0.343 . . . . 2.8999999999999999 111.046 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -133.3 155.71 48.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.044 -0.354 . . . . 3.8500000000000001 110.044 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.8 118.58 6.14 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.554 -0.832 . . . . 0.84999999999999998 111.354 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.89 106.63 17.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.878 0.37 . . . . 0.70999999999999996 110.481 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' HG13 ' A' ' 120' ' ' VAL . 20.7 mt -111.66 147.78 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.344 -0.613 . . . . 1.0800000000000001 109.344 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' NE2' HD22 ' A' ' 40' ' ' LEU . 47.1 tt0 -118.38 116.24 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.576 -0.528 . . . . 0.85999999999999999 109.576 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 19.0 mt -115.71 154.12 30.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 110.276 -0.268 . . . . 1.6200000000000001 110.276 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.727 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.2 p30 -112.03 167.4 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.497 -0.186 . . . . 1.22 110.497 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -19.11 50.55 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.507 0.563 . . . . 0.79000000000000004 114.507 -171.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 38.7 t70 -81.38 -14.85 56.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.367 0.603 . . . . 1.95 109.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 104.53 7.82 38.91 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.502 -0.772 . . . . 0.53000000000000003 112.009 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.727 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 40.1 m-80 -82.62 154.34 24.98 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.143 0.497 . . . . 1.3 110.483 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.832 HG21 ' HE2' ' A' ' 42' ' ' TYR . 9.1 mt -102.09 158.19 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.258 -0.883 . . . . 0.89000000000000001 108.767 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.0 mp -116.77 -68.35 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.635 0.731 . . . . 1.45 109.754 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.5 151.7 40.6 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.585 -174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.832 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.7 m-85 -109.94 179.04 4.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.636 -1.166 . . . . 1.25 109.116 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 45' ' ' ALA . 31.7 p-10 -109.74 163.75 13.21 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.874 -0.787 . . . . 2.1299999999999999 108.874 169.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.26 -7.12 44.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 1.48 111.842 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . . . -82.74 -23.77 33.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.458 -0.337 . . . . 1.52 111.378 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.02 -53.14 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.268 -0.642 . . . . 2.1200000000000001 109.268 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -55.76 -24.75 41.95 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 112.672 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.36 -33.36 75.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.842 0.353 . . . . 2.3500000000000001 110.918 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.8 mm -96.07 -69.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 2.5899999999999999 110.916 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.8 m -84.29 -60.43 2.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.727 0.299 . . . . 3.4100000000000001 110.281 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 119.39 40.51 0.62 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.091 -1.052 . . . . 2.3199999999999998 113.121 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -92.88 119.44 32.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.165 -0.68 . . . . 3.1400000000000001 109.165 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 19.6 m-20 -65.86 139.04 96.67 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 2.1000000000000001 112.503 -173.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.8 Cg_exo -66.98 121.56 8.77 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.691 2.261 . . . . 1.6799999999999999 111.796 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 68.7 mttm 83.96 7.17 0.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.028 0.83 . . . . 3.6099999999999999 112.604 171.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.609 ' HG3' HG13 ' A' ' 57' ' ' VAL . 2.6 pt20 -84.01 -16.96 42.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.909 0.862 . . . . 2.5 109.209 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.957 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.8 m -97.0 24.97 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.523 -1.217 . . . . 0.96999999999999997 112.789 -170.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.41 125.71 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.732 -0.469 . . . . 1.0900000000000001 109.732 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.95 5.77 88.82 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.227 -0.987 . . . . 0.66000000000000003 111.102 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.957 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 39.8 mttm -98.46 139.43 34.21 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.388 . . . . 1.8200000000000001 110.234 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 22.2 t-20 -86.25 111.96 20.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.761 -0.459 . . . . 0.71999999999999997 109.761 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HA ' HD11 ' A' ' 39' ' ' ILE . 80.9 t80 -57.72 -32.63 67.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.585 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 30.0 m-85 -86.42 1.22 52.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.9 -0.591 . . . . 1.1599999999999999 111.365 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -136.3 -62.55 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.327 0.492 . . . . 3.5800000000000001 112.327 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.82 -24.06 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.375 0.509 . . . . 2.2000000000000002 112.375 -164.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.83 13.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 112.215 0.45 . . . . 1.77 112.215 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.97 88.18 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.573 0.546 . . . . 0.60999999999999999 110.637 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.09 29.9 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.581 2.187 . . . . 0.81000000000000005 113.066 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.0 m -79.06 -30.61 44.12 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.983 -1.118 . . . . 0.84999999999999998 107.983 167.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 6.8 m -96.99 -25.15 15.49 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 112.57 -2.105 . . . . 1.3300000000000001 108.553 -119.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 11.0 p-10 -74.22 104.23 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 109.105 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.501 ' H ' ' HB3' ' A' ' 76' ' ' TYR . 48.7 m -160.29 151.65 16.17 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.283 -0.871 . . . . 1.5600000000000001 109.624 -173.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.85 -31.01 87.53 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.95 2.433 . . . . 1.1699999999999999 112.803 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.98 -2.36 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.343 0.497 . . . . 2.5600000000000001 112.343 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -134.73 -74.33 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.888 -0.325 . . . . 3.3599999999999999 110.537 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 85.8 t80 -57.54 -35.86 70.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.962 0.41 . . . . 0.79000000000000004 110.171 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' GLU . . . -57.67 -45.69 93.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.743 -0.662 . . . . 0.59999999999999998 112.048 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 72.5 mmtt -75.9 -38.68 57.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.669 0.235 . . . . 2.0899999999999999 111.096 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.808 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 66.4 t80 -56.06 -40.13 73.08 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.554 0.692 . . . . 0.67000000000000004 110.477 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -88.53 -16.66 32.08 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.292 -0.867 . . . . 1.0900000000000001 111.034 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 29.3 tt0 -70.25 -35.64 73.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.154 -0.476 . . . . 2.0699999999999998 110.563 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.731 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -76.37 -40.33 28.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.549 -0.834 . . . . 0.71999999999999997 111.513 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.6 t -54.49 -50.35 58.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 110.36 174.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.15 73.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.506 -0.77 . . . . 1.1399999999999999 111.988 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 p -90.74 -72.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 1.8200000000000001 110.959 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.75 -56.54 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.431 -0.89 . . . . 1.6499999999999999 113.497 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -122.1 149.62 43.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.379 0.609 . . . . 3.5 112.055 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA3' ' A' ' 82' ' ' GLY . 3.9 mm? -112.8 107.61 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.108 -0.951 . . . . 2.96 109.581 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.714 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.2 p30 -169.68 110.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.989 0.9 . . . . 2.2400000000000002 111.796 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -166.05 158.62 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.777 -1.101 . . . . 1.6299999999999999 109.413 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -127.77 119.97 26.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.127 0.489 . . . . 1.77 109.701 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.65 165.84 24.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.527 -0.545 . . . . 3.0099999999999998 109.527 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 51.1 mt-10 -104.32 115.2 29.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.06 0.457 . . . . 2.3900000000000001 110.423 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -118.33 152.74 35.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 3.3700000000000001 109.825 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -104.01 132.09 50.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 1.3999999999999999 110.594 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.848 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 79.4 m-85 -113.54 119.63 38.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.671 -0.492 . . . . 1.1799999999999999 109.671 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -123.2 -147.05 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 2.5699999999999998 109.629 -175.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 99' ' ' GLN . 54.5 t80 65.87 -85.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.044 0.537 . . . . 3.21 111.514 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.53 HE21 ' H3 ' ' A' ' 169' ' ' HC4 . 50.0 mt-30 -72.68 -51.17 20.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.45 0.643 . . . . 3.23 109.509 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.475 ' HE2' " H5'" ' A' ' 169' ' ' HC4 . 47.5 ttp -93.27 130.41 39.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.338 -0.846 . . . . 2.8500000000000001 109.783 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 m -52.85 117.55 11.36 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.766 -0.457 . . . . 2.1200000000000001 109.766 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -20.25 92.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.552 4.168 . . . . 1.47 114.725 -169.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -105.52 144.45 32.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 1.3999999999999999 111.184 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -103.32 117.66 35.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 3.0800000000000001 110.421 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 124' ' ' ARG . 29.5 m -127.97 165.06 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.991 0.425 . . . . 1.3300000000000001 111.001 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.597 ' HE2' HG11 ' A' ' 125' ' ' VAL . 18.5 ttmm -104.92 129.58 53.27 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.662 -1.236 . . . . 1.6899999999999999 107.662 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 121' ' ' PHE . 7.6 p -113.69 128.92 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.578 0.704 . . . . 1.27 110.096 -175.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -105.13 115.2 29.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.276 -0.875 . . . . 1.02 109.078 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.808 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 37.0 ttp -102.99 127.22 50.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.461 -0.94 . . . . 2.4900000000000002 108.461 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.719 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 20.8 ptmt -154.5 141.39 19.18 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.135 -0.32 . . . . 1.5700000000000001 110.135 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' LEU . 31.3 ttmt -84.46 136.77 33.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.122 0.487 . . . . 2.1299999999999999 111.367 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -112.65 165.84 11.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.718 -0.845 . . . . 1.5700000000000001 108.718 169.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.94 29.99 6.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.59 . . . . 4.4100000000000001 111.139 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -76.51 79.84 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.625 -1.25 . . . . 2.5499999999999998 107.625 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.31 -88.37 0.33 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.121 -1.192 . . . . 2.6200000000000001 110.121 -167.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.7 83.9 0.46 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.217 -1.031 . . . . 2.7599999999999998 108.217 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 p -146.42 152.27 38.77 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.683 -0.689 . . . . 1.0700000000000001 109.394 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.477 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -115.95 158.39 23.12 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.27 -0.641 . . . . 0.85999999999999999 109.27 -170.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 83.6 m95 -101.59 110.09 22.02 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.963 -0.754 . . . . 0.63 108.963 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.741 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -102.73 110.52 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 122.029 0.918 . . . . 0.91000000000000003 110.041 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.719 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 94.0 m-85 -103.93 127.91 51.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.4 -0.818 . . . . 0.79000000000000004 111.17 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.28 104.8 17.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.787 0.803 . . . . 1.1799999999999999 111.072 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -118.99 119.73 35.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.432 -0.803 . . . . 3.3100000000000001 109.919 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.3 ttt180 -68.88 135.72 51.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.987 0.423 . . . . 4.0300000000000002 110.696 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 106' ' ' LYS . 2.6 m . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.262 -0.875 . . . . 2.8700000000000001 110.776 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.848 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.569 HD13 ' N ' ' A' ' 27' ' ' ALA . 3.5 tm? . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.186 -0.672 . . . . 3.3399999999999999 109.186 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.569 ' N ' HD13 ' A' ' 26' ' ' LEU . . . -125.03 117.53 24.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.676 -0.693 . . . . 2.8999999999999999 109.481 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -31.9 150.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.813 1.32 . . . . 3.8500000000000001 113.38 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' CG ' ' A' ' 43' ' ' ASN . . . -101.24 104.39 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.472 -0.87 . . . . 0.84999999999999998 112.717 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.61 109.15 18.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.261 -0.469 . . . . 0.70999999999999996 109.819 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 32' ' ' GLN . 18.9 mt -105.26 153.93 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.8 tt0 -113.57 110.1 19.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.686 -0.486 . . . . 0.85999999999999999 109.686 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 79' ' ' PHE . 34.9 mt -111.98 150.36 30.68 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 109.45 -0.574 . . . . 1.6200000000000001 109.45 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 47.4 p30 -103.06 169.17 8.72 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.658 -0.417 . . . . 1.22 110.519 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.76 -14.67 16.34 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 113.922 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.65 -28.74 23.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.95 110.037 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.43 8.22 14.88 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.562 -0.744 . . . . 0.53000000000000003 111.443 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 90.1 m-20 -76.98 149.1 35.96 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.977 0.417 . . . . 1.3 110.744 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 42' ' ' TYR . 10.4 mt -92.87 153.68 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 58' ' ' ILE . 39.7 mt -122.67 -71.94 0.71 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.449 . . . . 1.45 110.189 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -125.71 136.36 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.399 0.619 . . . . 1.99 111.119 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -93.86 -176.0 3.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.936 -1.029 . . . . 1.25 111.005 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' CG ' ' HA2' ' A' ' 29' ' ' GLY . 7.8 p30 -125.05 -167.93 1.75 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.929 -1.032 . . . . 2.1299999999999999 109.764 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.32 -28.35 53.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.158 0.429 . . . . 1.48 112.158 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.77 -43.78 75.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 1.52 111.52 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -34.81 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.623 -0.262 . . . . 2.1200000000000001 110.634 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 52' ' ' ARG . . . -61.6 -21.35 60.34 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 121.205 -0.521 . . . . 1.4199999999999999 112.828 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -71.57 -28.61 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 2.3500000000000001 110.436 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -91.68 81.4 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.733 0.778 . . . . 2.5899999999999999 109.734 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 50' ' ' THR . 5.8 t -11.22 105.78 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 112.716 -2.038 . . . . 3.4100000000000001 114.363 174.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.39 3.88 22.3 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.231 -1.349 . . . . 2.3199999999999998 112.32 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HG3' ' HE1' ' A' ' 42' ' ' TYR . 6.5 mpt_? -115.16 94.8 4.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.788 0.327 . . . . 3.1400000000000001 110.878 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 16.5 m-20 -88.35 148.06 41.56 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.173 -0.467 . . . . 2.1000000000000001 110.442 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.011 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 40.0 Cg_exo -58.06 -34.93 99.0 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.112 2.541 . . . . 1.6799999999999999 113.653 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -131.61 19.61 4.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.75 0.648 . . . . 3.6099999999999999 112.75 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.633 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.19 8.57 44.27 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.454 -0.498 . . . . 2.5 110.929 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -121.19 29.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.96999999999999997 111.863 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 40' ' ' LEU . 22.7 mt -81.35 134.28 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.635 -0.426 . . . . 1.0900000000000001 110.51 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.6 29.61 74.18 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.22 -0.752 . . . . 0.66000000000000003 111.22 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 39' ' ' ILE . 3.7 mtmm -126.6 125.51 42.07 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.161 -0.52 . . . . 1.8200000000000001 109.76 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' ASN . 10.1 t-20 -73.65 114.26 11.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.874 -0.603 . . . . 0.71999999999999997 111.219 -170.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.552 ' HB2' HG12 ' A' ' 39' ' ' ILE . 90.6 t80 -56.47 -48.61 76.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.485 -0.78 . . . . 0.69999999999999996 111.146 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -79.94 5.25 14.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.011 -0.541 . . . . 1.1599999999999999 112.111 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -137.54 -53.16 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.028 0.381 . . . . 3.5800000000000001 112.028 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -96.42 -24.13 16.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.441 0.534 . . . . 2.2000000000000002 112.441 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.1 t -116.07 14.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 120.12 -0.632 . . . . 1.77 110.933 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.46 87.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.055 -0.52 . . . . 0.60999999999999999 110.342 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.45 -4.75 15.9 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.589 2.193 . . . . 0.81000000000000005 113.683 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -80.04 -13.62 59.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.227 -0.589 . . . . 0.84999999999999998 109.653 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -101.72 -4.23 26.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.821 -1.082 . . . . 1.3300000000000001 110.827 -157.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.07 95.63 6.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.918 -0.401 . . . . 1.8500000000000001 109.918 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.77 ' HB2' ' HD1' ' A' ' 75' ' ' PHE . 66.8 m -166.33 155.28 10.1 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.035 -0.728 . . . . 1.5600000000000001 109.035 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 31.0 Cg_endo -64.51 -20.87 66.22 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.456 2.104 . . . . 1.1699999999999999 112.04 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -91.79 -15.51 28.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.576 . . . . 2.5600000000000001 111.5 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.77 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 87.7 m-85 -106.75 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.287 0.565 . . . . 3.3599999999999999 109.72 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 41.1 t80 -63.53 -37.4 87.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.3 -0.864 . . . . 0.79000000000000004 110.321 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -62.78 -27.37 69.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.108 -0.568 . . . . 0.59999999999999998 112.483 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 68.1 mmtt -80.35 -29.52 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.751 0.31 . . . . 2.0899999999999999 110.555 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 64.7 t80 -68.43 -35.66 77.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.848 -0.797 . . . . 0.67000000000000004 108.848 170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -82.94 -3.82 57.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 111.239 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -53.68 -46.96 70.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.778 0.323 . . . . 2.0699999999999998 111.464 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.735 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -85.12 -42.84 6.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.086 -1.054 . . . . 0.71999999999999997 111.711 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 21.5 t -44.3 -49.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.667 0.787 . . . . 0.84999999999999998 112.031 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -42.42 38.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.862 0.465 . . . . 1.1399999999999999 111.953 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -77.46 -61.91 1.83 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.386 0.612 . . . . 1.8200000000000001 109.524 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.05 -54.16 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.503 -1.039 . . . . 1.6499999999999999 110.503 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 137.21 2.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.286 -0.957 . . . . 3.5 109.289 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.735 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 63.1 tp -165.89 125.18 1.65 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.868 -0.333 . . . . 2.96 111.514 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.56 131.56 44.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 2.2400000000000002 110.514 173.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 t -141.66 155.35 45.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.551 -0.75 . . . . 1.6299999999999999 109.888 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.4 ttp -130.27 119.35 22.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.83 -0.623 . . . . 1.77 110.512 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -130.72 155.01 47.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.085 -0.709 . . . . 3.0099999999999998 109.085 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 136.41 54.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.073 0.463 . . . . 2.3900000000000001 111.007 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.823 ' HD1' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -162.16 168.86 21.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.056 -0.52 . . . . 3.3700000000000001 110.418 -175.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.823 ' H ' ' HD1' ' A' ' 94' ' ' TYR . 25.6 m -102.53 143.29 32.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.3999999999999999 111.237 -173.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.611 ' CG ' " H6'" ' A' ' 169' ' ' HC4 . 17.4 m-85 -107.35 112.31 25.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.745 -0.835 . . . . 1.1799999999999999 108.745 173.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -118.76 14.12 13.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.294 0.479 . . . . 2.5699999999999998 112.294 -171.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 85.4 t80 -119.34 131.61 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.622 -0.51 . . . . 3.21 109.622 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.558 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 21.6 mm-40 75.51 -43.25 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.65 0.78 . . . . 3.23 110.477 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 tpt -105.88 142.03 36.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.505 -0.924 . . . . 2.8500000000000001 108.505 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.456 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -62.96 141.04 97.61 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.868 -1.16 . . . . 2.1200000000000001 107.868 173.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 51.0 Cg_exo -36.5 91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.78 2.987 . . . . 1.47 114.703 -173.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 t -108.9 146.57 33.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.903 -0.589 . . . . 1.3999999999999999 109.747 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -106.51 125.02 50.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.148 0.499 . . . . 3.0800000000000001 111.182 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 29.6 m -121.17 166.19 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 1.3300000000000001 111.079 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 36.2 ttpt -118.64 121.47 40.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.312 -0.996 . . . . 1.6899999999999999 108.312 174.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.6 103.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.905 -0.589 . . . . 1.27 109.499 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -105.55 102.13 11.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.673 -0.862 . . . . 1.02 108.673 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.44 149.81 25.83 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.863 -0.335 . . . . 2.4900000000000002 110.356 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 8.8 mtpm? -146.62 147.19 30.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.203 -0.666 . . . . 1.5700000000000001 109.203 -175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 1.2 tmmt? -87.18 137.48 32.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.266 0.555 . . . . 2.1299999999999999 111.154 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -140.33 -176.12 4.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.027 -1.101 . . . . 1.5700000000000001 108.027 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.11 -93.94 0.14 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.84 -0.8 . . . . 4.4100000000000001 108.84 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.6 p 42.89 38.96 1.55 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.231 0.826 . . . . 2.5499999999999998 113.231 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.57 15.64 20.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.614 -0.803 . . . . 2.6200000000000001 113.032 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 63.94 87.44 0.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.049 0.54 . . . . 2.7599999999999998 110.507 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 p -173.74 -176.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 1.0700000000000001 110.726 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.547 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 42.0 m-85 -121.05 147.59 45.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.996 -0.742 . . . . 0.85999999999999999 108.996 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.406 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 62.6 m95 -102.59 104.2 14.56 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.575 -0.898 . . . . 0.63 108.575 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 109' ' ' MET . 7.3 p -100.52 132.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.976 -1.011 . . . . 0.91000000000000003 111.417 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.84 113.88 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.406 -0.815 . . . . 0.79000000000000004 109.847 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.9 t -113.09 104.52 17.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 1.1799999999999999 110.31 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 159.39 42.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.388 -0.597 . . . . 3.3100000000000001 109.388 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 29.9 mtm180 -69.54 105.32 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.863 0.363 . . . . 4.0300000000000002 111.107 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 106' ' ' LYS . 11.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.879 -1.055 . . . . 2.8700000000000001 111.164 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.611 " H6'" ' CG ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.709 ' HG ' ' HA ' ' A' ' 45' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.918 -0.401 . . . . 3.3399999999999999 109.918 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.3 -49.09 3.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 2.8999999999999999 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.97 162.52 29.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 3.8500000000000001 109.664 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.69 119.74 6.46 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.464 -0.874 . . . . 0.84999999999999998 111.845 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.65 103.63 13.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.119 0.485 . . . . 0.70999999999999996 110.093 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.772 ' HB ' HG13 ' A' ' 120' ' ' VAL . 31.5 mt -108.2 159.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.203 -1.036 . . . . 1.0800000000000001 108.203 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.638 HE22 ' HB2' ' A' ' 113' ' ' LEU . 45.3 tt0 -133.42 134.16 43.28 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.618 -0.433 . . . . 0.85999999999999999 110.317 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.93 161.89 38.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.977 -0.556 . . . . 1.6200000000000001 110.536 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.667 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.5 p30 -103.93 169.09 8.71 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.062 -0.255 . . . . 1.22 110.741 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.65 -27.54 27.54 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 115.323 0.889 . . . . 0.79000000000000004 115.323 -170.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.96 -10.39 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.818 0.809 . . . . 1.95 111.263 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.41 2.19 21.48 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.359 -0.924 . . . . 0.53000000000000003 113.611 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.667 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 91.1 m-20 -71.06 126.7 30.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.191 0.496 . . . . 1.3 110.443 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 42' ' ' TYR . 17.2 mt -84.06 150.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.446 . . . . 0.89000000000000001 109.97 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.9 mp -110.03 -54.22 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.249 0.547 . . . . 1.45 109.942 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -166.22 149.14 7.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.215 -0.902 . . . . 1.99 110.785 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.787 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 8.9 m-30 -98.4 -176.89 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.241 -0.891 . . . . 1.25 110.641 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -112.37 163.99 13.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.494 -0.928 . . . . 2.1299999999999999 108.494 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.62 -27.6 17.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.48 111.474 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.709 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . . . -46.14 -54.14 9.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.152 -0.931 . . . . 1.52 112.51 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HG3' HD11 ' A' ' 31' ' ' ILE . 16.2 mm-40 -75.25 -29.92 60.35 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.961 0.41 . . . . 2.1200000000000001 110.922 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 -22.6 68.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.849 -0.691 . . . . 1.4199999999999999 111.635 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -87.81 -35.07 18.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.607 0.241 . . . . 2.3500000000000001 110.69 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 45' ' ' ALA . 45.9 mm -53.04 -54.03 19.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.142 0.496 . . . . 2.5899999999999999 110.249 176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 51' ' ' GLY . 5.9 t -140.08 -41.38 0.43 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 3.4100000000000001 111.041 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 50' ' ' THR . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.408 -0.901 . . . . 2.3199999999999998 111.734 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -113.78 99.53 7.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.002 -0.74 . . . . 3.1400000000000001 109.002 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.664 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 18.9 t70 -54.8 127.62 61.38 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.481 0.488 . . . . 2.1000000000000001 110.728 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.787 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 41.7 Cg_exo -59.16 -17.64 39.92 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.583 2.855 . . . . 1.6799999999999999 113.855 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -94.73 -1.83 52.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.758 0.313 . . . . 3.6099999999999999 111.025 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.664 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 54.7 mm-40 -102.64 5.24 39.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.12 0.486 . . . . 2.5 110.588 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.597 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.4 m -117.27 14.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.96999999999999997 111.654 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 40.0 mt -80.26 125.73 39.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.406 -0.517 . . . . 1.0900000000000001 110.407 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.3 10.52 78.81 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.843 -0.903 . . . . 0.66000000000000003 110.843 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.889 ' HD3' ' HB ' ' A' ' 66' ' ' VAL . 23.3 ttmt -104.88 135.72 45.72 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.64 -0.504 . . . . 1.8200000000000001 109.64 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -83.49 117.74 23.3 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.234 -0.439 . . . . 0.71999999999999997 111.491 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 57.8 t80 -72.11 0.63 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.799 -0.637 . . . . 0.69999999999999996 111.669 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 82.0 m-85 -116.74 -9.76 11.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.081 -0.387 . . . . 1.1599999999999999 111.222 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.3 -38.47 0.76 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.73 0.641 . . . . 3.5800000000000001 112.73 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 22.8 m-20 -90.43 -87.56 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.928 0.344 . . . . 2.2000000000000002 111.928 -174.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.889 ' HB ' ' HD3' ' A' ' 60' ' ' LYS . 6.4 p -83.16 14.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.992 0.901 . . . . 1.77 111.616 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -171.77 86.23 0.46 Allowed Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.486 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -90.8 4.38 4.39 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.365 2.044 . . . . 0.81000000000000005 113.597 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 11.4 p -84.65 -15.62 44.79 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 120.494 -0.483 . . . . 0.84999999999999998 110.152 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 6.8 p -87.46 -39.68 15.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.215 -1.357 . . . . 1.3300000000000001 111.048 -160.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -51.89 108.54 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.966 -0.561 . . . . 1.8500000000000001 110.784 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -161.74 149.63 12.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.5600000000000001 109.902 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.13 -26.25 82.29 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.379 2.053 . . . . 1.1699999999999999 111.409 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 13.9 pt-20 -96.91 1.29 50.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.851 -0.613 . . . . 2.5600000000000001 111.912 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' HD2' ' HE1' ' A' ' 92' ' ' PHE . 67.0 t80 -127.3 -70.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 3.3599999999999999 109.597 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.604 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 64.4 t80 -61.41 -38.39 86.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 0.79000000000000004 110.002 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.66 -34.98 91.41 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.054 -0.593 . . . . 0.59999999999999998 112.674 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HD2' ' O ' ' A' ' 74' ' ' GLU . 92.7 mttt -80.46 -31.18 37.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.311 0.577 . . . . 2.0899999999999999 110.093 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.774 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 72.8 t80 -61.27 -32.22 72.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.67000000000000004 110.377 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 13.2 mmmm -95.75 -5.48 41.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 1.0900000000000001 110.879 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -59.96 -52.93 63.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 2.0699999999999998 110.738 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -72.85 -27.9 68.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.57 -0.824 . . . . 0.71999999999999997 112.245 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.34 -54.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.84999999999999998 110.794 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.95 -29.6 70.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.576 . . . . 1.1399999999999999 110.566 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.0 m -74.04 -86.05 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.7 -0.682 . . . . 1.8200000000000001 110.05 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.4 -64.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.971 -0.852 . . . . 1.6499999999999999 110.971 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -92.37 132.72 36.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.801 -0.7 . . . . 3.5 110.182 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.1 tm? -110.26 105.5 14.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.943 -0.762 . . . . 2.96 108.943 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' MET . 22.7 p-10 -164.41 58.03 0.15 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.625 0.726 . . . . 2.2400000000000002 110.665 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -104.47 155.4 18.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.6299999999999999 110.499 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -128.96 124.15 34.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.611 -0.722 . . . . 1.77 110.024 177.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 50.5 p90 -144.23 168.1 20.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.507 -0.315 . . . . 3.0099999999999998 110.967 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -103.3 133.04 49.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.053 -0.521 . . . . 2.3900000000000001 110.087 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -149.44 166.48 28.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.026 -0.731 . . . . 3.3700000000000001 109.026 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -104.91 159.23 15.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.858 0.688 . . . . 1.3999999999999999 112.858 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -111.26 120.6 42.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.219 -0.66 . . . . 1.1799999999999999 109.219 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 21.5 t70 -133.92 -152.46 0.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.798 -0.816 . . . . 2.5699999999999998 108.798 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 40.4 t80 71.41 -68.1 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.956 0.503 . . . . 3.21 111.753 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.457 ' HG3' ' HD1' ' A' ' 98' ' ' TYR . 2.5 pp0? -112.24 -4.43 14.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.137 0.494 . . . . 3.23 110.755 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.6 tpp -126.92 143.8 51.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.723 -0.671 . . . . 2.8500000000000001 110.372 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -54.69 128.37 62.09 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.199 -1.037 . . . . 2.1200000000000001 108.199 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.1 90.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.547 2.831 . . . . 1.47 113.168 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.5 158.1 16.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.174 -0.921 . . . . 1.3999999999999999 110.701 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.957 ' HE2' ' HB ' ' A' ' 125' ' ' VAL . 18.1 ptmt -106.25 127.56 53.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 3.0800000000000001 111.387 -175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 122' ' ' VAL . 11.5 p -125.0 151.99 31.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.591 -0.731 . . . . 1.3300000000000001 110.353 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 105' ' ' VAL . 82.8 tttt -110.21 119.39 39.12 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.417 -0.957 . . . . 1.6899999999999999 108.417 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.9 p -112.34 129.74 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.453 0.644 . . . . 1.27 111.241 -171.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -112.71 104.59 12.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.005 -1.109 . . . . 1.02 108.005 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 79' ' ' PHE . 9.7 ptp -103.41 129.31 50.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.273 -0.421 . . . . 2.4900000000000002 110.628 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 59.6 mtpt -138.72 126.16 21.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.484 0.659 . . . . 1.5700000000000001 112.651 -168.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 25.3 tttp -70.36 114.63 8.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.51 1.124 . . . . 2.1299999999999999 111.498 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -177.8 93.67 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.535 0.939 . . . . 1.5700000000000001 113.535 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.638 ' HB2' HE22 ' A' ' 32' ' ' GLN . 28.7 tp 177.68 86.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.433 0.531 . . . . 4.4100000000000001 112.433 165.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 m 41.68 38.78 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.598 1.186 . . . . 2.5499999999999998 112.292 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.77 -123.96 1.23 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.931 -1.128 . . . . 2.6200000000000001 112.012 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.02 35.29 1.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.7599999999999998 111.059 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 p -100.36 135.33 41.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.95 -0.568 . . . . 1.0700000000000001 109.744 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.606 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 2.0 m-85 -109.37 161.33 15.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.775 -0.454 . . . . 0.85999999999999999 109.775 -169.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 109' ' ' MET . 88.9 m95 -100.92 114.72 28.86 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.689 -0.856 . . . . 0.63 108.689 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HB ' ' A' ' 31' ' ' ILE . 7.3 p -100.2 115.34 41.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.128 0.966 . . . . 0.91000000000000003 110.207 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.91 123.38 46.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.246 -0.888 . . . . 0.79000000000000004 111.146 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG13 HG21 ' A' ' 105' ' ' VAL . 66.3 t -104.7 105.62 18.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.122 -0.945 . . . . 1.1799999999999999 110.99 -176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -131.58 131.04 42.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.849 0.357 . . . . 3.3100000000000001 110.249 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.462 ' C ' ' HD2' ' A' ' 124' ' ' ARG . 7.4 ppt_? -72.88 157.41 37.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 4.0300000000000002 111.661 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.957 ' HB ' ' HE2' ' A' ' 104' ' ' LYS . 25.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.67 -0.681 . . . . 2.8700000000000001 109.166 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.828 -0.434 . . . . 3.3399999999999999 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.7 78.24 0.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.387 -0.369 . . . . 2.8999999999999999 110.125 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 55.76 -152.33 0.37 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.741 -0.663 . . . . 3.8500000000000001 110.451 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -103.68 132.82 11.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.59 -0.814 . . . . 0.84999999999999998 111.497 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -132.04 134.03 45.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.635 -0.506 . . . . 0.70999999999999996 109.635 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 120' ' ' VAL . 4.8 mp -128.01 144.43 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 109.775 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 40.4 tt0 -104.51 118.66 37.14 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.94 -1.133 . . . . 0.85999999999999999 107.94 170.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.4 pt? -130.1 150.14 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.43 -0.508 . . . . 1.6200000000000001 110.662 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -103.43 168.39 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.862 -0.421 . . . . 1.22 109.862 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.39 -29.05 22.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.381 0.512 . . . . 0.79000000000000004 114.381 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -75.2 -21.14 58.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.275 0.537 . . . . 1.95 111.324 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.14 4.44 38.43 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.898 -0.668 . . . . 0.53000000000000003 111.916 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.8 m-20 -77.23 141.18 40.15 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.978 -0.378 . . . . 1.3 109.978 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.5 mt -88.75 144.77 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.263 0.554 . . . . 0.89000000000000001 110.381 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -99.89 -59.29 1.74 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.264 -0.88 . . . . 1.45 110.227 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -165.13 153.06 11.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.757 -1.11 . . . . 1.99 110.027 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 4.7 m-30 -97.46 156.63 16.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 1.25 110.367 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.935 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 64.0 t30 -74.76 10.73 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.919 -0.582 . . . . 2.1299999999999999 111.104 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 42' ' ' TYR . . . 75.72 -42.34 0.46 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.896 -1.047 . . . . 1.48 112.213 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -56.87 -24.78 54.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.555 0.576 . . . . 1.52 112.555 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.75 -18.68 64.26 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.18 0.514 . . . . 2.1200000000000001 110.944 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.59 -7.6 78.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.613 -0.803 . . . . 1.4199999999999999 111.861 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.57 -46.87 5.57 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 2.3500000000000001 109.204 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 45' ' ' ALA . 30.8 mm -66.34 -67.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.419 -0.81 . . . . 2.5899999999999999 110.714 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 m -92.71 -56.97 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.479 -0.328 . . . . 3.4100000000000001 110.984 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.72 42.12 0.25 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.683 -0.77 . . . . 2.3199999999999998 112.156 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mmt180 -108.29 127.89 54.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.31 -0.256 . . . . 3.1400000000000001 110.31 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 56' ' ' GLN . 12.2 t70 -65.9 132.68 94.77 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 2.1000000000000001 110.306 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 7.3 Cg_exo -73.62 -12.88 24.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.986 2.457 . . . . 1.6799999999999999 114.209 -172.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -130.23 -7.45 4.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.605 0.965 . . . . 3.6099999999999999 113.605 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.576 ' HG2' ' CG ' ' A' ' 53' ' ' ASP . 77.6 mm-40 -75.23 -13.18 60.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.264 -0.575 . . . . 2.5 110.864 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.4 m -88.49 14.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.4 0.889 . . . . 0.96999999999999997 113.4 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' LEU . 38.6 mt -81.99 131.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.177 -0.609 . . . . 1.0900000000000001 110.131 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.34 26.63 72.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.011 -0.836 . . . . 0.66000000000000003 111.011 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -121.5 134.46 55.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.964 -0.618 . . . . 1.8200000000000001 110.177 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.4 114.66 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.79 0.329 . . . . 0.71999999999999997 110.297 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.73 -40.93 69.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.69999999999999996 111.389 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.604 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 72.2 m-85 -80.56 3.66 21.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.351 -0.386 . . . . 1.1599999999999999 111.534 -173.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -121.84 -51.65 2.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.48 -0.563 . . . . 3.5800000000000001 109.48 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -78.34 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 2.2000000000000002 112.155 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.0 t -96.22 16.38 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.794 0.33 . . . . 1.77 111.853 -168.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.99 77.2 0.74 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 121.989 -0.444 . . . . 0.60999999999999999 112.014 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -97.61 28.45 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.084 2.523 . . . . 0.81000000000000005 113.208 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.6 p -120.71 22.96 10.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.539 -0.541 . . . . 0.84999999999999998 109.539 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.9 m -136.58 -44.34 0.6 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.062 -1.426 . . . . 1.3300000000000001 109.41 -133.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 11.2 p-10 -68.98 119.88 13.97 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.207 -0.664 . . . . 1.8500000000000001 109.207 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 p -168.99 161.58 7.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.78 -0.645 . . . . 1.5600000000000001 109.743 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.96 -31.11 91.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.36 2.04 . . . . 1.1699999999999999 112.868 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.7 -4.66 54.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 2.5600000000000001 112.072 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -124.77 -70.82 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.181 -0.303 . . . . 3.3599999999999999 110.181 175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 93.8 t80 -60.44 -39.44 87.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 0.79000000000000004 110.284 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.11 -40.19 98.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.979 -0.629 . . . . 0.59999999999999998 112.219 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 74.0 mmtt -73.56 -26.14 60.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 2.0899999999999999 110.32 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -67.38 -35.49 79.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 110.276 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.1 mmmm -84.5 -14.89 47.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.994 -0.548 . . . . 1.0900000000000001 110.98 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 49.8 mm-40 -54.48 -52.28 62.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.154 0.502 . . . . 2.0699999999999998 111.016 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.525 ' H ' HD13 ' A' ' 88' ' ' LEU . . . -72.19 -33.34 62.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.71999999999999997 112.213 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' OH ' ' A' ' 118' ' ' TYR . 23.1 t -61.7 -51.61 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.84999999999999998 110.646 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.2 -21.7 66.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.843 -0.617 . . . . 1.1399999999999999 111.881 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -96.41 -77.57 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 1.8200000000000001 110.875 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.49 -77.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.5 -0.64 . . . . 1.6499999999999999 111.5 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.637 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.8 p30 -95.24 144.88 25.47 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.543 -0.54 . . . . 3.5 109.543 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 82' ' ' GLY . 54.6 tp -120.18 102.63 8.64 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.714 -0.476 . . . . 2.96 109.714 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 109' ' ' MET . 39.1 m-80 -148.65 97.41 2.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.017 -0.734 . . . . 2.2400000000000002 109.017 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -149.19 165.14 32.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.787 -0.642 . . . . 1.6299999999999999 110.496 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 ptp -132.97 129.58 38.41 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.828 -0.623 . . . . 1.77 109.972 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 45.5 p90 -146.51 165.25 30.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.023 -0.362 . . . . 3.0099999999999998 110.023 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -109.19 122.08 46.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 2.3900000000000001 110.971 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -131.83 153.84 49.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.792 -0.64 . . . . 3.3700000000000001 109.885 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 m -104.76 145.62 30.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.3999999999999999 110.458 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.648 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 97.9 m-85 -125.43 104.63 8.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.995 -0.372 . . . . 1.1799999999999999 109.995 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 9.1 p-10 -135.13 115.08 13.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.473 0.654 . . . . 2.5699999999999998 110.885 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 63.2 t80 -179.91 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.94 -1.027 . . . . 3.21 109.188 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -92.32 -35.87 13.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.905 -0.776 . . . . 3.23 108.905 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.28 144.17 25.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.131 -1.063 . . . . 2.8500000000000001 108.131 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.59 160.31 53.64 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 109.664 -0.495 . . . . 2.1200000000000001 109.664 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 50.3 Cg_exo -54.74 84.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 1.47 114.418 -171.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 p -102.13 147.7 26.3 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.291 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -121.24 130.36 53.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.007 -0.368 . . . . 3.0800000000000001 110.007 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 124' ' ' ARG . 35.8 m -122.87 164.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.175 0.512 . . . . 1.3300000000000001 111.658 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -104.25 111.72 24.45 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.837 -1.542 . . . . 1.6899999999999999 106.837 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 91' ' ' MET . 14.6 p -104.27 136.64 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-O 121.329 0.585 . . . . 1.27 109.701 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -111.95 114.33 27.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.647 -0.872 . . . . 1.02 108.647 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.2 tpp -100.39 133.68 44.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.46 -0.791 . . . . 2.4900000000000002 109.079 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 118' ' ' TYR . 12.2 mmmm -135.67 159.63 41.02 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.819 -0.808 . . . . 1.5700000000000001 108.819 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 64.7 tttp -104.86 121.05 42.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.126 0.489 . . . . 2.1299999999999999 111.657 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.624 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -107.91 99.02 8.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.694 -0.685 . . . . 1.5700000000000001 109.938 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.66 -19.54 62.08 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.595 -0.52 . . . . 4.4100000000000001 109.595 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 m -73.34 80.81 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.543 -0.753 . . . . 2.5499999999999998 110.174 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.05 9.18 13.84 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.524 -0.846 . . . . 2.6200000000000001 112.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 55.95 41.34 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.896 0.379 . . . . 2.7599999999999998 111.662 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -134.77 -167.14 1.93 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.514 -0.312 . . . . 1.0700000000000001 110.828 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.702 ' OH ' HG22 ' A' ' 83' ' ' VAL . 82.4 m-85 -135.55 153.51 51.67 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.003 -0.74 . . . . 0.85999999999999999 109.003 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 47.9 m95 -102.72 104.13 14.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.958 -0.756 . . . . 0.63 108.958 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 31' ' ' ILE . 11.6 p -100.34 125.66 54.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.108 0.956 . . . . 0.91000000000000003 111.39 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.73 137.06 54.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.894 -1.048 . . . . 0.79000000000000004 108.989 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 29' ' ' GLY . 27.0 m -104.69 141.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.093 -0.643 . . . . 1.1799999999999999 111.567 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -124.23 103.54 8.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.306 -0.861 . . . . 3.3100000000000001 109.257 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 15.0 ptm180 -75.05 120.78 21.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.506 -0.315 . . . . 4.0300000000000002 110.268 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.712 1.258 . . . . 2.8700000000000001 113.417 -174.025 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.648 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.433 HD22 ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.611 0.243 . . . . 3.3399999999999999 110.447 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.35 108.63 3.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.448 -0.342 . . . . 2.8999999999999999 110.254 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 69.65 142.34 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.116 0.885 . . . . 3.8500000000000001 112.137 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.42 123.49 7.88 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 0.84999999999999998 110.023 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -116.79 103.94 10.84 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.966 -0.294 . . . . 0.70999999999999996 110.362 -170.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 53.2 mt -108.7 114.34 46.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.971 -0.559 . . . . 1.0800000000000001 109.56 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -101.45 114.34 28.26 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.624 -0.88 . . . . 0.85999999999999999 108.624 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.24 160.53 34.61 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.632 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.4 169.88 8.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 1.22 110.574 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.28 -23.69 26.86 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 114.521 0.568 . . . . 0.79000000000000004 114.521 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -37.35 21.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.337 0.569 . . . . 1.95 110.751 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 128.96 11.3 2.9 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.479 -0.867 . . . . 0.53000000000000003 113.285 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -71.14 127.19 31.75 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.366 0.583 . . . . 1.3 109.727 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 16.2 mt -81.52 151.36 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.309 -0.626 . . . . 0.89000000000000001 109.309 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 58' ' ' ILE . 77.7 mt -129.82 -67.46 0.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.459 0.647 . . . . 1.45 110.115 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 63.2 mt-30 -112.61 138.38 49.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.633 -0.712 . . . . 1.99 110.347 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.832 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -118.41 -4.07 10.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.703 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 66.2 t30 63.23 172.89 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.538 -0.756 . . . . 2.1299999999999999 110.577 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 11.2 6.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 1.48 110.882 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -92.51 -63.78 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.229 -0.442 . . . . 1.52 111.472 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -57.26 -43.79 83.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 110.985 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA2' ' C ' ' A' ' 51' ' ' GLY . . . -68.82 -10.06 60.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.576 -0.821 . . . . 1.4199999999999999 113.148 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.15 -41.91 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.122 0.461 . . . . 2.3500000000000001 110.559 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 45' ' ' ALA . 6.1 pt -85.92 -47.56 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 112.296 0.48 . . . . 2.5899999999999999 112.296 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.7 p -105.82 -49.33 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.976 -0.453 . . . . 3.4100000000000001 111.175 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' ' HA2' ' A' ' 47' ' ' GLY . . . 139.91 -175.25 21.95 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.222 -0.751 . . . . 2.3199999999999998 111.222 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.704 ' HG2' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 71.57 99.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.308 0.643 . . . . 3.1400000000000001 111.407 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 3.6 m-20 -67.97 149.4 98.2 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 108.97 -0.752 . . . . 2.1000000000000001 108.97 171.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.832 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 10.3 Cg_endo -52.52 -31.78 50.43 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.788 2.325 . . . . 1.6799999999999999 111.938 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -71.35 -19.13 62.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.361 -0.836 . . . . 3.6099999999999999 111.46 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 15.3 mm-40 -94.97 -14.49 24.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 2.5 111.73 -171.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.694 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 3.4 m -111.23 18.93 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 113.033 0.753 . . . . 0.96999999999999997 113.033 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.732 HG22 ' HA ' ' A' ' 40' ' ' LEU . 8.3 pt -87.51 140.09 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.438 -0.505 . . . . 1.0900000000000001 110.586 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.72 10.04 71.03 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.223 -0.989 . . . . 0.66000000000000003 110.901 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 39' ' ' ILE . 87.1 mttt -114.71 135.99 53.55 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.761 -0.459 . . . . 1.8200000000000001 109.761 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 21.8 t-20 -81.62 115.78 21.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.146 -0.479 . . . . 0.71999999999999997 110.021 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 39' ' ' ILE . 48.1 t80 -50.73 -37.91 44.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.69999999999999996 111.618 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.641 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 38.2 m-85 -90.38 15.14 11.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.382 -0.372 . . . . 1.1599999999999999 111.577 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -148.66 -49.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 3.5800000000000001 111.716 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.03 -21.88 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.165 0.802 . . . . 2.2000000000000002 113.165 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 52' ' ' ARG . 5.4 p -149.58 14.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.357 -0.937 . . . . 1.77 112.82 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.25 94.52 0.43 Allowed Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.043 -0.526 . . . . 0.60999999999999999 111.703 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.02 -18.88 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.618 2.212 . . . . 0.81000000000000005 112.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.96 -12.03 48.78 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.142 -0.223 . . . . 0.84999999999999998 111.223 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 67' ' ' ALA . 10.9 t -82.56 -27.73 31.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.697 -0.401 . . . . 1.3300000000000001 110.854 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 19.1 t70 -67.05 110.36 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.217 -0.66 . . . . 1.8500000000000001 109.217 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -164.12 148.94 8.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.178 -0.464 . . . . 1.5600000000000001 109.791 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.81 -21.59 64.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.691 2.261 . . . . 1.1699999999999999 113.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.97 -21.59 19.69 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.97 -0.292 . . . . 2.5600000000000001 111.573 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 50.2 t80 -107.46 -72.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.767 0.317 . . . . 3.3599999999999999 110.176 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.69 -38.9 79.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.132 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.04 -40.25 93.17 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.59999999999999998 112.546 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 58.1 mttm -87.91 -21.95 24.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 2.0899999999999999 111.426 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.678 ' O ' HG23 ' A' ' 83' ' ' VAL . 84.6 t80 -62.17 -49.65 74.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.62 -0.882 . . . . 0.67000000000000004 108.62 170.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.43 -20.16 60.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.825 -1.08 . . . . 1.0900000000000001 110.309 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 30.3 tt0 -57.37 -36.72 71.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.425 -0.807 . . . . 2.0699999999999998 109.693 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.97 -32.62 8.84 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.611 -0.722 . . . . 0.71999999999999997 112.187 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.1 t -59.9 -53.04 54.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.59 0.219 . . . . 0.84999999999999998 111.59 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.83 -59.37 4.59 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.423 0.452 . . . . 1.1399999999999999 111.535 -175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.2 p -167.11 29.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.306 . . . . 1.8200000000000001 111.561 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.17 -10.71 19.88 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.53 -1.319 . . . . 1.6499999999999999 113.069 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 63.77 124.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.409 -0.589 . . . . 3.5 109.409 -169.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 118' ' ' TYR . 32.9 tp -103.67 104.19 14.2 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.655 -0.818 . . . . 2.96 111.432 -166.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.3 p-10 -165.03 104.68 0.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.497 1.142 . . . . 2.2400000000000002 109.429 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -165.41 166.63 18.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.996 -1.456 . . . . 1.6299999999999999 108.514 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.5 ptt? -133.25 122.22 23.61 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.072 0.463 . . . . 1.77 110.304 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -124.3 167.48 14.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.149 -0.478 . . . . 3.0099999999999998 110.41 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -102.59 119.32 38.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.748 -0.464 . . . . 2.3900000000000001 109.748 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -133.96 153.82 51.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.81 -0.632 . . . . 3.3700000000000001 110.319 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 p -104.45 150.49 24.51 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.72 0.295 . . . . 1.3999999999999999 111.295 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.442 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 53.0 m-85 -130.22 116.41 18.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.438 . . . . 1.1799999999999999 110.319 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' MET . 8.0 p-10 -124.54 -158.53 0.83 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.504 -0.771 . . . . 2.5699999999999998 109.238 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 67.1 t80 70.96 -74.64 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.685 0.394 . . . . 3.21 111.474 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.507 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 26.3 mm-40 -92.55 4.2 54.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.695 0.759 . . . . 3.23 110.357 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 tpt -150.0 152.0 34.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.659 -1.155 . . . . 2.8500000000000001 108.243 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 100' ' ' MET . 13.7 p -63.38 147.79 94.55 Favored Pre-proline 0 N--CA 1.443 -0.809 0 N-CA-C 108.069 -1.086 . . . . 2.1200000000000001 108.069 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.9 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.191 . . . . 1.47 112.649 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -99.51 149.22 23.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.931 -0.577 . . . . 1.3999999999999999 110.798 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -103.85 118.57 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.198 -0.667 . . . . 3.0800000000000001 109.198 174.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.5 m -123.05 163.73 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.592 0.711 . . . . 1.3300000000000001 111.616 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -110.79 114.88 28.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.905 -1.146 . . . . 1.6899999999999999 107.905 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.646 HG22 HG12 ' A' ' 122' ' ' VAL . 41.5 t -107.34 115.79 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.208 -0.451 . . . . 1.27 110.055 -168.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -104.27 109.03 20.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.658 -0.497 . . . . 1.02 109.658 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.691 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -103.97 134.32 47.45 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.842 -0.617 . . . . 2.4900000000000002 109.489 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -147.95 150.15 33.51 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.204 -0.295 . . . . 1.5700000000000001 110.204 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.515 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 42.9 tttm -87.01 128.72 35.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.667 0.27 . . . . 2.1299999999999999 111.037 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.34 127.65 30.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 1.5700000000000001 110.066 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.19 94.58 5.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.927 0.87 . . . . 4.4100000000000001 112.692 -174.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t -113.47 -62.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 104.3 -2.482 . . . . 2.5499999999999998 104.3 160.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.62 143.86 17.06 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 106.626 -2.59 . . . . 2.6200000000000001 106.626 151.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.92 100.14 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.661 1.231 . . . . 2.7599999999999998 111.12 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -156.7 -177.79 6.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.875 -1.057 . . . . 1.0700000000000001 109.003 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.515 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 9.0 m-85 -128.85 154.18 46.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.715 -0.846 . . . . 0.85999999999999999 108.715 -175.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 60.8 m95 -100.74 104.13 15.4 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.237 -1.023 . . . . 0.63 108.237 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.617 HG22 ' CB ' ' A' ' 109' ' ' MET . 47.9 t -101.8 104.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.889 -1.05 . . . . 0.91000000000000003 109.585 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 81.0 m-85 -103.16 138.64 39.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.79000000000000004 110.608 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.646 HG12 HG22 ' A' ' 107' ' ' VAL . 16.6 m -107.35 153.22 8.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.944 0.402 . . . . 1.1799999999999999 111.138 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -149.77 112.38 4.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.942 -0.572 . . . . 3.3100000000000001 110.186 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.651 ' HA ' HG12 ' A' ' 105' ' ' VAL . 20.5 ttt180 -73.1 145.34 46.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 4.0300000000000002 110.808 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 125' ' ' VAL . 3.2 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.153 -0.927 . . . . 2.8700000000000001 110.824 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.442 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.127 -0.694 . . . . 3.3399999999999999 109.127 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' H ' HD13 ' A' ' 26' ' ' LEU . . . -75.52 59.28 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.131 0.419 . . . . 2.8999999999999999 112.131 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 64.88 168.04 0.18 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.746 0.784 . . . . 3.8500000000000001 112.956 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.22 107.39 2.94 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.925 -0.87 . . . . 0.84999999999999998 110.925 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.55 128.82 51.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.70999999999999996 110.809 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 46' ' ' GLU . 57.5 mt -122.26 138.89 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.228 -0.656 . . . . 1.0800000000000001 109.228 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' A' ' 40' ' ' LEU . 62.6 tt0 -104.68 121.13 42.93 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.192 -0.67 . . . . 0.85999999999999999 109.192 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -137.01 153.74 50.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 1.6200000000000001 109.891 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 169.62 8.41 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.85 -0.34 . . . . 1.22 110.655 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.63 -22.59 8.46 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 115.313 0.885 . . . . 0.79000000000000004 115.313 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.36 -21.93 38.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.756 0.778 . . . . 1.95 110.638 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.88 3.94 31.76 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.093 -0.803 . . . . 0.53000000000000003 111.093 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.654 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.1 m120 -70.24 134.84 48.43 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.054 0.454 . . . . 1.3 110.705 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.1 mt -87.24 148.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.422 -0.808 . . . . 0.89000000000000001 110.015 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 32' ' ' GLN . 42.2 mt -117.69 -61.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.271 0.557 . . . . 1.45 110.516 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.8 136.89 18.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.389 0.614 . . . . 1.99 111.248 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.024 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.4 m-30 -92.5 153.1 19.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.899 -1.046 . . . . 1.25 110.77 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -88.04 166.22 14.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' HB3' HD11 ' A' ' 26' ' ' LEU . . . -53.46 -35.5 60.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.137 0.421 . . . . 1.48 112.137 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 26' ' ' LEU . . . -63.85 -48.07 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.751 0.278 . . . . 1.52 111.751 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG2' HD11 ' A' ' 31' ' ' ILE . 6.3 tp10 -72.46 -4.86 32.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.575 0.702 . . . . 2.1200000000000001 110.435 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.41 -54.12 0.62 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.486 -0.779 . . . . 1.4199999999999999 112.282 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.07 -38.36 61.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.984 0.421 . . . . 2.3500000000000001 111.36 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -81.78 -57.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 2.5899999999999999 109.823 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.4 m -57.42 -52.35 65.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.22 -0.9 . . . . 3.4100000000000001 112.032 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.73 42.77 0.92 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.625 -0.798 . . . . 2.3199999999999998 111.814 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -133.46 171.74 13.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.684 -0.488 . . . . 3.1400000000000001 109.684 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.804 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 16.1 t70 -105.76 130.93 22.24 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.701 -0.481 . . . . 2.1000000000000001 109.701 173.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.024 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 50.3 Cg_exo -55.02 -20.25 22.72 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.488 2.792 . . . . 1.6799999999999999 114.186 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -119.32 15.13 13.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.195 0.443 . . . . 3.6099999999999999 112.195 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.804 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 23.1 mm-40 -86.23 -13.23 47.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 2.5 110.161 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 57' ' ' VAL . 4.6 m -89.91 45.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.606 -0.724 . . . . 0.96999999999999997 112.179 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.06 133.2 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.641 -0.423 . . . . 1.0900000000000001 110.721 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 18.92 76.95 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.254 -0.738 . . . . 0.66000000000000003 111.254 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -124.25 151.79 43.75 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.623 0.249 . . . . 1.8200000000000001 111.084 -170.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -105.71 122.04 45.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.71999999999999997 109.416 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.7 t80 -54.09 -43.75 70.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.005 -0.543 . . . . 0.69999999999999996 111.733 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 70.9 m-85 -77.5 -5.41 49.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.16 -0.473 . . . . 1.1599999999999999 111.719 -172.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -128.37 -48.05 1.31 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.13 0.419 . . . . 3.5800000000000001 112.13 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -92.88 -22.54 19.2 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.483 0.549 . . . . 2.2000000000000002 112.483 -172.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.14 13.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.171 -0.612 . . . . 1.77 111.477 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 179.81 74.58 0.17 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.748 0.309 . . . . 0.60999999999999999 111.023 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.2 -4.1 11.05 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.766 2.311 . . . . 0.81000000000000005 113.64 -176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 p -113.1 18.24 18.15 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.096 -0.377 . . . . 0.84999999999999998 110.641 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p -97.17 -37.64 10.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 1.3300000000000001 111.125 164.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 59.1 t0 -59.96 102.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.207 0.527 . . . . 1.8500000000000001 110.486 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.2 p -163.55 154.86 14.37 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.618 -0.719 . . . . 1.5600000000000001 109.489 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.61 -21.41 71.97 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.6 2.2 . . . . 1.1699999999999999 113.001 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.62 -17.08 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.902 0.334 . . . . 2.5600000000000001 111.902 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.862 ' HE2' HG11 ' A' ' 107' ' ' VAL . 23.2 t80 -117.23 -68.92 0.88 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.825 -0.35 . . . . 3.3599999999999999 110.689 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.46 -35.22 79.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.79000000000000004 109.95 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.42 93.69 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.069 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 69.6 mmtt -71.4 -38.62 71.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.029 0.442 . . . . 2.0899999999999999 110.406 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.76 -37.06 80.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.797 -0.638 . . . . 0.67000000000000004 110.298 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.73 -20.98 32.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.832 -0.622 . . . . 1.0900000000000001 110.622 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -68.88 -35.83 77.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 2.0699999999999998 109.681 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.985 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -68.92 -36.67 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.538 -0.756 . . . . 0.71999999999999997 111.583 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.13 -51.76 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.212 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.44 69.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.623 . . . . 1.1399999999999999 111.162 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 t -65.95 -71.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.513 0.673 . . . . 1.8200000000000001 110.095 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.26 -62.59 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 108.884 -1.687 . . . . 1.6499999999999999 108.884 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.433 HD22 ' HA ' ' A' ' 87' ' ' ASN . 2.3 m120 -161.33 167.03 26.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.902 0.881 . . . . 3.5 108.674 167.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.985 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -125.59 152.79 44.64 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.8 -0.76 . . . . 2.96 111.299 -168.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.757 ' HA ' ' O ' ' A' ' 109' ' ' MET . 35.7 p30 -163.8 47.0 0.12 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.336 -1.302 . . . . 2.2400000000000002 109.162 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 p -102.36 165.21 11.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.843 -1.526 . . . . 1.6299999999999999 111.134 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -116.78 125.32 51.45 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.218 -0.901 . . . . 1.77 109.911 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.33 157.66 27.68 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.757 -0.461 . . . . 3.0099999999999998 109.757 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.25 111.11 23.59 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.595 -0.52 . . . . 2.3900000000000001 109.595 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -135.87 144.07 45.39 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.885 -0.598 . . . . 3.3700000000000001 109.408 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 104' ' ' LYS . 6.0 p -105.06 155.52 18.91 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.013 0.435 . . . . 1.3999999999999999 111.55 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 35.8 m-85 -116.19 104.73 11.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.919 -0.582 . . . . 1.1799999999999999 109.614 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 31.8 t70 -140.77 98.84 3.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.748 -0.66 . . . . 2.5699999999999998 110.198 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.61 ' HD1' ' HG2' ' A' ' 99' ' ' GLN . 65.2 t80 174.24 -71.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.675 0.61 . . . . 3.21 110.03 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG2' ' HD1' ' A' ' 98' ' ' TYR . 25.0 mm-40 -101.9 4.34 40.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.987 0.899 . . . . 3.23 109.319 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.5 tpp -137.99 139.4 39.64 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.114 -1.403 . . . . 2.8500000000000001 107.962 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.09 144.43 94.28 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 108.972 -0.751 . . . . 2.1200000000000001 108.972 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.4 90.9 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.349 2.699 . . . . 1.47 114.14 -167.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -89.85 143.73 26.54 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 110.683 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -110.91 107.87 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.395 -0.965 . . . . 3.0800000000000001 108.395 178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.6 m -129.64 163.17 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.789 0.804 . . . . 1.3300000000000001 112.365 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.66 123.02 47.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.408 -1.269 . . . . 1.6899999999999999 107.856 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.862 HG11 ' HE2' ' A' ' 75' ' ' PHE . 4.9 p -104.19 113.17 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.054 0.93 . . . . 1.27 109.759 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.492 ' CE1' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t-160 -104.9 104.24 13.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.976 -1.011 . . . . 1.02 108.813 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.757 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.3 pmm? -102.98 127.76 50.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.349 -0.612 . . . . 2.4900000000000002 109.349 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.564 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 42.4 mtmt -137.79 164.6 28.51 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 110.228 -0.286 . . . . 1.5700000000000001 110.228 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 3.9 tmtp? -94.92 149.98 20.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 2.1299999999999999 110.897 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -137.37 114.56 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.313 -0.858 . . . . 1.5700000000000001 109.333 173.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -87.72 32.71 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.5 0.667 . . . . 4.4100000000000001 110.703 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 p -79.73 -58.34 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.492 -0.777 . . . . 2.5499999999999998 109.935 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.44 20.98 5.48 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.409 -0.814 . . . . 2.6200000000000001 111.136 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.21 77.25 0.33 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.57 0.7 . . . . 2.7599999999999998 111.393 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.487 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 1.3 m -159.49 -171.22 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.51 -1.293 . . . . 1.0700000000000001 107.51 176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 78.6 m-85 -123.74 147.8 47.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 118.154 0.434 . . . . 0.85999999999999999 109.847 -174.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.593 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 70.9 m95 -103.93 108.54 19.92 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.241 -1.022 . . . . 0.63 108.241 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.21 135.96 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.574 0.702 . . . . 0.91000000000000003 110.437 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.564 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 98.6 m-85 -120.19 137.24 54.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.354 -0.839 . . . . 0.79000000000000004 110.715 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.6 t -104.01 102.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.304 -0.862 . . . . 1.1799999999999999 109.107 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -105.81 123.86 48.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.154 -0.476 . . . . 3.3100000000000001 109.883 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -66.14 137.37 56.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.726 0.298 . . . . 4.0300000000000002 110.818 -177.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 105' ' ' VAL . 3.3 p . . . . . 0 C--O 1.248 1.018 0 CA-C-N 116.35 -0.386 . . . . 2.8700000000000001 110.663 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.441 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.745 HD21 HG13 ' A' ' 49' ' ' ILE . 68.9 mt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.107 0.479 . . . . 3.3399999999999999 110.935 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.87 -56.46 2.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.93 -0.767 . . . . 2.8999999999999999 108.93 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 30' ' ' ALA . 35.0 p90 173.01 170.9 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.167 -0.924 . . . . 3.8500000000000001 109.354 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -104.07 115.26 5.0 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.732 -0.746 . . . . 0.84999999999999998 111.845 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -119.87 113.5 20.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.661 0.267 . . . . 0.70999999999999996 110.527 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.48 ' HB ' HG13 ' A' ' 120' ' ' VAL . 24.8 mt -120.2 146.42 25.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.416 -0.587 . . . . 1.0800000000000001 109.416 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.3 tt0 -115.74 136.34 53.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.255 -1.016 . . . . 0.85999999999999999 108.255 172.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.0 pt? -147.95 159.32 44.0 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.729 -0.388 . . . . 1.6200000000000001 110.999 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.624 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.8 p30 -102.85 167.79 9.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.308 -0.405 . . . . 1.22 110.201 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.2 -17.22 44.83 Favored Glycine 0 CA--C 1.517 0.198 0 CA-C-N 115.836 -0.62 . . . . 0.79000000000000004 113.855 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.92 -21.18 22.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.01 0.405 . . . . 1.95 111.139 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 117.09 3.49 17.51 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.418 -0.896 . . . . 0.53000000000000003 113.558 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 46.1 m-80 -71.11 128.93 37.58 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 117.453 0.627 . . . . 1.3 109.384 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.0 mt -83.5 144.08 10.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.047 -0.524 . . . . 0.89000000000000001 110.16 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -96.93 -75.47 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.45 110.066 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.528 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 16.9 pm0 -153.45 145.01 23.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 1.99 110.378 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.658 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.6 m-85 -90.68 156.91 17.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.142 -0.936 . . . . 1.25 109.313 170.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 58.7 t30 -70.6 156.47 39.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.85 -0.796 . . . . 2.1299999999999999 108.85 171.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.21 69.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 1.48 110.707 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 26' ' ' LEU . . . -69.84 -52.67 23.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.987 -0.551 . . . . 1.52 111.28 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.685 ' HB2' ' HA2' ' A' ' 29' ' ' GLY . 20.6 tp10 -61.41 -44.98 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 2.1200000000000001 111.286 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.06 -34.82 58.14 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.33 -0.938 . . . . 1.4199999999999999 113.009 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.25 -45.85 68.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.349 . . . . 2.3500000000000001 111.01 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.745 HG13 HD21 ' A' ' 26' ' ' LEU . 38.4 mm -74.32 -55.72 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.144 -0.48 . . . . 2.5899999999999999 111.307 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 m -64.26 -50.91 66.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.537 -0.302 . . . . 3.4100000000000001 111.781 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.79 44.51 0.41 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.342 -0.932 . . . . 2.3199999999999998 112.152 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 52' ' ' ARG . 57.5 mmt-85 -136.3 93.69 2.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.057 -0.72 . . . . 3.1400000000000001 109.057 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.91 142.11 79.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.759 0.652 . . . . 2.1000000000000001 112.759 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.44 114.23 1.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.135 2.557 . . . . 1.6799999999999999 112.26 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 77.38 11.63 2.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.835 -1.075 . . . . 3.6099999999999999 112.105 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -91.82 4.73 52.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.673 0.749 . . . . 2.5 109.056 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.71 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -110.23 14.84 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.764 -1.107 . . . . 0.96999999999999997 111.935 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 56.3 mt -80.43 128.22 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.451 -0.574 . . . . 1.0900000000000001 109.451 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 -8.39 65.66 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.123 -1.037 . . . . 0.66000000000000003 110.833 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 21.0 mttp -86.04 131.21 34.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.847 -0.797 . . . . 1.8200000000000001 108.847 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.1 t-20 -88.17 112.94 23.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.122 -0.631 . . . . 0.71999999999999997 109.866 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' A' ' 70' ' ' THR . 45.8 t80 -47.87 -64.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.361 -0.836 . . . . 0.69999999999999996 111.787 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -87.96 28.09 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.192 0.442 . . . . 1.1599999999999999 112.192 -169.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 38.9 ttpt -143.18 -42.43 0.3 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 3.5800000000000001 111.026 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' OD2' HG13 ' A' ' 66' ' ' VAL . 38.9 t70 -95.15 -77.02 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 2.2000000000000002 110.884 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.413 HG13 ' OD2' ' A' ' 65' ' ' ASP . 5.6 m -91.96 16.29 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.558 0.947 . . . . 1.77 113.558 -172.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -165.25 86.23 1.03 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.994 0.426 . . . . 0.60999999999999999 111.153 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 98' ' ' TYR . 79.4 Cg_endo -91.07 -4.84 4.34 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.683 2.255 . . . . 0.81000000000000005 114.257 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.769 ' HB3' ' HA ' ' A' ' 98' ' ' TYR . 11.8 p -73.67 -13.83 61.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.267 -0.573 . . . . 0.84999999999999998 109.814 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.582 HG23 ' HE1' ' A' ' 96' ' ' PHE . 11.1 m -91.49 -37.47 13.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.351 -1.295 . . . . 1.3300000000000001 110.607 -145.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.36 109.96 5.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.768 0.794 . . . . 1.8500000000000001 110.179 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.4 m -162.67 154.16 15.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.399 -0.819 . . . . 1.5600000000000001 109.314 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.17 -35.59 91.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.688 2.259 . . . . 1.1699999999999999 112.908 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.48 -16.15 60.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.248 0.462 . . . . 2.5600000000000001 112.248 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.432 ' HE2' HG11 ' A' ' 107' ' ' VAL . 61.5 t80 -124.5 -74.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 3.3599999999999999 110.485 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.46 -37.55 78.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 0.79000000000000004 110.966 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.29 -44.69 96.33 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.894 -0.67 . . . . 0.59999999999999998 112.106 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 71.9 mmtt -74.02 -32.29 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 2.0899999999999999 111.024 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.471 ' O ' HD11 ' A' ' 88' ' ' LEU . 89.3 t80 -60.14 -43.41 95.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.315 0.579 . . . . 0.67000000000000004 110.278 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.4 -19.6 45.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.86 -0.609 . . . . 1.0900000000000001 110.338 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.27 -37.68 83.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 2.0699999999999998 109.897 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.632 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.31 -44.83 41.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.799 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 79' ' ' PHE . 32.1 t -56.76 -50.47 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.84999999999999998 110.945 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -12.22 60.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 1.1399999999999999 112.229 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -101.26 -77.13 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.712 0.292 . . . . 1.8200000000000001 110.596 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.3 -62.23 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.738 -0.744 . . . . 1.6499999999999999 112.231 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -118.26 136.28 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.777 0.322 . . . . 3.5 110.552 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -104.74 123.17 47.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.179 -0.464 . . . . 2.96 110.261 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 36.9 t-20 -176.11 116.53 0.13 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.491 0.662 . . . . 2.2400000000000002 110.363 173.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 13.9 t -166.0 165.15 18.16 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.718 -1.128 . . . . 1.6299999999999999 109.031 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.61 ' HB3' ' HD2' ' A' ' 108' ' ' HIS . 22.6 ptm -140.0 108.64 5.91 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.335 0.588 . . . . 1.77 110.687 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -121.93 166.61 14.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.767 -0.651 . . . . 3.0099999999999998 110.548 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.59 121.55 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.495 -0.557 . . . . 2.3900000000000001 109.495 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -134.07 165.13 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.631 -0.713 . . . . 3.3700000000000001 109.458 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -104.42 147.17 27.86 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.734 -0.469 . . . . 1.3999999999999999 109.734 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HE1' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -139.45 103.33 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.198 -0.601 . . . . 1.1799999999999999 112.448 -169.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 7.3 t70 170.52 144.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 2.5699999999999998 108.958 167.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.769 ' HA ' ' HB3' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -72.02 -42.67 66.09 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.605 -0.725 . . . . 3.21 111.578 -176.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.466 HE21 ' HD2' ' A' ' 98' ' ' TYR . 48.6 mt-30 -137.02 -5.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.037 0.754 . . . . 3.23 113.037 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.92 160.51 29.13 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.17 -0.678 . . . . 2.8500000000000001 109.17 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.87 100.92 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 108.504 -0.924 . . . . 2.1200000000000001 108.504 167.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -39.55 99.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.425 3.417 . . . . 1.47 113.996 -161.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.5 m -56.42 153.39 9.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.359 -0.837 . . . . 1.3999999999999999 110.273 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.98 136.53 42.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.226 0.536 . . . . 3.0800000000000001 110.946 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 122' ' ' VAL . 10.6 p -144.4 156.2 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.381 -0.827 . . . . 1.3300000000000001 110.294 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.429 ' HE3' HG11 ' A' ' 125' ' ' VAL . 29.0 ttmt -109.38 128.77 55.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.098 -1.075 . . . . 1.6899999999999999 108.098 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 122' ' ' VAL . 50.3 t -119.56 114.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 109.221 -0.659 . . . . 1.27 109.221 -166.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 91' ' ' MET . 56.5 t-80 -104.78 122.78 46.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.899 -0.591 . . . . 1.02 109.969 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.4 mpt? -100.29 147.47 25.73 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.497 -0.927 . . . . 2.4900000000000002 108.497 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.612 ' HD3' ' HE1' ' A' ' 121' ' ' PHE . 21.8 ptmt -162.67 143.82 10.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.464 -0.569 . . . . 1.5700000000000001 109.464 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 84.4 tttt -94.0 122.51 36.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.451 . . . . 2.1299999999999999 111.111 -170.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.478 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -104.62 174.78 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.743 -0.662 . . . . 1.5700000000000001 109.335 175.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.4 tp -121.56 -28.7 4.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.812 0.339 . . . . 4.4100000000000001 110.129 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -71.34 100.24 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.424 -0.584 . . . . 2.5499999999999998 109.424 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.64 -6.01 33.22 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.301 -0.952 . . . . 2.6200000000000001 112.151 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 51.87 51.62 16.16 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.27 0.557 . . . . 2.7599999999999998 110.099 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.4 p -152.59 178.98 9.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.857 -0.611 . . . . 1.0700000000000001 110.568 -172.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 2.5 m-85 -117.22 155.68 29.01 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.569 -0.9 . . . . 0.85999999999999999 108.569 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.478 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 78.2 m95 -102.27 111.55 23.88 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.09 -0.707 . . . . 0.63 109.09 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.48 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.7 p -101.63 116.81 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.165 0.983 . . . . 0.91000000000000003 110.396 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.612 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 32.5 m-85 -109.36 125.15 52.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.795 . . . . 0.79000000000000004 110.529 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 107' ' ' VAL . 15.3 m -109.46 140.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.127 0.489 . . . . 1.1799999999999999 110.88 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -139.2 133.19 31.04 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.971 -0.559 . . . . 3.3100000000000001 110.088 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -72.05 123.05 21.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.892 -0.41 . . . . 4.0300000000000002 109.892 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 ' HE3' ' A' ' 106' ' ' LYS . 2.5 m . . . . . 0 C--O 1.247 0.948 0 CA-C-N 116.327 -0.397 . . . . 2.8700000000000001 110.599 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 44' ' ' ALA . 2.4 mm? . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.382 -0.229 . . . . 3.3399999999999999 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.12 -77.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.597 -0.274 . . . . 2.8999999999999999 111.417 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.21 170.78 9.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 3.8500000000000001 110.683 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 43' ' ' ASN . . . -104.23 147.16 16.44 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.416 -0.897 . . . . 0.84999999999999998 113.424 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.15 111.43 14.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.092 -0.707 . . . . 0.70999999999999996 109.092 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 120' ' ' VAL . 6.9 mm -103.53 160.37 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.134 -0.691 . . . . 1.0800000000000001 109.134 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' HG22 ' A' ' 31' ' ' ILE . 63.5 tt0 -133.42 113.67 12.8 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.175 -0.328 . . . . 0.85999999999999999 110.156 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.553 ' HG ' HG11 ' A' ' 120' ' ' VAL . 22.0 mt -112.63 151.98 29.5 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.351 -0.611 . . . . 1.6200000000000001 109.351 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.52 168.99 8.72 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.876 -0.329 . . . . 1.22 110.249 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.92 -27.48 37.14 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.569 0.543 . . . . 0.79000000000000004 114.326 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -44.03 20.09 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.508 0.654 . . . . 1.95 111.097 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.49 20.76 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.361 -0.924 . . . . 0.53000000000000003 112.902 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -84.52 142.64 29.88 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.484 -0.562 . . . . 1.3 109.484 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 6.0 mt -90.91 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.982 -0.747 . . . . 0.89000000000000001 108.982 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 58' ' ' ILE . 9.1 mp -118.19 -86.43 0.64 Allowed 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.134 0.492 . . . . 1.45 111.02 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -119.6 168.29 11.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.687 0.756 . . . . 1.99 111.655 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.767 ' H ' ' HB3' ' A' ' 54' ' ' PRO . 3.3 m-85 -132.94 -167.75 1.96 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.011 -1.449 . . . . 1.25 109.337 -174.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.459 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 63.4 t30 -128.13 160.74 31.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.749 -0.834 . . . . 2.1299999999999999 108.749 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.671 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -71.55 19.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.508 0.559 . . . . 1.48 112.508 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.64 -42.9 8.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.083 0.468 . . . . 1.52 110.149 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HB2' ' HD1' ' A' ' 42' ' ' TYR . 16.4 mm-40 -77.5 -17.27 58.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.555 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 52' ' ' ARG . . . -82.89 -26.18 46.4 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.449 -0.882 . . . . 1.4199999999999999 111.663 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -45.11 16.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 2.3500000000000001 110.609 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -83.16 -62.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 2.5899999999999999 111.21 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -75.76 -53.28 8.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.053 0.454 . . . . 3.4100000000000001 111.382 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.21 36.59 1.32 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 2.3199999999999998 111.226 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.467 ' H ' ' HA2' ' A' ' 47' ' ' GLY . 16.9 tpp85 -123.27 110.14 14.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.56 0.219 . . . . 3.1400000000000001 110.525 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.843 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 28.6 m-20 -77.74 154.6 80.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.542 -0.299 . . . . 2.1000000000000001 110.508 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HB3' ' H ' ' A' ' 42' ' ' TYR . 36.9 Cg_endo -67.47 -9.79 26.53 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.838 2.358 . . . . 1.6799999999999999 111.312 172.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.27 5.86 44.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.269 -0.878 . . . . 3.6099999999999999 111.185 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 83.4 mm-40 -97.82 -60.52 1.55 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 2.5 111.75 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.852 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 2.9 m -88.27 40.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.486 0.921 . . . . 0.96999999999999997 113.486 -169.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 40' ' ' LEU . 30.8 mt -91.23 120.34 40.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.466 -0.494 . . . . 1.0900000000000001 109.886 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.52 33.03 58.96 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.526 -1.03 . . . . 0.66000000000000003 110.526 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.852 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 35.6 mttm -121.7 135.56 54.95 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.673 -0.763 . . . . 1.8200000000000001 110.009 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -80.78 112.93 18.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.803 0.335 . . . . 0.71999999999999997 110.331 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 39' ' ' ILE . 71.6 t80 -57.55 -40.7 79.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.69999999999999996 111.385 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.496 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 55.5 m-85 -91.05 25.63 2.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.332 -0.394 . . . . 1.1599999999999999 111.712 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.79 -46.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.688 -0.405 . . . . 3.5800000000000001 111.113 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.28 -78.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 2.2000000000000002 111.703 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.18 36.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.982 1.373 . . . . 1.77 111.544 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -163.9 81.28 1.43 Allowed Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 113.995 -1.457 . . . . 0.60999999999999999 111.071 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -97.72 8.81 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.906 2.404 . . . . 0.81000000000000005 114.066 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 97' ' ' ASP . 1.7 p -77.69 -17.97 57.12 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.949 -0.7 . . . . 0.84999999999999998 110.25 170.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.1 t -96.45 -26.3 15.36 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.3300000000000001 110.964 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 63' ' ' PHE . 5.7 m-20 -65.76 131.7 46.96 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.842 -0.343 . . . . 1.8500000000000001 111.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.8 p 179.81 155.05 0.68 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 1.5600000000000001 109.515 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.9 -19.2 63.97 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.353 2.035 . . . . 1.1699999999999999 112.326 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 8.0 pt-20 -92.39 -24.9 18.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 2.5600000000000001 111.718 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HA ' ' CE1' ' A' ' 92' ' ' PHE . 87.0 t80 -104.34 -72.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.646 -0.422 . . . . 3.3599999999999999 110.075 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -38.26 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.928 -0.578 . . . . 0.79000000000000004 110.238 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.28 -34.79 90.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.86 -0.609 . . . . 0.59999999999999998 112.498 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.25 -35.13 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.817 0.309 . . . . 2.0899999999999999 110.464 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.591 ' O ' HG23 ' A' ' 83' ' ' VAL . 59.3 t80 -57.72 -45.82 85.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.219 -0.66 . . . . 0.67000000000000004 109.219 172.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -77.75 -17.71 57.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.671 . . . . 1.0900000000000001 111.241 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -61.24 -36.22 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.109 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.661 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -84.03 -51.36 4.01 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.161 -1.019 . . . . 0.71999999999999997 111.48 172.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.598 HG22 ' CZ ' ' A' ' 118' ' ' TYR . 48.4 t -45.82 -62.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.151 0.58 . . . . 0.84999999999999998 112.559 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.82 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 1.1399999999999999 111.411 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -70.07 0.36 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.103 -0.499 . . . . 1.8200000000000001 110.537 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.99 27.5 0.18 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.223 -0.751 . . . . 1.6499999999999999 111.223 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 111' ' ' LYS . 5.3 m120 67.02 107.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.559 0.744 . . . . 3.5 109.659 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.661 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 45.7 tp -149.65 148.93 29.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.63 -0.428 . . . . 2.96 111.541 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -88.63 144.44 26.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.046 -0.979 . . . . 2.2400000000000002 111.688 178.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -150.1 153.37 36.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.454 -0.793 . . . . 1.6299999999999999 109.874 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.8 ptm -126.35 125.39 42.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.547 -0.751 . . . . 1.77 109.734 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 32.5 p90 -144.11 165.54 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.866 0.365 . . . . 3.0099999999999998 111.01 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.72 124.52 49.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.898 -0.592 . . . . 2.3900000000000001 109.592 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -136.38 161.61 35.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.934 0.397 . . . . 3.3700000000000001 110.534 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 89.1 m -106.55 136.7 45.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 110.212 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.443 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 15.8 m-85 -125.34 104.73 8.63 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.222 -0.658 . . . . 1.1799999999999999 109.222 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 69' ' ' CYS . 5.0 p-10 -86.17 -63.35 1.33 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.145 -0.622 . . . . 2.5699999999999998 109.785 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.435 ' HB2' ' C3 ' ' A' ' 169' ' ' HC4 . 53.0 t80 47.19 55.09 8.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.761 -0.829 . . . . 3.21 108.761 -171.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.22 -28.43 0.14 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.14 -0.937 . . . . 3.23 111.033 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 33.6 ttp -67.7 163.35 21.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.234 -0.439 . . . . 2.8500000000000001 110.222 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 14.8 t -55.46 146.67 42.32 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 108.383 -0.969 . . . . 2.1200000000000001 108.383 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 22.5 Cg_endo -61.87 72.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.385 2.057 . . . . 1.47 113.289 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.48 HG23 HG23 ' A' ' 101' ' ' THR . 7.6 p -73.9 146.89 43.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.265 -0.425 . . . . 1.3999999999999999 110.846 172.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -104.63 146.81 28.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 3.0800000000000001 111.178 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 106' ' ' LYS . 7.7 p -142.65 158.78 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.547 -0.752 . . . . 1.3300000000000001 109.362 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 105' ' ' VAL . 38.1 ttmt -112.68 131.36 55.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.23 -1.026 . . . . 1.6899999999999999 108.23 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.79 139.31 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.451 0.643 . . . . 1.27 110.843 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -121.59 104.22 9.48 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.594 -0.891 . . . . 1.02 108.594 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 120' ' ' VAL . 5.1 ppp? -102.75 143.55 32.24 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 2.4900000000000002 109.689 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.653 ' HA ' ' HB3' ' A' ' 89' ' ' ASN . 51.2 mtpt -149.65 146.42 27.26 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 109.708 -0.479 . . . . 1.5700000000000001 109.708 -174.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HD2' ' CB ' ' A' ' 87' ' ' ASN . 41.8 tttm -75.21 146.35 41.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.335 -0.617 . . . . 2.1299999999999999 109.335 173.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -134.92 -159.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 1.5700000000000001 110.088 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.28 -166.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.15 -0.685 . . . . 4.4100000000000001 109.15 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.5 m 67.28 65.48 0.42 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.129 -0.693 . . . . 2.5499999999999998 109.129 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.32 51.58 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.333 -0.707 . . . . 2.6200000000000001 111.333 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.33 80.09 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.559 0.744 . . . . 2.7599999999999998 112.684 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.82 176.06 9.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.837 -1.172 . . . . 1.0700000000000001 107.837 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.598 ' CZ ' HG22 ' A' ' 83' ' ' VAL . 80.3 m-85 -104.71 147.48 27.63 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.08 0.466 . . . . 0.85999999999999999 110.121 -173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 51.3 m95 -102.99 103.1 13.18 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.493 -0.776 . . . . 0.63 109.099 175.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -103.27 104.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.601 -1.181 . . . . 0.91000000000000003 110.823 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 119' ' ' TRP . 11.6 m-85 -102.68 137.97 40.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.79000000000000004 110.225 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -112.99 154.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.969 0.414 . . . . 1.1799999999999999 111.894 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -165.24 153.09 11.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 3.3100000000000001 109.436 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -73.26 98.66 2.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.916 -0.314 . . . . 4.0300000000000002 111.791 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.401 1.063 . . . . 2.8700000000000001 112.167 172.252 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.443 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.842 -0.429 . . . . 3.3399999999999999 109.842 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -174.3 -76.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.844 0.354 . . . . 2.8999999999999999 110.89 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -127.25 162.16 26.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.189 -0.46 . . . . 3.8500000000000001 110.158 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.82 119.49 6.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.508 -0.854 . . . . 0.84999999999999998 112.709 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -104.8 126.18 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 0.70999999999999996 109.341 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.484 ' HB ' HG13 ' A' ' 120' ' ' VAL . 51.6 mt -128.39 149.13 32.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 1.0800000000000001 109.775 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 64.0 tt0 -112.01 134.65 53.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.987 -0.746 . . . . 0.85999999999999999 108.987 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD21 ' SD ' ' A' ' 109' ' ' MET . 2.6 pt? -139.67 153.41 47.28 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.136 -0.32 . . . . 1.6200000000000001 110.136 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.691 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.1 p30 -103.86 168.27 9.24 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.682 -0.407 . . . . 1.22 110.576 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -57.38 -14.47 13.14 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 115.136 0.815 . . . . 0.79000000000000004 115.136 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.08 -18.08 26.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.917 0.858 . . . . 1.95 110.391 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.28 26.42 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.682 -0.77 . . . . 0.53000000000000003 112.012 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.691 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 92.1 m-20 -71.58 138.17 48.58 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.73 0.3 . . . . 1.3 110.807 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 62' ' ' PHE . 14.0 mt -87.86 144.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.002 -0.545 . . . . 0.89000000000000001 109.685 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 4.1 mm? -101.93 -63.74 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.5 0.667 . . . . 1.45 110.231 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.08 169.5 23.22 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.005 -0.998 . . . . 1.99 110.572 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 52' ' ' ARG . 5.4 m-30 -113.91 175.94 5.25 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.113 -0.948 . . . . 1.25 109.364 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' ALA . 63.9 t30 -89.3 5.26 45.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.586 0.708 . . . . 2.1299999999999999 110.091 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 71.47 -15.54 0.42 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.351 -1.295 . . . . 1.48 110.875 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -60.5 -32.5 71.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.585 -0.734 . . . . 1.52 111.84 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.093 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 8.2 tp10 -78.77 -14.66 59.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.482 0.658 . . . . 2.1200000000000001 110.016 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.95 73.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.859 -0.686 . . . . 1.4199999999999999 111.464 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.63 -52.16 48.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 2.3500000000000001 110.836 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 HG22 ' A' ' 50' ' ' THR . 24.7 mt -83.82 -72.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 2.5899999999999999 111.799 -170.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 49' ' ' ILE . 11.9 t -173.73 43.24 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.049 0.928 . . . . 3.4100000000000001 111.054 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 1.093 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -109.05 -119.94 4.3 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.268 -0.967 . . . . 2.3199999999999998 113.673 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 24.9 mmt180 -139.21 153.46 47.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 3.1400000000000001 111.539 -171.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.694 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 12.0 m-20 -81.91 155.98 70.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.495 -0.928 . . . . 2.1000000000000001 108.495 163.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -29.94 85.57 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.112 1.874 . . . . 1.6799999999999999 111.896 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -72.73 -22.66 60.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 3.6099999999999999 111.598 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.694 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 67.4 mt-30 -81.95 -21.89 36.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.92 0.341 . . . . 2.5 111.92 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.0 m -121.54 62.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.687 0.625 . . . . 0.96999999999999997 112.687 -172.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -119.26 132.49 68.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.297 -0.561 . . . . 1.0900000000000001 111.058 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.2 -2.68 50.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.485 -0.864 . . . . 0.66000000000000003 111.549 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 47.6 mttp -88.36 146.0 25.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.407 . . . . 1.8200000000000001 110.609 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -94.25 107.24 19.2 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.785 -0.45 . . . . 0.71999999999999997 109.785 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HB2' HG12 ' A' ' 39' ' ' ILE . 82.2 t80 -51.39 -36.03 41.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.69999999999999996 111.416 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.8 m-85 -86.16 16.06 4.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.761 0.282 . . . . 1.1599999999999999 111.761 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -147.16 -45.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.423 0.527 . . . . 3.5800000000000001 112.423 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.55 -78.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.137 0.421 . . . . 2.2000000000000002 112.137 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.53 ' O ' " H2'" ' A' ' 169' ' ' HC4 . 9.1 p -108.6 14.53 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.007 0.908 . . . . 1.77 111.367 -170.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.55 ' HA ' ' H3 ' ' A' ' 169' ' ' HC4 . . . -158.07 71.82 4.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.607 -0.724 . . . . 0.60999999999999999 112.267 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.78 15.52 1.62 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.761 2.307 . . . . 0.81000000000000005 112.805 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.04 -23.79 59.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.18 -0.674 . . . . 0.84999999999999998 109.18 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 20.7 p -94.44 -32.04 13.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.587 -1.188 . . . . 1.3300000000000001 110.52 -136.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.715 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 12.6 p-10 -77.36 82.29 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.251 1.024 . . . . 1.8500000000000001 110.361 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -145.35 157.68 52.37 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.886 -1.052 . . . . 1.5600000000000001 109.534 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.87 -37.74 77.71 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.043 2.495 . . . . 1.1699999999999999 113.742 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.66 14.36 25.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.428 0.529 . . . . 2.5600000000000001 112.428 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.425 ' CD2' ' HE1' ' A' ' 92' ' ' PHE . 46.6 t80 -134.94 -73.99 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.246 -0.65 . . . . 3.3599999999999999 109.246 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 66.7 t80 -63.51 -36.4 83.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.889 -0.596 . . . . 0.79000000000000004 110.121 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -29.45 75.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.068 -0.586 . . . . 0.59999999999999998 112.366 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 68.7 mttm -87.28 -25.87 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.943 0.401 . . . . 2.0899999999999999 110.225 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 83' ' ' VAL . 79.6 t80 -62.56 -46.03 90.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.517 0.675 . . . . 0.67000000000000004 109.501 169.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 30.0 mmmt -77.89 -16.74 58.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.3 -0.864 . . . . 1.0900000000000001 110.481 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 40.9 tt0 -59.06 -39.97 83.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.674 . . . . 2.0699999999999998 110.501 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -84.55 -45.85 5.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.519 -0.848 . . . . 0.71999999999999997 112.107 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 79' ' ' PHE . 43.1 t -53.87 -52.94 30.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.662 0.385 . . . . 0.84999999999999998 111.489 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.02 60.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.175 0.435 . . . . 1.1399999999999999 112.175 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -98.02 -74.58 0.57 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.795 0.331 . . . . 1.8200000000000001 110.81 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.03 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.001 -0.619 . . . . 1.6499999999999999 111.561 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -109.82 156.74 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.475 -0.565 . . . . 3.5 109.475 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 45.6 tp -131.02 102.98 6.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 2.96 110.719 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 109' ' ' MET . 87.9 m-20 -143.76 97.98 3.16 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.783 -0.821 . . . . 2.2400000000000002 108.783 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -131.16 155.72 46.53 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.113 -0.494 . . . . 1.6299999999999999 111.797 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.4 ptt? -140.12 105.77 5.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 1.77 109.831 171.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HE1' ' CD2' ' A' ' 75' ' ' PHE . 25.7 p90 -127.2 167.13 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.764 -0.653 . . . . 3.0099999999999998 110.739 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 106' ' ' LYS . 45.1 mt-10 -103.67 122.9 45.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.007 -0.368 . . . . 2.3900000000000001 110.007 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -142.15 158.4 43.79 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.533 -0.543 . . . . 3.3700000000000001 109.533 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 104' ' ' LYS . 40.5 p -104.26 156.36 17.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.51 0.672 . . . . 1.3999999999999999 112.299 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.787 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 44.8 m-85 -121.85 112.61 18.55 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.653 -1.24 . . . . 1.1799999999999999 107.653 170.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 102' ' ' PRO . 4.5 m-20 -123.64 12.88 9.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.841 -166.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' C1 ' ' A' ' 169' ' ' HC4 . 86.2 t80 -110.85 -49.09 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 3.21 111.192 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -91.21 13.6 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 3.23 110.968 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 17.5 ptp -169.94 153.76 4.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 2.8500000000000001 109.702 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 10.1 t -58.01 142.95 79.01 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.25 -1.019 . . . . 2.1200000000000001 108.25 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 32.5 Cg_exo -31.65 86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.386 3.391 . . . . 1.47 114.976 -176.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 m -111.51 141.37 45.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 1.3999999999999999 110.882 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 95' ' ' THR . 22.2 ttmm -104.07 135.47 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.785 0.326 . . . . 3.0800000000000001 110.399 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -127.95 166.37 25.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.143 -0.48 . . . . 1.3300000000000001 110.669 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 93' ' ' GLU . 31.5 ttmt -110.81 117.02 32.28 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.346 -0.983 . . . . 1.6899999999999999 108.346 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 80.1 t -104.11 120.58 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.073 -0.512 . . . . 1.27 110.068 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.431 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 12.3 t-160 -104.04 109.08 20.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.159 -0.682 . . . . 1.02 109.159 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 58.0 tpp -101.68 132.69 47.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 2.4900000000000002 109.149 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 50.4 mtpt -137.62 131.57 31.75 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 121.153 -0.219 . . . . 1.5700000000000001 110.498 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 81.6 tttt -90.53 123.22 34.03 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.123 0.487 . . . . 2.1299999999999999 110.885 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.08 -175.24 2.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.675 -0.861 . . . . 1.5700000000000001 108.675 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.42 -94.97 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.42 -0.956 . . . . 4.4100000000000001 108.42 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 m 51.56 42.14 29.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.609 0.596 . . . . 2.5499999999999998 112.609 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.03 79.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.758 . . . . 2.6200000000000001 112.501 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.43 64.17 0.72 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.153 0.581 . . . . 2.7599999999999998 111.695 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 20.4 p -139.05 163.92 31.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.095 -0.502 . . . . 1.0700000000000001 110.694 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 4.9 m-85 -123.25 154.72 38.41 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.043 -1.095 . . . . 0.85999999999999999 108.043 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -103.63 109.17 20.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.875 -0.787 . . . . 0.63 108.875 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.484 HG13 ' HB ' ' A' ' 31' ' ' ILE . 14.6 p -100.71 134.35 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.682 0.753 . . . . 0.91000000000000003 110.796 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.423 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 80.8 m-85 -120.83 132.62 55.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.79000000000000004 110.037 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.1 t -103.17 104.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.886 -0.597 . . . . 1.1799999999999999 110.061 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -103.16 110.18 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.877 -0.786 . . . . 3.3100000000000001 108.877 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 105' ' ' VAL . 4.2 ptm180 -77.86 158.01 29.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.223 -0.444 . . . . 4.0300000000000002 111.472 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.592 -0.718 . . . . 2.8700000000000001 109.147 173.765 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.787 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.561 0.22 . . . . 3.3399999999999999 110.712 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.67 -70.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.425 -0.352 . . . . 2.8999999999999999 111.323 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.44 164.38 25.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.673 -0.491 . . . . 3.8500000000000001 109.673 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 120.02 6.54 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.258 -0.972 . . . . 0.84999999999999998 112.308 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.59 125.85 47.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.611 -0.515 . . . . 0.70999999999999996 109.611 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 42' ' ' TYR . 5.2 pt -132.17 165.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 1.0800000000000001 111.991 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.536 ' HG2' HD23 ' A' ' 40' ' ' LEU . 50.3 tt0 -115.03 121.01 41.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.889 -0.596 . . . . 0.85999999999999999 110.513 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.9 pt? -131.48 146.84 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.545 -0.539 . . . . 1.6200000000000001 109.545 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.24 170.01 8.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.134 -0.321 . . . . 1.22 110.134 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.27 -23.33 12.4 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 114.306 0.482 . . . . 0.79000000000000004 114.306 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.17 -21.56 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 1.95 110.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 96.51 4.9 59.22 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.151 -1.18 . . . . 0.53000000000000003 110.151 -173.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -79.15 134.04 36.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.693 -0.754 . . . . 1.3 109.705 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 19.7 mt -93.02 140.24 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.924 -0.58 . . . . 0.89000000000000001 110.154 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 ' HG2' ' A' ' 32' ' ' GLN . 1.4 mm? -107.13 -66.48 1.02 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.144 0.497 . . . . 1.45 111.19 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -134.21 137.39 44.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.492 0.663 . . . . 1.99 111.47 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.725 ' HA ' HG22 ' A' ' 31' ' ' ILE . 3.6 m-30 -102.95 126.75 50.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.775 -1.102 . . . . 1.25 109.268 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -60.03 155.82 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.026 -0.361 . . . . 2.1299999999999999 110.026 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.64 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.092 0.472 . . . . 1.48 109.874 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.27 70.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.969 -1.014 . . . . 1.52 112.61 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 38.7 tp10 -66.19 -47.96 72.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.378 . . . . 2.1200000000000001 110.566 -173.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.0 -10.18 72.59 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.834 -0.698 . . . . 1.4199999999999999 112.503 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -93.12 -52.1 4.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.87 0.367 . . . . 2.3500000000000001 110.884 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.6 mt -80.55 -72.1 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.394 -0.366 . . . . 2.5899999999999999 110.939 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.5 m -153.77 106.93 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.608 -0.516 . . . . 3.4100000000000001 109.608 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . 175.48 -139.75 4.87 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.067 -1.063 . . . . 2.3199999999999998 112.964 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 3.0 mpt_? -124.24 174.7 7.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.706 0.289 . . . . 3.1400000000000001 110.834 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.83 139.96 95.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.663 -0.699 . . . . 2.1000000000000001 111.055 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.53 111.99 0.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.874 2.382 . . . . 1.6799999999999999 112.497 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 81.49 11.2 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.239 -0.891 . . . . 3.6099999999999999 112.545 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -94.44 22.05 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.326 0.584 . . . . 2.5 110.243 172.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.692 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -119.68 22.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.899 . . . . 0.96999999999999997 111.26 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -88.51 136.61 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.878 -0.416 . . . . 1.0900000000000001 109.878 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.76 11.97 84.18 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.829 -0.909 . . . . 0.66000000000000003 110.829 -175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 65' ' ' ASP . 26.5 mttm -118.77 141.49 48.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.69 0.281 . . . . 1.8200000000000001 111.103 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 23.7 t-20 -87.76 114.75 24.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.145 -0.48 . . . . 0.71999999999999997 110.216 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -55.84 -35.22 66.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.963 0.411 . . . . 0.69999999999999996 111.645 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 70' ' ' THR . 66.7 m-85 -76.48 -7.96 56.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.17 -0.468 . . . . 1.1599999999999999 111.484 -174.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -136.45 -63.47 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.84 0.311 . . . . 3.5800000000000001 111.84 -175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 5.3 m-20 -66.93 -24.17 66.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.298 0.481 . . . . 2.2000000000000002 112.298 -173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -125.89 12.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.33 -0.548 . . . . 1.77 110.969 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 171.06 85.71 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.399 -0.364 . . . . 0.60999999999999999 111.434 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.0 -16.48 54.64 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.586 2.191 . . . . 0.81000000000000005 113.769 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.2 m -50.4 -37.17 36.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.719 0.236 . . . . 0.84999999999999998 110.901 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' A' ' 63' ' ' PHE . 10.3 m -92.82 -31.03 15.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.933 -1.031 . . . . 1.3300000000000001 109.896 -135.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.56 97.13 4.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.995 -1.002 . . . . 1.8500000000000001 110.16 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.5 m -164.05 152.21 11.11 Favored Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.046 -0.524 . . . . 1.5600000000000001 110.019 -169.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.71 -30.33 92.1 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.278 1.985 . . . . 1.1699999999999999 112.667 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HG3' ' HE2' ' A' ' 94' ' ' TYR . 9.5 pt-20 -86.14 6.37 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.271 0.471 . . . . 2.5600000000000001 112.271 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.682 ' HE2' HG11 ' A' ' 107' ' ' VAL . 57.3 t80 -141.58 -71.67 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.873 -0.418 . . . . 3.3599999999999999 109.873 173.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.663 ' CZ ' ' HE3' ' A' ' 80' ' ' LYS . 89.0 t80 -53.75 -37.87 63.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.79000000000000004 110.692 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.8 -31.66 78.93 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.226 -0.512 . . . . 0.59999999999999998 112.624 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -81.52 -32.67 32.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.521 0.677 . . . . 2.0899999999999999 109.459 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.48 -32.15 71.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.913 -1.039 . . . . 0.67000000000000004 109.588 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HE3' ' CZ ' ' A' ' 76' ' ' TYR . 0.9 OUTLIER -88.84 -16.06 32.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.171 -0.922 . . . . 1.0900000000000001 111.098 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.46 -51.33 63.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 2.0699999999999998 110.573 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.35 -44.01 98.26 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.724 -0.671 . . . . 0.71999999999999997 112.315 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 83' ' ' VAL . 23.4 t -55.85 -52.75 45.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.692 0.282 . . . . 0.84999999999999998 110.869 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.7 86.81 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 116.051 -0.522 . . . . 1.1399999999999999 111.196 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -66.33 -77.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.076 -0.511 . . . . 1.8200000000000001 110.78 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.43 -75.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.522 -0.631 . . . . 1.6499999999999999 111.522 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -97.62 147.66 24.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 3.5 110.13 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.002 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -111.21 110.4 20.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.568 -0.531 . . . . 2.96 109.568 -176.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -175.68 91.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.974 0.892 . . . . 2.2400000000000002 110.892 176.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 91' ' ' MET . 10.0 m -131.44 154.55 48.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.311 -0.859 . . . . 1.6299999999999999 109.23 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.473 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 19.6 ptt? -128.27 104.08 7.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.981 0.419 . . . . 1.77 110.155 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -125.15 166.59 16.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 3.0099999999999998 110.194 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.42 131.22 50.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.985 0.421 . . . . 2.3900000000000001 110.537 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.448 ' HE2' ' HG3' ' A' ' 74' ' ' GLU . 50.8 t80 -136.87 159.91 40.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.821 -0.627 . . . . 3.3700000000000001 109.679 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -102.97 113.63 27.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.943 0.402 . . . . 1.3999999999999999 110.315 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.667 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 42.8 m-85 -110.09 103.1 11.77 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.11 0.481 . . . . 1.1799999999999999 109.801 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 100' ' ' MET . 49.5 m-20 -126.41 101.74 6.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.653 -0.703 . . . . 2.5699999999999998 109.886 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.447 ' HD1' ' H3 ' ' A' ' 169' ' ' HC4 . 10.8 t80 -73.56 63.79 0.84 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.804 -1.184 . . . . 3.21 107.804 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 63.6 59.91 1.15 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.992 -1.004 . . . . 3.23 108.443 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.506 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 42.7 tpp -133.04 164.74 26.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.953 -1.021 . . . . 2.8500000000000001 111.09 -168.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.1 p -59.49 151.91 58.17 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 108.747 -0.835 . . . . 2.1200000000000001 108.747 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.17 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.641 2.227 . . . . 1.47 113.483 -171.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -90.71 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 1.3999999999999999 110.723 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.72 120.94 41.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.967 -0.383 . . . . 3.0800000000000001 109.967 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 124' ' ' ARG . 30.2 m -122.02 166.42 16.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.838 -0.619 . . . . 1.3300000000000001 110.459 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 82.8 tttt -103.56 120.92 41.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.763 -0.828 . . . . 1.6899999999999999 108.763 177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.682 HG11 ' HE2' ' A' ' 75' ' ' PHE . 6.5 p -106.45 115.99 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-O 122.096 0.951 . . . . 1.27 110.096 -174.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.501 ' CE1' ' HD2' ' A' ' 110' ' ' LYS . 18.7 t-160 -107.5 103.5 12.84 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.072 -0.967 . . . . 1.02 108.925 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.99 134.31 47.48 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.575 -0.45 . . . . 2.4900000000000002 110.078 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.501 ' HD2' ' CE1' ' A' ' 108' ' ' HIS . 8.8 mtpm? -140.65 134.75 30.87 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 120.688 0.28 . . . . 1.5700000000000001 110.928 -172.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 1.002 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 26.0 ttpp -80.85 136.75 36.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.322 -0.399 . . . . 2.1299999999999999 110.896 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -141.98 -173.21 3.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.403 -0.362 . . . . 1.5700000000000001 111.172 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.5 -164.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.201 -0.454 . . . . 4.4100000000000001 110.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.1 m 65.89 54.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.615 0.721 . . . . 2.5499999999999998 110.365 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.39 -2.4 8.88 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.196 -0.911 . . . . 2.6200000000000001 111.605 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.5 41.68 31.81 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.425 0.631 . . . . 2.7599999999999998 110.614 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.42 -175.75 2.75 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.51 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.456 ' HE1' ' HA2' ' A' ' 35' ' ' GLY . 5.6 m-85 -119.6 151.69 38.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.028 -0.73 . . . . 0.85999999999999999 109.028 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -102.44 108.5 19.84 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.348 -0.982 . . . . 0.63 108.348 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' A' ' 31' ' ' ILE . 10.9 p -101.68 137.71 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 119.801 -0.759 . . . . 0.91000000000000003 110.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -114.03 125.21 53.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.436 -0.802 . . . . 0.79000000000000004 110.185 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.05 114.88 48.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.378 . . . . 1.1799999999999999 110.011 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -139.07 129.19 25.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.88 -0.415 . . . . 3.3100000000000001 109.88 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.8 ptp180 -75.02 114.64 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.016 0.436 . . . . 4.0300000000000002 110.455 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 106' ' ' LYS . 6.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.068 -0.491 . . . . 2.8700000000000001 110.43 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.667 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.737 0.303 . . . . 3.3399999999999999 110.441 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.1 103.47 4.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 116.263 -0.426 . . . . 2.8999999999999999 110.218 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' VAL . 95.1 m-85 64.37 -172.08 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.927 0.767 . . . . 3.8500000000000001 111.388 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.78 130.72 10.34 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.475 -0.869 . . . . 0.84999999999999998 112.18 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.84 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.932 -0.395 . . . . 0.70999999999999996 109.932 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 32' ' ' GLN . 9.5 mm -114.5 152.39 16.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 1.0800000000000001 109.895 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 31' ' ' ILE . 64.4 tt0 -124.06 104.67 9.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.614 -0.513 . . . . 0.85999999999999999 109.614 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.522 ' CD1' HG12 ' A' ' 39' ' ' ILE . 1.9 mm? -105.47 143.62 33.38 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.399 -0.364 . . . . 1.6200000000000001 110.277 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p30 -104.38 167.69 9.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.041 -0.264 . . . . 1.22 110.435 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.01 -22.46 35.24 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.046 0.779 . . . . 0.79000000000000004 115.046 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.426 0.613 . . . . 1.95 110.35 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.84 43.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.192 -0.763 . . . . 0.53000000000000003 111.192 -176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 95.0 m-20 -88.19 146.44 25.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.076 0.465 . . . . 1.3 111.416 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.698 HD12 HG11 ' A' ' 57' ' ' VAL . 10.0 mt -95.41 148.24 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.89000000000000001 110.305 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.454 ' N ' HG22 ' A' ' 39' ' ' ILE . 83.1 mt -107.44 -80.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.027 -0.533 . . . . 1.45 109.76 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -116.78 136.9 52.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 1.99 111.571 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.057 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.4 m-30 -98.02 -175.61 3.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.892 -1.049 . . . . 1.25 110.64 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.73 161.34 20.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.626 -0.879 . . . . 2.1299999999999999 108.626 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -58.81 -23.31 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.527 0.566 . . . . 1.48 112.527 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.79 94.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 1.52 111.078 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.3 mp0 -63.8 -27.11 68.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 2.1200000000000001 111.281 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.64 -13.88 62.29 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.538 -0.839 . . . . 1.4199999999999999 112.575 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.73 -54.48 3.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.542 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.28 -60.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 2.5899999999999999 110.124 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.633 HG21 " H3'" ' A' ' 169' ' ' HC4 . 3.8 m -78.73 -54.7 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.88 -0.6 . . . . 3.4100000000000001 111.451 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.18 14.0 6.75 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 2.3199999999999998 112.033 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 66' ' ' VAL . 19.7 mmt180 -97.69 110.09 22.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 3.1400000000000001 110.005 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.575 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 15.3 m-20 -63.58 143.6 97.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.381 -0.372 . . . . 2.1000000000000001 110.743 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 71.6 Cg_exo -52.34 -28.01 33.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.871 3.047 . . . . 1.6799999999999999 114.804 -170.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -124.67 28.61 6.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.99 0.367 . . . . 3.6099999999999999 111.99 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.575 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 77.0 mm-40 -94.78 0.07 54.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.255 0.55 . . . . 2.5 110.967 175.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -93.38 -93.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 115.816 -0.629 . . . . 0.96999999999999997 111.442 175.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.8 mm 54.31 99.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.427 0.691 . . . . 1.0900000000000001 112.239 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.26 71.77 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.265 -1.134 . . . . 0.66000000000000003 110.265 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 6.7 mmtp -111.33 121.0 44.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.708 -1.246 . . . . 1.8200000000000001 109.553 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -71.24 105.38 3.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.214 0.53 . . . . 0.71999999999999997 110.843 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HB2' HG12 ' A' ' 39' ' ' ILE . 85.1 t80 -54.19 -39.16 66.38 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.69999999999999996 111.107 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 71.5 m-85 -82.69 30.54 0.43 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 111.213 -174.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -161.85 -42.4 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.226 -0.443 . . . . 3.5800000000000001 110.575 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.94 -78.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.563 -0.289 . . . . 2.2000000000000002 111.002 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.9 t -87.62 14.91 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.299 0.571 . . . . 1.77 111.222 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -177.76 94.62 0.23 Allowed Pre-proline 0 C--O 1.222 -0.383 0 O-C-N 122.125 -0.36 . . . . 0.60999999999999999 111.267 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 98' ' ' TYR . 3.9 Cg_exo -78.7 -19.89 10.96 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.419 2.079 . . . . 0.81000000000000005 112.834 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -76.87 -19.68 57.17 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.646 -0.422 . . . . 0.84999999999999998 110.864 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.69 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 18.4 p -73.86 -36.53 64.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.302 -0.863 . . . . 1.3300000000000001 111.119 -172.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 11.0 t70 -62.2 96.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.8500000000000001 109.895 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.5 p 175.79 158.0 0.4 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.32 -0.622 . . . . 1.5600000000000001 109.32 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.592 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 58.9 Cg_exo -52.87 -32.12 55.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.801 2.334 . . . . 1.1699999999999999 112.354 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.59 -59.02 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 2.5600000000000001 111.255 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.69 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 28.4 m-85 -96.09 -69.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.025 -0.534 . . . . 3.3599999999999999 111.357 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -63.03 -30.39 71.56 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.281 -0.418 . . . . 0.79000000000000004 111.116 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -61.44 -41.14 99.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.021 -0.609 . . . . 0.59999999999999998 112.177 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -79.23 -29.72 42.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 2.0899999999999999 110.121 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HD1' ' HE1' ' A' ' 109' ' ' MET . 84.7 t80 -57.82 -40.38 79.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.335 -0.848 . . . . 0.67000000000000004 110.634 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.4 -12.06 26.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.993 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 32.4 tt0 -68.86 -43.49 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 110.379 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.57 -43.41 92.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.695 -0.764 . . . . 0.71999999999999997 112.022 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 t -61.03 -49.48 84.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.84999999999999998 110.88 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -4.64 27.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 112.019 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.2 m -100.53 -73.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.634 0.254 . . . . 1.8200000000000001 110.782 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.91 -63.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 1.6499999999999999 111.952 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.15 139.57 46.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.606 -0.516 . . . . 3.5 109.606 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 111' ' ' LYS . 3.3 tm? -106.89 104.46 14.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.387 -0.597 . . . . 2.96 109.387 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.686 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.7 p30 -172.15 116.15 0.35 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.497 0.665 . . . . 2.2400000000000002 109.868 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.4 m -148.36 142.23 25.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.461 -0.79 . . . . 1.6299999999999999 109.887 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.0 ptm -119.92 120.1 35.4 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.448 -0.575 . . . . 1.77 109.448 173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' CD1' ' HD1' ' A' ' 94' ' ' TYR . 4.2 p90 -140.03 157.81 45.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.421 . . . . 3.0099999999999998 111.953 -172.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 106' ' ' LYS . 5.5 mp0 -104.42 121.64 43.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 2.3900000000000001 109.896 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 26.6 m-85 -142.9 165.82 26.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.286 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 13.5 m -107.36 144.26 34.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.39 -0.368 . . . . 1.3999999999999999 110.527 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.77 106.99 15.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 1.1799999999999999 109.478 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -130.47 111.01 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 2.5699999999999998 110.829 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 68' ' ' PRO . 72.7 t80 -175.76 -79.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.484 -0.78 . . . . 3.21 109.475 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -99.55 -34.28 10.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.419 -0.586 . . . . 3.23 109.419 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.6 ttm -82.11 137.86 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.041 -1.096 . . . . 2.8500000000000001 108.041 164.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -64.4 154.78 82.74 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.419 -0.586 . . . . 2.1200000000000001 109.419 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.47 87.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.136 2.557 . . . . 1.47 114.114 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -102.97 130.48 50.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.848 -0.615 . . . . 1.3999999999999999 109.952 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 22.3 pttp -103.62 124.84 49.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.401 -0.592 . . . . 3.0800000000000001 109.401 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 124' ' ' ARG . 15.1 m -132.11 165.52 31.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.827 -0.624 . . . . 1.3300000000000001 112.179 -171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 22.7 ttmm -104.75 111.01 23.57 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.288 -1.005 . . . . 1.6899999999999999 108.288 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 122' ' ' VAL . 59.8 t -104.63 127.75 58.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.611 -0.514 . . . . 1.27 109.611 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 12.1 t-160 -104.61 113.42 26.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.4 0.619 . . . . 1.02 109.458 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.686 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 27.3 tpp -101.13 123.54 45.44 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.518 -1.219 . . . . 2.4900000000000002 108.772 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 63.8 pttt -150.44 146.8 26.88 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.093 -0.643 . . . . 1.5700000000000001 111.512 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 48.6 tttm -87.52 140.27 29.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.567 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.1 -172.84 4.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.612 0.244 . . . . 1.5700000000000001 110.439 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.91 -168.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.196 -0.298 . . . . 4.4100000000000001 110.196 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m 75.15 72.86 0.09 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.806 0.691 . . . . 2.5499999999999998 110.094 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.38 -8.4 44.35 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.093 -0.803 . . . . 2.6200000000000001 111.093 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 55.03 80.81 0.12 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.598 0.713 . . . . 2.7599999999999998 111.165 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 2.6 p -156.51 -169.83 3.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.005 -0.998 . . . . 1.0700000000000001 109.063 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 8.5 m-85 -119.38 152.57 36.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.332 -0.988 . . . . 0.85999999999999999 108.332 -177.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 55.5 m95 -101.54 106.0 17.04 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.591 0.71 . . . . 0.63 109.148 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 108' ' ' HIS . 38.9 t -102.6 104.34 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.401 -1.272 . . . . 0.91000000000000003 110.612 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 98.7 m-85 -104.79 134.08 48.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.139 -0.937 . . . . 0.79000000000000004 110.253 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -113.48 144.9 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.585 -0.28 . . . . 1.1799999999999999 110.703 -176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 106' ' ' LYS . 18.5 ptpt -139.49 145.16 38.42 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.838 -0.431 . . . . 3.3100000000000001 109.838 173.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.716 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.5 tmt_? -84.4 111.69 19.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.639 -0.255 . . . . 4.0300000000000002 110.591 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.494 HG11 ' HE2' ' A' ' 106' ' ' LYS . 16.7 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.618 -0.706 . . . . 2.8700000000000001 111.033 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.633 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.446 -0.576 . . . . 3.3399999999999999 109.446 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.12 -48.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 2.8999999999999999 110.355 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.74 162.6 41.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 3.8500000000000001 109.91 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 45' ' ' ALA . . . -104.7 130.24 10.15 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.641 -0.79 . . . . 0.84999999999999998 111.302 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -135.76 104.13 5.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.172 0.51 . . . . 0.70999999999999996 111.163 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.924 ' HB ' HG13 ' A' ' 120' ' ' VAL . 34.6 mt -113.07 159.74 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.079 -1.082 . . . . 1.0800000000000001 108.079 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.646 HE22 HD23 ' A' ' 113' ' ' LEU . 64.6 tt0 -131.97 116.65 17.39 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.937 -0.477 . . . . 0.85999999999999999 110.467 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.39 165.2 12.42 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.433 -0.58 . . . . 1.6200000000000001 109.433 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -121.1 168.4 11.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.926 -0.398 . . . . 1.22 109.926 175.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.98 -24.62 35.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 114.415 0.526 . . . . 0.79000000000000004 114.415 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.62 -21.51 55.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.95 110.83 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.84 2.65 36.8 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.807 -0.633 . . . . 0.53000000000000003 111.845 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 92.6 m-20 -78.46 153.31 31.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.95 0.405 . . . . 1.3 110.864 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 60' ' ' LYS . 9.3 mt -96.87 146.88 6.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.715 -0.675 . . . . 0.89000000000000001 109.674 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -102.04 -46.96 4.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.629 0.728 . . . . 1.45 109.515 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -170.87 157.76 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.602 -1.181 . . . . 1.99 110.123 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.909 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 8.1 m-30 -110.54 177.82 4.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 1.25 110.456 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 22.6 t-20 -107.36 179.25 4.3 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.292 -1.003 . . . . 2.1299999999999999 108.292 172.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 -9.46 43.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.086 0.47 . . . . 1.48 109.908 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' CB ' ' HA2' ' A' ' 29' ' ' GLY . . . -55.71 -60.08 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.253 -0.885 . . . . 1.52 111.897 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.6 mp0 -65.55 -27.15 68.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 2.1200000000000001 111.22 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.2 -50.31 51.98 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.564 -0.827 . . . . 1.4199999999999999 111.786 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.1 -55.19 31.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.121 0.486 . . . . 2.3500000000000001 110.309 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.6 67.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.688 -1.226 . . . . 2.5899999999999999 107.688 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 18.9 m -36.32 90.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.754 -1.566 . . . . 3.4100000000000001 114.561 -169.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -104.42 -59.29 0.68 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.325 -1.307 . . . . 2.3199999999999998 110.46 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.909 ' HB2' ' HE1' ' A' ' 42' ' ' TYR . 35.3 mmt180 -149.51 168.79 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.634 0.373 . . . . 3.1400000000000001 110.444 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.682 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 8.9 m-20 -90.55 141.12 26.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 2.1000000000000001 109.759 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.769 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 52.8 Cg_exo -56.55 -25.88 61.15 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.193 2.595 . . . . 1.6799999999999999 114.086 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -103.79 6.67 36.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.188 0.44 . . . . 3.6099999999999999 112.188 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 82.9 mm-40 -102.82 6.13 39.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.069 0.461 . . . . 2.5 110.699 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 7.7 m -118.15 40.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.217 0.532 . . . . 0.96999999999999997 111.606 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.01 112.25 24.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.37 -0.377 . . . . 1.0900000000000001 110.64 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.21 11.72 71.32 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.964 -0.854 . . . . 0.66000000000000003 110.964 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.57 ' O ' HG13 ' A' ' 39' ' ' ILE . 7.2 tptt -88.02 121.55 30.56 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.992 -0.604 . . . . 1.8200000000000001 109.558 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 47.5 t-20 -71.78 110.99 6.68 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.442 -0.577 . . . . 0.71999999999999997 109.442 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 86.6 t80 -53.98 -41.0 67.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.429 -0.805 . . . . 0.69999999999999996 110.74 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 46.2 m-85 -85.86 9.48 16.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.237 -0.438 . . . . 1.1599999999999999 110.803 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 48.0 tptt -124.54 -61.95 1.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.386 -0.37 . . . . 3.5800000000000001 110.715 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -104.09 -22.8 13.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.17 0.433 . . . . 2.2000000000000002 112.17 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 52' ' ' ARG . 1.9 t -113.17 13.52 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.182 -0.607 . . . . 1.77 111.765 -170.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 167.27 79.57 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.971 -0.559 . . . . 0.60999999999999999 110.235 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.03 -17.15 50.95 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.751 2.301 . . . . 0.81000000000000005 113.035 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.893 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 13.9 p -76.36 -26.66 55.92 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.486 -0.486 . . . . 0.84999999999999998 110.225 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 1.9 m -80.1 -31.89 39.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.902 -1.045 . . . . 1.3300000000000001 110.486 -164.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 10.5 t70 -63.75 99.23 0.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.159 -0.682 . . . . 1.8500000000000001 109.159 172.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 8.8 t -169.56 149.46 3.68 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.723 -0.473 . . . . 1.5600000000000001 109.723 -175.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 5.3 Cg_exo -38.47 -42.79 1.8 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.742 3.628 . . . . 1.1699999999999999 114.584 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.799 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.01 -53.55 4.22 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.598 -0.441 . . . . 2.5600000000000001 111.19 -178.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 70' ' ' THR . 29.2 m-85 -59.63 -63.81 1.17 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.094 0.473 . . . . 3.3599999999999999 110.706 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 39.6 t80 -67.47 -28.68 68.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.614 . . . . 0.79000000000000004 110.097 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -63.62 -34.75 90.79 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.699 -0.682 . . . . 0.59999999999999998 112.605 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 72.1 mmtt -75.09 -36.97 61.67 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.123 0.487 . . . . 2.0899999999999999 109.751 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' O ' HD11 ' A' ' 88' ' ' LEU . 82.2 t80 -59.89 -35.4 74.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.825 . . . . 0.67000000000000004 110.69 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -94.52 -4.79 47.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.074 -0.512 . . . . 1.0900000000000001 111.808 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -49.97 73.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.034 0.445 . . . . 2.0699999999999998 110.269 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.14 -37.29 63.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.71999999999999997 111.794 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' OH ' ' A' ' 118' ' ' TYR . 21.9 t -52.86 -56.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 122.971 0.508 . . . . 0.84999999999999998 111.518 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.76 62.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 1.1399999999999999 112.048 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.9 m -88.67 -73.2 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.381 . . . . 1.8200000000000001 110.681 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.3 -72.14 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.936 -0.65 . . . . 1.6499999999999999 111.521 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.76 149.09 28.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.667 -0.864 . . . . 3.5 108.667 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -116.27 101.8 9.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.18 -0.674 . . . . 2.96 109.18 178.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 45.9 m-80 -149.12 83.14 1.44 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.383 -0.599 . . . . 2.2400000000000002 109.383 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.8 p -127.83 158.49 37.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 1.6299999999999999 111.289 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.2 ptm -137.44 113.74 10.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.893 -0.594 . . . . 1.77 110.302 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.714 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 8.8 p90 -136.65 164.73 27.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 3.0099999999999998 110.81 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.5 122.04 45.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 2.3900000000000001 110.702 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.714 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 5.1 m-85 -144.21 167.03 23.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 3.3700000000000001 110.089 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.0 t -103.63 154.22 19.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.268 0.556 . . . . 1.3999999999999999 111.983 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.407 ' CD1' " H6'" ' A' ' 169' ' ' HC4 . 67.7 m-85 -120.23 103.45 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.416 -0.957 . . . . 1.1799999999999999 108.416 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 24.3 t70 -113.23 -131.37 0.32 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.586 -0.734 . . . . 2.5699999999999998 109.516 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 61.7 t80 70.65 -70.23 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.434 0.694 . . . . 3.21 111.241 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -118.97 -2.14 10.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.302 0.572 . . . . 3.23 110.268 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.4 tpt -116.26 151.27 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.352 -0.84 . . . . 2.8500000000000001 109.301 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 103' ' ' THR . 9.8 t -55.98 142.45 65.05 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 108.345 -0.983 . . . . 2.1200000000000001 108.345 169.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 26.7 Cg_endo -62.84 72.16 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.73 2.287 . . . . 1.47 112.662 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.577 HG23 HG23 ' A' ' 101' ' ' THR . 1.4 p -81.78 144.33 31.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.917 -0.583 . . . . 1.3999999999999999 111.504 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -106.85 117.38 33.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.537 -0.301 . . . . 3.0800000000000001 110.346 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.24 166.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.073 -0.512 . . . . 1.3300000000000001 110.889 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -103.6 128.34 50.89 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.367 -0.975 . . . . 1.6899999999999999 108.367 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' MET . 7.4 p -116.37 139.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 109.486 -0.561 . . . . 1.27 109.486 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 11.6 t-160 -117.2 115.67 25.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.651 -0.704 . . . . 1.02 109.166 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 86.1 mmm -100.35 126.34 46.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.201 -0.666 . . . . 2.4900000000000002 109.201 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.0 mtpm? -141.84 121.58 13.47 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 120.837 0.351 . . . . 1.5700000000000001 111.187 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 76.5 tttt -73.17 131.42 42.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.045 -0.525 . . . . 2.1299999999999999 110.824 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.21 -160.76 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.967 0.358 . . . . 1.5700000000000001 111.967 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.646 HD23 HE22 ' A' ' 32' ' ' GLN . 13.7 tp 33.62 111.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.939 1.829 . . . . 4.4100000000000001 115.939 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.6 m -18.23 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 125.406 1.691 . . . . 2.5499999999999998 112.569 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.42 -8.14 0.55 Allowed Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.176 -0.92 . . . . 2.6200000000000001 111.449 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 59.62 24.3 13.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.793 0.806 . . . . 2.7599999999999998 110.054 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.9 p -82.67 171.57 13.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.493 -1.23 . . . . 1.0700000000000001 109.466 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.556 ' OH ' HG22 ' A' ' 83' ' ' VAL . 1.6 m-85 -128.07 153.35 46.9 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.338 -0.615 . . . . 0.85999999999999999 109.338 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -100.55 109.36 21.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.473 -0.936 . . . . 0.63 108.473 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.924 HG13 ' HB ' ' A' ' 31' ' ' ILE . 2.4 p -101.57 106.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 122.307 1.051 . . . . 0.91000000000000003 110.517 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -103.25 136.82 42.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.651 -1.159 . . . . 0.79000000000000004 109.975 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.69 147.01 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 1.1799999999999999 112.02 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -149.01 154.23 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.321 -0.854 . . . . 3.3100000000000001 109.457 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -100.95 121.89 42.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.018 -0.364 . . . . 4.0300000000000002 110.018 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.222 -0.894 . . . . 2.8700000000000001 110.521 179.083 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.407 " H6'" ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.802 -0.444 . . . . 3.3399999999999999 109.802 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.48 -67.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.108 0.48 . . . . 2.8999999999999999 110.082 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -135.16 -169.02 2.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.682 -0.69 . . . . 3.8500000000000001 109.64 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.24 117.2 5.74 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.115 -1.04 . . . . 0.84999999999999998 112.48 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.66 104.23 14.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.696 -0.483 . . . . 0.70999999999999996 109.696 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 120' ' ' VAL . 37.7 mt -107.85 157.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.869 -0.605 . . . . 1.0800000000000001 109.642 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.65 HE22 ' HB2' ' A' ' 113' ' ' LEU . 2.8 mt-30 -130.03 142.17 50.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.15 -0.315 . . . . 0.85999999999999999 110.15 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -140.27 153.87 46.65 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.294 -0.632 . . . . 1.6200000000000001 109.294 177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.7 OUTLIER -104.41 168.4 9.12 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.15 -23.77 18.54 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.467 0.479 . . . . 0.79000000000000004 114.205 -175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 -37.06 37.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.216 0.508 . . . . 1.95 110.528 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.54 5.0 6.69 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.639 -0.791 . . . . 0.53000000000000003 112.307 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -70.72 147.15 49.35 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.564 -0.532 . . . . 1.3 109.564 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 mt -94.43 146.89 6.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.301 -0.629 . . . . 0.89000000000000001 109.301 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 40' ' ' LEU . 4.0 mp -127.98 -80.46 0.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 1.45 109.8 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.5 mp0 -89.45 141.06 28.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.44 -0.8 . . . . 1.99 109.976 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -130.48 5.33 4.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.349 -0.387 . . . . 1.25 110.918 178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.92 -173.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.865 -0.607 . . . . 2.1299999999999999 109.93 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.83 5.38 45.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.446 0.641 . . . . 1.48 109.495 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 49' ' ' ILE . . . -77.95 -51.44 10.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.777 . . . . 1.52 111.338 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.03 -20.87 61.62 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.916 0.389 . . . . 2.1200000000000001 110.913 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.45 -19.83 77.93 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.714 -0.755 . . . . 1.4199999999999999 111.31 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -94.89 -16.67 22.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.202 0.525 . . . . 2.3500000000000001 110.185 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 45' ' ' ALA . 50.3 mm -82.73 -63.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.094 -0.503 . . . . 2.5899999999999999 111.152 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -139.92 40.88 1.98 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.161 0.981 . . . . 3.4100000000000001 111.1 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.25 37.27 64.32 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.106 -0.952 . . . . 2.3199999999999998 113.282 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 17.9 mmt-85 -98.6 85.67 3.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 3.1400000000000001 110.985 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 6.5 m-20 -67.31 148.59 98.71 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.277 -0.874 . . . . 2.1000000000000001 109.649 175.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 49.4 Cg_exo -55.5 -32.89 84.33 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.255 1.97 . . . . 1.6799999999999999 111.427 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -73.35 -18.35 61.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.724 -0.671 . . . . 3.6099999999999999 111.668 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 53' ' ' ASP . 79.4 mm-40 -78.25 -26.61 47.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.713 0.264 . . . . 2.5 111.713 -175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.0 m -109.13 14.8 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.257 0.836 . . . . 0.96999999999999997 113.257 -172.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 62.5 mt -83.83 133.42 29.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.608 -0.516 . . . . 1.0900000000000001 109.608 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.14 88.5 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.211 -0.995 . . . . 0.66000000000000003 110.885 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 34.8 mttm -104.88 133.03 50.38 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.126 -0.537 . . . . 1.8200000000000001 109.82 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -84.34 113.31 21.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.73 -0.388 . . . . 0.71999999999999997 110.138 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 66.8 t80 -54.51 -50.14 68.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.533 -0.758 . . . . 0.69999999999999996 111.173 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.6 m-85 -79.76 21.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.286 0.476 . . . . 1.1599999999999999 112.286 -172.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -149.92 -49.67 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.87 0.366 . . . . 3.5800000000000001 111.712 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -87.19 -76.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 2.2000000000000002 111.571 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' O ' " H2'" ' A' ' 169' ' ' HC4 . 1.8 t -86.13 15.72 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.964 0.411 . . . . 1.77 111.491 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -171.41 96.12 0.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 121.998 -0.439 . . . . 0.60999999999999999 111.835 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -89.96 -9.69 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.084 2.522 . . . . 0.81000000000000005 112.898 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -83.95 -4.03 58.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.84999999999999998 111.077 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.489 HG21 ' CE1' ' A' ' 62' ' ' PHE . 6.8 p -98.45 -38.74 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.064 -0.517 . . . . 1.3300000000000001 111.534 -164.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 13.4 t70 -68.69 91.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.299 -0.41 . . . . 1.8500000000000001 109.974 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.3 p -150.21 160.19 33.74 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 1.5600000000000001 110.596 -174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 -43.84 53.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.927 2.418 . . . . 1.1699999999999999 113.608 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -78.54 -26.0 45.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.383 0.512 . . . . 2.5600000000000001 112.383 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HE2' HG11 ' A' ' 107' ' ' VAL . 67.5 t80 -105.57 -67.9 0.9 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.46 . . . . 3.3599999999999999 110.894 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 89.7 t80 -64.18 -39.29 93.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 110.863 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.2 97.56 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.97 -0.634 . . . . 0.59999999999999998 112.366 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 50.5 mmtt -73.44 -32.21 64.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 2.0899999999999999 110.606 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.3 t80 -57.58 -45.87 84.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.555 0.693 . . . . 0.67000000000000004 110.092 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.294 -0.866 . . . . 1.0900000000000001 112.005 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 2.0699999999999998 110.726 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.769 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -73.99 -44.06 31.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.312 -0.947 . . . . 0.71999999999999997 111.317 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' PHE . 22.0 t -56.19 -55.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.248 -0.476 . . . . 0.84999999999999998 111.426 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.38 83.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.285 -0.416 . . . . 1.1399999999999999 112.001 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.1 m -73.52 -70.99 0.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.437 -0.347 . . . . 1.8200000000000001 111.432 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.2 -79.38 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.691 -0.766 . . . . 1.6499999999999999 111.843 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -92.33 149.57 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.289 -0.456 . . . . 3.5 110.786 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -121.11 120.58 35.71 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.033 -0.728 . . . . 2.96 109.033 177.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 109' ' ' MET . 9.6 p30 -159.59 123.11 3.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 2.2400000000000002 109.905 173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -164.59 159.42 19.08 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.134 -0.939 . . . . 1.6299999999999999 110.235 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 53.4 ttm -132.09 107.84 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.039 -0.726 . . . . 1.77 109.039 175.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -120.23 156.22 31.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 3.0099999999999998 109.641 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.34 120.13 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.443 0.64 . . . . 2.3900000000000001 110.254 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -138.6 165.79 26.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.09 -0.959 . . . . 3.3700000000000001 109.493 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' THR . 49.2 p -104.25 154.88 19.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.858 0.361 . . . . 1.3999999999999999 111.937 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CD1' ' H2 ' ' A' ' 169' ' ' HC4 . 20.2 m-85 -119.34 103.14 9.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.758 -0.83 . . . . 1.1799999999999999 108.758 171.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 1.7 p30 -128.58 20.86 6.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.189 -0.46 . . . . 2.5699999999999998 111.444 -172.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.584 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -59.76 -44.25 93.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.68 -0.691 . . . . 3.21 111.672 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -144.18 -44.77 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.691 -0.855 . . . . 3.23 108.691 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.9 ttt -71.31 151.83 43.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.855 -1.066 . . . . 2.8500000000000001 108.768 170.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 p -53.68 149.8 15.08 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.514 -0.55 . . . . 2.1200000000000001 109.514 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 97' ' ' ASP . 18.1 Cg_endo -59.74 80.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.454 2.103 . . . . 1.47 113.129 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.0 p -74.04 151.73 40.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.3999999999999999 110.742 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 124' ' ' ARG . 10.1 mtmp? -104.62 121.19 43.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.771 0.32 . . . . 3.0800000000000001 110.176 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 35.3 m -117.44 161.51 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.929 0.395 . . . . 1.3300000000000001 110.683 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -116.17 113.93 23.76 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.739 -1.208 . . . . 1.6899999999999999 107.739 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' A' ' 75' ' ' PHE . 14.8 p -106.25 142.35 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.134 0.492 . . . . 1.27 110.136 -170.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -115.35 110.98 20.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.036 -0.727 . . . . 1.02 109.036 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.7 tpp -101.84 130.78 48.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.54 -0.754 . . . . 2.4900000000000002 109.258 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 15.2 ptmm? -156.83 141.57 16.91 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.007 0.432 . . . . 1.5700000000000001 111.532 -177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.547 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 42.6 tttp -83.64 117.68 23.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.769 -0.651 . . . . 2.1299999999999999 111.243 -172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -176.12 108.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.133 0.42 . . . . 1.5700000000000001 112.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.65 ' HB2' HE22 ' A' ' 32' ' ' GLN . 38.9 tp 168.04 -109.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.943 0.897 . . . . 4.4100000000000001 109.146 171.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -85.81 19.3 2.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.338 0.59 . . . . 2.5499999999999998 109.677 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.83 -56.09 4.65 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.602 -0.726 . . . . 2.6200000000000001 111.531 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -93.11 31.1 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.445 0.64 . . . . 2.7599999999999998 111.219 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 28.8 t -146.95 142.2 27.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.384 -0.598 . . . . 1.0700000000000001 109.384 173.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.547 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 13.0 m-85 -120.01 164.88 15.45 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.422 -0.808 . . . . 0.85999999999999999 109.969 -167.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.575 ' HD1' ' HB3' ' A' ' 112' ' ' ALA . 73.2 m95 -102.32 108.39 19.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.905 -0.776 . . . . 0.63 108.905 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 31' ' ' ILE . 4.4 p -101.33 109.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.294 1.045 . . . . 0.91000000000000003 110.717 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.448 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 83.3 m-85 -102.35 124.44 47.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.244 -0.889 . . . . 0.79000000000000004 109.779 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.52 123.93 69.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.826 0.346 . . . . 1.1799999999999999 111.044 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -137.29 134.9 36.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.299 -0.63 . . . . 3.3100000000000001 109.299 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 2.6 ttp180 -77.98 146.19 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.332 -0.395 . . . . 4.0300000000000002 111.284 -172.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.734 -1.127 . . . . 2.8700000000000001 110.687 175.669 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.596 ' H2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.5 mm? . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.876 -0.416 . . . . 3.3399999999999999 109.876 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.39 -57.89 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.583 -0.28 . . . . 2.8999999999999999 111.351 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -102.73 148.45 25.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 3.8500000000000001 110.479 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA3' HG23 ' A' ' 122' ' ' VAL . . . -105.35 158.27 16.01 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.785 -0.721 . . . . 0.84999999999999998 112.686 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.66 112.2 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.394 -0.595 . . . . 0.70999999999999996 109.394 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.938 HG22 ' HA ' ' A' ' 42' ' ' TYR . 8.9 pt -131.66 166.74 28.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.046 0.387 . . . . 1.0800000000000001 112.046 -175.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -122.4 134.2 54.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.438 . . . . 0.85999999999999999 110.296 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.7 pt? -138.79 157.62 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.691 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.0 p30 -103.78 167.76 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.002 -0.279 . . . . 1.22 110.706 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.97 -14.03 22.13 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.762 0.665 . . . . 0.79000000000000004 114.762 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 26.7 t70 -86.33 -20.39 28.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.581 0.69 . . . . 1.95 110.312 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 112.19 0.59 26.73 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.588 -0.815 . . . . 0.53000000000000003 111.961 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.632 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 49.5 m-80 -74.56 138.05 42.81 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 120.911 0.386 . . . . 1.3 110.203 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 18.5 mt -88.58 148.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.086 -0.709 . . . . 0.89000000000000001 109.086 173.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 7.8 mp -112.87 -63.56 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.26 0.552 . . . . 1.45 110.736 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -136.77 126.63 25.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.565 -0.743 . . . . 1.99 110.67 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.074 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 1.6 m-30 -93.04 162.27 14.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.069 -0.969 . . . . 1.25 110.572 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.38 161.51 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.564 -0.902 . . . . 2.1299999999999999 108.564 166.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -12.34 59.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.795 0.331 . . . . 1.48 111.403 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 26' ' ' LEU . . . -63.55 -33.2 75.07 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.145 -0.479 . . . . 1.52 111.305 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.8 -21.37 64.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.305 0.574 . . . . 2.1200000000000001 109.892 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 51' ' ' GLY . . . -68.89 -30.54 72.41 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.639 -0.71 . . . . 1.4199999999999999 111.792 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -79.11 -32.57 44.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 2.3500000000000001 110.207 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.5 mm -74.88 -64.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 2.5899999999999999 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 52' ' ' ARG . 4.2 t -113.51 -38.62 4.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.795 0.331 . . . . 3.4100000000000001 111.094 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' HA2' ' HA2' ' A' ' 47' ' ' GLY . . . 101.31 53.6 1.0 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.44 -0.886 . . . . 2.3199999999999998 112.223 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.67 ' HG2' HG23 ' A' ' 50' ' ' THR . 14.2 mmt180 -119.14 125.74 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.595 -0.52 . . . . 3.1400000000000001 109.595 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.928 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -65.81 137.62 96.2 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.597 -0.274 . . . . 2.1000000000000001 110.783 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.074 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 88.7 Cg_exo -49.47 -25.25 10.23 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.836 3.024 . . . . 1.6799999999999999 114.222 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -101.6 -2.13 31.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.592 0.219 . . . . 3.6099999999999999 111.592 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.928 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 mm-40 -97.16 -0.88 46.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.561 0.22 . . . . 2.5 111.281 -177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 5.8 m -102.78 17.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.429 0.529 . . . . 0.96999999999999997 112.429 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -86.62 125.7 40.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.799 -0.445 . . . . 1.0900000000000001 109.799 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.5 1.66 90.51 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.065 -1.064 . . . . 0.66000000000000003 110.833 -174.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.8 mptp? -94.14 118.11 31.07 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.252 -0.474 . . . . 1.8200000000000001 110.184 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 36.9 t-20 -80.15 103.1 9.8 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.921 -0.581 . . . . 0.71999999999999997 109.975 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 68.7 t80 -62.22 -13.46 28.05 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 112.16 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 80.4 m-85 -104.82 11.49 33.72 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.856 -0.527 . . . . 1.1599999999999999 111.441 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 64' ' ' LYS . 13.3 tmtt? -149.48 -56.42 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.508 -0.477 . . . . 3.5800000000000001 111.524 -172.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.8 -77.74 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.541 -0.299 . . . . 2.2000000000000002 111.354 -167.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.2 m -78.53 16.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.451 0.538 . . . . 1.77 112.451 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -176.85 97.23 0.24 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.60999999999999999 110.331 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -93.71 1.48 3.25 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 113.447 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.5 4.11 53.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.959 -0.463 . . . . 0.84999999999999998 110.069 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 9.9 p -96.75 -46.81 6.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.617 -1.174 . . . . 1.3300000000000001 110.993 -167.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.47 110.72 0.92 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 1.8500000000000001 110.381 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -177.18 143.85 0.55 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 1.5600000000000001 108.4 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HA ' ' HA3' ' A' ' 77' ' ' GLY . 50.0 Cg_exo -54.3 -29.11 56.08 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.645 2.23 . . . . 1.1699999999999999 112.745 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 94' ' ' TYR . 8.1 pt-20 -90.67 9.3 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 2.5600000000000001 111.912 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 107' ' ' VAL . 67.3 t80 -142.71 -74.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.054 -0.35 . . . . 3.3599999999999999 110.054 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -65.25 -33.77 76.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 0.79000000000000004 110.29 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . -63.73 -34.97 91.39 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.832 -0.699 . . . . 0.59999999999999998 111.955 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.43 -28.29 52.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.203 0.525 . . . . 2.0899999999999999 110.184 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.52 -41.37 96.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 109.662 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -76.5 -20.37 57.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 1.0900000000000001 110.849 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.31 -46.47 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 2.0699999999999998 110.355 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.8 -41.39 83.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.71999999999999997 112.214 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.62 -49.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.843 0.354 . . . . 0.84999999999999998 110.765 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.83 76.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 1.1399999999999999 111.219 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.0 m -76.69 -83.42 0.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 1.8200000000000001 110.713 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.57 -58.03 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.0 -0.84 . . . . 1.6499999999999999 111.0 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.91 148.66 38.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.526 . . . . 3.5 110.293 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.6 tp -111.03 111.67 22.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.293 -0.632 . . . . 2.96 109.293 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 109' ' ' MET . 15.7 p30 -160.99 58.32 0.3 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.905 0.859 . . . . 2.2400000000000002 109.956 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -107.12 145.47 32.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.859 -1.064 . . . . 1.6299999999999999 110.296 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.5 ttp -122.17 117.88 27.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 1.77 110.319 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HE1' ' HD2' ' A' ' 75' ' ' PHE . 42.6 p90 -138.13 163.88 30.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.298 -0.41 . . . . 3.0099999999999998 110.432 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 35.1 tt0 -109.67 129.12 55.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.615 -0.513 . . . . 2.3900000000000001 109.615 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.517 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 30.4 t80 -135.14 165.03 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.424 -0.353 . . . . 3.3700000000000001 110.833 -172.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 m -105.25 137.79 42.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.772 0.32 . . . . 1.3999999999999999 111.709 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 105' ' ' VAL . 14.4 m-85 -113.01 108.36 17.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.02 -0.733 . . . . 1.1799999999999999 109.02 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -119.67 8.23 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 2.5699999999999998 110.556 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 99' ' ' GLN . 28.8 t80 -122.79 131.26 53.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 3.21 108.325 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.56 ' HG2' ' CD1' ' A' ' 98' ' ' TYR . 28.6 mm-40 67.96 8.51 6.53 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.219 0.533 . . . . 3.23 110.218 -173.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 23.6 ttt -166.3 140.64 4.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.399 -0.963 . . . . 2.8500000000000001 108.399 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.6 p -64.46 148.84 95.97 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.006 -0.738 . . . . 2.1200000000000001 109.006 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.1 89.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.993 2.462 . . . . 1.47 113.374 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 104' ' ' LYS . 3.8 m -109.97 154.91 22.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.907 -0.588 . . . . 1.3999999999999999 110.277 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 103' ' ' THR . 48.1 mmtm -102.84 117.94 35.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.498 -0.556 . . . . 3.0800000000000001 109.498 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 124' ' ' ARG . 25.0 m -122.0 163.29 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.3300000000000001 110.604 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 33.6 ttpt -109.02 128.6 55.1 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.905 -0.776 . . . . 1.6899999999999999 108.905 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 75' ' ' PHE . 96.3 t -114.11 110.73 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 108.491 -0.929 . . . . 1.27 108.491 -171.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -103.51 119.96 39.92 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.871 -0.788 . . . . 1.02 108.871 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.739 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 22.2 mmt -100.07 135.26 41.77 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.639 -0.874 . . . . 2.4900000000000002 108.639 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -150.94 121.93 7.65 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.895 0.379 . . . . 1.5700000000000001 110.858 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HG3' ' CE2' ' A' ' 118' ' ' TYR . 52.9 tttt -78.91 137.46 37.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.214 0.531 . . . . 2.1299999999999999 111.283 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 177.06 8.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.789 -1.189 . . . . 1.5700000000000001 107.789 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.4 -98.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.556 -0.858 . . . . 4.4100000000000001 109.572 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.9 p 43.42 47.15 5.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.82 0.448 . . . . 2.5499999999999998 112.145 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.57 13.76 49.8 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.668 -0.777 . . . . 2.6200000000000001 112.519 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.1 t70 63.76 86.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.735 0.814 . . . . 2.7599999999999998 111.076 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 p -164.86 157.69 16.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.237 -0.892 . . . . 1.0700000000000001 109.611 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 111' ' ' LYS . 2.6 m-85 -104.68 153.86 20.71 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.823 -0.806 . . . . 0.85999999999999999 108.823 -173.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -102.12 108.78 20.3 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.484 -0.932 . . . . 0.63 108.484 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.767 HG13 HG13 ' A' ' 31' ' ' ILE . 7.4 p -101.87 127.51 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.819 0.819 . . . . 0.91000000000000003 110.645 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -108.63 131.54 54.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.249 -0.887 . . . . 0.79000000000000004 110.317 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.449 HG23 ' HA3' ' A' ' 29' ' ' GLY . 0.9 OUTLIER -111.31 106.81 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.733 0.778 . . . . 1.1799999999999999 111.201 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -103.23 117.19 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.678 . . . . 3.3100000000000001 109.927 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.781 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.6 ptm180 -89.53 157.42 18.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.62 -0.718 . . . . 4.0300000000000002 110.56 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.949 -0.548 . . . . 2.8700000000000001 111.049 175.374 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 26' ' ' LEU . 3.2 tm? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 111.288 0.107 . . . . 3.3399999999999999 111.288 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.46 66.76 0.32 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.66 0.985 . . . . 2.8999999999999999 113.66 -168.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 98.4 m-85 65.17 136.67 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.737 0.815 . . . . 3.8500000000000001 113.147 172.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.41 104.59 2.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.357 -0.925 . . . . 0.84999999999999998 111.28 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -140.78 123.09 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.523 0.201 . . . . 0.70999999999999996 110.459 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 42' ' ' TYR . 12.1 pt -125.9 160.85 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 1.0800000000000001 111.102 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -119.72 115.49 24.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.391 -0.368 . . . . 0.85999999999999999 110.348 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD12 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -117.28 146.7 43.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.307 -0.627 . . . . 1.6200000000000001 109.307 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 38' ' ' ASN . 8.1 p30 -107.24 168.69 9.05 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.38 -0.528 . . . . 1.22 110.571 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.1 -10.78 16.25 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 114.362 0.505 . . . . 0.79000000000000004 114.362 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -87.33 -11.25 49.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.358 0.579 . . . . 1.95 110.342 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.27 10.49 60.81 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.484 -1.047 . . . . 0.53000000000000003 110.484 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . 55.7 t30 -85.79 147.37 26.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.631 -0.785 . . . . 1.3 110.26 -174.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.798 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 3.8 mm -93.55 149.46 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.908 -0.404 . . . . 0.89000000000000001 109.908 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -120.3 -62.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 1.45 109.781 175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -136.92 131.13 32.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.685 -0.689 . . . . 1.99 110.541 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.752 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 2.2 m-30 -98.29 179.95 4.56 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 1.25 109.977 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 58.1 t30 -123.01 173.86 7.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.336 -0.616 . . . . 2.1299999999999999 109.336 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.91 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.518 0.562 . . . . 1.48 112.518 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' PHE . . . -73.39 -42.92 61.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.947 0.351 . . . . 1.52 111.947 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.74 -15.52 59.07 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.348 -0.541 . . . . 2.1200000000000001 110.411 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.28 -6.55 74.36 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.965 -0.854 . . . . 1.4199999999999999 110.965 171.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.27 -48.03 5.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.314 -0.443 . . . . 2.3500000000000001 110.356 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.66 -63.68 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -53.93 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.306 0.484 . . . . 3.4100000000000001 112.306 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.22 18.29 1.34 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.434 -0.889 . . . . 2.3199999999999998 113.433 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -90.46 111.91 23.35 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.952 0.376 . . . . 3.1400000000000001 110.026 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 25.7 m-20 -71.94 149.22 92.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.567 -0.531 . . . . 2.1000000000000001 109.567 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 77.4 Cg_exo -49.79 -34.12 34.97 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.605 2.87 . . . . 1.6799999999999999 114.304 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -106.38 17.33 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.146 0.425 . . . . 3.6099999999999999 112.146 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 94.7 mt-30 -95.01 -9.28 34.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 2.5 111.074 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.798 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.7 m -104.29 21.55 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.473 0.545 . . . . 0.96999999999999997 112.473 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 115.91 29.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.456 -0.498 . . . . 1.0900000000000001 110.043 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.28 64.1 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.418 -1.073 . . . . 0.66000000000000003 110.418 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.4 mptp? -80.6 147.57 30.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.512 -0.844 . . . . 1.8200000000000001 111.196 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -107.67 113.77 27.28 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.687 -0.486 . . . . 0.71999999999999997 109.687 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.717 ' HB2' HD11 ' A' ' 39' ' ' ILE . 77.4 t80 -52.89 -50.75 63.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.316 -0.402 . . . . 0.69999999999999996 112.038 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.6 m-85 -76.97 5.84 7.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.043 -0.526 . . . . 1.1599999999999999 112.295 -168.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 -47.32 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.151 0.426 . . . . 3.5800000000000001 112.151 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -99.65 -23.77 14.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.218 0.451 . . . . 2.2000000000000002 112.218 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.8 t -120.87 14.46 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.524 -0.47 . . . . 1.77 110.9 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 66' ' ' VAL . . . 170.84 86.44 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.89 -0.595 . . . . 0.60999999999999999 110.352 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HG2' ' CE1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -96.0 35.92 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.182 2.588 . . . . 0.81000000000000005 113.582 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 17.2 p -121.73 20.58 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.8 -0.445 . . . . 0.84999999999999998 109.8 171.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -130.14 -44.49 1.15 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.929 -1.487 . . . . 1.3300000000000001 109.668 -136.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 4.5 p-10 -73.32 103.98 4.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.828 0.823 . . . . 1.8500000000000001 109.393 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 64.5 m -163.93 164.59 14.51 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.506 -0.77 . . . . 1.5600000000000001 109.579 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 6.4 Cg_endo -49.96 -31.06 25.99 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.072 2.514 . . . . 1.1699999999999999 112.69 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HB3' ' HE2' ' A' ' 94' ' ' TYR . 1.3 mp0 -69.86 -91.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.24 0.543 . . . . 2.5600000000000001 111.493 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HD1' ' HE2' ' A' ' 63' ' ' PHE . 45.6 t80 -60.74 -56.61 19.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.648 -0.705 . . . . 3.3599999999999999 111.811 -169.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 68.9 t80 -67.95 -38.5 82.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 110.464 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -47.61 90.32 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.59999999999999998 112.744 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.817 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.3 mmpt? -75.76 -28.72 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.931 0.365 . . . . 2.0899999999999999 110.527 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -58.97 -41.61 87.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.339 0.59 . . . . 0.67000000000000004 109.761 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.6 -11.07 49.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.447 -0.797 . . . . 1.0900000000000001 111.306 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' LYS . 6.9 tp10 -67.42 -40.14 85.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 2.0699999999999998 110.567 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.954 ' HA3' ' HB3' ' A' ' 88' ' ' LEU . . . -71.9 -32.54 63.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.554 -0.832 . . . . 0.71999999999999997 111.227 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 83' ' ' VAL . 20.1 t -66.21 -50.86 65.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.255 -0.472 . . . . 0.84999999999999998 110.673 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.94 83.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.782 -0.644 . . . . 1.1399999999999999 111.769 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 p -77.38 -71.54 0.4 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.045 0.45 . . . . 1.8200000000000001 110.527 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.45 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.091 -0.575 . . . . 1.6499999999999999 111.947 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.93 158.15 38.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 3.5 110.366 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.954 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 1.4 pt? -138.61 135.69 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.987 -0.552 . . . . 2.96 110.057 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 109' ' ' MET . 33.8 p-10 -164.01 47.94 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.445 1.117 . . . . 2.2400000000000002 108.9 175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -104.13 154.36 19.83 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.878 -1.51 . . . . 1.6299999999999999 109.955 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -112.95 115.53 28.55 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.107 0.479 . . . . 1.77 110.359 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.36 155.47 31.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 3.0099999999999998 109.199 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.33 121.88 44.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.238 0.542 . . . . 2.3900000000000001 111.18 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.645 ' HE2' ' HB3' ' A' ' 74' ' ' GLU . 46.2 m-85 -126.94 167.08 16.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.676 -0.693 . . . . 3.3700000000000001 111.091 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 m -106.68 139.6 40.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.885 -0.598 . . . . 1.3999999999999999 110.535 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CE2' HG11 ' A' ' 105' ' ' VAL . 13.0 m-85 -104.68 119.83 39.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.48 -0.933 . . . . 1.1799999999999999 108.48 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.3 -159.75 1.02 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.289 -0.634 . . . . 2.5699999999999998 109.289 -170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' CE1' ' HG2' ' A' ' 68' ' ' PRO . 90.2 t80 69.5 -76.94 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.981 0.512 . . . . 3.21 111.123 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -107.01 -26.69 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 3.23 109.646 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.8 tpp -84.86 139.32 31.98 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.606 -0.887 . . . . 2.8500000000000001 108.606 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.6 t -65.58 136.29 96.03 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.797 -1.186 . . . . 2.1200000000000001 107.797 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -43.51 91.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.3 2.666 . . . . 1.47 114.184 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.2 p -108.95 151.8 25.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.289 -0.414 . . . . 1.3999999999999999 111.304 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -109.84 116.44 31.66 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.457 -0.572 . . . . 3.0800000000000001 109.457 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 122' ' ' VAL . 11.3 p -121.0 156.1 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 1.3300000000000001 111.248 -171.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 105' ' ' VAL . 39.1 ttmt -109.37 118.27 36.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.319 -0.993 . . . . 1.6899999999999999 108.319 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 120' ' ' VAL . 86.3 t -104.55 117.01 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 115.727 -0.67 . . . . 1.27 109.485 -174.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -103.9 105.24 15.38 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.02 108.786 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 1.2 pmm? -103.68 128.84 50.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.993 -0.549 . . . . 2.4900000000000002 109.729 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 11.6 ptmm? -144.47 138.9 27.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 1.5700000000000001 111.259 -174.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.402 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 13.6 tttt -71.16 128.49 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.996 -0.547 . . . . 2.1299999999999999 111.939 -172.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . . . -115.55 93.96 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.821 -0.807 . . . . 1.5700000000000001 108.821 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.83 83.88 3.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.669 0.747 . . . . 4.4100000000000001 110.906 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t -141.51 26.6 1.94 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.717 -1.129 . . . . 2.5499999999999998 108.534 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.27 25.15 0.42 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.055 -0.975 . . . . 2.6200000000000001 112.055 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 55.93 75.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.138 0.575 . . . . 2.7599999999999998 112.17 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 39.6 t -153.02 165.75 34.58 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.374 -0.973 . . . . 1.0700000000000001 108.374 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.7 m-85 -132.14 157.47 44.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.725 -0.843 . . . . 0.85999999999999999 108.725 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 73.8 m95 -101.22 111.35 23.54 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.861 -0.792 . . . . 0.63 108.861 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 107' ' ' VAL . 3.5 t -102.25 119.8 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.56 0.695 . . . . 0.91000000000000003 109.865 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-85 -104.57 140.63 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 0.79000000000000004 111.185 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 105' ' ' VAL . 54.1 t -104.58 104.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.073 -0.967 . . . . 1.1799999999999999 110.314 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -111.73 105.13 13.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.956 0.408 . . . . 3.3100000000000001 110.595 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -72.63 109.55 6.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.543 -0.54 . . . . 4.0300000000000002 109.543 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.504 -0.76 . . . . 2.8700000000000001 110.393 -178.254 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.016 -0.365 . . . . 3.3399999999999999 110.016 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.03 -90.24 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.671 0.272 . . . . 2.8999999999999999 111.65 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -85.2 146.81 26.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.196 -0.298 . . . . 3.8500000000000001 110.196 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.44 112.61 4.26 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.309 -0.948 . . . . 0.84999999999999998 111.917 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -103.83 129.53 51.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.70999999999999996 110.923 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.528 ' HB ' HG13 ' A' ' 120' ' ' VAL . 58.2 mt -125.7 149.82 30.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.431 -0.804 . . . . 1.0800000000000001 108.999 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 31' ' ' ILE . 60.8 tt0 -115.18 122.89 47.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.115 -0.698 . . . . 0.85999999999999999 109.115 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD22 ' CG1' ' A' ' 120' ' ' VAL . 1.9 pt? -134.81 156.29 49.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.248 0.342 . . . . 1.6200000000000001 110.738 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 26.8 p30 -102.5 167.95 9.61 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.94 -0.304 . . . . 1.22 110.687 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.42 -2.71 3.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 114.963 0.745 . . . . 0.79000000000000004 114.963 -173.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -106.28 -18.92 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.581 0.691 . . . . 1.95 110.81 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 114.13 15.2 8.59 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.416 -0.897 . . . . 0.53000000000000003 113.254 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -86.44 135.58 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 117.125 0.463 . . . . 1.3 110.141 177.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 62' ' ' PHE . 23.0 mm -89.27 149.1 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.181 -0.463 . . . . 0.89000000000000001 109.938 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 39' ' ' ILE . 6.2 mp -121.19 -72.44 0.69 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.312 0.577 . . . . 1.45 110.177 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.4 134.19 55.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.719 -0.673 . . . . 1.99 111.666 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.547 ' HE2' HG21 ' A' ' 39' ' ' ILE . 2.3 m-85 -103.43 144.58 31.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.058 -0.974 . . . . 1.25 109.586 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 3.9 t30 -82.78 4.48 25.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.495 0.664 . . . . 2.1299999999999999 109.473 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.41 -22.39 0.24 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.36 -1.291 . . . . 1.48 112.228 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ASN . . . -65.32 -18.67 65.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.313 0.486 . . . . 1.52 112.313 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' HD11 ' A' ' 31' ' ' ILE . 2.6 tm-20 -70.39 -23.91 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.857 -0.794 . . . . 2.1200000000000001 108.857 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.13 13.4 67.76 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.777 -0.725 . . . . 1.4199999999999999 112.076 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.26 -44.76 71.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.163 0.506 . . . . 2.3500000000000001 110.314 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' H ' HG12 ' A' ' 49' ' ' ILE . 4.1 pt -78.45 -47.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.898 -0.592 . . . . 2.5899999999999999 112.153 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -61.93 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.995 0.426 . . . . 3.4100000000000001 110.945 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 138.89 126.5 2.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.893 -0.67 . . . . 2.3199999999999998 111.78 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 51' ' ' GLY . 26.6 mmt180 -139.1 156.12 47.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.39 -0.596 . . . . 3.1400000000000001 109.39 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.5 m-20 -103.21 120.04 53.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.044 0.449 . . . . 2.1000000000000001 111.311 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 26.4 Cg_exo -62.1 118.95 5.85 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.947 2.431 . . . . 1.6799999999999999 112.337 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 62.6 mttp 82.29 5.38 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.851 -1.068 . . . . 3.6099999999999999 112.224 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.25 -1.17 57.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.523 0.678 . . . . 2.5 109.558 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.795 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 3.5 m -98.88 10.29 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.143 -0.935 . . . . 0.96999999999999997 111.616 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 42.8 mt -80.99 132.27 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.345 -0.613 . . . . 1.0900000000000001 109.345 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.17 75.86 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.391 -0.909 . . . . 0.66000000000000003 110.842 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' HD2' ' HA ' ' A' ' 57' ' ' VAL . 17.0 mttm -109.52 132.04 54.5 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.121 -0.696 . . . . 1.8200000000000001 109.121 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.1 t-20 -90.0 102.98 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.755 -0.461 . . . . 0.71999999999999997 109.755 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.025 ' HB2' HD11 ' A' ' 39' ' ' ILE . 70.9 t80 -49.82 -39.15 37.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.69999999999999996 111.785 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.677 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m-85 -76.51 -20.5 56.85 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 1.1599999999999999 112.435 -171.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -116.84 -30.5 5.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.215 0.45 . . . . 3.5800000000000001 112.215 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -89.14 -79.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.037 0.384 . . . . 2.2000000000000002 112.037 -170.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 p -99.77 13.96 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.699 0.762 . . . . 1.77 111.685 -169.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -168.3 69.91 0.81 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.455 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 39.4 Cg_endo -68.94 11.31 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.644 2.229 . . . . 0.81000000000000005 113.688 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.8 m -79.92 -30.54 40.01 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.84999999999999998 109.717 173.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.677 ' OG1' ' HA ' ' A' ' 63' ' ' PHE . 17.3 p -78.93 -38.56 36.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.722 -1.127 . . . . 1.3300000000000001 110.383 -158.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 25.6 t70 -64.18 100.19 0.32 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.218 -0.66 . . . . 1.8500000000000001 109.218 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 30.5 t -149.63 147.78 23.9 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.919 -0.582 . . . . 1.5600000000000001 109.985 -171.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.38 -29.39 23.67 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.044 2.496 . . . . 1.1699999999999999 112.156 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.8 pt-20 -93.65 -60.03 1.86 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.638 -0.425 . . . . 2.5600000000000001 111.283 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 81.5 t80 -68.7 -52.31 32.23 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.198 -0.314 . . . . 3.3599999999999999 111.564 -169.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 51.7 t80 -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.79000000000000004 109.486 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.95 79.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 112.485 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 64.2 mmtt -81.91 -30.82 31.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.97 0.414 . . . . 2.0899999999999999 110.159 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -65.53 -30.64 71.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.67000000000000004 110.734 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 31.3 mmmt -82.79 -9.2 59.45 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.334 -0.848 . . . . 1.0900000000000001 111.47 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -58.88 -33.83 70.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.489 -0.323 . . . . 2.0699999999999998 111.71 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 1.058 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -88.08 -37.14 7.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.301 -0.952 . . . . 0.71999999999999997 112.139 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.04 -46.18 77.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.893 0.477 . . . . 0.84999999999999998 111.227 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -23.9 64.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 1.1399999999999999 111.798 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.2 m -104.99 -81.25 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.351 0.596 . . . . 1.8200000000000001 110.548 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.31 -48.6 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.886 -0.886 . . . . 1.6499999999999999 110.886 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.936 ' HA ' ' HG3' ' A' ' 111' ' ' LYS . 1.4 p-10 -124.17 150.94 44.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.868 -0.666 . . . . 3.5 111.335 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.058 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 56.5 tp -144.29 114.96 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 2.96 109.708 174.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 109' ' ' MET . 49.2 m-20 -124.8 89.61 3.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.613 . . . . 2.2400000000000002 109.667 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -124.74 165.58 17.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.159 -0.928 . . . . 1.6299999999999999 111.319 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.6 ttp -136.68 111.06 8.48 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.374 -0.973 . . . . 1.77 108.374 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -121.68 163.44 19.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.482 -0.326 . . . . 3.0099999999999998 110.211 -171.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -116.4 124.75 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.252 -0.647 . . . . 2.3900000000000001 109.252 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -138.08 159.19 42.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.294 -0.261 . . . . 3.3700000000000001 110.294 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.84 142.53 34.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.313 -0.403 . . . . 1.3999999999999999 111.085 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 12.7 m-85 -107.51 132.74 52.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.172 -0.467 . . . . 1.1799999999999999 109.753 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 100' ' ' MET . 13.1 t70 -143.21 -150.26 0.31 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.452 -0.944 . . . . 2.5699999999999998 108.452 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.7 t80 66.3 -82.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.759 0.424 . . . . 3.21 111.151 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.629 HE21 ' H3 ' ' A' ' 169' ' ' HC4 . 27.4 pt20 -99.6 -24.18 14.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.262 0.553 . . . . 3.23 109.819 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 101' ' ' THR . 52.6 tpp -91.79 141.61 28.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.847 . . . . 2.8500000000000001 108.996 173.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -72.38 143.17 85.18 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 108.757 -0.831 . . . . 2.1200000000000001 108.757 170.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -40.41 90.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.779 2.986 . . . . 1.47 114.186 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 m -123.24 144.64 49.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.843 -0.617 . . . . 1.3999999999999999 109.942 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.62 142.89 33.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.383 . . . . 3.0800000000000001 110.123 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 124' ' ' ARG . 23.7 m -128.78 164.52 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.06 -0.518 . . . . 1.3300000000000001 110.505 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -108.72 117.88 35.33 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.13 -1.063 . . . . 1.6899999999999999 108.13 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.418 HG11 ' HE2' ' A' ' 75' ' ' PHE . 11.7 p -104.59 133.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.412 0.625 . . . . 1.27 109.655 -172.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 7.7 t-160 -111.18 109.88 20.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.964 -0.754 . . . . 1.02 108.964 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 44.9 tpp -102.23 123.76 46.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.23 -0.655 . . . . 2.4900000000000002 109.23 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -141.81 136.43 30.63 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.588 -0.153 . . . . 1.5700000000000001 110.588 -174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.936 ' HG3' ' HA ' ' A' ' 87' ' ' ASN . 7.7 tmtt? -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.171 0.51 . . . . 2.1299999999999999 110.813 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.635 ' N ' ' HD3' ' A' ' 111' ' ' LYS . . . -146.62 160.46 42.15 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.549 -0.75 . . . . 1.5700000000000001 109.913 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -103.23 -0.62 30.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.746 0.308 . . . . 4.4100000000000001 110.479 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.6 m -61.78 106.47 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.505 -0.924 . . . . 2.5499999999999998 108.505 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.96 -103.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.526 -1.429 . . . . 2.6200000000000001 109.526 -164.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -179.07 84.54 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.775 -0.824 . . . . 2.7599999999999998 108.775 167.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 2.6 p -166.0 -172.24 2.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.447 -0.797 . . . . 1.0700000000000001 111.237 -171.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 111' ' ' LYS . 75.0 m-85 -110.86 155.32 22.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.489 -0.56 . . . . 0.85999999999999999 109.489 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -103.71 107.78 18.79 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.297 -1.001 . . . . 0.63 108.297 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.528 HG13 ' HB ' ' A' ' 31' ' ' ILE . 12.5 p -100.64 131.86 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.702 0.763 . . . . 0.91000000000000003 110.369 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.0 m-85 -115.2 128.82 56.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.457 -0.792 . . . . 0.79000000000000004 109.84 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -104.33 102.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.193 0.521 . . . . 1.1799999999999999 109.626 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -112.42 110.32 20.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 3.3100000000000001 109.698 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 5.7 ptm180 -74.6 166.55 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.535 -0.466 . . . . 4.0300000000000002 110.493 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.736 -0.65 . . . . 2.8700000000000001 109.81 177.547 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.629 ' H3 ' HE21 ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.857 0.36 . . . . 3.3399999999999999 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HA ' ' NH2' ' A' ' 124' ' ' ARG . . . -126.33 -37.36 2.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.514 . . . . 2.8999999999999999 110.868 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -80.18 117.02 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.989 -0.745 . . . . 3.8500000000000001 108.989 176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -102.47 115.56 5.24 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.332 -0.937 . . . . 0.84999999999999998 112.925 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' A' ' 43' ' ' ASN . . . -104.33 104.2 14.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 109.844 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 120' ' ' VAL . 29.6 mt -113.09 158.23 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.818 -0.808 . . . . 1.0800000000000001 108.818 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 48.9 tt0 -120.08 112.66 19.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.807 -0.558 . . . . 0.85999999999999999 110.32 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.677 ' HG ' HG11 ' A' ' 120' ' ' VAL . 6.7 mt -114.05 142.92 45.58 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.895 -0.78 . . . . 1.6200000000000001 108.895 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -102.71 168.96 8.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.769 -0.372 . . . . 1.22 110.275 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -50.58 -33.39 25.86 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.672 0.629 . . . . 0.79000000000000004 114.672 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.04 -21.09 43.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.357 0.578 . . . . 1.95 111.45 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.3 17.36 10.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.579 -0.82 . . . . 0.53000000000000003 112.75 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 7.5 m120 -83.16 147.7 27.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.372 . . . . 1.3 110.343 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.033 HD11 ' HB2' ' A' ' 62' ' ' PHE . 13.5 mm -92.76 145.31 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.703 -0.681 . . . . 0.89000000000000001 110.287 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 32' ' ' GLN . 3.8 mm? -97.68 -62.59 1.23 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 1.45 110.609 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -170.07 158.5 7.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.953 -1.021 . . . . 1.99 109.949 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' HE1' ' HB2' ' A' ' 52' ' ' ARG . 9.6 m-30 -110.94 147.74 33.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.523 -0.762 . . . . 1.25 109.376 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 30' ' ' ALA . 28.5 p-10 -80.36 -173.17 3.91 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.666 -0.494 . . . . 2.1299999999999999 109.666 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -78.21 20.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.009 0.374 . . . . 1.48 112.009 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . . . -97.38 -65.17 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.052 0.39 . . . . 1.52 112.052 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 27.9 tp10 -61.12 -51.02 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.682 -0.69 . . . . 2.1200000000000001 111.172 -172.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.96 -3.81 81.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.082 -0.58 . . . . 1.4199999999999999 112.648 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 34.7 t70 -84.2 -18.76 35.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.347 0.594 . . . . 2.3500000000000001 110.204 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -110.22 -65.18 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.57 -0.741 . . . . 2.5899999999999999 111.041 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.9 m -155.74 -42.11 0.08 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.524 0.202 . . . . 3.4100000000000001 111.42 -174.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -61.15 88.04 0.04 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 115.03 0.772 . . . . 2.3199999999999998 115.03 -170.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.85 ' HG2' " H3'" ' A' ' 169' ' ' HC4 . 20.0 mmm180 61.15 -176.87 0.12 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.999 0.904 . . . . 3.1400000000000001 113.273 170.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 5.8 t70 -102.75 132.68 21.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 114.471 -1.24 . . . . 2.1000000000000001 108.293 169.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 50.2 Cg_exo -55.29 -20.45 25.23 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.369 2.713 . . . . 1.6799999999999999 114.438 -174.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 1.9 mppt? -109.49 -3.49 16.96 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.037 -0.265 . . . . 3.6099999999999999 111.437 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -104.08 24.56 11.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.082 0.467 . . . . 2.5 111.784 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.76 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 m -118.52 10.99 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.035 0.445 . . . . 0.96999999999999997 111.319 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.73 133.33 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.653 -0.419 . . . . 1.0900000000000001 110.507 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.23 19.31 72.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.265 -0.734 . . . . 0.66000000000000003 111.265 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.55 148.25 47.91 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.659 -0.271 . . . . 1.8200000000000001 110.526 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 8.1 t-20 -98.96 125.16 44.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.035 0.445 . . . . 0.71999999999999997 111.512 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.033 ' HB2' HD11 ' A' ' 39' ' ' ILE . 48.5 t80 -64.72 -9.32 19.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 0.69999999999999996 111.868 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 52.0 m-85 -122.65 20.55 10.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.849 0.357 . . . . 1.1599999999999999 110.439 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 44.3 mmtm -150.79 -45.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 3.5800000000000001 111.824 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -101.84 -79.05 0.52 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.959 0.409 . . . . 2.2000000000000002 111.389 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 HG12 ' A' ' 57' ' ' VAL . 14.7 m -84.14 15.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 1.77 112.54 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -172.64 97.06 0.36 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.60999999999999999 109.89 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.92 19.87 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.19 2.593 . . . . 0.81000000000000005 113.674 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -110.79 13.63 22.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.484 -0.486 . . . . 0.84999999999999998 109.839 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.9 p -112.74 -43.73 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.943 -1.026 . . . . 1.3300000000000001 111.055 -164.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 16.1 t70 -65.22 105.06 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 1.8500000000000001 110.506 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.602 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 9.7 t -170.54 149.79 3.12 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 109.349 -0.612 . . . . 1.5600000000000001 109.349 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 47.6 Cg_exo -39.38 -43.46 2.77 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.281 3.32 . . . . 1.1699999999999999 114.98 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.674 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -92.38 -39.47 11.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.785 -0.366 . . . . 2.5600000000000001 111.748 -176.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 70' ' ' THR . 28.3 m-85 -71.74 -69.29 0.4 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.176 0.513 . . . . 3.3599999999999999 110.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.8 t80 -61.66 -32.7 72.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.79000000000000004 110.193 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -59.83 -31.34 71.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 112.915 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 30.9 mmtp -78.05 -34.22 50.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.219 0.51 . . . . 2.0899999999999999 110.836 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.58 -26.55 68.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 0.67000000000000004 110.334 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 19.5 mmmt -93.13 -6.54 47.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 1.0900000000000001 112.038 -175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 6.6 mm-40 -58.14 -42.35 85.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.268 0.47 . . . . 2.0699999999999998 112.268 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 88' ' ' LEU . . . -76.38 -41.36 25.83 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.999 -1.096 . . . . 0.71999999999999997 111.234 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.43 HG22 ' OH ' ' A' ' 118' ' ' TYR . 20.3 t -50.22 -48.15 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 123.121 0.568 . . . . 0.84999999999999998 111.121 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.42 -32.35 49.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.732 -0.667 . . . . 1.1399999999999999 112.502 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -90.08 -66.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.844 0.354 . . . . 1.8200000000000001 110.198 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.74 34.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.726 -0.749 . . . . 1.6499999999999999 111.864 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.793 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 0.7 OUTLIER 65.88 105.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.277 -0.638 . . . . 3.5 109.277 -176.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.464 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 33.6 tp -143.45 159.35 42.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.132 -0.627 . . . . 2.96 111.757 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 109' ' ' MET . 18.9 t30 -82.05 112.83 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.036 -0.984 . . . . 2.2400000000000002 111.224 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -125.27 146.48 49.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 1.6299999999999999 110.157 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.572 ' HB3' ' CD2' ' A' ' 108' ' ' HIS . 21.3 ptp -116.73 129.37 56.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.839 0.352 . . . . 1.77 110.216 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' HD1' ' HD1' ' A' ' 94' ' ' TYR . 13.1 p90 -141.63 148.13 38.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.861 0.362 . . . . 3.0099999999999998 110.968 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.94 116.67 30.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.75 -0.659 . . . . 2.3900000000000001 109.914 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HD1' ' HD1' ' A' ' 92' ' ' PHE . 38.7 m-85 -142.21 168.02 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.1 -0.5 . . . . 3.3700000000000001 110.91 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 104' ' ' LYS . 36.2 p -102.85 156.86 17.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.968 -0.56 . . . . 1.3999999999999999 111.654 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.428 ' CD1' " H6'" ' A' ' 169' ' ' HC4 . 19.8 m-85 -116.27 108.96 16.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 1.1799999999999999 109.194 172.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' MET . 7.1 p-10 -121.26 -153.75 0.56 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.943 -0.571 . . . . 2.5699999999999998 110.236 -177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 65.8 t80 71.43 -73.81 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.959 0.503 . . . . 3.21 111.477 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.44 -26.28 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.441 0.638 . . . . 3.23 109.807 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 16.5 tpt -103.31 140.61 37.19 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.17 -0.923 . . . . 2.8500000000000001 109.499 176.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 m -60.03 117.7 25.98 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.71 -0.848 . . . . 2.1200000000000001 108.71 172.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -38.15 93.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.096 3.197 . . . . 1.47 114.254 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 160.48 18.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 109.611 172.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.1 ptpt -115.49 146.49 41.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 3.0800000000000001 111.493 -178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 124' ' ' ARG . 18.9 m -130.6 165.66 30.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.004 -0.998 . . . . 1.3300000000000001 110.295 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -112.7 118.01 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.556 -0.905 . . . . 1.6899999999999999 108.556 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -105.02 104.87 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.88 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.572 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 6.7 t-160 -103.79 102.81 12.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.492 -0.929 . . . . 1.02 108.492 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 5.2 ppp? -107.85 140.79 40.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.585 -0.734 . . . . 2.4900000000000002 110.507 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.724 ' HE2' ' HE1' ' A' ' 121' ' ' PHE . 62.2 pttt -150.98 152.03 32.96 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.043 0.449 . . . . 1.5700000000000001 111.489 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.793 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 33.2 ttpt -75.58 136.62 40.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.696 -0.684 . . . . 2.1299999999999999 112.552 -172.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -130.98 107.29 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.369 -0.832 . . . . 1.5700000000000001 109.312 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -74.45 1.85 10.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.341 -0.39 . . . . 4.4100000000000001 111.135 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -51.89 -45.82 64.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 2.5499999999999998 111.149 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.36 29.15 2.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.587 -0.816 . . . . 2.6200000000000001 112.437 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.94 60.51 3.43 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.271 0.558 . . . . 2.7599999999999998 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.44 ' OG ' ' HG2' ' A' ' 32' ' ' GLN . 32.5 t -164.55 164.53 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.373 -0.973 . . . . 1.0700000000000001 108.373 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.762 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 21.1 m-85 -104.95 156.38 18.08 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.843 -0.429 . . . . 0.85999999999999999 109.843 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 62.8 m95 -101.58 106.12 17.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.398 -0.964 . . . . 0.63 108.398 172.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.677 HG11 ' HG ' ' A' ' 33' ' ' LEU . 4.2 p -101.94 122.51 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.86 0.838 . . . . 0.91000000000000003 110.473 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.724 ' HE1' ' HE2' ' A' ' 110' ' ' LYS . 94.4 m-85 -104.28 109.92 21.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.113 -0.949 . . . . 0.79000000000000004 109.676 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.17 108.06 23.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.08 -0.963 . . . . 1.1799999999999999 109.914 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -104.5 127.8 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 3.3100000000000001 110.241 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.728 ' HA ' HG12 ' A' ' 105' ' ' VAL . 49.7 mtm-85 -70.44 127.91 34.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.006 -0.543 . . . . 4.0300000000000002 109.732 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 104' ' ' LYS . 3.0 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.938 -1.03 . . . . 2.8700000000000001 111.326 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.85 " H3'" ' HG2' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.406 0.146 . . . . 3.3399999999999999 110.956 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 72.77 -60.43 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.822 0.701 . . . . 2.8999999999999999 111.494 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -78.97 153.45 30.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.603 -0.517 . . . . 3.8500000000000001 109.603 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.2 148.33 17.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.377 -0.916 . . . . 0.84999999999999998 112.518 -174.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' HD22 ' A' ' 43' ' ' ASN . . . -138.9 105.05 5.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.842 0.353 . . . . 0.70999999999999996 110.338 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.837 ' HB ' HG13 ' A' ' 120' ' ' VAL . 11.3 mm -108.67 160.83 7.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.767 -0.827 . . . . 1.0800000000000001 108.767 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 31' ' ' ILE . 59.2 tt0 -128.43 118.7 23.58 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.69 -0.485 . . . . 0.85999999999999999 109.69 172.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 120' ' ' VAL . 17.1 mt -116.05 155.51 28.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.699 -0.482 . . . . 1.6200000000000001 109.699 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 4.4 p30 -108.76 169.38 8.7 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.867 -0.333 . . . . 1.22 110.259 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -52.2 -20.52 6.92 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.3 0.88 . . . . 0.79000000000000004 115.3 -171.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.24 -19.84 23.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.901 0.851 . . . . 1.95 110.636 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.76 6.49 23.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.762 -0.733 . . . . 0.53000000000000003 112.292 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.645 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 89.7 m-20 -71.61 149.71 45.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.915 0.388 . . . . 1.3 110.486 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 62' ' ' PHE . 10.0 mt -95.4 149.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.693 -0.685 . . . . 0.89000000000000001 109.37 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.1 mp -113.49 -56.76 2.37 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.45 109.879 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -150.77 144.27 25.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.027 -0.988 . . . . 1.99 111.142 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.067 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 3.2 m-30 -101.1 175.26 5.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.575 -1.193 . . . . 1.25 110.271 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.44 HD22 ' HB3' ' A' ' 30' ' ' ALA . 18.2 t-20 -102.41 179.72 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.61 -0.885 . . . . 2.1299999999999999 108.61 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -86.56 13.51 8.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.833 0.349 . . . . 1.48 110.493 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -89.92 -40.98 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 1.52 110.828 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 52' ' ' ARG . 11.4 mp0 -59.74 -55.03 39.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 2.1200000000000001 110.374 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 51' ' ' GLY . . . -61.96 -30.8 76.41 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.562 -0.744 . . . . 1.4199999999999999 112.875 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.4 t70 -62.61 -33.43 74.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 2.3500000000000001 110.548 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.494 HG22 HG22 ' A' ' 50' ' ' THR . 44.7 mt -81.77 -62.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.776 -0.647 . . . . 2.5899999999999999 109.915 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 49' ' ' ILE . 9.4 t -179.44 131.43 0.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.157 -0.474 . . . . 3.4100000000000001 110.464 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . 57.33 -157.2 13.7 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.932 -0.576 . . . . 2.3199999999999998 112.808 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 4.4 mpp_? 53.95 79.85 0.12 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.755 -0.723 . . . . 3.1400000000000001 111.748 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' A' ' 56' ' ' GLN . 21.9 t70 -79.96 136.24 54.5 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 2.1000000000000001 110.598 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.067 ' HA ' ' HB2' ' A' ' 42' ' ' TYR . 11.1 Cg_endo -54.5 -33.56 78.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.667 2.911 . . . . 1.6799999999999999 114.123 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.94 2.02 48.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.434 . . . . 3.6099999999999999 111.129 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' CB ' ' HB3' ' A' ' 53' ' ' ASP . 22.4 tt0 -92.9 -8.4 43.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 2.5 110.966 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG21 ' CD2' ' A' ' 42' ' ' TYR . 3.2 m -112.93 58.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.623 0.601 . . . . 0.96999999999999997 112.623 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 40' ' ' LEU . 11.4 mt -122.39 139.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.687 -0.633 . . . . 1.0900000000000001 110.031 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.13 75.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.622 -0.799 . . . . 0.66000000000000003 111.191 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -114.36 139.64 49.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.147 -0.527 . . . . 1.8200000000000001 110.118 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.95 113.35 20.48 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.853 -0.425 . . . . 0.71999999999999997 109.853 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 84.2 t80 -47.21 -46.59 24.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.663 -0.699 . . . . 0.69999999999999996 111.542 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.862 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 49.6 m-85 -80.22 7.77 8.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 1.1599999999999999 111.614 -172.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -124.37 -50.77 1.76 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 3.5800000000000001 110.991 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.44 -79.68 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.687 0.625 . . . . 2.2000000000000002 112.687 -174.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.26 16.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.251 0.548 . . . . 1.77 111.373 -168.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB1' ' OG1' ' A' ' 70' ' ' THR . . . -165.93 70.45 1.22 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.421 . . . . 0.60999999999999999 110.851 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.11 -6.28 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.901 2.401 . . . . 0.81000000000000005 113.17 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 98' ' ' TYR . 7.5 p -84.59 -22.15 30.13 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.415 -0.587 . . . . 0.84999999999999998 109.415 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 ' OG1' ' HB1' ' A' ' 67' ' ' ALA . 2.2 m -79.38 -32.96 43.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.847 -1.524 . . . . 1.3300000000000001 110.477 -160.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.862 ' HB2' ' HB3' ' A' ' 63' ' ' PHE . 12.1 t70 -62.9 108.58 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.7 -0.682 . . . . 1.8500000000000001 109.999 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -162.95 155.78 16.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 1.5600000000000001 109.496 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.94 -32.7 97.93 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.374 2.049 . . . . 1.1699999999999999 111.913 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -80.44 -9.79 59.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 2.5600000000000001 112.482 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' A' ' 70' ' ' THR . 62.0 t80 -130.05 -67.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.109 -0.37 . . . . 3.3599999999999999 110.806 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -56.61 -41.53 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.79000000000000004 110.332 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.35 -34.3 84.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.04 -0.6 . . . . 0.59999999999999998 112.594 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.3 -36.95 38.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.391 . . . . 2.0899999999999999 110.243 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' HD1' ' HG2' ' A' ' 109' ' ' MET . 34.9 t80 -57.4 -44.54 84.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.67000000000000004 109.428 172.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -75.68 -18.91 59.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.638 -0.71 . . . . 1.0900000000000001 111.781 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -38.36 82.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.827 -0.434 . . . . 2.0699999999999998 109.827 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.682 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -72.34 -45.97 35.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.73 -0.748 . . . . 0.71999999999999997 111.481 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' PHE . 28.1 t -50.59 -48.52 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 122.979 0.511 . . . . 0.84999999999999998 111.1 176.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.4 -20.32 62.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.627 -0.715 . . . . 1.1399999999999999 112.01 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -99.14 -81.86 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.878 0.37 . . . . 1.8200000000000001 110.436 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -169.0 -60.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.826 -0.702 . . . . 1.6499999999999999 111.774 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -98.72 130.84 45.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.533 . . . . 3.5 109.627 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.682 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER -115.49 104.45 11.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.914 -0.773 . . . . 2.96 108.914 178.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.1 p-10 -149.32 95.44 2.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 122.135 0.969 . . . . 2.2400000000000002 110.227 171.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.9 m -142.86 145.16 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.112 -0.949 . . . . 1.6299999999999999 109.894 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -120.1 117.83 28.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.061 0.458 . . . . 1.77 109.778 174.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.03 154.15 36.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.04 -0.726 . . . . 3.0099999999999998 109.04 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 pt-20 -103.2 103.49 13.54 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 2.3900000000000001 110.553 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -110.78 161.27 15.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.704 -1.135 . . . . 3.3700000000000001 109.96 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' THR . 13.6 m -104.13 129.28 51.84 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.14 -0.482 . . . . 1.3999999999999999 110.938 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' CD1' ' H2 ' ' A' ' 169' ' ' HC4 . 27.3 m-85 -103.35 104.62 14.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.482 -0.933 . . . . 1.1799999999999999 108.482 174.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.59 8.39 9.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 2.5699999999999998 111.793 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 69' ' ' CYS . 71.6 t80 -79.22 -82.61 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.555 -0.293 . . . . 3.21 110.69 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -87.37 -37.86 16.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.518 . . . . 3.23 109.77 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.0 ttt -82.2 139.9 34.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.766 -0.827 . . . . 2.8500000000000001 108.766 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.16 143.55 92.26 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 109.264 -0.643 . . . . 2.1200000000000001 109.264 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -42.48 89.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.64 2.893 . . . . 1.47 114.187 -174.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.8 m -108.14 145.9 33.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.977 -0.556 . . . . 1.3999999999999999 110.585 175.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -103.34 104.73 14.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.143 0.497 . . . . 3.0800000000000001 110.443 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.7 m -117.15 165.51 12.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.625 -0.716 . . . . 1.3300000000000001 109.973 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 35.9 ttmt -110.94 119.39 38.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.622 -0.881 . . . . 1.6899999999999999 108.622 177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 91' ' ' MET . 54.9 t -105.64 127.12 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 115.408 -0.815 . . . . 1.27 108.848 -171.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 2.2 t-160 -109.97 114.45 27.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.31 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 4.1 mpp? -101.45 119.83 39.37 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.007 -0.738 . . . . 2.4900000000000002 109.007 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 58.7 pttt -143.25 124.52 14.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.413 0.625 . . . . 1.5700000000000001 112.227 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 118' ' ' TYR . 42.8 tttt -57.68 126.5 27.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.664 -1.153 . . . . 2.1299999999999999 111.162 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HB3' ' HD1' ' A' ' 119' ' ' TRP . . . -174.79 94.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.091 0.774 . . . . 1.5700000000000001 113.091 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.021 HD11 ' H ' ' A' ' 117' ' ' SER . 0.2 OUTLIER 177.73 -174.98 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.005 0.522 . . . . 4.4100000000000001 111.431 167.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 t -77.22 77.63 3.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.529 -0.915 . . . . 2.5499999999999998 108.529 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.14 -134.06 3.62 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.753 -1.213 . . . . 2.6200000000000001 112.979 -173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -143.32 25.32 1.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 2.7599999999999998 110.648 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 1.021 ' H ' HD11 ' A' ' 113' ' ' LEU . 4.3 m -98.87 167.32 10.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.943 -0.762 . . . . 1.0700000000000001 108.943 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -127.13 156.99 40.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.002 0.43 . . . . 0.85999999999999999 110.216 -169.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.627 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 35.9 m95 -101.02 110.63 22.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.942 -0.762 . . . . 0.63 108.942 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 31' ' ' ILE . 3.5 p -103.25 107.87 23.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.512 1.149 . . . . 0.91000000000000003 110.59 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.627 ' CE1' ' HB3' ' A' ' 119' ' ' TRP . 95.7 m-85 -102.78 140.72 36.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.734 -1.121 . . . . 0.79000000000000004 110.697 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.87 104.15 16.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.788 -0.642 . . . . 1.1799999999999999 109.744 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.99 126.01 51.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.559 . . . . 3.3100000000000001 109.807 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HA ' HG12 ' A' ' 105' ' ' VAL . 44.3 mtm180 -79.8 143.79 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.789 -0.365 . . . . 4.0300000000000002 110.372 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.337 -0.84 . . . . 2.8700000000000001 109.899 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.504 " H3'" ' HE ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 31.6 tp . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.668 -0.493 . . . . 3.3399999999999999 109.668 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -60.54 2.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 2.8999999999999999 111.734 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -77.19 152.24 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.085 -0.339 . . . . 3.8500000000000001 110.085 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.61 135.75 12.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.445 -0.883 . . . . 0.84999999999999998 113.243 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.9 104.62 12.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.514 -0.55 . . . . 0.70999999999999996 109.514 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 120' ' ' VAL . 60.5 mt -112.77 142.65 24.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.557 -0.534 . . . . 1.0800000000000001 109.557 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -109.41 116.19 31.37 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.553 -0.459 . . . . 0.85999999999999999 109.834 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 117' ' ' SER . 2.7 mm? -103.83 165.43 11.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.809 -1.182 . . . . 1.6200000000000001 107.809 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 47.3 p30 -108.19 167.16 10.21 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 1.22 110.333 173.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HE1' ' A' ' 118' ' ' TYR . . . -60.54 -2.12 2.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 114.403 0.521 . . . . 0.79000000000000004 114.403 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -100.33 -47.33 4.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.534 0.667 . . . . 1.95 109.675 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.46 6.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.501 -0.772 . . . . 0.53000000000000003 112.558 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -76.96 149.61 35.95 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.969 0.414 . . . . 1.3 110.43 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 12.6 mt -95.96 148.13 5.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.663 -0.699 . . . . 0.89000000000000001 109.591 175.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 39' ' ' ILE . 8.4 mp -115.64 -64.85 1.26 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.326 0.584 . . . . 1.45 111.945 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -150.66 158.8 44.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.219 -0.9 . . . . 1.99 110.641 -173.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 39' ' ' ILE . 5.3 m-30 -121.21 -174.19 2.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.065 -0.971 . . . . 1.25 110.158 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 26' ' ' LEU . 12.9 t-20 -114.81 178.96 4.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.844 -0.799 . . . . 2.1299999999999999 108.844 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.87 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 1.48 110.467 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' ILE . . . -43.67 -63.82 0.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.847 . . . . 1.52 112.786 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -61.99 -37.9 86.57 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.796 0.331 . . . . 2.1200000000000001 111.792 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.27 94.59 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.807 -0.711 . . . . 1.4199999999999999 111.681 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.0 -38.17 82.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 122.538 0.335 . . . . 2.3500000000000001 111.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 45' ' ' ALA . 48.9 mt -56.53 -60.31 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.075 0.464 . . . . 2.5899999999999999 110.692 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 51' ' ' GLY . 8.8 t -144.69 -42.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.139 -0.482 . . . . 3.4100000000000001 111.071 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 50' ' ' THR . . . 139.64 77.47 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.395 -0.907 . . . . 2.3199999999999998 112.192 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 1.2 mpt_? -118.14 119.78 35.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.822 0.344 . . . . 3.1400000000000001 110.28 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.73 133.32 31.08 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 2.1000000000000001 111.255 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 31.8 Cg_exo -60.37 -28.87 87.61 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.038 2.492 . . . . 1.6799999999999999 112.16 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 10.9 mmpt? -79.82 -12.2 59.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.434 -0.348 . . . . 3.6099999999999999 111.616 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -89.52 -24.6 21.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 2.5 111.325 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.734 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 m -98.64 16.31 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.96999999999999997 113.462 -170.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.59 125.46 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.266 -0.574 . . . . 1.0900000000000001 109.969 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 -1.77 88.37 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.289 -0.957 . . . . 0.66000000000000003 110.861 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' ILE . 14.0 mptt -95.93 140.61 30.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.854 -0.673 . . . . 1.8200000000000001 109.877 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 14.4 t-20 -90.34 116.87 28.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.408 -0.59 . . . . 0.71999999999999997 109.408 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' HA ' HD11 ' A' ' 39' ' ' ILE . 89.0 t80 -56.24 -42.3 77.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.865 -0.607 . . . . 0.69999999999999996 111.278 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.4 m-85 -82.06 1.25 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.595 . . . . 1.1599999999999999 111.399 -170.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.4 mmtp -122.23 -58.32 1.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.94 0.4 . . . . 3.5800000000000001 111.559 -176.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.31 -76.98 0.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.743 -0.662 . . . . 2.2000000000000002 111.969 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 14.6 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.042 0.925 . . . . 1.77 111.716 -172.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 62' ' ' PHE . . . -169.69 74.03 0.68 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.234 -0.893 . . . . 0.60999999999999999 110.636 175.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.45 -18.24 43.74 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.151 2.567 . . . . 0.81000000000000005 113.393 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.78 -8.06 59.03 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.975 -0.29 . . . . 0.84999999999999998 110.513 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -86.78 -19.97 28.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 1.3300000000000001 110.73 -176.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 63' ' ' PHE . 16.8 t70 -67.93 96.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.394 . . . . 1.8500000000000001 110.285 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' ' OE1' ' A' ' 74' ' ' GLU . 74.9 m -166.11 148.58 6.28 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.5600000000000001 109.477 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -53.27 -35.94 76.13 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.008 2.472 . . . . 1.1699999999999999 113.294 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 72' ' ' SER . 1.4 pm0 -86.36 -7.3 58.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.053 0.39 . . . . 2.5600000000000001 112.053 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 72' ' ' SER . 51.4 m-85 -112.56 -81.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 3.3599999999999999 109.927 173.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 75.2 t80 -59.67 -37.69 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.487 -0.779 . . . . 0.79000000000000004 110.555 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.24 94.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.088 -0.577 . . . . 0.59999999999999998 112.136 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 67.9 mmtt -67.8 -38.15 82.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.379 . . . . 2.0899999999999999 110.816 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 34' ' ' ASP . 93.6 t80 -57.5 -42.36 82.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.697 -0.683 . . . . 0.67000000000000004 110.614 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 14.5 mmmm -85.91 -13.95 46.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.645 -0.707 . . . . 1.0900000000000001 110.854 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -41.45 86.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.192 0.52 . . . . 2.0699999999999998 109.699 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.892 ' HA3' ' HB2' ' A' ' 88' ' ' LEU . . . -70.16 -32.13 69.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.71999999999999997 111.545 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.63 -51.09 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.84999999999999998 110.354 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.47 67.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 1.1399999999999999 111.677 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -93.27 -77.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 1.8200000000000001 110.735 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.19 -64.8 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.62 -0.592 . . . . 1.6499999999999999 111.62 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.781 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -121.99 155.56 35.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.649 -0.5 . . . . 3.5 109.649 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.892 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 2.4 tm? -135.1 104.34 5.89 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.277 -0.638 . . . . 2.96 109.277 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 110' ' ' LYS . 25.5 m-80 -133.28 93.98 3.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.805 -0.813 . . . . 2.2400000000000002 108.805 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.425 ' O ' ' HD2' ' A' ' 108' ' ' HIS . 33.9 p -134.24 164.07 28.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.221 -0.899 . . . . 1.6299999999999999 110.882 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.8 ptt? -132.89 109.0 9.3 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.644 -0.707 . . . . 1.77 109.66 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -104.62 155.53 18.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.012 -0.995 . . . . 3.0099999999999998 109.818 -172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -117.57 111.7 19.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.047 -0.353 . . . . 2.3900000000000001 110.047 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.503 ' HE1' ' HG3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -163.87 168.6 19.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.367 -0.379 . . . . 3.3700000000000001 110.285 -177.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.4 ' H ' ' HD2' ' A' ' 94' ' ' TYR . 12.4 t -102.92 153.25 20.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.161 -0.472 . . . . 1.3999999999999999 110.565 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.925 ' HB3' " H6'" ' A' ' 169' ' ' HC4 . 81.9 m-85 -114.9 103.24 10.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.759 -0.83 . . . . 1.1799999999999999 108.759 174.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -114.69 112.92 23.61 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.617 -0.72 . . . . 2.5699999999999998 111.078 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -174.2 -80.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 3.21 109.821 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.471 ' NE2' " H2'" ' A' ' 169' ' ' HC4 . 12.4 pt20 -94.81 -41.48 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 3.23 109.433 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 53.2 ttp -80.9 124.96 29.54 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.708 -0.849 . . . . 2.8500000000000001 108.708 171.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.8 m -56.89 120.07 35.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.619 -0.512 . . . . 2.1200000000000001 109.619 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -24.33 91.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 1 C-N-CA 125.345 4.03 . . . . 1.47 114.978 -170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -108.81 144.82 36.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.896 -0.779 . . . . 1.3999999999999999 108.896 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -104.16 122.43 45.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.069 0.462 . . . . 3.0800000000000001 109.992 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 124' ' ' ARG . 27.1 m -124.74 166.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.583 -0.735 . . . . 1.3300000000000001 110.321 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -103.95 117.33 34.05 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.682 -1.229 . . . . 1.6899999999999999 107.682 170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 91' ' ' MET . 6.8 p -104.21 119.36 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.899 0.856 . . . . 1.27 110.402 -170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 t-160 -103.6 105.3 15.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.006 -0.997 . . . . 1.02 109.362 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 57.5 tpp -103.9 123.54 47.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.713 -1.218 . . . . 2.4900000000000002 107.713 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.526 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 13.2 ptmm? -143.39 147.07 34.07 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.959 -0.696 . . . . 1.5700000000000001 111.033 -172.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.781 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 37.1 tttp -81.52 146.09 30.36 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.019 -0.537 . . . . 2.1299999999999999 111.217 -171.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.77 38.47 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.518 -0.919 . . . . 1.5700000000000001 108.518 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.77 -112.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.381 -0.528 . . . . 4.4100000000000001 110.732 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m 52.95 37.23 23.98 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.504 0.668 . . . . 2.5499999999999998 109.484 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.57 -90.7 0.55 Allowed Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.896 -1.282 . . . . 2.6200000000000001 109.896 -169.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -178.22 88.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.672 -0.862 . . . . 2.7599999999999998 108.672 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.0 p -135.95 -178.19 5.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.921 -0.581 . . . . 1.0700000000000001 111.503 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 88' ' ' LEU . 97.1 m-85 -131.31 144.33 51.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.564 -0.532 . . . . 0.85999999999999999 109.564 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 32.9 m95 -102.58 107.43 18.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.568 -0.901 . . . . 0.63 108.568 174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.9 p -100.37 142.77 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.784 -0.766 . . . . 0.91000000000000003 111.319 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.07 123.9 28.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.426 -0.807 . . . . 0.79000000000000004 109.725 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 m -105.01 103.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.429 0.633 . . . . 1.1799999999999999 111.31 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -104.42 121.42 43.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 3.3100000000000001 109.889 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.914 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -59.18 140.75 55.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.834 0.35 . . . . 4.0300000000000002 111.093 -179.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.766 -0.635 . . . . 2.8700000000000001 109.518 177.223 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.925 " H6'" ' HB3' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_